Citrus Sinensis ID: 026042
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 244 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.827 | 0.517 | 0.668 | 3e-81 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.778 | 0.207 | 0.465 | 2e-46 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.864 | 0.157 | 0.404 | 3e-42 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.856 | 0.162 | 0.427 | 1e-41 | |
| Q9NYL2 | 800 | Mitogen-activated protein | no | no | 0.803 | 0.245 | 0.38 | 5e-40 | |
| Q9ESL4 | 802 | Mitogen-activated protein | no | no | 0.803 | 0.244 | 0.38 | 6e-40 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.836 | 0.317 | 0.423 | 7e-40 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.790 | 0.167 | 0.429 | 5e-39 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.786 | 0.278 | 0.433 | 6e-39 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.733 | 0.134 | 0.4 | 5e-38 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 301 bits (770), Expect = 3e-81, Method: Compositional matrix adjust.
Identities = 135/202 (66%), Positives = 168/202 (83%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF+AACKKPPV+CIITEY++ G+LR YL+++EPYS+ + VL+LALDI+RGM+YLHSQG
Sbjct: 148 VQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQG 207
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
++HRDLKS NLLL ++M VKVADFG SCLE+QC AKG GTYRWMAPEMIKEK +T+KV
Sbjct: 208 VIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMIKEKPYTRKV 267
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWEL TAL PF MTP QAAFAV +KN RPP+P +C A ++LI RCWS +P
Sbjct: 268 DVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQPALAHLIKRCWSENP 327
Query: 181 DRRPHFDQIVSILEGYSESLEQ 202
+RP F IV++LE Y E +++
Sbjct: 328 SKRPDFSNIVAVLEKYDECVKE 349
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 2e-46, Method: Composition-based stats.
Identities = 89/191 (46%), Positives = 122/191 (63%), Gaps = 1/191 (0%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 62
+AAC PP C ITEYL GGSL LH ++ + + L KLA+ IA+GM YLH G++
Sbjct: 723 LMAACTAPPNLCFITEYLPGGSLYDALHSKK-IKMNMQLYKKLAIQIAQGMNYLHLSGVI 781
Query: 63 HRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 122
HRD+KS NLLL E M VK+ DFG+S L+S+ G+ WM+PE++ + +T+KVDV
Sbjct: 782 HRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPELLMGEDYTEKVDV 841
Query: 123 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 182
Y+FGI+LWEL T P+ + Q A AV K+ RPP+P P S+LI CW P +
Sbjct: 842 YAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLK 901
Query: 183 RPHFDQIVSIL 193
RP F +I+++L
Sbjct: 902 RPSFTEILNLL 912
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 3e-42, Method: Composition-based stats.
Identities = 87/215 (40%), Positives = 129/215 (60%), Gaps = 4/215 (1%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ F+ AC PP CI TEYL GGSL LH Q+ PL ++ K+ D++ GM++LHS
Sbjct: 1113 VTFMGACIDPP--CIFTEYLQGGSLYDVLHIQKIKLNPL-MMYKMIHDLSLGMEHLHSIQ 1169
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
+LHRDL S+N+LL E +K+ADFG++ S + G T RW +PE+ K + +KV
Sbjct: 1170 MLHRDLTSKNILLDEFKNIKIADFGLATTLSDDMTLSGITNP-RWRSPELTKGLVYNEKV 1228
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFG+V++E+ T PF+ + +A +N RP +PP CP + LI++CW+S P
Sbjct: 1229 DVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLITKCWASDP 1288
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPD 215
+RP F +I++ LE + F + I +PD
Sbjct: 1289 SQRPSFTEILTELETMKSKFIKQLSFLNDLIQNPD 1323
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (429), Expect = 1e-41, Method: Composition-based stats.
Identities = 92/215 (42%), Positives = 131/215 (60%), Gaps = 6/215 (2%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-- 60
F+ AC +P CI+TEYL+ GSL L E + L L+L D ARGM YLHS+
Sbjct: 911 FMGACTEPSSPCIVTEYLSRGSLANIL-LDESIEMDWGLRLQLGFDCARGMTYLHSRNPI 969
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
I+HRDLK++NLL+ + VKVADFG++ ++S AK GT W+APE++ E+ +T+K
Sbjct: 970 IIHRDLKTDNLLVDDSWQVKVADFGLATVKSHT-FAKTMCGTTGWVAPEVLAEEGYTEKA 1028
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYS+ IVLWELLT L P+ Q ++ + R P+P CP ++ L++RCW + P
Sbjct: 1029 DVYSYAIVLWELLTRLIPYAGKNTMQVVRSI-DRGERLPMPAWCPPKYAALMNRCWETDP 1087
Query: 181 DRRPHFDQIVSILEGY-SESLEQDPEFFSSFIPSP 214
RP F +I+ I+EG SE ++ E + P P
Sbjct: 1088 THRPSFPEILPIMEGMISEFQKEKKESIAQGRPIP 1122
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NYL2|MLTK_HUMAN Mitogen-activated protein kinase kinase kinase MLT OS=Homo sapiens GN=MLTK PE=1 SV=3 | Back alignment and function description |
|---|
Score = 164 bits (415), Expect = 5e-40, Method: Compositional matrix adjust.
Identities = 76/200 (38%), Positives = 121/200 (60%), Gaps = 4/200 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF +PP + I+TEY + GSL Y++ + ++ ++ A D+A+GM YLH +
Sbjct: 66 IQFYGVILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMDHIMTWATDVAKGMHYLHMEA 125
Query: 61 ---ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
++HRDLKS N+++ D +K+ DFG S + + GT+ WMAPE+I+ +
Sbjct: 126 PVKVIHRDLKSRNVVIAADGVLKICDFGASRFHNHT-THMSLVGTFPWMAPEVIQSLPVS 184
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+ D YS+G+VLWE+LT PF + Q A+ V +KN R +P +CP++F+ L+ +CW
Sbjct: 185 ETCDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWE 244
Query: 178 SSPDRRPHFDQIVSILEGYS 197
+ +RP F QI+SILE S
Sbjct: 245 ADAKKRPSFKQIISILESMS 264
|
Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2. Isoform 1, but not isoform 2, causes cell shrinkage and disruption of actin stress fibers. Isoform 1 may have role in neoplastic cell transformation and cancer development. Isoform 1, but not isoform 2, phosphorylates histone H3 at 'Ser-28'. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9ESL4|MLTK_MOUSE Mitogen-activated protein kinase kinase kinase MLT OS=Mus musculus GN=Mltk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 6e-40, Method: Compositional matrix adjust.
Identities = 76/200 (38%), Positives = 120/200 (60%), Gaps = 4/200 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF +PP + I+TEY + GSL Y++ + + ++ A D+A+GM YLH +
Sbjct: 66 IQFYGVILEPPNYGIVTEYASLGSLYDYINSNRSEEMDMEHIMTWATDVAKGMHYLHMEA 125
Query: 61 ---ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
++HRDLKS N+++ D +K+ DFG S + + GT+ WMAPE+I+ +
Sbjct: 126 PVKVIHRDLKSRNVVIAADGVLKICDFGASRFHNHT-THMSLVGTFPWMAPEVIQSLPVS 184
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+ D YS+G+VLWE+LT PF + Q A+ V +KN R +P +CP++F+ L+ +CW
Sbjct: 185 ETCDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLHQCWE 244
Query: 178 SSPDRRPHFDQIVSILEGYS 197
+ +RP F QI+SILE S
Sbjct: 245 ADAKKRPSFKQIISILESMS 264
|
Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2. Isoform 1, but not isoform 2, phosphorylates histone H3 at 'Ser-28'. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 7e-40, Method: Compositional matrix adjust.
Identities = 88/208 (42%), Positives = 126/208 (60%), Gaps = 4/208 (1%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF+ +C PP CI TEY+ GSL LH Q + +L++K+ +D A+G+ YLH+
Sbjct: 432 IQFLGSCLIPPDICICTEYMPRGSLYSILHDQ-ALQLQWSLLIKMMIDAAKGVIYLHNST 490
Query: 61 --ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
ILHRDLKS NLL+ E+ VKVADFG+S +E Q G+ GT W +PE+++ +R+T+
Sbjct: 491 PVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCWTSPEVLRSQRYTE 549
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
K DVYSFGI+LWE T P+ + P Q FAV ++ RPPVP P + L+ C +
Sbjct: 550 KADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNE 609
Query: 179 SPDRRPHFDQIVSILEGYSESLEQDPEF 206
+P RP +Q + LE S D ++
Sbjct: 610 NPSHRPTMEQCLERLESIDSSGYSDLQY 637
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 161 bits (407), Expect = 5e-39, Method: Composition-based stats.
Identities = 89/207 (42%), Positives = 123/207 (59%), Gaps = 14/207 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQ------QEPYSVPLNLVLKLALDIARGMQ 54
+ F+ AC KP CIITEY+AGGSL LH + YS PL VLK+A D+A G+
Sbjct: 911 VMFIGACYKPA--CIITEYMAGGSLYNILHNPNSSTPKVKYSFPL--VLKMATDMALGLL 966
Query: 55 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWMAPEMI 111
+LHS I+HRDL S+N+LL E +K++DFG+S +S+ GS G RW PE+
Sbjct: 967 HLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTMTNGGICNPRWRPPELT 1026
Query: 112 KEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 170
K H ++KVDVY F +V+WE+LT PF ++ QA+ V RPP+P C
Sbjct: 1027 KNLGHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRPPIPEYCDPELKL 1086
Query: 171 LISRCWSSSPDRRPHFDQIVSILEGYS 197
L+++CW + P+ RP F IV+ L+ S
Sbjct: 1087 LLTQCWEADPNDRPPFTYIVNKLKEIS 1113
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (406), Expect = 6e-39, Method: Compositional matrix adjust.
Identities = 85/196 (43%), Positives = 120/196 (61%), Gaps = 4/196 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF+ +C P CI TEY+ GSL LH E + +LV ++ +D A+G+ YLH
Sbjct: 449 IQFLGSCLISPDICICTEYMPRGSLYSILHN-EKIKISWSLVKRMMIDAAKGIIYLHGST 507
Query: 61 --ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
ILHRDLKS NLL+ E+ VKVADFG+S +E Q G+ GT W +PE+++ +R+T+
Sbjct: 508 PVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQ-GATMTACGTPCWTSPEVLRSQRYTE 566
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
K DVYSFGI+LWE T P+ + P Q FAV ++ RPP P P + L+ C +
Sbjct: 567 KADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPTPKYGPPKYIQLLKDCLNE 626
Query: 179 SPDRRPHFDQIVSILE 194
+P +RP +Q + ILE
Sbjct: 627 NPSQRPTMEQCLEILE 642
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 5e-38, Method: Composition-based stats.
Identities = 74/185 (40%), Positives = 111/185 (60%), Gaps = 6/185 (3%)
Query: 14 CIITEYLAGGSLRKYLH-----QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68
CI+ E+L G+L + +H QQ+ + L+L +A DIARGMQ+LH++ I+HRDLKS
Sbjct: 1144 CIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAFDIARGMQHLHTRNIIHRDLKS 1203
Query: 69 ENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
NLL+ + +K+AD GI+ E+ GT W APE+++ + + +K DVYS+ IV
Sbjct: 1204 SNLLMDKHFNIKIADLGIA-RETSFTQTMTTIGTVAWTAPEILRHESYNQKADVYSYAIV 1262
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 188
L+ELLT P+ + P A V K RP +P C + L+ CWS P++RP F++
Sbjct: 1263 LYELLTGEEPYQGIPPMNAGILVASKGLRPELPDNCDPNWKKLVVWCWSEDPNKRPSFEE 1322
Query: 189 IVSIL 193
I + L
Sbjct: 1323 ITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 244 | ||||||
| 224119322 | 323 | predicted protein [Populus trichocarpa] | 0.930 | 0.702 | 0.867 | 1e-116 | |
| 297733791 | 302 | unnamed protein product [Vitis vinifera] | 0.930 | 0.751 | 0.863 | 1e-114 | |
| 147839113 | 741 | hypothetical protein VITISV_012751 [Viti | 0.930 | 0.306 | 0.854 | 1e-114 | |
| 449469533 | 361 | PREDICTED: serine/threonine-protein kina | 0.975 | 0.659 | 0.803 | 1e-112 | |
| 255540687 | 354 | protein with unknown function [Ricinus c | 0.967 | 0.666 | 0.855 | 1e-112 | |
| 357461999 | 387 | Fibroblast growth factor receptor [Medic | 0.975 | 0.614 | 0.806 | 1e-110 | |
| 356508663 | 357 | PREDICTED: serine/threonine-protein kina | 0.938 | 0.641 | 0.826 | 1e-110 | |
| 356565010 | 352 | PREDICTED: serine/threonine-protein kina | 0.922 | 0.639 | 0.831 | 1e-110 | |
| 356516676 | 357 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.967 | 0.661 | 0.802 | 1e-108 | |
| 356513323 | 352 | PREDICTED: serine/threonine-protein kina | 0.922 | 0.639 | 0.826 | 1e-108 |
| >gi|224119322|ref|XP_002318042.1| predicted protein [Populus trichocarpa] gi|222858715|gb|EEE96262.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 422 bits (1086), Expect = e-116, Method: Compositional matrix adjust.
Identities = 197/227 (86%), Positives = 212/227 (93%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ FVAACKKPPVFCIITEYLAGGSLRK+LHQQEPYSVPL+LVLKLALDIA GMQYLHSQG
Sbjct: 66 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPYSVPLDLVLKLALDIAHGMQYLHSQG 125
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDM VKVADFGISCLES CG+AKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 126 ILHRDLKSENLLLGEDMSVKVADFGISCLESHCGNAKGFTGTYRWMAPEMIKEKHHTKKV 185
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLTA+TPFDNMTPEQAAFAVCQKNARPP+PP CP AFS+LI+RCWSS+P
Sbjct: 186 DVYSFGIVLWELLTAMTPFDNMTPEQAAFAVCQKNARPPLPPKCPLAFSHLINRCWSSNP 245
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIA 227
D+RPHFDQIV+ILE YSESLEQD FF+S+ P+ +HTILRC P IA
Sbjct: 246 DKRPHFDQIVAILESYSESLEQDAGFFTSYKPTTNHTILRCFPKLIA 292
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733791|emb|CBI15038.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1070), Expect = e-114, Method: Compositional matrix adjust.
Identities = 196/227 (86%), Positives = 208/227 (91%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ FVAACKKPPVFCIITEYLAGGSLRK+LHQQEPYSVP +LVLK +LDIA GMQYLHSQG
Sbjct: 66 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPYSVPYDLVLKFSLDIACGMQYLHSQG 125
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDMCVKVADFGISCLE+QCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 126 ILHRDLKSENLLLGEDMCVKVADFGISCLETQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 185
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLTAL PFDNMTPEQAAFAV QKNARPP+ P CP AF +LISRCWSSS
Sbjct: 186 DVYSFGIVLWELLTALIPFDNMTPEQAAFAVSQKNARPPLDPACPMAFRHLISRCWSSSA 245
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIA 227
D+RPHFD+IVSILE YSES +QDP+FFSS+ PS DH LRCLP CIA
Sbjct: 246 DKRPHFDEIVSILESYSESFKQDPDFFSSYKPSDDHAFLRCLPKCIA 292
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147839113|emb|CAN68094.1| hypothetical protein VITISV_012751 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 416 bits (1069), Expect = e-114, Method: Compositional matrix adjust.
Identities = 194/227 (85%), Positives = 206/227 (90%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ FVAACKKPPVFCIITEYLAGGSLRK+LHQQEP SVP +LVLK +LDIA GMQYLHSQG
Sbjct: 505 ITFVAACKKPPVFCIITEYLAGGSLRKFLHQQEPXSVPYDLVLKFSLDIACGMQYLHSQG 564
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDMCVKVADFGISCLE+QCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 565 ILHRDLKSENLLLGEDMCVKVADFGISCLETQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 624
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLTAL PFDNMTPEQ AFAV QKNARPP+ P CP AF +LISRCWSSS
Sbjct: 625 DVYSFGIVLWELLTALIPFDNMTPEQXAFAVSQKNARPPLDPACPMAFRHLISRCWSSSA 684
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIA 227
D+RPHFD+IVSILE YSES +QDP+FFSS+ PS DH LRCLP CIA
Sbjct: 685 DKRPHFDEIVSILESYSESFKQDPDFFSSYKPSDDHAFLRCLPKCIA 731
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469533|ref|XP_004152474.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] gi|449487764|ref|XP_004157789.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1053), Expect = e-112, Method: Compositional matrix adjust.
Identities = 192/239 (80%), Positives = 209/239 (87%), Gaps = 1/239 (0%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ F+AACKKPPVFCIITEY+ GGSLRKYLHQQEP+SVPLNLVLKLALDI+RGMQYLHSQG
Sbjct: 119 ITFIAACKKPPVFCIITEYMTGGSLRKYLHQQEPHSVPLNLVLKLALDISRGMQYLHSQG 178
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 238
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLTALTPFDN+TPEQAAFAVCQKNARPP+P CP+AF +LI RCWS P
Sbjct: 239 DVYSFGIVLWELLTALTPFDNLTPEQAAFAVCQKNARPPLPSACPQAFRHLIKRCWSKKP 298
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTI-LRCLPTCIARHCCAHSKAKE 238
D+RPHFD+IVSILE Y ES +DPEFF ++PS I +CLP CI + A K +
Sbjct: 299 DKRPHFDEIVSILETYVESYNEDPEFFCHYVPSSSRYIAWKCLPKCITKQSSASLKPRN 357
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540687|ref|XP_002511408.1| protein with unknown function [Ricinus communis] gi|223550523|gb|EEF52010.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 409 bits (1050), Expect = e-112, Method: Compositional matrix adjust.
Identities = 202/236 (85%), Positives = 219/236 (92%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ FVAACKK PV+CIITEYLAGGSLRKYLHQQEP+SVPLNLVLKLA+DIARGMQYLHSQG
Sbjct: 119 ITFVAACKKTPVYCIITEYLAGGSLRKYLHQQEPHSVPLNLVLKLAIDIARGMQYLHSQG 178
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 179 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 238
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP+PP CP AFS+LI+RCWSS+P
Sbjct: 239 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPLPPACPPAFSHLINRCWSSNP 298
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKA 236
D+RPHFD+IV+ILE Y+ESLEQDPEFFS++ P H+ILRC P C A +C + KA
Sbjct: 299 DKRPHFDEIVAILEIYTESLEQDPEFFSNYKPHSGHSILRCFPICRAGNCYSSVKA 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461999|ref|XP_003601281.1| Fibroblast growth factor receptor [Medicago truncatula] gi|355490329|gb|AES71532.1| Fibroblast growth factor receptor [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 403 bits (1036), Expect = e-110, Method: Compositional matrix adjust.
Identities = 192/238 (80%), Positives = 211/238 (88%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ F+AACKKPPVFCIITEYLAGGSLRKYLHQQEP+SVP LVLKLALDIARGM+YLHSQG
Sbjct: 150 LTFIAACKKPPVFCIITEYLAGGSLRKYLHQQEPHSVPHELVLKLALDIARGMKYLHSQG 209
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLL EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI+EK HTKKV
Sbjct: 210 ILHRDLKSENLLLDEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIREKHHTKKV 269
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLTAL PFDNMTPEQAAFAV KNARPP+P CP AFS LI+RCWSS+P
Sbjct: 270 DVYSFGIVLWELLTALIPFDNMTPEQAAFAVSYKNARPPLPSECPWAFSNLINRCWSSNP 329
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTCIARHCCAHSKAKE 238
++RPHF +IVSILE ++ESLE DP+FF+++ P P +TIL CLP C AR KAK+
Sbjct: 330 NKRPHFVEIVSILECFTESLELDPDFFTTYKPRPINTILGCLPKCKARQKSDTCKAKQ 387
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508663|ref|XP_003523074.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1034), Expect = e-110, Method: Compositional matrix adjust.
Identities = 191/231 (82%), Positives = 208/231 (90%), Gaps = 2/231 (0%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ F+AACKKPPVFCIITEYLAGGSL K+LH Q+P +PL LVLKLALDIARGM+YLHSQG
Sbjct: 120 ITFIAACKKPPVFCIITEYLAGGSLGKFLHHQQPNILPLKLVLKLALDIARGMKYLHSQG 179
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK HTKKV
Sbjct: 180 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKHHTKKV 239
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLT TPFDNMTPEQAA+AV KNARPP+P CP AFS LI+RCWSS+P
Sbjct: 240 DVYSFGIVLWELLTGKTPFDNMTPEQAAYAVSHKNARPPLPSKCPWAFSDLINRCWSSNP 299
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP--DHTILRCLPTCIARH 229
D+RPHFD+IVSILE Y+ESL+QDPEFFS++ PSP +TIL CLP C ARH
Sbjct: 300 DKRPHFDEIVSILEYYTESLQQDPEFFSTYKPSPTSSNTILGCLPKCNARH 350
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565010|ref|XP_003550738.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1034), Expect = e-110, Method: Compositional matrix adjust.
Identities = 187/225 (83%), Positives = 207/225 (92%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ FVAACKKPPVFCIITEYL+GGSLRKYL Q+ P+SVPL +VLKLALDIARGMQYLHSQG
Sbjct: 119 ITFVAACKKPPVFCIITEYLSGGSLRKYLVQEGPHSVPLRVVLKLALDIARGMQYLHSQG 178
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGED+CVKVADFGISCLESQ GSAKGFTGTYRWMAPEMIKEKRHTKKV
Sbjct: 179 ILHRDLKSENLLLGEDLCVKVADFGISCLESQTGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSF IVLWELLT LTPFDNMTPEQAA+AV KN RPP+P CPKAFS+LI+RCWSS+P
Sbjct: 239 DVYSFAIVLWELLTGLTPFDNMTPEQAAYAVTHKNERPPLPCDCPKAFSHLINRCWSSNP 298
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTC 225
D+RPHFD+IV+ILE Y+E+LEQDPEFFS++ P P++ ILRCL C
Sbjct: 299 DKRPHFDEIVAILESYTEALEQDPEFFSTYKPCPNNIILRCLSKC 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516676|ref|XP_003527019.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1023), Expect = e-108, Method: Compositional matrix adjust.
Identities = 191/238 (80%), Positives = 208/238 (87%), Gaps = 2/238 (0%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ F+AACKKPPVFCIITEYLAGGSL K+LH Q+P +PL LVLKLALDIARGM+YLHSQG
Sbjct: 120 ITFIAACKKPPVFCIITEYLAGGSLGKFLHHQQPNILPLKLVLKLALDIARGMKYLHSQG 179
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG TGTYRWMAPEMIKEK HTKKV
Sbjct: 180 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGXTGTYRWMAPEMIKEKHHTKKV 239
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWELLT TPFDNMTPEQAA+AV KNARPP+P CP AFS LI+RCWSS+P
Sbjct: 240 DVYSFGIVLWELLTGKTPFDNMTPEQAAYAVSHKNARPPLPSECPWAFSDLINRCWSSNP 299
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP--DHTILRCLPTCIARHCCAHSKA 236
D+RPHFD+IVSILE Y+ESL+QDPEFFS++ PSP +TIL C P C ARH KA
Sbjct: 300 DKRPHFDEIVSILEYYTESLQQDPEFFSTYKPSPSSSNTILGCFPKCNARHKFGACKA 357
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513323|ref|XP_003525363.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 398 bits (1022), Expect = e-108, Method: Compositional matrix adjust.
Identities = 186/225 (82%), Positives = 204/225 (90%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ FVAACKKPPVFCIITEYLAGGSLRKYL QQ P+SV +VLKLALDIARGMQYLHSQG
Sbjct: 119 ITFVAACKKPPVFCIITEYLAGGSLRKYLVQQGPHSVTHKVVLKLALDIARGMQYLHSQG 178
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
ILHRDLKSENLLLGED+CVKVADFGISCLESQ GSAKGFTGTYRWMAPEMIKEKRHTKKV
Sbjct: 179 ILHRDLKSENLLLGEDLCVKVADFGISCLESQTGSAKGFTGTYRWMAPEMIKEKRHTKKV 238
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSF IVLWELLT LTPFDNMTPEQAA+AV KN RPP+P CPKAFS+LI+RCWSS+P
Sbjct: 239 DVYSFAIVLWELLTGLTPFDNMTPEQAAYAVTHKNERPPLPCDCPKAFSHLINRCWSSNP 298
Query: 181 DRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPTC 225
D+RPHF++IV+ILE Y E+LEQDPEFFS++ P P++ ILRCL C
Sbjct: 299 DKRPHFNEIVTILESYIEALEQDPEFFSTYKPRPNNIILRCLSKC 343
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 244 | ||||||
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.831 | 0.386 | 0.541 | 3.1e-60 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.795 | 0.472 | 0.525 | 1.8e-55 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.795 | 0.470 | 0.525 | 9.9e-55 | |
| TAIR|locus:2102802 | 475 | AT3G46930 [Arabidopsis thalian | 0.811 | 0.416 | 0.492 | 1.3e-50 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.827 | 0.351 | 0.468 | 2.9e-48 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.786 | 0.351 | 0.482 | 2.6e-47 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.782 | 0.335 | 0.453 | 7.1e-45 | |
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.831 | 0.609 | 0.464 | 4.5e-43 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.795 | 0.560 | 0.473 | 1.2e-42 | |
| TAIR|locus:2077244 | 391 | ATMRK1 [Arabidopsis thaliana ( | 0.762 | 0.475 | 0.427 | 2.5e-42 |
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 110/203 (54%), Positives = 149/203 (73%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++FV A K PPV+C++T+YL GSLR +LH+ E S+PL +++ A+DIARGM+Y+HS+
Sbjct: 271 IKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHSRR 330
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
I+HRDLK EN+L+ E+ +K+ADFGI+C E C GTYRWMAPEMIK K H +K
Sbjct: 331 IIHRDLKPENVLIDEEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEMIKRKPHGRKA 390
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFG+VLWE++ P+++M P QAAFAV KN RP +P CP A LI +CWS +P
Sbjct: 391 DVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKALIEQCWSVAP 450
Query: 181 DRRPHFDQIVSILEGYSESLEQD 203
D+RP F QIV +LE ++ SLE++
Sbjct: 451 DKRPEFWQIVKVLEQFAISLERE 473
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
Identities = 102/194 (52%), Positives = 142/194 (73%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++F+ AC+KP V+CI+TEY GGS+R++L +++ +VPL L +K ALD+ARGM Y+H +
Sbjct: 192 VRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGMAYVHGRN 251
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
+HRDLKS+NLL+ D +K+ADFG++ +E Q TGTYRWMAPEMI+ + + +KV
Sbjct: 252 FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRAYNQKV 311
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWEL+T L PF NMT QAAFAV + RP VP C S +++RCW ++P
Sbjct: 312 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPNDCLPVLSDIMTRCWDANP 371
Query: 181 DRRPHFDQIVSILE 194
+ RP F ++V +LE
Sbjct: 372 EVRPCFVEVVKLLE 385
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 9.9e-55, P = 9.9e-55
Identities = 102/194 (52%), Positives = 140/194 (72%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++F+ AC KP V+CI+TEY GGS+R++L +++ +VPL L + ALD+ARGM Y+H +
Sbjct: 193 VRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERN 252
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
+HRDLKS+NLL+ D +K+ADFG++ +E Q TGTYRWMAPEMI+ + +T+KV
Sbjct: 253 FIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 312
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
DVYSFGIVLWEL+T L PF NMT QAAFAV + RP VP C +++RCW + P
Sbjct: 313 DVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADP 372
Query: 181 DRRPHFDQIVSILE 194
+ RP F +IV++LE
Sbjct: 373 EVRPCFAEIVNLLE 386
|
|
| TAIR|locus:2102802 AT3G46930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 526 (190.2 bits), Expect = 1.3e-50, P = 1.3e-50
Identities = 99/201 (49%), Positives = 134/201 (66%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
CIITEY+ GSLR YLH+ E S+PL ++ LDIA+GM+Y+HS+ I+H+DLK EN+L+
Sbjct: 235 CIITEYVPRGSLRSYLHKLEQKSLPLEQLIDFGLDIAKGMEYIHSREIVHQDLKPENVLI 294
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D +K+ADFGI+C E C GTYRWMAPE++K H +K DVYSFG++LWE++
Sbjct: 295 DNDFHLKIADFGIACEEEYCDVLGDNIGTYRWMAPEVLKRIPHGRKCDVYSFGLLLWEMV 354
Query: 134 TALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192
P++ M EQ A+AV K RP +P CP A LI RCWSS D+RP F QIV +
Sbjct: 355 AGALPYEEMKFAEQIAYAVIYKKIRPVIPTDCPAAMKELIERCWSSQTDKRPEFWQIVKV 414
Query: 193 LEGYSESLEQDPEFFSSFIPS 213
LE + +SL + + + +PS
Sbjct: 415 LEHFKKSLTSEGKL--NLLPS 433
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
Identities = 97/207 (46%), Positives = 139/207 (67%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQ 59
+QF+ AC KPP CI+TE++ GGS+ YLH+Q+ + +P + K+A+DI +GM YLH
Sbjct: 348 VQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQKGVFKLPT--LFKVAIDICKGMSYLHQN 405
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
I+HRDLK+ NLL+ E+ VKVADFG++ +++Q G TGTYRWMAPE+I+ K + K
Sbjct: 406 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHK 465
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSS 178
DV+S+GIVLWELLT P++ MTP QAA V QK RP +P T PK + L+ R W
Sbjct: 466 ADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPK-LAELLERLWEH 524
Query: 179 SPDRRPHFDQIVSILEGYSESLEQDPE 205
+RP F +I+ L+ ++ + ++ E
Sbjct: 525 DSTQRPDFSEIIEQLQEIAKEVGEEGE 551
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 495 (179.3 bits), Expect = 2.6e-47, P = 2.6e-47
Identities = 94/195 (48%), Positives = 133/195 (68%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF+ AC + P CI+TE++A GS+ +LH+Q+ + L +LK+ALD+A+GM YLH
Sbjct: 344 VQFLGACTRSPTLCIVTEFMARGSIYDFLHKQK-CAFKLQTLLKVALDVAKGMSYLHQNN 402
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
I+HRDLK+ NLL+ E VKVADFG++ ++ + G TGTYRWMAPE+I+ K + K
Sbjct: 403 IIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKA 462
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSS 179
DV+S+ IVLWELLT P+ +TP QAA V QK RP +P T PK L+ RCW
Sbjct: 463 DVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKVKG-LLERCWHQD 521
Query: 180 PDRRPHFDQIVSILE 194
P++RP F++I+ +L+
Sbjct: 522 PEQRPLFEEIIEMLQ 536
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 7.1e-45, P = 7.1e-45
Identities = 88/194 (45%), Positives = 129/194 (66%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+QF+ AC + P CI+TE++ GS+ +LH+ + + +LK+ALD+++GM YLH
Sbjct: 350 VQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGV-FKIQSLLKVALDVSKGMNYLHQNN 408
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
I+HRDLK+ NLL+ E VKVADFG++ ++++ G TGTYRWMAPE+I+ K + +
Sbjct: 409 IIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRA 468
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSS 179
DV+S+ IVLWELLT P+ +TP QAA V QK RP +P T PK + L+ +CW
Sbjct: 469 DVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPK-LTELLEKCWQQD 527
Query: 180 PDRRPHFDQIVSIL 193
P RP+F +I+ +L
Sbjct: 528 PALRPNFAEIIEML 541
|
|
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 455 (165.2 bits), Expect = 4.5e-43, P = 4.5e-43
Identities = 99/213 (46%), Positives = 129/213 (60%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++F+ ACK P + I+TE L G SLRKYL P + L L L ALDIAR + LH+ G
Sbjct: 79 VKFIGACKDP-LMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIARALHCLHANG 137
Query: 61 ILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK------- 112
I+HRDLK +NLLL E+ VK+ADFG++ ES TGTYRWMAPE+
Sbjct: 138 IIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQG 197
Query: 113 EKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 171
EK+H KVDVYSFGIVLWELLT PF+ M+ QAA+A K RP +P + +++
Sbjct: 198 EKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPEGISPSLAFI 257
Query: 172 ISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 204
+ CW P+ RP F QI+ +L + +L P
Sbjct: 258 VQSCWVEDPNMRPSFSQIIRLLNEFLLTLTPPP 290
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 451 (163.8 bits), Expect = 1.2e-42, P = 1.2e-42
Identities = 97/205 (47%), Positives = 127/205 (61%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++F+ ACK+P V I+TE L GG+LRKYL P + + + ALDIARGM+ LHS G
Sbjct: 81 VKFIGACKEP-VMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIARGMECLHSHG 139
Query: 61 ILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM-------IK 112
I+HRDLK ENLLL D VK+ADFG++ ES TGTYRWMAPE+ +
Sbjct: 140 IIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTVTLRLG 199
Query: 113 EKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 171
EK+H KVD YSF IVLWELL PF+ M+ QAA+A KN RP + P+ +
Sbjct: 200 EKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSAE-SLPEELGDI 258
Query: 172 ISRCWSSSPDRRPHFDQIVSILEGY 196
++ CW+ P+ RP+F I+ +L Y
Sbjct: 259 VTSCWNEDPNARPNFTHIIELLLNY 283
|
|
| TAIR|locus:2077244 ATMRK1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 80/187 (42%), Positives = 128/187 (68%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C++ EY+AGG+L+K+L ++ +P+ V++LALD+ARG+ YLHS+ I+HRD+KSEN+LL
Sbjct: 182 CVVVEYVAGGTLKKFLIKKYRAKLPIKDVIQLALDLARGLSYLHSKAIVHRDVKSENMLL 241
Query: 74 GEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ +K+ADFG++ +E+Q G TGT +MAPE+++ K + +K DVYSFG+ LWE+
Sbjct: 242 QPNKTLKIADFGVARVEAQNPQDMTGETGTLGYMAPEVLEGKPYNRKCDVYSFGVCLWEI 301
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192
P+ + + + + AV +N RP +P CP A + ++ RCW +PDRRP +++V +
Sbjct: 302 YCCDMPYADCSFAEISHAVVHRNLRPEIPKCCPHAVANIMKRCWDPNPDRRPEMEEVVKL 361
Query: 193 LEGYSES 199
LE S
Sbjct: 362 LEAIDTS 368
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XII000286 | hypothetical protein (323 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 244 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-68 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-67 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-62 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-59 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-57 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-48 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-43 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-43 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-41 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-41 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-40 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-39 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-39 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-39 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-39 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-38 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-37 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-36 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-36 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-35 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-35 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-35 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-35 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-35 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-35 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-35 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-35 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-34 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-33 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-33 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-33 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-33 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-33 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-33 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-33 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-32 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-32 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-32 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-31 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-31 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-31 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-31 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-31 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-31 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-30 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-30 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-30 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-29 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-29 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-29 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-29 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-29 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-29 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-29 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-29 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-28 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-28 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-28 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-28 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-27 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-26 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-26 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-26 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-26 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-25 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-25 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-25 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-24 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-24 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-24 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-23 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-23 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-23 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-22 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-22 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-22 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-22 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-21 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-21 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-21 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-20 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-19 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-19 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-19 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-18 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-18 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-18 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-17 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-17 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-16 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-13 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-12 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 1e-68
Identities = 76/195 (38%), Positives = 112/195 (57%), Gaps = 4/195 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C + I+ EY+ GG L YL + P + L+ +L AL IARGM+YL S+
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL + N L+GE++ VK++DFG+S KG RWMAPE +KE + T K
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSK 184
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFG++LWE+ T P+ M+ + + +K R P PP CP L+ +CW+
Sbjct: 185 SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL-KKGYRLPKPPNCPPELYKLMLQCWAE 243
Query: 179 SPDRRPHFDQIVSIL 193
P+ RP F ++V IL
Sbjct: 244 DPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (528), Expect = 7e-67
Identities = 75/195 (38%), Positives = 112/195 (57%), Gaps = 5/195 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C + I+ EY+ GG L YL + P + L+ +L AL IARGM+YL S+
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLESKNF 123
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL + N L+GE++ VK++DFG+S +G RWMAPE +KE + T K
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSK 183
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFG++LWE+ T P+ M+ E+ + + R P PP CP L+ +CW+
Sbjct: 184 SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-KNGYRLPQPPNCPPELYDLMLQCWAE 242
Query: 179 SPDRRPHFDQIVSIL 193
P+ RP F ++V IL
Sbjct: 243 DPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 3e-62
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 20/203 (9%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C + I+TEY+ GG L +L + + L +L++AL IA+GM+YL S+
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----------RWMAPEMI 111
+HRDL + N L+ E++ VK++DFG+S Y +WMAPE +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLS-------RDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 112 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 170
K+ + T K DV+SFG++LWE+ T P+ M+ E+ + + R P P CP
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-EDGYRLPRPENCPDELYE 235
Query: 171 LISRCWSSSPDRRPHFDQIVSIL 193
L+ +CW+ P+ RP F ++V L
Sbjct: 236 LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-59
Identities = 73/204 (35%), Positives = 111/204 (54%), Gaps = 12/204 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY-------SVPLNLVLKLALDIARGMQ 54
+ + C + ++ EY+ GG L YL + P ++ L +L A+ IA+GM+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 55 YLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWMAPEMI 111
YL S+ +HRDL + N L+GED+ VK++DFG+S + TG RWMAPE +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 112 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 170
K+ T K DV+SFG++LWE+ T TP+ ++ E+ + +K R P P CP
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-RKGYRLPKPEYCPDELYE 238
Query: 171 LISRCWSSSPDRRPHFDQIVSILE 194
L+ CW P+ RP F ++V LE
Sbjct: 239 LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 3e-57
Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 4/191 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + ++ EY GG L L ++ + I ++YLHS+G
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRL--SEDEARFYLRQILSALEYLHSKG 117
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
I+HRDLK EN+LL ED VK+ADFG++ F GT +MAPE++ K + K V
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSS 178
D++S G++L+ELLT PF F K P PP LI +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 179 SPDRRPHFDQI 189
P++R ++
Sbjct: 238 DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-51
Identities = 72/199 (36%), Positives = 108/199 (54%), Gaps = 13/199 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + A + ++ EY GG L YL + P S + K+AL I RG++YLHS G
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS--EDEAKKIALQILRGLEYLHSNG 118
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKR-HT 117
I+HRDLK EN+LL E+ VK+ADFG++ +S S F GT +MAPE++ +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS------YL 171
KVDV+S G++L+ELLT PF + ++ PP+ PK S L
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 172 ISRCWSSSPDRRPHFDQIV 190
I +C + P +RP ++I+
Sbjct: 237 IKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-48
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 37/196 (18%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + ++ EY GGSL+ L + E + + +L++ L I G++YLHS G
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNG 112
Query: 61 ILHRDLKSENLLLGED-MCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRH-T 117
I+HRDLK EN+LL D VK+ADFG+S L S K GT +MAPE++ K + +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+K D++S G++L+EL LI +
Sbjct: 173 EKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQ 199
Query: 178 SSPDRRPHFDQIVSIL 193
P++RP +I+ L
Sbjct: 200 KDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 2e-43
Identities = 60/183 (32%), Positives = 93/183 (50%), Gaps = 4/183 (2%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
CI+ EY GG L + + +Q+ P +L + + ++YLHS+ ILHRD+K +N
Sbjct: 74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133
Query: 71 LLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+ L + VK+ DFGIS L S AK GT +++PE+ + K + K D++S G VL
Sbjct: 134 IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVL 193
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+EL T PF+ + A + + PP+P L+S P+ RP QI
Sbjct: 194 YELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
Query: 190 VSI 192
+
Sbjct: 253 LQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-43
Identities = 73/198 (36%), Positives = 111/198 (56%), Gaps = 4/198 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q A C + I+TEY++ GSL +L E + L ++ +A IA GM YL S+
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY 124
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL + N+L+GE++ K+ADFG++ L + + + +G +W APE R T K
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFGI+L E++T P+ MT + V ++ R P PP CP+ L+ +CW
Sbjct: 185 SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV-ERGYRMPRPPNCPEELYDLMLQCWDK 243
Query: 179 SPDRRPHFDQIVSILEGY 196
P+ RP F+ + S LE Y
Sbjct: 244 DPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-42
Identities = 71/193 (36%), Positives = 100/193 (51%), Gaps = 20/193 (10%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
IITEY+ GSL K+L + + LV + IA GM+YL +HRDL + N+L+
Sbjct: 82 IITEYMENGSLDKFLRENDGKFTVGQLV-GMLRGIASGMKYLSEMNYVHRDLAARNILVN 140
Query: 75 EDMCVKVADFGIS-CLESQCGSAKGFTGTY---------RWMAPEMIKEKRHTKKVDVYS 124
++ KV+DFG+S LE TY RW APE I ++ T DV+S
Sbjct: 141 SNLVCKVSDFGLSRRLED-------SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 125 FGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
FGIV+WE+++ P+ +M+ + AV + R P P CP A L+ CW + R
Sbjct: 194 FGIVMWEVMSYGERPYWDMSNQDVIKAV-EDGYRLPPPMDCPSALYQLMLDCWQKDRNER 252
Query: 184 PHFDQIVSILEGY 196
P F QIVS L+
Sbjct: 253 PTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 3e-41
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 8/181 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I EY++GGSL L + +P ++ K I G+ YLHS GI+HRD+K N+L
Sbjct: 76 LNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANIL 133
Query: 73 LGEDMCVKVADFGIS----CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
+ D VK+ADFG + +E+ G+ GT WMAPE+I+ + + + D++S G
Sbjct: 134 VDSDGVVKLADFGCAKRLGDIETGEGT-GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCT 192
Query: 129 LWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 187
+ E+ T P+ + AA + + P +P + + +C P +RP D
Sbjct: 193 VIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTAD 252
Query: 188 Q 188
+
Sbjct: 253 E 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-41
Identities = 71/200 (35%), Positives = 109/200 (54%), Gaps = 6/200 (3%)
Query: 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
+Q A C + P++ I+TE + GSL +YL ++ L ++ +A +A GM YL +Q
Sbjct: 64 IQLYAVCTLEEPIY-IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
+HRDL + N+L+GE+ KVADFG++ + E + +G +W APE R +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS 182
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K DV+SFGI+L E++T P+ MT + V + R P PP CPK ++ CW
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDIMLDCW 241
Query: 177 SSSPDRRPHFDQIVSILEGY 196
PD RP F+ + LE +
Sbjct: 242 KEDPDDRPTFETLQWKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 6e-41
Identities = 65/181 (35%), Positives = 98/181 (54%), Gaps = 4/181 (2%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+TEY+A GSL YL + + L L ALD+ GM+YL + +HRDL + N+L+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
ED+ KV+DFG++ SQ + +W APE ++EK+ + K DV+SFGI+LWE+ +
Sbjct: 137 EDLVAKVSDFGLAKEASQGQDSGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
Query: 135 -ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
P+ + + V +K R P CP ++ CW P +RP F Q+ L
Sbjct: 195 FGRVPYPRIPLKDVVPHV-EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
Query: 194 E 194
Sbjct: 254 A 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-40
Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+I EYL GSLR YL + + L +L + I +GM YL SQ +HRDL + N+L+
Sbjct: 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTY------RWMAPEMIKEKRHTKKVDVYSFGI 127
+ VK++DFG++ + + + W APE ++ + + DV+SFG+
Sbjct: 143 ESEDLVKISDFGLAKVLPE--DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGV 200
Query: 128 VLWELLTALTPF--------DNMTPEQAAFAVCQ------KNARPPVPPTCPKAFSYLIS 173
L+EL T P + Q V + + R P PP+CP L+
Sbjct: 201 TLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMK 260
Query: 174 RCWSSSPDRRPHFDQIVSILE 194
CW + P RP F ++ I++
Sbjct: 261 LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 3e-39
Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 5/195 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q C K I+TEY+A G L YL ++ + +L + D+ M+YL S G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL + N L+GED VKV+DFG++ L+ Q S++G +W PE+ R + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFG+++WE+ + P++ + + +V R P P ++ CW
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRPKLAPTEVYTIMYSCWHE 240
Query: 179 SPDRRPHFDQIVSIL 193
P+ RP F +++S L
Sbjct: 241 KPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-39
Identities = 66/192 (34%), Positives = 113/192 (58%), Gaps = 9/192 (4%)
Query: 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
+K P++ I+ E + GGSL +L +++ + + +L+++LD A GM+YL S+ +HRDL
Sbjct: 63 QKQPIY-IVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 68 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT----YRWMAPEMIKEKRHTKKVDVY 123
+ N L+GE+ +K++DFG+S E + G G +W APE + R+T + DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMS-REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 124 SFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 182
S+GI+LWE + TP+ M+ +Q + + R P P CP+ L+ +CW+ P+
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPEN 238
Query: 183 RPHFDQIVSILE 194
RP F +I + L+
Sbjct: 239 RPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-39
Identities = 69/196 (35%), Positives = 111/196 (56%), Gaps = 7/196 (3%)
Query: 5 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 64
A + P++ IITEY+ GSL +L E + +N ++ +A IA GM ++ + +HR
Sbjct: 68 AVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 65 DLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 122
DL++ N+L+ E +C K+ADFG++ L +++ + +G +W APE I T K DV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 123 YSFGIVLWELLT-ALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
+SFGI+L E++T P+ MT PE ++ R P P CP+ L+ CW P
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRMPRPDNCPEELYELMRLCWKEKP 244
Query: 181 DRRPHFDQIVSILEGY 196
+ RP F+ + S+LE +
Sbjct: 245 EERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-39
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEP-------YSVP-LNLVLKLALDIARGMQY 55
V + +P + ++ E +A G L+ YL + P P L +++A +IA GM Y
Sbjct: 77 VVSTGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134
Query: 56 LHSQGILHRDLKSENLLLGEDMCVKVADFG----ISCLESQCGSAKGFTGTYRWMAPEMI 111
L ++ +HRDL + N ++ ED+ VK+ DFG I + KG RWMAPE +
Sbjct: 135 LAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV-RWMAPESL 193
Query: 112 KEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 170
K+ T K DV+SFG+VLWE+ T A P+ ++ E+ V P CP
Sbjct: 194 KDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL-PENCPDKLLE 252
Query: 171 LISRCWSSSPDRRPHFDQIVSILE 194
L+ CW +P RP F +IVS L+
Sbjct: 253 LMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-38
Identities = 62/188 (32%), Positives = 95/188 (50%), Gaps = 3/188 (1%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ A C IITE + GSL +L E +P+ ++ +A +A GM YL Q
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL + N+L+GED+ KVADFG++ ++ + Y+W APE + K
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFGI+L+E+ T P+ M + R P P CP+ ++ CW++
Sbjct: 185 SDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAA 243
Query: 179 SPDRRPHF 186
P+ RP F
Sbjct: 244 EPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-37
Identities = 61/184 (33%), Positives = 105/184 (57%), Gaps = 10/184 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ E ++ G+L +L + V + +L+ +LD+A GM+YL S+ ++HRDL + N+L+
Sbjct: 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS 134
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
ED KV+DFG++ + S G + +W APE +K K+ + K DV+S+G++LWE
Sbjct: 135 EDGVAKVSDFGLARVGS-----MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWE 189
Query: 132 LLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
+ + P+ M+ ++ V +K R P CP L++ CW + P +RP F ++
Sbjct: 190 VFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLR 248
Query: 191 SILE 194
LE
Sbjct: 249 EKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-37
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 6/197 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + + PV+ I+ E G LR YL Q YS+ L ++ + ++ + YL S+
Sbjct: 70 VKLIGVITENPVW-IVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--RWMAPEMIKEKRHTK 118
+HRD+ + N+L+ CVK+ DFG+S K G +WMAPE I +R T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
DV+ FG+ +WE+L + PF + + R P+PP CP L+++CW+
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWA 246
Query: 178 SSPDRRPHFDQIVSILE 194
P +RP F ++ + L
Sbjct: 247 YDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 9e-37
Identities = 59/173 (34%), Positives = 92/173 (53%), Gaps = 4/173 (2%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
II EY GSLR+ + + P+ P +LV + +G+ YLH QG++HRD+K+ N+L
Sbjct: 74 LYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL 131
Query: 73 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D VK+ADFG++ L GT WMAPE+I+ + D++S G + E
Sbjct: 132 TTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIE 191
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
LLT P+ ++ P A F + Q + PP+P + +C+ P+ RP
Sbjct: 192 LLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQKDPNLRP 243
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-36
Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 8/175 (4%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I+ EY G L K L Q +P + V + + I G+ +LHS+ ILHRD+KS NL L
Sbjct: 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL 134
Query: 74 GEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
VK+ D G++ L A GT +++PE+ ++K + +K DV++ G+VL+E
Sbjct: 135 DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYEC 194
Query: 133 LTALTPFDNMTPEQAAFAVCQKNAR---PPVPPTCPKAFSYLISRCWSSSPDRRP 184
T PFD A+ K R PPV + + LI +C + +RP
Sbjct: 195 CTGKHPFD----ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-36
Identities = 73/192 (38%), Positives = 107/192 (55%), Gaps = 8/192 (4%)
Query: 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
K PV I+TEY+ GSL +L + + + LV L IA GM+YL G +HRDL
Sbjct: 76 KSKPVM-IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-GIASGMKYLSDMGYVHRDLA 133
Query: 68 SENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVY 123
+ N+L+ ++ KV+DFG+S LE +A G RW APE I ++ T DV+
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVW 193
Query: 124 SFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 182
S+GIV+WE+++ P+ M+ + A+ ++ R P P CP A L+ CW +
Sbjct: 194 SYGIVMWEVMSYGERPYWEMSNQDVIKAI-EEGYRLPAPMDCPAALHQLMLDCWQKDRNE 252
Query: 183 RPHFDQIVSILE 194
RP F+QIVSIL+
Sbjct: 253 RPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-35
Identities = 65/197 (32%), Positives = 108/197 (54%), Gaps = 5/197 (2%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 62
+ K+ P++ IITEY+A GSL +L E V L ++ + IA GM Y+ + +
Sbjct: 67 YAVVTKEEPIY-IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 63 HRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
HRDL++ N+L+ E + K+ADFG++ + +++ + +G +W APE I T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFGI+L+E++T P+ M+ A+ Q+ R P CP ++ CW
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDIMKTCWKEK 244
Query: 180 PDRRPHFDQIVSILEGY 196
+ RP FD + S+L+ +
Sbjct: 245 AEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-35
Identities = 57/176 (32%), Positives = 91/176 (51%), Gaps = 13/176 (7%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ EY GG L +L ++ +S A +I ++YLHS GI++RDLK EN+L
Sbjct: 68 LYLVLEYAPGGELFSHLSKEGRFSEER--ARFYAAEIVLALEYLHSLGIIYRDLKPENIL 125
Query: 73 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
L D +K+ DFG++ L S+ F GT ++APE++ K + K VD +S G++L+E
Sbjct: 126 LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRR 183
+LT PF ++ + +K + P P+ S LIS P +R
Sbjct: 186 MLTGKPPFYAEDRKE----IYEKILK--DPLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 36/216 (16%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYL--HQQEPYSVPLNL-------VLKLALDIARG 52
+ + C P C+I EY+ G L ++L H E + N +L +A IA G
Sbjct: 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG 142
Query: 53 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY--------- 103
M+YL S +HRDL + N L+G++ +K+ADFG+ S ++ Y
Sbjct: 143 MRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM--------SRNLYSSDYYRVQGRAPL 194
Query: 104 --RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPEQA---AFAVCQKNA 156
RWMA E + + T K DV++FG+ LWE+LT P++++T +Q A + +
Sbjct: 195 PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG 254
Query: 157 RP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
R P PP CPK L+ CW + RP F +I
Sbjct: 255 RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-35
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 9 KPPVFCIITEYLAGGSLRKYLH----QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 64
K P +I ++ G L +L P +PL +LK +DIA GM+YL ++ +HR
Sbjct: 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137
Query: 65 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKE 113
DL + N +L EDM V VADFG+ S K ++G Y +W+A E + +
Sbjct: 138 DLAARNCMLREDMTVCVADFGL--------SKKIYSGDYYRQGRIAKMPVKWIAIESLAD 189
Query: 114 KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 172
+ +T K DV++FG+ +WE+ T TP+ + + + N R P C L+
Sbjct: 190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDCLDELYDLM 248
Query: 173 SRCWSSSPDRRPHFDQIVSILE 194
CW + P RP F ++ +LE
Sbjct: 249 YSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-35
Identities = 66/197 (33%), Positives = 104/197 (52%), Gaps = 4/197 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q + C + P F IITE++ G+L YL + V ++L +A I+ M+YL +
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDL + N L+GE+ VKVADFG+S L + G +W APE + + +
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K DV++FG++LWE+ T ++P+ + Q + + +K R P CP L+ CW
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMERPEGCPPKVYELMRACWQ 243
Query: 178 SSPDRRPHFDQIVSILE 194
+P RP F +I E
Sbjct: 244 WNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-35
Identities = 69/199 (34%), Positives = 112/199 (56%), Gaps = 5/199 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q A + P++ I+TEY++ GSL +L E ++ L ++ +A +A GM Y+
Sbjct: 64 VQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDL+S N+L+G+ + K+ADFG++ L +++ + +G +W APE R T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K DV+SFGI+L EL+T P+ M + V ++ R P P CP + L+ +CW
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV-ERGYRMPCPQDCPISLHELMLQCWK 241
Query: 178 SSPDRRPHFDQIVSILEGY 196
P+ RP F+ + S LE Y
Sbjct: 242 KDPEERPTFEYLQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-35
Identities = 70/199 (35%), Positives = 113/199 (56%), Gaps = 5/199 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q A + P++ I+TEY++ GSL +L + + L ++ +A IA GM Y+
Sbjct: 64 VQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDL++ N+L+GE++ KVADFG++ L +++ + +G +W APE R T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K DV+SFGI+L EL T P+ M + V ++ R P PP CP++ L+ +CW
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWR 241
Query: 178 SSPDRRPHFDQIVSILEGY 196
P+ RP F+ + + LE Y
Sbjct: 242 KEPEERPTFEYLQAFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-35
Identities = 69/194 (35%), Positives = 105/194 (54%), Gaps = 10/194 (5%)
Query: 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
K PV IITE++ G+L +L Q + + LV L IA GM+YL +HRDL
Sbjct: 76 KSRPVM-IITEFMENGALDSFLRQNDGQFTVIQLVGMLR-GIAAGMKYLSEMNYVHRDLA 133
Query: 68 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY------RWMAPEMIKEKRHTKKVD 121
+ N+L+ ++ KV+DFG+S S +T + RW APE I ++ T D
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASD 193
Query: 122 VYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
V+S+GIV+WE+++ P+ +M+ + A+ +++ R P P CP A L+ CW
Sbjct: 194 VWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKDR 252
Query: 181 DRRPHFDQIVSILE 194
+ RP F QIVS L+
Sbjct: 253 NARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 8e-35
Identities = 69/185 (37%), Positives = 99/185 (53%), Gaps = 7/185 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
IITEY+ G+L KYL + LV L IA GM+YL +HRDL + N+L+
Sbjct: 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNYVHRDLAARNILVN 141
Query: 75 EDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
++ KV+DFG+S LE +G RW APE I ++ T DV+SFGIV+W
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201
Query: 131 ELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
E+++ P+ +M+ + A+ R P P CP A L+ +CW RRP F I
Sbjct: 202 EVMSFGERPYWDMSNHEVMKAI-NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260
Query: 190 VSILE 194
V++L+
Sbjct: 261 VNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-35
Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E+ +GGSL+ L + L + + ++ +G++YLHS GI+HRD+K+ N+L
Sbjct: 74 IVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANIL 130
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
L D VK+ DFG+S S + GT WMAPE+I K + K D++S GI EL
Sbjct: 131 LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAFS----YLISRCWSSSPDRRP 184
P+ + P +A F + PP P+ +S + +C +P++RP
Sbjct: 191 AEGKPPYSELPPMKALFKIATNG-----PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-34
Identities = 68/195 (34%), Positives = 110/195 (56%), Gaps = 5/195 (2%)
Query: 5 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 64
A + P++ I+TE++ GSL +L + + + L ++ +A IA GM Y+ +HR
Sbjct: 68 AVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 65 DLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 122
DL++ N+L+G+++ K+ADFG++ L +++ + +G +W APE R T K DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 123 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
+SFGI+L EL+T P+ M + V ++ R P P CP++ L+ CW PD
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPESLHELMKLCWKKDPD 245
Query: 182 RRPHFDQIVSILEGY 196
RP F+ I S LE Y
Sbjct: 246 ERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 59/184 (32%), Positives = 100/184 (54%), Gaps = 13/184 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ EY+ GGSL + V +N + + ++ +G++YLHSQ ++HRD+KS+N+L
Sbjct: 92 VVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNIL 148
Query: 73 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
L +D VK+ADFG + L + GT WMAPE+IK K + KVD++S GI+ E
Sbjct: 149 LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL----ISRCWSSSPDRRPHFD 187
+ P+ P +A F + K P P+ +S +++C P++RP +
Sbjct: 209 MAEGEPPYLREPPLRALFLITTK---GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAE 265
Query: 188 QIVS 191
+++
Sbjct: 266 ELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 9e-34
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGS----LRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 56
+Q++ I EY+ GGS LR Y +E LV + G+ YL
Sbjct: 71 VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ------LVRFFTEQVLEGLAYL 124
Query: 57 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKE 113
HS+GILHRDLK++NLL+ D K++DFGIS G+ WMAPE+I
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 114 KR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-----TCPK 166
++ KVD++S G V+ E+ P+ + A F + K + PP+PP P
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 167 AFSYLISRCWSSSPDRRP 184
A +L + C++ +PD RP
Sbjct: 245 ALDFL-NACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV------------------PLNLV--L 43
V A KP C++ EY+A G L ++L + P + PL+ L
Sbjct: 76 VCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133
Query: 44 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSAKGFT 100
+A +A GM YL + +HRDL + N L+GE+M VK+ADFG+S +++
Sbjct: 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDA 193
Query: 101 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 159
RWM PE I R+T + DV+++G+VLWE+ + + P+ M E+ + V N
Sbjct: 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL-S 252
Query: 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
P CP L+ CWS P RP F I IL+
Sbjct: 253 CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-33
Identities = 59/178 (33%), Positives = 95/178 (53%), Gaps = 4/178 (2%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
CI+ EY G L K + +++ + + ++ + + RG+Q LH Q ILHRDLKS N+
Sbjct: 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANI 134
Query: 72 LLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
LL + VK+ D GIS + + AK GT +MAPE+ K + ++ K D++S G +L+E
Sbjct: 135 LLVANDLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ T PF+ + + + V + PP+PP + I P RP+ D+I
Sbjct: 194 MATFAPPFEARSMQDLRYKVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-33
Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 6/194 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q+ + I EY+ GGS++ L + + K I G++YLHS
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE--TVTRKYTRQILEGVEYLHSNM 124
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGIS----CLESQCGSAKGFTGTYRWMAPEMIKEKRH 116
I+HRD+K N+L VK+ DFG S + S K TGT WM+PE+I + +
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
+K DV+S G + E+LT P+ A F + + P +P + R +
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244
Query: 177 SSSPDRRPHFDQIV 190
+ +RP ++++
Sbjct: 245 VENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 4 VAAC-KKPPVFCIITEYLAGGSLRKYLHQQEP------YSVPLNLVLKL--------ALD 48
+ C ++ P++ ++ EY A G+LR +L + P P L A
Sbjct: 82 LGVCTQEGPLY-VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TYRW 105
+ARGM++L S+ +HRDL + N+L+ ED +K+ADFG++ + T +W
Sbjct: 141 VARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKW 200
Query: 106 MAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 164
MAPE + ++ +T + DV+SFG++LWE+ T +P+ + E+ F + ++ R P C
Sbjct: 201 MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-LFKLLKEGYRMEKPQNC 259
Query: 165 PKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
+ +L+ CW P +RP F Q+V L+
Sbjct: 260 TQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-33
Identities = 64/193 (33%), Positives = 108/193 (55%), Gaps = 7/193 (3%)
Query: 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
++ + C ++ P++ I+ E + GG +L +++ + ++K ALD A GM YL S+
Sbjct: 55 VKLIGVCTQRQPIY-IVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESK 112
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGISCLESQ-CGSAKGFTGT-YRWMAPEMIKEKRHT 117
+HRDL + N L+GE+ +K++DFG+S E S+ G +W APE + R++
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
+ DV+S+GI+LWE + + P+ MT +QA V +K R P CP ++ RCW
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCW 231
Query: 177 SSSPDRRPHFDQI 189
P+ RP F ++
Sbjct: 232 DYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-33
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 25/200 (12%)
Query: 11 PVFCIITEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
P+ +I ++ G L +L +EP+++PL +++ +DIA GM+YL S+ +HRDL
Sbjct: 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDL 139
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKR 115
+ N +L E+M V VADFG+ S K ++G Y +W+A E + +
Sbjct: 140 AARNCMLNENMTVCVADFGL--------SKKIYSGDYYRQGCASKLPVKWLALESLADNV 191
Query: 116 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 174
+T DV++FG+ +WE++T TP+ + + + K R PP C + L+ +
Sbjct: 192 YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-IYNYLIKGNRLKQPPDCLEDVYELMCQ 250
Query: 175 CWSSSPDRRPHFDQIVSILE 194
CWS P RP F + LE
Sbjct: 251 CWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-33
Identities = 65/195 (33%), Positives = 111/195 (56%), Gaps = 5/195 (2%)
Query: 5 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHR 64
A K P++ IITE++A GSL +L E PL ++ + IA GM ++ + +HR
Sbjct: 68 AVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 65 DLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDV 122
DL++ N+L+ + K+ADFG++ + +++ + +G +W APE I T K DV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 123 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
+SFGI+L E++T P+ M+ + A+ ++ R P P CP+ ++ RCW + P+
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKNRPE 245
Query: 182 RRPHFDQIVSILEGY 196
RP F+ I S+L+ +
Sbjct: 246 ERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-33
Identities = 61/191 (31%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q C + C++ E++ G L YL Q +L + LD+ GM YL S
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN 120
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
++HRDL + N L+GE+ VKV+DFG++ L+ Q S+ G +W +PE+ +++
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA--RPPVPPTCPKAFSYLISRC 175
K DV+SFG+++WE+ + TP++N + + V NA R P ++ L+ C
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETINAGFRLYKPRLASQSVYELMQHC 237
Query: 176 WSSSPDRRPHF 186
W P+ RP F
Sbjct: 238 WKERPEDRPSF 248
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-33
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
CK P ++ E G L KYL ++ +P++ + +LA +A GM YL S+ +HRDL
Sbjct: 65 CKGEP-LMLVMELAPLGPLLKYL-KKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKR 115
+ N+LL K++DFG+S A G Y +W APE I +
Sbjct: 122 AARNVLLVNRHQAKISDFGMS-------RALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 116 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 174
+ K DV+S+G+ LWE + P+ M + A+ + R P P CP+ ++
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLS 233
Query: 175 CWSSSPDRRPHFDQIVSILEGYSE 198
CW P+ RP F ++ S E
Sbjct: 234 CWKYRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 64/200 (32%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
++ + C +K P++ I+ E + GG +L + P + + ++++ + A GM+YL S+
Sbjct: 56 VRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESK 113
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR-----WMAPEMIKEK 114
+HRDL + N L+ E +K++DFG+S E A TG + W APE +
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS--TGGMKQIPVKWTAPEALNYG 171
Query: 115 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 173
R++ + DV+SFGI+LWE + P+ N++ +Q A+ ++ R P P CP A L+
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLME 230
Query: 174 RCWSSSPDRRPHFDQIVSIL 193
RCW P +RP F + L
Sbjct: 231 RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 63/183 (34%), Positives = 100/183 (54%), Gaps = 8/183 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+TEY+A GSL YL + + + +LK +LD+ M+YL + +HRDL + N+L+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
ED KV+DFG+ ++ S+ TG +W APE ++EK+ + K DV+SFGI+LWE+
Sbjct: 137 EDNVAKVSDFGL----TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
Query: 133 LT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191
+ P+ + P + +K + P CP ++ +CW RP F Q+
Sbjct: 193 YSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251
Query: 192 ILE 194
LE
Sbjct: 252 QLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-32
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 7/198 (3%)
Query: 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
+Q C K+ P++ I+TEY++ G L YL + P L L++ D+ GM YL S+
Sbjct: 62 VQLYGVCTKQRPIY-IVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLESK 119
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
+HRDL + N L+ + CVKV+DFG+S L+ + S+ G RW PE++ + +
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K DV++FG+++WE+ + P++ + V Q R P + ++ CW
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLASEKVYAIMYSCW 238
Query: 177 SSSPDRRPHFDQIVSILE 194
+ RP F Q++S +E
Sbjct: 239 HEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-32
Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 7 CKKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLAL--DIARGMQYLHSQ 59
C++ +I EY G L+++L + PL+ K+AL IA GM +L +
Sbjct: 77 CREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA 136
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
+HRDL + N L+ VKV+ +S S+ + RW+APE ++E +
Sbjct: 137 RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS 196
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K DV+SFG+++WE+ T PF ++ E+ + PVP CP L++RCW
Sbjct: 197 TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCW 256
Query: 177 SSSPDRRPHFDQIVSILE 194
+ +P RP F ++VS L
Sbjct: 257 AVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 58/181 (32%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 15 IITEYLAGGSLR-------KYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
I+ EY GS+ K L ++E + +L L +G++YLHS +HRD+K
Sbjct: 75 IVMEYCGAGSVSDIMKITNKTLTEEE-----IAAILYQTL---KGLEYLHSNKKIHRDIK 126
Query: 68 SENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 126
+ N+LL E+ K+ADFG+S L GT WMAPE+I+E + K D++S G
Sbjct: 127 AGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG 186
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPP---VPPTCPKAFSYLISRCWSSSPDRR 183
I E+ P+ ++ P +A F + N PP P F+ + +C P+ R
Sbjct: 187 ITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER 244
Query: 184 P 184
P
Sbjct: 245 P 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 61/176 (34%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
II EY GGS L +P + + + ++ G++YLH +G +HRD+K+ N+LL
Sbjct: 76 IIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS 132
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
E+ VK+ADFG+S L S F GT WMAPE+IK+ + +K D++S GI EL
Sbjct: 133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSPDRRP 184
P ++ P + F + + N PP+ K F +S C + P RP
Sbjct: 193 KGEPPLSDLHPMRVLFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERP 243
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-31
Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----YS-----VPLNL-----VLKLA 46
+ + AC + +I EY + G+LR+YL + P Y VP ++ A
Sbjct: 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCA 146
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TY 103
+ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG++ K T
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFG++LWE+ T +P+ + P + F + ++ R P
Sbjct: 207 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLKEGHRMDKPS 265
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
C ++ CW + P +RP F Q+V L+
Sbjct: 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-31
Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 19/212 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----YSVPLNLV----------LKLA 46
+ + AC + +I EY + G+LR+YL + P YS + V +
Sbjct: 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCT 143
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TY 103
+ARGM+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K T
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFG+++WE+ T +P+ + P + F + ++ R P
Sbjct: 204 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPA 262
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
C ++ CW + P RP F Q+V L+
Sbjct: 263 NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 67/186 (36%), Positives = 94/186 (50%), Gaps = 21/186 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSV----PLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++ YL+GGSL + P + VLK L +G++YLHS G +HRD+K+ N
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNGQIHRDIKAGN 132
Query: 71 LLLGEDMCVKVADFGIS-CLE----SQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYS 124
+LLGED VK+ADFG+S L K F GT WMAPE++++ + K D++S
Sbjct: 133 ILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWS 192
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT------CPKAFSYLISRCWSS 178
FGI EL T P+ P + Q + PP T K+F +IS C
Sbjct: 193 FGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKYSKSFRKMISLCLQK 250
Query: 179 SPDRRP 184
P +RP
Sbjct: 251 DPSKRP 256
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-31
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL--------------VLKLA 46
+ + C + +I EY A G+LR++L + P ++ A
Sbjct: 81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TY 103
+ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG++ K +
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFGI++WE+ T +P+ + P + F + ++ R P
Sbjct: 201 KWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELFKLLREGHRMDKPS 259
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
C L+ CW + P +RP F Q+V L+
Sbjct: 260 NCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 8e-31
Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 23/193 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++TE GSL L + ++ + A+ IA GM+YL S+ +HRDL + N+LL
Sbjct: 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131
Query: 75 EDMCVKVADFGIS---CLESQCGSAKGFTGTYR----------WMAPEMIKEKRHTKKVD 121
D VK+ DFG+ Y W APE ++ + + D
Sbjct: 132 SDDKVKIGDFGLMRALPQNEDH---------YVMEEHLKVPFAWCAPESLRTRTFSHASD 182
Query: 122 VYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
V+ FG+ LWE+ T P+ ++ Q + ++ R P CP+ ++ +CW+ +P
Sbjct: 183 VWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNP 242
Query: 181 DRRPHFDQIVSIL 193
RP F + L
Sbjct: 243 ADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 9e-31
Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---EPYSV-----------------PLN 40
++ AC + +I EY GSLR +L + P + L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 41 L--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC----LESQCG 94
+ ++ A I+RGMQYL ++HRDL + N+L+ E +K++DFG+S +S
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 95 SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153
+KG +WMA E + + +T + DV+SFG++LWE++T P+ + PE+ F + +
Sbjct: 186 RSKGRIPV-KWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLLK 243
Query: 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
R P C + L+ CW PD+RP F I LE
Sbjct: 244 TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-31
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 4/195 (2%)
Query: 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 63
+ AC +ITEY G L +L ++ + L +L + +A+GM +L S+ +H
Sbjct: 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164
Query: 64 RDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKV 120
RDL + N+LL VK+ DFG++ + KG +WMAPE I +T +
Sbjct: 165 RDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 224
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+S+GI+LWE+ + P+ M + + + ++ R P P ++ CW +
Sbjct: 225 DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDAD 284
Query: 180 PDRRPHFDQIVSILE 194
P +RP F QIV ++
Sbjct: 285 PLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL--------------VLKLALDI 49
+ C K C++ EYLA G L ++L + P+S L +A+ I
Sbjct: 74 LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 50 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY------ 103
A GM+YL S +HRDL + N L+GE + VK++DFG+S ++ Y
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD--------IYSADYYRVQSK 185
Query: 104 -----RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157
RWM PE I + T + D++SFG+VLWE+ + L P+ + ++ + +
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-RSRQL 244
Query: 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
P P CP L+ CW+ P RRP F I
Sbjct: 245 LPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-30
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 25/200 (12%)
Query: 11 PVFCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
P +I ++ G L +L P +P +++K DIA GM+YL S+ +HRDL
Sbjct: 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDL 138
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKR 115
+ N +L E+M V VADFG+ S K + G Y +W+A E + ++
Sbjct: 139 AARNCMLNENMNVCVADFGL--------SKKIYNGDYYRQGRIAKMPVKWIAIESLADRV 190
Query: 116 HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 174
+T K DV+SFG+ +WE+ T TP+ + + + ++ R PP C L+S
Sbjct: 191 YTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSS 249
Query: 175 CWSSSPDRRPHFDQIVSILE 194
CW +P RP F+ + LE
Sbjct: 250 CWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 73/258 (28%), Positives = 123/258 (47%), Gaps = 25/258 (9%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----YS----------VPLNLVLKLA 46
+ + AC + ++ EY + G+LR+YL + P YS + ++ A
Sbjct: 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCA 140
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG---TY 103
+ARGM+YL SQ +HRDL + N+L+ ED +K+ADFG++ K T
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFG++LWE+ T +P+ + P + F + ++ R P
Sbjct: 201 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFKLLKEGHRMDKPA 259
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 222
C ++ CW + P +RP F Q+V L+ D E+ +P ++
Sbjct: 260 NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD-EYLDLSVPFEQYS----- 313
Query: 223 PTCIARHCCAHSKAKELF 240
P C S +F
Sbjct: 314 PGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-30
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 31/201 (15%)
Query: 15 IITEYLAGGSLRKYL-----HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69
I+ E +AGG L+ +L + P S+ + +L A D+A+G +YL +HRD+ +
Sbjct: 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAAR 145
Query: 70 NLLL---GEDMCVKVADFGISCLESQCGSAKGFTGT--YR----------WMAPEMIKEK 114
N LL G K+ADFG+ A+ YR WM PE +
Sbjct: 146 NCLLTCKGPGRVAKIADFGM---------ARDIYRASYYRKGGRAMLPIKWMPPEAFLDG 196
Query: 115 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 173
T K DV+SFG++LWE+ + P+ T ++ V R P CP +++
Sbjct: 197 IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG-GGRLDPPKGCPGPVYRIMT 255
Query: 174 RCWSSSPDRRPHFDQIVSILE 194
CW +P+ RP+F I+ ++
Sbjct: 256 DCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 3/177 (1%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I E + GGSL K L + + P+ + I G++YLH + +HRD+K N+L+
Sbjct: 78 YIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWEL 132
+ VK+ADFG++ + AK F G+ WMAPE+I ++ + D++S G + E+
Sbjct: 136 DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
T P+ + A F + + PP+P I +C P RP ++
Sbjct: 196 ATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 68/207 (32%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I EY+ GSLR YL + + + L +L A I GM YLHSQ +HRDL + N+LL
Sbjct: 85 LIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141
Query: 75 EDMCVKVADFGIS---------CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 125
D VK+ DFG++ + G + F W A E +KE + + DV+SF
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVECLKENKFSYASDVWSF 196
Query: 126 GIVLWELLTALTP-------FDNMT-PEQAAFAVC------QKNARPPVPPTCPKAFSYL 171
G+ L+ELLT F+ M P+Q V ++ R P P CP+ L
Sbjct: 197 GVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYIL 256
Query: 172 ISRCWSSSPDRRPHFDQIVSILEGYSE 198
+ CW + RP F ++ IL+
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 60/185 (32%), Positives = 99/185 (53%), Gaps = 12/185 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I EY+ GGS+ L+ Y + LV I +G+ YLH++GI+HRD+K N+L+
Sbjct: 83 IFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV 139
Query: 74 GEDMCVKVADFGISC-LESQCGSAK------GFTGTYRWMAPEMIKEKRHTKKVDVYSFG 126
+K++DFGIS LE+ S K G+ WMAPE++K+ +T+K D++S G
Sbjct: 140 DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186
++ E+LT PF + T QA F + + NA P +P + + + ++RP
Sbjct: 200 CLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTA 258
Query: 187 DQIVS 191
+++
Sbjct: 259 AELLK 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 11/182 (6%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLL 72
I+ EY+ GGSL L + +P ++ +A I +G+ YLH++ I+HRD+K NLL
Sbjct: 75 SIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132
Query: 73 LGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ VK+ADFGIS LE+ F GT +M+PE I+ + ++ D++S G+ L E
Sbjct: 133 INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
Query: 132 LLTALTPFDNMTPEQAAF-----AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186
PF P Q +F A+C F IS C P +RP
Sbjct: 193 CALGKFPFLP--PGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSA 250
Query: 187 DQ 188
+
Sbjct: 251 AE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-29
Identities = 66/190 (34%), Positives = 97/190 (51%), Gaps = 15/190 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS--------VPLNLVLKLALDIARGMQYLHSQGILHRDL 66
+I E + G L+ YL P L ++++A +IA GM YL++ +HRDL
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145
Query: 67 KSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDV 122
+ N ++ ED VK+ DFG++ E+ KG G RWM+PE +K+ T DV
Sbjct: 146 AARNCMVAEDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDV 204
Query: 123 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
+SFG+VLWE+ T A P+ M+ EQ V + P CP L+ CW +P
Sbjct: 205 WSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPK 263
Query: 182 RRPHFDQIVS 191
RP F +I+S
Sbjct: 264 MRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 61/189 (32%), Positives = 100/189 (52%), Gaps = 14/189 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ Y+ G LR ++ + +L+ L +A+GM+YL S+ +HRDL + N +L
Sbjct: 74 VVLPYMKHGDLRNFIRSETHNPTVKDLI-GFGLQVAKGMEYLASKKFVHRDLAARNCMLD 132
Query: 75 EDMCVKVADFGIS--CLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVL 129
E VKVADFG++ + + S TG +WMA E ++ ++ T K DV+SFG++L
Sbjct: 133 ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 192
Query: 130 WELLT-ALTPFDNMTPEQAAFAVCQ---KNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 185
WEL+T P+ P+ +F + + R P CP ++ CW P+ RP
Sbjct: 193 WELMTRGAPPY----PDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPT 248
Query: 186 FDQIVSILE 194
F ++VS +E
Sbjct: 249 FSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-29
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 7/174 (4%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLLLG 74
+ + L GG LR +L Q+ +S +K +I ++YLHS+GI+HRD+K +N+LL
Sbjct: 78 VVDLLLGGDLRYHLSQKVKFS---EEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
E V + DF I+ + +GT +MAPE++ + ++ VD +S G+ +E L
Sbjct: 135 EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194
Query: 135 ALTPFDN--MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186
P+ T A Q+ A P T I++ P +R
Sbjct: 195 GKRPYRGHSRTIRDQIRAK-QETADVLYPATWSTEAIDAINKLLERDPQKRLGD 247
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-29
Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS----------VPLNLVLKLALDIA 50
++ + C C+ITEY+ G L ++L Q+E S V + +L +A+ IA
Sbjct: 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY------- 103
GM+YL S +HRDL + N L+G +K+ADFG+ S ++G Y
Sbjct: 140 SGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM--------SRNLYSGDYYRIQGRA 191
Query: 104 ----RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT--PFDNMTPEQAA------FAV 151
RWMA E I + T DV++FG+ LWE+ T P+ ++ EQ F
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRN 251
Query: 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ P CP L+ RCWS RP F++I
Sbjct: 252 QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 27/204 (13%)
Query: 15 IITEYLAGGSLRKYLHQ------QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68
++ Y+ G+L+ +L Q P ++ ++ +A+ IA GM YLH +G++H+D+ +
Sbjct: 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAA 145
Query: 69 ENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-----------RWMAPEMIKEKRHT 117
N ++ E++ VK+ D + L S F Y +WMA E + K ++
Sbjct: 146 RNCVIDEELQVKITD---NAL-----SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS 197
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+SFG++LWEL+T TP+ + P + A A + R P CP +++ CW
Sbjct: 198 SASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELFAVMACCW 256
Query: 177 SSSPDRRPHFDQIVSILEGYSESL 200
+ P+ RP F Q+V L + L
Sbjct: 257 ALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-29
Identities = 70/229 (30%), Positives = 102/229 (44%), Gaps = 44/229 (19%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYL--HQQEPYSVPLN---------------LVL 43
++ + C C+ITEY+ G L ++L H + N +L
Sbjct: 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141
Query: 44 KLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY 103
+AL IA GM+YL S +HRDL + N L+GE++ +K+ADFG+ S + G Y
Sbjct: 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM--------SRNLYAGDY 193
Query: 104 -----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL--TPFDNMTPEQAA-- 148
RWMA E I + T DV++FG+ LWE+L P+ +T EQ
Sbjct: 194 YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
Query: 149 ----FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
F + PP CP+ L+ +CWS RP F I + L
Sbjct: 254 AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-28
Identities = 53/196 (27%), Positives = 97/196 (49%), Gaps = 5/196 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q C + I+TE++ G L YL Q++ +++L + D+ GM+YL
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSMCQDVCEGMEYLERNS 120
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDL + N L+ VKV+DFG++ L+ + S+ G +W PE+ +++
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K DV+SFG+++WE+ T PF+ + + + + R P ++ CW
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCWH 239
Query: 178 SSPDRRPHFDQIVSIL 193
P+ RP F +++ +
Sbjct: 240 EKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV----------PLNLV--LKLALD 48
++F C + ++ EY+ G L K+L P + L L L++A+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----- 103
IA GM YL SQ +HRDL + N L+G D+ VK+ DFG+ S +T Y
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM--------SRDVYTTDYYRVGG 182
Query: 104 ------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156
RWM PE I ++ T + DV+SFG+VLWE+ T P+ ++ E+ + Q
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRL 242
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
P TCP ++ CW P +R + I L+
Sbjct: 243 LQR-PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-28
Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------YSVPLNLVLKLALDIAR 51
++ +A C C+ITEY+ G L ++L + EP ++ + ++ +A IA
Sbjct: 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIAS 141
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY-------- 103
GM+YL S +HRDL + N L+G++ +K+ADFG+ S ++G Y
Sbjct: 142 GMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM--------SRNLYSGDYYRIQGRAV 193
Query: 104 ---RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL--TPFDNMTPEQAA------FAVC 152
RWM+ E I + T DV++FG+ LWE+LT P+ ++ EQ F
Sbjct: 194 LPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQ 253
Query: 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
+ P P CP + L+ CW + RP F +I + L
Sbjct: 254 GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 55/182 (30%), Positives = 95/182 (52%), Gaps = 6/182 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+IT+ + G L Y+ + L L + IA+GM YL + ++HRDL + N+L+
Sbjct: 84 QLITQLMPLGCLLDYVRNHKDNIGSQYL-LNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142
Query: 74 GEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
VK+ DFG++ L + + A+G +WMA E I + +T K DV+S+G+ +W
Sbjct: 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 131 ELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
EL+T P++ + P + +K R P PP C ++ +CW + RP F ++
Sbjct: 203 ELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261
Query: 190 VS 191
++
Sbjct: 262 IN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 65/185 (35%), Positives = 91/185 (49%), Gaps = 24/185 (12%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSV---PLN-----LVLKLALDIARGMQYLHSQGILHRDL 66
I+ EY GGSL Q+ Y V PL+ V + L +G+ YLH G +HRD+
Sbjct: 77 IVMEYCGGGSL------QDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETGKIHRDI 127
Query: 67 KSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKR---HTKKVDV 122
K N+LL ED VK+ADFG+S L + K F GT WMAPE+ +R + K D+
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187
Query: 123 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSS 179
++ GI EL P ++ P +A F + + N PP F I +C +
Sbjct: 188 WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKD 247
Query: 180 PDRRP 184
P +RP
Sbjct: 248 PKKRP 252
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-28
Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 15/193 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS-------VP-LNLVLKLALDIARGMQYLHSQGILHRDL 66
++ E +A G L+ YL P + P L ++++A +IA GM YL+++ +HRDL
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145
Query: 67 KSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDV 122
+ N ++ D VK+ DFG++ E+ KG G RWMAPE +K+ T D+
Sbjct: 146 AARNCMVAHDFTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDM 204
Query: 123 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
+SFG+VLWE+ + A P+ ++ EQ P CP+ + L+ CW +P
Sbjct: 205 WSFGVVLWEITSLAEQPYQGLSNEQ-VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPK 263
Query: 182 RRPHFDQIVSILE 194
RP F +IV++L+
Sbjct: 264 MRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-28
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I EY +GG+L + L + +++ L + G+ YLHS GI+HRD+K N+ L
Sbjct: 75 YIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132
Query: 74 GEDMCVKVADFGISCLESQCGSA-----KGFTGTYRWMAPEMIKEKR---HTKKVDVYSF 125
+ +K+ DFG + + + GT +MAPE+I + H + D++S
Sbjct: 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSL 192
Query: 126 GIVLWELLTALTPFDNMTPE-QAAFAVCQKNARPPVP------PTCPKAFSYLISRCWSS 178
G V+ E+ T P+ + E Q F V + +PP+P P K F + RC S
Sbjct: 193 GCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEG-KDF---LDRCLES 247
Query: 179 SPDRRP 184
P +RP
Sbjct: 248 DPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-28
Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 21/204 (10%)
Query: 5 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYS-----------VPLNL----VLKLALDI 49
++ PV C++ EYL G L ++L + P+S V +L L +A+ I
Sbjct: 75 VVTQEQPV-CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133
Query: 50 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM 106
A GM+YL S +H+DL + N+L+GE + VK++D G+S + + RWM
Sbjct: 134 AAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM 193
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
PE I + + D++SFG+VLWE+ + L P+ + Q + +K P CP
Sbjct: 194 PPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEVIEMVRKRQLLPCSEDCP 252
Query: 166 KAFSYLISRCWSSSPDRRPHFDQI 189
L++ CW P RRP F I
Sbjct: 253 PRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 18 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 77
EY G L +Y+ + S+ A +I ++YLHS+GI+HRDLK EN+LL +DM
Sbjct: 82 EYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM 139
Query: 78 CVKVADFGISCL-------ESQCGSAKG--------------FTGTYRWMAPEMIKEKRH 116
+K+ DFG + + ES G A F GT +++PE++ EK
Sbjct: 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISR 174
K D+++ G +++++LT PF + QK PP P LI +
Sbjct: 200 GKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQKILKLEYSFPPNFPPDAKDLIEK 255
Query: 175 CWSSSPDRRPHFDQIVSILEGYSESLEQDPEFF 207
P R + EGY + L+ P FF
Sbjct: 256 LLVLDPQDRL------GVNEGY-DELKAHP-FF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-27
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 30/204 (14%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EYL GSLR YL Q+ + +L A I +GM+YL S+ +HRDL + N+L+
Sbjct: 84 LVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE 142
Query: 75 EDMCVKVADFGISCLESQ---------CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 125
+ VK+ DFG++ + Q G + F W APE + E + + DV+SF
Sbjct: 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----WYAPESLTESKFSVASDVWSF 197
Query: 126 GIVLWELLT----ALTP----FDNMTPE-QAAFAVC------QKNARPPVPPTCPKAFSY 170
G+VL+EL T + +P M + Q V + N R P PP CP
Sbjct: 198 GVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA 257
Query: 171 LISRCWSSSPDRRPHFDQIVSILE 194
++ CW++ P +RP F ++ +E
Sbjct: 258 IMKECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 17/218 (7%)
Query: 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
P ++T+ + G L Y+H+ + ++ L+L + IA+GM YL + ++HRDL + N
Sbjct: 81 PTIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARN 139
Query: 71 LLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
+L+ VK+ DFG++ L + + +A G +WMA E I ++ T + DV+S+G+
Sbjct: 140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGV 199
Query: 128 VLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186
+WEL+T P+D + P + + +K R P PP C ++ +CW D RP F
Sbjct: 200 TIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKF 258
Query: 187 DQIVSILEGYSESLEQDPEFFSSF-------IPSPDHT 217
++ + + +DP+ + +PSP+ +
Sbjct: 259 KELAAEF----SRMARDPQRYLVIQGDDRMKLPSPNDS 292
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 7e-27
Identities = 55/180 (30%), Positives = 98/180 (54%), Gaps = 6/180 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+IT+ + G L Y+ + + ++ +L + IA+GM YL + ++HRDL + N+L+
Sbjct: 85 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK 143
Query: 75 EDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
VK+ DFG++ L + + A+G +WMA E I + +T + DV+S+G+ +WE
Sbjct: 144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 203
Query: 132 LLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
L+T P+D + P ++ +K R P PP C ++ +CW D RP F +++
Sbjct: 204 LMTFGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-27
Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ EYL GG L L S+ ++ +I ++YLHS GI+HRDLK +N+L+
Sbjct: 69 YLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI 126
Query: 74 GEDMCVKVADFGIS---CLESQCG------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 124
+ +K+ DFG+S + Q K GT ++APE+I + H+K VD +S
Sbjct: 127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
G +L+E L + PF TPE+ + P LIS+ P++R
Sbjct: 187 LGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRL 246
Query: 185 HFDQIVSILEGYSESLEQDPEFFS 208
I E ++ P FF
Sbjct: 247 GAKSI--------EEIKNHP-FFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-26
Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 2/177 (1%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I EY GG+L + +Q+ +VL I + Y+H GILHRD+K+ N+ L
Sbjct: 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT 135
Query: 75 EDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ +K+ DFGIS L S+ A+ GT +M+PE+ + ++ K D+++ G VL+ELL
Sbjct: 136 KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
T FD P + Q N PV L+ P++RP D+++
Sbjct: 196 TLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 16/214 (7%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV-------PLNL----VLKLALDI 49
++F C + ++ EY+ G L K+L P +V P L +L +A I
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 50 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TYRWM 106
A GM YL SQ +HRDL + N L+GE++ VK+ DFG+S + G T RWM
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
PE I ++ T + DV+S G+VLWE+ T P+ ++ + + Q P TCP
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-PRTCP 248
Query: 166 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199
K L+ CW P R + +I S+L+ +++
Sbjct: 249 KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-26
Identities = 66/195 (33%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 15 IITEYLAGGSLRKYLHQ---QEPYSVPLNLV--LKLALDIARGMQYLHSQGILHRDLKSE 69
II E + GG L YL + L L L + LD+A+G YL +HRDL +
Sbjct: 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAAR 135
Query: 70 NLLLGE-----DMCVKVADFGIS--CLESQCGSAKGFTG--TYRWMAPEMIKEKRHTKKV 120
N L+ E D VK+ DFG++ +S +G G RWMAPE + + + T +
Sbjct: 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-EGLLPVRWMAPESLLDGKFTTQS 194
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFG+++WE+LT P+ + Q R P CP L++ CW+
Sbjct: 195 DVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQD 253
Query: 180 PDRRPHFDQIVSILE 194
P RP FD+I IL+
Sbjct: 254 PSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 57/177 (32%), Positives = 91/177 (51%), Gaps = 2/177 (1%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ + GG L L +Q+ +P N V++ + IA +QYLH + ILHRDLK++N+ L
Sbjct: 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT 136
Query: 75 EDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+KV D GI+ LE+QC A GT +M+PE+ K + K DV++ G ++E+
Sbjct: 137 RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
T F+ + + + PP+P LI+ S P++RP I+
Sbjct: 197 TLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLA 46
+ + AC+ I EY G+L +L + ++ +L+ A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 106
D+A GMQYL + +HRDL + N+L+GE++ K+ADFG+S E RWM
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWM 185
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
A E + +T K DV+SFG++LWE+++ TP+ MT + + + R P C
Sbjct: 186 AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCD 244
Query: 166 KAFSYLISRCWSSSPDRRPHFDQI 189
L+ +CW P RP F QI
Sbjct: 245 DEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS--------------VPLNLVLKLA 46
++F C ++ EY+ G L K+L P + + L+ +L +A
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TY 103
IA GM YL SQ +HRDL + N L+G ++ VK+ DFG+S + G T
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA--RPPV 160
RWM PE I ++ T + DV+SFG++LWE+ T P+ ++ + + Q RP V
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249
Query: 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
CPK ++ CW P +R + +I IL
Sbjct: 250 ---CPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I E+L GSL++YL + + + L LK A+ I +GM YL S+ +HRDL + N+L+
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNK-INLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143
Query: 75 EDMCVKVADFGISCLESQCGSAKGF-------TGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
+ VK+ DFG L + K + W APE + + + DV+SFG+
Sbjct: 144 SEHQVKIGDFG---LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV 200
Query: 128 VLWELLT-------ALTPFDNMT-PEQAAFAVC------QKNARPPVPPTCPKAFSYLIS 173
L+ELLT +T F M P V ++ R P PP CP+ L+
Sbjct: 201 TLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMR 260
Query: 174 RCWSSSPDRRPHFDQIVSILE 194
+CW P +R F ++ E
Sbjct: 261 KCWEFQPSKRTTFQNLIEGFE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-25
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q++ C I E++ GGS+ L++ P P+ K I G+ YLH+
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV--FCKYTKQILDGVAYLHNNC 122
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSA----KGFTGTYRWMAPEMIKE 113
++HRD+K N++L + +K+ DFG + G+ K GT WMAPE+I E
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY--- 170
+ +K D++S G ++E+ T P +M A F + R +P P +FS
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLMPRL-PDSFSAAAI 239
Query: 171 -LISRCWSSSPDRRPHFDQIV 190
++ C + RP Q++
Sbjct: 240 DFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 103 bits (256), Expect = 1e-25
Identities = 55/178 (30%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 13 FCIITEYLAGGSLRKYLHQ-QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
++ EY+ GGSL L + + + L + I ++YLHS+GI+HRD+K EN+
Sbjct: 73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENI 132
Query: 72 LLGED-MCVKVADFGISCLESQCGSA-------KGFTGTYRWMAPEMIKEKRH---TKKV 120
LL D VK+ DFG++ L GS GT +MAPE++ +
Sbjct: 133 LLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSS 192
Query: 121 DVYSFGIVLWELLTALTPF---DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 175
D++S GI L+ELLT L PF N + + + P + + LIS+
Sbjct: 193 DIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKA 250
|
Length = 384 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLA 46
+ + AC+ + EY G+L +L + ++ +L A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 106
D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S + RWM
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 178
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
A E + +T DV+S+G++LWE+++ TP+ MT + + + R P C
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCD 237
Query: 166 KAFSYLISRCWSSSPDRRPHFDQI 189
L+ +CW P RP F QI
Sbjct: 238 DEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 60/171 (35%), Positives = 88/171 (51%), Gaps = 5/171 (2%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
II EYL GGS L +P + + + +I +G+ YLHS+ +HRD+K+ N+LL
Sbjct: 79 IIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
E VK+ADFG++ L F GT WMAPE+IK+ + K D++S GI EL
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
P ++ P + F + KN+ P + K F + C + P RP
Sbjct: 196 KGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-25
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++T+ + G L Y+ + + + +L + IA+GM YL ++HRDL + N+L+
Sbjct: 85 LVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK 143
Query: 75 EDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
VK+ DFG++ L + A G +WMA E I +R T + DV+S+G+ +WE
Sbjct: 144 SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWE 203
Query: 132 LLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
L+T P+D + P + + +K R P PP C ++ +CW + RP F ++V
Sbjct: 204 LMTFGAKPYDGI-PAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
Query: 191 SILEGYSESLEQDPEFF 207
+ +DP F
Sbjct: 263 DEF----SRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-25
Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 17/183 (9%)
Query: 9 KPPVFCIITEYLAGGSLRKYLHQQ---EPY-SVPLNLVLKLALDIARGMQYLHSQGILHR 64
K P II EY GGS+R + E Y SV + VL +AL +Y+H G++HR
Sbjct: 73 KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-VAL------KYIHKVGVIHR 125
Query: 65 DLKSENLLLGEDMCVKVADFGISCLESQCGSAKG-FTGTYRWMAPEMIKE-KRHTKKVDV 122
D+K+ N+L+ VK+ DFG++ L +Q S + F GT WMAPE+I E K + K D+
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185
Query: 123 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSP 180
+S GI ++E+ T P+ ++ +A + + +PP K ++ C P
Sbjct: 186 WSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEP 243
Query: 181 DRR 183
R
Sbjct: 244 KER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 8e-25
Identities = 60/171 (35%), Positives = 85/171 (49%), Gaps = 5/171 (2%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
II EYL GGS L EP + + + +I +G+ YLHS+ +HRD+K+ N+LL
Sbjct: 79 IIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
E VK+ADFG++ L F GT WMAPE+IK+ + K D++S GI EL
Sbjct: 136 EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
P + P + F + KN P + K + C + P RP
Sbjct: 196 KGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 1e-24
Identities = 58/170 (34%), Positives = 94/170 (55%), Gaps = 7/170 (4%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ EYL GG L H Q A +I G+Q+LH +GI++RDLK +N+LL +
Sbjct: 74 VMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 76 DMCVKVADFGISCLESQCGSAKG--FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D +K+ADFG+ C E+ G K F GT ++APE++K +++ + VD +SFG++L+E+L
Sbjct: 132 DGHIKIADFGM-CKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
+PF ++ ++ N RP P K +S+ + P +R
Sbjct: 191 IGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-24
Identities = 62/171 (36%), Positives = 86/171 (50%), Gaps = 5/171 (2%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
II EYL GGS L + +LK +I +G+ YLHS+ +HRD+K+ N+LL
Sbjct: 79 IIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRDIKAANVLLS 135
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
E VK+ADFG++ L F GT WMAPE+I++ + K D++S GI EL
Sbjct: 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
P +M P + F + KN P + K F I C + P RP
Sbjct: 196 KGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-24
Identities = 60/182 (32%), Positives = 97/182 (53%), Gaps = 6/182 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY GG L K +++Q + +L + I+ G++++H + ILHRD+KS+N+ L
Sbjct: 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135
Query: 75 ED-MCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
++ M K+ DFGI+ L A GT +++PE+ + + + K D++S G VL+EL
Sbjct: 136 KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192
T PF+ Q +CQ P+ P + LIS+ + SP RP I SI
Sbjct: 196 CTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRP---SITSI 251
Query: 193 LE 194
L+
Sbjct: 252 LK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-24
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYS-------------VPLNLVLKLAL 47
++F C + ++ EY+ G L ++L P + + L +L +A
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 48 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTG-TYR 104
IA GM YL S +HRDL + N L+G+ + VK+ DFG+S + G T R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 105 WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 163
WM PE I ++ T + D++SFG+VLWE+ T P+ ++ +A + Q P T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELER-PRT 248
Query: 164 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
CP ++ CW P +R I S L+
Sbjct: 249 CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-24
Identities = 53/181 (29%), Positives = 94/181 (51%), Gaps = 9/181 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E +GG L K+L ++ + ++ V++L ++ GM+YL + +HRDL + N+LL
Sbjct: 71 LVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129
Query: 75 EDMCVKVADFGIS-CLESQCGSAKGFTG---TYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
K++DFG+S L + K + +W APE I ++ + + DV+S+GI +W
Sbjct: 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMW 189
Query: 131 ELLT-ALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 188
E + P+ M PE +F ++ R P CP L+ CW + RP+F +
Sbjct: 190 EAFSYGQKPYKKMKGPEVMSF--IEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAK 247
Query: 189 I 189
+
Sbjct: 248 V 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-24
Identities = 60/178 (33%), Positives = 92/178 (51%), Gaps = 12/178 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLL 73
I EY+ GGSL K L + + +P ++ K+A+ + +G+ YLH + I+HRD+K N+L+
Sbjct: 76 ICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV 134
Query: 74 GEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+K+ DFG+S + S AK F GT +MAPE I+ ++ K D++S G+ L E
Sbjct: 135 NSRGQIKLCDFGVSGQLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191
Query: 132 LLTALTPFDNMT-PEQAAFAVCQK--NARPPVPPT--CPKAFSYLISRCWSSSPDRRP 184
L T P+ P F + Q N PP P+ F ++ C P RP
Sbjct: 192 LATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-24
Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 5/149 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ EY+ GG L H Q A +I G+Q+LH +GI++RDLK +N+LL
Sbjct: 72 FFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 74 GEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ADFG+ C E G F GT ++APE++ + + VD ++ G++L+E
Sbjct: 130 DSEGHIKIADFGM-CKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYE 188
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPV 160
+L +PF+ ++ ++ + R P
Sbjct: 189 MLAGQSPFEGDDEDELFQSILEDEVRYPR 217
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-24
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++T+ GSL ++ Q P +L + IA+GM YL ++HR+L + N+LL
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK 143
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT---GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
D V++ADFG++ L ++ +WMA E I R+T + DV+S+G+ +WE
Sbjct: 144 SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWE 203
Query: 132 LLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
+++ P+ M P + + +K R P C ++ +CW + RP F ++
Sbjct: 204 MMSYGAEPYAGMRPHEVP-DLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELA 262
Query: 191 S 191
+
Sbjct: 263 N 263
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-24
Identities = 55/152 (36%), Positives = 81/152 (53%), Gaps = 6/152 (3%)
Query: 42 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 101
+L A D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S Q K G
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS--RGQEVYVKKTMG 183
Query: 102 TY--RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158
RWMA E + +T DV+S+G++LWE+++ TP+ MT + + + R
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRL 242
Query: 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
P C L+ +CW P RP F QI+
Sbjct: 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 6e-24
Identities = 59/170 (34%), Positives = 95/170 (55%), Gaps = 7/170 (4%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ EYL GG L H Q + L A +I G+Q+LHS+GI++RDLK +N+LL
Sbjct: 74 VMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131
Query: 76 DMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D +K+ADFG+ C E+ G AK F GT ++APE++ +++ VD +SFG++L+E+L
Sbjct: 132 DGHIKIADFGM-CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
+PF E+ ++ N P P + ++ + + P+RR
Sbjct: 191 IGQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 8e-24
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSL----RKYLHQQEPYSVPLNLVLKLALDIARGMQYL 56
++F A+ + FCIITEY G L + H + ++ N V + + + G+ Y+
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK--TLSENQVCEWFIQLLLGVHYM 122
Query: 57 HSQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKR 115
H + ILHRDLK++N+ L ++ +K+ DFG+S L C A FTGT +M+PE +K +
Sbjct: 123 HQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181
Query: 116 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 175
+ K D++S G +L+E+ F+ + + P +P T + + ++
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT-PSLPETYSRQLNSIMQSM 240
Query: 176 WSSSPDRRPHFDQIVSI 192
+ P RP +I+
Sbjct: 241 LNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-23
Identities = 58/186 (31%), Positives = 91/186 (48%), Gaps = 13/186 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+TEY++ G+L +L + E V L + + +A GM+YL G +H+ L + +L+
Sbjct: 83 IVTEYMSNGALDSFLRKHEGQLVAGQL-MGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN 141
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYR------WMAPEMIKEKRHTKKVDVYSFGIV 128
D+ K++ F Q ++ T W APE I+ + DV+SFGIV
Sbjct: 142 SDLVCKISGFR----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIV 197
Query: 129 LWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 187
+WE+++ P+ +M+ + AV + R P P CP L+ CW RP F
Sbjct: 198 MWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFS 256
Query: 188 QIVSIL 193
QI SIL
Sbjct: 257 QIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-23
Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 4/160 (2%)
Query: 39 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSA 96
+L +ARGM++L S+ +HRDL + N+LL + VK+ DFG++ + +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 97 KGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 154
KG T +WMAPE I + +T DV+S+GI+LWE+ + TP+ M + + +
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS 355
Query: 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
R P + ++ +CW+S P++RP F + I+E
Sbjct: 356 GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-23
Identities = 57/173 (32%), Positives = 91/173 (52%), Gaps = 9/173 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EYLAGGSL + + + V + L + +++LHS ++HRD+KS+N+LLG
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQVIHRDIKSDNILLG 149
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
D VK+ DFG C + +K T GT WMAPE++ K + KVD++S GI+ E+
Sbjct: 150 MDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYLISRCWSSSPDRR 183
+ P+ N P +A + + N P P F ++RC ++R
Sbjct: 209 VEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-23
Identities = 61/187 (32%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I EY GGSL + + + ++ K+A + +G+ YLHS+ I+HRD+K N+L
Sbjct: 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL 137
Query: 73 LGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
L VK+ DFG+S + S A FTGT +MAPE I+ K ++ DV+S G+ L
Sbjct: 138 LTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 131 ELLTALTPF-----DNMTP-EQAAFAVCQKNARPPVPPTCP-------KAFSYLISRCWS 177
E+ PF + P E ++ V N P P + F I +C
Sbjct: 195 EVAQNRFPFPPEGEPPLGPIELLSYIV---NMPNPELKDEPGNGIKWSEEFKDFIKQCLE 251
Query: 178 SSPDRRP 184
P RRP
Sbjct: 252 KDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 3e-23
Identities = 57/175 (32%), Positives = 91/175 (52%), Gaps = 8/175 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I +Y+ GG L +L+Q+E ++ + V +I + +LH GI++RD+K EN+LL
Sbjct: 82 LILDYVNGGELFTHLYQREHFT--ESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139
Query: 75 EDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLW 130
+ V + DFG+S L + A F GT +MAPE+I+ H K VD +S G++ +
Sbjct: 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 131 ELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
ELLT +PF D Q+ + ++PP P T I + P +R
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-23
Identities = 52/141 (36%), Positives = 67/141 (47%), Gaps = 16/141 (11%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 111
G+ YLHS +HRD+K+ N+LL E VK+ADFG + L A F GT WMAPE+I
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL---VSPANSFVGTPYWMAPEVI 183
Query: 112 ---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK-- 166
E ++ KVDV+S GI EL P NM A + + Q + PT
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-----SPTLSSND 238
Query: 167 ---AFSYLISRCWSSSPDRRP 184
F + C P RP
Sbjct: 239 WSDYFRNFVDSCLQKIPQDRP 259
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 3e-23
Identities = 57/173 (32%), Positives = 91/173 (52%), Gaps = 9/173 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EYLAGGSL + + + + + + + + +LHS ++HRD+KS+N+LLG
Sbjct: 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
D VK+ DFG C + +K T GT WMAPE++ K + KVD++S GI+ E+
Sbjct: 150 MDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRR 183
+ P+ N P +A + + N P + P F ++RC DRR
Sbjct: 209 VEGEPPYLNENPLRALYLIA-TNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-23
Identities = 47/185 (25%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 15 IITEYLAGGSL----RKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-----SQGILHRD 65
I+ EY GG L +K ++E + + ++ + + H +LHRD
Sbjct: 78 IVMEYCEGGDLAQLIQKC--KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135
Query: 66 LKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 124
LK N+ L + VK+ DFG++ L AK + GT +M+PE + + +K D++S
Sbjct: 136 LKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS 195
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
G +++EL PF Q A + + R +P + +I + PD+RP
Sbjct: 196 LGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRP 254
Query: 185 HFDQI 189
+++
Sbjct: 255 STEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-23
Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 15/183 (8%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
F + E++AGGS+ L + + +++ + RG+ YLH I+HRD+K NLL
Sbjct: 78 FNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLHENQIIHRDVKGANLL 135
Query: 73 L---GEDMCVKVADFGISC-LESQ---CGSAKG-FTGTYRWMAPEMIKEKRHTKKVDVYS 124
+ G+ +++ADFG + L ++ G +G GT +MAPE+++ +++ + DV+S
Sbjct: 136 IDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWS 193
Query: 125 FGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
G V+ E+ TA P++ F + P +P + RC P+
Sbjct: 194 VGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPE 253
Query: 182 RRP 184
RP
Sbjct: 254 DRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-23
Identities = 56/183 (30%), Positives = 98/183 (53%), Gaps = 9/183 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I E+ GGSL+ H P S + + ++ + +G+ YLHS+G +HRD+K N+LL
Sbjct: 83 ICMEFCGGGSLQDIYHVTGPLSE--SQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLW 130
++ VK+ADFG+S + + K F GT WMAPE+ +R + + D+++ GI
Sbjct: 141 DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAI 200
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK---AFSYLISRCWSSSPDRRPHFD 187
EL P ++ P +A F + + N +PP K +F + + + +P +RP +
Sbjct: 201 ELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAE 260
Query: 188 QIV 190
+++
Sbjct: 261 KLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 8e-23
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 20/197 (10%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQ 59
+Q++ + + F I E + GGSL L + P ++ I G++YLH
Sbjct: 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 60 GILHRDLKSENLLLGE-DMCVKVADFGIS--------CLESQCGSAKGFTGTYRWMAPEM 110
I+HRD+K +N+L+ VK++DFG S C E+ FTGT ++MAPE+
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-------FTGTLQYMAPEV 180
Query: 111 IKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKA 167
I + + + D++S G + E+ T PF + QAA F V P +P +
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 168 FSYLISRCWSSSPDRRP 184
I RC+ PD+R
Sbjct: 241 AKNFILRCFEPDPDKRA 257
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-23
Identities = 53/188 (28%), Positives = 87/188 (46%), Gaps = 10/188 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E G L K+L + + V + +L ++ GM+YL +HRDL + N+LL
Sbjct: 72 LVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV 129
Query: 75 EDMCVKVADFGIS---CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDVYSFGIVL 129
K++DFG+S + AK G + +W APE + + + K DV+SFG+++
Sbjct: 130 TQHYAKISDFGLSKALGADENYYKAKT-HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
Query: 130 WELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 188
WE + P+ M + + + R P CP L+ CW+ D RP F
Sbjct: 189 WEAFSYGQKPYKGMKGNEVT-QMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAV 247
Query: 189 IVSILEGY 196
+ L Y
Sbjct: 248 VELRLRNY 255
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-22
Identities = 45/135 (33%), Positives = 70/135 (51%), Gaps = 9/135 (6%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ EYL GG + +P + + ++ G++ LH +GI+HRD+K ENLL+
Sbjct: 73 YLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130
Query: 74 GEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ DFG+S LE+ K F GT ++APE I K D +S G V++E
Sbjct: 131 DQTGHLKLTDFGLSRNGLEN-----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185
Query: 132 LLTALTPFDNMTPEQ 146
L PF TP+
Sbjct: 186 FLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-22
Identities = 53/181 (29%), Positives = 95/181 (52%), Gaps = 5/181 (2%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ +Y GG L K ++ Q P + +L + I ++++H + ILHRD+KS+N+ L
Sbjct: 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 135
Query: 75 EDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+D +K+ DFGI+ L S A+ GT +++PE+ + + + K D+++ G VL+E+
Sbjct: 136 KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
T F+ + + + + PPV L+S+ + +P RP + SIL
Sbjct: 196 TLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRP---SVNSIL 251
Query: 194 E 194
E
Sbjct: 252 E 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-22
Identities = 38/134 (28%), Positives = 72/134 (53%)
Query: 6 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 65
A + C++ + GG L+ +++ P + A I G+++LH + I++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 125
LK EN+LL + V+++D G++ KG GT +MAPE+++ + + VD ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180
Query: 126 GIVLWELLTALTPF 139
G L+E++ +PF
Sbjct: 181 GCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 3e-22
Identities = 52/172 (30%), Positives = 89/172 (51%), Gaps = 7/172 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EYLAGGSL + + + + + + + +++LHS ++HRD+KS+N+LLG
Sbjct: 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D VK+ DFG + + GT WMAPE++ K + KVD++S GI+ E++
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRR 183
P+ N P +A + + N P + P F ++RC ++R
Sbjct: 211 EGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-22
Identities = 54/160 (33%), Positives = 95/160 (59%), Gaps = 19/160 (11%)
Query: 16 ITEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
+ EY+ GG L ++ Q +EP++V A +IA G+ +LHS+GI++RDLK +N+
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPHAV------FYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 72 LLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+L + +K+ADFG+ C E+ G + + F GT ++APE+I + + K VD ++FG++L
Sbjct: 133 MLDAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 169
+E+L PFD ++ ++ + N + PK+ S
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHN------VSYPKSLS 225
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 4e-22
Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 8/175 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I +Y+ GG L +L Q+E + V + +I +++LH GI++RD+K EN+LL
Sbjct: 82 LILDYINGGELFTHLSQRERFKE--QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139
Query: 75 EDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLW 130
+ V + DFG+S E + A F GT +MAP++++ + H K VD +S G++++
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 131 ELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
ELLT +PF D QA + + PP P +I R P +R
Sbjct: 200 ELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-22
Identities = 56/171 (32%), Positives = 97/171 (56%), Gaps = 14/171 (8%)
Query: 33 EPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS--- 87
E Y PL L ++ + +ARGM++L S+ +HRDL + N+LL E+ VK+ DFG++
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
Query: 88 ---CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT 143
+ G A+ +WMAPE I +K +T + DV+SFG++LWE+ + +P+ +
Sbjct: 224 YKDPDYVRKGDARL---PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280
Query: 144 PEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
++ ++ R P P+ +S ++ CW ++P+ RP F ++V IL
Sbjct: 281 IDEEFCRRLKEGTRMRAPEYATPEIYSIMLD-CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 6e-22
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 15 IITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
++ E+L GG+L + E + + L + + + +LH+QG++HRD+KS+++
Sbjct: 93 VVMEFLEGGALTDIVTHTRMNEEQ------IATVCLAVLKALSFLHAQGVIHRDIKSDSI 146
Query: 72 LLGEDMCVKVADFGI-SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
LL D VK++DFG + + + K GT WMAPE+I + +VD++S GI++
Sbjct: 147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 163
E++ P+ N P QA K R +PP
Sbjct: 207 EMVDGEPPYFNEPPLQA-----MKRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-22
Identities = 57/185 (30%), Positives = 91/185 (49%), Gaps = 14/185 (7%)
Query: 15 IITEYLAGGSLRKYLHQQE-PYSVP-LNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E+ GG+L + + E + P + V + L+ + +LHS ++HRDLK+ N+L
Sbjct: 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLHSHKVIHRDLKAGNIL 135
Query: 73 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVYSFG 126
L D VK+ADFG+S +S F GT WMAPE++ K+ + K D++S G
Sbjct: 136 LTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG 195
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP 184
I L EL P + P + + K+ P + P +F+ + C PD RP
Sbjct: 196 ITLIELAQMEPPHHELNPMRVLLKI-LKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254
Query: 185 HFDQI 189
++
Sbjct: 255 TAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 8e-22
Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 7/197 (3%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGI 61
+ P +I EY G LR+ L +++ + L +A+D +G+ L+
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNK 144
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKK 119
+++L S + L+ E+ +K+ G+ + S Y + +M+ + +T K
Sbjct: 145 PYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIK 202
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
D+YS G+VLWE+ T PF+N+T ++ + KN +P CP ++ C S
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262
Query: 180 PDRRPHFDQIVSILEGY 196
+RP+ +I+ L Y
Sbjct: 263 SIKRPNIKEILYNLSLY 279
|
Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 8e-22
Identities = 47/132 (35%), Positives = 63/132 (47%), Gaps = 18/132 (13%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDLK 67
+ EY GG L L AR +YLH++GI++RDLK
Sbjct: 71 LMEYCLGGELWTILRD----------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 68 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
ENLLL + VK+ DFG + F GT ++APE+I K + VD +S GI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180
Query: 128 VLWELLTALTPF 139
+L+ELLT PF
Sbjct: 181 LLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 8e-22
Identities = 53/158 (33%), Positives = 83/158 (52%), Gaps = 16/158 (10%)
Query: 46 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS------CLESQCGSAKGF 99
+ +ARGM++L S+ +HRDL + N+LL E+ VK+ DFG++ + GSA+
Sbjct: 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR-- 237
Query: 100 TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK---N 155
+WMAPE I +K +T + DV+SFG++LWE+ + +P+ + Q CQ+
Sbjct: 238 -LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV---QINEEFCQRLKDG 293
Query: 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
R P ++ CW P RP F +V IL
Sbjct: 294 TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 9e-22
Identities = 49/126 (38%), Positives = 79/126 (62%), Gaps = 5/126 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ E+L GG L H Q+ L A +I G+Q+LHS+GI++RDLK +N++L
Sbjct: 74 VMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR 131
Query: 76 DMCVKVADFGISCLESQCGSAKG--FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D +K+ADFG+ C E+ G + F GT ++APE+++ ++T VD +SFG++L+E+L
Sbjct: 132 DGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
Query: 134 TALTPF 139
+PF
Sbjct: 191 IGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-21
Identities = 54/178 (30%), Positives = 95/178 (53%), Gaps = 2/178 (1%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY GG L + + Q P + +L+ + + G+Q++H + +LHRD+KS+N+ L
Sbjct: 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT 134
Query: 75 EDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
++ VK+ DFG + L + G+ A + GT ++ PE+ + + K D++S G +L+EL
Sbjct: 135 QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC 194
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191
T PF + + VCQ + + P+P LI + + +P RP I+S
Sbjct: 195 TLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 1e-21
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 8 KKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 63
K PP ++ E+ GS+ + + ++ + + +I RG+ +LH ++H
Sbjct: 75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIH 134
Query: 64 RDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK-----EKRHT 117
RD+K +N+LL E+ VK+ DFG+S L+ G F GT WMAPE+I + +
Sbjct: 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 194
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K D++S GI E+ P +M P +A F + + A K F I C
Sbjct: 195 FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLV 254
Query: 178 SSPDRRPHFDQIV 190
+ +RP +Q++
Sbjct: 255 KNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 2e-21
Identities = 40/114 (35%), Positives = 68/114 (59%), Gaps = 7/114 (6%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L+KYL ++ P + NL+ + + RG+ Y HS ILHRDLK +N+L+ D +K+ADF
Sbjct: 84 LKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADF 142
Query: 85 GIS---CLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT 134
G++ + + + + T YR APE++ K ++ VD++S G + E++T
Sbjct: 143 GLARAFGIPLRTYTHEVVTLWYR--APEILLGSKHYSTAVDIWSVGCIFAEMIT 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-21
Identities = 50/158 (31%), Positives = 84/158 (53%), Gaps = 6/158 (3%)
Query: 42 VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 101
+L + +A+GM +L S+ +HRDL + N+LL K+ DFG++ + + S G
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA-RDIRNDSNYVVKG 274
Query: 102 TYR----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156
R WMAPE I +T + DV+S+GI+LWE+ + +P+ M + + + ++
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY 334
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
R P P ++ CW + P +RP F QIV ++E
Sbjct: 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 3e-21
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 12/172 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLLL 73
++ EY+ GG L +L + + P V + A + ++YLHS I++RDLK ENLLL
Sbjct: 78 LVMEYVPGGELFSHLRKSGRFPEP---VARFYAAQVVLALEYLHSLDIVYRDLKPENLLL 134
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D +K+ DFG + G GT ++APE+I K + K VD ++ GI+++E+L
Sbjct: 135 DSDGYIKITDFGFAKRVK--GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML 192
Query: 134 TALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 183
PF + P + +K + P LI +R
Sbjct: 193 AGYPPFFDDNP----IQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-21
Identities = 53/177 (29%), Positives = 89/177 (50%), Gaps = 5/177 (2%)
Query: 22 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81
+ R L + P ++LV + +A GM++L S+ +HRDL + N+L+ E VK+
Sbjct: 222 ERTRRDTLINESPALSYMDLV-GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKI 280
Query: 82 ADFGIS--CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALT 137
DFG++ + +KG T +WMAPE I +T DV+SFGI+LWE+ T T
Sbjct: 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT 340
Query: 138 PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
P+ + + + ++ R P ++ +CW + RP F Q+V ++
Sbjct: 341 PYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-21
Identities = 54/152 (35%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I EY+ GGS++ Q + Y ++ ++ K I GM YLHS I+HRD+K N+L
Sbjct: 83 IFMEYMPGGSVKD---QLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR 139
Query: 74 GEDMCVKVADFGISC-LESQCGSAKGF---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
VK+ DFG S L++ C S G TGT WM+PE+I + + +K DV+S G +
Sbjct: 140 DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTV 199
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVP 161
E+LT P+ A F + + P +P
Sbjct: 200 VEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-21
Identities = 58/185 (31%), Positives = 96/185 (51%), Gaps = 11/185 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS-VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I EY GGSL+ H P S + + V + L +G+ YLHS+G +HRD+K N+LL
Sbjct: 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKGKMHRDIKGANILL 139
Query: 74 GEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVL 129
++ VK+ADFG++ + + K F GT WMAPE+ K + + D+++ GI
Sbjct: 140 TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK---AFSYLISRCWSSSPDRRPHF 186
EL P ++ P +A F + + N +PP K F + + +P +RP
Sbjct: 200 IELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTA 259
Query: 187 DQIVS 191
+++++
Sbjct: 260 ERLLT 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 4e-21
Identities = 47/132 (35%), Positives = 77/132 (58%), Gaps = 8/132 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EY+ GG L YL +S L A +I ++YLHS+ I++RDLK EN+LL
Sbjct: 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFY--ASEIVCALEYLHSKEIVYRDLKPENILLD 135
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
++ +K+ DFG ++ + +T GT ++APE+I+ K H K VD ++ GI+++E+
Sbjct: 136 KEGHIKLTDFGF----AKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
Query: 133 LTALTPFDNMTP 144
L PF + P
Sbjct: 192 LVGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-21
Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 2/178 (1%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY GG+L +Y+ ++ + + +L + I + ++H++ ILHRDLK++N+LL
Sbjct: 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
Query: 75 E-DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ M VK+ DFGIS + S A GT +++PE+ + K + +K D+++ G VL+EL
Sbjct: 136 KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191
+ F+ + P+ LI + P +RP QI++
Sbjct: 196 SLKRAFEAANLPALVLKI-MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 5e-21
Identities = 56/173 (32%), Positives = 92/173 (53%), Gaps = 9/173 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EYLAGGSL + + + V + L + +++LH+ ++HRD+KS+N+LLG
Sbjct: 93 VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQVIHRDIKSDNVLLG 149
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
D VK+ DFG C + +K T GT WMAPE++ K + KVD++S GI+ E+
Sbjct: 150 MDGSVKLTDFGF-CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 208
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRR 183
+ P+ N P +A + + N P + P F ++RC ++R
Sbjct: 209 VEGEPPYLNENPLRALYLIA-TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 5e-21
Identities = 48/128 (37%), Positives = 76/128 (59%), Gaps = 6/128 (4%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C + EY AGG L ++H + +S P + A + G+QYLH I++RDLK +NLLL
Sbjct: 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFY--AACVVLGLQYLHENKIVYRDLKLDNLLL 134
Query: 74 GEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ VK+ADFG+ C E + F GT ++APE++ E +T+ VD + G++++E
Sbjct: 135 DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYE 193
Query: 132 LLTALTPF 139
+L +PF
Sbjct: 194 MLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 5e-21
Identities = 63/189 (33%), Positives = 95/189 (50%), Gaps = 21/189 (11%)
Query: 18 EYLAGGS---LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
E GGS L K L ++ + + + + RG+ YLH ++HRD+K +N+LL
Sbjct: 89 ELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT 147
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI--KEKR---HTKKVDVYSFGIV 128
++ VK+ DFG+S L+S G F GT WMAPE+I E+ + + DV+S GI
Sbjct: 148 KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC------PKAFSYLISRCWSSSPDR 182
EL P +M P +A F K R P PPT K F+ IS C + ++
Sbjct: 208 AIELADGKPPLCDMHPMRALF----KIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQ 262
Query: 183 RPHFDQIVS 191
RP ++++
Sbjct: 263 RPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-21
Identities = 49/170 (28%), Positives = 88/170 (51%), Gaps = 8/170 (4%)
Query: 32 QEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 89
S PL+L +L+ + +A+GM +L S+ +HRD+ + N+LL + K+ DFG++
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA-R 260
Query: 90 ESQCGSAKGFTGTYR----WMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 144
+ S G R WMAPE I + +T + DV+S+GI+LWE+ + +P+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
Query: 145 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
+ + ++ + P P ++ CW+ P RP F QI +++
Sbjct: 321 NSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-21
Identities = 55/174 (31%), Positives = 93/174 (53%), Gaps = 7/174 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I +Y++GG + +L+Q++ +S + V + +I +++LH GI++RD+K EN+LL
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFSE--DEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139
Query: 75 EDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWE 131
+ V + DFG+S L + F GT +MAPE+I+ K H K VD +S GI+++E
Sbjct: 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNAR--PPVPPTCPKAFSYLISRCWSSSPDRR 183
LLT +PF V ++ + PP P L+ + P +R
Sbjct: 200 LLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 51/150 (34%), Positives = 89/150 (59%), Gaps = 13/150 (8%)
Query: 16 ITEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
+ EY+ GG L + Q +EP++V A +IA G+ +LHS+GI++RDLK +N+
Sbjct: 79 VMEYVNGGDLMYQIQQVGRFKEPHAV------FYAAEIAIGLFFLHSKGIIYRDLKLDNV 132
Query: 72 LLGEDMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+L + +K+ADFG+ C E+ + K F GT ++APE+I + + K VD ++FG++L
Sbjct: 133 MLDSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPP 159
+E+L PF+ ++ ++ + N P
Sbjct: 192 YEMLAGQAPFEGEDEDELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 49/127 (38%), Positives = 80/127 (62%), Gaps = 5/127 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I ++L GG L L ++ ++ ++ LA ++A + +LHS GI++RDLK EN+LL
Sbjct: 75 LILDFLRGGDLFTRLSKEVMFTEE-DVKFYLA-ELALALDHLHSLGIIYRDLKPENILLD 132
Query: 75 EDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
E+ +K+ DFG+S ES K F GT +MAPE++ + HT+ D +SFG++++E+
Sbjct: 133 EEGHIKLTDFGLS-KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 191
Query: 133 LTALTPF 139
LT PF
Sbjct: 192 LTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-20
Identities = 55/169 (32%), Positives = 86/169 (50%), Gaps = 10/169 (5%)
Query: 1 MQFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLH 57
+Q+ + P I E++ GGS++ Q + Y ++ N+ K I G+ YLH
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKD---QLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 58 SQGILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGF---TGTYRWMAPEMIKE 113
S I+HRD+K N+L VK+ DFG S L++ C S G TGT WM+PE+I
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+ + +K D++S G + E+LT P+ A F + + P +PP
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-20
Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 14/177 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I TE++ GGSL Y +P +++ ++A+ + +G+ YL S ILHRD+K N+L+
Sbjct: 76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN 129
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
VK+ DFG+S + AK + GT +MAPE I +++ DV+S GI EL
Sbjct: 130 TRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188
Query: 135 ALTPFDNMTPEQAAFA-----VCQKNARPPVPPT--CPKAFSYLISRCWSSSPDRRP 184
P+ + Q + C + PPV P + F + I++C P RP
Sbjct: 189 GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-20
Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 9/150 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E+L GG+L + Q + V + L + + YLHSQG++HRD+KS+++LL
Sbjct: 95 VLMEFLQGGALTDIVSQTRLNEEQIATVCESVL---QALCYLHSQGVIHRDIKSDSILLT 151
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D VK++DFG + K GT WMAPE+I + +VD++S GI++ E++
Sbjct: 152 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPT 163
P+ + +P QA K R PP
Sbjct: 212 DGEPPYFSDSPVQA-----MKRLRDSPPPK 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 9/149 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E+L GG+L + + + + L + R + YLH+QG++HRD+KS+++LL
Sbjct: 96 VVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT 152
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D +K++DFG + + K GT WMAPE+I + +VD++S GI++ E++
Sbjct: 153 SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPP 162
P+ N P QA + R +PP
Sbjct: 213 DGEPPYFNEPPLQA-----MRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 52/170 (30%), Positives = 94/170 (55%), Gaps = 8/170 (4%)
Query: 31 QQEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS- 87
Q++ Y L L ++ + +A+GM++L S+ +HRDL + N+LL E+ VK+ DFG++
Sbjct: 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
Query: 88 -CLESQCGSAKGFTG-TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 144
+ KG +WMAPE I ++ +T + DV+SFG++LWE+ + +P+ +
Sbjct: 228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287
Query: 145 EQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
++ ++ R P T P+ + ++ CW P +RP F ++V L
Sbjct: 288 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 4e-20
Identities = 50/146 (34%), Positives = 82/146 (56%), Gaps = 10/146 (6%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTG 101
L + + + ++HS+ ++HRD+KS N+LL + VK+ DFG S + + S + F G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 102 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---P 158
T ++APE+ + K ++KK D++S G++L+ELLT PFD E+ V K
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRYD 263
Query: 159 PVPPTCPKAFSYLISRCWSSSPDRRP 184
P+PP+ +++ SS P RRP
Sbjct: 264 PLPPSISPEMQEIVTALLSSDPKRRP 289
|
Length = 496 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 6e-20
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 20/198 (10%)
Query: 8 KKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 63
K PP ++ E+ GS+ + + ++ + + + +I RG+ +LH+ ++H
Sbjct: 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIH 144
Query: 64 RDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK-----EKRHT 117
RD+K +N+LL E+ VK+ DFG+S L+ G F GT WMAPE+I + +
Sbjct: 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD 204
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC-----PKAFSYLI 172
+ D++S GI E+ P +M P +A F + R P PP K F I
Sbjct: 205 YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNP-PPKLKSKKWSKKFIDFI 259
Query: 173 SRCWSSSPDRRPHFDQIV 190
C + RP +Q++
Sbjct: 260 EGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 7e-20
Identities = 52/144 (36%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 110
+G+ YLHS ++HRD+K+ N+LL E VK+ADFG + + S A F GT WMAPE+
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS---PANSFVGTPYWMAPEV 192
Query: 111 I---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-CPK 166
I E ++ KVDV+S GI EL P NM A + + Q N P +
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTLQSNEWSD 251
Query: 167 AFSYLISRCWSSSPDRRPHFDQIV 190
F + C P RP ++++
Sbjct: 252 YFRNFVDSCLQKIPQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 8e-20
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 7/173 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C + EY+ GG L +L ++ +S + +I + YLHS I++RDLK ENL+
Sbjct: 70 LCFVMEYVNGGELFFHLSRERVFSE--DRTRFYGAEIVSALDYLHSGKIVYRDLKLENLM 127
Query: 73 LGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
L +D +K+ DFG+ C E + + K F GT ++APE++++ + + VD + G+V++
Sbjct: 128 LDKDGHIKITDFGL-CKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
E++ PF N E+ + ++ + P T L+S P++R
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILMEDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-20
Identities = 49/187 (26%), Positives = 94/187 (50%), Gaps = 13/187 (6%)
Query: 15 IITEYLAGGSLRKYLH--QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E G L + + +++ +P + K + + ++++HS+ I+HRD+K N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVF 138
Query: 73 LGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ VK+ D G+ S+ +A GT +M+PE I E + K D++S G +L+E
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 132 LLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLISRCWSSSPDRRPH 185
+ +PF D M +++C+K + PP +S L+SRC + P++RP
Sbjct: 199 MAALQSPFYGDKMN----LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPD 254
Query: 186 FDQIVSI 192
++ +
Sbjct: 255 ISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-19
Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 8/215 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+I EY +GG L K + Q+ +P V L I + +HS+ ++HRDLKS N+
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 73 LGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
L +K+ DFG S S S A F GT ++APE+ + KR++KK D++S G++L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ELLT PF + + V P P L+ S +P RP Q+
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQL 320
Query: 190 VSI-LEGYSESLEQDPEFFSSFIPSPDHT-ILRCL 222
+ Y +L QD S I D ILR L
Sbjct: 321 LHTEFLKYVANLFQDIVRHSETISPHDREEILRQL 355
|
Length = 478 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 50/137 (36%), Positives = 69/137 (50%), Gaps = 6/137 (4%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 110
+G+ YLHS ++HRD+K+ N+LL E VK+ADFG + S A F GT WMAPE+
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEV 188
Query: 111 I---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 167
I E ++ KVDV+S GI EL P NM A + + Q ++ +
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS 248
Query: 168 FSYLISRCWSSSPDRRP 184
F + C P RP
Sbjct: 249 FRGFVDYCLQKIPQERP 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-19
Identities = 46/146 (31%), Positives = 85/146 (58%), Gaps = 5/146 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ EY+ GG L ++ Q + P + A +I+ G+ +LH +GI++RDLK +N++L
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136
Query: 76 DMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ +K+ADFG+ C E + + F GT ++APE+I + + K VD +++G++L+E+L
Sbjct: 137 EGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPP 159
PFD ++ ++ + N P
Sbjct: 196 AGQPPFDGEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-19
Identities = 48/128 (37%), Positives = 74/128 (57%), Gaps = 7/128 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLAL-DIARGMQYLHSQGILHRDLKSENLLL 73
+I EYL+GG L +L ++ + + L +I+ +++LH QGI++RDLK EN+LL
Sbjct: 77 LILEYLSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133
Query: 74 GEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
VK+ DFG+ C ES F GT +MAPE++ H K VD +S G ++++
Sbjct: 134 DAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYD 192
Query: 132 LLTALTPF 139
+LT PF
Sbjct: 193 MLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-19
Identities = 47/149 (31%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E+L GG+L + + V L + + + LH+QG++HRD+KS+++LL
Sbjct: 94 VVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIHRDIKSDSILLT 150
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D VK++DFG + + K GT WMAPE+I + +VD++S GI++ E++
Sbjct: 151 HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPP 162
P+ N P +A K R +PP
Sbjct: 211 DGEPPYFNEPPLKA-----MKMIRDNLPP 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 4e-19
Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 19/196 (9%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGI 61
F A C+ E++ GSL + + P +P+ ++ K+A+ + G+ YL++ I
Sbjct: 68 FYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGKIAVAVVEGLTYLYNVHRI 125
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 121
+HRD+K N+L+ +K+ DFG+S E A F GT +M+PE I+ ++T K D
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184
Query: 122 VYSFGIVLWELLTALTPFDNMTPEQAAFAV-----------CQKNARPPVPPTC--PKAF 168
V+S GI + EL PF PP P+ P+
Sbjct: 185 VWSLGISIIELALGKFPFAF--SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242
Query: 169 SYLISRCWSSSPDRRP 184
+ C P RP
Sbjct: 243 RDFVDACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-19
Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 7/159 (4%)
Query: 43 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 102
+ + IA GM++L S ++H+DL + N+L+ + + VK++D G+ E G
Sbjct: 127 VHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL-FREVYAADYYKLMGN 185
Query: 103 ----YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157
RWM+PE I + + D++S+G+VLWE+ + L P+ + Q + +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEMIRNRQV 244
Query: 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196
P P CP L+ CW+ P RRP F I S L +
Sbjct: 245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-19
Identities = 51/152 (33%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I EY+ GGS++ Q + Y ++ N+ + I +G+ YLHS I+HRD+K N+L
Sbjct: 83 IFVEYMPGGSIKD---QLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR 139
Query: 74 GEDMCVKVADFGISC-LESQCGSAKGF---TGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
VK+ DFG S +++ C S G TGT WM+PE+I + + +K DV+S +
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVP 161
E+LT P+ A F + + +P +P
Sbjct: 200 VEMLTEKPPWAEYEAMAAIFKIATQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 9e-19
Identities = 44/130 (33%), Positives = 74/130 (56%), Gaps = 5/130 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C + EY GG L +L ++ +S +I + YLHS +++RDLK ENL+L
Sbjct: 71 CFVMEYANGGELFFHLSRERVFSEDRARFY--GAEIVSALGYLHSCDVVYRDLKLENLML 128
Query: 74 GEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D +K+ DFG+ C E S + K F GT ++APE++++ + + VD + G+V++E
Sbjct: 129 DKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 187
Query: 132 LLTALTPFDN 141
++ PF N
Sbjct: 188 MMCGRLPFYN 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 43/136 (31%), Positives = 78/136 (57%), Gaps = 5/136 (3%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C + EY GG L +L ++ ++ +I ++YLHS+ +++RD+K ENL+
Sbjct: 70 LCFVMEYANGGELFFHLSRERVFTE--ERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 127
Query: 73 LGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
L +D +K+ DFG+ C E S + K F GT ++APE++++ + + VD + G+V++
Sbjct: 128 LDKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 131 ELLTALTPFDNMTPEQ 146
E++ PF N E+
Sbjct: 187 EMMCGRLPFYNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 49/133 (36%), Positives = 75/133 (56%), Gaps = 10/133 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLLL 73
+ E++ GG L + H ++ P N V K ++ +YLHS+ I++RDLK ENLLL
Sbjct: 95 FLLEFVVGGEL--FTHLRKAGRFP-NDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL 151
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
VKV DFG ++ + FT GT ++APE+I+ K H K VD ++ G++L+E
Sbjct: 152 DNKGHVKVTDFGF----AKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYE 207
Query: 132 LLTALTPFDNMTP 144
+ PF + TP
Sbjct: 208 FIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-18
Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 6/144 (4%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 110
+G+ YLHS ++HRD+K+ N+LL E VK+ DFG + + + A F GT WMAPE+
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEV 182
Query: 111 I---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 167
I E ++ KVDV+S GI EL P NM A + + Q + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 168 FSYLISRCWSSSPDRRPHFDQIVS 191
F + C P RP + ++
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-18
Identities = 55/180 (30%), Positives = 90/180 (50%), Gaps = 16/180 (8%)
Query: 15 IITEYLAGGSLRKYLHQQE-PYSVP-LNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E+ AGG++ + + E P + P + +V K L+ + YLH I+HRDLK+ N+L
Sbjct: 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLHENKIIHRDLKAGNIL 135
Query: 73 LGEDMCVKVADFGISCLESQCGSAK-GFTGTYRWMAPEMI-----KEKRHTKKVDVYSFG 126
D +K+ADFG+S ++ + F GT WMAPE++ K++ + K DV+S G
Sbjct: 136 FTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 195
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSSPDRR 183
I L E+ P + P + + + + PP P F + +C + D R
Sbjct: 196 ITLIEMAQIEPPHHELNPMRVLLKIAK--SEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 22/188 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E++ GGSL E + + +A I G+ YLH + I+HRD+K NLL+
Sbjct: 149 VLLEFMDGGSLEGTHIADEQF------LADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202
Query: 75 EDMCVKVADFGISCLESQ----CGSAKGFTGTYRWMAPEMIKEKRHTKKV-----DVYSF 125
VK+ADFG+S + +Q C S+ GT +M+PE I + D++S
Sbjct: 203 SAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSL 259
Query: 126 GIVLWELLTALTPFD-NMTPEQAAF--AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDR 182
G+ + E PF + A+ A+C P P T + F + IS C P +
Sbjct: 260 GVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-PEAPATASREFRHFISCCLQREPAK 318
Query: 183 RPHFDQIV 190
R Q++
Sbjct: 319 RWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-18
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 18/149 (12%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C++ EY+ GG L +P+++ + ++YLH+ GI+HRDLK +NLL+
Sbjct: 77 CMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134
Query: 74 GEDMCVKVADFGISCL----------------ESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
+K+ DFG+S + +++ K GT ++APE+I + +
Sbjct: 135 TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG 194
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
K VD ++ GI+L+E L PF TPE+
Sbjct: 195 KPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-18
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
C++ +Y GG L + L +Q + + A ++ ++YLH GI++RDLK EN+
Sbjct: 75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134
Query: 72 LLGEDMCVKVADFGISCLESQCGSA------------------------------KGFTG 101
LL E + ++DF +S F G
Sbjct: 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVG 194
Query: 102 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF 139
T ++APE+I H VD ++ GI+L+E+L TPF
Sbjct: 195 TEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-18
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 19/166 (11%)
Query: 37 VPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQC 93
+P +++ K+ + I + + YL G++HRD+K N+LL VK+ DFGIS ++S+
Sbjct: 111 IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170
Query: 94 GSAKGFTGTYRWMAPEMIKEKRHTKK----VDVYSFGIVLWELLTALTPFDNMTPEQAAF 149
+ G +MAPE I K DV+S GI L EL T P+ N E F
Sbjct: 171 KTRSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---F 225
Query: 150 AVCQK--NARPPVPPTCPKAFSYL----ISRCWSSSPDRRPHFDQI 189
V K PP P + FS + C + +RP + ++
Sbjct: 226 EVLTKILQEEPPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYREL 270
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-18
Identities = 47/126 (37%), Positives = 70/126 (55%), Gaps = 5/126 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +Y+ GG L + H Q S P A +IA + YLHS I++RDLK EN+LL
Sbjct: 74 VLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS 131
Query: 76 DMCVKVADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
V + DFG+ C E S F GT ++APE+++++ + + VD + G VL+E+L
Sbjct: 132 QGHVVLTDFGL-CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
Query: 134 TALTPF 139
L PF
Sbjct: 191 YGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-18
Identities = 41/129 (31%), Positives = 74/129 (57%), Gaps = 3/129 (2%)
Query: 14 CIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
C++ + GG LR +++ +E P I G+++LH + I++RDLK EN+
Sbjct: 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENV 128
Query: 72 LLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
LL D V+++D G++ L+ KG+ GT +MAPE+++ + + VD ++ G+ L+
Sbjct: 129 LLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLY 188
Query: 131 ELLTALTPF 139
E++ A PF
Sbjct: 189 EMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-18
Identities = 54/180 (30%), Positives = 90/180 (50%), Gaps = 15/180 (8%)
Query: 15 IITEYLAGGSLR---KYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
I+ E G L KY +Q+ +P V K + + ++++HS+ ++HRD+K N+
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV 137
Query: 72 LLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
+ VK+ D G+ S+ +A GT +M+PE I E + K D++S G +L+
Sbjct: 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
Query: 131 ELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRP 184
E+ +PF D M F++CQK + PP + +S L+S C PD+RP
Sbjct: 198 EMAALQSPFYGDKMN----LFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-18
Identities = 35/126 (27%), Positives = 72/126 (57%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C++ + GG L+ +++ + A +I G++ LH + I++RDLK EN+LL
Sbjct: 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ ++++D G++ + + +G GT +MAPE++K +R+T D + G +++E++
Sbjct: 136 DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI 195
Query: 134 TALTPF 139
+PF
Sbjct: 196 EGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 35/127 (27%), Positives = 70/127 (55%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C++ + GG L+ +++ L A +I G++ LH + ++RDLK EN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENIL 134
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
L + ++++D G++ + S +G GT +MAPE++ +R+T D + G +++E+
Sbjct: 135 LDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
Query: 133 LTALTPF 139
+ +PF
Sbjct: 195 IEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-17
Identities = 53/181 (29%), Positives = 94/181 (51%), Gaps = 22/181 (12%)
Query: 24 SLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVK 80
SL K+ + + ++P +++ K+A+ I + ++YLHS+ ++HRD+K N+L+ + VK
Sbjct: 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVK 144
Query: 81 VADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK----KVDVYSFGIVLWELLT 134
+ DFGIS ++S + G +MAPE I + + K K DV+S GI + EL T
Sbjct: 145 LCDFGISGYLVDSVAKTID--AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202
Query: 135 ALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKA-----FSYLISRCWSSSPDRRPHFDQ 188
P+D+ TP Q V ++ P P F +++C + RP++ +
Sbjct: 203 GRFPYDSWKTPFQQLKQVVEEP-----SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257
Query: 189 I 189
+
Sbjct: 258 L 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-17
Identities = 50/203 (24%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---EPYSVPLNLVLKLALDIARGMQYLH 57
+Q + C + + ++ E+ G L+ YL +++ ++A ++A G+ +LH
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 58 SQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEM---- 110
+H DL N L D+ VK+ D+G++ E + RW+APE+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 111 ---IKEKRHTKKVDVYSFGIVLWELLTALT-PFDNMTPEQA-AFAVCQKNARPPVP---- 161
+ K TKK +++S G+ +WEL TA P+ +++ EQ V +++ + P P
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237
Query: 162 PTCPKAFSYLISRCWSSSPDRRP 184
+ + ++ CW P+ RP
Sbjct: 238 KYSDRWYE-VMQFCW-LDPETRP 258
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 37/127 (29%), Positives = 73/127 (57%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C++ + GG L+ +++ + A +I G++ LH + I++RDLK EN+L
Sbjct: 75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENIL 134
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
L + ++++D G++ + + KG GT +MAPE++K +R+T D ++ G +L+E+
Sbjct: 135 LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194
Query: 133 LTALTPF 139
+ +PF
Sbjct: 195 IAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 48/144 (33%), Positives = 75/144 (52%), Gaps = 15/144 (10%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK----GFTGTYRWMA 107
G+Q+LH+ I+HRD+K N+LL + VK+ DFG+S +Q S + GT WMA
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS---AQLTSTRLRRNTSVGTPFWMA 196
Query: 108 PEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV-- 160
PE+I + + + DV+S GI EL P +M P + F + +N P +
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI-PRNPPPTLLH 255
Query: 161 PPTCPKAFSYLISRCWSSSPDRRP 184
P ++F++ IS+C + RP
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-17
Identities = 35/129 (27%), Positives = 72/129 (55%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C++ + GG L+ +++ + + V+ + I G+ +LHS I++RD+K EN+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
L + +++D G++ + GT +MAPE++KE+ ++ VD ++ G ++E+
Sbjct: 128 LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
Query: 133 LTALTPFDN 141
+ TPF +
Sbjct: 188 VAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 6e-17
Identities = 53/174 (30%), Positives = 91/174 (52%), Gaps = 8/174 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENL 71
C + EY GG L +L ++ +S + +I + YLHS+ +++RDLK ENL
Sbjct: 70 LCFVMEYANGGELFFHLSRERVFSE--DRARFYGAEIVSALDYLHSEKNVVYRDLKLENL 127
Query: 72 LLGEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+L +D +K+ DFG+ C E + K F GT ++APE++++ + + VD + G+V+
Sbjct: 128 MLDKDGHIKITDFGL-CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 186
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR 183
+E++ PF N E+ + + R P P+A S L+S P +R
Sbjct: 187 YEMMCGRLPFYNQDHEKLFELILMEEIRFP-RTLSPEAKS-LLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EY+ GG L H Q +P A +I + +LH +GI++RDLK +N+LL
Sbjct: 73 LVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD 130
Query: 75 EDMCVKVADFGISCLES--QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
D +K+ D+G+ C E + F GT ++APE+++ + + VD ++ G++++E+
Sbjct: 131 ADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
Query: 133 LTALTPFD------NMTPEQAAFAVC-QKNARPP 159
+ +PFD +M E F V +K R P
Sbjct: 190 MAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-17
Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 13/187 (6%)
Query: 15 IITEYLAGGSLRKYLH--QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E G L + + +++ +P V K + + ++++HS+ ++HRD+K N+
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVF 138
Query: 73 LGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ VK+ D G+ S+ +A GT +M+PE I E + K D++S G +L+E
Sbjct: 139 ITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 132 LLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTCPKAFS----YLISRCWSSSPDRRPH 185
+ +PF D M +++C+K + PP +S L++ C + P++RP
Sbjct: 199 MAALQSPFYGDKMN----LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 254
Query: 186 FDQIVSI 192
+ +
Sbjct: 255 ITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-17
Identities = 47/126 (37%), Positives = 71/126 (56%), Gaps = 5/126 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +++ GG L + H Q S P A +IA + YLHS I++RDLK EN+LL
Sbjct: 74 VLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS 131
Query: 76 DMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
V + DFG+ C E +Q + F GT ++APE+I+++ + VD + G VL+E+L
Sbjct: 132 QGHVVLTDFGL-CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
Query: 134 TALTPF 139
L PF
Sbjct: 191 YGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-16
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 15 IITEYLAGGSLRKYLHQ-----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69
I+ E+ GG++ + + EP + ++ + L+ +QYLHS I+HRDLK+
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEP---QIQVICRQMLE---ALQYLHSMKIIHRDLKAG 139
Query: 70 NLLLGEDMCVKVADFGISCLESQCGSAK-GFTGTYRWMAPEMI-----KEKRHTKKVDVY 123
N+LL D +K+ADFG+S + + F GT WMAPE++ K+ + K D++
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 199
Query: 124 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT--CPKAFSY----LISRCWS 177
S GI L E+ P + P + + + PPT P +S +
Sbjct: 200 SLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-----PPTLSQPSKWSMEFRDFLKTALD 254
Query: 178 SSPDRRPHFDQIV 190
P+ RP Q++
Sbjct: 255 KHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-16
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 19/207 (9%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---EPYSVPLNLVLKLALDIARGMQYLH 57
+Q + C + + ++ E+ G L+ YL E + + ++A +IA G+ +LH
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 58 SQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEK 114
+H DL N LL D+ VK+ D+G+S E + RW+APE++ E
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 115 R-------HTKKVDVYSFGIVLWELLTALT-PFDNMTPEQA-AFAVCQKNARPPVPP--- 162
TK+ +V+S G+ +WEL + P+ +++ EQ + V ++ + P P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ ++ CW P++RP +++
Sbjct: 238 PLSDRWYEVMQFCW-LQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-16
Identities = 44/186 (23%), Positives = 89/186 (47%), Gaps = 11/186 (5%)
Query: 15 IITEYLAGGSLRKYL------HQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLK 67
I+ + + G L ++ Q+ N+ +++ L ++YLH + I+HRDL
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL----ALRYLHKEKRIVHRDLT 141
Query: 68 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
N++LGED V + DFG++ + GT + PE++K + + +K DV++FG
Sbjct: 142 PNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGC 201
Query: 128 VLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 187
+L+++ T PF + A + + P + + +I+ C + + RP
Sbjct: 202 ILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDII 261
Query: 188 QIVSIL 193
Q+ +++
Sbjct: 262 QVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-16
Identities = 39/127 (30%), Positives = 73/127 (57%), Gaps = 5/127 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ EY+ GG L H Q +P + +I+ + YLH +GI++RDLK +N+LL
Sbjct: 74 VIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 131
Query: 76 DMCVKVADFGISCLES--QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ +K+ D+G+ C E + F GT ++APE+++ + + VD ++ G++++E++
Sbjct: 132 EGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190
Query: 134 TALTPFD 140
+PFD
Sbjct: 191 AGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-16
Identities = 43/126 (34%), Positives = 71/126 (56%), Gaps = 5/126 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +Y+ GG L +L ++ + P A ++A + YLHS I++RDLK EN+LL
Sbjct: 74 VLDYVNGGELFFHLQRERCFLEPRARFY--AAEVASAIGYLHSLNIIYRDLKPENILLDS 131
Query: 76 DMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
V + DFG+ C E + F GT ++APE+++++ + + VD + G VL+E+L
Sbjct: 132 QGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
Query: 134 TALTPF 139
L PF
Sbjct: 191 YGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 38/91 (41%), Positives = 56/91 (61%), Gaps = 5/91 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 105
I RG++Y+HS +LHRDLK NLLL + +K+ DFG++ + GF Y RW
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 106 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
APE M+ K +TK +D++S G +L E+L+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-16
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY--SVPLNLVLKLALDIARGMQYLHS 58
+Q + C + + ++ EY G L+ YL Q++ + + L L+ ++A +IA G+ ++H
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR 115
LH DL N L D+ VKV D+GI E + RW+APE++ E
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 116 -------HTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 167
TK +V++ G+ LWEL A P+ +++ + V + P
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237
Query: 168 FS----YLISRCWSSSPDRRPHFDQIVSIL 193
+S ++ CW SP++R +++ +L
Sbjct: 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-16
Identities = 45/125 (36%), Positives = 64/125 (51%), Gaps = 14/125 (11%)
Query: 20 LAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 77
L G L + Q L + + L I RG++Y+HS GI+HRDLK N+ + ED
Sbjct: 101 LMGADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC 155
Query: 78 CVKVADFGISCLESQCGSA-KGFTGTYRW-MAPEMIKEKRH-TKKVDVYSFGIVLWELLT 134
+K+ DFG L G+ T RW APE++ H + VD++S G ++ ELLT
Sbjct: 156 ELKILDFG---LARHTDDEMTGYVAT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
Query: 135 ALTPF 139
T F
Sbjct: 212 GKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-16
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 56 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 115
LH G +HRDLK EN L+ +K+ DFG+S + A G+ +MAPE+++ K
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 116 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
+ VD +S G +L+E L PF TP +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-16
Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 5/126 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +Y+ GG L +L ++ + P A +IA + YLHS I++RDLK EN+LL
Sbjct: 74 VLDYINGGELFYHLQRERCFLEPRARFY--AAEIASALGYLHSLNIVYRDLKPENILLDS 131
Query: 76 DMCVKVADFGISCLES--QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ + DFG+ C E+ G+ F GT ++APE++ ++ + + VD + G VL+E+L
Sbjct: 132 QGHIVLTDFGL-CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
Query: 134 TALTPF 139
L PF
Sbjct: 191 YGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC-----LESQCGSAKGFTGTY 103
I G++Y+HS +LHRDLK NLL+ D +K+ DFG++ G + T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT- 172
Query: 104 RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 139
RW APE M+ + +TK +DV+S G +L ELL P
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 6e-16
Identities = 38/120 (31%), Positives = 62/120 (51%), Gaps = 8/120 (6%)
Query: 20 LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79
L L +H +P + + + RG++Y+HS ++HRDLK NLL+ ED +
Sbjct: 89 LMESDLHHIIHSDQPLT--EEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCEL 146
Query: 80 KVADFGIS-CLESQCGSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWELL 133
++ DFG++ L S K F Y RW APE ++ +T +D++S G + E+L
Sbjct: 147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-16
Identities = 39/127 (30%), Positives = 72/127 (56%), Gaps = 4/127 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++T+Y++GG L + H Q+ + ++ +++LH I++RDLK EN+LL
Sbjct: 73 LVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130
Query: 75 EDMCVKVADFGISCLE-SQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWEL 132
+ + DFG+S + + F GT ++APE ++ EK +TK VD +S G++++E+
Sbjct: 131 ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190
Query: 133 LTALTPF 139
+PF
Sbjct: 191 CCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 46/215 (21%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLV------LKLALDIARGMQYLHSQGILHRDLKS 68
++ EY+ GG L L +++ P L LALD +H G +HRD+K
Sbjct: 78 LVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALD------SVHKLGFIHRDIKP 129
Query: 69 ENLLLGEDMCVKVADFGIS-----------------CLESQCGSAKGFT----------- 100
+N+L+ D +K+ADFG+ L +
Sbjct: 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189
Query: 101 --GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNA 156
GT ++APE+++ + + D +S G++L+E+L PF + T ++ + +++
Sbjct: 190 TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL 249
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191
R P P LI R DR F++I S
Sbjct: 250 RFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKS 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-15
Identities = 35/91 (38%), Positives = 54/91 (59%), Gaps = 7/91 (7%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY----RW 105
+ ++Y+HS ++HRDLK N+LL D VK+ADFG++ L + + T RW
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 106 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
APE ++ R+TK VD++S G +L E+L
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-15
Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 21/132 (15%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
F ++ EY+ L + L E +P V + +G+ Y+H+ GI+HRDLK NLL
Sbjct: 74 FVLVMEYM-PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLL 131
Query: 73 LGEDMCVKVADFGISCLES---------QCGSAKGFTGTYRW-MAPEMIKEKRH-TKKVD 121
+ D +K+ADFG++ L S Q + RW APE++ R VD
Sbjct: 132 ISADGVLKIADFGLARLFSEEEPRLYSHQVAT--------RWYRAPELLYGARKYDPGVD 183
Query: 122 VYSFGIVLWELL 133
+++ G + ELL
Sbjct: 184 LWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 17/183 (9%)
Query: 15 IITEYLAGGSL----RKYLHQQEPYSVPL-NLVLKLALDIARGMQYLHSQGILHRDLKSE 69
++ E GGS+ + +L + E P+ +L AL G+Q+LH +HRD+K
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL---MGLQHLHVNKTIHRDVKGN 153
Query: 70 NLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVY 123
N+LL + VK+ DFG+S L S GT WMAPE+I + + + DV+
Sbjct: 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213
Query: 124 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPD 181
S GI EL P ++ P +A F + +N P + P F+ I +C + +
Sbjct: 214 SLGITAIELGDGDPPLADLHPMRALFKI-PRNPPPTLHQPELWSNEFNDFIRKCLTKDYE 272
Query: 182 RRP 184
+RP
Sbjct: 273 KRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-15
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 23/192 (11%)
Query: 13 FCIITEYLAGGSLRK-YLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSEN 70
C+ EY+ GSL K Y +P +++ ++ + +G+++L + I+HRD+K N
Sbjct: 76 MCM--EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133
Query: 71 LLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEK------RHTKKVDVY 123
+L+ + VK+ DFG+S L + AK G +MAPE IK +T + DV+
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASL--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW 191
Query: 124 SFGIVLWELLTALTPFDNMTPEQAA--FAVCQKNARPPVPPTCPKAFSY----LISRCWS 177
S G+ + E+ P+ PE A FA PPT P +S +++C +
Sbjct: 192 SLGLSILEMALGRYPY---PPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLN 247
Query: 178 SSPDRRPHFDQI 189
P+RRP + Q+
Sbjct: 248 KIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 41/128 (32%), Positives = 74/128 (57%), Gaps = 8/128 (6%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLL 72
I E++ GGSL + L ++ +P N++ K+++ + RG+ YL + I+HRD+K N+L
Sbjct: 75 SICMEHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNIL 132
Query: 73 LGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
+ +K+ DFG+S ++S A F GT +M+PE ++ +T + D++S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 131 ELLTALTP 138
E+ P
Sbjct: 190 EMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 41/140 (29%), Positives = 79/140 (56%), Gaps = 15/140 (10%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ E+++GG L H Q +P + +I+ + +LH +GI++RDLK +N+LL
Sbjct: 74 VIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 76 DMCVKVADFGISCLESQCGSAKG-----FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
+ +K+ D+G+ C E G G F GT ++APE+++ + + VD ++ G++++
Sbjct: 132 EGHIKLTDYGM-CKE---GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 187
Query: 131 ELLTALTPFD----NMTPEQ 146
E++ +PFD + P+Q
Sbjct: 188 EMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-15
Identities = 39/127 (30%), Positives = 71/127 (55%), Gaps = 5/127 (3%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ E++ GG L ++ + + A +I + +LH +GI++RDLK +N+LL
Sbjct: 74 VMEFVNGGDLMFHIQKSRRFDEARARFY--AAEITSALMFLHDKGIIYRDLKLDNVLLDH 131
Query: 76 DMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ K+ADFG+ C E + F GT ++APE+++E + VD ++ G++L+E+L
Sbjct: 132 EGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190
Query: 134 TALTPFD 140
PF+
Sbjct: 191 CGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 8e-15
Identities = 41/96 (42%), Positives = 53/96 (55%), Gaps = 13/96 (13%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG------FTGTYR 104
RG++YLHS ILHRDLK NLL+ D +K+ADFG++ GS T YR
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR---SFGSPNRKMTHQVVTRWYR 169
Query: 105 WMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 139
APE++ RH VD++S G + ELL PF
Sbjct: 170 --APELLFGARHYGVGVDMWSVGCIFAELLLR-VPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 14/134 (10%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I+ EY+ L L Q + + RG++Y+HS +LHRDLK N+ +
Sbjct: 92 YIVQEYMET-DLANVLEQGP---LSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147
Query: 74 G-EDMCVKVADFGISCLESQCGSAKGF------TGTYRWMAPEMIKEKRH-TKKVDVYSF 125
ED+ +K+ DFG++ + S KG+ T YR +P ++ + TK +D+++
Sbjct: 148 NTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAA 205
Query: 126 GIVLWELLTALTPF 139
G + E+LT F
Sbjct: 206 GCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-14
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 31/196 (15%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
++ EY+ G L +LH+ E +V L+ L +A +A + YL + ++H ++ +N+L+
Sbjct: 77 MVEEYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA 135
Query: 74 ------GEDMCVKVADFGIS-CLESQCGSAKGFTGTYR-----WMAPEMIK--EKRHTKK 119
G +K++D GI + S+ R W+APE I+ + T
Sbjct: 136 RYGLNEGYVPFIKLSDPGIPITVLSR---------EERVERIPWIAPECIRNGQASLTIA 186
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
D +SFG L E+ + P ++ E+ F Q R P+ P C + + LI++CW+
Sbjct: 187 ADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--QDQHRLPM-PDCAELAN-LINQCWT 242
Query: 178 SSPDRRPHFDQIVSIL 193
P +RP F I+ L
Sbjct: 243 YDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-14
Identities = 42/103 (40%), Positives = 61/103 (59%), Gaps = 7/103 (6%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE----SQCGSAKGFTGTYR 104
I RG++YLHS GILHRD+K NLL+ + +K+ DFG++ +E S+ + + T YR
Sbjct: 112 ILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 105 WMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
APE++ RH T VD++S G + ELL F +P Q
Sbjct: 172 --APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-14
Identities = 37/91 (40%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 105
I RG++YLHS ++HRDLK N+L+ + +K+ DFG++ KGF Y RW
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 106 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
APE ++ R+TK +D++S G + ELLT
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 39/130 (30%), Positives = 72/130 (55%), Gaps = 11/130 (8%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ EY+ GG L + + + P + A ++ + +LH G+++RDLK +N+LL
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFY--AAEVTLALMFLHRHGVIYRDLKLDNILLDA 131
Query: 76 DMCVKVADFGISCLESQCGSAKG-----FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
+ K+ADFG+ C E G G F GT ++APE+++E + VD ++ G++++
Sbjct: 132 EGHCKLADFGM-CKE---GILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMY 187
Query: 131 ELLTALTPFD 140
E++ PF+
Sbjct: 188 EMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 35 YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 94
+P +L+ + +G+ + HS GILHRDLK ENLL+ + +K+ADFG+
Sbjct: 93 RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGL------AR 146
Query: 95 SAKGFTGTY------RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDN 141
S Y RW APE ++ +K ++ VD++S G + ELL+ L P +
Sbjct: 147 SFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 33/97 (34%), Positives = 57/97 (58%)
Query: 37 VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA 96
+P++ L + I G++YLH+Q I+HRD+K+EN+ + + V + D G + +
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF 213
Query: 97 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
G GT APE++ ++ K D++S GIVL+E+L
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 37/96 (38%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 104
L I RG++Y+HS I+HRDLK NL + ED +K+ DFG++ G+ T
Sbjct: 125 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRW 182
Query: 105 WMAPE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 139
+ APE M+ + + VD++S G ++ ELLT T F
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCG--SAKGFTG 101
L L + RG+QYLH I+HRDLK NLLL + C+K+ADFG++ + K T
Sbjct: 113 LMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 102 TYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT 134
YR APE++ +T +D+++ G +L ELL
Sbjct: 173 WYR--APELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 6e-14
Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 11/98 (11%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTG---T-- 102
+ G+QYLHS GILHRD+K N+L+ D +K+ADFG++ + ++ +T T
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR--NSADYTNRVITLW 166
Query: 103 YRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPF 139
YR PE++ R+ +VD++S G +L EL F
Sbjct: 167 YR--PPELLLGATRYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 8e-14
Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGT- 102
L L + G+ +LH ILHRDLK+ NLLL +K+ DFG L + GS K +T
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFG---LAREYGSPLKPYTQLV 167
Query: 103 ----YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 134
YR APE ++ K ++ +D++S G + ELLT
Sbjct: 168 VTLWYR--APELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-14
Identities = 41/135 (30%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 6 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 65
A P I + + GG L +L Q +S + A +I G++++H++ +++RD
Sbjct: 65 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE--AEMRFYAAEIILGLEHMHNRFVVYRD 122
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYS 124
LK N+LL E V+++D G++C S+ GT+ +MAPE++ K + D +S
Sbjct: 123 LKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFS 181
Query: 125 FGIVLWELLTALTPF 139
G +L++LL +PF
Sbjct: 182 LGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-13
Identities = 32/86 (37%), Positives = 55/86 (63%), Gaps = 3/86 (3%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 108
I RG++Y+HS G++HRDLK N+L+ E+ +K+ DFG++ Q G+ T + AP
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA--RIQDPQMTGYVSTRYYRAP 174
Query: 109 E-MIKEKRHTKKVDVYSFGIVLWELL 133
E M+ +++ +VD++S G + E+L
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 35/109 (32%), Positives = 59/109 (54%), Gaps = 2/109 (1%)
Query: 28 YLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87
Y + ++ + +L + + R +QYLH I+HRD+K+EN+ + V + DFG +
Sbjct: 170 YCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 88 CLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
C + K G+ GT APE++ + VD++S GIVL+E+ T
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 41/127 (32%), Positives = 73/127 (57%), Gaps = 8/127 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLL 73
I E++ GGSL + L +E +P ++ K+++ + RG+ YL + I+HRD+K N+L+
Sbjct: 80 ICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137
Query: 74 GEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+K+ DFG+S ++S A F GT +M+PE ++ ++ + D++S G+ L E
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
Query: 132 LLTALTP 138
L P
Sbjct: 195 LAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA-KGFTGTY 103
L + +G++Y+H+ GI+HRDLK NL + ED +K+ DFG L Q S G+ T
Sbjct: 123 LVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFG---LARQTDSEMTGYVVTR 179
Query: 104 RWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPF 139
+ APE+I +T+ VD++S G ++ E+LT F
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 9/145 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q A + ++ EY+ GG L + Y VP ++ + +HS G
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEK---- 114
++HRD+K +N+LL + +K+ADFG + G + T GT +++PE++K +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 115 RHTKKVDVYSFGIVLWELLTALTPF 139
+ ++ D +S G+ L+E+L TPF
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 40/135 (29%), Positives = 73/135 (54%), Gaps = 17/135 (12%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EY+ GG L + Y VP ++ + +HS G +HRD+K +N+LL
Sbjct: 120 MVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 75 EDMCVKVADFGISCLES------QCGSAKGFTGTYRWMAPEMIKEK----RHTKKVDVYS 124
+ +K+ADFG +C++ +C +A GT +++PE++K + + ++ D +S
Sbjct: 177 KSGHLKLADFG-TCMKMNKEGMVRCDTA---VGTPDYISPEVLKSQGGDGYYGRECDWWS 232
Query: 125 FGIVLWELLTALTPF 139
G+ L+E+L TPF
Sbjct: 233 VGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 4/135 (2%)
Query: 6 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRD 65
A P C I + + GG L +L Q +S + A +I G++++H++ +++RD
Sbjct: 65 AFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE--KEMRFYATEIILGLEHMHNRFVVYRD 122
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYS 124
LK N+LL E V+++D G++C S+ GT+ +MAPE++ K + D +S
Sbjct: 123 LKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 125 FGIVLWELLTALTPF 139
G +L++LL +PF
Sbjct: 182 LGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 41/132 (31%), Positives = 68/132 (51%), Gaps = 26/132 (19%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L+K++ +PL L+ + +G+ + HS +LHRDLK +NLL+ + +K+ADF
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADF 144
Query: 85 GISCLESQCGSAKGF------------TGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWE 131
G+ A+ F T YR APE ++ K ++ VD++S G + E
Sbjct: 145 GL---------ARAFGVPVRTYTHEVVTLWYR--APEILLGCKYYSTAVDIWSLGCIFAE 193
Query: 132 LLT--ALTPFDN 141
++T AL P D+
Sbjct: 194 MVTRRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 40/127 (31%), Positives = 69/127 (54%), Gaps = 8/127 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E++ GG +L + + + P ++ A I +YL S I++RDLK ENLLL
Sbjct: 108 LVLEFVIGGEFFTFLRRNKRF--PNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+D +K+ DFG ++ + +T GT ++APE++ H K D ++ GI ++E+
Sbjct: 166 KDGFIKMTDFGF----AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 133 LTALTPF 139
L PF
Sbjct: 222 LVGCPPF 228
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 25/138 (18%)
Query: 24 SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 83
SL K L ++ SV L + I ++Y+HS+G+LHRDLK +N+LLG V + D
Sbjct: 101 SLSKELAEKT--SVGA--FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156
Query: 84 FGI--------------------SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 123
+G C S K GT +MAPE + ++ D+Y
Sbjct: 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK-IVGTPDYMAPERLLGVPASESTDIY 215
Query: 124 SFGIVLWELLTALTPFDN 141
+ G++L+++LT P+
Sbjct: 216 ALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 41/128 (32%), Positives = 63/128 (49%), Gaps = 13/128 (10%)
Query: 18 EYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---G 74
EY+ G +LR+ L +P +L L + + H+QGI+HRDLK +N+++ G
Sbjct: 59 EYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--------GTYRWMAPEMIKEKRHTKKVDVYSFG 126
KV DFGI L A T GT + APE ++ + T D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 127 IVLWELLT 134
++ E LT
Sbjct: 177 LIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-13
Identities = 36/96 (37%), Positives = 55/96 (57%), Gaps = 3/96 (3%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 104
L + G++Y+HS GI+HRDLK NL + ED +K+ DFG++ G+ T
Sbjct: 122 LVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVTRW 179
Query: 105 WMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 139
+ APE+I H + VD++S G ++ E+LT T F
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 4e-13
Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 105
I +G+ ++H G HRDLK ENLL+ VK+ADFG L + S +T Y RW
Sbjct: 108 ILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPPYT-DYVSTRW 163
Query: 106 M-APEMI-KEKRHTKKVDVYSFGIVLWELLTALTP 138
APE++ + ++ VD+++ G ++ EL T L P
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-13
Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 8/91 (8%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 105
+ RG++Y+HS +LHRDLK NLLL + +K+ DFG++ S+ G F Y RW
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG---DFMTEYVVTRW 173
Query: 106 M-APEMI-KEKRHTKKVDVYSFGIVLWELLT 134
APE++ +T +DV+S G + ELL
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLG 204
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-13
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 53 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE-SQCGSAKGFTGTYRWMAPEMI 111
++ LH +++RDLK EN+LL + + DFG+ L F GT ++APE++
Sbjct: 106 LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL 165
Query: 112 KEKRHTKKVDVYSFGIVLWELLTALTPF-DNMTPE 145
+TK VD ++ G++L+E+LT L PF D E
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-13
Identities = 36/147 (24%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY-----SVPLNLVLKLALDIARGMQY 55
+ + A + C++ + KY Y +PL + + + + Y
Sbjct: 149 INLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 56 LHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK---GFTGTYRWMAPEMIK 112
LH +GI+HRD+K+EN+ L E + DFG +C G++GT +PE++
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLA 260
Query: 113 EKRHTKKVDVYSFGIVLWELLTALTPF 139
+ K D++S G+VL+E+
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-13
Identities = 41/149 (27%), Positives = 76/149 (51%), Gaps = 17/149 (11%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q A + ++ EY+ GG L + Y +P ++ + +HS G
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLES------QCGSAKGFTGTYRWMAPEMIKEK 114
+HRD+K +N+LL + +K+ADFG +C++ +C +A GT +++PE++K +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANGMVRCDTA---VGTPDYISPEVLKSQ 218
Query: 115 RHT----KKVDVYSFGIVLWELLTALTPF 139
++ D +S G+ L+E+L TPF
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-13
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I+ ++A GS L P + L+ + RG+ YLH G +HR++K+ ++L+
Sbjct: 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS 135
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYR----------WMAPEMIKEKRH--TKKVDV 122
D V ++ G+S L S + + Y W++PE++++ + K D+
Sbjct: 136 GDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDI 193
Query: 123 YSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 174
YS GI EL T PF +M Q + QK PP P F SR
Sbjct: 194 YSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITTFPCEESR 242
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-13
Identities = 36/109 (33%), Positives = 59/109 (54%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
LR YL + P +P + L RG+ +LH+ I+HRDLK EN+L+ VK+ADF
Sbjct: 93 LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADF 152
Query: 85 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
G++ + S + T + APE++ + + VD++S G + E+
Sbjct: 153 GLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-13
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVAD 83
KY+++ +P ++ K+A+ + + YL + I+HRD+K N+LL + +K+ D
Sbjct: 92 FYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCD 151
Query: 84 FGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTK---KVDVYSFGIVLWELLTALTPF 139
FGIS L + G +MAPE I + DV+S GI L+E+ T P+
Sbjct: 152 FGISGQLVDSIAKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
Query: 140 DNMTP--EQAAFAVCQKNARPPV-PPTCPKAFSY----LISRCWSSSPDRRPHFDQIVS 191
+Q V PP+ + + FS I+ C +RP + +++
Sbjct: 211 PKWNSVFDQLTQVV---KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 32/127 (25%), Positives = 70/127 (55%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C++ + GG L+ +++ + A ++ G++ L + I++RDLK EN+L
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
L + ++++D G++ + + +G GT +MAPE+I +++T D + G +++E+
Sbjct: 135 LDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEM 194
Query: 133 LTALTPF 139
+ +PF
Sbjct: 195 IQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 35/100 (35%), Positives = 58/100 (58%), Gaps = 5/100 (5%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 104
L + RG++Y+HS GI+HRDLK N+ + ED +++ DFG++ G+ T
Sbjct: 123 LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA--RQADDEMTGYVATRW 180
Query: 105 WMAPE-MIKEKRHTKKVDVYSFGIVLWELL--TALTPFDN 141
+ APE M+ + + VD++S G ++ ELL AL P ++
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-12
Identities = 39/114 (34%), Positives = 57/114 (50%), Gaps = 11/114 (9%)
Query: 36 SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGISCLES 91
S+P ++V L I G+ YLHS +LHRDLK N+L+ E VK+ D G++ L
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-F 162
Query: 92 QCGSAKGFTG-----TYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPF 139
T + APE++ RH TK +D+++ G + ELLT F
Sbjct: 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-12
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC---------GSAKGFTG- 101
G+ YLH ILHRD+K+ N+L+ +K+ADFG++ G + +T
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 102 -TYRWM-APEMI-KEKRHTKKVDVYSFGIVLWELLT 134
RW PE++ E+R+T VD++ G V E+ T
Sbjct: 187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-12
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 9/115 (7%)
Query: 34 PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 93
P +P + V + + + Y HS I+HRD+K EN+L+ E +K+ DFG + +
Sbjct: 94 PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARA-LRA 152
Query: 94 GSAKGFTGTY---RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDN 141
A T Y RW APE ++ + + K VDV++ G ++ ELL L P D+
Sbjct: 153 RPASPLT-DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 8e-12
Identities = 32/107 (29%), Positives = 61/107 (57%), Gaps = 2/107 (1%)
Query: 31 QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CL 89
++ P + + V K I RG+++ HS I+HRD+K EN+L+ + VK+ DFG + L
Sbjct: 91 EKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
Query: 90 ESQCGSAKGFTGTYRWMAPEM-IKEKRHTKKVDVYSFGIVLWELLTA 135
+ + T + APE+ + + ++ + VD+++ G ++ E+LT
Sbjct: 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-12
Identities = 47/176 (26%), Positives = 87/176 (49%), Gaps = 14/176 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLL 73
I E++ GGSL + L ++ +P ++ K+++ + +G+ YL + I+HRD+K N+L+
Sbjct: 80 ICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 137
Query: 74 GEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+K+ DFG+S ++S A F GT +M+PE ++ ++ + D++S G+ L E
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
Query: 132 LLTA---LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
+ + P D E + + P+ +S S PD RP
Sbjct: 195 MAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS---SYGPDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-12
Identities = 37/101 (36%), Positives = 58/101 (57%), Gaps = 9/101 (8%)
Query: 38 PLNL--VLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQC 93
PL L V +A + + Y+H +GI+HRD+K+EN+L+ ED+C + DFG +C
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGS 313
Query: 94 GSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
S G GT APE++ +T VD++S G+V++E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 47/197 (23%), Positives = 91/197 (46%), Gaps = 40/197 (20%)
Query: 15 IITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ E++ G L ++H++ + + P K+A +A + YL + ++H ++ ++N+LL
Sbjct: 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASALSYLEDKDLVHGNVCTKNILL 138
Query: 74 GEDMC-------VKVADFGI--------SCLESQCGSAKGFTGTYRWMAPEMIKEKRH-T 117
+ +K++D GI C+E W+APE +++ ++ +
Sbjct: 139 AREGIDGECGPFIKLSDPGIPITVLSRQECVER-----------IPWIAPECVEDSKNLS 187
Query: 118 KKVDVYSFGIVLWEL-LTALTPF-DNMTPEQAAF--AVCQKNARPPVPPTCPKAFSYLIS 173
D +SFG LWE+ P D E+ F C V P+C K + L++
Sbjct: 188 IAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM-----LVTPSC-KELADLMT 241
Query: 174 RCWSSSPDRRPHFDQIV 190
C + P++RP F I+
Sbjct: 242 HCMNYDPNQRPFFRAIM 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 32/109 (29%), Positives = 58/109 (53%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L YL + VP + + + RG+ +LHS ++HRDLK +N+L+ +K+ADF
Sbjct: 95 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 154
Query: 85 GISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
G++ + S + T + APE++ + + VD++S G + E+
Sbjct: 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 13/140 (9%)
Query: 11 PVFCIITEYLAGGSLRKYL---HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
P ++ EYL L+K++ + +P + + +G+ + H G++HRDLK
Sbjct: 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137
Query: 68 SENLLLGED-MCVKVADFGISCLESQCGSAKGFTG---TYRWMAPEMIKEKRH-TKKVDV 122
+NLL+ + +K+AD G+ S K +T T + APE++ H + VD+
Sbjct: 138 PQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDI 195
Query: 123 YSFGIVLWELLT--ALTPFD 140
+S G + E+ L P D
Sbjct: 196 WSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-11
Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 6/128 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I +Y+ G L L ++ S V K+ + + LH I+H D+K EN+L
Sbjct: 86 LIMDYIKDGDLFDLLKKEGKLSEAE--VKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 75 EDMC-VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ + D+G+ + G+ + GT + +PE IK + D ++ G++ +ELL
Sbjct: 144 RAKDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200
Query: 134 TALTPFDN 141
T PF
Sbjct: 201 TGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 38/113 (33%), Positives = 61/113 (53%), Gaps = 9/113 (7%)
Query: 32 QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGIS 87
++P +P ++V L I G+ YLH+ +LHRDLK N+L+ E VK+AD G +
Sbjct: 100 KKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159
Query: 88 CLESQ----CGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTA 135
L + T+ + APE++ RH TK +D+++ G + ELLT+
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 41/119 (34%), Positives = 60/119 (50%), Gaps = 8/119 (6%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMA 107
G+ Y H + LHRD+K N+LL +K+ADFG++ L ES+ + K T YR
Sbjct: 128 GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR--P 185
Query: 108 PE-MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
PE ++ E+R+ +DV+S G +L EL T P E A + + P P P
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWP 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-10
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 9/113 (7%)
Query: 32 QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL----GEDMCVKVADFGIS 87
++P +P +V L I G+ YLH+ +LHRDLK N+L+ E VK+AD G +
Sbjct: 100 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159
Query: 88 CLESQ----CGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTA 135
L + T+ + APE++ RH TK +D+++ G + ELLT+
Sbjct: 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 29/88 (32%), Positives = 50/88 (56%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 111
G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T + APE+I
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 112 KEKRHTKKVDVYSFGIVLWELLTALTPF 139
+ + VD++S G ++ EL+ F
Sbjct: 195 LGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 24/123 (19%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L+KY+ + L+ + +G+ Y HS +LHRDLK +NLL+ + +K+ADF
Sbjct: 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADF 143
Query: 85 GISCLESQCGSAKGF------------TGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWE 131
G+ A+ F T YR APE++ R + VD++S G + E
Sbjct: 144 GL---------ARAFGVPVRTYTHEVVTLWYR--APEILLGSRQYSTPVDIWSIGCIFAE 192
Query: 132 LLT 134
++
Sbjct: 193 MVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 26/134 (19%)
Query: 15 IITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+I E+L+ L+KYL + LV I +G+ + HS+ +LHRDLK +NLL+
Sbjct: 76 LIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134
Query: 74 GEDMCVKVADFGISCLESQCGSAKGF------------TGTYRWMAPE-MIKEKRHTKKV 120
+K+ADFG+ A+ F T YR APE ++ R++ V
Sbjct: 135 DNKGVIKLADFGL---------ARAFGIPVRVYTHEVVTLWYR--APEVLLGSPRYSTPV 183
Query: 121 DVYSFGIVLWELLT 134
D++S G + E+ T
Sbjct: 184 DIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 36/130 (27%), Positives = 69/130 (53%), Gaps = 8/130 (6%)
Query: 15 IITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ EY+ L+KY+ ++ N V + +G+ + H +LHRDLK +NLL+
Sbjct: 75 LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI 133
Query: 74 GEDMCVKVADFGIS---CLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVL 129
+ +K+ADFG++ + S + T YR AP+++ R ++ +D++S G ++
Sbjct: 134 NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYR--APDVLLGSRTYSTSIDIWSVGCIM 191
Query: 130 WELLTALTPF 139
E++T F
Sbjct: 192 AEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-10
Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 17/186 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
++ EY+ GSL YL + + + ++ L++A +A + +L +G+ H ++ ++N+LL
Sbjct: 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134
Query: 74 -------GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSF 125
G +K++D GIS + W+ PE I+ ++ + D +SF
Sbjct: 135 REEDRKTGNPPFIKLSDPGISI---TVLPKEILLERIPWVPPECIENPQNLSLAADKWSF 191
Query: 126 GIVLWELLTALT-PFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
G LWE+ + P + Q + + P P A LI++C PD RP
Sbjct: 192 GTTLWEIFSGGDKPLSALDS-QKKLQFYEDRHQLPAPKWTELAN--LINQCMDYEPDFRP 248
Query: 185 HFDQIV 190
F I+
Sbjct: 249 SFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 33/93 (35%), Positives = 56/93 (60%), Gaps = 14/93 (15%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG--SAKGFTGTY--- 103
+ + + ++H GI HRD+K EN+L+ +D +K+ADFG SC G S +T Y
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC----RGIYSKPPYT-EYIST 161
Query: 104 RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
RW APE ++ + + K+D+++ G V +E+L+
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 10/77 (12%)
Query: 15 IITEYLAGGSLRKYLHQ----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++ EYL GG ++ LH E +V K ++A + YLH GI+HRDLK +N
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAV------KYISEVALALDYLHRHGIIHRDLKPDN 134
Query: 71 LLLGEDMCVKVADFGIS 87
+L+ + +K+ DFG+S
Sbjct: 135 MLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-10
Identities = 27/82 (32%), Positives = 49/82 (59%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 111
G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T + APE+I
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 112 KEKRHTKKVDVYSFGIVLWELL 133
+ + VD++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-10
Identities = 33/103 (32%), Positives = 58/103 (56%), Gaps = 6/103 (5%)
Query: 40 NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS---CLESQCGSA 96
+V + +G+ + HS +LHRDLK +NLL+ ++ +K+ADFG++ + +C SA
Sbjct: 99 EIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158
Query: 97 KGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLTALTP 138
+ T YR P+ + K ++ +D++S G + EL A P
Sbjct: 159 EVVTLWYR--PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 27/82 (32%), Positives = 49/82 (59%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 111
G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T + APE+I
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 112 KEKRHTKKVDVYSFGIVLWELL 133
+ + VD++S G ++ E++
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 49/189 (25%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L YL + +P + L + RG+ +LHS I+HRDLK +N+L+ D VK+ADF
Sbjct: 92 LATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADF 151
Query: 85 GIS---CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL--LTAL--- 136
G++ E S T YR APE++ + + VD++S G + EL L
Sbjct: 152 GLARIYSFEMALTSVV-VTLWYR--APEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208
Query: 137 ---------------TPFDNMTPEQAAF---AVCQKNARPP---VPPTCPKAFSYLISRC 175
P + P + + R VP C + L+ +
Sbjct: 209 TSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLD-LLKKM 267
Query: 176 WSSSPDRRP 184
+ +P +R
Sbjct: 268 LTFNPHKRI 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 27/82 (32%), Positives = 49/82 (59%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 111
G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T + APE+I
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189
Query: 112 KEKRHTKKVDVYSFGIVLWELL 133
+ + VD++S G ++ E++
Sbjct: 190 LGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 6/156 (3%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EY+ L L ++ P VP V + + + + H I+HRD+K ENLL+
Sbjct: 77 LVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134
Query: 75 EDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ +K+ DFG + S+ +A + T + +PE++ + K VD++S G +L EL
Sbjct: 135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 168
F + F + + P+P K F
Sbjct: 195 SDGQPLFPGESEIDQLFTI--QKVLGPLPAEQMKLF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RWM- 106
R ++Y+H+ + HRDLK +N+L D +K+ DFG++ + F Y RW
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 107 APEMIKE--KRHTKKVDVYSFGIVLWELLT 134
APE+ ++T +D++S G + E+LT
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 33/135 (24%), Positives = 66/135 (48%), Gaps = 13/135 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ EY GG L L++ Y ++ ++ + +H G +HRD+K EN+L
Sbjct: 78 LVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 73 LGEDMCVKVADFGISCLESQCGS--AKGFTGTYRWMAPEMIK------EKRHTKKVDVYS 124
+ +K+ADFG + + +K GT ++APE++ + + + D +S
Sbjct: 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS 194
Query: 125 FGIVLWELLTALTPF 139
G++ +E++ +PF
Sbjct: 195 LGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 53/214 (24%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +Y+ GG + L + E + P L ++ ++ +H G +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMEVF--PEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL 136
Query: 76 DMCVKVADFGI-------------------------------SCLESQCGS--------- 95
D +K+ DFG+ +CG
Sbjct: 137 DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRA 196
Query: 96 --------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 147
A GT ++APE++ K +T+ D +S G++L+E+L PF TP +
Sbjct: 197 TKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTET 256
Query: 148 AFAVCQKNARPPVPPT---CPKAFSYLISRCWSS 178
V +PP P+A + C S+
Sbjct: 257 QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSA 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 37/132 (28%), Positives = 69/132 (52%), Gaps = 23/132 (17%)
Query: 15 IITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E++ ++ KY+ + + +++PL LV + + R + Y+HS+ I HRDLK +NLL
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLL 202
Query: 73 LGEDM-CVKVADFGISCLESQCGSAKGFTGTYR---------WMAPE-MIKEKRHTKKVD 121
+ + +K+ DF GSAK R + APE M+ +T +D
Sbjct: 203 IDPNTHTLKLCDF---------GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHID 253
Query: 122 VYSFGIVLWELL 133
++S G ++ E++
Sbjct: 254 LWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 31 QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CL 89
++ P VP +L+ K+ + + + H +HRD+K EN+L+ + +K+ DFG + L
Sbjct: 91 EKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150
Query: 90 ESQCGSAKGFTGTYRWM-APEMI-KEKRHTKKVDVYSFGIVLWELLT 134
+ T RW APE++ + ++ VDV++ G V ELLT
Sbjct: 151 TGPGDDYTDYVAT-RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-09
Identities = 41/126 (32%), Positives = 65/126 (51%), Gaps = 10/126 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EYL L+K++ ++ L+ I RG+ Y HS +LHRDLK +NLL+
Sbjct: 78 LVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136
Query: 75 EDM-CVKVADFGISCLESQCG-SAKGFTG---TYRWMAPEMIKEKRH-TKKVDVYSFGIV 128
+K+ADFG L G + FT T + APE++ RH + VD++S G +
Sbjct: 137 RRTNALKLADFG---LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCI 193
Query: 129 LWELLT 134
E++
Sbjct: 194 FAEMVN 199
|
Length = 294 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 57/267 (21%), Positives = 98/267 (36%), Gaps = 81/267 (30%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +Y+ GG + L + + P +L ++ ++ +H G +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRMGIF--PEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR 136
Query: 76 DMCVKVADFGI----------------------------------SCLESQCGS------ 95
D +K+ DFG+ +C +CG
Sbjct: 137 DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC---RCGDRLKPLE 193
Query: 96 -----------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 144
A GT ++APE++ +T+ D +S G++L+E+L PF TP
Sbjct: 194 RRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
Query: 145 EQAAFAVCQKNARPPVPPTC---PKAFSYLISRCWSSSPDRR------------PHFDQI 189
+ V +PP P+A +I C P+ R P F I
Sbjct: 254 LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPEDRLGKNGADEIKAHPFFKTI 311
Query: 190 VSILEGYSESLEQDPEFFSSFIPSPDH 216
+S L Q + +IP H
Sbjct: 312 -----DFSSDLRQQS---APYIPKITH 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 36/133 (27%), Positives = 73/133 (54%), Gaps = 10/133 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ +Y GG L L + E +P ++ ++ + +H +HRD+K +N+LL
Sbjct: 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
Query: 75 EDMCVKVADFGISCLE-SQCGSAKG--FTGTYRWMAPEMIKEK-----RHTKKVDVYSFG 126
+ +++ADFG SCL+ +Q G+ + GT +++PE+++ ++ + D +S G
Sbjct: 137 MNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 127 IVLWELLTALTPF 139
+ ++E+L TPF
Sbjct: 196 VCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-09
Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 2/98 (2%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE- 109
RG+ Y H + +LHRDLK +NLL+ E +K+ADFG++ +S W P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPD 174
Query: 110 -MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
++ ++ ++D++ G + +E+ T F T E+
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-09
Identities = 43/131 (32%), Positives = 69/131 (52%), Gaps = 15/131 (11%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL---LGEDMCVKV 81
L +Y+ Q P N+ L + RG+ Y+H Q ILHRDLK +NLL LGE +K+
Sbjct: 89 LAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKL 144
Query: 82 ADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLTALT 137
ADFG++ + SQ S++ T YR P+ ++ ++ +D++ G + E+L
Sbjct: 145 ADFGLARAKSIPSQTYSSEVVTLWYR--PPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202
Query: 138 PFDNMT--PEQ 146
F ++ EQ
Sbjct: 203 AFPGVSDVFEQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 34/133 (25%), Positives = 70/133 (52%), Gaps = 10/133 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ +Y GG L L + E +P ++ ++ + +H +HRD+K +N+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
Query: 75 EDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFG 126
+ +++ADFG SCL E + GT +++PE+++ + ++ + D +S G
Sbjct: 137 MNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG 195
Query: 127 IVLWELLTALTPF 139
+ ++E+L TPF
Sbjct: 196 VCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-08
Identities = 37/174 (21%), Positives = 69/174 (39%), Gaps = 48/174 (27%)
Query: 16 ITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+ +Y+ GG + L + + +L ++ ++ +H G +HRD+K +N+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIF--EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136
Query: 76 DMCVKVADFGISCL------------------------------ESQCG----------- 94
D +K+ DFG+ C +C
Sbjct: 137 DGHIKLTDFGL-CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 95 ----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 144
A GT ++APE++ +T+ D +S G++L+E+L PF TP
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 249
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 34/202 (16%)
Query: 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
C + ++ E++ G L L ++E VP+ + +A +A + YL + ++H ++
Sbjct: 85 CVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNV 143
Query: 67 KSENLLL-------GEDMCVKVADFGISCLESQCGSAKGFTGTYR--------WMAPEMI 111
++N+LL G +K++D G+S FT R W+APE +
Sbjct: 144 CAKNILLARLGLAEGTSPFIKLSDPGVS-----------FTALSREERVERIPWIAPECV 192
Query: 112 KEKRH-TKKVDVYSFGIVLWEL-LTALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAF 168
+ D +SFG L E+ P TP E+ F +K R P P+C +
Sbjct: 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY--EKKHRLP-EPSCKE-L 248
Query: 169 SYLISRCWSSSPDRRPHFDQIV 190
+ LIS+C + P +RP F I+
Sbjct: 249 ATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 28/89 (31%), Positives = 52/89 (58%), Gaps = 6/89 (6%)
Query: 52 GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKG--FTG---TYRWM 106
G+ Y+H ILHRD+K+ N+L+ +D +K+ADFG++ S ++K +T T +
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 107 APEMIKEKRH-TKKVDVYSFGIVLWELLT 134
PE++ +R +D++ G ++ E+ T
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 43/187 (22%), Positives = 75/187 (40%), Gaps = 38/187 (20%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I E+L GG + L +++ + +A + +H G +HRD+K +NLLL
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA--IDSIHQLGFIHRDIKPDNLLLD 135
Query: 75 EDMCVKVADFGISC-----------------------LESQCGSAKGFT----------- 100
VK++DFG+ ++ K T
Sbjct: 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFS 195
Query: 101 --GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158
GT ++APE+ + + K D +S G++++E+L PF + TP++ V
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETL 255
Query: 159 PVPPTCP 165
PP P
Sbjct: 256 IFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 2/95 (2%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE- 109
RG+ Y H + ILHRDLK +NLL+ E +K+ADFG++ +S W P
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173
Query: 110 -MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 143
++ ++ +D++ G +L+E+ T F T
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 45/187 (24%), Positives = 76/187 (40%), Gaps = 38/187 (20%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I E+L GG + L +++ S +A + +H G +HRD+K +NLLL
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA--IDAIHQLGFIHRDIKPDNLLLD 135
Query: 75 EDMCVKVADFGI---------------------SCLESQCGSAK---------------G 98
VK++DFG+ S Q ++K
Sbjct: 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYS 195
Query: 99 FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158
GT ++APE+ + + K D +S G++++E+L PF + TP++ V
Sbjct: 196 TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL 255
Query: 159 PVPPTCP 165
PP P
Sbjct: 256 VFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 2/99 (2%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 108
I RG+ Y H + +LHRDLK +NLL+ E +K+ADFG++ +S W P
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 109 E--MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 145
++ ++ ++D++ G + +E+ + F T E
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 10/142 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+++ +A GS L P +P + + D+ + Y+HS+G +HR +K+ ++LL
Sbjct: 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS 135
Query: 75 EDMCVKVADFGISC--------LESQCGSAKGFTGTYRWMAPEMIKEKRH--TKKVDVYS 124
D V ++ S K W++PE++++ +K D+YS
Sbjct: 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS 195
Query: 125 FGIVLWELLTALTPFDNMTPEQ 146
GI EL PF +M Q
Sbjct: 196 VGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-08
Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 6/124 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ ++ GG L ++ + ++P V + A ++ + LH +GI+ RDL N+LL
Sbjct: 62 LVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
Query: 75 EDMCVKVADFG-ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ +++ F S +E C + Y APE+ T+ D +S G +L+ELL
Sbjct: 120 DRGHIQLTYFSRWSEVEDSCDG-EAVENMY--CAPEVGGISEETEACDWWSLGAILFELL 176
Query: 134 TALT 137
T T
Sbjct: 177 TGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-08
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 3/107 (2%)
Query: 38 PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK 97
P N+ L L + RG+ Y+H + ILHRDLK +NLL+ + +K+ADFG++ +S
Sbjct: 102 PENVKLFL-FQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160
Query: 98 GFTGTYRWMAPE--MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM 142
W P ++ ++ +D++ G + E++ + F M
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 38/147 (25%), Positives = 77/147 (52%), Gaps = 20/147 (13%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--- 57
++ + C+ +I EY+ G +L + L ++ K+A+ IA+ +++LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRC 800
Query: 58 SQGILHRDLKSENLLL-GED---MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 113
S ++ +L E +++ G+D + + + G+ C +++C + + +APE +
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLRLSLP--GLLCTDTKCFISSAY------VAPETRET 852
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPFD 140
K T+K D+Y FG++L ELLT +P D
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 30/143 (20%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
++ +Y GG L L + E +L D+AR + +H G +HRD+
Sbjct: 78 LVMDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVLAIDSVHQLGYVHRDI 128
Query: 67 KSENLLLGEDMC--VKVADFGISCLE-SQCGSAKGF--TGTYRWMAPEMIK-----EKRH 116
K +N+LL D +++ADFG SCL G+ + GT +++PE+++ + R+
Sbjct: 129 KPDNVLL--DKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 117 TKKVDVYSFGIVLWELLTALTPF 139
+ D +S G+ ++E+L TPF
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 19/37 (51%), Positives = 28/37 (75%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87
RG+ Y H + +LHRDLK +NLL+ E +K+ADFG++
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-07
Identities = 37/148 (25%), Positives = 57/148 (38%), Gaps = 20/148 (13%)
Query: 45 LALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYR 104
+ L ++ LH Q KS N+LL D +K+ G S + + Y
Sbjct: 22 VCLQCLGALRELHRQA------KSGNILLTWDGLLKL--DG-SV--AFKTPEQSRPDPY- 69
Query: 105 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 164
+MAPE+I+ + +T+K D+YS GI L+E L P++ A + P
Sbjct: 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR 129
Query: 165 PKAFSYL--------ISRCWSSSPDRRP 184
+ C S P RR
Sbjct: 130 SNLEGVSAARSFEDFMRLCASRLPQRRE 157
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 31/151 (20%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ + +A L+K + ++ + V + L I G+ LH +HRDL N+ +
Sbjct: 96 NLVMDIMAS-DLKKVVDRKIRLTESQ--VKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152
Query: 74 GEDMCVKVADFGISCLESQCG--------------------SAKGFTGTYRWMAPEMI-K 112
K+ADFG++ + G ++K T YR APE++
Sbjct: 153 NSKGICKIADFGLA---RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYR--APELLMG 207
Query: 113 EKRHTKKVDVYSFGIVLWELLT--ALTPFDN 141
+++ VD++S G + ELLT L P +N
Sbjct: 208 AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-07
Identities = 37/144 (25%), Positives = 69/144 (47%), Gaps = 19/144 (13%)
Query: 53 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEM 110
++Y+H + ++HRD+K EN+ L D + + DFG + + A G+ GT +PE+
Sbjct: 280 VEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEI 339
Query: 111 IKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMT--PEQA------AFAVCQKNARPPVP 161
+ + + D++S G++L ++L+ P + P + + +VC + P P
Sbjct: 340 LAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEF--PDP 397
Query: 162 PTCPKAFSYLISRCWSSSPDRRPH 185
P K F Y+ S+ D H
Sbjct: 398 PC--KLFDYI----DSAEIDHAGH 415
|
Length = 501 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 40/181 (22%), Positives = 77/181 (42%), Gaps = 49/181 (27%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS--VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+I EYL GG + L +++ ++ + + L I +H G +HRD+K +NLL
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAI----DSIHKLGYIHRDIKPDNLL 133
Query: 73 LGEDMCVKVADFGI------------------------SCLESQCGSAKGFTGTYR---- 104
L +K++DFG+ S+ S+K T++
Sbjct: 134 LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRR 193
Query: 105 -----------WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153
++APE+ + + K+ D +S G++++E+L PF + P++ +
Sbjct: 194 ALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQET----YR 249
Query: 154 K 154
K
Sbjct: 250 K 250
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-06
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 39/203 (19%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHS-------QGILH 63
I+ E+ G L + + Q+ Y + + +DI R + Y H+ + +LH
Sbjct: 91 ILMEFCDAGDLSRNI--QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLH 148
Query: 64 RDLKSENLLLGEDM-----------------CVKVADFGIS---CLESQCGSAKGFTGTY 103
RDLK +N+ L + K+ DFG+S +ES S G Y
Sbjct: 149 RDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG--TPY 206
Query: 104 RWMAPEMI--KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 161
W +PE++ + K + K D+++ G +++EL + TPF + ++ P+
Sbjct: 207 YW-SPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIK 265
Query: 162 PTCPKAFSYLISRCWSSSPDRRP 184
K + LI + S RP
Sbjct: 266 GK-SKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 20/47 (42%), Positives = 31/47 (65%)
Query: 39 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 85
+N++ + + G++ LH GI+HRD+K ENLL+ D VK+ DFG
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-05
Identities = 19/46 (41%), Positives = 31/46 (67%)
Query: 101 GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
GT ++APE++ K H VD ++ G+ L+E LT + PF++ TP+Q
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ 587
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 23/81 (28%), Positives = 41/81 (50%), Gaps = 18/81 (22%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
+I E+L GG L L + + +S D+ R ++ +H G +HRD+
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSE----------DVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 67 KSENLLLGEDMCVKVADFGIS 87
K +N+L+ +K++DFG+S
Sbjct: 128 KPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 7e-04
Identities = 24/76 (31%), Positives = 41/76 (53%), Gaps = 9/76 (11%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
F I+ EY+ G L+ ++ L+L+ +I R + LHS GI+H DL + N++
Sbjct: 74 FIIVMEYIEGEPLKDLINSNGM------EELELSREIGRLVGKLHSAGIIHGDLTTSNMI 127
Query: 73 L-GEDMCVKVADFGIS 87
L G + + DFG++
Sbjct: 128 LSGGKIY--LIDFGLA 141
|
Length = 211 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 32/144 (22%), Positives = 62/144 (43%), Gaps = 14/144 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++T ++A GS + + + + + + + + Y+H G +HR +K+ ++L+
Sbjct: 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
Query: 75 EDMCVKVADFGISCLESQCGSA----------KGFTGTYRWMAPEMIKE--KRHTKKVDV 122
D KV G+ S K W++PE++++ + + K D+
Sbjct: 136 VDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193
Query: 123 YSFGIVLWELLTALTPFDNMTPEQ 146
YS GI EL PF +M Q
Sbjct: 194 YSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.002
Identities = 19/73 (26%), Positives = 34/73 (46%), Gaps = 10/73 (13%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY+ G L+ L +L+ ++ + + LH GI+H DL + N++L
Sbjct: 76 IVMEYIEGELLKDALE-----EARPDLLREVGRLVGK----LHKAGIVHGDLTTSNIILS 126
Query: 75 EDMCVKVADFGIS 87
+ DFG+
Sbjct: 127 GGRIYFI-DFGLG 138
|
Length = 204 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.002
Identities = 18/73 (24%), Positives = 35/73 (47%), Gaps = 10/73 (13%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY+ G L+ + L+ ++ + + LH GI+H DL + N+++
Sbjct: 74 IVMEYIEGKPLKDVIE-----EGNDELLREIGRLVGK----LHKAGIVHGDLTTSNIIVR 124
Query: 75 EDMCVKVADFGIS 87
+D + DFG+
Sbjct: 125 DDKLY-LIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 244 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.98 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.62 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.6 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.51 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.49 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.45 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.44 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.41 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.4 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.24 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.23 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.11 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.02 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.67 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.88 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.77 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.74 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.2 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.07 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.82 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.71 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.23 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.16 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.09 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.06 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.03 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.99 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.95 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.89 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.83 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.56 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.08 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.94 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.5 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.46 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.24 | |
| PLN02236 | 344 | choline kinase | 94.17 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.67 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.6 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.54 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.05 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.88 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 92.76 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 92.54 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.2 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 91.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 91.59 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 90.46 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 90.26 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=294.44 Aligned_cols=193 Identities=30% Similarity=0.521 Sum_probs=170.7
Q ss_pred CcEEEEeecCCc-EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPV-FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~ 78 (244)
|.+|+.|..+.. .+|+||||.||||.+++...+ .+++....+++.++++||.|||+ ++|+||||||+|||++.+|.
T Consensus 140 V~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 140 VGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred eeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC
Confidence 678999999995 999999999999999999876 68999999999999999999996 89999999999999999999
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC-----CHHHHHHHHHh
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM-----TPEQAAFAVCQ 153 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~ 153 (244)
+||||||.+...... ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... ..-+....+.
T Consensus 218 VKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv- 295 (364)
T KOG0581|consen 218 VKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV- 295 (364)
T ss_pred EEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-
Confidence 999999999776654 667899999999999999999999999999999999999999999874 3444444443
Q ss_pred hCCCCCCCCC-chHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 026042 154 KNARPPVPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYS 197 (244)
Q Consensus 154 ~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~ 197 (244)
....+..|.. ++++++.|+..||++||.+||++.|+++ ++.++.
T Consensus 296 ~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 296 DEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 4455666665 9999999999999999999999999997 555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=286.70 Aligned_cols=202 Identities=50% Similarity=0.920 Sum_probs=184.3
Q ss_pred CcEEEEeecCC-cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCcEEEcCCC-
Q 026042 1 MQFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDM- 77 (244)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~-i~H~dikp~nil~~~~~- 77 (244)
|+++|.|.+.. .++|||||+++|+|.+++.+.....++...+.+++.+|+.|+.|||+++ |+||||||+|||++.++
T Consensus 102 V~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~ 181 (362)
T KOG0192|consen 102 VQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGK 181 (362)
T ss_pred eeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCC
Confidence 67999999998 7999999999999999998854447999999999999999999999999 99999999999999998
Q ss_pred cEEEecCCCccccccc-CCCCCCCcccceeccceec--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 78 CVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.+||+|||+++..... .......||+.|||||++. ...++.|+||||||+++|||+||+.||......+....+...
T Consensus 182 ~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~ 261 (362)
T KOG0192|consen 182 TLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG 261 (362)
T ss_pred EEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 9999999999765543 3344478999999999999 568999999999999999999999999999998888888888
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
..++..+..+++.+..++..||..||..||++.+++..|+.+......
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999999999999988776553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=293.62 Aligned_cols=187 Identities=29% Similarity=0.494 Sum_probs=173.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|++.++.|||+|+|+.++|..+++++. .+++.+++.++.||+.||.|||+++|+|||||..|++++++..+|
T Consensus 81 V~f~~~FEDs~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 81 VQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred EeeeeEeecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEE
Confidence 689999999999999999999999999999655 799999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||+|..... .....+.+||+.|.|||++.....+..+||||+||++|-|+.|++||...+..+....+... ...
T Consensus 159 IgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--~Y~ 236 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--EYS 236 (592)
T ss_pred ecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--Ccc
Confidence 999999987664 46788999999999999999999999999999999999999999999998888888777544 456
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.|...+.+..+||.++|+.||.+|||+++++.
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 66689999999999999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=289.22 Aligned_cols=188 Identities=26% Similarity=0.428 Sum_probs=169.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++|-.|++...+|+|+||+++|+|.++|++.+ .+++..++.++.||++||+|||++|||||||||+|||+|.+|+++
T Consensus 137 vkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 137 VKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred EEEEEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEE
Confidence 578999999999999999999999999999987 699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC------------CC--CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 81 VADFGISCLESQCG------------SA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 81 l~dfg~~~~~~~~~------------~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
|.|||.+....... .. ..++||..|.+||++.....+..+|||+|||++|+|+.|.+||.+.+...
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl 294 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL 294 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH
Confidence 99999886533211 11 45889999999999999999999999999999999999999999988777
Q ss_pred HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 147 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
....++ .....+++..++..++||.++|..||.+|++..+|.+.
T Consensus 295 iFqkI~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 IFQKIQ--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHH--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 666664 34467888999999999999999999999999999884
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=276.26 Aligned_cols=181 Identities=28% Similarity=0.446 Sum_probs=164.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++-.|+++..+|+|+||+.||.|...+++.+ .+++..++-++.+|+.||.|||++||+||||||+|||+|..|.++
T Consensus 88 v~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 88 VKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred eeeEEecccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEE
Confidence 578889999999999999999999999999887 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccc-ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.. ........+++||+.|||||++.+.+++..+|+||||+++|+|++|..||.+.+.......+.... ...
T Consensus 166 LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~ 244 (357)
T KOG0598|consen 166 LTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPL 244 (357)
T ss_pred EeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCC
Confidence 999999974 344456677899999999999999999999999999999999999999999998888777665433 455
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP 184 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp 184 (244)
.+..++.+.+++++++|..||++|.
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhc
Confidence 5666999999999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=283.48 Aligned_cols=189 Identities=28% Similarity=0.438 Sum_probs=164.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---C
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---M 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---~ 77 (244)
|+++++|...+..|||+||++||+|.+.+-.++ .+.+...+.++.||+.|+.|||++||+||||||+|||++.+ .
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcce
Confidence 689999999999999999999999999998877 57778889999999999999999999999999999999876 5
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCC---CCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHh
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH---TKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQ 153 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~ 153 (244)
.+||+|||+|..........+.+||+.|.|||++..... ..+.|+||+||++|-+++|.+||.+..... ...++..
T Consensus 317 llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred EEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 799999999999888888899999999999999977643 458899999999999999999998765555 4444433
Q ss_pred hCCC--CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNAR--PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... +.....++++..++|.+||..||++|||++|+++
T Consensus 397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3222 2334667899999999999999999999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=280.26 Aligned_cols=192 Identities=28% Similarity=0.539 Sum_probs=165.8
Q ss_pred CcEEEEeecCC--cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CC
Q 026042 1 MQFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DM 77 (244)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~ 77 (244)
|+++|...... .+++.|||+++|+|.+++.+.++ .+++..+..+++|+++||+|||++|++|+||||+|||++. +|
T Consensus 77 V~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~ 155 (313)
T KOG0198|consen 77 VQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG 155 (313)
T ss_pred EeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC
Confidence 45666543444 69999999999999999999887 7999999999999999999999999999999999999999 79
Q ss_pred cEEEecCCCcccccc----cCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHH
Q 026042 78 CVKVADFGISCLESQ----CGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAV 151 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~ 151 (244)
.+||+|||++..... ........||+.|||||++..+ ....++|||||||++.||+||+.||.. .........+
T Consensus 156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i 235 (313)
T KOG0198|consen 156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI 235 (313)
T ss_pred eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH
Confidence 999999998875542 2334567899999999999863 334699999999999999999999998 5566666666
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
......+.+|..++++.++|+.+|+..+|++|||++++++..
T Consensus 236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 656666788999999999999999999999999999999844
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=279.58 Aligned_cols=198 Identities=35% Similarity=0.685 Sum_probs=178.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|+.++.+|||+||++.|+|.+|++...+..+...+.+.++.||++|++||+++++|||||.+.||||+++..+|
T Consensus 264 V~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vK 343 (468)
T KOG0197|consen 264 VKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVK 343 (468)
T ss_pred EEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEE
Confidence 68999999999999999999999999999986666789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+|+...+... .........|.|||.+..+.++.++||||||++++||+| |+.||.+++..+....+ ....+
T Consensus 344 IsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-e~GyR 422 (468)
T KOG0197|consen 344 ISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-ERGYR 422 (468)
T ss_pred EcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-hccCc
Confidence 999999985443222 223334668999999999999999999999999999999 99999999999887766 57778
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.+.|..||+.+.+++..||..+|++|||++.+...++.+...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 899999999999999999999999999999999999877553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=280.19 Aligned_cols=187 Identities=28% Similarity=0.492 Sum_probs=169.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-~~~ 79 (244)
+++++++.....+|+||||+.||+|.+++.+.+ .+.+..+..+++|+++|++|||++||+||||||+||+++.+ +.+
T Consensus 83 ~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 83 IRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred eEEEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCE
Confidence 578999999999999999999999999999955 68889999999999999999999999999999999999999 999
Q ss_pred EEecCCCcccc-cccCCCCCCCcccceeccceeccCC-C-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 80 KVADFGISCLE-SQCGSAKGFTGTYRWMAPEMIKEKR-H-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 80 kl~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
||+|||++... .........+|++.|+|||++.+.. + +.++||||+|+++|.|++|..||+..+.......+ ...
T Consensus 161 Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki--~~~ 238 (370)
T KOG0583|consen 161 KLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI--RKG 238 (370)
T ss_pred EEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH--hcC
Confidence 99999999877 4666788999999999999998876 6 58999999999999999999999997766666553 445
Q ss_pred CCCCCCCc-hHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPPVPPTC-PKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+|..+ +.++..++.+||..+|.+|+++.++++
T Consensus 239 ~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 56677777 999999999999999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=267.08 Aligned_cols=185 Identities=27% Similarity=0.448 Sum_probs=159.9
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccCCCCCCcEEEcCCCcEEE
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHS--QG--ILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~--~~--i~H~dikp~nil~~~~~~~kl 81 (244)
++...++||||||.+|+|..+|+. ...+.++++.+|+++.|++.||.++|. .+ ++||||||.||+++.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 344448999999999999999975 455579999999999999999999999 45 999999999999999999999
Q ss_pred ecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||+++...... ...+.+|||.||+||.+.+.+++.++||||+||++|||+.-..||.+.+-.+....+.+.. .++.
T Consensus 170 GDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~ 248 (375)
T KOG0591|consen 170 GDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPL 248 (375)
T ss_pred ccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCC
Confidence 9999998765433 3567889999999999999999999999999999999999999999987777766665553 3445
Q ss_pred C-CCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 161 P-PTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 161 ~-~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
| ..++.++..+|..|+..||+.||+.-.++..+
T Consensus 249 p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 249 PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 5 78999999999999999999999965555443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=260.02 Aligned_cols=177 Identities=28% Similarity=0.458 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++.|.+.+..||||||++||.|..++++.+ +++++.++-++.|++.||+|||+++|++||+||+|||+|.+|.+|
T Consensus 107 v~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 107 VKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred EEEEEeeccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEE
Confidence 578899999999999999999999999999988 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||+|..... ...+.+||+.|+|||.+...+++.++|+||||+++|||+.|.+||...++.+....+. .....+
T Consensus 185 itDFGFAK~v~~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~f 260 (355)
T KOG0616|consen 185 ITDFGFAKRVSG--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKF 260 (355)
T ss_pred EEeccceEEecC--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccC
Confidence 999999977655 3678899999999999999999999999999999999999999999988877666664 444678
Q ss_pred CCCchHHHHHHHHHhcccCCCCC
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRR 183 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~R 183 (244)
|+.++.++++|+.++|+.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 88999999999999999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=269.69 Aligned_cols=189 Identities=27% Similarity=0.523 Sum_probs=167.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---- 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---- 76 (244)
|++++++..++++|+|||||.||+|.+||++++ .+++..++.++.||+.||++||+++|+||||||.|||++.+
T Consensus 72 V~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 72 VRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARND 149 (429)
T ss_pred eeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCC
Confidence 689999999999999999999999999999987 68999999999999999999999999999999999999875
Q ss_pred --CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 77 --MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 77 --~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
-.+||+|||+|+.........+.+|++-|||||++..+.|+.|+|+||+|+++|+|++|+.||+..+..+....+...
T Consensus 150 ~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred CCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 358999999999988877888999999999999999999999999999999999999999999999998887766555
Q ss_pred CCCCC-CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPP-VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+ .+...+..+.+++...+..+|..|-+..+...
T Consensus 230 ~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 230 NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 44443 44556677778888888888888866655443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=280.39 Aligned_cols=192 Identities=29% Similarity=0.484 Sum_probs=177.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++|+.++.+.++|+|.||++||-|.+++-+++ ++++..+++++.||+.|+.|+|..+|+|||+||+|+|+|.++.+|
T Consensus 75 l~LydVwe~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIK 152 (786)
T KOG0588|consen 75 LRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIK 152 (786)
T ss_pred eeeeeeeccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEe
Confidence 579999999999999999999999999999888 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||+|..........+.+|.+.|++||++.+.+| +.++||||-|+++|.|++|++||++.+.......+ ......
T Consensus 153 IADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV--~~G~f~ 230 (786)
T KOG0588|consen 153 IADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV--QRGVFE 230 (786)
T ss_pred eeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH--HcCccc
Confidence 999999998888888889999999999999999876 78999999999999999999999988888777666 444567
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
+|..++.+..+|+++||..||.+|.|++|+++ ++.++
T Consensus 231 MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 231 MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 77999999999999999999999999999998 45443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=279.25 Aligned_cols=188 Identities=27% Similarity=0.526 Sum_probs=168.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++.|-.++.+++||||++||+|.|.+.... +++.++..++++++.||+|||.+||+|||||.+|||++.+|.+|
T Consensus 333 Vnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vK 409 (550)
T KOG0578|consen 333 VNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVK 409 (550)
T ss_pred HHHHHHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEE
Confidence 456777777899999999999999999999875 89999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-hCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ-KNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~ 158 (244)
|+|||++....... ...+.+||+.|||||+.....|+.+.||||||+++.||+.|+.||-..++-..++.+.. .....
T Consensus 410 ltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~l 489 (550)
T KOG0578|consen 410 LTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKL 489 (550)
T ss_pred EeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCc
Confidence 99999987765544 55678899999999999999999999999999999999999999998777766665543 33334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++++|++|+.+||+.|+++|+++.|||+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 566889999999999999999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=268.64 Aligned_cols=188 Identities=24% Similarity=0.419 Sum_probs=165.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++|-.|++..++||||||++||++..+|.+.+ .+++..+..++.+++-||..+|+.|++||||||+|+|||.+|.+|
T Consensus 204 VKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiK 281 (550)
T KOG0605|consen 204 VKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIK 281 (550)
T ss_pred EEEEEEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEe
Confidence 689999999999999999999999999999887 699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc----------------------cC-C-------------------------CCCCCcccceeccceec
Q 026042 81 VADFGISCLESQ----------------------CG-S-------------------------AKGFTGTYRWMAPEMIK 112 (244)
Q Consensus 81 l~dfg~~~~~~~----------------------~~-~-------------------------~~~~~~~~~y~aPE~~~ 112 (244)
|+|||++..... .. . ....+|||.|+|||++.
T Consensus 282 LSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll 361 (550)
T KOG0605|consen 282 LSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL 361 (550)
T ss_pred eccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh
Confidence 999999742110 00 0 01356999999999999
Q ss_pred cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCC--CCchHHHHHHHHHhcccCCCCCCC---HH
Q 026042 113 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPH---FD 187 (244)
Q Consensus 113 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ 187 (244)
+.+++...|+|||||++|||+.|.+||.+.++.++...+.........| ...+++.++||.+|+. ||++|.. ++
T Consensus 362 ~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 362 GKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred cCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 9999999999999999999999999999999999998888776555555 4567999999999999 9999975 66
Q ss_pred HHHH
Q 026042 188 QIVS 191 (244)
Q Consensus 188 el~~ 191 (244)
||.+
T Consensus 441 EIK~ 444 (550)
T KOG0605|consen 441 EIKK 444 (550)
T ss_pred HHhc
Confidence 6665
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.39 Aligned_cols=194 Identities=25% Similarity=0.430 Sum_probs=167.9
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~ 75 (244)
|++++++.+ ....++|+||+++|+|.+++.+.. .+++.....++.+++.||.+||+. +++||||||+||+++.
T Consensus 81 v~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 81 LKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE 158 (283)
T ss_pred EEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC
Confidence 568888866 457899999999999999998765 578899999999999999999984 9999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
++.+||+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+..+....+..
T Consensus 159 ~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~ 236 (283)
T PHA02988 159 NYKLKIICHGLEKILSS--PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIIN 236 (283)
T ss_pred CCcEEEcccchHhhhcc--ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 99999999999865432 1234467889999999976 6789999999999999999999999998887776666655
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.......+..+++.+.+++.+||+.||++|||++++++.|+.+..
T Consensus 237 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 237 KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 555666666789999999999999999999999999999987653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=264.92 Aligned_cols=198 Identities=28% Similarity=0.559 Sum_probs=161.8
Q ss_pred CcEEEEeec-CCcEEEEEeccCCCCHHHHHhhcCC---------------------------------------------
Q 026042 1 MQFVAACKK-PPVFCIITEYLAGGSLRKYLHQQEP--------------------------------------------- 34 (244)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~--------------------------------------------- 34 (244)
|+++++|.. +..+++||||+++|+|.+++.....
T Consensus 74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (338)
T cd05102 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST 153 (338)
T ss_pred eeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence 467787765 4468999999999999999975321
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccccC---CC
Q 026042 35 ---------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SA 96 (244)
Q Consensus 35 ---------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~ 96 (244)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~ 233 (338)
T cd05102 154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233 (338)
T ss_pred CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcc
Confidence 246778889999999999999999999999999999999999999999999986542211 12
Q ss_pred CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHh
Q 026042 97 KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 175 (244)
Q Consensus 97 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 175 (244)
....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................+..+++.+.+++.+|
T Consensus 234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 313 (338)
T cd05102 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLAC 313 (338)
T ss_pred cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 23345678999999988889999999999999999997 99999876544433333334444556677899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhhh
Q 026042 176 WSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 176 l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
|+.||.+||++.++++.|+.+..
T Consensus 314 l~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 314 WQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=267.84 Aligned_cols=191 Identities=26% Similarity=0.476 Sum_probs=177.2
Q ss_pred CcEEEEeecCCc-EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPV-FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|.+++.|..++. .+|||+||+||+|.+.|.+..+..++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.+
T Consensus 66 v~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~V 145 (426)
T KOG0589|consen 66 VEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKV 145 (426)
T ss_pred eeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCce
Confidence 457788888888 9999999999999999998887789999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|+|||+|....... ...+..||+.|++||.+.+.+++.|+|||||||++|||++-+.+|.+.+.......+.... ..
T Consensus 146 kLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~ 224 (426)
T KOG0589|consen 146 KLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YS 224 (426)
T ss_pred eecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CC
Confidence 999999998776655 6778899999999999999999999999999999999999999999999888877776444 67
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
+.+..++.+++.+|..||..+|..||++.+|+..
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 8889999999999999999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=259.18 Aligned_cols=191 Identities=19% Similarity=0.342 Sum_probs=160.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.+++..++|+||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~k 142 (285)
T cd05631 63 VSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIR 142 (285)
T ss_pred EEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEE
Confidence 35778899999999999999999999988765544689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~ 158 (244)
|+|||++.............|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+......... ......
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05631 143 ISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE 222 (285)
T ss_pred EeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc
Confidence 999999876544333445678999999999999899999999999999999999999998765432221111 123334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
..+..++..+.+|+++||+.||.+||+ ++++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 556678999999999999999999997 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=264.43 Aligned_cols=190 Identities=21% Similarity=0.405 Sum_probs=165.5
Q ss_pred CcEEEEeecCC-cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++.+.+.+.+ .+|+||||| ..+|+++++.+ ++.+++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+
T Consensus 72 ikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~i 149 (538)
T KOG0661|consen 72 IKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVI 149 (538)
T ss_pred hhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccccee
Confidence 45667777777 999999999 67999999988 5689999999999999999999999999999999999999988899
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||+|||+|+......+-...+.|.+|+|||++.. +.|+.+.|+||+||+++|+.+-+..|.+.+.-+.+..+......+
T Consensus 150 KiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP 229 (538)
T KOG0661|consen 150 KIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTP 229 (538)
T ss_pred EecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCC
Confidence 9999999998877777777889999999998754 578999999999999999999999999988877776664432222
Q ss_pred ----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 159 ----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 159 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
...+.++.+..++|.+|+.+||++|||+.|+++.
T Consensus 230 ~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 230 DKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1113367889999999999999999999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.61 Aligned_cols=187 Identities=25% Similarity=0.411 Sum_probs=163.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 58 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~k 135 (323)
T cd05571 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIK 135 (323)
T ss_pred CCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence 467889999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. ....
T Consensus 136 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~ 213 (323)
T cd05571 136 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIR 213 (323)
T ss_pred EeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCC
Confidence 999999865322 2233456789999999999988999999999999999999999999988776665554432 3345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..+++++.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 6778899999999999999999999 7999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.46 Aligned_cols=196 Identities=27% Similarity=0.507 Sum_probs=166.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++..|..+..+|+||.||.+||+.++++......+++..+..+++++++||.|||++|.+|||||+.||||+.+|.+|
T Consensus 87 v~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~Vk 166 (516)
T KOG0582|consen 87 VTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVK 166 (516)
T ss_pred ceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEE
Confidence 56888999999999999999999999999998777899999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-C---C-CCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCG-S---A-KGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~---~-~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||.+....... + . ..+.|++.|||||++.+ ..|+.|+||||||++.+|+.+|..||..+.+.+......+
T Consensus 167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq 246 (516)
T KOG0582|consen 167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ 246 (516)
T ss_pred EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 99999864322211 1 1 56689999999999533 4789999999999999999999999999998887766554
Q ss_pred hCCCCCC--------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 154 KNARPPV--------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 154 ~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
....... ...++..+++++..||++||.+|||++++++ +++..
T Consensus 247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 4432111 1235678999999999999999999999997 55543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=274.39 Aligned_cols=181 Identities=28% Similarity=0.468 Sum_probs=163.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
++++.+|++..++|.||||+.||++..+++.. .+++.++.-+++.++.||.|||++||+|||||.+|||+|..|.+|
T Consensus 432 ~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 432 VNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred eecccccccCCeEEEEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEE
Confidence 46889999999999999999999954444433 599999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... ......+++||+.|+|||++.++.|+.++|+||||+++|||+.|..||.+.+.++....+.. ....
T Consensus 509 iADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--d~~~ 586 (694)
T KOG0694|consen 509 IADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--DEVR 586 (694)
T ss_pred ecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCCC
Confidence 99999997654 55678899999999999999999999999999999999999999999999999988877754 4466
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
.|..++.+...+++++|.++|.+|..+
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCC
Confidence 777889999999999999999999865
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=260.85 Aligned_cols=187 Identities=24% Similarity=0.402 Sum_probs=160.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+|+||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 56 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~k 133 (312)
T cd05585 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIA 133 (312)
T ss_pred eceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEE
Confidence 467889999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++||||+||++|+|++|..||...+..+....+. .....
T Consensus 134 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~ 211 (312)
T cd05585 134 LCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLR 211 (312)
T ss_pred EEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCC
Confidence 999999865322 222345578999999999998899999999999999999999999998877666555443 23445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps---~~el~~ 191 (244)
.+..+++.+.+++.+||+.||.+||+ +.++++
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 66788999999999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=251.39 Aligned_cols=196 Identities=23% Similarity=0.428 Sum_probs=162.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|.+++.|.....+++|+|||+. ++.+-+++..+ +++...+.++++|++.|+.|+|+++++||||||+||+++.+|.+|
T Consensus 64 VnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 64 VNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVK 141 (396)
T ss_pred HHHHHHHHhcceeEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEE
Confidence 4567889999999999999955 88888887665 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|||||+|+... +...-...+.|.+|.|||.+.+ .+|+..+||||+||++.||++|...|.+.+.-+..+.+.......
T Consensus 142 LCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 142 LCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred eccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 99999998776 3334445678999999999887 689999999999999999999999999887666555443321111
Q ss_pred -------------------CC----------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 026042 159 -------------------PV----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 198 (244)
Q Consensus 159 -------------------~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~~ 198 (244)
+. .+..+..+.+++.+||..||++|++-++++. .++++.+
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 11 1234567889999999999999999999996 4455444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=269.39 Aligned_cols=199 Identities=40% Similarity=0.755 Sum_probs=182.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|.+.|+|+....+|||||||..|-|...++... .+.......|..+|+.|+.|||.+.|||||||.-||||+.+..+|
T Consensus 175 I~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 175 ITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eeEeeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEE
Confidence 468899999999999999999999999999866 688899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||-+...........+.||..|||||++...+.++|+||||||++||||+||..||...+....+..+-......+.
T Consensus 253 IsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 253 ISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPV 332 (904)
T ss_pred eccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccC
Confidence 99999998777766777899999999999999999999999999999999999999999988877776666666777789
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
|..+|+.|+-|+++||+-.|+.||++++++..|+=....+-
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence 99999999999999999999999999999999875554433
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=253.72 Aligned_cols=190 Identities=28% Similarity=0.455 Sum_probs=171.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
.+|+.++.+++.|++||||+||+|...++++.++.++++.++-++.+++-||+|||..||++|||||+||||-++|.+-|
T Consensus 141 TLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 141 TLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred hhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEe
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCccccc----------------------------------c-c----------------------CCCCCCCcccc
Q 026042 82 ADFGISCLES----------------------------------Q-C----------------------GSAKGFTGTYR 104 (244)
Q Consensus 82 ~dfg~~~~~~----------------------------------~-~----------------------~~~~~~~~~~~ 104 (244)
+||.++.... . . .....++||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 9998752100 0 0 01224568999
Q ss_pred eeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCC
Q 026042 105 WMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184 (244)
Q Consensus 105 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 184 (244)
|+|||++.+...+.++|+|+||+++|||+.|.-||.+.+.+++...+.......+..+.++..+++||+++|.+||.+|.
T Consensus 301 YlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 301 YLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred cccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999999999999999999999999999999998887777777778899999999999999999999
Q ss_pred C----HHHHHH
Q 026042 185 H----FDQIVS 191 (244)
Q Consensus 185 s----~~el~~ 191 (244)
. ++||.+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 8 777776
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=257.83 Aligned_cols=185 Identities=28% Similarity=0.426 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||+++++|.+++.+.+ .+++..+..++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred hhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence 356778888999999999999999999998765 588899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+... ....
T Consensus 142 l~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~ 217 (291)
T cd05612 142 LTDFGFAKKLRD--RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEF 217 (291)
T ss_pred EEecCcchhccC--CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCC
Confidence 999999865433 223456899999999999888999999999999999999999999988776655554332 3456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
+..++..+.+++.+||+.||.+|++ ++++++
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 6677899999999999999999995 888886
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=259.19 Aligned_cols=188 Identities=24% Similarity=0.375 Sum_probs=162.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 141 (333)
T cd05600 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIK 141 (333)
T ss_pred ccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEE
Confidence 578899999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+.........
T Consensus 142 L~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 219 (333)
T cd05600 142 LTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219 (333)
T ss_pred EEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC
Confidence 999999875443 334567899999999999889999999999999999999999999988776665544432222211
Q ss_pred C------CCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 161 P------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 161 ~------~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
+ ..++.++.+++.+||..+|.+||+++++++.
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1 2458999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.88 Aligned_cols=197 Identities=26% Similarity=0.553 Sum_probs=164.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----------------------------------------------
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------------------------------- 33 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------------------------------------------- 33 (244)
|+++++|..++..++||||+++|+|.+++++..
T Consensus 105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 578999999999999999999999999986532
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccc
Q 026042 34 ---------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 92 (244)
Q Consensus 34 ---------------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~ 92 (244)
...+++..+++++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 12467888999999999999999999999999999999999999999999999865432
Q ss_pred cCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHH
Q 026042 93 CGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 168 (244)
Q Consensus 93 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 168 (244)
... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....................+...++++
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEI 344 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHH
Confidence 211 112234567999999988889999999999999999997 9999987765554444444444555666678999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 169 SYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 169 ~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.+++.+||+.+|.+||++.+++++|+++.
T Consensus 345 ~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 345 YSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=258.82 Aligned_cols=188 Identities=26% Similarity=0.421 Sum_probs=162.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+|
T Consensus 58 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 135 (328)
T cd05593 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIK 135 (328)
T ss_pred cceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEE
Confidence 467889999999999999999999999997765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+. .....
T Consensus 136 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~ 213 (328)
T cd05593 136 ITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIK 213 (328)
T ss_pred EecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCcc
Confidence 999999865322 222334568999999999988889999999999999999999999998877665544432 23345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~~ 192 (244)
.+..++.++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 6778899999999999999999997 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=258.52 Aligned_cols=182 Identities=24% Similarity=0.384 Sum_probs=159.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..|+||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 59 v~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~k 136 (320)
T cd05590 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCK 136 (320)
T ss_pred hceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence 468899999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ....
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~~ 214 (320)
T cd05590 137 LADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVV 214 (320)
T ss_pred EeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCCC
Confidence 999999764322 2233455689999999999988899999999999999999999999998877766555532 3345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
.+..++.++.+++.+||+.||.+||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 566789999999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=257.27 Aligned_cols=186 Identities=28% Similarity=0.452 Sum_probs=160.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+.|++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 59 ~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~k 136 (316)
T cd05620 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIK 136 (316)
T ss_pred cCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 468899999999999999999999999998765 588899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|+..|+|||.+.+..++.++||||+|+++|+|++|..||...+.......+. .....
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~ 214 (316)
T cd05620 137 IADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPH 214 (316)
T ss_pred eCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCC
Confidence 999998764321 222345678999999999998899999999999999999999999998877766555443 23345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH-HHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD-QIV 190 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-el~ 190 (244)
.+..++.++.+++.+||+.||.+||++. +++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 5667889999999999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=257.89 Aligned_cols=187 Identities=25% Similarity=0.419 Sum_probs=161.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 58 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 135 (323)
T cd05595 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 135 (323)
T ss_pred cceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEE
Confidence 467889999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.. ....
T Consensus 136 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~ 213 (323)
T cd05595 136 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIR 213 (323)
T ss_pred ecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCC
Confidence 999998764322 2223345689999999999988999999999999999999999999988776665554432 2344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..+++++.+++.+||..||.+|+ ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 6678899999999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=255.32 Aligned_cols=187 Identities=24% Similarity=0.410 Sum_probs=162.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..|+||||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~k 136 (318)
T cd05570 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIK 136 (318)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEE
Confidence 468899999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.. ....
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~--~~~~ 214 (318)
T cd05570 137 IADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE--DEVR 214 (318)
T ss_pred ecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--CCCC
Confidence 999998864222 2223345689999999999998999999999999999999999999988776665554432 3345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF-----DQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~el~~ 191 (244)
.+..++..+.+++.+||+.||.+||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 567789999999999999999999999 77776
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=268.61 Aligned_cols=190 Identities=31% Similarity=0.452 Sum_probs=164.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++..++..|+||||++||+|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 128 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~ 207 (478)
T PTZ00267 128 VKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207 (478)
T ss_pred eEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc
Confidence 57899999999999999999999999988642 2335888999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
+||+|||++....... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+...
T Consensus 208 ~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~- 286 (478)
T PTZ00267 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG- 286 (478)
T ss_pred EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999987644322 234556899999999999889999999999999999999999999987776665555433
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+.+..++.++.+++.+||+.+|++||++++++.
T Consensus 287 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 333456678899999999999999999999999875
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.45 Aligned_cols=188 Identities=21% Similarity=0.362 Sum_probs=162.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+|.++
T Consensus 59 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~k 136 (321)
T cd05591 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCK 136 (321)
T ss_pred cceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence 468899999999999999999999999998765 588899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ...
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~ 214 (321)
T cd05591 137 LADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVL 214 (321)
T ss_pred EeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 999999864322 22234456899999999999889999999999999999999999999988877666555432 344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-------HFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~el~~~ 192 (244)
.+..++.++.+++.+||+.||.+|+ ++.++++.
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 5566889999999999999999999 78888763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=249.30 Aligned_cols=194 Identities=34% Similarity=0.658 Sum_probs=165.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++...+..++++||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||
T Consensus 71 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dl 150 (283)
T cd05048 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDL 150 (283)
T ss_pred ceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 4688999999999999999999999999976421 35788899999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||++++++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.
T Consensus 151 kp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 151 AARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred ccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999986543221 1223446788999999988889999999999999999998 99999988
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
+..+....+. .......+..+++++.+++.+||+.||.+||++.++++.|+.
T Consensus 231 ~~~~~~~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 231 SNQEVIEMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8776655544 333445677899999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=255.45 Aligned_cols=187 Identities=30% Similarity=0.502 Sum_probs=161.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~k 136 (316)
T cd05592 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIK 136 (316)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEE
Confidence 467889999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+. .....
T Consensus 137 L~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~ 214 (316)
T cd05592 137 IADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPH 214 (316)
T ss_pred EccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCC
Confidence 999999865322 223345578999999999998889999999999999999999999999887766555443 33455
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD-QIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-el~~ 191 (244)
.+..++.++.+++.+||+.+|.+||++. ++++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 6677899999999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=257.58 Aligned_cols=185 Identities=26% Similarity=0.418 Sum_probs=161.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred CcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.. .....
T Consensus 159 l~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~--~~~~~ 234 (329)
T PTZ00263 159 VTDFGFAKKVPD--RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA--GRLKF 234 (329)
T ss_pred EeeccCceEcCC--CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCcCC
Confidence 999999865433 22345789999999999988899999999999999999999999988776665554432 33456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
+..++..+.+++.+||+.||.+|++ ++++++
T Consensus 235 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 6778899999999999999999986 677775
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=254.43 Aligned_cols=183 Identities=26% Similarity=0.397 Sum_probs=158.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+++++|.+++.+.. .+++..+..++.||+.||.|||++|++||||||+||+++.+|.+|
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~k 136 (323)
T cd05575 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVV 136 (323)
T ss_pred CCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEE
Confidence 568899999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+... ...
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~ 214 (323)
T cd05575 137 LTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLR 214 (323)
T ss_pred EeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 999999864322 22334556899999999999889999999999999999999999999988776655554332 334
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD 187 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ 187 (244)
.+..+++.+.+++.+||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 5567799999999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=255.25 Aligned_cols=187 Identities=27% Similarity=0.438 Sum_probs=162.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 140 (323)
T cd05584 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVK 140 (323)
T ss_pred hceeeEEecCCeEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence 467899999999999999999999999998765 578889999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.. ....
T Consensus 141 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~--~~~~ 218 (323)
T cd05584 141 LTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK--GKLN 218 (323)
T ss_pred EeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCC
Confidence 999999864322 2223445789999999999888899999999999999999999999998877665555433 3345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..+++.+.+++.+||+.+|.+|| +++++++
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 6777899999999999999999999 8888877
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=255.84 Aligned_cols=186 Identities=27% Similarity=0.439 Sum_probs=160.3
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++...+..|+||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.+|.++|
T Consensus 65 ~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL 142 (324)
T cd05587 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKI 142 (324)
T ss_pred eeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEE
Confidence 56788899999999999999999999998765 5789999999999999999999999999999999999999999999
Q ss_pred ecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||++.... .........|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+.......+.. .....
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~ 220 (324)
T cd05587 143 ADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSY 220 (324)
T ss_pred eecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCC
Confidence 9999876422 22233455689999999999988899999999999999999999999998877666555533 33456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF-----DQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~-----~el~~ 191 (244)
+..++..+.+++.+||+.+|.+|++. +++++
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 67789999999999999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=252.17 Aligned_cols=187 Identities=28% Similarity=0.472 Sum_probs=171.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++|++|+..+...|||||..+|.|+|||.+.+ .+++..++.+++||.+|+.|+|.++++|||||.+|||+|+|+.+|
T Consensus 116 I~IyEVFENkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 116 IQIYEVFENKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred eehhhhhcCCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCee
Confidence 468899999999999999999999999999887 699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++-.+.......+++|++-|.+||.+++.+| ++..|-||||+++|-++.|.+||++.+-.....++.....+.+
T Consensus 194 IADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 194 IADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP 273 (668)
T ss_pred eeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC
Confidence 999999988887788889999999999999999987 7899999999999999999999999999888888766555443
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
. -|....-||++||..||++|.|++++...
T Consensus 274 ~---~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 E---TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C---CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 3 34567889999999999999999999874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=257.89 Aligned_cols=186 Identities=24% Similarity=0.388 Sum_probs=162.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+|.++
T Consensus 94 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......|++.|+|||++.+..++.++|+||+||++|+|++|..||...+.......+.. .....
T Consensus 172 L~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~ 247 (340)
T PTZ00426 172 MTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYF 247 (340)
T ss_pred EecCCCCeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCC
Confidence 999999865432 23455789999999999888899999999999999999999999998777655555433 23445
Q ss_pred CCCchHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVSI 192 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~~ 192 (244)
+..+++.+.+++++||+.+|.+|+ +++++++.
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 677889999999999999999995 88888863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=258.53 Aligned_cols=195 Identities=29% Similarity=0.561 Sum_probs=163.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----------------------------------------------
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------------------------------- 33 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------------------------------------------- 33 (244)
|+++++|..++..++||||++||+|.++++...
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 102 VNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 578999999999999999999999999997532
Q ss_pred --------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 34 --------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 34 --------------------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 124678889999999999999999999999999999999999999999999998
Q ss_pred ccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCCCCC
Q 026042 88 CLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPT 163 (244)
Q Consensus 88 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (244)
........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....................+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC 341 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence 65433211 112334567999999999899999999999999999998 89999877655544444444444555666
Q ss_pred chHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 164 CPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 164 ~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
.+.++.+++.+||+.||++||++.++++.|+.
T Consensus 342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 78999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=246.40 Aligned_cols=194 Identities=28% Similarity=0.551 Sum_probs=164.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+++++|.+++.+... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.++
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEE
Confidence 5789999999999999999999999999987543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
++|||.+........ .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+....+. ....
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~ 226 (266)
T cd05064 148 ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFR 226 (266)
T ss_pred ECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCC
Confidence 999998654322111 112334578999999988899999999999999999775 999998887766555443 3344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.+.+..++..+.+++.+||+.+|.+||+++++.+.|.+.
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 556778899999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=245.22 Aligned_cols=195 Identities=34% Similarity=0.626 Sum_probs=166.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++++||+++++|.+++.......+++..++.++.|++.||+|||++|++|+||||+||++++++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k 144 (263)
T cd05052 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 144 (263)
T ss_pred hheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEE
Confidence 46889999999999999999999999999876555689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC--CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+...... ....
T Consensus 145 l~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~ 223 (263)
T cd05052 145 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYR 223 (263)
T ss_pred eCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCC
Confidence 9999998654332211 12223567999999988889999999999999999998 999998877665544443 3344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 566778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=244.48 Aligned_cols=194 Identities=33% Similarity=0.640 Sum_probs=167.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++......++|+||+++++|.+++.+..+..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~k 144 (261)
T cd05148 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCK 144 (261)
T ss_pred hheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEE
Confidence 46789999999999999999999999999886666789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||.+........ .....++..|++||...+..++.++|+||||+++++|++ |..||...+..+...... .....
T Consensus 145 l~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 223 (261)
T cd05148 145 VADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRM 223 (261)
T ss_pred EccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcC
Confidence 999999865433221 223345678999999988889999999999999999998 899998877666555544 34445
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
..+..+++.+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 6667889999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=254.27 Aligned_cols=186 Identities=27% Similarity=0.460 Sum_probs=160.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|..++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 65 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~k 141 (324)
T cd05589 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVK 141 (324)
T ss_pred hceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEE
Confidence 46899999999999999999999999988653 489999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+... ...
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~ 219 (324)
T cd05589 142 IADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVR 219 (324)
T ss_pred eCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 999998764322 22234567899999999999889999999999999999999999999988776665554332 344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..+++.+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 6677899999999999999999999 5777766
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=247.71 Aligned_cols=197 Identities=31% Similarity=0.594 Sum_probs=167.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++..++..++||||+++++|.+++..+.. ..+++..++.++.|++.||+|||++|++||||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl 149 (291)
T cd05094 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDL 149 (291)
T ss_pred ceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 4688999999999999999999999999976431 24788999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 150 kp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 150 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred CcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986543221 1223446788999999988889999999999999999998 99999887
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
+.......+. .......+..++..+.+++.+||+.+|.+||++.+++++|+++..
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 230 SNTEVIECIT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CHHHHHHHHh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 7766554443 333344556678999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=254.96 Aligned_cols=181 Identities=27% Similarity=0.445 Sum_probs=158.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++...+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||
T Consensus 65 ~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL 142 (323)
T cd05616 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred eEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEE
Confidence 57788999999999999999999999998765 5889999999999999999999999999999999999999999999
Q ss_pred ecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||++.... .........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+.. .....
T Consensus 143 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~ 220 (323)
T cd05616 143 ADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAY 220 (323)
T ss_pred ccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCC
Confidence 9999986432 22233456789999999999999999999999999999999999999998887766655543 33456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
+...+.++.+++.+||+.+|.+|++.
T Consensus 221 p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 221 PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 67789999999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=257.29 Aligned_cols=187 Identities=26% Similarity=0.424 Sum_probs=161.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++..++..|+||||+++++|.+++.+.. .+++..+..++.|++.||.|||+ +|++||||||+||+++.+|.+
T Consensus 58 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~ 135 (325)
T cd05594 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 135 (325)
T ss_pred CceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCE
Confidence 467889999999999999999999999987765 58899999999999999999997 799999999999999999999
Q ss_pred EEecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||+|||++..... ........|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+. ....
T Consensus 136 kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~ 213 (325)
T cd05594 136 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEI 213 (325)
T ss_pred EEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCC
Confidence 9999999764322 222334568999999999988899999999999999999999999998877665554443 2334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
..+..+++++.+++.+||+.||.+|+ ++.++++
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 56677899999999999999999996 8999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=244.68 Aligned_cols=195 Identities=33% Similarity=0.609 Sum_probs=166.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||+++++|.+++.+..+..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~ 143 (261)
T cd05072 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCK 143 (261)
T ss_pred eeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEE
Confidence 46788899999999999999999999999876555788999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+.. ...
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~ 222 (261)
T cd05072 144 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYR 222 (261)
T ss_pred ECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCC
Confidence 999999865433211 122335678999999988889999999999999999998 9999988777665555433 333
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.+....++.++.+++.+|+..+|++||+++++.++|+++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 445567889999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=241.91 Aligned_cols=189 Identities=24% Similarity=0.437 Sum_probs=168.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++.++++++.++++|+|.|+.|.|.|++.... .+++...++++.|+++|++|||.++|+|||+||+||+++++.+++
T Consensus 86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred EEeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceE
Confidence 468899999999999999999999999999887 699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||+++...........+||++|+|||.+.. ..++...|+|+.|+++|.++.|..||-....--....++..
T Consensus 164 isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred EeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 999999999988888889999999999998753 35788999999999999999999999765555555555554
Q ss_pred CCCC--CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP--PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... +...+.+...+++|++||+.||.+|.|++|++.
T Consensus 244 kyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 244 KYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 4333 334677889999999999999999999999997
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=253.86 Aligned_cols=187 Identities=28% Similarity=0.458 Sum_probs=160.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.+++..++||||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 59 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~k 136 (316)
T cd05619 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIK 136 (316)
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence 468899999999999999999999999998754 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|+..|+|||++.+..++.++|+||+||++|+|++|..||...+..+....+.. ....
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~ 214 (316)
T cd05619 137 IADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPC 214 (316)
T ss_pred EccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCC
Confidence 999999864322 1223345689999999999988899999999999999999999999998877665554432 2344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD-QIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-el~~ 191 (244)
.+..++.++.+++.+||+.+|.+||++. ++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 5567889999999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=249.85 Aligned_cols=193 Identities=20% Similarity=0.326 Sum_probs=158.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++||||++|++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||+++.++.++
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~ 135 (277)
T cd05607 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCR 135 (277)
T ss_pred EEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEE
Confidence 46778899999999999999999999999776655688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC---CC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---AR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~ 157 (244)
|+|||++.............++..|+|||.+.+..++.++|+||+||++|+|++|..||................ ..
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 215 (277)
T cd05607 136 LSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215 (277)
T ss_pred EeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc
Confidence 999999866544333344568899999999988889999999999999999999999997654322211111111 11
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
......+++++.+++.+||+.||.+||++.|+++.+
T Consensus 216 ~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 122246789999999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=255.96 Aligned_cols=187 Identities=24% Similarity=0.377 Sum_probs=160.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++.+.. .+++..+..++.||+.||.|||++|++||||||+||+++.++.++
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~k 136 (325)
T cd05602 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 136 (325)
T ss_pred CceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 468899999999999999999999999998755 578889999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+... ...
T Consensus 137 l~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~ 214 (325)
T cd05602 137 LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQ 214 (325)
T ss_pred EccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcC
Confidence 999999864322 22334567899999999999989999999999999999999999999987776655544332 334
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.++.++..+.+++.+||+.+|.+|+++.+.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 55678999999999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=247.96 Aligned_cols=199 Identities=33% Similarity=0.542 Sum_probs=166.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|++++++...+..++++||+++++|.+++.+... ..+++..++.++.|++.||+|||++|++||||
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dl 145 (297)
T cd05089 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDL 145 (297)
T ss_pred hheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcC
Confidence 4688999999999999999999999999976431 24788899999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 145 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 145 (244)
||+||+++.++.+||+|||++..............+..|+|||...+..++.++||||||+++|+|++ |..||......
T Consensus 146 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 146 AARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred CcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999999754322111222233457999999988889999999999999999997 99999888776
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
+...... .......+..++..+.+++.+||..+|.+||+++++++.|..+....
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ELYEKLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 6554443 33344556678999999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=255.04 Aligned_cols=188 Identities=23% Similarity=0.448 Sum_probs=157.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~k 136 (329)
T cd05588 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK 136 (329)
T ss_pred CceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE
Confidence 578899999999999999999999999987765 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccc-cccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Q 026042 81 VADFGISCLE-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAV 151 (244)
Q Consensus 81 l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~ 151 (244)
|+|||++... ..........|+..|+|||++.+..++.++|+||||+++|+|++|..||.... ..+.....
T Consensus 137 L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 216 (329)
T cd05588 137 LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV 216 (329)
T ss_pred ECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH
Confidence 9999998642 22223345678999999999999899999999999999999999999996321 11112221
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH------FDQIVS 191 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~el~~ 191 (244)
........+..++..+.+++.+||+.||.+|++ ++++++
T Consensus 217 -~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 217 -ILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 123344567788999999999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=246.66 Aligned_cols=198 Identities=32% Similarity=0.598 Sum_probs=167.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ 69 (244)
+++++++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~ 149 (288)
T cd05093 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149 (288)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 578899999999999999999999999997543 124889999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 026042 70 NLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 145 (244)
Q Consensus 70 nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 145 (244)
||++++++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||......
T Consensus 150 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred eEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986442211 1223335678999999988889999999999999999998 99999887776
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.....+.. ......+..++.++.+++.+||+.+|.+||++.++.+.|+++...
T Consensus 230 ~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 EVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 65555443 233445567889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=249.41 Aligned_cols=190 Identities=22% Similarity=0.366 Sum_probs=157.3
Q ss_pred CcEEEEee-----cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACK-----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|+++++|. .....++|+||+. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 67 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~ 145 (290)
T cd07862 67 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 145 (290)
T ss_pred ceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC
Confidence 45677764 4567899999995 69999998766557899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++.++|+|||++.............++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 146 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~ 225 (290)
T cd07862 146 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225 (290)
T ss_pred CCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence 99999999999876544444455678999999999988889999999999999999999999998877655544443211
Q ss_pred CCC-------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARP-------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+ ...+.+++.+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100 011346778899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=242.82 Aligned_cols=192 Identities=27% Similarity=0.550 Sum_probs=161.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++. +...++|+||+++++|.+++.+.. .+++..+..++.|++.||++||++|++|+||||.||+++.++.++
T Consensus 59 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~k 135 (257)
T cd05116 59 VRMIGICE-AESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAK 135 (257)
T ss_pred ceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEE
Confidence 46777775 456789999999999999997654 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+....++.++|+||||+++|+|++ |..||...+.......+. ..
T Consensus 136 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~ 214 (257)
T cd05116 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SG 214 (257)
T ss_pred ECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CC
Confidence 999999865433221 112233578999999988888999999999999999998 999998877766555443 33
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.....+..++.++.++|.+||+.||++||+++++.+.|+++
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 44566778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=258.62 Aligned_cols=189 Identities=24% Similarity=0.423 Sum_probs=162.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred cchhhheecCCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEE
Confidence 457788899999999999999999999998774 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC------------------------------CCCCCCcccceeccceeccCCCCCccchhhhHHHHH
Q 026042 81 VADFGISCLESQCG------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130 (244)
Q Consensus 81 l~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 130 (244)
|+|||++....... ......|++.|+|||.+.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999986544322 223456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhhCCCCC--CCCCchHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 026042 131 ELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRPH-FDQIVSI 192 (244)
Q Consensus 131 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps-~~el~~~ 192 (244)
+|++|..||...+.......+........ ....+++++.++|.+||. +|.+||+ ++++++.
T Consensus 222 ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 222 EMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99999999998887666555554222222 333469999999999997 9999999 9999973
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=247.78 Aligned_cols=196 Identities=29% Similarity=0.552 Sum_probs=166.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++++||+++++|.++++......+++.++..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 102 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred ceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence 57889999999999999999999999999875544589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.................
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~ 261 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence 99999986443221 1222345678999999988889999999999999999998 9999987766554444444444
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
....+...++.+.+++.+||+.+|++||++.++++.|++.
T Consensus 262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 4455566789999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=248.72 Aligned_cols=198 Identities=31% Similarity=0.551 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++..++..|+|+||+++++|.+++++.. ...+++..++.++.|++.||+|||++|++||||
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl 150 (303)
T cd05088 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 150 (303)
T ss_pred ceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCcccccc
Confidence 578899999999999999999999999997643 124788999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 145 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 145 (244)
||+||+++.++.++|+|||++..............+..|+|||.+.+..++.++||||||+++++|++ |..||...+..
T Consensus 151 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 151 AARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred chheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999999999999854322212222234567999999988888999999999999999998 99999877665
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+...... .......+..++..+.+++.+||+.+|++||+++++++.|..+...
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 231 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHHHHHh-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 5444332 2223344556789999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=255.57 Aligned_cols=184 Identities=28% Similarity=0.449 Sum_probs=160.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+|+||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 61 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 138 (318)
T cd05582 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 138 (318)
T ss_pred ccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEE
Confidence 578899999999999999999999999997755 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++...... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+.. ....
T Consensus 139 L~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~--~~~~ 216 (318)
T cd05582 139 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK--AKLG 216 (318)
T ss_pred EeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc--CCCC
Confidence 9999998654332 223355789999999999888889999999999999999999999998877666555433 2345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQ 188 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~e 188 (244)
.+..+++.+.+++++||+.||.+||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 66778999999999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=244.05 Aligned_cols=193 Identities=33% Similarity=0.607 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp 68 (244)
+++++++..+...++||||+++++|.++++..+. ..+++..+..++.|++.||.+||++|++|+||||
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp 150 (280)
T cd05049 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLAT 150 (280)
T ss_pred hheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecccccc
Confidence 4678999999999999999999999999976532 3477889999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCH
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 144 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 144 (244)
+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.
T Consensus 151 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred ceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999986432211 1223345678999999998899999999999999999998 9999988777
Q ss_pred HHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 145 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.+....+. .......+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 231 EEVIECIT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 66555544 33334455678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=241.27 Aligned_cols=194 Identities=36% Similarity=0.612 Sum_probs=165.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||+++++|.+++....+..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 143 (261)
T cd05068 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICK 143 (261)
T ss_pred cceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEE
Confidence 46789999999999999999999999999876655789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC--CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSA--KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++......... .....+..|+|||...+..++.++|+||||+++++|++ |+.||.+.+.......+. ....
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~ 222 (261)
T cd05068 144 VADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYR 222 (261)
T ss_pred ECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 9999998655422111 11223457999999988889999999999999999999 999999887766655543 3334
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
...+..++..+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 45566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=232.84 Aligned_cols=188 Identities=27% Similarity=0.447 Sum_probs=172.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++|+||-+....|+++||..+|+|...++..+...+++..++.++.|++.||.|+|..+++||||||+|+|++..|.+|
T Consensus 85 lrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 85 LRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred HhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCee
Confidence 46899999999999999999999999999977777899999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
++|||-+.... .....+.+||..|++||+..+...+..+|+|++|++.||++.|..||......+....+.. .....
T Consensus 165 iAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--~~~~~ 241 (281)
T KOG0580|consen 165 IADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--VDLKF 241 (281)
T ss_pred ccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--ccccC
Confidence 99999987665 5667789999999999999999999999999999999999999999999886666666543 34556
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
|+.++.+..++|.+|+.++|.+|....|+++
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 6999999999999999999999999999987
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=242.17 Aligned_cols=190 Identities=28% Similarity=0.501 Sum_probs=164.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 67 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred eeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 478899999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC----CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++......... ....++..|+|||.+.+..++.++|+||||+++|++++|+.||...+.............
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 224 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 224 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC
Confidence 9999998643321111 234577899999999988899999999999999999999999987766655555555555
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
....+..++..+.+++.+||..+|.+||++.++++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 566777889999999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=260.41 Aligned_cols=187 Identities=30% Similarity=0.529 Sum_probs=166.1
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++|+.+-.+..++++||||.||++.+.++... .+++..+.-++++++.||.|||.++.+|||||+.||++..+|.+||
T Consensus 75 ~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl 152 (467)
T KOG0201|consen 75 EYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKL 152 (467)
T ss_pred hhhhheeecccHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEE
Confidence 57888999999999999999999999999766 4577888889999999999999999999999999999999999999
Q ss_pred ecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||.+...... ....+++||+.|||||++.+..|+.++||||||++.+||.+|.+|+....+....+.+. +...+.+
T Consensus 153 ~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-k~~PP~L 231 (467)
T KOG0201|consen 153 ADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-KSAPPRL 231 (467)
T ss_pred EecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-CCCCCcc
Confidence 999998765433 34478999999999999999899999999999999999999999999988865544442 4445556
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+++.+++|+..||++||+.||++.+|++
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 6689999999999999999999999999996
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=253.28 Aligned_cols=187 Identities=29% Similarity=0.429 Sum_probs=156.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~k 145 (332)
T cd05614 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVV 145 (332)
T ss_pred ccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEE
Confidence 467888999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~ 153 (244)
|+|||++....... ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||..... ...... .
T Consensus 146 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~ 223 (332)
T cd05614 146 LTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR--I 223 (332)
T ss_pred EeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH--H
Confidence 99999986543221 22345789999999998765 478899999999999999999999964322 121111 1
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.......+..+++.+.+++.+||+.||.+|| +++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 224 LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 2334556677899999999999999999999 7778876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=240.85 Aligned_cols=193 Identities=36% Similarity=0.708 Sum_probs=167.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~ 73 (244)
+++++++..+...++|+||+++++|.+++.... ...+++..++.++.|++.||++||++|++|+||+|+||++
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili 138 (262)
T cd00192 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV 138 (262)
T ss_pred heeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE
Confidence 467889999999999999999999999998752 2368999999999999999999999999999999999999
Q ss_pred cCCCcEEEecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026042 74 GEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 149 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~ 149 (244)
+.++.++|+|||.+...... .......++..|+|||.+....++.++|+||+|+++++|++ |..||...+..+...
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 218 (262)
T cd00192 139 GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE 218 (262)
T ss_pred CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999998765443 22334557889999999988889999999999999999999 699999887766655
Q ss_pred HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 150 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.... ......+..++.++.+++.+||..+|.+||++.++++.|+
T Consensus 219 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 219 YLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 5443 4455667788999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=255.15 Aligned_cols=190 Identities=23% Similarity=0.366 Sum_probs=157.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.++...|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.+|.++
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred ceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEE
Confidence 568899999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC------------------------------------CCCCCCcccceeccceeccCCCCCccchhh
Q 026042 81 VADFGISCLESQCG------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 124 (244)
Q Consensus 81 l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 124 (244)
|+|||++....... .....+||+.|+|||++.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 99999976432110 012357899999999999889999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCC--CCchHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 026042 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSS--SPDRRPHFDQIVSI 192 (244)
Q Consensus 125 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~--~p~~Rps~~el~~~ 192 (244)
|||++|+|++|..||.+.+.......+.........+ ..+++++.+++.+++.. ++..||+++|+++.
T Consensus 222 lGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 222 LGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999999999999999887776665554433333333 24678999999987652 23356899999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=250.03 Aligned_cols=189 Identities=24% Similarity=0.448 Sum_probs=156.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++..++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~ 143 (331)
T cd06649 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI 143 (331)
T ss_pred CeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcE
Confidence 578999999999999999999999999998765 588999999999999999999986 69999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ------ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------ 153 (244)
+|+|||++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.......
T Consensus 144 kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (331)
T cd06649 144 KLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGE 222 (331)
T ss_pred EEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccc
Confidence 99999998654332 23445689999999999988899999999999999999999999976655433221110
Q ss_pred ---------------------------------------hCCCCC-CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 154 ---------------------------------------KNARPP-VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 154 ---------------------------------------~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
....+. ....+++++.+|+.+||+.||++|||++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 223 EGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000111 112467899999999999999999999999973
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=255.44 Aligned_cols=189 Identities=25% Similarity=0.399 Sum_probs=159.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++||+|.+++.+. .+++..+..++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~k 182 (370)
T cd05596 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182 (370)
T ss_pred ceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEE
Confidence 46888999999999999999999999999764 378899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccC----CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++....... ......|++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+...
T Consensus 183 L~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 183 LADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred EEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 99999986543322 22356789999999988653 3788999999999999999999999988776665555443
Q ss_pred CCCCCCCC--CchHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 026042 155 NARPPVPP--TCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 192 (244)
Q Consensus 155 ~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~el~~~ 192 (244)
......+. .++.++.+++.+||..+|.+ |++++++++.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 33333333 57899999999999999988 9999999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=243.86 Aligned_cols=193 Identities=33% Similarity=0.609 Sum_probs=164.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++..+...++|+||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+
T Consensus 72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nil 151 (277)
T cd05032 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM 151 (277)
T ss_pred eEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEE
Confidence 4789999999999999999999999999975332 13678899999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 73 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+..
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 152 VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred EcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence 9999999999999986543221 1223345778999999988889999999999999999998 99999887776665
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.... .......+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVI-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 5554 44455667778999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=242.86 Aligned_cols=196 Identities=31% Similarity=0.546 Sum_probs=162.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++...+..+++|||+++++|.+++.+... ..+++..+..++.|++.||+|||++|++|+||
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~di 138 (270)
T cd05047 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 138 (270)
T ss_pred eeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 4788999999999999999999999999976431 24788999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 145 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 145 (244)
||+||+++.++.++|+|||++..............+..|+|||.+....++.++|+||||+++++|++ |..||...+..
T Consensus 139 kp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~ 218 (270)
T cd05047 139 AARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 218 (270)
T ss_pred ccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH
Confidence 99999999999999999999753322111222233567999999988889999999999999999997 99999887766
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
+....+. .......+..++.++.+++.+|+..+|.+||++.++++.|.++.
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 5544443 22333455667889999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=239.55 Aligned_cols=192 Identities=31% Similarity=0.632 Sum_probs=161.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++.+... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~k 134 (252)
T cd05084 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLK 134 (252)
T ss_pred ceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEE
Confidence 5788999999999999999999999999976542 578999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC---CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||.+......... .....+..|+|||.+.++.++.++|+||||+++|+|++ |..||............. ...
T Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~ 213 (252)
T cd05084 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGV 213 (252)
T ss_pred ECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCC
Confidence 9999997643321111 11123457999999988889999999999999999998 999998777665544443 334
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
....+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 214 RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 45566778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.51 Aligned_cols=188 Identities=23% Similarity=0.449 Sum_probs=156.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+++++|..++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 59 v~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~k 136 (329)
T cd05618 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 136 (329)
T ss_pred CceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEE
Confidence 578899999999999999999999999987765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--------PEQAAFAV 151 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~ 151 (244)
|+|||++.... .........|+..|+|||++.+..++.++|+||||+++|+|++|..||.... ........
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~ 216 (329)
T cd05618 137 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 216 (329)
T ss_pred EeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH
Confidence 99999986432 2223345678999999999999899999999999999999999999995311 11111111
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH------FDQIVS 191 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~el~~ 191 (244)
........+..++..+.+++.+||+.||.+||+ +.++++
T Consensus 217 -i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 217 -ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred -HhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 123344567788999999999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=247.16 Aligned_cols=191 Identities=21% Similarity=0.370 Sum_probs=161.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++++++.++
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 142 (285)
T cd05605 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred eeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEE
Confidence 45788899999999999999999999998765544689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--hCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~ 158 (244)
|+|||++.............|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......... .....
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05605 143 ISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE 222 (285)
T ss_pred EeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc
Confidence 9999998765433333455789999999999888899999999999999999999999987655433222211 22233
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
..+..++..+.+++.+||..||.+|| +++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 45567889999999999999999999 8888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=246.99 Aligned_cols=192 Identities=35% Similarity=0.664 Sum_probs=160.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..++|+||+++|+|.+++.......+++..++.++.|++.||.|||+++++|++|+++||+++.++.+|
T Consensus 64 ~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~K 143 (259)
T PF07714_consen 64 VKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVK 143 (259)
T ss_dssp E-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 47899999888899999999999999999987444789999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++...... ...........|+|||.+....++.++||||||++++|+++ |+.||...+..+....+ ....
T Consensus 144 l~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~ 222 (259)
T PF07714_consen 144 LSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQ 222 (259)
T ss_dssp EESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence 9999998665221 12233446789999999988889999999999999999999 78999998887766665 4555
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
....+..++..+.+++.+||+.+|.+||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 5667788999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.78 Aligned_cols=183 Identities=25% Similarity=0.355 Sum_probs=157.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+||||++|++|..++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~k 136 (321)
T cd05603 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVV 136 (321)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 568889999999999999999999999987654 578899999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... .........|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.......+.. ....
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~ 214 (321)
T cd05603 137 LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--KPLQ 214 (321)
T ss_pred EccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--CCCC
Confidence 99999986432 22233455689999999999888899999999999999999999999988876665554432 3345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD 187 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ 187 (244)
.+...+..+.+++.+||+.+|.+|+++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 6667889999999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=246.53 Aligned_cols=194 Identities=34% Similarity=0.619 Sum_probs=158.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-----------------YSVPLNLVLKLALDIARGMQYLHSQGILH 63 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-----------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H 63 (244)
|++++++...+..++|+||+++++|.+++..... ..+++..++.++.|++.||.|||+.|++|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 5789999999999999999999999999865321 23577889999999999999999999999
Q ss_pred CCCCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh--CCCC
Q 026042 64 RDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTP 138 (244)
Q Consensus 64 ~dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p 138 (244)
|||||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999986543221 1223345778999999988889999999999999999986 6778
Q ss_pred CCCCCHHHHHHHHHhh------CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 139 FDNMTPEQAAFAVCQK------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 139 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
|...+..+........ ......++.++..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 8877665544333221 1112335678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=239.97 Aligned_cols=192 Identities=32% Similarity=0.593 Sum_probs=162.2
Q ss_pred CcEEEEe-ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++ ..+...++++||+++++|.+++++.....+++..++.++.|++.||+|||++|++|+||||+||+++.++.+
T Consensus 62 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~ 141 (256)
T cd05082 62 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVA 141 (256)
T ss_pred eeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcE
Confidence 3566654 566778999999999999999987665568899999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|+|||++...... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+. .....
T Consensus 142 kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 218 (256)
T cd05082 142 KVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKM 218 (256)
T ss_pred EecCCccceecccc--CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCC
Confidence 99999987654322 123344568999999988889999999999999999997 999998877666554443 33344
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
..+..+++.+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 5567789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=249.53 Aligned_cols=198 Identities=29% Similarity=0.571 Sum_probs=162.2
Q ss_pred CcEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCC---------------------------------------------
Q 026042 1 MQFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEP--------------------------------------------- 34 (244)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~--------------------------------------------- 34 (244)
++++++|. .+..+++++||+++++|.+++.....
T Consensus 74 v~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (337)
T cd05054 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL 153 (337)
T ss_pred hheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence 45677664 45678999999999999999965321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccccC---CCC
Q 026042 35 --------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAK 97 (244)
Q Consensus 35 --------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~ 97 (244)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~ 233 (337)
T cd05054 154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233 (337)
T ss_pred hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc
Confidence 257888999999999999999999999999999999999999999999999987543221 122
Q ss_pred CCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhc
Q 026042 98 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176 (244)
Q Consensus 98 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 176 (244)
...++..|+|||++.+..++.++|||||||++++|++ |..||.+....+..............+..+++++.+++.+||
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence 3345678999999999999999999999999999998 999998755444443444444455556678899999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhh
Q 026042 177 SSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 177 ~~~p~~Rps~~el~~~l~~~~~ 198 (244)
+.+|.+||++.++++.|.++..
T Consensus 314 ~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 314 HNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=253.48 Aligned_cols=186 Identities=26% Similarity=0.372 Sum_probs=159.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|..++.+.. .+++..+..++.||+.||.|||++|++||||||+||+++.+|.++
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~k 136 (325)
T cd05604 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVV 136 (325)
T ss_pred ccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEE
Confidence 568899999999999999999999999988755 588999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... .........|+..|+|||.+.+..++.++|||||||++|+|++|..||...+..+....+... ...
T Consensus 137 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~ 214 (325)
T cd05604 137 LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLV 214 (325)
T ss_pred EeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--Ccc
Confidence 99999986432 222334567899999999999989999999999999999999999999887776655544332 334
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~ 190 (244)
.++..+..+.+++.+||+.+|.+||++.+.+
T Consensus 215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 4556889999999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=240.06 Aligned_cols=194 Identities=35% Similarity=0.640 Sum_probs=165.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||+++++|.+++....+ .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~ 146 (266)
T cd05033 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCK 146 (266)
T ss_pred ceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEE
Confidence 4678899999999999999999999999987554 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+. ...
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~ 225 (266)
T cd05033 147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGY 225 (266)
T ss_pred ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCC
Confidence 99999987653211 1112234568999999988889999999999999999998 999998877666554443 333
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..+.+..++..+.+++.+|++.+|++||+++++++.|+++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4455677899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=251.86 Aligned_cols=183 Identities=24% Similarity=0.440 Sum_probs=154.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..|+||||++|++|..++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~k 136 (327)
T cd05617 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIK 136 (327)
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEE
Confidence 467889999999999999999999999988765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHh
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM------TPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~ 153 (244)
|+|||++.... .........|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ...+......
T Consensus 137 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~- 215 (327)
T cd05617 137 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI- 215 (327)
T ss_pred EeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-
Confidence 99999886422 222334567899999999999889999999999999999999999999632 1222222222
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
.......+..++..+.+++.+||+.||.+|+++
T Consensus 216 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 216 LEKPIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 233345677789999999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=254.52 Aligned_cols=197 Identities=31% Similarity=0.571 Sum_probs=165.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----------------------------------------------
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------------------------------- 33 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------------------------------------------- 33 (244)
|+++++|......|+||||+++|+|.+++.++.
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred eeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 578999999999999999999999999986532
Q ss_pred -----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 34 -----------------------------------------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 34 -----------------------------------------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
...+++..+..++.|++.||.|||+.|++|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 124677888999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999999999986543221 1223346678999999988889999999999999999997 99999876
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
..................+..++..+.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 6555444444444455666788999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=232.60 Aligned_cols=189 Identities=26% Similarity=0.415 Sum_probs=168.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---C
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---M 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---~ 77 (244)
|++.+.+++.++.|||+|++.|++|..-|-.+. -+++..+...++||+++|.|+|.+||+|||+||+|+++.+. .
T Consensus 73 vrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 73 VRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred eehhhhhcccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCC
Confidence 467788899999999999999999977665543 58889999999999999999999999999999999999653 3
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++...........+.|++.|||||+++..+++..+|||+-|+++|-++.|.+||.+.+.......++.....
T Consensus 151 ~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd 230 (355)
T KOG0033|consen 151 AVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD 230 (355)
T ss_pred ceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC
Confidence 69999999998777666667888999999999999999999999999999999999999999998888888888776555
Q ss_pred CC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+ ..++++++.++|+++||..||.+|.|+.|.+.
T Consensus 231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 43 45788999999999999999999999999875
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=239.27 Aligned_cols=193 Identities=29% Similarity=0.588 Sum_probs=162.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++. ....++|+||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|+||||+||+++.++.++
T Consensus 59 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~k 135 (257)
T cd05060 59 VRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAK 135 (257)
T ss_pred eeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEE
Confidence 46777775 456799999999999999998766 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC----CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||.+......... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+ ...
T Consensus 136 l~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~-~~~ 214 (257)
T cd05060 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-ESG 214 (257)
T ss_pred eccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcC
Confidence 9999998654332211 11223457999999988889999999999999999998 99999887766554444 334
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.....+..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 215 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 445667788999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=249.92 Aligned_cols=181 Identities=25% Similarity=0.434 Sum_probs=157.9
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++...+..|+||||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|
T Consensus 65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL 142 (323)
T cd05615 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKI 142 (323)
T ss_pred heeeEEecCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEE
Confidence 57788899999999999999999999998765 5889999999999999999999999999999999999999999999
Q ss_pred ecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||++...... .......|++.|+|||++.+..++.++|+||+|+++|+|++|..||...+.......+... ....
T Consensus 143 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~ 220 (323)
T cd05615 143 ADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSY 220 (323)
T ss_pred eccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCC
Confidence 999998653222 2234556899999999998888999999999999999999999999988777666555432 3455
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
+..++..+.+++.+||+.+|.+|++.
T Consensus 221 p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 221 PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 67788999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=254.29 Aligned_cols=188 Identities=21% Similarity=0.334 Sum_probs=157.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...|+||||+++++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~k 136 (330)
T cd05586 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIA 136 (330)
T ss_pred cceEEEEecCCeEEEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 467888999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++..... ........|+..|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+..... .
T Consensus 137 l~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-~ 215 (330)
T cd05586 137 LCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV-R 215 (330)
T ss_pred EecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC-C
Confidence 999999865322 2234456789999999998654 478999999999999999999999988777665554433222 1
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRP----HFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~el~~ 191 (244)
.....+++.+.+++.+||..||.+|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 22235789999999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=254.99 Aligned_cols=188 Identities=23% Similarity=0.394 Sum_probs=159.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.+|.++
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred cceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---------------------------------------CCCCCCcccceeccceeccCCCCCccc
Q 026042 81 VADFGISCLESQCG---------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVD 121 (244)
Q Consensus 81 l~dfg~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~D 121 (244)
|+|||++....... ......||+.|+|||++.+..++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 99999875422110 011246899999999998889999999
Q ss_pred hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCC--CCchHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 026042 122 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 191 (244)
Q Consensus 122 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~el~~ 191 (244)
||||||++|+|++|..||...+.......+.........+ ..+++++.++|.+|+. +|.+|++ +.++++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999999999999999999888776655554433333333 3568999999999997 8999997 888887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=239.06 Aligned_cols=191 Identities=27% Similarity=0.576 Sum_probs=162.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++||||+++++|.+++....+ .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05114 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVK 140 (256)
T ss_pred eeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEE
Confidence 4688999999999999999999999999986543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+..+....+.. ...
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~ 219 (256)
T cd05114 141 VSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFR 219 (256)
T ss_pred ECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCC
Confidence 999998865432111 122234568999999988889999999999999999999 9999988877666555543 233
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
...+...+..+.+++.+||+.+|.+||+++++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 444566788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=243.84 Aligned_cols=196 Identities=30% Similarity=0.590 Sum_probs=165.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--------------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--------------~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++..++..++++||+++++|.++++.. ....+++..++.++.|++.||.|||++|++|+||
T Consensus 79 ~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred eeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 46889999999999999999999999999753 2335888999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|++++ |..||.+.
T Consensus 159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999999865433211 112234567999999988889999999999999999997 99999887
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
...+...... .......+..++..+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 239 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PVEELFKLLK-EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 7666554443 33344556678899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.18 Aligned_cols=189 Identities=21% Similarity=0.331 Sum_probs=157.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 64 VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred ceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC------------------------------------------------CCCCCCcccceeccceec
Q 026042 81 VADFGISCLESQCG------------------------------------------------SAKGFTGTYRWMAPEMIK 112 (244)
Q Consensus 81 l~dfg~~~~~~~~~------------------------------------------------~~~~~~~~~~y~aPE~~~ 112 (244)
|+|||++....... ......|++.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 99999885221100 001246899999999998
Q ss_pred cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCC--CCchHHHHHHHHHhcccCCCCC---CCHH
Q 026042 113 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRR---PHFD 187 (244)
Q Consensus 113 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R---ps~~ 187 (244)
+..++.++|||||||++|+|++|..||...+..+....+.........+ ..++.++.+++.+||. +|.+| +++.
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 8889999999999999999999999998877666555544333333333 3578999999999997 66665 5999
Q ss_pred HHHHH
Q 026042 188 QIVSI 192 (244)
Q Consensus 188 el~~~ 192 (244)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=238.46 Aligned_cols=193 Identities=27% Similarity=0.541 Sum_probs=164.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.. ...++|+||+++++|.+++.+.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.+|
T Consensus 59 v~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~k 137 (257)
T cd05040 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVK 137 (257)
T ss_pred cceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEE
Confidence 467788877 8899999999999999999876534689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+....
T Consensus 138 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 217 (257)
T cd05040 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEG 217 (257)
T ss_pred eccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 99999986543311 1123446778999999988889999999999999999998 999998877776655555444
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 445556678899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=245.11 Aligned_cols=190 Identities=22% Similarity=0.376 Sum_probs=159.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++.+..++..++|+||++|++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~ 142 (285)
T cd05630 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIR 142 (285)
T ss_pred eeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEE
Confidence 35678888999999999999999999999776655689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---AAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~ 157 (244)
|+|||++.............|+..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ..... .....
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~-~~~~~ 221 (285)
T cd05630 143 ISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQ 221 (285)
T ss_pred EeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh-hhhhh
Confidence 999999865443333344578999999999998889999999999999999999999998654321 11111 11222
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
...+..+++++.+++.+||+.||.+||| ++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 3455678899999999999999999999 889887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.75 Aligned_cols=200 Identities=31% Similarity=0.616 Sum_probs=167.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|++++++..++..++++||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 160 (314)
T cd05099 81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDL 160 (314)
T ss_pred eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 5788999999999999999999999999976431 34788899999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.+||+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999865432211 112223457999999988889999999999999999999 89999887
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
+..+....+. .......+..++.++.+++.+||..+|.+||++.++++.|.+......
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 241 PVEELFKLLR-EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 7666554443 333345567788999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=238.56 Aligned_cols=190 Identities=30% Similarity=0.492 Sum_probs=163.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||++|++|.+++....+..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~ 141 (256)
T cd08529 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVK 141 (256)
T ss_pred ehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEE
Confidence 46788999999999999999999999999886555789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++....... ......++..|+|||+..+..++.++|+||||+++++|++|..||...+......... ......
T Consensus 142 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 220 (256)
T cd08529 142 IGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPP 220 (256)
T ss_pred EcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 99999876543322 2234467889999999998889999999999999999999999998877655444433 333445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 55578899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=241.15 Aligned_cols=193 Identities=32% Similarity=0.582 Sum_probs=161.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++..+...++|+||+++++|.+++.+... ..+++..+..++.|++.||.|||+.|++|+||||+||+
T Consensus 72 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil 151 (277)
T cd05062 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 151 (277)
T ss_pred eeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEE
Confidence 5688999999999999999999999999976432 13567888999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 73 LGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.....
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~ 231 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231 (277)
T ss_pred EcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999998764322111 112345678999999988889999999999999999998 78999887766555
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.... .......+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 4433 33334556778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.00 Aligned_cols=192 Identities=34% Similarity=0.633 Sum_probs=165.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++......++|+||+++++|.++++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~ 142 (256)
T cd05039 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAK 142 (256)
T ss_pred eeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEE
Confidence 46788999899999999999999999999876655689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+........ ....+..|+|||.+....++.++|+||||++++++++ |..||...+..+...... ......
T Consensus 143 l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 219 (256)
T cd05039 143 VSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRME 219 (256)
T ss_pred Ecccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCC
Confidence 999999876533221 2334567999999988888999999999999999997 999998887766554443 333445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
.+..+++.+.+++.+||..+|.+||++.+++++|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 566788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=257.06 Aligned_cols=186 Identities=27% Similarity=0.482 Sum_probs=167.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|.+++||++..++++|.||+.| +|..++...+ .++++.+..++.++++||.|||+++|.|||+||.||+++.+|.+|
T Consensus 64 v~m~esfEt~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 64 VEMLESFETSAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred hhHHHhhcccceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCcee
Confidence 4678999999999999999966 9999999877 699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
++|||+++....... .....||+-|||||...+++++..+|+|||||++||+++|++||-.....+....+.... ..
T Consensus 141 lcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~--v~ 218 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP--VK 218 (808)
T ss_pred echhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC--CC
Confidence 999999987665443 345679999999999999999999999999999999999999999887777766664433 44
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.|...+..+..|+..+|.+||..|.++.+++.
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 55688899999999999999999999999997
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=239.07 Aligned_cols=193 Identities=34% Similarity=0.628 Sum_probs=161.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++. .+..+++|||+++++|.+++.+..+..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++
T Consensus 64 ~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~ 142 (260)
T cd05069 64 VPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCK 142 (260)
T ss_pred eeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEE
Confidence 35667665 45678999999999999999876655688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... ......++..|+|||...+...+.++|+||||+++|+|++ |..||.+.........+. ....
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~ 221 (260)
T cd05069 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYR 221 (260)
T ss_pred ECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99999986543221 1122345678999999988889999999999999999999 999998877665544432 3334
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
...+...+..+.+++.+||..+|++||++++++++|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 45566788999999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=241.70 Aligned_cols=194 Identities=31% Similarity=0.595 Sum_probs=163.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dik 67 (244)
+++++++..+...++++||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+|||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlk 149 (280)
T cd05092 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149 (280)
T ss_pred ceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 4688999999999999999999999999986542 247889999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 026042 68 SENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT 143 (244)
Q Consensus 68 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 143 (244)
|+||++++++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 150 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 150 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred HhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 999999999999999999986432211 1122334678999999988889999999999999999998 999998777
Q ss_pred HHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 144 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
..+...... .......+..+++.+.+++.+||+.||.+||++.++++.|++
T Consensus 230 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 230 NTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 665554443 333345566788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=238.48 Aligned_cols=193 Identities=26% Similarity=0.591 Sum_probs=161.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++. ....++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+|
T Consensus 58 i~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k 135 (257)
T cd05115 58 VRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK 135 (257)
T ss_pred EEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEE
Confidence 46778775 4578899999999999999976443 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+....++.++|+||||+++|++++ |..||...........+ ...
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~ 214 (257)
T cd05115 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQG 214 (257)
T ss_pred eccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCC
Confidence 999999864332211 111223568999999988889999999999999999996 99999888776655444 344
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.....+..+++++.+++.+||..+|++||++.++.+.|+.+
T Consensus 215 ~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 45567778899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=254.02 Aligned_cols=189 Identities=23% Similarity=0.375 Sum_probs=156.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++
T Consensus 64 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~k 141 (381)
T cd05626 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIK 141 (381)
T ss_pred eeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 588899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc------------------------------------------------CCCCCCCcccceeccceec
Q 026042 81 VADFGISCLESQC------------------------------------------------GSAKGFTGTYRWMAPEMIK 112 (244)
Q Consensus 81 l~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~ 112 (244)
|+|||++...... .......||+.|+|||.+.
T Consensus 142 L~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 221 (381)
T cd05626 142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221 (381)
T ss_pred EeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc
Confidence 9999986422100 0012346899999999998
Q ss_pred cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC--CCCchHHHHHHHHHhc--ccCCCCCCCHHH
Q 026042 113 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCW--SSSPDRRPHFDQ 188 (244)
Q Consensus 113 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l--~~~p~~Rps~~e 188 (244)
+..++.++|||||||++|+|++|..||...+.......+......... ...+++++.+++.+|+ ..++..|+++++
T Consensus 222 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred CCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 888999999999999999999999999887766555544432222233 3357899999999955 455556999999
Q ss_pred HHH
Q 026042 189 IVS 191 (244)
Q Consensus 189 l~~ 191 (244)
+++
T Consensus 302 ~l~ 304 (381)
T cd05626 302 IKA 304 (381)
T ss_pred Hhc
Confidence 997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=238.97 Aligned_cols=191 Identities=29% Similarity=0.598 Sum_probs=161.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++||||+.+++|.+++..... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+|
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~k 140 (256)
T cd05113 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVK 140 (256)
T ss_pred eeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEE
Confidence 4788999999999999999999999999987554 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....++..|++||.+.+..++.++|+||||+++|+|++ |..||...+.......+.. ...
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~ 219 (256)
T cd05113 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLR 219 (256)
T ss_pred ECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-CCC
Confidence 999998764432211 112234568999999988889999999999999999998 9999988776655544433 333
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
...+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 445566789999999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.29 Aligned_cols=198 Identities=31% Similarity=0.616 Sum_probs=165.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++..++..|+|+||+++++|.+++..+.. ..+++..++.++.|++.||+|||++|++|+||
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 166 (307)
T cd05098 87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL 166 (307)
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 4688999999999999999999999999976432 24788899999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999999999999865432111 112234468999999988889999999999999999998 88999877
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+..+..... ........+..++.++.+++.+||..+|.+||++.++++.|+.+...
T Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 665544433 33444556677899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=252.81 Aligned_cols=189 Identities=22% Similarity=0.344 Sum_probs=158.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+++++|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED-QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred cceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEE
Confidence 4677889999999999999999999999987633 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceec------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
|+|||++........ .....+++.|+|||.+. ...++.++||||||+++|+|++|..||...+.......+.
T Consensus 143 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 222 (330)
T cd05601 143 LADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM 222 (330)
T ss_pred eccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence 999999865433221 22346899999999986 4567889999999999999999999998877766555544
Q ss_pred hhCCCCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....... ....+++.+.+++.+||. +|.+||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 223 NFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 3332222 234578999999999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=239.43 Aligned_cols=191 Identities=28% Similarity=0.489 Sum_probs=164.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++.+..++..|+++||+++++|.+++....+..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~ 140 (255)
T cd08219 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVK 140 (255)
T ss_pred ceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEE
Confidence 46788999999999999999999999999876555689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
++|||.+....... ......++..|+|||++.+...+.++|+||+|+++++|++|..||...+......... ......
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 219 (255)
T cd08219 141 LGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKP 219 (255)
T ss_pred EcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCC
Confidence 99999986543322 2234568889999999988889999999999999999999999999877666554443 333445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.+..++..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 667788999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=241.05 Aligned_cols=194 Identities=31% Similarity=0.613 Sum_probs=162.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE---------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 65 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~d 65 (244)
|++++++..+...|+||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++|+|
T Consensus 70 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 149 (283)
T cd05090 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKD 149 (283)
T ss_pred eeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhc
Confidence 468899999999999999999999999986432 12477888999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 026042 66 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 141 (244)
Q Consensus 66 ikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~ 141 (244)
|||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||.+
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 150 LAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986543221 1233345678999999988889999999999999999998 9999987
Q ss_pred CCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 142 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
.+.......+. .......+..++..+.+++.+|++.+|.+||++.++++.|.+
T Consensus 230 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 230 FSNQEVIEMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 76655444433 344455667889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=238.01 Aligned_cols=195 Identities=35% Similarity=0.632 Sum_probs=162.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++. ....++|+||+++++|.+++.+..+..+++..+..++.|++.||++||+.|++|+||||+||+++.++.++
T Consensus 64 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~ 142 (262)
T cd05071 64 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 142 (262)
T ss_pred ceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEE
Confidence 35666664 45678999999999999999876555688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....++..|+|||...+..++.++|+||||+++|++++ |..||.+....+....+. ....
T Consensus 143 L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~ 221 (262)
T cd05071 143 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 221 (262)
T ss_pred eccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCC
Confidence 999999865433221 123345678999999988889999999999999999999 899998877666554443 2333
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
...+..++..+.+++.+|++.+|++||++.+++++|+.+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4455678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=244.50 Aligned_cols=189 Identities=21% Similarity=0.302 Sum_probs=152.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||++++++..+..... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+|
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN--GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred cchhhhEecCCEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEE
Confidence 467788999999999999998866655544332 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+..+....+......
T Consensus 141 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07848 141 LCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPL 220 (287)
T ss_pred EeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 99999987643321 223456889999999998888999999999999999999999999877654433322111000
Q ss_pred ------------------C-----------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ------------------P-----------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ------------------~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .....++..+.+++.+||+.||.+|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 221 PAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 001235778999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=242.46 Aligned_cols=198 Identities=30% Similarity=0.602 Sum_probs=166.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++...+..++|+||+++++|.+++.+... ..+++..+..++.|++.||.|||++|++|+||
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dl 163 (304)
T cd05101 84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDL 163 (304)
T ss_pred hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 4688999999999999999999999999976431 24677889999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|++++ |..||.+.
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999865432221 222335678999999988889999999999999999998 88999887
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+..+...... .......+..++..+.+++.+||..+|.+||++.++++.|.++...
T Consensus 244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 PVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 7766655543 3334455667889999999999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=242.73 Aligned_cols=191 Identities=25% Similarity=0.417 Sum_probs=156.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..+...++||||++|++|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 135 (280)
T cd05608 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN 135 (280)
T ss_pred eeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 45778889999999999999999999888542 2336899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--hC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~ 155 (244)
++|+|||.+....... ......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.............. ..
T Consensus 136 ~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 215 (280)
T cd05608 136 VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN 215 (280)
T ss_pred EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc
Confidence 9999999986543322 23345689999999999999999999999999999999999999976543221111111 12
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.....+..++..+.+++.+||+.||.+|| +++++++
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 22345567899999999999999999999 6677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=237.95 Aligned_cols=191 Identities=31% Similarity=0.643 Sum_probs=161.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||++|++|.+++..+.. .+++..++.++.|++.||+|||++|++|+||||+||+++.++.+|
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05059 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVK 140 (256)
T ss_pred EEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEE
Confidence 4678899999999999999999999999987554 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+. ....
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~ 219 (256)
T cd05059 141 VSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYR 219 (256)
T ss_pred ECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCc
Confidence 999998865432111 112223457999999988889999999999999999998 899998877666554443 3344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
...+..++..+.+++.+||..+|++||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 556677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=243.53 Aligned_cols=189 Identities=22% Similarity=0.344 Sum_probs=154.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|+||++ ++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~k 143 (288)
T cd07871 66 VTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELK 143 (288)
T ss_pred eeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence 568899999999999999996 599999876543 578899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+......+
T Consensus 144 l~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07871 144 LADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223 (288)
T ss_pred ECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998653322 22334567899999998865 567999999999999999999999998877665544332211100
Q ss_pred ----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....++.+..+++.+||+.||.+|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 011245778999999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=241.67 Aligned_cols=197 Identities=31% Similarity=0.576 Sum_probs=165.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------PYSVPLNLVLKLALDIARGMQYLHS 58 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------------------~~~~~~~~~~~~~~~l~~~L~~lH~ 58 (244)
|++++.+..++..++++||+.+++|.+++.... ...+++..++.++.|++.||+|||+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 145 (290)
T cd05045 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145 (290)
T ss_pred eeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 578899999999999999999999999987532 1247788999999999999999999
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT- 134 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 134 (244)
+|++||||||+||++++++.++|+|||++........ .....++..|+|||...+..++.++||||||+++++|++
T Consensus 146 ~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~ 225 (290)
T cd05045 146 MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225 (290)
T ss_pred CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999865322211 122345678999999888889999999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
|..||.+.......... ........+..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 226 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 226 GGNPYPGIAPERLFNLL-KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCCCCCCHHHHHHHH-hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 99999887766654443 3334445567788999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=237.34 Aligned_cols=194 Identities=35% Similarity=0.637 Sum_probs=161.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++. ....+++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||++++++.++
T Consensus 64 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~ 142 (260)
T cd05070 64 VQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK 142 (260)
T ss_pred EEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEE
Confidence 35677765 45678999999999999999876555689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....++..|+|||...+..++.++|+||||+++|+|++ |..||...+..+....+. ....
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~ 221 (260)
T cd05070 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYR 221 (260)
T ss_pred eCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999999865432211 112234567999999988889999999999999999999 999998877665554443 3344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.+.+...+..+.+++.+|+..+|++|||++++.++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 556677889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=239.14 Aligned_cols=195 Identities=27% Similarity=0.527 Sum_probs=162.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++. +...++++||+++++|.+++....+ .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+|
T Consensus 72 v~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~k 149 (279)
T cd05111 72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQ 149 (279)
T ss_pred ceEEEEEC-CCccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEE
Confidence 46788775 4557799999999999999987543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||.+........ .....++..|++||.+.+..++.++|+||||+++|++++ |..||.+......... .....
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~ 228 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-LEKGE 228 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCC
Confidence 999999865432221 223346678999999988889999999999999999998 9999988766554333 33444
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
....+..++.++..++.+|+..+|++||++.|+++.|..+..
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 455566778899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.17 Aligned_cols=188 Identities=24% Similarity=0.457 Sum_probs=154.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~ 79 (244)
|+++++|..++..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+. +++|+||||+||+++.+|.+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~ 143 (333)
T cd06650 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 143 (333)
T ss_pred cceeEEEEECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCE
Confidence 578999999999999999999999999998765 578899999999999999999985 79999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC------- 152 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------- 152 (244)
||+|||++...... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.............
T Consensus 144 kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (333)
T cd06650 144 KLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP 222 (333)
T ss_pred EEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCc
Confidence 99999998654322 2334568899999999988889999999999999999999999997655433221110
Q ss_pred ------------------------------------hhCCCCCC-CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 ------------------------------------QKNARPPV-PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ------------------------------------~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+.. ...++.++.+|+.+||+.||++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00011111 1235788999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=253.14 Aligned_cols=188 Identities=23% Similarity=0.401 Sum_probs=156.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++.+..++..|+||||++||+|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~k 141 (382)
T cd05625 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIK 141 (382)
T ss_pred CeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc------------------------------------------------CCCCCCCcccceeccceec
Q 026042 81 VADFGISCLESQC------------------------------------------------GSAKGFTGTYRWMAPEMIK 112 (244)
Q Consensus 81 l~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~~y~aPE~~~ 112 (244)
|+|||++...... .......|++.|+|||++.
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 221 (382)
T cd05625 142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221 (382)
T ss_pred EeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc
Confidence 9999986421100 0012346899999999999
Q ss_pred cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC--CCCchHHHHHHHHHhcccCCCCCCC---HH
Q 026042 113 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRPH---FD 187 (244)
Q Consensus 113 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~ 187 (244)
+..++.++|||||||++|+|++|..||...+..+....+......... ...++++..+++.+|+ .+|.+|++ ++
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 889999999999999999999999999988776655555433333333 3467899999999976 59999987 88
Q ss_pred HHHH
Q 026042 188 QIVS 191 (244)
Q Consensus 188 el~~ 191 (244)
++++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 8775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=240.75 Aligned_cols=191 Identities=20% Similarity=0.351 Sum_probs=160.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++.+..++..++++||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~k 142 (285)
T cd05632 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred eeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEE
Confidence 35678889999999999999999999998765555689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--hCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ--KNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~ 158 (244)
|+|||++.............|+..|+|||.+.+..++.++|+||+|+++++|++|..||...........+.. .....
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05632 143 ISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE 222 (285)
T ss_pred EecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc
Confidence 9999988654433333455789999999999888899999999999999999999999987765443333222 22223
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
..+..++.++.+|+.+||+.+|.+||+ +++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 455678899999999999999999999 677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.53 Aligned_cols=189 Identities=23% Similarity=0.373 Sum_probs=157.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++.+..++.+|+||||++|++|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+||+++.++.++
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ik 141 (376)
T cd05598 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIK 141 (376)
T ss_pred ceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEE
Confidence 568899999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--------------------------------------------CCCCCCCcccceeccceeccCCC
Q 026042 81 VADFGISCLESQC--------------------------------------------GSAKGFTGTYRWMAPEMIKEKRH 116 (244)
Q Consensus 81 l~dfg~~~~~~~~--------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 116 (244)
|+|||++...... .......|++.|+|||++.+..+
T Consensus 142 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 221 (376)
T cd05598 142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221 (376)
T ss_pred EEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC
Confidence 9999986421100 00113468999999999999899
Q ss_pred CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC--CCCCchHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 026042 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRP---HFDQIVS 191 (244)
Q Consensus 117 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp---s~~el~~ 191 (244)
+.++|||||||++|+|++|..||...+..+....+........ ....+++++.+++.+|+ .+|.+|+ ++.++++
T Consensus 222 ~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 222 TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred CcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999999999999999998877665554433322222 23467899999999976 5999999 8999987
Q ss_pred H
Q 026042 192 I 192 (244)
Q Consensus 192 ~ 192 (244)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=251.69 Aligned_cols=189 Identities=24% Similarity=0.410 Sum_probs=158.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++||+|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred eeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEE
Confidence 57889999999999999999999999999764 378899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++....... ......|++.|+|||++.+.. ++.++|+||+||++|+|++|..||...+.......+...
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05621 183 LADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred EEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 99999987543322 223567999999999986543 688999999999999999999999988776666655543
Q ss_pred CCCCCCCC--CchHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 026042 155 NARPPVPP--TCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 192 (244)
Q Consensus 155 ~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~el~~~ 192 (244)
......+. .++..+++++.+||..++.+ |+++.++++.
T Consensus 263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 33333333 56899999999999855543 8899999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=239.67 Aligned_cols=194 Identities=26% Similarity=0.508 Sum_probs=163.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|++++++......++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||
T Consensus 71 v~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dl 150 (283)
T cd05091 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDL 150 (283)
T ss_pred CeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 578999999999999999999999999985321 124778889999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||++++++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 151 ATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred chhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999998765432211 223345678999999988889999999999999999998 88899887
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
...+....+. .......+..++..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 231 ~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 231 SNQDVIEMIR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 7766555443 333445677899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=234.27 Aligned_cols=192 Identities=32% Similarity=0.636 Sum_probs=162.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||+++++|.+++..... .+++..+..++.|++.+|.|+|++|++|+||+|+||+++.++.++
T Consensus 55 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~ 133 (250)
T cd05085 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLK 133 (250)
T ss_pred CeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEE
Confidence 4688999999999999999999999999976543 578999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++........ .....++..|+|||.+....++.++|+||||+++|++++ |..||...........+. ....
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~ 212 (250)
T cd05085 134 ISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYR 212 (250)
T ss_pred ECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999999864332211 112234567999999988889999999999999999998 999998877666554443 3334
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
...+..++..+.+++.+|++.+|.+||++.++++.|.
T Consensus 213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4556778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=239.11 Aligned_cols=194 Identities=32% Similarity=0.589 Sum_probs=155.7
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++.. ....++||||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 145 (283)
T cd05080 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL 145 (283)
T ss_pred eeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc
Confidence 457777755 44689999999999999999764 3899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------
Q 026042 79 VKVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------- 146 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------- 146 (244)
++|+|||++........ .....++..|+|||.+.+...+.++||||||+++++|++|..||......-
T Consensus 146 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 225 (283)
T cd05080 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQ 225 (283)
T ss_pred EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccc
Confidence 99999999865433211 122335667999999988889999999999999999999999986533210
Q ss_pred ------HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 147 ------AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 147 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
............+.+..++..+.+++.+||+.+|++||+++++++.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 001111122233445678899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=236.34 Aligned_cols=195 Identities=37% Similarity=0.687 Sum_probs=165.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++....+..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~ 143 (261)
T cd05034 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCK 143 (261)
T ss_pred eeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEE
Confidence 46788899989999999999999999999887655789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... .......+..|+|||.+.+...+.++|+||+|++++++++ |+.||.+.+.......+. ....
T Consensus 144 l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~ 222 (261)
T cd05034 144 IADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYR 222 (261)
T ss_pred ECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99999886543211 1112234568999999988889999999999999999998 999998877666555443 3334
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+...+..+.+++.+||..+|.+||+++++.+.|+.+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 455666789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=238.82 Aligned_cols=193 Identities=28% Similarity=0.563 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
+++++++.+....++|+||++|++|.+++.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~ 151 (277)
T cd05036 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTC 151 (277)
T ss_pred eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEec
Confidence 4688999999999999999999999999976542 24788999999999999999999999999999999999987
Q ss_pred CC---cEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 76 DM---CVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 76 ~~---~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
++ .++|+|||++........ ......+..|+|||.+.+..++.++|||||||++|+|++ |..||...+.....
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 65 589999999865422111 112233568999999988889999999999999999997 99999987776654
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
..+. .......+..++..+.+++.+|++.+|++||++.++++.|+
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVT-GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 4433 33445566778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=241.01 Aligned_cols=189 Identities=24% Similarity=0.365 Sum_probs=154.6
Q ss_pred cEEEEeec-----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 2 QFVAACKK-----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 2 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
++++++.. ....++++||+. ++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 66 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~ 144 (288)
T cd07863 66 RLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG 144 (288)
T ss_pred eeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 45666543 456899999996 599999987655568999999999999999999999999999999999999999
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
+.++|+|||++.............++..|+|||.+.+..++.++||||+||++|+|++|..||.+....+....+.....
T Consensus 145 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~ 224 (288)
T cd07863 145 GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224 (288)
T ss_pred CCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence 99999999998765544444456688999999999888899999999999999999999999987766554433322110
Q ss_pred CC-------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RP-------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ...+.++..+.+++.+||+.||.+||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 011346788999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=248.22 Aligned_cols=197 Identities=35% Similarity=0.569 Sum_probs=156.9
Q ss_pred CcEEEEeecCC-cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG---ILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~---i~H~dikp~nil~~~~ 76 (244)
|+++|||.+++ ..+||+||+++|+|.+++.......++|.++.+|+.+++.||+|||... |+|||||++|||+|++
T Consensus 134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 68999999999 4999999999999999998765436899999999999999999999864 9999999999999999
Q ss_pred CcEEEecCCCcccccc-cCCCCCC-CcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC---H---HHHH
Q 026042 77 MCVKVADFGISCLESQ-CGSAKGF-TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---P---EQAA 148 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~---~~~~ 148 (244)
+..||+|||++..... ....... .||.+|++||....+..+.++||||||++++|+++|+.+.+... . .+..
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999999966544 3333333 89999999999998999999999999999999999998887532 1 1111
Q ss_pred HHHHhhC-----CCCCCC-CCch-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 149 FAVCQKN-----ARPPVP-PTCP-----KAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 149 ~~~~~~~-----~~~~~~-~~~~-----~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
....... ..+.+. ..++ ..+..+..+|++.+|.+||+|.+++++|+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 1111111 111111 2222 23567888999999999999999999985543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=244.67 Aligned_cols=189 Identities=22% Similarity=0.367 Sum_probs=156.5
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++.+..... ..+|||+|||+. +|.-++...+ ..+++.++.-++.||+.||+|||++|++|||||.+|||||.+|.
T Consensus 179 ikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~ 256 (560)
T KOG0600|consen 179 IKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV 256 (560)
T ss_pred cceeeEEEecCCceEEEEEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC
Confidence 4566666555 789999999965 9999988643 36999999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC--CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
+||+|||+|++..... .-...+.|.+|.|||.+.+. .|+.+.|+||.||++.||+.|++.|.+.+.-+.+..+....
T Consensus 257 LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 257 LKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC 336 (560)
T ss_pred EEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence 9999999999765544 34456789999999998775 78999999999999999999999999988766655553321
Q ss_pred CCC--------CCC-------------------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARP--------PVP-------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~--------~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+ .+| ..++....+|+..+|..||.+|.|+.+.++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 011 224567789999999999999999999886
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=243.49 Aligned_cols=189 Identities=21% Similarity=0.329 Sum_probs=149.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..+...++||||+ +++|.+++.++.+ .+++..+..++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus 66 v~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 143 (303)
T cd07869 66 VLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELK 143 (303)
T ss_pred CeEEEEEecCCeEEEEEECC-CcCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 46889999999999999999 5699998876543 578899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhhCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~ 157 (244)
|+|||++...... .......+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+..... ....+......
T Consensus 144 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (303)
T cd07869 144 LADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223 (303)
T ss_pred ECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence 9999998643321 22334567899999998865 457889999999999999999999998754322 22111110000
Q ss_pred C---------------------CCC---------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 P---------------------PVP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~---------------------~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+ ..+ ..+++.+.+++.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0 000 123467889999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=251.90 Aligned_cols=188 Identities=24% Similarity=0.412 Sum_probs=156.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+|.++
T Consensus 64 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred eeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence 468899999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC------------------------------------CCCCCCcccceeccceeccCCCCCccchhh
Q 026042 81 VADFGISCLESQCG------------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 124 (244)
Q Consensus 81 l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 124 (244)
|+|||++....... ......|++.|+|||++.+..++.++|+||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 99999875332110 011346899999999999999999999999
Q ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCC--CchHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 026042 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP--TCPKAFSYLISRCWSSSPDRRPH---FDQIVS 191 (244)
Q Consensus 125 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~el~~ 191 (244)
|||++|+|++|..||...+.......+.........+. .+++++.++|.+++ .+|.+|++ ++++++
T Consensus 222 lGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 222 LGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred ccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 99999999999999998887766655544333333332 46889999999977 49999985 566665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.01 Aligned_cols=189 Identities=24% Similarity=0.385 Sum_probs=157.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++|++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus 106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ik 182 (371)
T cd05622 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182 (371)
T ss_pred CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEE
Confidence 57889999999999999999999999999764 378899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++....... ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...
T Consensus 183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 99999987543322 223567999999999986543 788999999999999999999999988776665555443
Q ss_pred CCCCCC--CCCchHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 026042 155 NARPPV--PPTCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 192 (244)
Q Consensus 155 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~--Rps~~el~~~ 192 (244)
...... ...++..+.++|.+||..++.+ |++++++++.
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 322223 3468899999999999844433 7899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=241.90 Aligned_cols=198 Identities=30% Similarity=0.599 Sum_probs=165.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|+++++|..++..++++||+++++|.+++.+.. ...+++..+..++.|++.||.|||++|++||||
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 578899999999999999999999999997642 124677888999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999865433211 122233567999999988889999999999999999998 89999888
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+..+....+. .......+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 241 PVEELFKLLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred CHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 7766555443 3334455667889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=236.55 Aligned_cols=194 Identities=34% Similarity=0.653 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+... .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEE
Confidence 5788999999999999999999999999987643 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC----CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||.+......... ....++..|++||.+.+..++.++|+||||++++++++ |..||...+..+....+. ..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~ 225 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EG 225 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CC
Confidence 9999998654332211 11223467999999988889999999999999999887 999998877665544443 33
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+.+..+++.+.+++.+|++.+|.+||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 34455567889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=236.48 Aligned_cols=194 Identities=34% Similarity=0.613 Sum_probs=163.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++.+++...+..++||||+++++|.+++....+ .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~k 147 (268)
T cd05063 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECK 147 (268)
T ss_pred eEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEE
Confidence 4688999999999999999999999999976543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC----CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGSA----KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++......... .....+..|++||.+....++.++|+||||+++|++++ |..||...+..+....+.. .
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~ 226 (268)
T cd05063 148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-G 226 (268)
T ss_pred ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-C
Confidence 9999998654322111 11123457999999988888999999999999999997 9999988777665555433 3
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+.+..++..+.+++.+|++.+|++||++.++++.|.++
T Consensus 227 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 34445566889999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=237.65 Aligned_cols=191 Identities=28% Similarity=0.494 Sum_probs=157.5
Q ss_pred CcEEEEeec------CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKK------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
+++++++.. ....|+++||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~ 145 (272)
T cd06637 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145 (272)
T ss_pred eeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC
Confidence 356677654 35689999999999999999876555689999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCccccccc-CCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 026042 75 EDMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 148 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 148 (244)
.++.++|+|||++...... .......++..|+|||++. +..++.++|+||+|+++|+|++|..||.........
T Consensus 146 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~ 225 (272)
T cd06637 146 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 225 (272)
T ss_pred CCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 9999999999998654322 2234456888999999885 335788999999999999999999999876665554
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...............++..+.+++.+||..+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 4443333334444567899999999999999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=247.11 Aligned_cols=187 Identities=19% Similarity=0.333 Sum_probs=146.7
Q ss_pred cEEEEeecC-----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 2 QFVAACKKP-----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 2 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
++++++... ...|+||||+ +++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 63 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~ 139 (338)
T cd07859 63 EIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139 (338)
T ss_pred eecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 455555332 3589999999 569999998765 58899999999999999999999999999999999999999
Q ss_pred CcEEEecCCCcccccccCC----CCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 77 MCVKVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
+.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~ 219 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 219 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence 9999999999865322111 134568999999999865 5788999999999999999999999987654332211
Q ss_pred HHhh--------------------------CCCC---CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQK--------------------------NARP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~--------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+... .... ...+.+++.+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 220 ITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1000 0000 011345778899999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=247.49 Aligned_cols=191 Identities=25% Similarity=0.384 Sum_probs=158.7
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|+++++.. ..+.+|||+|||..|.+...-.... .+++.+++++++.++.||+|||.+||+||||||+|+|++++|.
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~--els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP--ELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcc--cccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 56777774 4567899999998887754433322 2889999999999999999999999999999999999999999
Q ss_pred EEEecCCCccccccc------CCCCCCCcccceeccceeccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 026042 79 VKVADFGISCLESQC------GSAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 148 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 148 (244)
+||+|||.+...... .......||+.|+|||...++. .+.+.||||+|++||-|+.|+.||-+...-+..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999998654221 1123467999999999987632 478999999999999999999999988887777
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
..++......+..+...+.+++||.+||++||+.|.++.++....
T Consensus 329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 777666665555566789999999999999999999999988743
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=234.77 Aligned_cols=191 Identities=28% Similarity=0.457 Sum_probs=165.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++++||+++++|.+++.+..+..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+|
T Consensus 62 ~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~k 141 (256)
T cd08221 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIK 141 (256)
T ss_pred eEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEE
Confidence 47889999999999999999999999999876555689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+....... ......++..|+|||...+...+.++|+||||+++++|++|..||...+..+....+.... ...
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~ 220 (256)
T cd08221 142 LGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTP 220 (256)
T ss_pred ECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCC
Confidence 99999986543332 2344568899999999988888999999999999999999999998877666655554333 334
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.+..++..+.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 446678999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=225.50 Aligned_cols=190 Identities=22% Similarity=0.329 Sum_probs=157.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|.+++.|...+.+.||+||++ .+|...|+.... .++...+..++.++++||+|||++.|+||||||.|++++++|.+|
T Consensus 64 i~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 64 IELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred hhhhhhccCCCceEEEEEecc-ccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEE
Confidence 467889999999999999995 599999988654 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCC-CCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCGSAK-GFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||+++......... ..+.|.+|.|||.+.+ +.|+...|+||.||++.||+-|.+-|.+.+.-+....+......+
T Consensus 142 iADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP 221 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTP 221 (318)
T ss_pred eecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCC
Confidence 99999999876554433 3478999999998766 468999999999999999999988888766544444433222211
Q ss_pred C--------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 159 P--------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 159 ~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
. .-+..+.+..+|+.+||..||.+|+++.|++++
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 112345677999999999999999999999984
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=233.70 Aligned_cols=191 Identities=31% Similarity=0.631 Sum_probs=160.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+ ..++++||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 62 ~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~k 140 (254)
T cd05083 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAK 140 (254)
T ss_pred CeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEE
Confidence 4677777655 468999999999999999876655688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+...... .........|+|||.+.+..++.++|+||||+++++|++ |..||...+..+....+. ......
T Consensus 141 l~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 217 (254)
T cd05083 141 VSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRME 217 (254)
T ss_pred ECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCC
Confidence 9999987653321 122334568999999988889999999999999999997 999998887766554443 334444
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
.+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 566788999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=235.81 Aligned_cols=194 Identities=32% Similarity=0.620 Sum_probs=162.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++....+ .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ceEEEEECCCCceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEE
Confidence 4688899999999999999999999999987543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCC----C--CcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCGSAKG----F--TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~----~--~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||++........... . ..+..|++||.+.+..++.++|+||+|+++|++++ |..||...+..+....+.
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~- 225 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE- 225 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-
Confidence 999998765432221111 1 12357999999988889999999999999999886 999998877665554442
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.....+.+..++..+.+++.+||..+|++||+++++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3344455667889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=235.38 Aligned_cols=195 Identities=31% Similarity=0.578 Sum_probs=161.3
Q ss_pred CcEEEEeecCCc------EEEEEeccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 026042 1 MQFVAACKKPPV------FCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70 (244)
Q Consensus 1 v~~~~~~~~~~~------~~lv~e~~~~~~L~~~i~~~----~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~n 70 (244)
+++++++..... .++++||+++++|..++... ....+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 64 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~N 143 (273)
T cd05035 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARN 143 (273)
T ss_pred eeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhe
Confidence 456777655554 79999999999999998543 22358889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 71 LLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 71 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
|++++++.+||+|||.+........ .....++..|++||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 144 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05035 144 CMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223 (273)
T ss_pred EEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865432221 112234568999999988889999999999999999999 999998877666
Q ss_pred HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 147 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...... .......+..++..+.+++.+||+.||++||++.++++.|+++
T Consensus 224 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 IYDYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 554443 3344556778899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=241.75 Aligned_cols=195 Identities=28% Similarity=0.599 Sum_probs=163.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
++++++|... ..++++||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 72 v~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~k 149 (316)
T cd05108 72 CRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVK 149 (316)
T ss_pred CeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEE
Confidence 5688888765 56799999999999999987653 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC---CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++......... ....++..|++||.+.+..++.++||||||+++|+|++ |..||.+....+.. .+.....
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~ 228 (316)
T cd05108 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGE 228 (316)
T ss_pred EccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCC
Confidence 9999998765432221 12234568999999998899999999999999999998 99999887665543 3334444
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+.+..++..+.+++.+||..+|.+||++.+++..+.....
T Consensus 229 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 555667788999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=256.65 Aligned_cols=180 Identities=28% Similarity=0.514 Sum_probs=154.6
Q ss_pred cEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 12 VFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.+++||||+++|+|.++++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence 3689999999999999997532 33688999999999999999999999999999999999999999999999999865
Q ss_pred cccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchH
Q 026042 90 ESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 166 (244)
Q Consensus 90 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (244)
.... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......... ....+.+..+++
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~ 271 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDPLPPSISP 271 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCCH
Confidence 4322 223456789999999999998999999999999999999999999998877665554443 333456778899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 167 AFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 167 ~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
++.+++.+||+.+|.+||++.++++.
T Consensus 272 ~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 272 EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 99999999999999999999999863
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=234.85 Aligned_cols=193 Identities=34% Similarity=0.661 Sum_probs=162.0
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++ ..+..++++||+++++|.+++....+..+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|
T Consensus 65 ~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l 143 (260)
T cd05067 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKI 143 (260)
T ss_pred eEEEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEE
Confidence 466665 4567899999999999999998766667899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 82 ADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 82 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|||.+....... ......++..|+|||.+....++.++|+||||++++++++ |..||.+.+..+...... .....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05067 144 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRM 222 (260)
T ss_pred ccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCC
Confidence 9999986543211 1223345678999999988889999999999999999998 999998877665544433 33344
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
+.+...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 56677889999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=236.68 Aligned_cols=196 Identities=22% Similarity=0.401 Sum_probs=160.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..++..++++||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 65 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~ 144 (267)
T cd08229 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV 144 (267)
T ss_pred hhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC
Confidence 46788899999999999999999999998742 2335889999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ--AAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~ 155 (244)
++|+|||++....... ......++..|+|||.+.+...+.++|+||||+++++|++|..||.+..... .........
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T cd08229 145 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 224 (267)
T ss_pred EEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC
Confidence 9999999876543322 1234468889999999988889999999999999999999999997654322 111111112
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.....+..++..+.+++.+||..+|++|||+.++++.++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 22223345788999999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=236.50 Aligned_cols=194 Identities=28% Similarity=0.588 Sum_probs=160.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.. ...++++||+++|+|.+++....+ .+++..+..++.|++.||+|||++|++||||||+||++++++.+|
T Consensus 72 ~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~k 149 (279)
T cd05109 72 CRLLGICLT-STVQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVK 149 (279)
T ss_pred ceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE
Confidence 356777765 456799999999999999987543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC---CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++......... ....++..|+|||...+..++.++||||||+++|+|++ |..||...........+ ....
T Consensus 150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~ 228 (279)
T cd05109 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGE 228 (279)
T ss_pred ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCC
Confidence 9999998654322211 12234568999999988889999999999999999998 99999877665544433 3344
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
....+..++..+.+++.+||+.||++||++.++++.|....
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 44556778999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=235.89 Aligned_cols=188 Identities=30% Similarity=0.565 Sum_probs=160.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++++||+++++|.+++.... .+++..+..++.|++.||++||+.|++|+||+|+||++++++.++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 69 VQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred eeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEE
Confidence 468899999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCG-------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.........
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~- 225 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG- 225 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-
Confidence 99999876543211 1123457889999999988888999999999999999999999998876655444332
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......+..++..+.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 23445566778999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=236.38 Aligned_cols=196 Identities=23% Similarity=0.383 Sum_probs=160.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..++..++++||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.
T Consensus 65 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~ 144 (267)
T cd08228 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV 144 (267)
T ss_pred eeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC
Confidence 46788899999999999999999999998642 2235788999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~ 155 (244)
++|+|||.+....... ......++..|+|||.+.+...+.++|+||+|+++++|++|..||..... ......+....
T Consensus 145 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (267)
T cd08228 145 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224 (267)
T ss_pred EEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC
Confidence 9999999876543322 12344678899999999888889999999999999999999999965432 22222222222
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
........++..+.+++.+||+.+|++||++.++++.++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 22223346778999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=252.78 Aligned_cols=188 Identities=29% Similarity=0.407 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC--Cc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~--~~ 78 (244)
|++++||...++.|||+|.+ +.+|.++++.+.-.+++...++.++.||+.||.+||..||||+||||+|||+.+- ..
T Consensus 251 Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 251 VRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred EEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCc
Confidence 68999999999999999999 6799999999887789999999999999999999999999999999999999764 37
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|++|||.|+....... ..+.+..|.|||++.+.+++.+.|||||||+++||++|.+.|.+.+..+....+......+
T Consensus 330 vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred eeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 99999999988665333 6778999999999999999999999999999999999998898888776655553221111
Q ss_pred --------------------------------------------------CCC-----------CCchHHHHHHHHHhcc
Q 026042 159 --------------------------------------------------PVP-----------PTCPKAFSYLISRCWS 177 (244)
Q Consensus 159 --------------------------------------------------~~~-----------~~~~~~l~~li~~~l~ 177 (244)
..| ......+.+++.+||+
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 001 0112468899999999
Q ss_pred cCCCCCCCHHHHHH
Q 026042 178 SSPDRRPHFDQIVS 191 (244)
Q Consensus 178 ~~p~~Rps~~el~~ 191 (244)
.||.+|+|..+.++
T Consensus 488 ~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 488 WDPAERITPAQALN 501 (586)
T ss_pred cCchhcCCHHHHhc
Confidence 99999999999997
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=237.30 Aligned_cols=195 Identities=31% Similarity=0.586 Sum_probs=161.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++..+...++||||+++|+|.+++++... ...+...+..++.|++.||.|||++|++||||||+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred eeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 4688999999999999999999999999976331 23456788999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 73 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
++.++.++|+|||++....... ......++..|+|||.+.++.++.++|+||||+++|+|++ |..||.+....+..
T Consensus 152 i~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred EcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986432211 1122234678999999988889999999999999999998 78999887766654
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..+. .......+..+++.+.+++.+||+.+|++||++.++++.|+..
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 KFVM-DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHH-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 4433 2333445567789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=247.26 Aligned_cols=197 Identities=30% Similarity=0.545 Sum_probs=165.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC----------------------------------------------
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------------------------------------------- 34 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---------------------------------------------- 34 (244)
|+++++|...+..++|+||+++|+|.+++++...
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 5788999999999999999999999999975421
Q ss_pred --------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 026042 35 --------------------------------------------------YSVPLNLVLKLALDIARGMQYLHSQGILHR 64 (244)
Q Consensus 35 --------------------------------------------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~ 64 (244)
..+++..++.++.|++.||.|||+.|++|+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 135667788999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 026042 65 DLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 140 (244)
Q Consensus 65 dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~ 140 (244)
||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++ |..||.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999986532211 1223346788999999988889999999999999999998 899998
Q ss_pred CCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 141 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.....+..............+..++.++.+++.+||..+|.+||++++|++.|+++.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 776555544444445455667778999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=246.24 Aligned_cols=194 Identities=25% Similarity=0.409 Sum_probs=174.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~~ 79 (244)
|++|++..++..+|||+|.-.+|+|.|||-++.. .+.+..+.+++.||+.|+.|+|+.+++||||||+||.+-+ -|-+
T Consensus 80 VRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlV 158 (864)
T KOG4717|consen 80 VRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLV 158 (864)
T ss_pred eeeeehhcccceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCce
Confidence 6899999999999999999999999999987764 6899999999999999999999999999999999998865 6899
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||.|||++-.+.+.....+.+|...|.|||.+.+..| .++.||||||+++|-+++|+.||...+..+..-.++ ....
T Consensus 159 KLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKY 236 (864)
T KOG4717|consen 159 KLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKY 236 (864)
T ss_pred EeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccc
Confidence 9999999988888888889999999999999988876 578999999999999999999999877777665553 4456
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYS 197 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~ 197 (244)
..|..++.++++||..||..||.+|.+.+||.. +|++..
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 788999999999999999999999999999986 555443
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=238.09 Aligned_cols=194 Identities=34% Similarity=0.645 Sum_probs=160.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE---------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
+++++++..+...++++||+++++|.+++.+.. ...+++..++.++.|++.||+|||++|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 468899999999999999999999999997654 12578999999999999999999999999999999999
Q ss_pred EEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh--CCCCCCCCCHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPEQ 146 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~ 146 (244)
+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 99999999999999986533221 1223445678999999988889999999999999999988 778888776665
Q ss_pred HHHHHHhh------CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 147 AAFAVCQK------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 147 ~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
........ ......+..++.++.+++.+||+.+|.+||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 54443322 1112334567889999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=238.74 Aligned_cols=190 Identities=26% Similarity=0.474 Sum_probs=155.5
Q ss_pred cEEEEee------cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 2 QFVAACK------KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 2 ~~~~~~~------~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
++++++. .+...|++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~ 156 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE 156 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 4566663 3568899999999999999998766556888999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCccccccc-CCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q 026042 76 DMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 149 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 149 (244)
++.++|+|||++...... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||..........
T Consensus 157 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 157 NAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 999999999997654322 2234456889999999875 3457889999999999999999999998766555444
Q ss_pred HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 150 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..............++..+.++|.+||+.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 433333333334568899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=233.16 Aligned_cols=195 Identities=29% Similarity=0.594 Sum_probs=158.5
Q ss_pred CcEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++. .++..++++||+.+++|.+++.+... ..++..+..++.|++.||.|||+.|++|+||||+||+++.++.+
T Consensus 59 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~ 137 (262)
T cd05058 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTV 137 (262)
T ss_pred ceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcE
Confidence 46777664 56678999999999999999987543 46777888999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 026042 80 KVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 153 (244)
||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.........
T Consensus 138 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~- 216 (262)
T cd05058 138 KVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL- 216 (262)
T ss_pred EECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-
Confidence 999999986432211 1123345678999999988889999999999999999999 567777766655444332
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.......+...++.+.+++.+||..+|++||++.++++.|+.+.
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 33334445667899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=234.59 Aligned_cols=193 Identities=33% Similarity=0.639 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++......++|+||+++++|.+++.+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~ 141 (269)
T cd05044 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSE 141 (269)
T ss_pred eeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEec
Confidence 467889999999999999999999999997532 224788999999999999999999999999999999999998
Q ss_pred CC-----cEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 76 DM-----CVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 76 ~~-----~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
++ .++|+|||++....... ......++..|+|||.+.+...+.++|+||||+++|+|++ |..||...+..+
T Consensus 142 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~ 221 (269)
T cd05044 142 KGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221 (269)
T ss_pred CCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH
Confidence 77 89999999986443221 1223345678999999988889999999999999999998 999998776655
Q ss_pred HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 147 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
....+ ........+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 222 ~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 222 VLQHV-TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHH-hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 44433 233344556778899999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=233.15 Aligned_cols=190 Identities=27% Similarity=0.484 Sum_probs=163.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-~~~ 79 (244)
+++++.+..++..++|+||+++++|.+++....+..+++..+..++.|++.+|.+||++|++|+||+|+||+++.+ +.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~ 141 (256)
T cd08220 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVV 141 (256)
T ss_pred hheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 3577888889999999999999999999988665568999999999999999999999999999999999999865 468
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
+|+|||.+.............++..|+|||.+.+...+.++|+||+|+++++|++|..||...+......... ......
T Consensus 142 ~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~ 220 (256)
T cd08220 142 KIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAP 220 (256)
T ss_pred EEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCC
Confidence 9999999876554444445668889999999988888999999999999999999999998877665544443 233345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++..+.+++.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 66678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=234.48 Aligned_cols=195 Identities=32% Similarity=0.587 Sum_probs=158.6
Q ss_pred CcEEEEeec------CCcEEEEEeccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 026042 1 MQFVAACKK------PPVFCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70 (244)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~~----~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~n 70 (244)
|++++++.. ....++++||+++++|.+++... ....+++..+..++.|++.||.|||++|++||||||+|
T Consensus 63 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 142 (272)
T cd05075 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142 (272)
T ss_pred ceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence 456676632 23568999999999999988432 22347899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 71 LLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 71 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
|+++.++.++|+|||++....... ......++..|++||...+..++.++|+||||+++|+|++ |..||......+
T Consensus 143 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred eEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999987543221 1122345678999999998889999999999999999999 899998877665
Q ss_pred HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 147 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
....+. .......+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 223 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 223 IYDYLR-QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 544443 3333455667889999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=235.37 Aligned_cols=194 Identities=29% Similarity=0.560 Sum_probs=163.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~ 73 (244)
|++++++......++|+||+++++|.+++..... ..+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili 150 (275)
T cd05046 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150 (275)
T ss_pred eeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE
Confidence 4688999999999999999999999999986552 258899999999999999999999999999999999999
Q ss_pred cCCCcEEEecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026042 74 GEDMCVKVADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 150 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 150 (244)
+.++.++++|||++...... .......++..|++||.+.+...+.++||||||++++++++ |..||...........
T Consensus 151 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 151 SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 99999999999987543221 12233345678999999988888999999999999999998 8899987766665555
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
..........+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 54444444456678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=251.11 Aligned_cols=185 Identities=22% Similarity=0.377 Sum_probs=147.9
Q ss_pred CcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cEEEecCCCc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CVKVADFGIS 87 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~-~~kl~dfg~~ 87 (244)
..+++||||++ ++|.+++.. ..+..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 35779999996 588888754 2234688999999999999999999999999999999999999765 6999999999
Q ss_pred ccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC---------
Q 026042 88 CLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR--------- 157 (244)
Q Consensus 88 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 157 (244)
.............+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 765544444556789999999987654 6899999999999999999999999887665544433321110
Q ss_pred ------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 158 ------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 158 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
...+...++++.+|+.+||+.||.+|||+.|+++ ++..+
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0123456789999999999999999999999996 45443
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=234.90 Aligned_cols=189 Identities=28% Similarity=0.507 Sum_probs=160.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++++||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~ 142 (265)
T cd06631 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIK 142 (265)
T ss_pred eeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEE
Confidence 467899999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-------cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQ-------CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||.+..... ........++..|+|||.+.+..++.++|+||||+++++|++|..||...+..........
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 222 (265)
T cd06631 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA 222 (265)
T ss_pred eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh
Confidence 999998764321 1112244578899999999888889999999999999999999999987765544433332
Q ss_pred h-CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 K-NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ......+..++..+.+++.+||+.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2 3334566778999999999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=256.90 Aligned_cols=198 Identities=32% Similarity=0.667 Sum_probs=176.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------CC----CCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------YS----VPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------~~----~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp 68 (244)
|+++|.|..++-+|||+|||..|||.+|++.+.+ .. ++..+.+.++.||+.|+.||-++.++||||-.
T Consensus 552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 7899999999999999999999999999976442 12 77889999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccCCCC---CCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCH
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCGSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 144 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 144 (244)
.|+||.++-.|||+|||+++..-....-+ ...-..+|||||.+..++++.++||||+|+++||+++ |..||.+.+.
T Consensus 632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn 711 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN 711 (774)
T ss_pred hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence 99999999999999999998654332211 2234679999999999999999999999999999999 9999999999
Q ss_pred HHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 145 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
++.+..+..... .+.|.++|.++.+|+..||+.+|.+||++.||-..|++....
T Consensus 712 ~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 712 QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 999988876665 889999999999999999999999999999999999987654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=232.35 Aligned_cols=194 Identities=33% Similarity=0.642 Sum_probs=161.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.. ...++++||+++++|.+++.+..+..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 64 ~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~ 142 (260)
T cd05073 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK 142 (260)
T ss_pred ceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEE
Confidence 456777776 7789999999999999999876555688899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....++..|+|||.+....++.++|+||||+++|++++ |..||...+.......+. ....
T Consensus 143 l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~ 221 (260)
T cd05073 143 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYR 221 (260)
T ss_pred ECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCC
Confidence 999998865432211 122334567999999988889999999999999999998 999998877665544333 3334
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+...+.++.+++.+|++.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 445567889999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=235.39 Aligned_cols=194 Identities=21% Similarity=0.424 Sum_probs=164.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~ 77 (244)
+++++++..++..++++||++|++|.+++... .+..+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 72 VRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred eeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC
Confidence 46788999999999999999999999998542 23368899999999999999999996 6899999999999999999
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.++|+|||.+.............++..|++||.+.+..++.++|+||||+++|+|++|..||..................
T Consensus 152 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 152 KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 99999999987654433344556888999999998888999999999999999999999999877666555544433333
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
+.....+++.+.+++.+||+.||++||++.|+.++++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 3333467899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=232.78 Aligned_cols=189 Identities=28% Similarity=0.497 Sum_probs=159.0
Q ss_pred cEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 2 QFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 2 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
++++.+. .+...|+++||+++++|.+++....+..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~ 142 (257)
T cd08223 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIK 142 (257)
T ss_pred eeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEE
Confidence 4556654 345689999999999999999876555689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++...... .......+++.|+|||...+..++.++|+||+|++++++++|..||...+.......... .....
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~ 221 (257)
T cd08223 143 VGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPP 221 (257)
T ss_pred EecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCC
Confidence 9999998654322 223345678899999999888899999999999999999999999988776655444433 33345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++.+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 56778899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=241.77 Aligned_cols=191 Identities=27% Similarity=0.457 Sum_probs=160.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++.+..+...|+|+||+.|++|.+++.+..+..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 64 PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIM 143 (316)
T ss_pred hhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEE
Confidence 46788999999999999999999999999876555789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC------------------------------CCCCCCcccceeccceeccCCCCCccchhhhHHHHH
Q 026042 81 VADFGISCLESQCG------------------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130 (244)
Q Consensus 81 l~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 130 (244)
|+|||++....... ......|+..|+|||.+.+..++.++||||||+++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence 99999875432211 112345788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 026042 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH----FDQIVS 191 (244)
Q Consensus 131 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~el~~ 191 (244)
+|++|..||...+.......+.............++.+.+++.+||+.+|++||+ +++++.
T Consensus 224 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 224 EMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 9999999998887766555544333333333346899999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=245.17 Aligned_cols=185 Identities=27% Similarity=0.426 Sum_probs=149.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|+||+++++|.+.. ..++..+..++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus 135 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 208 (353)
T PLN00034 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVK 208 (353)
T ss_pred ceeeeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEE
Confidence 56889999999999999999999986531 346678889999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH--HHH
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--AVC 152 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~ 152 (244)
|+|||++...... .......|+..|+|||.+.. ...+.++|||||||++|+|++|+.||......+... ...
T Consensus 209 L~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~ 288 (353)
T PLN00034 209 IADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI 288 (353)
T ss_pred EcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 9999998654332 22345578999999998743 234578999999999999999999997433222211 111
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+..++.++.++|.+||+.||.+||++.|+++
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 223334556678899999999999999999999999998
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=238.74 Aligned_cols=188 Identities=27% Similarity=0.511 Sum_probs=158.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...|+|+||++|++|.+++.+. .+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~k 156 (296)
T cd06654 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK 156 (296)
T ss_pred eeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 46788999999999999999999999999754 378899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||.+....... ......++..|+|||.+.+...+.++|+||||+++|+|++|..||...+............ ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (296)
T cd06654 157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236 (296)
T ss_pred ECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC
Confidence 99999876543322 1233468889999999988888999999999999999999999998776544433322211 122
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 334567889999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=232.79 Aligned_cols=189 Identities=29% Similarity=0.533 Sum_probs=163.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++++||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.+|
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~k 142 (258)
T cd06632 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVK 142 (258)
T ss_pred hheeeeEecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 468899999999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+.............++..|++||.+.... ++.++|+||+|++++++++|..||....................
T Consensus 143 l~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 222 (258)
T cd06632 143 LADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPP 222 (258)
T ss_pred EccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCC
Confidence 99999886554433344566888999999987766 89999999999999999999999987765554444443344556
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++.+.+++.+||+.+|++||++.+++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 66778999999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=231.71 Aligned_cols=192 Identities=33% Similarity=0.641 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++......++|+||+++++|.+++.+... .+++..+..++.+++.+|.+||++|++|+||+|+||+++.++.++
T Consensus 55 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~ 133 (251)
T cd05041 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLK 133 (251)
T ss_pred EEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEE
Confidence 3578899999999999999999999999976543 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||.+........ ......+..|+|||.+.++.++.++|+||||+++|+|++ |..||............. ...
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~ 212 (251)
T cd05041 134 ISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGY 212 (251)
T ss_pred EeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCC
Confidence 999999865432111 112233567999999988889999999999999999998 899998877655444432 333
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
....+...+..+.+++.+||..+|.+||++.|+++.|+
T Consensus 213 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 44556678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=244.55 Aligned_cols=184 Identities=22% Similarity=0.350 Sum_probs=163.5
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 82 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~ 82 (244)
+--.|.+.+.+|+|+..|.||+|.-.|-+.++..+++..+.-++++|+-||++||+++|++||+||+|||+|+.|.++|+
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRIS 329 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRIS 329 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEee
Confidence 34457899999999999999999999999887789999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCCCCCC
Q 026042 83 DFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARPPV 160 (244)
Q Consensus 83 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~ 160 (244)
|+|+|+......+....+||.+|||||++....|+...|+|||||++|+|+.|..||.......-...+. ........
T Consensus 330 DLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 330 DLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred ccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc
Confidence 9999999888888888899999999999999999999999999999999999999998765443322222 23444566
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
+..++++.+++.+.+|++||.+|..-
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccC
Confidence 78899999999999999999999743
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=235.63 Aligned_cols=190 Identities=26% Similarity=0.466 Sum_probs=158.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|..++.+... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++
T Consensus 65 i~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~k 143 (282)
T cd06643 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIK 143 (282)
T ss_pred eeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEE
Confidence 4688899999999999999999999998875432 688999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++...... .......++..|+|||.+. +..++.++|+||+|+++|+|++|..||...+..+........
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 223 (282)
T cd06643 144 LADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 223 (282)
T ss_pred EccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc
Confidence 9999998654322 2234456889999999873 345678999999999999999999999887765554444332
Q ss_pred CC-CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NA-RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ....+..++..+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 224 EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22 23345668899999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=233.70 Aligned_cols=186 Identities=25% Similarity=0.447 Sum_probs=154.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++..+...++||||+++++|.++++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred hheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccc
Confidence 5688999999999999999999999999987653 5788999999999999999999999999999999999987664
Q ss_pred ------EEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHH
Q 026042 79 ------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFA 150 (244)
Q Consensus 79 ------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~ 150 (244)
++++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++| ..|+...+.......
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~ 217 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF 217 (258)
T ss_pred cCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH
Confidence 69999998754432 233457888999999876 4578999999999999999998 567766555443222
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
. ......+...+.++.+++.+||+.+|++|||++++++.|
T Consensus 218 ~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 218 Y---EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred H---HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1 223445556678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=236.69 Aligned_cols=194 Identities=32% Similarity=0.639 Sum_probs=158.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
+++++++..++..++|+||+++++|.+++.+... ..+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 4788999999999999999999999999976432 2366788999999999999999999999999999999
Q ss_pred EEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh--CCCCCCCCCHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPEQ 146 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~ 146 (244)
+++.++.++|+|||++........ .....++..|++||...++.++.++|+||||+++|+|++ |..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999865432211 112234578999998888889999999999999999998 788998776655
Q ss_pred HHHHHHh------hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 147 AAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 147 ~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
....... .....+.+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4432211 11122345667899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=234.28 Aligned_cols=189 Identities=30% Similarity=0.419 Sum_probs=163.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++++||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~ 133 (262)
T cd05572 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVK 133 (262)
T ss_pred eeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEE
Confidence 467889999999999999999999999998765 488899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~ 158 (244)
|+|||.+.............++..|++||.+.+..++.++|+||+|+++|+|++|..||.... .......+.......
T Consensus 134 l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 213 (262)
T cd05572 134 LVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213 (262)
T ss_pred EeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC
Confidence 999999876544333344567889999999988888999999999999999999999998776 444444444334556
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
..+...++.+.+++.+||+.+|++||+ +.|+++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 666777899999999999999999999 788877
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=233.38 Aligned_cols=195 Identities=29% Similarity=0.613 Sum_probs=162.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.. ...++|+||+++++|.+++.+... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~ 147 (270)
T cd05056 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVK 147 (270)
T ss_pred hceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeE
Confidence 467888875 456799999999999999987543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++........ .....+...|+|||.+....++.++|+||||++++++++ |..||...+..+....+ .....
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~ 226 (270)
T cd05056 148 LGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-ENGER 226 (270)
T ss_pred EccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCc
Confidence 999998865433221 112234467999999988889999999999999999986 99999887766554433 23344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..++..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 45667889999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=234.37 Aligned_cols=193 Identities=25% Similarity=0.567 Sum_probs=155.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~ 77 (244)
+++++++......++||||+++++|.+++..... ...++..+..++.|++.||+|||++|++||||||+||+++.++
T Consensus 58 i~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~ 137 (269)
T cd05042 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL 137 (269)
T ss_pred ceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC
Confidence 5788999999999999999999999999977542 2346778899999999999999999999999999999999999
Q ss_pred cEEEecCCCcccccccC---CCCCCCcccceeccceecc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 78 CVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
.+||+|||++....... ......++..|+|||++.. ...+.++||||||+++|+|++ |..||......+
T Consensus 138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (269)
T cd05042 138 SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217 (269)
T ss_pred cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 99999999975432211 1223345677999998643 356889999999999999999 889998877665
Q ss_pred HHHHHHhhCC----CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 147 AAFAVCQKNA----RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 147 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.......... .+..+..+++.+.+++..|+ .||++||+++++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 218 VLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 5444433222 12334567889999999998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=236.85 Aligned_cols=190 Identities=27% Similarity=0.482 Sum_probs=154.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 69 i~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~ 146 (267)
T cd06646 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVK 146 (267)
T ss_pred eeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEE
Confidence 467889999999999999999999999997655 578999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++....... ......++..|+|||.+. ...++.++|+||+|+++++|++|..||...+.............
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 226 (267)
T cd06646 147 LADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF 226 (267)
T ss_pred ECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC
Confidence 99999986543222 233456888999999874 34578899999999999999999999976554433222211111
Q ss_pred CC---CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 157 RP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 157 ~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.. .....++..+.+++.+||+.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11 1123568899999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=233.01 Aligned_cols=195 Identities=24% Similarity=0.459 Sum_probs=160.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..++..++|+||+++++|.+++.+. ....+++.+++.++.+++.||.+||+.|++|+||+|+||+++.++.
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~ 144 (267)
T cd08224 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV 144 (267)
T ss_pred eeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc
Confidence 46788899999999999999999999999753 2335789999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--EQAAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~ 155 (244)
++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++|..||..... .+...... ..
T Consensus 145 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~ 223 (267)
T cd08224 145 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KC 223 (267)
T ss_pred EEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cC
Confidence 9999999876543322 22334678899999999888899999999999999999999999965432 22222222 22
Q ss_pred CCCCCCC-CchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+.+. .++..+.+++.+||..+|++||++.++++.++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 2233333 6788999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=235.37 Aligned_cols=187 Identities=30% Similarity=0.552 Sum_probs=160.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++... .+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~ 138 (274)
T cd06609 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVK 138 (274)
T ss_pred eeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence 46788899999999999999999999999865 578999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+... ....
T Consensus 139 l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-~~~~ 217 (274)
T cd06609 139 LADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN-NPPS 217 (274)
T ss_pred EcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc-CCCC
Confidence 9999998665443 2334456788999999998888999999999999999999999999877655544443332 2333
Q ss_pred CCCC-chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~-~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+.. ++..+.+++.+||..+|++||+++++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 3334 8899999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=231.90 Aligned_cols=192 Identities=39% Similarity=0.754 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++++||+++++|.+++.......+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~ 143 (258)
T smart00219 64 VKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVK 143 (258)
T ss_pred heEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEE
Confidence 46889999999999999999999999999876543389999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCC--CCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+.......... ...++..|++||...+..++.++|+||+|+++++|++ |..||...+.......... ...
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~ 222 (258)
T smart00219 144 ISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYR 222 (258)
T ss_pred EcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCC
Confidence 99999986544321111 2236788999999988889999999999999999998 8899988777666555543 334
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
...+..++..+.+++.+|+..+|.+|||+.++++.|
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 455667899999999999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=233.04 Aligned_cols=190 Identities=29% Similarity=0.515 Sum_probs=159.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+++||+++++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~ 141 (262)
T cd06613 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG-PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVK 141 (262)
T ss_pred hceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEE
Confidence 4688999999999999999999999999987532 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||.+....... ......++..|++||.+.+. .++.++|+||+|+++++|++|..||...+.............
T Consensus 142 l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~ 221 (262)
T cd06613 142 LADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF 221 (262)
T ss_pred ECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence 99999886544322 23345678899999998776 788999999999999999999999988776655544433321
Q ss_pred CC---CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .....++.++.+++.+||..+|.+||++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 223456788999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=235.80 Aligned_cols=194 Identities=34% Similarity=0.609 Sum_probs=158.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~n 70 (244)
+++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 5788999999999999999999999999965321 136788899999999999999999999999999999
Q ss_pred EEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh--CCCCCCCCCHH
Q 026042 71 LLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPE 145 (244)
Q Consensus 71 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~ 145 (244)
|+++.++.+||+|||++....... ......++..|+|||...++.++.++|+||||+++++|++ |..||...+..
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999986532221 1122334678999999988889999999999999999988 67788877665
Q ss_pred HHHHHHHh------hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 146 QAAFAVCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 146 ~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
+....... .......+...++.+.+++.+|++.+|++||+++++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 54433321 11112334567899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=241.56 Aligned_cols=191 Identities=20% Similarity=0.373 Sum_probs=152.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|+||+++++|.+++..+....+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~ 141 (327)
T cd08227 62 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 141 (327)
T ss_pred eeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEE
Confidence 57899999999999999999999999999876544689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--------CCCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 81 VADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 81 l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
+.||+......... ......++..|+|||++.+ ..++.++|||||||++++|++|..||...........
T Consensus 142 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 221 (327)
T cd08227 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (327)
T ss_pred EcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence 99998643221110 1122346678999999876 4588999999999999999999999987654443322
Q ss_pred HHhhCCC--------------------------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 151 VCQKNAR--------------------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 151 ~~~~~~~--------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
....... ......+++.+.+++.+||+.||.+|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 301 (327)
T cd08227 222 KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA 301 (327)
T ss_pred HhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH
Confidence 2211100 00112346789999999999999999999
Q ss_pred HHHHH
Q 026042 187 DQIVS 191 (244)
Q Consensus 187 ~el~~ 191 (244)
+++++
T Consensus 302 ~ell~ 306 (327)
T cd08227 302 STLLN 306 (327)
T ss_pred HHHhc
Confidence 99997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=242.98 Aligned_cols=191 Identities=20% Similarity=0.347 Sum_probs=157.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||+++|+|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 64 TTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred eeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEE
Confidence 3578889999999999999999999999987433 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...+..+....+..
T Consensus 143 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (332)
T cd05623 143 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (332)
T ss_pred EeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 99999986433222 123356899999999885 34578899999999999999999999998877766665544
Q ss_pred hCCCCCCC---CCchHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 026042 154 KNARPPVP---PTCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 192 (244)
Q Consensus 154 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~el~~~ 192 (244)
.......+ ..+++++.+++++|+..++++ |++++++++.
T Consensus 223 ~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 223 HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 33322233 457899999999999765444 6899999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.31 Aligned_cols=186 Identities=23% Similarity=0.334 Sum_probs=147.7
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++...+ ..|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 83 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~ 157 (359)
T cd07876 83 ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 157 (359)
T ss_pred eeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 45677775443 5799999995 578777753 367889999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.+|.+||+|||++.............++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+...........
T Consensus 158 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~ 237 (359)
T cd07876 158 SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQ 237 (359)
T ss_pred CCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999987654433444567899999999999989999999999999999999999999876543322211110
Q ss_pred CC--------------------CC--------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NA--------------------RP--------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~--------------------~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .. ......++.+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 238 LGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred cCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00 011123567899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=235.36 Aligned_cols=193 Identities=34% Similarity=0.667 Sum_probs=160.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------------YSVPLNLVLKLALDIARGMQYLHSQG 60 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------------~~~~~~~~~~~~~~l~~~L~~lH~~~ 60 (244)
+++++++..+...++|+||+++++|.+++..... ..+++..++.++.|++.||.+||++|
T Consensus 71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~ 150 (288)
T cd05050 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK 150 (288)
T ss_pred heEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4688999999999999999999999999975321 24678889999999999999999999
Q ss_pred CccCCCCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CC
Q 026042 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-AL 136 (244)
Q Consensus 61 i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 136 (244)
++|+||||+||+++.++.++|+|||.+....... .......+..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 151 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~ 230 (288)
T cd05050 151 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM 230 (288)
T ss_pred eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876432211 1222234567999999988889999999999999999997 88
Q ss_pred CCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 137 TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 137 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.||.+.+..+....+. .......+..++..+.+++.+||+.+|.+||++.|+++.|+
T Consensus 231 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 231 QPYYGMAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 8998877766555443 23333456678899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=233.34 Aligned_cols=188 Identities=27% Similarity=0.445 Sum_probs=159.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+|+||++|++|.++++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 60 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~ 137 (260)
T cd05611 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137 (260)
T ss_pred eeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEE
Confidence 468899999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--CC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA--RP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~ 158 (244)
|+|||++..... .....++..|++||.+.+..++.++|+||+|+++|+|++|..||...+............. ..
T Consensus 138 l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (260)
T cd05611 138 LTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214 (260)
T ss_pred Eeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 999998765432 3345678899999999888889999999999999999999999988777665544433222 22
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
.....+++.+.+++.+||+.+|++||++.++.+.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23346789999999999999999999776555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=231.33 Aligned_cols=191 Identities=25% Similarity=0.406 Sum_probs=159.1
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
|++++++.+.+ .+++|+||+ ..+|..++..... ..++...+..+++||+.||+|||++||+||||||.||+
T Consensus 74 v~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlL 152 (323)
T KOG0594|consen 74 VRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLL 152 (323)
T ss_pred EEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEE
Confidence 46788887777 899999999 6699999988664 36778899999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCccccc-ccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 73 LGEDMCVKVADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++++|.+||+|||+|+... +...-..-++|.+|.|||++.+. .++...||||+||+++||++++..|.+....+....
T Consensus 153 i~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~ 232 (323)
T KOG0594|consen 153 ISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR 232 (323)
T ss_pred ECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 9999999999999998655 33334556789999999998776 789999999999999999999999999888776666
Q ss_pred HHhhCCCCC----------------C-----C-------CCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 151 VCQKNARPP----------------V-----P-------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 151 ~~~~~~~~~----------------~-----~-------~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
+......+. . + +..++...+++.+||+.+|.+|.|+...++.
T Consensus 233 If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 233 IFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 544333221 0 0 1112467899999999999999999999984
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=242.57 Aligned_cols=188 Identities=26% Similarity=0.390 Sum_probs=170.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---- 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---- 76 (244)
|++++.+++...+++|||++.||.|.+.|.+. .+++..+..++.|++.++.|||+.|++|||+||+|+++...
T Consensus 99 v~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~ 175 (382)
T KOG0032|consen 99 VQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGS 175 (382)
T ss_pred EEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCC
Confidence 57899999999999999999999999999887 38999999999999999999999999999999999999653
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
+.++++|||++............+||+.|+|||++.+.+++...|+||+|+++|.|++|..||.+.+.......+.....
T Consensus 176 ~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~ 255 (382)
T KOG0032|consen 176 GRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF 255 (382)
T ss_pred CcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC
Confidence 47999999999887776677889999999999999999999999999999999999999999999888777776665544
Q ss_pred C--CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 R--PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+.++...+++++.||..||.+|+++.++++
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2 3444677999999999999999999999999998
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=232.76 Aligned_cols=195 Identities=27% Similarity=0.575 Sum_probs=164.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.. ...++|+||+++++|.+++.+... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 72 VRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred ceEEEEEec-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEE
Confidence 467888877 788999999999999999987654 488999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC---CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||.+......... ....++..|+|||.+....++.++|+||||++++++++ |..||......+....+. ...
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~ 228 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGE 228 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCC
Confidence 9999998654322211 11223567999999988889999999999999999998 999999887766554443 344
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
....+..++..+.+++.+||..+|++||++.++++.|..+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 455566788999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=241.27 Aligned_cols=191 Identities=21% Similarity=0.351 Sum_probs=155.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+++.|+||||++|++|.+++.+... .+++..+..++.|++.||+|||++|++||||||+||+++.+|.++
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred CceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEE
Confidence 4678899999999999999999999999976432 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||++........ .....|++.|+|||++.. ..++.++||||+||++|+|++|..||...+..+....+..
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05597 143 LADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred EEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 999999865433222 223468999999999863 4568899999999999999999999988776665555443
Q ss_pred hCCCCCC---CCCchHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 026042 154 KNARPPV---PPTCPKAFSYLISRCWSSSPDR--RPHFDQIVSI 192 (244)
Q Consensus 154 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~--Rps~~el~~~ 192 (244)
....... ...++..+.+++++||..++++ |++++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 223 HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 3322222 2347899999999988654443 7899999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=233.65 Aligned_cols=189 Identities=28% Similarity=0.520 Sum_probs=154.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++...+ .+++.+++.++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 69 i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~ 146 (267)
T cd06645 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVK 146 (267)
T ss_pred eeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 467889999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++...... .......|+..|+|||.+. ...++.++|+||||+++|+|++|..||.................
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~ 226 (267)
T cd06645 147 LADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226 (267)
T ss_pred ECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCC
Confidence 9999997644322 2233456889999999874 44578899999999999999999999876554433332222222
Q ss_pred CCCC---CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPPV---PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... ...++..+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1111 1246788999999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=235.58 Aligned_cols=188 Identities=23% Similarity=0.379 Sum_probs=155.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
.+++++..++..++||||+++++|.+++..+. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|
T Consensus 61 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l 138 (279)
T cd05633 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 138 (279)
T ss_pred EEEEEEecCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEE
Confidence 46778888999999999999999999998765 5899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCcccceeccceec-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCCCC
Q 026042 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPP 159 (244)
Q Consensus 82 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~ 159 (244)
+|||++...... ......++..|+|||.+. +..++.++|+||+|+++++|++|..||......... ...........
T Consensus 139 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 217 (279)
T cd05633 139 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217 (279)
T ss_pred ccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcC
Confidence 999998654332 223446899999999886 456789999999999999999999999754322111 11112233345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~~ 192 (244)
.+..++.++.+++.+||..||.+|| +++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 5677899999999999999999999 69999883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=247.51 Aligned_cols=201 Identities=31% Similarity=0.595 Sum_probs=182.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++||++....-++||||+|.||+|.+++++.++ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+|
T Consensus 224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEE
Confidence 6899999999999999999999999999999875 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCC-CCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCGSAK-GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||+++......... ...-...|+|||.+...-++.++||||+|+++||+++ |..||.+....+....+.....+.
T Consensus 303 ISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM 382 (474)
T ss_pred eCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC
Confidence 99999987654322222 2235679999999999999999999999999999999 889999999999988888888889
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
+.+...|.++..++.+|+..+|++||++.++.+.++.+......
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 99999999999999999999999999999999999988776553
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=235.63 Aligned_cols=188 Identities=27% Similarity=0.511 Sum_probs=160.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+. .+++.++..++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus 79 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~k 155 (296)
T cd06655 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVK 155 (296)
T ss_pred eeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 46789999999999999999999999999754 478999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|++++|..||...+............ ...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06655 156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (296)
T ss_pred EccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCccc
Confidence 999998765433222 234467889999999988889999999999999999999999998877655444333222 222
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..+++.+.++|.+||..+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 345678899999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.14 Aligned_cols=192 Identities=18% Similarity=0.299 Sum_probs=150.8
Q ss_pred cEEEEeecC-CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCC--
Q 026042 2 QFVAACKKP-PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDM-- 77 (244)
Q Consensus 2 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~-- 77 (244)
++++++..+ .++|+|+|++ |++|.+++.+.+ .+++..+..++.|++.||.|||+ .||+||||||+||+++.++
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred eeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcc
Confidence 466777554 5789999998 789999998765 58899999999999999999998 5999999999999998765
Q ss_pred --------------cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 026042 78 --------------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 143 (244)
Q Consensus 78 --------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 143 (244)
.+||+|||.+..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754322 2345678999999999999999999999999999999999999998776
Q ss_pred HHHHHHHHHhhCCCC-------------------------CC---------------CCCchHHHHHHHHHhcccCCCCC
Q 026042 144 PEQAAFAVCQKNARP-------------------------PV---------------PPTCPKAFSYLISRCWSSSPDRR 183 (244)
Q Consensus 144 ~~~~~~~~~~~~~~~-------------------------~~---------------~~~~~~~l~~li~~~l~~~p~~R 183 (244)
..+....+....... .. .....+.+.+||.+||..||.+|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 544333221111000 00 00113567799999999999999
Q ss_pred CCHHHHHH--HHHhhhh
Q 026042 184 PHFDQIVS--ILEGYSE 198 (244)
Q Consensus 184 ps~~el~~--~l~~~~~ 198 (244)
||++|+++ ++..+..
T Consensus 430 ~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 430 LNARQMTTHPYVLKYYP 446 (467)
T ss_pred CCHHHHhcCccccccCC
Confidence 99999998 5554433
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=244.38 Aligned_cols=188 Identities=26% Similarity=0.452 Sum_probs=149.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..+...++|+|++ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 146 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vk 222 (391)
T PHA03212 146 IQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC 222 (391)
T ss_pred CCEeEEEEECCeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEE
Confidence 57899999999999999999 579999987765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHH
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-------PEQAAFAV 151 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~ 151 (244)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||-... .......+
T Consensus 223 L~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i 302 (391)
T PHA03212 223 LGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI 302 (391)
T ss_pred EEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence 9999998643221 22334579999999999998899999999999999999999988764321 11111111
Q ss_pred Hh--------------------------hCCCCC-CC------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQ--------------------------KNARPP-VP------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~--------------------------~~~~~~-~~------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .....+ .. ...+.++.+++.+||+.||.+|||++|+++
T Consensus 303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000000 00 124668999999999999999999999996
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=256.93 Aligned_cols=185 Identities=27% Similarity=0.405 Sum_probs=155.9
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
..++|+||||+||+|-|++..+....+++.++++|+.++++|+++||... |||||||-+|||++.+|..||||||.++
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 45789999999999999998766557999999999999999999999997 9999999999999999999999999986
Q ss_pred cccccCCCC----------CCCcccceecccee---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 89 LESQCGSAK----------GFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 89 ~~~~~~~~~----------~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
......... ...-|+.|+|||++ .+.+.++|+|||||||+||.|+....||..... ..+....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~ 270 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGN 270 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEecc
Confidence 543332111 22358999999986 566789999999999999999999999986422 2233344
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+..+.++..+.+||+.||+.||++||++.+++..+..+...
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 45555578999999999999999999999999999988877654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=232.94 Aligned_cols=197 Identities=28% Similarity=0.562 Sum_probs=163.1
Q ss_pred CcEEEEeec-CCcEEEEEeccCCCCHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 026042 1 MQFVAACKK-PPVFCIITEYLAGGSLRKYLHQQEP------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~ 73 (244)
+++++++.. +...++++||+++++|.+++..... ..+++..++.++.|++.||+|||++|++|+||+|+||++
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~ 150 (280)
T cd05043 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI 150 (280)
T ss_pred CeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE
Confidence 467787655 5788999999999999999976432 358899999999999999999999999999999999999
Q ss_pred cCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHH
Q 026042 74 GEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAF 149 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~ 149 (244)
++++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||++++++++ |+.||...+..+...
T Consensus 151 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 230 (280)
T cd05043 151 DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA 230 (280)
T ss_pred cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 9999999999999865422111 122345678999999988889999999999999999998 999998877655443
Q ss_pred HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 150 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
... .......+..+++.+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus 231 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YLK-DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHH-cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 332 333344556678999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=237.38 Aligned_cols=189 Identities=21% Similarity=0.354 Sum_probs=153.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||++ ++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~k 144 (309)
T cd07872 67 VTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELK 144 (309)
T ss_pred ceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 578999999999999999996 599998876543 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+......
T Consensus 145 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 224 (309)
T cd07872 145 LADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224 (309)
T ss_pred ECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999986533222 2234467889999998865 45789999999999999999999999887665443333211100
Q ss_pred -------------------C--------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -------------------P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .....+++++.+++.+||+.||.+|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0 011346788999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=233.60 Aligned_cols=195 Identities=30% Similarity=0.575 Sum_probs=154.7
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++... ...++|+||++|++|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 147 (284)
T cd05079 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 147 (284)
T ss_pred eeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC
Confidence 3567777664 678999999999999999976543 5789999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----------
Q 026042 79 VKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----------- 143 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----------- 143 (244)
++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|+++..|.....
T Consensus 148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05079 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH 227 (284)
T ss_pred EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc
Confidence 9999999986543321 1223446678999999988889999999999999999999765542110
Q ss_pred ---HHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 144 ---PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 144 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...............+.+..++..+.+|+.+||+.+|++||++.++++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00111111222333445667889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=250.58 Aligned_cols=194 Identities=40% Similarity=0.718 Sum_probs=165.5
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 82 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~ 82 (244)
++|||..+.. .||..+|+|-+|+.+++-... .+...+.+.|++|++.|+.|||.++|+|+|||..||++.+++.|||+
T Consensus 453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIg 530 (678)
T KOG0193|consen 453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIG 530 (678)
T ss_pred eehhhcCCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEe
Confidence 6899999888 899999999999999987653 68889999999999999999999999999999999999999999999
Q ss_pred cCCCccccccc---CCCCCCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--
Q 026042 83 DFGISCLESQC---GSAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-- 154 (244)
Q Consensus 83 dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-- 154 (244)
|||++.....- .......|...|||||++..+ +++..+||||||+++|||++|..||.....++.++.+-..
T Consensus 531 DFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l 610 (678)
T KOG0193|consen 531 DFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYL 610 (678)
T ss_pred cccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccccc
Confidence 99998654332 233455688899999998654 6899999999999999999999999976777666655444
Q ss_pred -CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 155 -NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 155 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.........+++++++|+..||..++++||.+.+|+..|+.+..
T Consensus 611 ~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 22223456789999999999999999999999999998876654
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=254.16 Aligned_cols=191 Identities=29% Similarity=0.519 Sum_probs=168.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~ 78 (244)
|+++|++.+++++-|.||-++||+|.++++..-+ ..-.+.....+..||++||.|||++.|+|||||-+||+|+. .|.
T Consensus 635 VrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGv 714 (1226)
T KOG4279|consen 635 VRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGV 714 (1226)
T ss_pred HHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccce
Confidence 6789999999999999999999999999987543 33478888999999999999999999999999999999976 789
Q ss_pred EEEecCCCcccccc-cCCCCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhh
Q 026042 79 VKVADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~ 154 (244)
+||+|||-+..... .....++.||..|||||++..+ .|+.++|||||||++.||.||++||-... +...++.+-..
T Consensus 715 lKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy 794 (1226)
T KOG4279|consen 715 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY 794 (1226)
T ss_pred EEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce
Confidence 99999998865433 3346788999999999999765 57899999999999999999999998764 44455666666
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+++|..++.+.+.||.+|+.++|.+||++.++++
T Consensus 795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7778999999999999999999999999999999997
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=242.12 Aligned_cols=190 Identities=22% Similarity=0.366 Sum_probs=155.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+||||++||+|.+++.+... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 64 ~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred eeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEE
Confidence 3578889999999999999999999999987432 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||++........ .....|++.|+|||.+.+ +.++.++|+||+|+++|+|++|+.||...+..+....+..
T Consensus 143 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05624 143 LADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred EEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence 999999865433221 223568999999998865 4578899999999999999999999988777666555544
Q ss_pred hCCCCCCC---CCchHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 026042 154 KNARPPVP---PTCPKAFSYLISRCWSSSPDR--RPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~el~~ 191 (244)
.......+ ..++.++.+++.+||..++++ |++++++++
T Consensus 223 ~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 223 HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 33333333 346889999999999866544 467888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=231.14 Aligned_cols=190 Identities=27% Similarity=0.501 Sum_probs=159.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...|+++||+++++|.+++..... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 61 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~ 139 (256)
T cd06612 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAK 139 (256)
T ss_pred eeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEE
Confidence 4688999999999999999999999999976443 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+............ ...
T Consensus 140 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd06612 140 LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTL 219 (256)
T ss_pred EcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCC
Confidence 99999987554332 2334457889999999988889999999999999999999999998776655443332211 112
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 233457789999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=236.23 Aligned_cols=193 Identities=28% Similarity=0.448 Sum_probs=159.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||++|++|.++++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 64 VSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred eeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEE
Confidence 467899999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc----------------CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Q 026042 81 VADFGISCLESQC----------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 144 (244)
Q Consensus 81 l~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 144 (244)
|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|++++|..||.+.+.
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999987531100 011123567889999999888899999999999999999999999988777
Q ss_pred HHHHHHHHhhCCC-CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 145 EQAAFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 145 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
.+........... +.....++.++.+++.+||+.+|++||+..++.+.++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 222 EELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 6655554433222 22233678999999999999999999997666665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=232.37 Aligned_cols=186 Identities=24% Similarity=0.438 Sum_probs=151.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
++++++|..+...++||||+++++|..++.+..+ .+++..+..++.|++.||+|||++|++||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 5789999999999999999999999999976443 588999999999999999999999999999999999997643
Q ss_pred ----cEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 026042 78 ----CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 78 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~ 151 (244)
.++++|||.+..... .....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||............
T Consensus 158 ~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 489999998754322 122356788999998865 56799999999999999985 699999876655433222
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
. . ....+...++.+.+++.+||+.+|.+||++.++++.|
T Consensus 235 ~-~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 E-K--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H-h--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1 1 2233344567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=231.42 Aligned_cols=193 Identities=25% Similarity=0.535 Sum_probs=152.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~ 77 (244)
|++++++.+....++||||+++++|.+++..... ...++..+..++.|++.||.|||++|++|+||||+||+++.++
T Consensus 58 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~ 137 (269)
T cd05087 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL 137 (269)
T ss_pred eeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC
Confidence 4688999999999999999999999999975432 2456678889999999999999999999999999999999999
Q ss_pred cEEEecCCCcccccccC---CCCCCCcccceeccceeccC-------CCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 78 CVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEK-------RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||||+++++|++ |..||...+..+
T Consensus 138 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 138 TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 99999999986432211 12234567889999988542 35789999999999999996 999998776665
Q ss_pred HHHHHHhhCCC----CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 147 AAFAVCQKNAR----PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 147 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
........... +......++.+.+++.+|+ .+|++|||+++|+..|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 218 VLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 44332221111 1222346788999999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=230.98 Aligned_cols=186 Identities=22% Similarity=0.434 Sum_probs=151.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++..+...++|+||+++++|..++.+... .+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~ 145 (262)
T cd05077 67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG 145 (262)
T ss_pred eeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC
Confidence 5789999999999999999999999999876543 5889999999999999999999999999999999999987654
Q ss_pred -----EEEecCCCcccccccCCCCCCCcccceeccceec-cCCCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHHHHH
Q 026042 79 -----VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 79 -----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~ 151 (244)
++++|||.+..... .....++..|+|||.+. +..++.++||||||+++|+|+ .|..||......+.....
T Consensus 146 ~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 222 (262)
T cd05077 146 ECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222 (262)
T ss_pred CCCceeEeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH
Confidence 89999998754422 23345778899999886 456899999999999999997 588998776544332211
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
..........++++.+++.+||+.||++||++.+|++.|
T Consensus 223 ---~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 ---EGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---hcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111222334567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=233.98 Aligned_cols=191 Identities=23% Similarity=0.359 Sum_probs=158.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..|+|+||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~ 135 (277)
T cd05577 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVR 135 (277)
T ss_pred eeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEE
Confidence 45778899999999999999999999999876655689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~ 158 (244)
|+|||.+.............++..|++||.+.+..++.++|+||+|+++++|++|..||...........+. ......
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 215 (277)
T cd05577 136 ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV 215 (277)
T ss_pred EccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc
Confidence 999998865543333344567889999999988888999999999999999999999997654421111111 122233
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
..+..+++.+.+++.+||+.+|.+|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 45567789999999999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=234.14 Aligned_cols=185 Identities=27% Similarity=0.418 Sum_probs=161.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 64 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred cceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEE
Confidence 478899999999999999999999999998765 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++...... .....+++.|++||.+.+...+.++|+||||+++++|++|..||...+.......+. ......
T Consensus 142 l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~ 217 (290)
T cd05580 142 ITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRF 217 (290)
T ss_pred EeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccC
Confidence 9999998765433 344568899999999988888999999999999999999999998877554444433 334456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
+..++..+.+++.+||..+|.+|+ +++++++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 677899999999999999999998 7788875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=229.53 Aligned_cols=193 Identities=27% Similarity=0.551 Sum_probs=154.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|+++++|......|+||||+++++|.+++.+... ...++..+..++.|++.||+|||+.+++|+||||+||+++.++.
T Consensus 58 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~ 137 (268)
T cd05086 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT 137 (268)
T ss_pred hheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc
Confidence 5788999999999999999999999999986432 24566778899999999999999999999999999999999999
Q ss_pred EEEecCCCccccccc---CCCCCCCcccceeccceecc-------CCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHH
Q 026042 79 VKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 147 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 147 (244)
++|+|||++...... .......++..|+|||.+.. ...+.++||||||+++|+|++ |..||...+..+.
T Consensus 138 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 217 (268)
T cd05086 138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV 217 (268)
T ss_pred EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999987532211 12234567889999998743 235789999999999999997 6779987776655
Q ss_pred HHHHHhhC----CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 148 AFAVCQKN----ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 148 ~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
........ ..+..+..+++.+.+++..|+ .+|++||+++++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 54433322 223344567889999999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=232.35 Aligned_cols=186 Identities=20% Similarity=0.378 Sum_probs=156.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~-~~ 79 (244)
+++++++..++..++||||+++++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .+
T Consensus 72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeE
Confidence 468899999999999999999999999998765 689999999999999999999999999999999999999988 99
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QKNAR 157 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~ 157 (244)
+|+|||.+..... .....++..|+|||.+.+..++.++|+||+|+++++|++|..||............. .....
T Consensus 150 ~l~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T PHA03390 150 YLCDYGLCKIIGT---PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK 226 (267)
T ss_pred EEecCccceecCC---CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc
Confidence 9999998765432 233467889999999988889999999999999999999999998554332211111 11223
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPH-FDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~el~~ 191 (244)
...+..+++.+.+++.+||+.+|.+||+ ++++++
T Consensus 227 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 3445578999999999999999999995 688875
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=228.91 Aligned_cols=191 Identities=30% Similarity=0.632 Sum_probs=160.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++......++|+||+++++|.+++....+ .+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~ 140 (256)
T cd05112 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVK 140 (256)
T ss_pred eeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEE
Confidence 4678899999999999999999999999986543 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. ....
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 219 (256)
T cd05112 141 VSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFR 219 (256)
T ss_pred ECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCC
Confidence 99999876443221 1122334568999999988889999999999999999998 999998877665554443 2223
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
...+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 334555789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=231.65 Aligned_cols=180 Identities=24% Similarity=0.395 Sum_probs=148.8
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.-+..|+|+|+| +.+|...|+.+. .++...+..+++|++.||+|+|+.|++|||+||.|++++.+..+|++|||+|+
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 467789999999 679999999876 58899999999999999999999999999999999999999999999999998
Q ss_pred ccccc---CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC------
Q 026042 89 LESQC---GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------ 158 (244)
Q Consensus 89 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 158 (244)
..... ......+.|.+|.|||.+.. ..++.+.||||+||++.||++|+..|.+.+.-+....+......+
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 76542 22345567999999998754 578999999999999999999999998766544333332211111
Q ss_pred ------------------C-----CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ------------------P-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ------------------~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .-++.++...+++.+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1 11456788899999999999999999999998
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=229.94 Aligned_cols=190 Identities=26% Similarity=0.487 Sum_probs=163.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.......+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~ 141 (256)
T cd08218 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIK 141 (256)
T ss_pred eeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEE
Confidence 46788999999999999999999999999876554688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+....... ......++..|+|||.+.++..+.++|+||||++++++++|..||...+..+....+. ......
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~ 220 (256)
T cd08218 142 LGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPP 220 (256)
T ss_pred EeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCC
Confidence 99999886543322 1223457888999999988889999999999999999999999998877666555543 333445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++..+.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 56778899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=232.86 Aligned_cols=190 Identities=26% Similarity=0.471 Sum_probs=155.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|..++.+... .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k 150 (292)
T cd06644 72 VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIK 150 (292)
T ss_pred eeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEE
Confidence 4678889999999999999999999988866443 588999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||.+...... .......++..|+|||.+. ...++.++|+||||+++|+|++|..||...+...........
T Consensus 151 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 230 (292)
T cd06644 151 LADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 230 (292)
T ss_pred EccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC
Confidence 9999987543222 2223456788999999884 334678999999999999999999999877655444333222
Q ss_pred CC-CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NA-RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ....+..++.++.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 22334567889999999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=238.85 Aligned_cols=198 Identities=27% Similarity=0.532 Sum_probs=158.3
Q ss_pred CcEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCC---------------------------------------------
Q 026042 1 MQFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEP--------------------------------------------- 34 (244)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~--------------------------------------------- 34 (244)
|++++++. .+...++++||+++|+|.+++.....
T Consensus 74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (343)
T cd05103 74 VNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV 153 (343)
T ss_pred hhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence 35666664 45678999999999999999975321
Q ss_pred --------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccccC
Q 026042 35 --------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG 94 (244)
Q Consensus 35 --------------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~ 94 (244)
..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233 (343)
T ss_pred CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence 135777888999999999999999999999999999999999999999999986532211
Q ss_pred ---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHH
Q 026042 95 ---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 170 (244)
Q Consensus 95 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 170 (244)
......++..|+|||.+.+..++.++|+||||+++++|++ |..||.....................+...++++.+
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 313 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 1122334667999999988889999999999999999997 999998765443333333334444555667889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 171 LISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 171 li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
++.+||+.+|.+||++.++++.|+.+..
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=236.21 Aligned_cols=189 Identities=25% Similarity=0.473 Sum_probs=155.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++..++..++|+||++|++|.+++++.. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+
T Consensus 62 v~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~ 139 (308)
T cd06615 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI 139 (308)
T ss_pred CeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcE
Confidence 578899999999999999999999999998764 58899999999999999999997 599999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC----
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN---- 155 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---- 155 (244)
+|+|||++...... ......++..|+|||.+.+..++.++|+||||+++++|++|..||...+............
T Consensus 140 ~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 218 (308)
T cd06615 140 KLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGE 218 (308)
T ss_pred EEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccc
Confidence 99999987654322 2344578899999999988888999999999999999999999997655333222111000
Q ss_pred -------------------------------CCCCCC-CCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 156 -------------------------------ARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 156 -------------------------------~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
..+..+ ..++.++.+++.+||..+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111 2367789999999999999999999999973
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=230.19 Aligned_cols=185 Identities=23% Similarity=0.342 Sum_probs=157.9
Q ss_pred eecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---CcEEEec
Q 026042 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---MCVKVAD 83 (244)
Q Consensus 7 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---~~~kl~d 83 (244)
+...+.+.+|||.++||.|...|+.++...+++.++..|+.||..|+.|||+.+|+||||||+|+|.+.+ ..+||+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 4556778999999999999999999998899999999999999999999999999999999999999764 4699999
Q ss_pred CCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhCCCC-
Q 026042 84 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKNARP- 158 (244)
Q Consensus 84 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~- 158 (244)
||++..........+.+.|+.|.|||++...+++...|+||+|+++|-|++|.+||...... .....+.......
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 99998776666677888999999999999999999999999999999999999999754321 1222222222222
Q ss_pred -CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 -PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+..+.++++.+++|+.+|..+|.+|.|++++++
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 223567899999999999999999999999987
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=229.60 Aligned_cols=185 Identities=24% Similarity=0.469 Sum_probs=151.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
+++++++.. ...++|+||+++++|.+++.+... .+++..+..++.|++.||+|||++|++|+||||+||+++.++
T Consensus 64 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~ 141 (259)
T cd05037 64 VKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNE 141 (259)
T ss_pred hheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCcccc
Confidence 467888877 778999999999999999987654 588899999999999999999999999999999999999887
Q ss_pred ----cEEEecCCCcccccccCCCCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026042 78 ----CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 150 (244)
Q Consensus 78 ----~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 150 (244)
.++|+|||++..... .....++..|+|||.+.+. .++.++|+||||++++++++ |..||...+.......
T Consensus 142 ~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~ 218 (259)
T cd05037 142 GYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218 (259)
T ss_pred CCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH
Confidence 799999999865433 2234566789999998776 78999999999999999999 6888877654332222
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
.. .. ...+......+.+++.+||+.+|.+||++.++++.|
T Consensus 219 ~~-~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 219 YQ-DQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred Hh-cC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 21 11 122222337899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.69 Aligned_cols=190 Identities=25% Similarity=0.413 Sum_probs=168.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++||+=-+....+|.||||+||+|.+.++..+ ..++.....+..|++.|+.|||+.||+||||||.||+++.+|.+|
T Consensus 1297 V~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1297 VRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred cccCceeecHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEE
Confidence 577888888889999999999999999999866 467777888999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-----CCCCCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 81 VADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 81 l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
++|||.|....... ......||+.|||||++.+. +...++|||||||+++||+||+.||...+.+-.+....
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V 1454 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV 1454 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH
Confidence 99999987654332 23456799999999999764 46789999999999999999999999998887777777
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.....+++|..++++-++|+..||..||.+|.++.||++.
T Consensus 1455 ~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 7888899999999999999999999999999999988873
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=222.30 Aligned_cols=188 Identities=24% Similarity=0.370 Sum_probs=149.3
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcEEEecC
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADF 84 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~~~~kl~df 84 (244)
.....||+++|+..|+|.+.|+.. ++..+++.+++.|+.++++||++||+.. ++||||||.||++.+.+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 345689999999999999999764 3346899999999999999999999998 999999999999999999999999
Q ss_pred CCcccccccCCCC----------CCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHH
Q 026042 85 GISCLESQCGSAK----------GFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPE--QAAF 149 (244)
Q Consensus 85 g~~~~~~~~~~~~----------~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~ 149 (244)
|.++...-..... .-..|..|.|||.+.-. ..+.++|||||||++|.|+.|..||...-.. ....
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 9876432211111 23468899999998654 4689999999999999999999999742211 1111
Q ss_pred HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 150 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.+.......+..+.+++.+.++|.+||+.||.+||++.+++..++.+
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11122222333455899999999999999999999999999988765
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=232.28 Aligned_cols=190 Identities=27% Similarity=0.478 Sum_probs=158.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...|+||||+++++|.+++.+... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~ 143 (280)
T cd06611 65 VGLYEAYFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVK 143 (280)
T ss_pred eEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEE
Confidence 4688999999999999999999999999987543 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||.+....... ......++..|++||.+. ...++.++|+||||+++|+|++|..||...+...........
T Consensus 144 l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (280)
T cd06611 144 LADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS 223 (280)
T ss_pred EccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC
Confidence 99999876543322 223446788999999874 345678999999999999999999999887766554444322
Q ss_pred CC-CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NA-RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ....+..++.++.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 224 EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 21 22335578899999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=242.06 Aligned_cols=176 Identities=22% Similarity=0.304 Sum_probs=144.6
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 45799999995 588888754 3678899999999999999999999999999999999999999999999999765
Q ss_pred cccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC------------
Q 026042 91 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------ 158 (244)
Q Consensus 91 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 158 (244)
..........++..|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 55444455678999999999999899999999999999999999999998876655443332211100
Q ss_pred ----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+.+++.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000112457899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=241.25 Aligned_cols=186 Identities=20% Similarity=0.286 Sum_probs=148.8
Q ss_pred CcEEEEeecC------CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKP------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
+++++++... ...|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 79 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~ 153 (355)
T cd07874 79 ISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_pred hceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC
Confidence 3566666433 35799999995 578887754 378889999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.++.+||+|||++.............++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+........
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (355)
T cd07874 154 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_pred CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999987655544445567899999999999888999999999999999999999999876644332222111
Q ss_pred CCC----------------------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NAR----------------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred hCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000 0011223567899999999999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=231.42 Aligned_cols=191 Identities=29% Similarity=0.505 Sum_probs=153.9
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++.... ..++|+||+++++|.+++.... +..+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~ 145 (275)
T cd06608 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNIL 145 (275)
T ss_pred heEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEE
Confidence 46778886544 5899999999999999987643 446899999999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCccccccc-CCCCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 73 LGEDMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
++.++.++|+|||.+...... .......++..|+|||.+.. ..++.++|+||||+++++|++|..||.......
T Consensus 146 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 225 (275)
T cd06608 146 LTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225 (275)
T ss_pred EccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence 999999999999987654322 22334567889999998743 346789999999999999999999998766555
Q ss_pred HHHHHHhhCCC-CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 147 AAFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 147 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+...... ...+..+++.+.+++.+||..||++|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 44444322221 1222347789999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=232.39 Aligned_cols=187 Identities=23% Similarity=0.366 Sum_probs=156.1
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++...+..++|+||++|++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|
T Consensus 61 ~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl 138 (278)
T cd05606 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 138 (278)
T ss_pred eeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEE
Confidence 56778889999999999999999999997655 5899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCCCC
Q 026042 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPP 159 (244)
Q Consensus 82 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~ 159 (244)
+|||++...... ......|+..|+|||.+.++ .++.++|+||+|+++++|++|..||......... ...........
T Consensus 139 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 217 (278)
T cd05606 139 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217 (278)
T ss_pred ccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC
Confidence 999998654332 23345789999999998754 6789999999999999999999999765322111 11112233455
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..++..+.+++.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 6667889999999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=231.56 Aligned_cols=188 Identities=32% Similarity=0.538 Sum_probs=159.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||++|++|.+++... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~ 141 (277)
T cd06640 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred eeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEE
Confidence 46889999999999999999999999999753 478899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++....... ......++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+ .......
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~ 220 (277)
T cd06640 142 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPT 220 (277)
T ss_pred EcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCC
Confidence 99999986543322 223345788899999998888999999999999999999999999887765544433 2233344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.+..++..+.+++.+||+.+|.+||++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 555678899999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=230.76 Aligned_cols=195 Identities=31% Similarity=0.580 Sum_probs=152.8
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++. .+...++|+||+++++|.+++.+... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 68 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~ 146 (284)
T cd05081 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE-RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR 146 (284)
T ss_pred eEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe
Confidence 35666653 34578999999999999999976543 5789999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------
Q 026042 79 VKVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------- 146 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------- 146 (244)
++|+|||++........ .....+...|+|||...+..++.++|+||||+++++|++|..++.......
T Consensus 147 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd05081 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226 (284)
T ss_pred EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence 99999999875433221 111223456999999988889999999999999999999877654332110
Q ss_pred -------HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 147 -------AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 147 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..............+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 01111222233344567889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=226.70 Aligned_cols=189 Identities=25% Similarity=0.448 Sum_probs=159.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~ 79 (244)
|+-+|||..+...+|.||.+ +.-+..++++..+ ++++..+-++...+++||.||-.+ ||+|||+||+|||+|..|.+
T Consensus 154 V~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~-piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 154 VQCFGYFITNTDVFICMELM-STCAEKLLKRIKG-PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred eeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcC-CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCE
Confidence 56689999999999999999 5577777776554 689999999999999999999975 89999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
||||||.+-...++.......|-+.|||||.+... .|+.++||||||++++|+.||+.||.+.+.+-..........
T Consensus 232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 99999999888777777777899999999988543 578999999999999999999999998654433332222233
Q ss_pred CCCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+.++ ..+++.+.+|+..||++|+++||.+.+|++
T Consensus 312 PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 33333 348999999999999999999999999997
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=258.27 Aligned_cols=200 Identities=33% Similarity=0.624 Sum_probs=176.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|+++|+|-+....+|++|||+||+|..||++.+ ...++....+.++.+++.|..||++++++||||...|+|++.
T Consensus 758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~ 837 (1025)
T KOG1095|consen 758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE 837 (1025)
T ss_pred eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc
Confidence 689999999999999999999999999999862 235788999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccC--CCCCC-CcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 026042 76 DMCVKVADFGISCLESQCG--SAKGF-TGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~--~~~~~-~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 151 (244)
...+|++|||+|+...... +.... .-...|||||.+..+.++.++||||||+++||+++ |..||.+.++.+.+...
T Consensus 838 ~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~ 917 (1025)
T KOG1095|consen 838 RRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV 917 (1025)
T ss_pred cCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH
Confidence 9999999999998432211 11111 23468999999999999999999999999999999 99999999999888766
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.... +...|..||..+.+++.+||+.+|++||++..|++.+.++.....
T Consensus 918 ~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 918 LEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred HhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 6555 889999999999999999999999999999999998887766443
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=234.42 Aligned_cols=189 Identities=33% Similarity=0.569 Sum_probs=156.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++......++|+||+.+++|.+++.... .+++..+..++.|++.||.+||++|++|+||||+||+++.++.++
T Consensus 61 ~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~ 138 (260)
T PF00069_consen 61 VQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVK 138 (260)
T ss_dssp CHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEE
T ss_pred ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 468899999999999999999889999999555 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccc-cccCCCCCCCcccceeccceec-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--
Q 026042 81 VADFGISCLE-SQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-- 156 (244)
Q Consensus 81 l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 156 (244)
|+|||.+... ..........++..|+|||.+. +...+.++|+||||+++++|++|..||......+..........
T Consensus 139 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 139 LIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP 218 (260)
T ss_dssp ESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence 9999998652 2333445667899999999998 78899999999999999999999999998733322222211111
Q ss_pred -C--CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 -R--PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 -~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .......+..+.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 1111222489999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=232.67 Aligned_cols=195 Identities=29% Similarity=0.629 Sum_probs=161.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
++++++|... ..++++||+++|+|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+|
T Consensus 72 v~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~k 149 (303)
T cd05110 72 VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVK 149 (303)
T ss_pred ccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceE
Confidence 4678888654 46799999999999999987543 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++........ .....++..|++||...+..++.++||||||+++|++++ |..||.+......... .....
T Consensus 150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~ 228 (303)
T cd05110 150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-LEKGE 228 (303)
T ss_pred EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCC
Confidence 999999875432221 122334678999999988889999999999999999997 9999987765554333 33444
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
....+..++..+.+++.+|+..+|++||+++++++.|..+..
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 229 RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 445566788999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=227.92 Aligned_cols=188 Identities=31% Similarity=0.529 Sum_probs=160.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++.+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~ 139 (264)
T cd06623 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEV 139 (264)
T ss_pred eeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCE
Confidence 467889999999999999999999999998764 68999999999999999999999 999999999999999999999
Q ss_pred EEecCCCcccccccCCC-CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhC
Q 026042 80 KVADFGISCLESQCGSA-KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKN 155 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~ 155 (244)
+|+|||.+......... ....++..|+|||.+....++.++|+||||+++|+|++|..||.... ..+....+. ..
T Consensus 140 ~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~ 218 (264)
T cd06623 140 KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DG 218 (264)
T ss_pred EEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cC
Confidence 99999998755433322 24567889999999988889999999999999999999999998764 333333333 33
Q ss_pred CCCCCCCC-chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+.. ++..+.+++.+||..+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33444555 8899999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=241.28 Aligned_cols=188 Identities=26% Similarity=0.410 Sum_probs=151.2
Q ss_pred CcEEEEeecCC-----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPP-----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++.... ..|+|+||+. ++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 62 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~ 138 (372)
T cd07853 62 LSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS 138 (372)
T ss_pred CCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC
Confidence 35667777666 7899999995 68999887654 5899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccC--CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 76 DMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
++.+||+|||++....... ......++..|+|||.+.+. .++.++||||+||++++|++|+.||.+.+..+....+.
T Consensus 139 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 139 NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999999999986543221 22234578899999998764 47899999999999999999999998876554433322
Q ss_pred hhC-----------------------CCC-------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKN-----------------------ARP-------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~-----------------------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ... ......++++.+++.+||+.||.+|||+.++++
T Consensus 219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 110 000 122345788999999999999999999999997
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=230.96 Aligned_cols=189 Identities=20% Similarity=0.382 Sum_probs=153.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|..++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 63 VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIK 140 (286)
T ss_pred eeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEE
Confidence 467899999999999999999888887776544 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+..+....+......
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07847 141 LCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDL 220 (286)
T ss_pred ECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999987554332 2234457789999998865 45788999999999999999999999877665444332211000
Q ss_pred ------------------CC----------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ------------------PP----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ------------------~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+ ..+.++..+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 01245788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=245.18 Aligned_cols=190 Identities=27% Similarity=0.510 Sum_probs=166.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++.|...+.++|+.|||.||-+...+-..+. .+++.++..+++|++.||.|||+++|+|||||..|||++-+|.++
T Consensus 92 vkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdir 170 (1187)
T KOG0579|consen 92 VKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIR 170 (1187)
T ss_pred HHHHHHHhccCceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEe
Confidence 4567777888999999999999999998877554 799999999999999999999999999999999999999999999
Q ss_pred EecCCCcccc-cccCCCCCCCcccceecccee-----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLE-SQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||.+... ........++||+.|||||++ ..++|+.++||||||+++.+|..+.+|....++...+..+...
T Consensus 171 LADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS 250 (1187)
T KOG0579|consen 171 LADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 250 (1187)
T ss_pred eecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc
Confidence 9999997543 233345678999999999975 5578999999999999999999999999999988877666443
Q ss_pred -CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 -NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....-|+.|+..|.+|+.+||.+||+.||++.+|++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 3334567899999999999999999999999999986
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=228.92 Aligned_cols=188 Identities=28% Similarity=0.495 Sum_probs=155.7
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++.. +...++++||+++++|.+++.+.. .+++...+.++.|++.||++||+.|++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~ 144 (266)
T cd06651 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN 144 (266)
T ss_pred eeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC
Confidence 356777654 467899999999999999998765 4788999999999999999999999999999999999999999
Q ss_pred EEEecCCCccccccc----CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 79 VKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|++++|..||...............
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~ 224 (266)
T cd06651 145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ 224 (266)
T ss_pred EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC
Confidence 999999998643221 1122345788999999998888999999999999999999999999877665555544444
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+..+++.+..++ +|+..+|.+||+++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 444555667788899998 577789999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.37 Aligned_cols=189 Identities=31% Similarity=0.564 Sum_probs=156.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++++.. .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~ 148 (272)
T cd06629 71 VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICK 148 (272)
T ss_pred ceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEE
Confidence 468899999999999999999999999998764 588899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++....... ......++..|+|||...... ++.++|+||||++++++++|..||...+............
T Consensus 149 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 228 (272)
T cd06629 149 ISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR 228 (272)
T ss_pred EeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc
Confidence 99999986543211 122345788999999987654 7899999999999999999999997666554443333222
Q ss_pred CCCCCC----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+ ..++..+.+++.+||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 222222 346889999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=232.71 Aligned_cols=196 Identities=22% Similarity=0.356 Sum_probs=156.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||++ ++|.+++.+... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~k 144 (301)
T cd07873 67 VTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELK 144 (301)
T ss_pred ceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEE
Confidence 578999999999999999995 599999876543 578999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+......
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 224 (301)
T cd07873 145 LADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTP 224 (301)
T ss_pred ECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999986533222 22334568899999987654 5788999999999999999999999887765443322211100
Q ss_pred -------------------C--------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 026042 158 -------------------P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 198 (244)
Q Consensus 158 -------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~~ 198 (244)
+ .....+++.+.++|.+||+.||.+|||+.|+++ +++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 225 TEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred ChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 0 011346788999999999999999999999997 5544443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=230.22 Aligned_cols=184 Identities=29% Similarity=0.493 Sum_probs=151.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|..+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 62 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~ 135 (279)
T cd06619 62 IGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVK 135 (279)
T ss_pred eeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEE
Confidence 56889999999999999999999996552 367888999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHh
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-------QAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~ 153 (244)
|+|||++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ........
T Consensus 136 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 214 (279)
T cd06619 136 LCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214 (279)
T ss_pred EeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc
Confidence 9999998654332 334457899999999999888999999999999999999999999653321 11111111
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...........++++.+++.+||+.+|++||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11112223457889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=226.45 Aligned_cols=189 Identities=26% Similarity=0.537 Sum_probs=155.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~k 139 (264)
T cd06626 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIK 139 (264)
T ss_pred hheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 467888899999999999999999999998764 478899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC-----CCCCcccceeccceeccCC---CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 81 VADFGISCLESQCGSA-----KGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
|+|||.+......... ....++..|+|||.+.+.. .+.++|+||+|++++++++|..||...+.........
T Consensus 140 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~ 219 (264)
T cd06626 140 LGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV 219 (264)
T ss_pred EcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH
Confidence 9999998654332221 1345788999999988766 7899999999999999999999998764333322222
Q ss_pred hhCCCCCCCCC--chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPPVPPT--CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+.. +++.+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22333344443 4889999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=228.08 Aligned_cols=188 Identities=29% Similarity=0.492 Sum_probs=155.3
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++.+ ...+++++||++|++|.+++.+.. .+++..+..++.|++.||++||++|++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN 144 (265)
T ss_pred eeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC
Confidence 356777765 356889999999999999998765 4788999999999999999999999999999999999999999
Q ss_pred EEEecCCCccccccc----CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 79 VKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
++|+|||.+...... .......++..|+|||.+.+...+.++|+||||+++|+|++|..||...............
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 224 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC
Confidence 999999988653321 1123345788999999998888899999999999999999999999876655544444333
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+...+..+.+++++|+. +|.+||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 33445566778889999999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=234.46 Aligned_cols=187 Identities=26% Similarity=0.458 Sum_probs=155.2
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++.+..++..++|+||+++++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL 159 (292)
T cd06658 83 DMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKL 159 (292)
T ss_pred HHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEE
Confidence 4567788899999999999999999998653 4788999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCCC
Q 026042 82 ADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARPP 159 (244)
Q Consensus 82 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 159 (244)
+|||++....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+.... ....
T Consensus 160 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T cd06658 160 SDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK 239 (292)
T ss_pred ccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccc
Confidence 9999876433222 2234567889999999988889999999999999999999999998776655444332211 1112
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+..+.+++.+|+..+|.+|||++++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 23356789999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=234.52 Aligned_cols=188 Identities=28% Similarity=0.516 Sum_probs=157.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~ 155 (297)
T cd06656 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVK 155 (297)
T ss_pred eeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 46889999999999999999999999999764 378899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~ 158 (244)
|+|||.+....... ......++..|++||...+..++.++|+||+|+++|++++|..||...+........... ....
T Consensus 156 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 235 (297)
T cd06656 156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (297)
T ss_pred ECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC
Confidence 99999886543322 223446788999999998888899999999999999999999999776543332222111 1122
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 244567889999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=229.78 Aligned_cols=188 Identities=25% Similarity=0.454 Sum_probs=157.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||++|++|.+++.. . .+++..+..++.|++.||++||++|++||||+|+||+++.++.++
T Consensus 79 v~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~--~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 155 (285)
T cd06648 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTH-T--RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVK 155 (285)
T ss_pred heEEEEEEcCCeEEEEEeccCCCCHHHHHHh-C--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEE
Confidence 4678899999999999999999999999987 2 478899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-CC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~ 158 (244)
|+|||.+....... ......++..|+|||...+..++.++|+||+|+++++|++|..||...+............. ..
T Consensus 156 l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd06648 156 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL 235 (285)
T ss_pred EcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC
Confidence 99999875433221 22345688899999999888899999999999999999999999987766555444432211 11
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++..+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 122347889999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=228.25 Aligned_cols=190 Identities=32% Similarity=0.612 Sum_probs=157.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++.+..+...++|+|++++++|.+++++... ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.+
T Consensus 62 ~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~ 141 (267)
T cd06610 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV 141 (267)
T ss_pred EEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCE
Confidence 3577888999999999999999999999987533 468999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCC-----CCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 80 KVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
+|+|||++........ .....++..|++||.+... ..+.++|+||||+++++|++|..||...+..........
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 221 (267)
T cd06610 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221 (267)
T ss_pred EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence 9999998765433221 2344578899999998776 789999999999999999999999987766554433332
Q ss_pred hCCCCCCC-----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARPPVP-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ..... ..++..+.+++.+||+.+|++||++.++++
T Consensus 222 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 222 ND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CC-CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 21 11111 256789999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=241.18 Aligned_cols=189 Identities=23% Similarity=0.433 Sum_probs=152.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++......|++||++ +++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 149 v~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~ 225 (392)
T PHA03207 149 INLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV 225 (392)
T ss_pred cceeeeEeeCCEEEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEE
Confidence 57889999999999999999 569999996544 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~ 154 (244)
|+|||++........ .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+.... .....+...
T Consensus 226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred EccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 999999865433221 23457899999999999889999999999999999999999999654321 111111110
Q ss_pred C-------------------------CCC--CC-----CCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 155 N-------------------------ARP--PV-----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 155 ~-------------------------~~~--~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
. .+. .. ...++.++.++|.+||..||++||++.|++..
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 000 00 12346678899999999999999999999984
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=227.13 Aligned_cols=191 Identities=24% Similarity=0.444 Sum_probs=160.0
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccCCCCCCcE
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLH-----SQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH-----~~~i~H~dikp~ni 71 (244)
+++++++. .+...++++||+++++|.+++... ....+++..++.++.|++.||.+|| +.+++|+||+|+||
T Consensus 62 ~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ni 141 (265)
T cd08217 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANI 141 (265)
T ss_pred ceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHE
Confidence 35666663 456689999999999999999764 2336889999999999999999999 88999999999999
Q ss_pred EEcCCCcEEEecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
+++.++.++|+|||++........ .....++..|++||.+.+...+.++|+||||+++++|++|..||...+.......
T Consensus 142 li~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 221 (265)
T cd08217 142 FLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK 221 (265)
T ss_pred EEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH
Confidence 999999999999999876544332 3345688999999999888889999999999999999999999988775544433
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
+ ........+..++..+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 I-KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred H-hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 3 3344455677889999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=229.95 Aligned_cols=195 Identities=31% Similarity=0.631 Sum_probs=158.5
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++.. +...++++||+++++|.+++..... .+++..+..++.|++.||++||++|++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~ 147 (284)
T cd05038 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL 147 (284)
T ss_pred heEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC
Confidence 457788877 6689999999999999999987653 5889999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------
Q 026042 79 VKVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------- 146 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------- 146 (244)
++|+|||.+........ .....++..|++||...+..++.++|+||||+++++|++|..|+.......
T Consensus 148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 227 (284)
T cd05038 148 VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227 (284)
T ss_pred EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc
Confidence 99999999876542211 112234567999999988889999999999999999999999886532221
Q ss_pred ------HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 147 ------AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 147 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..............+..++.++.+++.+||..+|.+||++.+++++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11122223333444567789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=230.16 Aligned_cols=190 Identities=23% Similarity=0.299 Sum_probs=152.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++..++..|+|+||++ ++|.+++.... +..+++..++.++.|++.||.|||++|++|+||+|+||+++.+|.+
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~ 140 (285)
T cd07861 62 VCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVI 140 (285)
T ss_pred eeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcE
Confidence 478899999999999999996 69999987643 2468999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-
Q 026042 80 KVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA- 156 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 156 (244)
+|+|||++....... ......++..|+|||.+.+. .++.++|+||||+++++|++|..||.+...............
T Consensus 141 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd07861 141 KLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT 220 (285)
T ss_pred EECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999986433221 12233568899999987654 568899999999999999999999987654433322211100
Q ss_pred --------------------------CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 --------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 --------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......+++++.+++.+||+.||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 221 PTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00112346889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=229.92 Aligned_cols=192 Identities=25% Similarity=0.421 Sum_probs=152.6
Q ss_pred CcEEEEe-----ecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 026042 1 MQFVAAC-----KKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~ 73 (244)
+++++++ ..++..++||||++|++|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili 157 (286)
T cd06638 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL 157 (286)
T ss_pred eeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE
Confidence 3566766 3456789999999999999988642 22357889999999999999999999999999999999999
Q ss_pred cCCCcEEEecCCCcccccccC-CCCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH
Q 026042 74 GEDMCVKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 147 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 147 (244)
+.++.++|+|||++....... ......++..|+|||.+.. ..++.++|+||+|+++++|++|..||........
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 158 TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 999999999999986543322 2234568899999998753 3468899999999999999999999987665443
Q ss_pred HHHHHhhC-CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 148 AFAVCQKN-ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
........ .....+..++..+.+++.+||+.+|++||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 33221111 1122345578899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=228.18 Aligned_cols=188 Identities=19% Similarity=0.302 Sum_probs=151.8
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..+ +..++|+||++ ++|.+++..... .+++..++.++.|++.||+|||+.|++|+||+|+||+++. +.
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~ 137 (282)
T cd07831 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI 137 (282)
T ss_pred cceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC
Confidence 4678888877 89999999995 589888876442 5899999999999999999999999999999999999999 99
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
++|+|||++.............++..|+|||.+.. ...+.++|+||+|+++|+|++|..||.+.+..+...........
T Consensus 138 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~ 217 (282)
T cd07831 138 LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT 217 (282)
T ss_pred eEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCC
Confidence 99999999876544333344567889999997644 55788999999999999999999999877654433322211100
Q ss_pred ----------------CC-----------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ----------------PP-----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ----------------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ....++..+.+++.+||+.+|++||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 11346789999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=239.42 Aligned_cols=189 Identities=23% Similarity=0.428 Sum_probs=148.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..+...++|+|++ .++|.+++.+... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 120 v~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~k 197 (357)
T PHA03209 120 IRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC 197 (357)
T ss_pred cChhheEEeCCeeEEEEEcc-CCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 57889999999999999999 5699999876443 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCC-CCCCCHH---------HHHHH
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPE---------QAAFA 150 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~---------~~~~~ 150 (244)
|+|||.+.............|+..|+|||++.+..++.++|||||||++|+|+++..+ |...... .....
T Consensus 198 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~ 277 (357)
T PHA03209 198 IGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277 (357)
T ss_pred EecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHH
Confidence 9999998754433334456789999999999988999999999999999999985444 3322111 00111
Q ss_pred HHhhCC--CCCC------------------------------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNA--RPPV------------------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~--~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+..... .... ...++..+.++|.+||+.||.+|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 278 IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 110000 0000 0134566778999999999999999999987
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=239.18 Aligned_cols=188 Identities=21% Similarity=0.342 Sum_probs=150.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++|+|=-.++++||||||- ..+|..++++.... .+.-.++.+..||+.++.++|.+||+|.||||.|+++ -.|.+|
T Consensus 423 IqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LK 499 (677)
T KOG0596|consen 423 IQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLK 499 (677)
T ss_pred EEEeeeeccCceEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEE
Confidence 57899999999999999987 67999999987653 3333788899999999999999999999999999998 568999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccC-----------CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEK-----------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
|+|||.|....... .....+||+.||+||.+... ..++++|||||||++|+|+.|+.||.......
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~ 579 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI 579 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH
Confidence 99999986544332 24567899999999987432 25789999999999999999999998766443
Q ss_pred HHHHHHhhC-CCCCCCCCch-HHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 147 AAFAVCQKN-ARPPVPPTCP-KAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 147 ~~~~~~~~~-~~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+... ...+++..-+ .++.++++.||+.||.+||++.+|++
T Consensus 580 aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 333222222 2223333322 23999999999999999999999998
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=230.43 Aligned_cols=190 Identities=27% Similarity=0.445 Sum_probs=153.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~ 77 (244)
|++++++..++..|+++||++ ++|.+++... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~ 141 (283)
T cd06617 63 VTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG 141 (283)
T ss_pred eeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC
Confidence 578899999999999999995 6999888653 223689999999999999999999997 999999999999999999
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceecc----CCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE----KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVC 152 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~ 152 (244)
.+||+|||++.............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..... .+......
T Consensus 142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (283)
T cd06617 142 QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV 221 (283)
T ss_pred CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence 999999999876544333334567889999998865 3468899999999999999999999975432 22222222
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...........++.++.+++.+||..+|.+||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 222222223457899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=228.58 Aligned_cols=187 Identities=27% Similarity=0.544 Sum_probs=155.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||++|++|.++++.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 65 i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~ 141 (277)
T cd06917 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVK 141 (277)
T ss_pred eeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEE
Confidence 46788999999999999999999999998764 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||.+....... ......++..|+|||.+.++ .++.++|+||||+++|+|++|..||.+.+......... .....
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-~~~~~ 220 (277)
T cd06917 142 LCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPP 220 (277)
T ss_pred EccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-cCCCC
Confidence 99999886544322 22344688899999988654 56899999999999999999999998876554433221 11222
Q ss_pred CCCC-CchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~-~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+. .++.++.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 2222 37889999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=230.58 Aligned_cols=187 Identities=32% Similarity=0.550 Sum_probs=157.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+|+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~ 141 (277)
T cd06642 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred HhhhcccccCCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEE
Confidence 45778888999999999999999999998753 478899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++....... ......++..|+|||.+.+..++.++|+||||+++++|++|..|+............ .......
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~ 220 (277)
T cd06642 142 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPT 220 (277)
T ss_pred EccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCCCC
Confidence 99999986543322 222345788999999998888999999999999999999999999766554433322 2233344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 55667889999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=229.20 Aligned_cols=187 Identities=29% Similarity=0.504 Sum_probs=155.1
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~k 80 (244)
++++++..++..++++||+++++|.+++.... ..+++..+..++.|++.||.+||+ .|++|+||+|+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~ 141 (265)
T cd06605 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIK 141 (265)
T ss_pred hhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEE
Confidence 56788888999999999999999999998763 368899999999999999999999 9999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-----PEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~~ 155 (244)
|+|||.+......... ...++..|+|||.+.+..++.++|+||+|+++++|++|..||...+ ..+..... ...
T Consensus 142 l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 219 (265)
T cd06605 142 LCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNE 219 (265)
T ss_pred EeecccchhhHHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcC
Confidence 9999988654332222 2668889999999988889999999999999999999999997542 11221121 122
Q ss_pred CCCCCCCC-chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+.. ++..+.++|.+||..+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 22333333 7889999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=244.64 Aligned_cols=189 Identities=27% Similarity=0.423 Sum_probs=177.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++|..|.+.++.|++||-|-||.|+..+++++ .++...+.-++..+++|++|||++||++|||||+|++++.+|.+|
T Consensus 483 vrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 483 VRLYRTFRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred HHHHHHhccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceE
Confidence 567888999999999999999999999999988 688899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|.|||++..........+++||+.|.|||.+.....+.++|.||||+++||+++|.+||.+.++......+.+......+
T Consensus 561 LVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~ 640 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEF 640 (732)
T ss_pred EeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhc
Confidence 99999999998888899999999999999999999999999999999999999999999999999999988888888889
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
|..++....++|+++...+|.+|.. +.++..
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 9999999999999999999999975 555554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=231.33 Aligned_cols=179 Identities=17% Similarity=0.236 Sum_probs=143.0
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccccc
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 91 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~ 91 (244)
..++++|++ ..++.+.+.... ..++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 101 ~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 101 YRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177 (294)
T ss_pred EEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence 457888988 558888877654 35778899999999999999999999999999999999999999999999986543
Q ss_pred cc--------CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHH-----HhhCCC
Q 026042 92 QC--------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-EQAAFAV-----CQKNAR 157 (244)
Q Consensus 92 ~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~-----~~~~~~ 157 (244)
.. .......||+.|+|||.+.+..++.++|||||||++++|++|..||..... ....... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (294)
T PHA02882 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEG 257 (294)
T ss_pred cCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhh
Confidence 21 112234689999999999999999999999999999999999999987632 2211111 111111
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
......+++.+.+++..|+..+|.+||+++++++.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 258 KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 123356689999999999999999999999999876
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=223.54 Aligned_cols=189 Identities=31% Similarity=0.598 Sum_probs=160.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++++||+++++|.+++.... ..+++..+..++.|++.+|.+||++|++||||+|+||+++.++.++
T Consensus 60 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~ 138 (253)
T cd05122 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVK 138 (253)
T ss_pred eEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEE
Confidence 357888999999999999999999999998763 2689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||.+.............++..|++||.+.+...+.++|+||||+++++|++|..||...+.......... ......
T Consensus 139 l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~ 217 (253)
T cd05122 139 LIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGL 217 (253)
T ss_pred EeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCc
Confidence 9999998765543324456688899999999888889999999999999999999999988765555444433 222222
Q ss_pred C--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 P--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+ ..++..+.+++.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2 334899999999999999999999999886
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=227.47 Aligned_cols=189 Identities=26% Similarity=0.513 Sum_probs=157.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~-~~ 79 (244)
|++++++..++..++|+||+++++|.+++.+.. .+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .+
T Consensus 66 v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~ 143 (268)
T cd06630 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRL 143 (268)
T ss_pred ehhhceeccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 467889999999999999999999999998765 588999999999999999999999999999999999998876 59
Q ss_pred EEecCCCcccccccC-----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH
Q 026042 80 KVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---AAFAV 151 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~ 151 (244)
+|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..||....... .....
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (268)
T cd06630 144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI 223 (268)
T ss_pred EEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH
Confidence 999999986543321 1223457889999999988888999999999999999999999997544322 22222
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.........+..+++++.+++.+||..+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2233445566678899999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=226.56 Aligned_cols=191 Identities=29% Similarity=0.496 Sum_probs=154.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~ 78 (244)
+++++++..++..++|+||+++++|.+++..... ...++..+..++.|++.||+|||++|++|+||||+||+++. ++.
T Consensus 68 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~ 147 (268)
T cd06624 68 VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV 147 (268)
T ss_pred eeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCe
Confidence 4688999999999999999999999999986532 12377888999999999999999999999999999999976 678
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhh
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~ 154 (244)
++|+|||.+....... ......++..|+|||.+... .++.++|+||+|+++++|++|..||....... ........
T Consensus 148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (268)
T cd06624 148 VKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF 227 (268)
T ss_pred EEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh
Confidence 9999999876543222 22334578899999998654 37889999999999999999999997654322 22222222
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+++++.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 3344566778899999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=242.87 Aligned_cols=183 Identities=23% Similarity=0.363 Sum_probs=157.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE-cCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-GEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~-~~~~~~ 79 (244)
|++.+.+..+.+.|+|||.+.|+-|.+.|...+. +. ..+..|+++|+.|+.|||++|++|||+||+|||+ ++.|.+
T Consensus 379 v~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~l 455 (612)
T KOG0603|consen 379 VKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHL 455 (612)
T ss_pred eeecceecCCceeeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcE
Confidence 4677889999999999999999999998887662 33 7888899999999999999999999999999999 588999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
+|+|||.+...... ....+-|..|.|||+.....++++.||||||+++|+|++|..||..-.... .+......+.
T Consensus 456 rltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~ 530 (612)
T KOG0603|consen 456 RLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPK 530 (612)
T ss_pred EEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCc
Confidence 99999998765443 334466889999999999999999999999999999999999998765552 2223334445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+|...++|+++||+.||.+|+++.++..
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 55889999999999999999999999999987
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=228.74 Aligned_cols=190 Identities=26% Similarity=0.413 Sum_probs=152.7
Q ss_pred cEEEEeecC-----CcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 2 QFVAACKKP-----PVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 2 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
++++++... ...++|+||++|++|.++++.. ....+++..++.++.|++.||.+||+.|++|+||||+||+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~ 162 (291)
T cd06639 83 KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc
Confidence 566776543 4689999999999999998642 233688999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccC-CCCCCCcccceeccceeccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 026042 75 EDMCVKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 148 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 148 (244)
.++.++|+|||.+....... ......++..|+|||.+... .++.++|+||+|+++|+|++|+.||...+.....
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 99999999999886543322 22345678899999987543 3588999999999999999999999887765554
Q ss_pred HHHHhhC-CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 149 FAVCQKN-ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 149 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+.... .....+..++..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 4432221 112234557788999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=228.25 Aligned_cols=190 Identities=30% Similarity=0.564 Sum_probs=159.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||++|++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~ 156 (286)
T cd06614 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK 156 (286)
T ss_pred eEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEE
Confidence 467889999999999999999999999998865 3588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP- 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 158 (244)
|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 157 l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06614 157 LADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL 236 (286)
T ss_pred ECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99999875433221 2233457789999999988888999999999999999999999998877665544433222211
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 223347899999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=229.28 Aligned_cols=186 Identities=25% Similarity=0.370 Sum_probs=157.8
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++.+..+...++|+||+.|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|
T Consensus 64 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred HHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEE
Confidence 45567788899999999999999999998764 6889999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCCCC
Q 026042 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--QAAFAVCQKNARPP 159 (244)
Q Consensus 82 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 159 (244)
+|||.+.............++..|+|||.+.....+.++|+||+|+++|+|++|..||...+.. ....... ......
T Consensus 142 ~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 220 (258)
T cd05578 142 TDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ-ETADVL 220 (258)
T ss_pred eecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh-cccccc
Confidence 9999987655443444566888999999998888999999999999999999999999877642 2222211 224556
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH--HHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF--DQIV 190 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~--~el~ 190 (244)
.+..++..+.+++.+||+.+|.+||++ ++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 677889999999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=223.71 Aligned_cols=189 Identities=29% Similarity=0.570 Sum_probs=162.0
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++.+... ...++++||+++++|.+++.+.. .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.
T Consensus 62 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~ 139 (260)
T cd06606 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV 139 (260)
T ss_pred eeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC
Confidence 3577888887 89999999999999999998766 6899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhh
Q 026042 79 VKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~ 154 (244)
++|+|||.+........ .....++..|++||...+...+.++|+||||+++++|++|..||.... ...........
T Consensus 140 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (260)
T cd06606 140 VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219 (260)
T ss_pred EEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc
Confidence 99999999876555432 445668899999999988889999999999999999999999998776 22222332222
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+...+..+.+++.+|++.+|++||++.+++.
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 3445666778999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=223.88 Aligned_cols=190 Identities=32% Similarity=0.561 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++.+.+..++..++|+||+++++|.+++.+.. +..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~ 141 (258)
T cd08215 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL 141 (258)
T ss_pred hheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc
Confidence 357788888899999999999999999998753 347899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
++|+|||.+....... ......+++.|+|||...+...+.++|+||+|+++++|++|..||...+..+...... ....
T Consensus 142 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~ 220 (258)
T cd08215 142 VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQY 220 (258)
T ss_pred EEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCC
Confidence 9999999986544432 2334567889999999988889999999999999999999999998887666555443 3335
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..++..+.+++.+||..+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 5666788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=231.49 Aligned_cols=189 Identities=25% Similarity=0.439 Sum_probs=157.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 81 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~k 157 (297)
T cd06659 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVK 157 (297)
T ss_pred hhhhhheeeCCeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEE
Confidence 35778888999999999999999999988653 478999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...+.......+.... ...
T Consensus 158 L~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 237 (297)
T cd06659 158 LSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL 237 (297)
T ss_pred EeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCc
Confidence 99999875433221 2234568899999999988889999999999999999999999998766555443332211 112
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.....++..+.+++.+||+.+|.+||+++++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2334678899999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=227.99 Aligned_cols=189 Identities=30% Similarity=0.487 Sum_probs=157.9
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++.+..++..|+++||+++++|.+++.+.. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|
T Consensus 57 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l 134 (265)
T cd05579 57 KLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKL 134 (265)
T ss_pred HHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEE
Confidence 45667788999999999999999999998765 6899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccC---------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 82 ADFGISCLESQCG---------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 82 ~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
+|||++....... ......++..|++||.......+.++|+||||++++++++|..||.............
T Consensus 135 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 135 TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214 (265)
T ss_pred EecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 9999876533221 2234457789999999988888999999999999999999999998887766555443
Q ss_pred hhCCCCCCCCC--chHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 153 QKNARPPVPPT--CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 153 ~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
... ...+.. ++..+.+++.+||+.+|.+||++.++.+.|+
T Consensus 215 ~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 215 NGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 322 223333 4899999999999999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.79 Aligned_cols=198 Identities=22% Similarity=0.355 Sum_probs=157.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE---------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
|++++++..++..|+||||++|++|.+++.... ....+...+..++.|++.||+|||++|++||||||+||
T Consensus 65 Vkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNI 144 (932)
T PRK13184 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNI 144 (932)
T ss_pred CeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheE
Confidence 578899999999999999999999999987421 12345677889999999999999999999999999999
Q ss_pred EEcCCCcEEEecCCCccccccc-------------------CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQC-------------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 132 (244)
+++.+|.++|+|||++...... .......|++.|+|||.+.+..++.++||||+||++++|
T Consensus 145 LLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyEL 224 (932)
T PRK13184 145 LLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224 (932)
T ss_pred EEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHH
Confidence 9999999999999998654110 011234689999999999998999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhhC-CCCCCCCCchHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 026042 133 LTALTPFDNMTPEQAAFAVCQKN-ARPPVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYSE 198 (244)
Q Consensus 133 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~el~~~l~~~~~ 198 (244)
++|..||...+............ ........+++.+.+++.+||+.||++|+ +++++++.|+.+..
T Consensus 225 LTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 225 LTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred HHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999998755443322211111 11112246788999999999999999995 67778787777654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=228.49 Aligned_cols=189 Identities=28% Similarity=0.514 Sum_probs=156.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++......++|+||+++++|.+++.+.+ .+++..+..++.+++.+|.|||+ .|++|+||+|+||+++.++.+
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~ 143 (284)
T cd06620 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI 143 (284)
T ss_pred ceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcE
Confidence 468899999999999999999999999998765 58899999999999999999997 599999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----------HHH
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-----------QAA 148 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~ 148 (244)
+|+|||++...... ......++..|+|||.+.+..++.++|+||+||+++++++|..||...... ...
T Consensus 144 ~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd06620 144 KLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222 (284)
T ss_pred EEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence 99999987543222 223457899999999998888999999999999999999999999865432 111
Q ss_pred HHHHhhCCCCCCC-CCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 149 FAVCQKNARPPVP-PTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 149 ~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
..+.. ......+ ..++..+.+++.+|++.||++||++.|+++..
T Consensus 223 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 223 QQIVQ-EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHhh-ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111 1122222 23778999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=226.81 Aligned_cols=189 Identities=24% Similarity=0.381 Sum_probs=154.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~ 139 (286)
T cd07832 62 VKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLK 139 (286)
T ss_pred cceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEE
Confidence 46889999999999999999 999999997654 3689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... ......++..|+|||.+.+. .++.++||||+|+++++|++|..||.+.+.......+......
T Consensus 140 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 219 (286)
T cd07832 140 IADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT 219 (286)
T ss_pred EeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCC
Confidence 99999987554332 13345688899999998654 4689999999999999999998888776654433332221110
Q ss_pred C----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 P----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ...+..+.++.+++.+||..+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 011345688999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=228.44 Aligned_cols=190 Identities=26% Similarity=0.454 Sum_probs=155.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..++..++|+||+++++|..+++... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~ 141 (286)
T cd06622 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ 141 (286)
T ss_pred HhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC
Confidence 356788889999999999999999999987642 2258999999999999999999997 59999999999999999999
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCC------CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
++|+|||.+...... ......++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.............
T Consensus 142 ~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 220 (286)
T cd06622 142 VKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS 220 (286)
T ss_pred EEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH
Confidence 999999988654322 233445788999999885543 4789999999999999999999997665444332221
Q ss_pred --hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 --QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+..++.++.+++.+||+.+|.+||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 221 AIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 223344566678999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=231.55 Aligned_cols=191 Identities=24% Similarity=0.446 Sum_probs=152.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||+++++|.+++.+..+..+++..+..++.|++.||.|||++|++|+||||+||+++.+|.++
T Consensus 62 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~k 141 (314)
T cd08216 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVV 141 (314)
T ss_pred hhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceE
Confidence 45778899999999999999999999999876555789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--------CCCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 81 VADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 81 l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
|+|||.+....... ......++..|+|||.+.. ..++.++|+||+|+++++|++|..||...........
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (314)
T ss_pred EecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999875432211 1223446778999999865 3578899999999999999999999987654443322
Q ss_pred HHhhCCC--------------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNAR--------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....... ......++.++.+++.+||+.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 2111100 0011223567889999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=229.48 Aligned_cols=179 Identities=25% Similarity=0.386 Sum_probs=153.5
Q ss_pred cEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEecCCCcc
Q 026042 12 VFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISC 88 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-~~~kl~dfg~~~ 88 (244)
+..+||||++ .+|.+.++.. .+..++.-.++-+.+||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|.
T Consensus 96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 5578999995 5999999852 23368888899999999999999999999999999999999985 899999999999
Q ss_pred cccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC--------
Q 026042 89 LESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------- 159 (244)
Q Consensus 89 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 159 (244)
.........+...+..|+|||.+.+. .|+.+.||||.||++.||+-|+.-|.+.+..+....+......+.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 88888888888999999999988765 689999999999999999999999999877766655543322221
Q ss_pred -------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 -------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 -------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+++..+|+.++|..+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 22446789999999999999999999999997
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=254.75 Aligned_cols=190 Identities=21% Similarity=0.347 Sum_probs=152.1
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CCccCCCCCC
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQ-------GILHRDLKSE 69 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~-------~i~H~dikp~ 69 (244)
|+++++|. ....+||||||+++++|.++|.... ...+++..++.++.||+.||.|||+. +|+|+||||+
T Consensus 75 Vrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPe 154 (1021)
T PTZ00266 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQ 154 (1021)
T ss_pred CeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHH
Confidence 56788774 4567999999999999999997632 23589999999999999999999985 4999999999
Q ss_pred cEEEcC-----------------CCcEEEecCCCcccccccCCCCCCCcccceeccceecc--CCCCCccchhhhHHHHH
Q 026042 70 NLLLGE-----------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLW 130 (244)
Q Consensus 70 nil~~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ 130 (244)
||+++. .+.+||+|||++.............+++.|+|||++.+ ..++.++|||||||++|
T Consensus 155 NILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 155 NIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred HeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 999964 23489999999876544444455678999999999854 45789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 131 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+|++|..||...+............. .......+.++.+||..||..+|.+||++.+++.
T Consensus 235 ELLTGk~PF~~~~~~~qli~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHCCCCCCcCCcHHHHHHHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999986654433333322221 2222456899999999999999999999999995
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=224.10 Aligned_cols=190 Identities=29% Similarity=0.528 Sum_probs=160.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~-~~ 79 (244)
+++++++..+...++|+||+++++|.+++.+..+..+++..+..++.|++.||.|||+.|++|+||+|+||++++++ .+
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~ 141 (257)
T cd08225 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVA 141 (257)
T ss_pred hhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeE
Confidence 45778899999999999999999999999876655689999999999999999999999999999999999999876 46
Q ss_pred EEecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|+|||.+........ .....++..|+|||...+..++.++|+||+|++++++++|..||...+..+...... .....
T Consensus 142 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~ 220 (257)
T cd08225 142 KLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFA 220 (257)
T ss_pred EecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCC
Confidence 9999998865443221 223457889999999988889999999999999999999999998777665554433 23334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+.+++.+|+..+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 455677889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=221.64 Aligned_cols=183 Identities=24% Similarity=0.311 Sum_probs=152.0
Q ss_pred eecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 7 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
...-+.+|||||||+. +|...+.... +++...+++-++.|+++|++|||++.|+|||+||+|+|++..|.+|++|||+
T Consensus 146 G~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 146 GSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred ccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccch
Confidence 3556679999999965 9999999876 4789999999999999999999999999999999999999999999999999
Q ss_pred cccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC-----
Q 026042 87 SCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----- 159 (244)
Q Consensus 87 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 159 (244)
|+...... .-...+.|.+|.|||.+.+. .|+.+.|+||+||++.||+++++.|.+...-+....+......+.
T Consensus 224 AR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 224 AREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 98766543 34456789999999998775 589999999999999999999999988776655554433222210
Q ss_pred ------------------------CCC-CchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 ------------------------VPP-TCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ------------------------~~~-~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
++. .+++.-.+|+..+|..||.+|.|+++.++
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 03466778999999999999999999987
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=224.70 Aligned_cols=176 Identities=20% Similarity=0.268 Sum_probs=146.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||++|++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 48 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 125 (237)
T cd05576 48 VCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQ 125 (237)
T ss_pred eehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEE
Confidence 356788888999999999999999999998765 488999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
++|||.+...... .....++..|+|||......++.++|+||+|+++|+|++|..|+....... ........
T Consensus 126 l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~ 197 (237)
T cd05576 126 LTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNI 197 (237)
T ss_pred Eecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCC
Confidence 9999976544332 223345678999999988888999999999999999999998875432210 11122235
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
+..++..+.+++.+||+.||.+||++
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCC
Confidence 56788999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=220.96 Aligned_cols=188 Identities=30% Similarity=0.615 Sum_probs=161.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||+++++|.+++.+.. .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~ 139 (254)
T cd06627 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVK 139 (254)
T ss_pred cEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEE
Confidence 457888899999999999999999999998764 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+........ .....++..|++||...+...+.++|+|++|+++++|++|..||...+......... ......
T Consensus 140 l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 218 (254)
T cd06627 140 LADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPP 218 (254)
T ss_pred EeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCC
Confidence 999999876544332 234567889999999988888999999999999999999999998766544444333 344456
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++..+.+++.+||..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 67788999999999999999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=223.60 Aligned_cols=188 Identities=32% Similarity=0.547 Sum_probs=160.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
++.+++..+...++|+||+++++|.+++.+.. +..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus 63 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~ 142 (256)
T cd08530 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLV 142 (256)
T ss_pred hhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcE
Confidence 45677788899999999999999999987632 2358889999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
+|+|||++...... ......++..|++||.+.+..++.++|+||+|+++++|++|..||...+......... ......
T Consensus 143 kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 220 (256)
T cd08530 143 KIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPP 220 (256)
T ss_pred EEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCC
Confidence 99999998665443 3334567889999999988889999999999999999999999999887665544433 333445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++.++.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 55678899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=227.78 Aligned_cols=187 Identities=30% Similarity=0.489 Sum_probs=155.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++.++|..++..++|+||+. ++|.+++..... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 78 IEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK-PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred EEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEE
Confidence 467899999999999999995 688888865443 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++..... .....++..|+|||.+. ...++.++||||||+++|+|++|..||...+..............
T Consensus 156 L~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (307)
T cd06607 156 LADFGSASLVSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 232 (307)
T ss_pred EeecCcceecCC---CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Confidence 999998765432 23456788999999874 356788999999999999999999999887766554444332222
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
......+++.+.+++.+||..+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 22344578899999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.64 Aligned_cols=175 Identities=23% Similarity=0.388 Sum_probs=142.2
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...|++++++ +++|.++++.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 88999888653 4899999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC------------
Q 026042 91 SQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------------ 157 (244)
Q Consensus 91 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 157 (244)
.. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 33 2334568999999999876 46889999999999999999999999876654433322211100
Q ss_pred ---------CC--------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ---------PP--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ---------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .....++.+.+++.+||..||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 01234567889999999999999999999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=231.06 Aligned_cols=180 Identities=29% Similarity=0.460 Sum_probs=162.7
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++..+|++-+.+|.||||+.||+|--.|+.-+ .+.+..+.-++.+|+.||-+||++||++||||.+||+++..|.+||
T Consensus 414 qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 414 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred HHHHHhhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEe
Confidence 45567888999999999999999999999887 5778899999999999999999999999999999999999999999
Q ss_pred ecCCCccc-ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||++.- ........+++||+.|+|||.+..++|+.++|+||+|+++|||+.|+.||++.+.++....+.... ...
T Consensus 492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--vsy 569 (683)
T KOG0696|consen 492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--VSY 569 (683)
T ss_pred eecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--CcC
Confidence 99999864 334456788999999999999999999999999999999999999999999999988877775443 567
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCC
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPH 185 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps 185 (244)
|..++.+...+....|.+.|.+|..
T Consensus 570 PKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 570 PKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred cccccHHHHHHHHHHhhcCCccccC
Confidence 7889999999999999999999963
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=239.17 Aligned_cols=189 Identities=24% Similarity=0.388 Sum_probs=148.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|+|++ .++|.+++..... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 223 v~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vk 300 (461)
T PHA03211 223 LALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300 (461)
T ss_pred CcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEE
Confidence 57899999999999999999 5799999876543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHH
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM--------TPEQAAF 149 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~ 149 (244)
|+|||+++....... .....|+..|+|||++.+..++.++|||||||++|||++|..++-.. ...+...
T Consensus 301 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~ 380 (461)
T PHA03211 301 LGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380 (461)
T ss_pred EcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHH
Confidence 999999865432211 22456899999999999888999999999999999999876543211 1112221
Q ss_pred HHHhhCCC-CCCC-------------------------------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 150 AVCQKNAR-PPVP-------------------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 150 ~~~~~~~~-~~~~-------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+...... ...+ ...+..+.+||.+||+.||.+|||+.|+++
T Consensus 381 ~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 381 IIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 11111100 0000 123457899999999999999999999997
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=225.35 Aligned_cols=175 Identities=28% Similarity=0.444 Sum_probs=157.3
Q ss_pred EeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCC
Q 026042 6 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 6 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
.|+..+.+|.||||..||.|.-.+.+.. .+++..++-+..+|++||.|||+++|++||+|.+|.++|.+|.+||.|||
T Consensus 236 sFQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 236 SFQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred hhccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecc
Confidence 5788999999999999999998887755 68999999999999999999999999999999999999999999999999
Q ss_pred Cccc-ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCc
Q 026042 86 ISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTC 164 (244)
Q Consensus 86 ~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (244)
++.- .......++++||+.|+|||++....++.+.|+|.+|+++|||++|+.||.+.+.+.....+.. ....+|..+
T Consensus 314 LCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr~l 391 (516)
T KOG0690|consen 314 LCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--EDLKFPRTL 391 (516)
T ss_pred cchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh--hhccCCccC
Confidence 9864 3445567899999999999999999999999999999999999999999998877766555433 335678889
Q ss_pred hHHHHHHHHHhcccCCCCCC
Q 026042 165 PKAFSYLISRCWSSSPDRRP 184 (244)
Q Consensus 165 ~~~l~~li~~~l~~~p~~Rp 184 (244)
+++.+.|+..+|.+||.+|.
T Consensus 392 s~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 SPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CHHHHHHHHHHhhcChHhhc
Confidence 99999999999999999996
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=224.46 Aligned_cols=187 Identities=31% Similarity=0.547 Sum_probs=159.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+. .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++
T Consensus 65 v~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~ 141 (277)
T cd06641 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK 141 (277)
T ss_pred eEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEE
Confidence 46889999999999999999999999999753 478999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++....... ......++..|+|||.+.+...+.++|+||+|+++++|++|..||...........+ .......
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~ 220 (277)
T cd06641 142 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPT 220 (277)
T ss_pred EeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCC
Confidence 99999875443221 123345788899999998888899999999999999999999999877655544433 2333445
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++.++.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 56678899999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=228.57 Aligned_cols=189 Identities=20% Similarity=0.294 Sum_probs=147.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||++ ++|.+++.+..+ .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~ 139 (284)
T cd07839 62 VRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELK 139 (284)
T ss_pred eeHHHHhccCCceEEEEecCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEE
Confidence 356677888999999999995 589988876443 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFD-NMTPEQAAFAVCQKNA- 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~- 156 (244)
|+|||++....... ......++..|+|||.+.+. .++.++||||||+++|+|++|..|+. +.+.......+.....
T Consensus 140 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07839 140 LADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219 (284)
T ss_pred ECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999986543221 22334568899999988664 46899999999999999999988853 3333322222111000
Q ss_pred -----------------C---------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 -----------------R---------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 -----------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+.+++++.+++.+||+.||.+|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 220 PTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=230.55 Aligned_cols=190 Identities=27% Similarity=0.470 Sum_probs=166.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++||.+-....++||||||..|++.+.++.+. +.+++..+..++...+.||+|||...-+|||||..|||++.+|..|
T Consensus 91 VKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AK 169 (502)
T KOG0574|consen 91 VKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAK 169 (502)
T ss_pred hhhhhhhccCCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhh
Confidence 678999999999999999999999999998754 4799999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||.+....+ ....++..||+.|||||++..-.|.-++||||||++..||..|++||....+...++.+.... ...
T Consensus 170 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF 249 (502)
T KOG0574|consen 170 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF 249 (502)
T ss_pred hhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC
Confidence 999999865443 334567889999999999999999999999999999999999999999877766554442211 112
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..|..|+.++.+++++||-++|++|.|+.+|++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 345678999999999999999999999999987
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=227.81 Aligned_cols=189 Identities=26% Similarity=0.418 Sum_probs=150.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLH---QQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~---~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~ 76 (244)
|++++++..++..++++||+. ++|.++.. ......+++..+..++.|++.||+|||+. |++||||||+||+++.+
T Consensus 66 v~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~ 144 (288)
T cd06616 66 VKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN 144 (288)
T ss_pred eeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC
Confidence 578899999999999999994 57766543 23334689999999999999999999975 99999999999999999
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVC 152 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~ 152 (244)
+.++|+|||++.............++..|+|||.+.+. .++.++|+||+|+++++|++|..||...... +......
T Consensus 145 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 224 (288)
T cd06616 145 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224 (288)
T ss_pred CcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc
Confidence 99999999998655443334445688899999998766 6789999999999999999999999876521 1111111
Q ss_pred hhCCCCC----CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPP----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+. ....++.++.+++.+||+.+|.+||+++++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 225 -KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 12347889999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=226.42 Aligned_cols=189 Identities=29% Similarity=0.488 Sum_probs=158.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|+||+. |+|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 88 v~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~k 165 (317)
T cd06635 88 IEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVK 165 (317)
T ss_pred EEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEE
Confidence 468899999999999999996 588888765433 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++..... .....++..|+|||.+. .+..+.++|+||+|+++++|++|..||...+.......+......
T Consensus 166 l~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd06635 166 LADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242 (317)
T ss_pred EecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC
Confidence 999998754332 23446788999999873 456788999999999999999999999887766665555444444
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
......+++.+.+++.+||+.+|.+||++.++++.+-
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 4445678899999999999999999999999998544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=225.49 Aligned_cols=189 Identities=21% Similarity=0.355 Sum_probs=152.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++++||++++.+..+..+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++
T Consensus 63 ~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~k 140 (288)
T cd07833 63 VNLKEAFRRKGRLYLVFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLK 140 (288)
T ss_pred eehhheEEECCEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence 467888889999999999998766666555443 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||......+...........
T Consensus 141 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 220 (288)
T cd07833 141 LCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220 (288)
T ss_pred EEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999987654433 23345678899999999887 7899999999999999999999999876554433222110000
Q ss_pred ------------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..++.++.+++.+||..+|++||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0112335788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=225.40 Aligned_cols=190 Identities=23% Similarity=0.391 Sum_probs=153.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+. ++|.+++....+..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++
T Consensus 62 ~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~ 140 (284)
T cd07860 62 VKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 140 (284)
T ss_pred cchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 467788899999999999995 6999999876655789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+...............
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~ 220 (284)
T cd07860 141 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 220 (284)
T ss_pred EeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999876543221 222334678899999886644 5889999999999999999999998766544433322211110
Q ss_pred ---------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....++.++.++|.+||+.||.+||+++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 221 DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 012346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=229.64 Aligned_cols=198 Identities=25% Similarity=0.445 Sum_probs=155.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..++..++|+||+.+++|.+++.+.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++
T Consensus 62 v~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~ 141 (328)
T cd08226 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVS 141 (328)
T ss_pred ceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEE
Confidence 57899999999999999999999999999886655689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--------CCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 81 VADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++||+.+........ .....++..|++||++.+. .++.++|+||+||++++|++|..||...........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~ 221 (328)
T cd08226 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ 221 (328)
T ss_pred EechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH
Confidence 999975432211110 1112345679999998764 468999999999999999999999987665444322
Q ss_pred HHhhCC---------------------------------------------CCCCCCCchHHHHHHHHHhcccCCCCCCC
Q 026042 151 VCQKNA---------------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPH 185 (244)
Q Consensus 151 ~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps 185 (244)
...... .......+++.+.+++++||+.||++|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 301 (328)
T cd08226 222 KLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301 (328)
T ss_pred HhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC
Confidence 211100 01112335678999999999999999999
Q ss_pred HHHHHH--HHHhhhh
Q 026042 186 FDQIVS--ILEGYSE 198 (244)
Q Consensus 186 ~~el~~--~l~~~~~ 198 (244)
+.++++ ++.....
T Consensus 302 a~e~l~~~~~~~~~~ 316 (328)
T cd08226 302 ASSLLSHAFFKQVKE 316 (328)
T ss_pred HHHHhhCHHHHHHHH
Confidence 999986 5555444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=224.45 Aligned_cols=190 Identities=24% Similarity=0.372 Sum_probs=155.8
Q ss_pred CcEEEEeecCCc-----EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPV-----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
+++++++...+. .++++||+. ++|.+++.+.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 64 ~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~ 142 (287)
T cd07838 64 VRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS 142 (287)
T ss_pred ceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc
Confidence 467888887777 999999995 58999998765446899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++++|++|..||...+..+....+....
T Consensus 143 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07838 143 DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI 222 (287)
T ss_pred CCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence 99999999999866544333344457889999999988889999999999999999999999998877655444333211
Q ss_pred CCC-------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARP-------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ......+..+.+++.+||+.||.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 100 001234577889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=221.28 Aligned_cols=188 Identities=28% Similarity=0.486 Sum_probs=157.9
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++.. ++.+++++||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 67 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~ 144 (264)
T cd06653 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN 144 (264)
T ss_pred ceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC
Confidence 456777755 356889999999999999998765 4788999999999999999999999999999999999999999
Q ss_pred EEEecCCCccccccc----CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 79 VKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
++|+|||++...... .......++..|+|||.+.+...+.++|+||||++++++++|..||...............
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 224 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ 224 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC
Confidence 999999998654221 1122345788999999998888899999999999999999999999887666655555444
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+++.+.+++.+|+. +|..||++.+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 44556778889999999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=236.79 Aligned_cols=197 Identities=35% Similarity=0.634 Sum_probs=176.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++|+|+...-+|||.|||..|+|.+|+++.....++.-..+.++.||.+|++||..++++||||-..|+|+.++..+|
T Consensus 326 VqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 326 VQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred HHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEE
Confidence 68999999999999999999999999999987766788788899999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
++|||+++....... ....-....|.|||.+.-..++.++|||+||+++||+.| |-.||.+.+..+.. ....+..+
T Consensus 406 vADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-~LLEkgyR 484 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-GLLEKGYR 484 (1157)
T ss_pred eeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-HHHhcccc
Confidence 999999987654332 223334678999999988899999999999999999998 88999999887764 45568888
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...|..||+.+.+|+++||+++|.+||++.|+-+.++.++.
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999987765
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=226.28 Aligned_cols=189 Identities=26% Similarity=0.437 Sum_probs=151.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++..+...|+++||+ +++|.+++..... .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.+
T Consensus 77 ~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~ 154 (296)
T cd06618 77 VKCYGYFITDSDVFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV 154 (296)
T ss_pred HhhheeeecCCeEEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCE
Confidence 45788999999999999999 5588888876443 68899999999999999999997 599999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhh
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQK 154 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~ 154 (244)
+|+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... ........
T Consensus 155 kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (296)
T cd06618 155 KLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE 234 (296)
T ss_pred EECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC
Confidence 999999986554333333445778999999986543 7889999999999999999999997644332 22222222
Q ss_pred CC-CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NA-RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .......++.++.+++.+||+.+|.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 235 EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 11222347899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=231.87 Aligned_cols=186 Identities=20% Similarity=0.315 Sum_probs=148.6
Q ss_pred CcEEEEeecC------CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKP------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
+++++++... ...|+|+||+. ++|.+.+... ++...+..++.|++.||+|||++|++|+||||+||+++
T Consensus 78 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~ 152 (353)
T cd07850 78 IGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 152 (353)
T ss_pred cceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 3566666433 45799999994 5999988653 78889999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.++.++|+|||.+.............++..|+|||.+.+..++.++|+||||+++++|++|..||...+.......+...
T Consensus 153 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 153 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred CCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999987654443344556788999999999889999999999999999999999999876644332222111
Q ss_pred CCCC-----------------------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP-----------------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~-----------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+ ..+...+..+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 001134667899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=229.00 Aligned_cols=190 Identities=23% Similarity=0.323 Sum_probs=141.9
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQE-------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~-------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
|++++++. .+...++++||+ +++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Ni 139 (317)
T cd07868 61 ISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 139 (317)
T ss_pred cceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence 45677763 456789999999 569999886421 22488899999999999999999999999999999999
Q ss_pred EE----cCCCcEEEecCCCcccccccC----CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCC
Q 026042 72 LL----GEDMCVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNM 142 (244)
Q Consensus 72 l~----~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 142 (244)
++ +.++.+||+|||++....... ......+++.|+|||.+.+. .++.++|+||+||++++|++|..||...
T Consensus 140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 140 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99 456789999999986543221 22345689999999998764 5799999999999999999999999643
Q ss_pred CHH---------HHHHHHHhhCC------------------------CC------------CCCCCchHHHHHHHHHhcc
Q 026042 143 TPE---------QAAFAVCQKNA------------------------RP------------PVPPTCPKAFSYLISRCWS 177 (244)
Q Consensus 143 ~~~---------~~~~~~~~~~~------------------------~~------------~~~~~~~~~l~~li~~~l~ 177 (244)
... .....+..... .. ......+..+.+++.+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 299 (317)
T cd07868 220 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299 (317)
T ss_pred cccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhc
Confidence 221 00000000000 00 0001124568899999999
Q ss_pred cCCCCCCCHHHHHH
Q 026042 178 SSPDRRPHFDQIVS 191 (244)
Q Consensus 178 ~~p~~Rps~~el~~ 191 (244)
.||.+|||++|+++
T Consensus 300 ~dP~~R~t~~e~l~ 313 (317)
T cd07868 300 MDPIKRITSEQAMQ 313 (317)
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=249.58 Aligned_cols=184 Identities=23% Similarity=0.385 Sum_probs=160.3
Q ss_pred EEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecC
Q 026042 5 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84 (244)
Q Consensus 5 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~df 84 (244)
-.|+++.++|+||||++||+|-.++.+.. .+|+..++.++..|+.||..+|+.|+|||||||+|||+|..|.+||+||
T Consensus 142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccc
Confidence 34789999999999999999999999987 6999999999999999999999999999999999999999999999999
Q ss_pred CCcccccccC--CCCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 85 GISCLESQCG--SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 85 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|.+......+ .....+|||.|.|||++.. +.|+...|+||+|+++|||+.|.-||...+.-++...++.....
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES 299 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh
Confidence 9876544322 3556789999999998853 45789999999999999999999999998888888777766545
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPH---FDQIVS 191 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~el~~ 191 (244)
..+| ..+|++.++||.+.+. +|..|.. ++++..
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 5555 5689999999999886 5677776 888887
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=220.90 Aligned_cols=183 Identities=29% Similarity=0.404 Sum_probs=157.4
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++.+..++..++|+||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus 57 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l 134 (250)
T cd05123 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKL 134 (250)
T ss_pred HHHHHeecCCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEE
Confidence 45677888999999999999999999998765 5889999999999999999999999999999999999999999999
Q ss_pred ecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 82 ADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 82 ~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+|||.+...... .......++..|++||...+...+.++|+||||++++++++|..||...+.......+.. .....
T Consensus 135 ~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~ 212 (250)
T cd05123 135 TDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRF 212 (250)
T ss_pred eecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCC
Confidence 999998665433 233455678899999999888889999999999999999999999987776544444332 44567
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQ 188 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~e 188 (244)
+...+..+.+++.+||..||++||++.+
T Consensus 213 ~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 7777999999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=225.01 Aligned_cols=188 Identities=24% Similarity=0.436 Sum_probs=156.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~ 156 (292)
T cd06657 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVK 156 (292)
T ss_pred hheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 46788999999999999999999999988653 478899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||++....... ......++..|++||.+.+..++.++|+||+|+++++|++|..||................ ...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06657 157 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL 236 (292)
T ss_pred EcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc
Confidence 99999875443221 2234567889999999988888999999999999999999999998766555443332211 112
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....++..+.+++.+||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 233567889999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=224.38 Aligned_cols=190 Identities=22% Similarity=0.341 Sum_probs=153.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+++||+ +++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 61 v~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~ 139 (283)
T cd07835 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALK 139 (283)
T ss_pred cCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEE
Confidence 46788899999999999999 56999999876655689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||.+....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+......
T Consensus 140 l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (283)
T cd07835 140 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP 219 (283)
T ss_pred EeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999986543221 12233567889999987664 5688999999999999999999999876654433332211000
Q ss_pred --------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 --------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......++..+.+++.+||+.+|.+||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0112456788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=224.71 Aligned_cols=186 Identities=30% Similarity=0.490 Sum_probs=155.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...|+|+||+. ++|.+++..... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~k 161 (313)
T cd06633 84 IEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVK 161 (313)
T ss_pred ccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEE
Confidence 468899999999999999995 588888876443 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++.... ......++..|+|||.+. ...++.++|+||||+++++|++|..||...+..............
T Consensus 162 L~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (313)
T cd06633 162 LADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238 (313)
T ss_pred EeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence 99999875432 233456888999999974 356788999999999999999999999887665555544433333
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......++..+.+++.+||+.+|.+||++.+++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3344567888999999999999999999999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=220.43 Aligned_cols=195 Identities=30% Similarity=0.600 Sum_probs=156.2
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQE----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~n 70 (244)
|++++++.... ..++++||+.+++|.+++.... ...++...+..++.|++.||+|||++|++|+||||+|
T Consensus 64 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~n 143 (273)
T cd05074 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143 (273)
T ss_pred ceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhh
Confidence 45667664432 3478999999999999875321 2247888999999999999999999999999999999
Q ss_pred EEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 71 LLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 71 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
|+++.++.++|+|||.+....... ......++..|++||......++.++||||||+++|+|++ |..||...+...
T Consensus 144 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~ 223 (273)
T cd05074 144 CMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE 223 (273)
T ss_pred EEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH
Confidence 999999999999999987543221 1122334578999999988888999999999999999999 899998877655
Q ss_pred HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 147 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
....+. .......+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 224 ~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 224 IYNYLI-KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 444433 2333444566789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=224.59 Aligned_cols=187 Identities=29% Similarity=0.481 Sum_probs=155.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+. ++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 78 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred ccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEE
Confidence 467889999999999999995 688888765432 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++..... .....++..|+|||.+. ....+.++||||||+++++|++|..||...+..............
T Consensus 156 l~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06634 156 LGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232 (308)
T ss_pred ECCcccceeecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC
Confidence 999998765432 23446788999999874 345788999999999999999999999877655544444333333
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
......++..+.++|.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 33345688899999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=222.36 Aligned_cols=189 Identities=23% Similarity=0.415 Sum_probs=152.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++..++..++|+||+ +++|.+++....+..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|
T Consensus 62 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l 140 (283)
T cd07830 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKI 140 (283)
T ss_pred hHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEE
Confidence 4556777889999999999 889999998765456899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC--
Q 026042 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP-- 158 (244)
Q Consensus 82 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 158 (244)
+|||.+.............++..|+|||.+.. ..++.++|+||||+++++|++|..||...+..+............
T Consensus 141 ~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd07830 141 ADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220 (283)
T ss_pred eecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence 99999876544334445567889999998754 457899999999999999999999997765544333222110000
Q ss_pred --------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 --------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+.+++++||+.+|++||++.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001123578999999999999999999999876
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=224.51 Aligned_cols=189 Identities=23% Similarity=0.327 Sum_probs=151.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||+ +++|.+++.... ..+++..++.++.|+++||.|||++|++|+||+|+||+++.+|.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 65 IGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred hhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEE
Confidence 46788899999999999999 889999998754 2589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+............
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~ 222 (298)
T cd07841 143 LADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222 (298)
T ss_pred EccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence 99999986544322 2223356788999998854 457899999999999999999988887665443332221110000
Q ss_pred --------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 --------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011334678999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=225.96 Aligned_cols=189 Identities=26% Similarity=0.503 Sum_probs=155.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~k 155 (293)
T cd06647 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK 155 (293)
T ss_pred eehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEE
Confidence 35678888899999999999999999999764 368899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~ 158 (244)
|+|||++....... ......++..|++||.+.+..++.++|+||||++++++++|..||...+........... ....
T Consensus 156 L~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd06647 156 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (293)
T ss_pred EccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCC
Confidence 99999875443322 223446788899999998888899999999999999999999999876654432222111 1111
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
..+..++..+.+++.+||..+|.+||++++++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234567889999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.11 Aligned_cols=187 Identities=28% Similarity=0.470 Sum_probs=169.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++.+......+|+||||+.+|.+.+++.+++ ...+..+..++.|+++|++|||+++|+|||||++||+++.+-.+|
T Consensus 118 vkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnik 195 (596)
T KOG0586|consen 118 VKLFSVIETEATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIK 195 (596)
T ss_pred eeeeeeeeecceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccccee
Confidence 689999999999999999999999999999988 466689999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..........+++|++.|.|||++.+..+ ++.+|+|++|+++|-|+.|.+||++.+.......... ....
T Consensus 196 IaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--gk~r 273 (596)
T KOG0586|consen 196 IADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--GKYR 273 (596)
T ss_pred eeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee--eeec
Confidence 999999998888778889999999999999988765 7899999999999999999999998776665544433 3345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
++..++.++.++|+++|.++|.+|++.+++++
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 56667889999999999999999999999987
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=223.07 Aligned_cols=189 Identities=21% Similarity=0.342 Sum_probs=148.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+. ++|.+++.+... .+++..++.++.|++.||.|||++|++|+||+|+||+++.+|.++
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~k 143 (291)
T cd07844 66 VTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELK 143 (291)
T ss_pred eeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEE
Confidence 467899999999999999996 599999987654 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.... ..+....+......
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07844 144 LADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT 223 (291)
T ss_pred ECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence 99999886533211 1222346788999998865 457899999999999999999999997654 22221111110000
Q ss_pred -------------------------C---CCCCCch--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -------------------------P---PVPPTCP--KAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -------------------------~---~~~~~~~--~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ......+ ..+.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0001233 77889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=221.54 Aligned_cols=189 Identities=30% Similarity=0.455 Sum_probs=149.9
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
|++++++.. ++..++||||++|++|.+++... ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+
T Consensus 62 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~ 141 (287)
T cd06621 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK 141 (287)
T ss_pred eeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC
Confidence 456777744 44789999999999999987642 23357889999999999999999999999999999999999999
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHH
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-----PEQAAFAV 151 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~ 151 (244)
+.++|+|||++....... .....++..|++||.+.+..++.++|+||||+++|+|++|..||.... ..+.....
T Consensus 142 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (287)
T cd06621 142 GQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220 (287)
T ss_pred CeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH
Confidence 999999999976543322 223457889999999988889999999999999999999999997652 12222221
Q ss_pred HhhCCCCCCC------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQKNARPPVP------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .......+ ..+++.+.+++.+||..+|.+|||+.|+++
T Consensus 221 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 221 V-NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred h-cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1 11111111 235788999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=223.99 Aligned_cols=191 Identities=29% Similarity=0.408 Sum_probs=155.3
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++..+...++|+||+++++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred hhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEE
Confidence 46678888999999999999999999998654 5888999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccC--CCCCCCcccceeccceeccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhh
Q 026042 82 ADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQK 154 (244)
Q Consensus 82 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~ 154 (244)
+|||++....... ......++..|++||.+.+.. .+.++|+||+|+++++|++|..||...... ..... ...
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-~~~ 225 (288)
T cd05583 147 TDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-RIL 225 (288)
T ss_pred EECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-HHH
Confidence 9999876543222 122345788999999987654 688999999999999999999999643221 11111 112
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
......+..++..+.+++.+||+.+|.+|||+.++.+.|..
T Consensus 226 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 226 KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 33345666788999999999999999999998888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=237.64 Aligned_cols=186 Identities=29% Similarity=0.489 Sum_probs=165.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|.|-|+|-.....++||||| -|+-.|++.-+.. ++.+..+..|+.+.+.||+|||+.+.+|||||..|||+++.|.+|
T Consensus 89 ieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VK 166 (948)
T KOG0577|consen 89 IEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVK 166 (948)
T ss_pred ccccceeeccchHHHHHHHH-hccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeee
Confidence 45778899999999999999 5599999876543 688899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+.... +.++++|||.|||||++. .+.|+-++||||||++..|+...++|+-+++.....+.+......
T Consensus 167 LaDFGSAsi~~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesP 243 (948)
T KOG0577|consen 167 LADFGSASIMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 243 (948)
T ss_pred eccccchhhcC---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCC
Confidence 99999886543 467889999999999864 467899999999999999999999999999999888887766655
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..-.+.|+..|+.|+..||++-|.+|||.++++.
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 5556789999999999999999999999999886
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=222.55 Aligned_cols=188 Identities=22% Similarity=0.303 Sum_probs=151.1
Q ss_pred cEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 2 QFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 2 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
++++++... +..|+|+||+. ++|.+++..... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+
T Consensus 68 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~ 145 (293)
T cd07843 68 TVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGIL 145 (293)
T ss_pred EEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcE
Confidence 567777666 89999999996 599999987543 58999999999999999999999999999999999999999999
Q ss_pred EEecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-
Q 026042 80 KVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA- 156 (244)
Q Consensus 80 kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 156 (244)
+|+|||.+...... .......++..|+|||.+.+. ..+.++|+||+|+++++|++|..||...........+.....
T Consensus 146 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 225 (293)
T cd07843 146 KICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225 (293)
T ss_pred EEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999988754432 222334567889999988664 468999999999999999999999987765544333221110
Q ss_pred ----------------------------CCCCCCC-chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 ----------------------------RPPVPPT-CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ----------------------------~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+.. +++.+.+++++||+.+|++||++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0112222 5788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=235.56 Aligned_cols=186 Identities=28% Similarity=0.485 Sum_probs=159.6
Q ss_pred CcEEEEeecCCc--EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcC-
Q 026042 1 MQFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGE- 75 (244)
Q Consensus 1 v~~~~~~~~~~~--~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~- 75 (244)
|++|.++.+... +-+|+|.+..|+|..|+++++ ..+.+.+..|++||+.||.|||++. |+|||||-+||+|+.
T Consensus 104 irfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~ 181 (632)
T KOG0584|consen 104 IRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN 181 (632)
T ss_pred eeeeeheecCCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC
Confidence 578888866666 889999999999999999988 5888999999999999999999995 999999999999987
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhh
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQK 154 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~ 154 (244)
.|.+||+|+|+|........ ...+|||.|||||+.. ..|++.+||||||++++||+|+..||..-. +.+....+...
T Consensus 182 ~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG 259 (632)
T KOG0584|consen 182 LGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG 259 (632)
T ss_pred cCceeecchhHHHHhhcccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence 58999999999987666443 3488999999999986 789999999999999999999999998754 55555555444
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+..--.+++++||.+||.. ..+|+|+.||++
T Consensus 260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 444444444478999999999999 899999999997
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=221.83 Aligned_cols=190 Identities=24% Similarity=0.359 Sum_probs=152.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~~ 79 (244)
+++++++..+...|+|+||++ ++|.+++.......+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.+
T Consensus 64 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~ 142 (294)
T PLN00009 64 VRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNAL 142 (294)
T ss_pred eeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEE
Confidence 468899999999999999995 68999887766556788899999999999999999999999999999999985 5579
Q ss_pred EEecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 80 KVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 80 kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
||+|||++...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+...........
T Consensus 143 kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~ 222 (294)
T PLN00009 143 KLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT 222 (294)
T ss_pred EEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998644322 122334567899999988664 5788999999999999999999999877665544433221110
Q ss_pred C---------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 P---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+ ......++.+.+++.+||+.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 012346788999999999999999999999997
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=228.03 Aligned_cols=190 Identities=23% Similarity=0.341 Sum_probs=141.6
Q ss_pred CcEEEEe--ecCCcEEEEEeccCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQ-------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~--~~~~~~~lv~e~~~~~~L~~~i~~~-------~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
|++++++ ..+...++|+||++ ++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||
T Consensus 61 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Ni 139 (317)
T cd07867 61 IALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANI 139 (317)
T ss_pred eeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHE
Confidence 4567776 44678899999995 5898887532 122478889999999999999999999999999999999
Q ss_pred EE----cCCCcEEEecCCCcccccccC----CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCC
Q 026042 72 LL----GEDMCVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNM 142 (244)
Q Consensus 72 l~----~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 142 (244)
++ +.++.+||+|||++....... ......++..|+|||.+.+. .++.++||||+|+++|+|++|..||...
T Consensus 140 l~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 140 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99 456789999999987543321 12345678999999998764 5789999999999999999999999643
Q ss_pred CHHH---------HHHHHHhhC------------------------CC------------CCCCCCchHHHHHHHHHhcc
Q 026042 143 TPEQ---------AAFAVCQKN------------------------AR------------PPVPPTCPKAFSYLISRCWS 177 (244)
Q Consensus 143 ~~~~---------~~~~~~~~~------------------------~~------------~~~~~~~~~~l~~li~~~l~ 177 (244)
.... ....+.... .. .......+..+.+++.+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 299 (317)
T cd07867 220 QEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299 (317)
T ss_pred cccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhc
Confidence 3210 000000000 00 00011234568889999999
Q ss_pred cCCCCCCCHHHHHH
Q 026042 178 SSPDRRPHFDQIVS 191 (244)
Q Consensus 178 ~~p~~Rps~~el~~ 191 (244)
.||.+|||+.|+++
T Consensus 300 ~dP~~R~t~~e~l~ 313 (317)
T cd07867 300 MDPTKRITSEQALQ 313 (317)
T ss_pred cCcccccCHHHHhc
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=221.88 Aligned_cols=190 Identities=21% Similarity=0.323 Sum_probs=149.5
Q ss_pred CcEEEEeecCCc-----EEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPPV-----FCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~~-----~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++...+. .|+|+||+++ +|.+++.... +..+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 64 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil 142 (295)
T cd07837 64 VRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLL 142 (295)
T ss_pred cceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEE
Confidence 457777776666 8999999975 8999987543 235799999999999999999999999999999999999
Q ss_pred EcC-CCcEEEecCCCccccccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q 026042 73 LGE-DMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 149 (244)
Q Consensus 73 ~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 149 (244)
++. ++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+......
T Consensus 143 ~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 222 (295)
T cd07837 143 VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222 (295)
T ss_pred EecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 998 889999999988654321 12223356788999998765 457899999999999999999999998766554433
Q ss_pred HHHhhCCCC--------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 150 AVCQKNARP--------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 150 ~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+......+ ...+.+++.+.++|.+||..+|.+||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 322211000 011346788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=223.32 Aligned_cols=189 Identities=25% Similarity=0.334 Sum_probs=150.7
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++... +..++|+||+. ++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~ 146 (309)
T cd07845 69 VELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC 146 (309)
T ss_pred cceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 4567777544 56899999995 59999988643 36899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+.....
T Consensus 147 ~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 226 (309)
T cd07845 147 LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLG 226 (309)
T ss_pred EEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999986544321 2223345778999998865 4578999999999999999999999988776665544433211
Q ss_pred CC-----------------CC-----------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RP-----------------PV-----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~-----------------~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .. ....++.+.++|.+||+.||++|||+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 227 TPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00 0124788899999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=222.98 Aligned_cols=189 Identities=23% Similarity=0.401 Sum_probs=150.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|..+..... .+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++
T Consensus 63 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~ 140 (286)
T cd07846 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVK 140 (286)
T ss_pred hhHHHhcccCCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEE
Confidence 356778889999999999999988888776544 488999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-- 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 156 (244)
|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+....+.....
T Consensus 141 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 220 (286)
T cd07846 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220 (286)
T ss_pred EEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCC
Confidence 99999876543322 2233457889999998865 3468899999999999999999999976554332222211000
Q ss_pred ------------------CC---------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 ------------------RP---------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+ ...+.++..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 012356788999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=222.42 Aligned_cols=189 Identities=24% Similarity=0.410 Sum_probs=152.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++ +|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 61 ~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~ 138 (283)
T cd05118 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLK 138 (283)
T ss_pred chHHHhhccCCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEE
Confidence 3567788888999999999965 9998887754 3689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||.+....... ......++..|+|||.+.+. ..+.++|+||||+++|+|++|+.||...+..+....+.......
T Consensus 139 l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~ 218 (283)
T cd05118 139 LADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP 218 (283)
T ss_pred EeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999886554432 22334577889999998776 68999999999999999999999998766544333322111100
Q ss_pred ----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....++.++.++|.+||+.||.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 112346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=222.89 Aligned_cols=186 Identities=27% Similarity=0.489 Sum_probs=158.0
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++..++..++||||+++++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|
T Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l 143 (280)
T cd05581 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKI 143 (280)
T ss_pred hHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEe
Confidence 45567788899999999999999999998865 5899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccC---------------------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 026042 82 ADFGISCLESQCG---------------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 140 (244)
Q Consensus 82 ~dfg~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 140 (244)
+|||++....... ......++..|++||.......+.++|+||||++++++++|..||.
T Consensus 144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 9999876543322 1223456789999999988889999999999999999999999998
Q ss_pred CCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 026042 141 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF----DQIVS 191 (244)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~el~~ 191 (244)
..+......... ......+..+++.+.+++.+||+.+|.+||++ +++++
T Consensus 224 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 224 GSNEYLTFQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CccHHHHHHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 877554443332 33445667789999999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=219.44 Aligned_cols=189 Identities=22% Similarity=0.302 Sum_probs=146.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..|+|+||+ +++|.+++..... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~ 143 (291)
T cd07870 66 VLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELK 143 (291)
T ss_pred eEEEEEEecCCeEEEEEecc-cCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEE
Confidence 46789999999999999999 5788888765432 577888999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~ 157 (244)
|+|||++....... ......++..|+|||.+.+. .++.++|+||||+++++|++|..||...+..... .........
T Consensus 144 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07870 144 LADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV 223 (291)
T ss_pred EeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCC
Confidence 99999886532221 22334568899999998654 5788999999999999999999999865543211 111100000
Q ss_pred ---------------------CCCC---------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ---------------------PPVP---------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ---------------------~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+ -..+..+.+++.+|+..||.+|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 012568899999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=221.31 Aligned_cols=189 Identities=29% Similarity=0.449 Sum_probs=152.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...|+|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~k 145 (290)
T cd05613 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 145 (290)
T ss_pred hceeeEeecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEE
Confidence 357788899999999999999999999998765 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--Hhh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV--CQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~ 154 (244)
|+|||++....... ......++..|++||.+.+. ..+.++|+||+|+++|+|++|..||...........+ ...
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~ 225 (290)
T cd05613 146 LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225 (290)
T ss_pred EeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh
Confidence 99999886543321 22345678899999998653 4678999999999999999999999743222111111 112
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
....+.+..+++.+.+++.+||+.+|.+|| +++++++
T Consensus 226 ~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 233455667889999999999999999997 6777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=238.02 Aligned_cols=190 Identities=18% Similarity=0.296 Sum_probs=145.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~ 77 (244)
|++++++...+..|+|+|++ +++|.+++.... ........++.++.||+.||.|||++||+||||||+||+++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 57899999999999999999 568888875432 11234567888999999999999999999999999999999999
Q ss_pred cEEEecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCC-CCCCC--CHHHHHHHHH
Q 026042 78 CVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT-PFDNM--TPEQAAFAVC 152 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~~--~~~~~~~~~~ 152 (244)
.+||+|||++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|.. |+... ........+.
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999987654322 2234678999999999999899999999999999999999875 44322 1211111111
Q ss_pred hhCC---------------------CCCC---------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNA---------------------RPPV---------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~---------------------~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... .... ....+..+.+++.+||+.||.+||++.|+++
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1000 0000 0124567788899999999999999999997
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=222.57 Aligned_cols=187 Identities=22% Similarity=0.353 Sum_probs=147.9
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++.. +...|+|+||+. ++|.+++.+. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.+|.
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~ 145 (337)
T cd07852 70 VKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR 145 (337)
T ss_pred cceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc
Confidence 467787754 346899999995 5999998765 4788889999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC------CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026042 79 VKVADFGISCLESQCG------SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 151 (244)
++|+|||.+....... ......++..|+|||.+.+ ...+.++|+||||+++|+|++|+.||.+.........+
T Consensus 146 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 146 VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999886443221 1223457889999998755 45788999999999999999999999766544332222
Q ss_pred HhhCCC-----------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQKNAR-----------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...... ......++.++.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 111100 0112336789999999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=227.37 Aligned_cols=174 Identities=26% Similarity=0.418 Sum_probs=142.7
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccccc
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLES 91 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~ 91 (244)
..++|+||+ +++|.+++... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 489999999 77999999763 48999999999999999999999999999999999999999999999999986543
Q ss_pred ccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC------------
Q 026042 92 QCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------ 158 (244)
Q Consensus 92 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 158 (244)
.. .....++..|+|||.+.+ ..++.++|+||||++++++++|..||.+.+.......+......+
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 32 334467888999998765 367899999999999999999999998776654443332211100
Q ss_pred -----------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 -----------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......++.+.+++.+||+.+|.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 011235788999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=223.64 Aligned_cols=188 Identities=21% Similarity=0.278 Sum_probs=152.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+. ++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 467899999999999999995 69999998755 588999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---------------CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCH
Q 026042 81 VADFGISCLESQC---------------GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTP 144 (244)
Q Consensus 81 l~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 144 (244)
|+|||.+...... .......++..|+|||.+.+. .++.++|+||||+++++|++|..||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999988654310 111123457789999988764 468999999999999999999999988776
Q ss_pred HHHHHHHHhhCCCC--------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 145 EQAAFAVCQKNARP--------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 145 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+....+......+ ......+..+.+++.+||+.+|.+||++++++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 55444332211100 011345678999999999999999999999997
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=217.76 Aligned_cols=188 Identities=29% Similarity=0.520 Sum_probs=155.8
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
++++++......++|+||+++++|.+++.. .....+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.+
T Consensus 66 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred HHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCE
Confidence 456677788899999999999999999875 22336899999999999999999999999999999999999975 569
Q ss_pred EEecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|+|||.+...... .......++..|++||.+.+..++.++|+||+|+++++|++|..||............. .....
T Consensus 145 ~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~ 223 (260)
T cd08222 145 KIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTP 223 (260)
T ss_pred eecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCC
Confidence 99999987654322 22334567889999999988888999999999999999999999998766555444432 23344
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++.++.+++.+|+..+|++||++.++++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 456678899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=223.62 Aligned_cols=191 Identities=24% Similarity=0.375 Sum_probs=153.6
Q ss_pred cEEEEeecCC-----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 2 QFVAACKKPP-----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 2 ~~~~~~~~~~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
++++++.... ..|+++||++ ++|.+++.+.. .+++..++.++.|++.||++||++|++|+||||+||+++.+
T Consensus 63 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~ 139 (330)
T cd07834 63 GLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN 139 (330)
T ss_pred hhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 3445555554 7899999996 59999998765 68999999999999999999999999999999999999999
Q ss_pred CcEEEecCCCcccccccC----CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026042 77 MCVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 151 (244)
+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+....+
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i 219 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI 219 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 999999999987654432 23344578899999999887 7899999999999999999999999877765544333
Q ss_pred HhhCCCC-----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 152 CQKNARP-----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 152 ~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
....... ......+..+.+++.+||+.+|++||++++++. ++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 3211110 012335788999999999999999999999997 3544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=218.38 Aligned_cols=190 Identities=21% Similarity=0.340 Sum_probs=151.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++...+..++|+||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.+
T Consensus 61 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~ 139 (284)
T cd07836 61 VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGEL 139 (284)
T ss_pred eeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcE
Confidence 4688999999999999999965 9999987654 2358999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 80 KVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
+|+|||.+....... ......++..|++||.+.+. .++.++|+||||++++++++|..||.+.+..+....+......
T Consensus 140 ~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07836 140 KLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219 (284)
T ss_pred EEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 999999886443221 12234567889999987654 5688999999999999999999999876655443332211100
Q ss_pred C----------------C-----------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 P----------------P-----------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~----------------~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+ . ..+..+..+.+++.+|++.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0 11245678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=221.88 Aligned_cols=190 Identities=23% Similarity=0.318 Sum_probs=147.2
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
+++++++... ...++|+||++ ++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 65 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~ 143 (316)
T cd07842 65 VSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG 143 (316)
T ss_pred cceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcC
Confidence 4688899888 88999999995 58888875432 225789999999999999999999999999999999999999
Q ss_pred ----CCcEEEecCCCcccccccC----CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 76 ----DMCVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 76 ----~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
++.+||+|||++....... ......++..|+|||.+.+. .++.++|+||||+++++|++|..||.......
T Consensus 144 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 223 (316)
T cd07842 144 EGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI 223 (316)
T ss_pred CCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccc
Confidence 8999999999987543322 12344578899999987664 57899999999999999999999997654322
Q ss_pred ---------HHHHHHh------------------------hCCCCCCC-----------CCchHHHHHHHHHhcccCCCC
Q 026042 147 ---------AAFAVCQ------------------------KNARPPVP-----------PTCPKAFSYLISRCWSSSPDR 182 (244)
Q Consensus 147 ---------~~~~~~~------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~ 182 (244)
....+.. .......+ ...+..+.+++.+||+.||.+
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 303 (316)
T cd07842 224 KKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTK 303 (316)
T ss_pred cccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCccc
Confidence 0000000 00011111 145678899999999999999
Q ss_pred CCCHHHHHH
Q 026042 183 RPHFDQIVS 191 (244)
Q Consensus 183 Rps~~el~~ 191 (244)
|||+.|+++
T Consensus 304 Rps~~eil~ 312 (316)
T cd07842 304 RITAEEALE 312 (316)
T ss_pred CcCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=217.02 Aligned_cols=189 Identities=24% Similarity=0.343 Sum_probs=151.4
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++... +..++|+||++ ++|.+++.+.. ..+++..++.++.|++.||++||+.|++|+||+|+||++++++.
T Consensus 61 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~ 138 (287)
T cd07840 61 VRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV 138 (287)
T ss_pred eeheeeEecCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC
Confidence 3567888877 89999999996 59999987653 26899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC--CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+....
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~ 218 (287)
T cd07840 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218 (287)
T ss_pred EEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999987554432 1233456788999998765 457899999999999999999999998776554433332211
Q ss_pred CCC-----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARP-----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... .....+++.+.+++.+||..+|.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 100 001113788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=230.21 Aligned_cols=195 Identities=34% Similarity=0.702 Sum_probs=170.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++|.|.+.. .+||||.++-|.|..|++.+.. .++......++.||+.||+|||+.+++||||-..||++.....+|
T Consensus 454 ikLIGv~~e~P-~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 454 IKLIGVCVEQP-MWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred hheeeeeeccc-eeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence 68999998765 5699999999999999998765 688889999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCC--cccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++...+...-.... -...|||||.++-+.++.++|||.||+.+||++. |..||.+..+.+.+-.+ ....+
T Consensus 532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeR 610 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGER 610 (974)
T ss_pred ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCC
Confidence 99999998766544332223 3568999999999999999999999999999988 99999988777654433 46777
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.+.|++||+.+..++.+||+.+|.+||++.++...|.....
T Consensus 611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999998876544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=238.35 Aligned_cols=197 Identities=34% Similarity=0.608 Sum_probs=177.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++.|+.+..+-.+||.|||++|+|..|++++.+ .++..++..+++.|+.|++||.+.|++||||...|||++.+-..|
T Consensus 693 IrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCK 771 (996)
T KOG0196|consen 693 IRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCK 771 (996)
T ss_pred EEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEE
Confidence 5788999999999999999999999999999887 489999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC-CCCC---cccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGSA-KGFT---GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~-~~~~---~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++|||+++...+.... .+.. -..+|.|||.+..++++.++|+||+|+++||.++ |..||=.+++.+.+..+. ..
T Consensus 772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~g 850 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QG 850 (996)
T ss_pred eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hc
Confidence 9999999876543321 1112 2468999999999999999999999999999888 999999999999888774 66
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.+.+.|..||..+.+|+..||++|-.+||.+.+|+..|+++..+
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 77888999999999999999999999999999999999998764
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=224.40 Aligned_cols=179 Identities=22% Similarity=0.343 Sum_probs=143.6
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...|+|+||+ +++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 82 NDVYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred CcEEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 4589999999 579999998765 5899999999999999999999999999999999999999999999999998754
Q ss_pred ccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-------------
Q 026042 91 SQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN------------- 155 (244)
Q Consensus 91 ~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 155 (244)
... .......++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+.+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 332 22234457889999998765 468899999999999999999999997765432222111100
Q ss_pred ----------CC------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 156 ----------AR------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 156 ----------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.. ....+.+++.+.+++++||+.+|.+||+++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00 01124578889999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=224.06 Aligned_cols=180 Identities=22% Similarity=0.384 Sum_probs=143.5
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.....++|+||+ +++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.+|.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 79 DFKDVYVVMDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred CCceEEEEEehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 445789999999 469999997655 58999999999999999999999999999999999999999999999999986
Q ss_pred cccccCC-----CCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--------
Q 026042 89 LESQCGS-----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-------- 154 (244)
Q Consensus 89 ~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 154 (244)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5432211 123467889999998765 45789999999999999999999999876543322211110
Q ss_pred ----------------CCCCC-----CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 ----------------NARPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ----------------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..... .....+.++.+++.+||+.+|++||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011 11346789999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=217.95 Aligned_cols=189 Identities=21% Similarity=0.329 Sum_probs=144.9
Q ss_pred CcEEEEeecCC--------cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPP--------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~--------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++.... ..++|+||+. ++|.+++..... .+++..++.++.|++.||.|||++|++|+||+|+||+
T Consensus 74 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil 151 (310)
T cd07865 74 VNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV-KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151 (310)
T ss_pred cceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 35666665543 4599999995 589888876532 5899999999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCcccccccCC-----CCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 73 LGEDMCVKVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
++.++.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+...
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred ECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999865432221 1234567889999987654 46889999999999999999999998766544
Q ss_pred HHHHHHhhCCCC-----------------CC-------------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 147 AAFAVCQKNARP-----------------PV-------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 147 ~~~~~~~~~~~~-----------------~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+....... .. +...+..+.++|.+||..||.+||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 332222111000 00 0112466789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=210.58 Aligned_cols=188 Identities=33% Similarity=0.504 Sum_probs=157.0
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++......++++||+++++|.+++..... ++...++.++.+++.++.+||+.|++|+||+|.||+++.++.++|
T Consensus 51 ~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l 128 (244)
T smart00220 51 RLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKL 128 (244)
T ss_pred HHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEE
Confidence 456778888899999999998999999987653 788999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCC
Q 026042 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP 161 (244)
Q Consensus 82 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 161 (244)
+|||.+.............++..|++||...+...+.++|+|++|++++++++|..||......................
T Consensus 129 ~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 208 (244)
T smart00220 129 ADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 208 (244)
T ss_pred ccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc
Confidence 99999876655444556678889999999988888999999999999999999999998743333333332222222222
Q ss_pred CC--chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 162 PT--CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 162 ~~--~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ++..+.+++.+|+..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 22 8899999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=215.02 Aligned_cols=188 Identities=26% Similarity=0.388 Sum_probs=151.0
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++++++...+..++|+||++ ++|.+++.+.. ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|
T Consensus 62 ~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l 139 (282)
T cd07829 62 KLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKL 139 (282)
T ss_pred HHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEE
Confidence 45677788899999999996 59999998763 25899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---
Q 026042 82 ADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA--- 156 (244)
Q Consensus 82 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 156 (244)
+|||.+....... ......++..|+|||.+.+. .++.++|+||||++++++++|..||...+.......+.....
T Consensus 140 ~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (282)
T cd07829 140 ADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219 (282)
T ss_pred ecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCc
Confidence 9999886544322 22233456789999998766 789999999999999999999999987665444332221100
Q ss_pred -------------C---C--------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 -------------R---P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 -------------~---~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. . ...+..+..+.+++.+||..+|.+||++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0 011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=221.92 Aligned_cols=178 Identities=25% Similarity=0.398 Sum_probs=140.2
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...|+++||+. ++|.+++... .+++..+..++.|++.||.+||+.|++||||||+||+++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 45899999995 5898888653 4889999999999999999999999999999999999999999999999998654
Q ss_pred cccC----CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC---------
Q 026042 91 SQCG----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA--------- 156 (244)
Q Consensus 91 ~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 156 (244)
.... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+.+.......+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 3221 1123467889999998654 5688999999999999999999999976654332221111000
Q ss_pred ---------------CCC-----CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 157 ---------------RPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 157 ---------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
... ..+..+..+.+++.+||+.+|.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 113457789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=215.58 Aligned_cols=179 Identities=23% Similarity=0.330 Sum_probs=142.3
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...++|+||+++ +|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||.+...
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 389999999965 8888877653 26899999999999999999999999999999999999999999999999998654
Q ss_pred cccCC--CCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC---------
Q 026042 91 SQCGS--AKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--------- 158 (244)
Q Consensus 91 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 158 (244)
..... .....++..|++||.+.+. ..+.++||||+|+++++|++|+.||...+.......+.......
T Consensus 167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T cd07864 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246 (302)
T ss_pred cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence 33221 1223457789999987653 56889999999999999999999998766544443332211110
Q ss_pred -------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 -------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....++..+.+++.+||..+|.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 012246789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=220.19 Aligned_cols=188 Identities=24% Similarity=0.406 Sum_probs=145.9
Q ss_pred cEEEEeecC------CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 2 QFVAACKKP------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 2 ~~~~~~~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
++++++... ..+++|+||+. .+|.+++. ..+++..+..++.|++.||+|||++|++||||+|+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~ 152 (342)
T cd07879 78 GLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152 (342)
T ss_pred chhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 455665543 34699999995 58877653 24788999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
++.++|+|||++..... ......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+.+.......+...
T Consensus 153 ~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~ 230 (342)
T cd07879 153 DCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230 (342)
T ss_pred CCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999865432 2234467889999998866 45789999999999999999999999887654443332221
Q ss_pred CCC---------------------C--------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 155 NAR---------------------P--------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 155 ~~~---------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
... . ...+..++.+.+++.+||+.||.+||++++++. +++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 100 0 001245678999999999999999999999995 45543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=216.19 Aligned_cols=178 Identities=24% Similarity=0.345 Sum_probs=141.5
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...++++||+ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+...
T Consensus 79 ~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 79 NELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred CcEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 5678999999 569999997655 5889999999999999999999999999999999999999999999999998653
Q ss_pred cccC-----CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC--------
Q 026042 91 SQCG-----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-------- 156 (244)
Q Consensus 91 ~~~~-----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 156 (244)
.... ......++..|+|||.+.+ ..++.++|+||+|++++++++|..||...+.......+.....
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 3211 1223468899999998765 4678999999999999999999999987654332222111100
Q ss_pred ----------------C-----CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 ----------------R-----PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ----------------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0112335788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=217.44 Aligned_cols=186 Identities=25% Similarity=0.381 Sum_probs=153.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~----- 75 (244)
|++.+||...++.|||+|.+ |-|+.+++.++.-.+++...++.+++|++.++++||+.+++|.|+||+||++.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 46788999999999999999 889999999987778999999999999999999999999999999999999931
Q ss_pred ---------------CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 026042 76 ---------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 140 (244)
Q Consensus 76 ---------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 140 (244)
+..++++|||.|+..... ....+.|..|.|||++.+-+++.+.||||+||+|.|+.+|...|.
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 235899999998775442 366778999999999999999999999999999999999999988
Q ss_pred CCCHHHHHHHHHhhCCCCCCC----------------------------------------------CCchHHHHHHHHH
Q 026042 141 NMTPEQAAFAVCQKNARPPVP----------------------------------------------PTCPKAFSYLISR 174 (244)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~l~~li~~ 174 (244)
.-+..+.+..+ ..-. .++| ......+.+|+++
T Consensus 311 tHen~EHLaMM-erIl-Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 311 THENLEHLAMM-ERIL-GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cCCcHHHHHHH-HHhh-CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 66544422111 1000 0100 0011368899999
Q ss_pred hcccCCCCCCCHHHHHH
Q 026042 175 CWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 175 ~l~~~p~~Rps~~el~~ 191 (244)
||..||.+|+|+.|+++
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999987
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=214.06 Aligned_cols=185 Identities=23% Similarity=0.408 Sum_probs=146.7
Q ss_pred CcEEEEeec-CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKK-PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++.. +...++++||+ +++|.++++.. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 72 v~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~ 147 (328)
T cd07856 72 ISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDL 147 (328)
T ss_pred eeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCE
Confidence 457777754 66889999999 67999988753 37788889999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh----
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK---- 154 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---- 154 (244)
+|+|||.+..... ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+...
T Consensus 148 ~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 148 KICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred EeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998865432 2233456888999998765 56899999999999999999999999876543322111110
Q ss_pred --------------------CCCCC-----CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 --------------------NARPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 --------------------~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..... ....+++.+.++|.+||+.+|++||++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001 11346789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=229.81 Aligned_cols=197 Identities=31% Similarity=0.607 Sum_probs=169.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE------P--------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~------~--------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|.++++|..++..++|.||+..|+|.+++++++ . ..++......++.||+.|++||++..++|||+
T Consensus 365 v~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 365 VNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred hhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 468899999999999999999999999998766 0 13778899999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCCC--CCCC--cccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGSA--KGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 141 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~ 141 (244)
-..||+++.+..+|++|||+++.......- .... -...|||||.+....++.++||||+|+++||+++ |..||.+
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999854332211 1111 2446999999999999999999999999999999 9999998
Q ss_pred CCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 142 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
...............+...|..+++++.++++.||+.+|.+||++.++.+.++...
T Consensus 525 ~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 525 IPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 76333335566778888999999999999999999999999999999999999853
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=213.67 Aligned_cols=181 Identities=23% Similarity=0.335 Sum_probs=140.5
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
....+++|+||+. ++|...+.... ..+++..+..++.|+++||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3446799999995 58888776543 268999999999999999999999999999999999999999999999999886
Q ss_pred cccccCCC------------CCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 89 LESQCGSA------------KGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 89 ~~~~~~~~------------~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
........ ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 53322111 123457789999987654 57899999999999999999999998776554433332211
Q ss_pred CCC---------------------CCC-------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARP---------------------PVP-------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~---------------------~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ..+ ....+.+.+++.+||+.+|.+|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100 000 223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=216.75 Aligned_cols=181 Identities=21% Similarity=0.345 Sum_probs=140.8
Q ss_pred eecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEEEecCC
Q 026042 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVKVADFG 85 (244)
Q Consensus 7 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~~kl~dfg 85 (244)
+......|+|+||++ ++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+|||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 444567899999995 5999888653 4789999999999999999999999999999999999985 5678999999
Q ss_pred CcccccccCC----CCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-----
Q 026042 86 ISCLESQCGS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN----- 155 (244)
Q Consensus 86 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----- 155 (244)
.+........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9865422111 122356888999997654 467889999999999999999999998765544333221110
Q ss_pred ------------------CCC-----CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ------------------ARP-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... .....++.++.+++.+||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 012346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=216.15 Aligned_cols=185 Identities=22% Similarity=0.405 Sum_probs=147.4
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
+++++++..+. .+++|+||+ |++|.+++... .+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 77 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~ 152 (343)
T cd07880 77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152 (343)
T ss_pred cceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 35566665543 458999999 78999988753 488999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.++.++|+|||++..... ......++..|++||.+.+ ..++.++|+||||++++++++|..||...+.......+..
T Consensus 153 ~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~ 230 (343)
T cd07880 153 EDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK 230 (343)
T ss_pred CCCCEEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999865432 2234467889999998866 4578999999999999999999999987665433332221
Q ss_pred hCCC-----------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNAR-----------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... ......++..+.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100 0112456778999999999999999999999995
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=223.25 Aligned_cols=181 Identities=24% Similarity=0.409 Sum_probs=151.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++|-.|++++.+|+||||++||++-.++-+.+ -+++..++.++.++.-|+++.|..|+|||||||+|||||.+|.+|
T Consensus 692 VrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 692 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EEEEEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCcee
Confidence 689999999999999999999999999988877 688999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc---------ccCC----------------------------------CCCCCcccceeccceeccCCCC
Q 026042 81 VADFGISCLES---------QCGS----------------------------------AKGFTGTYRWMAPEMIKEKRHT 117 (244)
Q Consensus 81 l~dfg~~~~~~---------~~~~----------------------------------~~~~~~~~~y~aPE~~~~~~~~ 117 (244)
|.|||++..+. .... ....+||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 99999974210 0000 1134599999999999999999
Q ss_pred CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC--CCCCCchHHHHHHHHHhcccCCCCCC
Q 026042 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP--PVPPTCPKAFSYLISRCWSSSPDRRP 184 (244)
Q Consensus 118 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp 184 (244)
...|+|+.|++||||+.|+.||...++.+....++.+.... ....+++++..++|.++.. +++.|.
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 99999999999999999999999888777666555444333 4446789999999988543 455664
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=197.03 Aligned_cols=162 Identities=24% Similarity=0.292 Sum_probs=128.6
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccccCCCCCCCcc
Q 026042 23 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT 102 (244)
Q Consensus 23 ~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 102 (244)
|||.+++++++. .+++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||.+...... ...|+
T Consensus 1 GsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGR-PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCc
Confidence 689999987542 6999999999999999999999998 999999999999999 9988654432 22678
Q ss_pred cceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhhCCCC-----CCCCCchH--HHHHHHHH
Q 026042 103 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQKNARP-----PVPPTCPK--AFSYLISR 174 (244)
Q Consensus 103 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~--~l~~li~~ 174 (244)
+.|+|||++.+..++.++||||+|+++|+|++|..||........ ........... ..+..++. .+.+++.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543222 22221111111 11122333 69999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhh
Q 026042 175 CWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 175 ~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
||..+|.+||++.++++.+....
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999876554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=218.85 Aligned_cols=196 Identities=31% Similarity=0.570 Sum_probs=166.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++.|..++.+++|+||+++|+|.+|+.++......-....+++.||++|++||.+.+++|||+.+.|+|++.++.+|
T Consensus 598 veLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iK 677 (807)
T KOG1094|consen 598 VELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIK 677 (807)
T ss_pred eEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEE
Confidence 57999999999999999999999999999988543344456678999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh--CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT--ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||+++....... ....+-..+|||+|.+.-++++.++|+|++|+++||+++ ...||...+.++.........
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~ 757 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF 757 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc
Confidence 999999985433222 223345679999999999999999999999999999865 788999988887766554322
Q ss_pred CC------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 AR------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
.. ...|..++..+.+++..||..+-.+||+++++...|+..
T Consensus 758 ~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 758 RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22 245678999999999999999999999999999998754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=214.31 Aligned_cols=185 Identities=25% Similarity=0.361 Sum_probs=145.2
Q ss_pred cEEEEeec------CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 2 QFVAACKK------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 2 ~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
++++++.. ....|++++++ |++|.++++.. .+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155 (345)
T ss_pred ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC
Confidence 45555543 24578899988 88999988754 4789999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
++.++|+|||++..... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||...+.......+...
T Consensus 156 ~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 156 DCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred CCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999865432 2234567889999998766 46788999999999999999999999766554433222111
Q ss_pred CC------------------------CCC-----CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 155 NA------------------------RPP-----VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 155 ~~------------------------~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.. .+. .....++.+.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 10 000 012357789999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=207.21 Aligned_cols=179 Identities=24% Similarity=0.468 Sum_probs=155.3
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEe
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVA 82 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~ 82 (244)
+..+|++...++.|.||++||+|--.++++. .++++.++.+..+|+-||.|||++||++||+|.+||++|..|.+||.
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghiklt 393 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT 393 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeec
Confidence 4567899999999999999999988887766 69999999999999999999999999999999999999999999999
Q ss_pred cCCCccc-ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCC-------CCCHHHHHHHHHhh
Q 026042 83 DFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD-------NMTPEQAAFAVCQK 154 (244)
Q Consensus 83 dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-------~~~~~~~~~~~~~~ 154 (244)
|+|+... ..+.....+++||+.|.|||.+.+..++...|+|+||++++||+.|+.||+ ..+.++..++++ -
T Consensus 394 dygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-l 472 (593)
T KOG0695|consen 394 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-L 472 (593)
T ss_pred ccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-h
Confidence 9999864 455567789999999999999999999999999999999999999999996 223344444443 3
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCC
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRP 184 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 184 (244)
.....+|..++.....+++..|++||.+|.
T Consensus 473 ekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 EKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 344566777788888899999999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=205.30 Aligned_cols=188 Identities=24% Similarity=0.404 Sum_probs=150.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
++++++|+++..+|||||-+.||+|...|.++. .+++.++.+++..|+.||.+||.+||.|||+||+|||-....
T Consensus 139 lqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 139 LQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred HHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcC
Confidence 467899999999999999999999999999877 689999999999999999999999999999999999997644
Q ss_pred cEEEecCCCcccccccC--------CCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCC--
Q 026042 78 CVKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNM-- 142 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-- 142 (244)
.+||+||.+........ ...+.+|+..|||||+.. ...|+.+.|.||||+++|-|++|..||.+.
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 58999998764321111 123567899999999763 235789999999999999999999999643
Q ss_pred -----CHH-------HHHHHHHhhCCCCCCC----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 143 -----TPE-------QAAFAVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 143 -----~~~-------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+.. +..+.-++ .....+| ..++.+.+++++.+|..++..|.++.+++.
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQ-EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQ-EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHh-ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 211 12222222 2222333 456889999999999999999999988887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=207.73 Aligned_cols=191 Identities=25% Similarity=0.363 Sum_probs=154.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~ 76 (244)
|++||.+=..+..+|.||.| ..||..+-+. .....+++..+-.++...+.||.||-.. .|+||||||+|||++..
T Consensus 126 VkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 126 VKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH 204 (361)
T ss_pred HHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC
Confidence 56788887888889999999 6788776542 2333689999999999999999999875 89999999999999999
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|.+||||||.+-....+.......|-..|||||.+.. ..++.++|+||||++++|+.||..|+.+.+.--....+...
T Consensus 205 G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 9999999999876666555666678899999998854 35899999999999999999999999987653222222222
Q ss_pred CCCCC--CC---CCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 155 NARPP--VP---PTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 155 ~~~~~--~~---~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
...+. .+ -+++..+..+|.-||.+|-+.||.+.+|+++
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22222 22 3378899999999999999999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=221.76 Aligned_cols=189 Identities=26% Similarity=0.497 Sum_probs=167.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++||..-+ .-..||+|.++.|+|.+.+++.....+.......++.||+.|+.||..++++||||-..|+++.....+|
T Consensus 174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVK 252 (1039)
T KOG0199|consen 174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVK 252 (1039)
T ss_pred eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceee
Confidence 688999888 6677999999999999999984444688899999999999999999999999999999999999988999
Q ss_pred EecCCCcccccccCCCC----CCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGSAK----GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||+.+......... .......|+|||.++...++.++|+|++|+++|||++ |+.||.+....+....+. ..
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~ 331 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AG 331 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cc
Confidence 99999987654433222 2234568999999999999999999999999999999 999999999988888776 77
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+.+.+..|++++.+++..||..+|.+||++..|.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 778889999999999999999999999999999974
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=239.87 Aligned_cols=189 Identities=23% Similarity=0.378 Sum_probs=147.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH---SQGILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH---~~~i~H~dikp~nil~~~~~ 77 (244)
|+++++|.+++..|+||||+++|+|.++++. +++..+.+++.|++.||+||| +.+++||||||+||+++.++
T Consensus 746 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~ 820 (968)
T PLN00113 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820 (968)
T ss_pred ceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence 6899999999999999999999999999963 688999999999999999999 66999999999999999988
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-----EQAAFAVC 152 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~ 152 (244)
..++. |+...... ......++..|+|||...+..++.++||||+|+++|||++|+.||+.... .+......
T Consensus 821 ~~~~~-~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~ 896 (968)
T PLN00113 821 EPHLR-LSLPGLLC---TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY 896 (968)
T ss_pred ceEEE-eccccccc---cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence 77765 55443221 12233678999999999988999999999999999999999999864211 11110000
Q ss_pred -----hhCCCCCC------CCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 153 -----QKNARPPV------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 153 -----~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.....+.. ......++.+++.+|++.+|++||+++|+++.|++...
T Consensus 897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00000111 11123457789999999999999999999999987655
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.38 Aligned_cols=178 Identities=17% Similarity=0.195 Sum_probs=130.9
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-----------
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----------- 77 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~----------- 77 (244)
....++.++||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..|
T Consensus 51 ~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~ 128 (793)
T PLN00181 51 DDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCS 128 (793)
T ss_pred ccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccC
Confidence 345678889988 679999997643 3589999999999999999999999999999999999996544
Q ss_pred --------cEEEecCCCcccccccC-----------------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHH
Q 026042 78 --------CVKVADFGISCLESQCG-----------------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132 (244)
Q Consensus 78 --------~~kl~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 132 (244)
.+|++|||+++...... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 129 ~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~EL 208 (793)
T PLN00181 129 DSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFEL 208 (793)
T ss_pred cccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHH
Confidence 45566666654311000 00113478889999999998999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 133 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
++|..|+..... ......... .+............++.+||+.+|.+||++.|+++
T Consensus 209 l~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 209 FCPVSSREEKSR--TMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hhCCCchhhHHH--HHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 999888653221 111111111 11111112345678899999999999999999986
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=226.00 Aligned_cols=86 Identities=30% Similarity=0.597 Sum_probs=80.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++......|+||||+.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 67 v~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred CeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEE
Confidence 568889999999999999999999999998755 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcc
Q 026042 81 VADFGISC 88 (244)
Q Consensus 81 l~dfg~~~ 88 (244)
|+|||++.
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=229.45 Aligned_cols=175 Identities=31% Similarity=0.524 Sum_probs=134.9
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
....+||=||||+..+|.++++++.... ....+|+++++|+.||+|+|++|++||||||.||++++++.+||+|||++.
T Consensus 667 ~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 667 KPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred cceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccch
Confidence 3467899999999988888887765211 467899999999999999999999999999999999999999999999986
Q ss_pred ccc-------------------ccCCCCCCCcccceeccceeccCC---CCCccchhhhHHHHHHHHhCCCCCCC-CCHH
Q 026042 89 LES-------------------QCGSAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDN-MTPE 145 (244)
Q Consensus 89 ~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~ 145 (244)
... ........+||.-|+|||++.+.. ++.|+|+||||++++||+. ||.. +...
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa 822 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA 822 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHH
Confidence 511 001233567999999999997754 8999999999999999974 4543 2333
Q ss_pred HHHHHHHhhCCCCCCCCC------chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 146 QAAFAVCQKNARPPVPPT------CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....... ...+|.. --+.=..+|++|++.||.+|||+.||+.
T Consensus 823 ~iL~~LR----~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 823 SILTNLR----KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcc----cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3332222 2222211 1234567999999999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=224.98 Aligned_cols=190 Identities=28% Similarity=0.499 Sum_probs=163.5
Q ss_pred cEEEEee-----cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 2 QFVAACK-----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 2 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
.+|++|. .++.++||||||.|||..|++++..+..+.|..+..|++.++.||.+||+..++|||||-.||+++.+
T Consensus 80 ~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 80 TFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred eEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc
Confidence 4556653 35778999999999999999998778889999999999999999999999999999999999999999
Q ss_pred CcEEEecCCCccccc-ccCCCCCCCcccceeccceeccC-----CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 77 MCVKVADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
|.+||+|||++.... ......+.+||+.|||||++... .++.++|+||||++..||..|.+|+-.+-+...++.
T Consensus 160 ~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~ 239 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 239 (953)
T ss_pred CcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc
Confidence 999999999986543 34456788899999999998543 467899999999999999999999999888877766
Q ss_pred HHhhCCCCC-CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNARPP-VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+........ .+..|++.+.++|..||.+|..+||++.++++
T Consensus 240 IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 543322222 25679999999999999999999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=222.45 Aligned_cols=183 Identities=20% Similarity=0.220 Sum_probs=130.1
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPY------------------SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~------------------~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ 69 (244)
..+...++|+||+.+++|.+++...... ......+..++.|++.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 5677899999999999999998754310 1122346689999999999999999999999999
Q ss_pred cEEEcC-CCcEEEecCCCcccccc--cCCCCCCCcccceeccceeccC----------------------CCCCccchhh
Q 026042 70 NLLLGE-DMCVKVADFGISCLESQ--CGSAKGFTGTYRWMAPEMIKEK----------------------RHTKKVDVYS 124 (244)
Q Consensus 70 nil~~~-~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~s 124 (244)
|||++. ++.+||+|||++..... ........+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999986 67899999999865322 1223456789999999965322 1334669999
Q ss_pred hHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------hCCCCCCC----------CCchHHHHHHHHHhcccCCCCCCC
Q 026042 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQ---------KNARPPVP----------PTCPKAFSYLISRCWSSSPDRRPH 185 (244)
Q Consensus 125 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~----------~~~~~~l~~li~~~l~~~p~~Rps 185 (244)
+||++|+|+++..+++.... .....+.. ........ ........+|+.+||+.||++|||
T Consensus 365 lGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 99999999997766543211 10000000 00000000 111234558999999999999999
Q ss_pred HHHHHH
Q 026042 186 FDQIVS 191 (244)
Q Consensus 186 ~~el~~ 191 (244)
+.++++
T Consensus 444 a~e~L~ 449 (566)
T PLN03225 444 AKAALA 449 (566)
T ss_pred HHHHhC
Confidence 999998
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=215.36 Aligned_cols=195 Identities=23% Similarity=0.360 Sum_probs=161.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|.+.-.|++.+..++|||-+ .|++.++|-.....++++.....++.||+.||.|||-+||+|.|+||+|||+.+..
T Consensus 626 V~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FP 704 (888)
T KOG4236|consen 626 VNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFP 704 (888)
T ss_pred eEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCC
Confidence 45666789999999999999 56887777555444799999999999999999999999999999999999997753
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
++||||||+++...........+||+.|+|||++..+.+.+.-|+||+|+++|--++|..||.....-....+....-..
T Consensus 705 QvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyP 784 (888)
T KOG4236|consen 705 QVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYP 784 (888)
T ss_pred ceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccC
Confidence 69999999999998888888999999999999999999999999999999999999999999764321111111112223
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
+.....++.+..+||..+|+..-++|-+.+..++ +|+++
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 3444678899999999999999999999988876 44443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=186.86 Aligned_cols=150 Identities=30% Similarity=0.458 Sum_probs=126.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~ 77 (244)
|++||-.......+|.||.+ ..||..+-++ ..+...++..+-+++..++.||.|||++ .++|||+||+|||++..|
T Consensus 108 V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G 186 (282)
T KOG0984|consen 108 VHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG 186 (282)
T ss_pred EEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC
Confidence 56788888888999999999 6799888765 2344789999999999999999999987 899999999999999999
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceecc----CCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHH
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE----KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAV 151 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~ 151 (244)
++|+||||.+-...++.......|-..|+|||.+.. ..|+.++||||||+++.||.+++.||+... +-+...++
T Consensus 187 qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 187 QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 999999999876665555555678889999998743 468999999999999999999999998764 33333333
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=195.69 Aligned_cols=183 Identities=25% Similarity=0.348 Sum_probs=140.3
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----CcEEEe
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQE---PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED----MCVKVA 82 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~----~~~kl~ 82 (244)
+...++++||.+. +|+..|+-+. .+.++...+..++.||+.|+.|||++-++|||+||.||++..+ |.+||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 7889999999966 9999996433 3468889999999999999999999999999999999999877 899999
Q ss_pred cCCCccccccc----CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------HHH
Q 026042 83 DFGISCLESQC----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE---------QAA 148 (244)
Q Consensus 83 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~ 148 (244)
|||+++..... ......+.|.+|.|||.+.+. .++.+.|+||+||++.||++-++.|.+...+ +..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 99999865432 234566789999999998775 5899999999999999999987777543221 011
Q ss_pred HHHHhhCCCC---------CCC--------------CC------------chHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 149 FAVCQKNARP---------PVP--------------PT------------CPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 149 ~~~~~~~~~~---------~~~--------------~~------------~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
..+......+ ..| .+ -++.-.+|+.++|+.||-+|.|+++.++..
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111111100 000 00 123356899999999999999999999844
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=198.38 Aligned_cols=189 Identities=25% Similarity=0.436 Sum_probs=153.8
Q ss_pred CcEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCccCCCCCCcEEEcC--
Q 026042 1 MQFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--GILHRDLKSENLLLGE-- 75 (244)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~--~i~H~dikp~nil~~~-- 75 (244)
|++|+|++ +.+.+|-|+|||+|.+|.-|++.+. .+++..++.|+.||+.||.||... -|+|-||||.|||+-+
T Consensus 530 VKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 530 VKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 68899995 5667899999999999999999877 689999999999999999999987 5999999999999944
Q ss_pred -CCcEEEecCCCcccccccCC--------CCCCCcccceeccceeccC----CCCCccchhhhHHHHHHHHhCCCCCCCC
Q 026042 76 -DMCVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFGIVLWELLTALTPFDNM 142 (244)
Q Consensus 76 -~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~ 142 (244)
.|.+||.|||++........ .....||.+|++||.+.-+ ..+.++||||+|+++|.++.|+.||...
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 47899999999976543222 3356699999999987543 3588999999999999999999999865
Q ss_pred CHHHHHHHH----HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 143 TPEQAAFAV----CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 143 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
-..+.+... .......+..+.++.+...||++||+..-++|.+..+|..
T Consensus 688 qsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 688 QSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 443333221 1223334455778999999999999999999988877764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=208.97 Aligned_cols=189 Identities=23% Similarity=0.354 Sum_probs=155.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~ 78 (244)
|+++..|...+++|||+|.+ ..+|.+.+++.+ +.++....+..++.||+.||..|-..|++|.||||+|||+++ ...
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 35677889999999999999 789999998854 345788999999999999999999999999999999999987 457
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||||||.|-..... .......+..|.|||.+.+-+|+...|+||+||+|||+.||+..|.+.+..+.+...+......
T Consensus 576 LKLCDfGSA~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 576 LKLCDFGSASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred eeeccCccccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 899999988665543 3334456789999999999999999999999999999999999999988887765543322111
Q ss_pred C----------------------------------------CC-----------CCc-------hHHHHHHHHHhcccCC
Q 026042 159 P----------------------------------------VP-----------PTC-------PKAFSYLISRCWSSSP 180 (244)
Q Consensus 159 ~----------------------------------------~~-----------~~~-------~~~l~~li~~~l~~~p 180 (244)
+ .| ..+ -..|.+|+.+||.+||
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP 734 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP 734 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence 0 00 001 1468899999999999
Q ss_pred CCCCCHHHHHH
Q 026042 181 DRRPHFDQIVS 191 (244)
Q Consensus 181 ~~Rps~~el~~ 191 (244)
.+|.+..+.+.
T Consensus 735 ~KRit~nqAL~ 745 (752)
T KOG0670|consen 735 EKRITVNQALK 745 (752)
T ss_pred hhcCCHHHHhc
Confidence 99999999886
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=206.07 Aligned_cols=182 Identities=20% Similarity=0.204 Sum_probs=133.8
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQEP----------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~~----------------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dik 67 (244)
.+..++|+||+++++|.++++...+ ..+++..++.++.|++.+|.|||+.+++|||||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLK 336 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIK 336 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 4568999999999999999875321 123567788999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEecCCCcccccccCCCC--CCCcccceeccceeccCC----------------------CCCccchh
Q 026042 68 SENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKR----------------------HTKKVDVY 123 (244)
Q Consensus 68 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~----------------------~~~~~Di~ 123 (244)
|+||+++.++.+||+|||++.......... ...+++.|++||.+.... ...+.|+|
T Consensus 337 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dvw 416 (507)
T PLN03224 337 PENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSY 416 (507)
T ss_pred hHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchh
Confidence 999999999999999999986543322222 223478999999875322 12346999
Q ss_pred hhHHHHHHHHhCCC-CCCCCCHHHHHH-----------HHHhhCCCCCCCCCchHHHHHHHHHhcccCC---CCCCCHHH
Q 026042 124 SFGIVLWELLTALT-PFDNMTPEQAAF-----------AVCQKNARPPVPPTCPKAFSYLISRCWSSSP---DRRPHFDQ 188 (244)
Q Consensus 124 slG~~l~~l~~g~~-p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~e 188 (244)
|+||++++|++|.. |+.......... ...............++...+++.+||..+| .+|+|++|
T Consensus 417 SlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 417 TAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred hHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 99999999999875 665322111100 0011112223335568899999999999766 68999999
Q ss_pred HHH
Q 026042 189 IVS 191 (244)
Q Consensus 189 l~~ 191 (244)
+++
T Consensus 497 aL~ 499 (507)
T PLN03224 497 ALS 499 (507)
T ss_pred HhC
Confidence 987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=184.39 Aligned_cols=182 Identities=21% Similarity=0.342 Sum_probs=145.2
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
....+|+||++|+. +|.-++.+.. ..++...+.++..++..||.|+|+..|+|||+||.|++|+.+|.++|+|||+++
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 45668999999965 9999987653 268899999999999999999999999999999999999999999999999997
Q ss_pred cccccCCC-----CCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh--CCCCC-
Q 026042 89 LESQCGSA-----KGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPP- 159 (244)
Q Consensus 89 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~- 159 (244)
........ ...+.|.+|.+||.+.+. .++.+.|+|+.||++.+|+++..-+.+.+..+....+..- .....
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 65443221 234468999999988764 6899999999999999999999989888776655444221 11111
Q ss_pred -----------------CCC-------------CchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 160 -----------------VPP-------------TCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 160 -----------------~~~-------------~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.+. .-.++..+++.++|..||.+|+++++++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110 012466789999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=193.09 Aligned_cols=176 Identities=22% Similarity=0.331 Sum_probs=143.8
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...|+|||++ ..+|...+.. .++-..+..++.|++.|++|||+.||+||||||+||++..++.+|+.|||+++..
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3568999999 6699999983 3566889999999999999999999999999999999999999999999999877
Q ss_pred cccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC------------
Q 026042 91 SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------------ 158 (244)
Q Consensus 91 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 158 (244)
.........+.+..|.|||+..+..+...+||||+||++.||++|...|.+.+.-+....+......+
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 66666777889999999999999889999999999999999999998887654432222221111111
Q ss_pred -----------------CCC-----------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 -----------------PVP-----------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 -----------------~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+| ..-....++++.+||..+|++|.++++++.
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 111245789999999999999999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=191.01 Aligned_cols=196 Identities=23% Similarity=0.468 Sum_probs=164.7
Q ss_pred EEEEe-ecCCcEEEEEeccCCCCHHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 3 FVAAC-KKPPVFCIITEYLAGGSLRKYLHQ------QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 3 ~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~------~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
+.+.+ .+....++++.+..-|+|+.++.. ...+.++..+...++.|++.|++|||++|++|.||...|++|++
T Consensus 352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD 431 (563)
T ss_pred eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh
Confidence 44555 455667899999988999999983 22334666778889999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCC---CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 026042 76 DMCVKVADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 151 (244)
.-++||+|=.+++..-+...+ ..--....||++|.+....++.++|+||||+++|||++ |+.|+...++.+....+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 999999999888754433221 11223568999999999999999999999999999999 99999999998876554
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.+..+..-|.+||+++..++..||...|++||++++++.-|..+-..
T Consensus 512 -kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 -KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 57778888999999999999999999999999999999998876544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=214.30 Aligned_cols=187 Identities=29% Similarity=0.446 Sum_probs=143.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCH---HHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPL---NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~---~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-- 75 (244)
|++|+.=+++.+.||..|.| .-+|.++++... ..... ...+.++.|+++||++||+.+|+||||||.||||+.
T Consensus 566 iRyyc~E~d~qF~YIalELC-~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~ 643 (903)
T KOG1027|consen 566 IRYYCSEQDRQFLYIALELC-ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS 643 (903)
T ss_pred EEEEeeccCCceEEEEehHh-hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC
Confidence 56777778899999999999 569999998851 11111 345788999999999999999999999999999976
Q ss_pred -CC--cEEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHH
Q 026042 76 -DM--CVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 147 (244)
Q Consensus 76 -~~--~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 147 (244)
++ +++|+|||++....... ......||.+|+|||++.....+.++||||+||++|+.++ |..||...-..+.
T Consensus 644 ~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~ 723 (903)
T KOG1027|consen 644 ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA 723 (903)
T ss_pred CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh
Confidence 33 68999999987644322 2445679999999999999988999999999999999998 5899976433221
Q ss_pred HHHHHhhCCC-CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 148 AFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 148 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+...... ..+.+....+..+||.+|++++|..||++.+++.
T Consensus 724 --NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 724 --NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 11111111 1111221228899999999999999999999975
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=211.15 Aligned_cols=195 Identities=28% Similarity=0.590 Sum_probs=168.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+|++++|.... ..||++|+++|+|.||++.+++ .+-.+..+.|..||++|+.|||.++++||||-..||||..-..+|
T Consensus 761 ~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvk 838 (1177)
T KOG1025|consen 761 LRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVK 838 (1177)
T ss_pred HHHhhhcccch-HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEE
Confidence 46788887776 7899999999999999998765 566788899999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCC---CCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSAK---GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
+.|||++.......... ...-.+.|||-|.+....++..+||||+|+++||++| |..|+++...++..... ....
T Consensus 839 itdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-e~ge 917 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-EKGE 917 (1177)
T ss_pred EEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-hccc
Confidence 99999997654433222 2223568899999999999999999999999999999 99999998887765554 4555
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
+..-|+.++.++..++.+||..|+..||+++++...+..+..
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 588899999999999999999999999999999998887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=175.17 Aligned_cols=189 Identities=20% Similarity=0.342 Sum_probs=152.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++..-.++...+|+||| ..+|..+.....+ .++.+.++.++.|++.||.++|++++.|||+||.|.+++.+|.+|
T Consensus 64 vrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelk 141 (292)
T KOG0662|consen 64 VRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_pred eehhhhhccCceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEE
Confidence 56778888899999999999 6699999987554 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCC-CCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++-.+-.. .-..-+.|.+|.+|.++.+.. ++...|+||.||++.|+.. |.+.|.+.+..+....+......
T Consensus 142 ladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~ 221 (292)
T KOG0662|consen 142 LADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_pred ecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCC
Confidence 99999997554322 233456789999999987765 6889999999999999987 77778888777665555332221
Q ss_pred CC---------CC------------------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PP---------VP------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~---------~~------------------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+. .+ +.....-+++++++|.-+|..|.++++.++
T Consensus 222 p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 222 PTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 10 00 011123468999999999999999998876
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=205.67 Aligned_cols=186 Identities=28% Similarity=0.492 Sum_probs=143.6
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CC--cEEEecC
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DM--CVKVADF 84 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~--~~--~~kl~df 84 (244)
.....+|||||.||||...+++-. ..++++.+.+.++..+..||.|||.+||+||||||.||++-. +| ..||+||
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 345679999999999999997632 346999999999999999999999999999999999999943 34 4699999
Q ss_pred CCcccccccCCCCCCCcccceeccceec-cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhCCCC-
Q 026042 85 GISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE----QAAFAVCQKNARP- 158 (244)
Q Consensus 85 g~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~- 158 (244)
|.|+-..+...-.+..||..|++||+.. ++.++...|.||+||++|+++||..||...... +....+..+....
T Consensus 169 G~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 169 GAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9999888877788899999999999998 488999999999999999999999999643222 2333332221111
Q ss_pred ------------------CCCCCchH----HHHHHHHHhcccCCCCCC--CHHHHHHHHHh
Q 026042 159 ------------------PVPPTCPK----AFSYLISRCWSSSPDRRP--HFDQIVSILEG 195 (244)
Q Consensus 159 ------------------~~~~~~~~----~l~~li~~~l~~~p~~Rp--s~~el~~~l~~ 195 (244)
+.+.+.+. .+...+..+|..+|++|. ...+....+..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d 309 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD 309 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence 22233333 345677788899999998 55555444443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=193.32 Aligned_cols=185 Identities=31% Similarity=0.559 Sum_probs=151.5
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCcEEEcCCCcEEEe
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---------GILHRDLKSENLLLGEDMCVKVA 82 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~---------~i~H~dikp~nil~~~~~~~kl~ 82 (244)
.++||++|.+.|+|.+|++.+. .+|....+++..|++||+|||+. .|+|||||..||||.+++..-|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 7899999999999999999886 89999999999999999999973 49999999999999999999999
Q ss_pred cCCCcccccccCC---CCCCCcccceeccceeccCCC------CCccchhhhHHHHHHHHhC------------CCCCC-
Q 026042 83 DFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRH------TKKVDVYSFGIVLWELLTA------------LTPFD- 140 (244)
Q Consensus 83 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~------~~~~Di~slG~~l~~l~~g------------~~p~~- 140 (244)
|||+|........ ....+||.+|||||++.+.-. -.+.||||+|.++|||++. +.||.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999976554332 335779999999999976532 2468999999999999883 22333
Q ss_pred ----CCCHHHHHHHHHhhCCCCCCCCCc-----hHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 141 ----NMTPEQAAFAVCQKNARPPVPPTC-----PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 141 ----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
..+.++....+..+..++.++..| ...+++.+..||+.|++.|.|+.=+.+.+..+...
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 123345555556677777777655 46789999999999999999999999988876553
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=176.40 Aligned_cols=158 Identities=35% Similarity=0.620 Sum_probs=138.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~~ 79 (244)
+++++++......++++|++.|++|.+++.... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.+
T Consensus 54 ~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~ 132 (215)
T cd00180 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKV 132 (215)
T ss_pred eeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcE
Confidence 357888888899999999999899999998763 25788999999999999999999999999999999999999 8999
Q ss_pred EEecCCCcccccccC-CCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 80 KVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
+|+|||.+....... ......+...|++||..... ..+.+.|+|++|++++++
T Consensus 133 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------- 187 (215)
T cd00180 133 KLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------- 187 (215)
T ss_pred EEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------
Confidence 999999886544322 13345578899999999877 788999999999999998
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 --------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 678999999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=185.99 Aligned_cols=184 Identities=34% Similarity=0.613 Sum_probs=149.2
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCCCcEEEcCCCcEEEec
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKSENLLLGEDMCVKVAD 83 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~--------~i~H~dikp~nil~~~~~~~kl~d 83 (244)
.++||.+|.+.|||.||+.+. .++....++++..++.||+|||.. .|+|||||..||+|..+|..-|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 579999999999999999985 488899999999999999999974 399999999999999999999999
Q ss_pred CCCccccccc-----CCCCCCCcccceeccceeccCC------CCCccchhhhHHHHHHHHh-----C-----CCCCCCC
Q 026042 84 FGISCLESQC-----GSAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLT-----A-----LTPFDNM 142 (244)
Q Consensus 84 fg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~-----g-----~~p~~~~ 142 (244)
+|+|...... ...+..+||.+|||||++...- --..+||||||.++||+.. | +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999765443 2355778999999999986542 1357999999999999966 2 5687654
Q ss_pred CH-----HHHHHHHHhhCCCCCCCCCch-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 143 TP-----EQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 143 ~~-----~~~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.+ ++....+-....++.+|..|. ..+.++++.||..+|..|.|+-.+.+.|.++..
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 33 333333334566677776664 356789999999999999999999998887764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=188.63 Aligned_cols=72 Identities=35% Similarity=0.630 Sum_probs=65.1
Q ss_pred CcEEEEee----cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEE
Q 026042 1 MQFVAACK----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~ 73 (244)
|++++.|. .+.+.|||+|++ |.+|..+|....-+.++...+++|++|++.||.|||++ ||+|.||||+|||+
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 56777774 467899999999 88999999987767899999999999999999999987 99999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=173.43 Aligned_cols=183 Identities=20% Similarity=0.351 Sum_probs=143.2
Q ss_pred eecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-C-CcEEEecC
Q 026042 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-D-MCVKVADF 84 (244)
Q Consensus 7 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~-~~~kl~df 84 (244)
|++.+.+..++||++.|+|.+-+...+ +-+....+++.|+++||.|+|+++++|||||.+||||-. + -++|||||
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeec
Confidence 567788999999999999999887754 778889999999999999999999999999999999954 3 37999999
Q ss_pred CCcccccccCCCCCCCcccceeccceeccC-----CCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhhCC
Q 026042 85 GISCLESQCGSAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNA 156 (244)
Q Consensus 85 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~ 156 (244)
|+++..+. .....-.+..|.+||..... ...+..|+|.||++++.+++|..||... +........+.+..
T Consensus 168 G~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 168 GLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 99876543 12223346678999976432 2467899999999999999999999843 33344445555555
Q ss_pred CCCCCC---CchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 157 RPPVPP---TCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 157 ~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
.+..|. .+++.+..+.++-|..++++|--..+..++-.
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 555553 46788889999999999999966666666544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-24 Score=178.67 Aligned_cols=197 Identities=20% Similarity=0.326 Sum_probs=158.4
Q ss_pred cEEEEe-ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----
Q 026042 2 QFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---- 76 (244)
Q Consensus 2 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---- 76 (244)
++++.+ ..+.+.||||+.+ |.+|.++........++...+..++.|++.+|++||+.|++||||||+|+++...
T Consensus 84 ~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~ 162 (322)
T KOG1164|consen 84 KLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSE 162 (322)
T ss_pred EEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcc
Confidence 356666 5788899999998 9999999987776689999999999999999999999999999999999999865
Q ss_pred -CcEEEecCCCcc--cccccC--------C-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Q 026042 77 -MCVKVADFGISC--LESQCG--------S-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 144 (244)
Q Consensus 77 -~~~kl~dfg~~~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 144 (244)
..+.|.|||+++ ...... . .....||..|++++.+.+...+++.|+||+++++.++..|..||.+...
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 359999999998 311111 1 2345699999999999999999999999999999999999999977654
Q ss_pred HHHHHHHHhhCCCC--C-CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 145 EQAAFAVCQKNARP--P-VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 145 ~~~~~~~~~~~~~~--~-~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.............. . .....+..+..+...+-..+...+|++..+...++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 243 TDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred cchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 32222222211111 1 3345668888888888889999999999999998877654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=192.69 Aligned_cols=138 Identities=25% Similarity=0.476 Sum_probs=124.3
Q ss_pred CcEEEEeecCCcEEEEEeccC-CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLA-GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~-~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|+++++|++++++||++|.-. |.+|.++|..++ .+++..+..++.|++.|+++||+.||+|||||-+||.++.+|-+
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeE
Confidence 578999999999999999763 679999999887 68999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDN 141 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~ 141 (244)
||+|||.+... ...+-..++||..|.|||++.+.+| +...|||+||+++|.++....||.+
T Consensus 710 klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 710 KLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEeeccchhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999987543 3355678899999999999998876 7889999999999999988888854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=169.15 Aligned_cols=151 Identities=33% Similarity=0.508 Sum_probs=127.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++......++++|++++++|.+++..... .+++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++
T Consensus 60 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~ 138 (225)
T smart00221 60 VKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVK 138 (225)
T ss_pred hhheeeeecCCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 3577888888999999999999999999987652 178899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceecccee-ccCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLTALTPFDN-MTPEQAAFAVC 152 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~ 152 (244)
|+|||.+....... ......+...|++||.+ ....++.++|+|+||+++++|++|+.||.. .+........+
T Consensus 139 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 139 LADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred EeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 99999887654432 33445677889999998 666778899999999999999999999977 45444444433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=165.39 Aligned_cols=177 Identities=14% Similarity=0.239 Sum_probs=137.4
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEecCCCcc
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVADFGISC 88 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-~~~kl~dfg~~~ 88 (244)
.....+|+||+.+.+...+... ++...+..++.+++.||.|+|+.||+|||+||.|+++|.. -.++|+|+|+|.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 4556799999988887776653 5667888999999999999999999999999999999985 469999999998
Q ss_pred cccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhh------------
Q 026042 89 LESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFD-NMTPEQAAFAVCQK------------ 154 (244)
Q Consensus 89 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~------------ 154 (244)
+..+...-+..+.+..|--||.+..- .++..-|+|||||++..|+..+.||- +.+..+..-.+...
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 87766666666777888999988664 57899999999999999999888873 33332211111000
Q ss_pred -----------------------CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 -----------------------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 -----------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.........++++..+++.++|..|..+|+|+.|.+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000111224688999999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=174.75 Aligned_cols=179 Identities=26% Similarity=0.385 Sum_probs=136.3
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccc
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 92 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~ 92 (244)
.|++.|.+ ..+|...|-.-. .++...++-+++||+.||+|||+.||.||||||.|.++++|..+||||||+++....
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 46677777 457777776543 688889999999999999999999999999999999999999999999999987554
Q ss_pred cCCCC--CCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC-----------
Q 026042 93 CGSAK--GFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----------- 158 (244)
Q Consensus 93 ~~~~~--~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 158 (244)
..... .-+.|..|.|||.+.+. .++.+.||||+||++.|++..+..|...++-+....+..-...+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 33322 23468899999988664 68999999999999999999888887766554443332211111
Q ss_pred ---------CCCCC------------chHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 159 ---------PVPPT------------CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 159 ---------~~~~~------------~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
..++. -..+-..++.++|..||++|.+.++.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111 1235567888999999999999988887554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=187.50 Aligned_cols=188 Identities=28% Similarity=0.519 Sum_probs=159.0
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
-|++.+-.....++.||||.||+|.+.-+-.+ .+++.++..+.++.+.||+|||+.|-+|||||-.||++++.|.+|+
T Consensus 76 ay~gsylr~dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvkl 153 (829)
T KOG0576|consen 76 AYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKL 153 (829)
T ss_pred HHHhhhhhhcCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceee
Confidence 46777888899999999999999999887666 6899999999999999999999999999999999999999999999
Q ss_pred ecCCCcccccc-cCCCCCCCcccceecccee---ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 82 ADFGISCLESQ-CGSAKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 82 ~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.|||.+..... -...+.+.||+.|||||+- +.+.+....|+|++|++..|+-.-+.|.-..-+.+..+.+-.....
T Consensus 154 aDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q 233 (829)
T KOG0576|consen 154 ADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ 233 (829)
T ss_pred cccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC
Confidence 99999865443 2345688999999999975 4457899999999999999998877776665666665555444433
Q ss_pred CC---CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
++ .+..|++.|.+|++.+|.++|.+||+++.++.
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 32 33568999999999999999999999998876
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.5e-23 Score=161.64 Aligned_cols=198 Identities=17% Similarity=0.303 Sum_probs=163.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---- 77 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~---- 77 (244)
++|-+..++.+..||+|.+ |.||.|+..-.++ .++...+..++.||+.-++++|++++|+|||||+|+||...+
T Consensus 88 ~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~ 165 (449)
T KOG1165|consen 88 QVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDA 165 (449)
T ss_pred ceeeeccccchhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCC
Confidence 3566778999999999999 9999999987765 799999999999999999999999999999999999997543
Q ss_pred -cEEEecCCCcccccccCC--------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--
Q 026042 78 -CVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-- 146 (244)
Q Consensus 78 -~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-- 146 (244)
.+.++|||++....+... .+...||.+||+...+.+...+++.|+-|||-++++++.|.+||.+.....
T Consensus 166 n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK 245 (449)
T KOG1165|consen 166 NVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK 245 (449)
T ss_pred ceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH
Confidence 589999999976554433 456779999999999999999999999999999999999999998765432
Q ss_pred -HHHHHHhhCCCC---CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 147 -AAFAVCQKNARP---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 147 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
-...+-...... .+..++|.++...+...-.++-.+-|+++-+...+....+...
T Consensus 246 ~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 246 EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 222222222222 2336689999999999989999999999999998887766543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=165.75 Aligned_cols=185 Identities=21% Similarity=0.363 Sum_probs=139.4
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCcEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMCVK 80 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~~k 80 (244)
++.+.+..++...+|+||++..+..++... ++...+..+++.++.||+++|.+||+||||||.|++.+. .+...
T Consensus 99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred cchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCce
Confidence 466778899999999999999999998875 556899999999999999999999999999999999986 57789
Q ss_pred EecCCCcccccc--------c------CC-------------------------------CCCCCcccceeccceeccC-
Q 026042 81 VADFGISCLESQ--------C------GS-------------------------------AKGFTGTYRWMAPEMIKEK- 114 (244)
Q Consensus 81 l~dfg~~~~~~~--------~------~~-------------------------------~~~~~~~~~y~aPE~~~~~- 114 (244)
|+|||++..... . .. .....||++|.|||++...
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 999999851000 0 00 0023489999999988654
Q ss_pred CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHH------------HhhCCC------------------------
Q 026042 115 RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAV------------CQKNAR------------------------ 157 (244)
Q Consensus 115 ~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~------------~~~~~~------------------------ 157 (244)
..+.+.||||.|++++.++++..||-....+ .....+ ......
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 4688999999999999999999998422111 000000 000000
Q ss_pred -------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......+..+.+++.+||+.||.+|.++++.++
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0001123447889999999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=182.05 Aligned_cols=176 Identities=26% Similarity=0.381 Sum_probs=142.2
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccc
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQ 92 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~ 92 (244)
.+-.||||++ +|..++.+.. .+....+-.++.|++.|+.|+|+.|+.|||+|++|++++.+|.+|++|||.+.....
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred chhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 3344999998 9999999874 477889999999999999999999999999999999999999999999999865433
Q ss_pred cC-----CCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-------CCC
Q 026042 93 CG-----SAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-------RPP 159 (244)
Q Consensus 93 ~~-----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~ 159 (244)
.. ......|+..|+|||++.+..+ ....||||.|+++..|.+|+.||......+..+....... ...
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 22 2346779999999999988877 5678999999999999999999986655443311111110 111
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+...++...+.+|.+||+.+|.+|.|++++++
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 22446778899999999999999999999997
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=152.87 Aligned_cols=204 Identities=18% Similarity=0.300 Sum_probs=164.2
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCcE
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMCV 79 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~---~~~~ 79 (244)
+..|++++.+-.+|||.+ |.||.++..-... .++..+++-++-|++.-++|+|.++++||||||+|++..- ...+
T Consensus 76 i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 76 IRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred hhhhccccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceE
Confidence 345678888999999999 9999999875443 6888999999999999999999999999999999999964 3469
Q ss_pred EEecCCCccccccc--------CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H
Q 026042 80 KVADFGISCLESQC--------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA---A 148 (244)
Q Consensus 80 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~ 148 (244)
.|+|||++....+. .......||..|.+-..+.+...+.+.|+-|+|+++.++-.|..||.+.....- .
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 99999999654332 234456799999999988888889999999999999999999999998754322 2
Q ss_pred HHHHhhCCC---CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCccccc
Q 026042 149 FAVCQKNAR---PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFS 208 (244)
Q Consensus 149 ~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~~~~~~ 208 (244)
..+...... ......+|.++.-.+..|-...-.+-|++.-+.+.+.-+...+.....+..
T Consensus 234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iy 296 (341)
T KOG1163|consen 234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIY 296 (341)
T ss_pred HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEe
Confidence 222222211 234477899999999999999999999999999999888877766555433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.5e-21 Score=155.36 Aligned_cols=182 Identities=23% Similarity=0.385 Sum_probs=142.1
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--CCC--cEEEec
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDM--CVKVAD 83 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~--~~~--~~kl~d 83 (244)
.++..+|+||.-+. -+|..++..+. .+.....-++.|+++|+.|||++|+.|||+|.+||++. +++ .+.++|
T Consensus 313 g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred CCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 46788999999994 59999998764 45677888999999999999999999999999999994 333 589999
Q ss_pred CCCcccccc-------cCCCCCCCcccceeccceeccCC------CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 84 FGISCLESQ-------CGSAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 84 fg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
||.+.--.. ....-...|+-..||||.....+ .-.++|.|+.|.+.||++....||.+.........
T Consensus 389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r 468 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR 468 (598)
T ss_pred cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh
Confidence 997532111 01112344778899999876543 24589999999999999999999987444333333
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
..+....+..++.+++.+++++..+|+.||.+|++..-....+
T Consensus 469 ~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 469 TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 3456667889999999999999999999999999876665544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-20 Score=150.07 Aligned_cols=191 Identities=31% Similarity=0.480 Sum_probs=151.7
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CV 79 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~-~~ 79 (244)
++++.+......+++++++.++++.+++..... ..++......++.|++.++.++|+.|++|||+||+||+++..+ .+
T Consensus 62 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~ 141 (384)
T COG0515 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVV 141 (384)
T ss_pred eEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeE
Confidence 567777777778999999999999977776542 1578899999999999999999999999999999999999988 79
Q ss_pred EEecCCCcccccccC-------CCCCCCcccceeccceecc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCH----H
Q 026042 80 KVADFGISCLESQCG-------SAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTP----E 145 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~ 145 (244)
+++|||.+....... ......++..|++||...+ ...+...|+|++|++++++++|..||..... .
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~ 221 (384)
T COG0515 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS 221 (384)
T ss_pred EEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHH
Confidence 999999986443322 2356779999999999987 5788999999999999999999999877663 3
Q ss_pred HHHHHHHhhCCC-C--CCCCCc----hHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 146 QAAFAVCQKNAR-P--PVPPTC----PKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 146 ~~~~~~~~~~~~-~--~~~~~~----~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.....+...... . ...... ...+.+++..++..+|..|.+..+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 333333222221 1 111221 2578999999999999999988887764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-22 Score=159.10 Aligned_cols=163 Identities=23% Similarity=0.316 Sum_probs=108.6
Q ss_pred cEEEEEeccCCCCHHHHHhh---cCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 12 VFCIITEYLAGGSLRKYLHQ---QEPY--SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~---~~~~--~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
..+++|+-+ .+||.+++.- .... .+.......+..|+++.+++||+.|++|+||+|+|++++.+|.++|+||+.
T Consensus 113 n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~ 191 (288)
T PF14531_consen 113 NRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSS 191 (288)
T ss_dssp SEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGG
T ss_pred hhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHH
Confidence 347888888 5699888653 2211 122233466779999999999999999999999999999999999999987
Q ss_pred cccccccCCCCCCCcccceeccceeccC--------CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 87 SCLESQCGSAKGFTGTYRWMAPEMIKEK--------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 87 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
....+..... ...+..|.+||..... .++.+.|.|+||+++|.|++|..||+.......... ...
T Consensus 192 ~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~f~ 264 (288)
T PF14531_consen 192 LVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----DFS 264 (288)
T ss_dssp EEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----GGT
T ss_pred HeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----cch
Confidence 6554443222 2344778899876432 468899999999999999999999986543321110 112
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCC
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRR 183 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~R 183 (244)
... .+|+.++.+|..+|+.+|++|
T Consensus 265 ~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 265 RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TSS----HHHHHHHHHHT-SSGGGS
T ss_pred hcC-CcCHHHHHHHHHHccCCcccC
Confidence 223 789999999999999999987
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=145.46 Aligned_cols=189 Identities=34% Similarity=0.642 Sum_probs=159.4
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~~~~ 79 (244)
.+++.|....+..+|..|++-|+|+..++...+...+..++.+++..++.|++|||+.. |----++...+++|++-..
T Consensus 251 pvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta 330 (448)
T KOG0195|consen 251 PVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA 330 (448)
T ss_pred hhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh
Confidence 46788999999999999999999999999988777888999999999999999999984 3333688899999987655
Q ss_pred EEe--cCCCcccccccCCCCCCCcccceeccceeccCC---CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 80 KVA--DFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 80 kl~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
+|. |--++ .......-.+.|++||.++..+ .-+++|+|||+++++|+.|...||....+.+.-..+...
T Consensus 331 rismad~kfs------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 331 RISMADTKFS------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred heecccceee------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 543 32211 1122334478899999997765 356899999999999999999999999999888888888
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..+..+|+..+..+..++.-|+..||.+||.++.++-.|+.+
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 888999999999999999999999999999999999888765
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-21 Score=162.51 Aligned_cols=170 Identities=28% Similarity=0.461 Sum_probs=128.9
Q ss_pred CCcEEEEEeccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
..++||.|++|...+|.+|+.+. ..-..+......++.|++.|+.| +|.+|+|+||.||+...+..+||.|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 34789999999999999999743 33346678889999999999999 999999999999999999999999999976
Q ss_pred cccccC-------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 89 LESQCG-------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 89 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
...... ......||..||+||.+.++.++.++||||||++++|++. -.-.+.. ......+......+..
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEF 481 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHH
Confidence 544433 4556789999999999999999999999999999999987 2222211 1111111111111122
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
...+|. =..|+.+++.+.|.+||++
T Consensus 482 ~~d~p~-e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 482 LQDYPE-EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhcCcH-HHHHHHHhcCCCcccCchH
Confidence 233333 3579999999999999943
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-21 Score=161.29 Aligned_cols=173 Identities=28% Similarity=0.398 Sum_probs=147.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++.-.++.+...++++++..||.|...+.+.. .+.+.....+...++-+++++|+.|++|+|+|++||+++.+|.++
T Consensus 60 v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~ 137 (612)
T KOG0603|consen 60 VKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIK 137 (612)
T ss_pred eeeeeeeccccchhHhhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccc
Confidence 345566788999999999999999999888776 577788889999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
+.|||+++........ +|+..|||||.++ ....++|+|++|++.++|++|..||.. +....+. ......
T Consensus 138 ~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il--~~~~~~ 206 (612)
T KOG0603|consen 138 LTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL--KAELEM 206 (612)
T ss_pred cCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh--hhccCC
Confidence 9999998765443333 8999999999998 678899999999999999999999988 3333322 224566
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
|...+....+++.+++..+|..|...
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 77788899999999999999999755
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=169.00 Aligned_cols=171 Identities=20% Similarity=0.227 Sum_probs=128.8
Q ss_pred eecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 7 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
-.+++..|||-+|.. .+|.|.+..++ -+..-+.+-++.|++.||..+|..||+|||||.+||||+.-+.+.|.||..
T Consensus 90 ~~t~kAAylvRqyvk-hnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 90 LVTDKAAYLVRQYVK-HNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHhhHHHHHHHHHHh-hhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccc
Confidence 345667788999994 59999998765 455667777899999999999999999999999999999988999999975
Q ss_pred cccc--cccCCC------CCCCcccceeccceeccC----------C-CCCccchhhhHHHHHHHHh-CCCCCCC-----
Q 026042 87 SCLE--SQCGSA------KGFTGTYRWMAPEMIKEK----------R-HTKKVDVYSFGIVLWELLT-ALTPFDN----- 141 (244)
Q Consensus 87 ~~~~--~~~~~~------~~~~~~~~y~aPE~~~~~----------~-~~~~~Di~slG~~l~~l~~-g~~p~~~----- 141 (244)
-.+. ...++. .+......|.|||.+... + .+++.||||+||+++|+++ |+++|.-
T Consensus 167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a 246 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA 246 (1431)
T ss_pred cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh
Confidence 4321 111111 122244589999977441 1 4678999999999999988 8888851
Q ss_pred ------CCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 142 ------MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 142 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.+.+..+.. --+..++.++..|++.||.+|.++++.++-
T Consensus 247 Yr~~~~~~~e~~Le~------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEK------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHh------------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111 113478999999999999999999999975
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=148.04 Aligned_cols=196 Identities=32% Similarity=0.589 Sum_probs=152.4
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-ccCCCCCCcEEEcCCCcEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI-LHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i-~H~dikp~nil~~~~~~~k 80 (244)
+++|.+-.+...++|.+||..|+|.|.+.... ..+++-....+.+.++.||.|+|.-.+ .|+.++..|++++....+|
T Consensus 11 ~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lk 89 (484)
T KOG1023|consen 11 KFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLK 89 (484)
T ss_pred hheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEE
Confidence 57889999999999999999999999998833 468888889999999999999998855 9999999999999999999
Q ss_pred EecCCCcccccc---cCCCCCCCcccceeccceeccCC-------CCCccchhhhHHHHHHHHhCCCCCCCC----CHHH
Q 026042 81 VADFGISCLESQ---CGSAKGFTGTYRWMAPEMIKEKR-------HTKKVDVYSFGIVLWELLTALTPFDNM----TPEQ 146 (244)
Q Consensus 81 l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~ 146 (244)
|.|||+...... ........-..-|.|||.+.+.. .+.+.|+||+|++++|+++...||+.. +..+
T Consensus 90 lt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~e 169 (484)
T KOG1023|consen 90 LTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDE 169 (484)
T ss_pred echhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHH
Confidence 999999765432 11122223456789999887641 467899999999999999999999753 2223
Q ss_pred HHHHHHhhCCCCCCC-----CCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 147 AAFAVCQKNARPPVP-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
....+.........| ...++++..++.+||..+|.+||+++++...++....
T Consensus 170 ii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 170 IILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 333333212211222 1345578999999999999999999999988776544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.9e-19 Score=158.71 Aligned_cols=138 Identities=34% Similarity=0.481 Sum_probs=117.1
Q ss_pred HHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccccccc----------------CCCCCCCcccceecccee
Q 026042 48 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC----------------GSAKGFTGTYRWMAPEMI 111 (244)
Q Consensus 48 ~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~----------------~~~~~~~~~~~y~aPE~~ 111 (244)
+++.+++|+|+.||+|+|+||+|.+|+.-|.+|+.|||++...... ...+..+||+.|.|||++
T Consensus 151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 4588999999999999999999999999999999999987542211 113456899999999999
Q ss_pred ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-CCCCCCchHHHHHHHHHhcccCCCCCCC
Q 026042 112 KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPH 185 (244)
Q Consensus 112 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps 185 (244)
..+.|+..+|+|++|+++|+++.|..||.+.++++........... +.....++++.++++.++|..+|..|.-
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 9999999999999999999999999999999988877666543332 3345678899999999999999999953
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.3e-17 Score=123.44 Aligned_cols=122 Identities=20% Similarity=0.141 Sum_probs=90.0
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCcEEEcCCCcEEEecCCCccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL-KSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di-kp~nil~~~~~~~kl~dfg~~~~ 89 (244)
+..+++|||+.|.+|...+.. ....++.|++.+|.++|++|++|||| ||+||+++.+|.++|+|||++..
T Consensus 71 ~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 71 DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 446899999999998754321 11357789999999999999999999 79999999999999999999975
Q ss_pred ccccCCC------C--------CCCcccceeccceeccC-CC-CCccchhhhHHHHHHHHhCCCCCCC
Q 026042 90 ESQCGSA------K--------GFTGTYRWMAPEMIKEK-RH-TKKVDVYSFGIVLWELLTALTPFDN 141 (244)
Q Consensus 90 ~~~~~~~------~--------~~~~~~~y~aPE~~~~~-~~-~~~~Di~slG~~l~~l~~g~~p~~~ 141 (244)
....... . -...++.+++|+...-- .. -.+.++++.|+-+|.++|+..+.-+
T Consensus 142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 4332210 0 01135666666644322 22 3677999999999999998877543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.1e-17 Score=128.48 Aligned_cols=102 Identities=16% Similarity=0.284 Sum_probs=77.2
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.+..+|+|||++|.+|.++.. +++ ....+++.+|..+|+.|++|||++|.||+++.+| ++|+|||....
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~ 183 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRC 183 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCccc
Confidence 456899999999999988732 232 2455999999999999999999999999999988 99999997654
Q ss_pred ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHH
Q 026042 90 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133 (244)
Q Consensus 90 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 133 (244)
........ .......+..++|+|+||+++..+.
T Consensus 184 ~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 184 TAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 32211110 0223445668999999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-16 Score=141.46 Aligned_cols=178 Identities=19% Similarity=0.233 Sum_probs=134.0
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-------CCcEE
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------DMCVK 80 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-------~~~~k 80 (244)
.-.+..++|+||.+.|+|.+++.... .+++..+..+..||+..+++||..+||||||||+|+++.. .-.++
T Consensus 764 ~~~~~S~lv~ey~~~Gtlld~~N~~~--~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 764 VFQNASVLVSEYSPYGTLLDLINTNK--VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ccCCcceeeeeccccccHHHhhccCC--CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 34566789999999999999999544 6899999999999999999999999999999999999942 23599
Q ss_pred EecCCCcccccc---cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-
Q 026042 81 VADFGISCLESQ---CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA- 156 (244)
Q Consensus 81 l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 156 (244)
|+|||.+..... ...-....+|-.+-.+|+..+.++++.+|.|.|+.+++-|+.|+.-- .+....
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~ 910 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSW 910 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcce
Confidence 999999865433 22334566788999999999999999999999999999999985311 110100
Q ss_pred --CCCCCCCch-HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 --RPPVPPTCP-KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 --~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...++..+. ..+.+|+..+|+.|=..=|.+.+|...++....
T Consensus 911 ~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 911 MVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred eccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 111222222 345678888888554445777777777765543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=8.8e-17 Score=133.68 Aligned_cols=104 Identities=21% Similarity=0.289 Sum_probs=78.7
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC-CCCcEEEcCCCcEEEecCCCccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL-KSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di-kp~nil~~~~~~~kl~dfg~~~~ 89 (244)
+..|+||||++|++|... .. .. ...++.|++.+|.|||++|++|||| ||+||+++.++.++|+|||++..
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999632 11 11 1467889999999999999999999 99999999999999999999875
Q ss_pred ccccCCC---------CCCCcccceeccceeccCC------CCCccchh
Q 026042 90 ESQCGSA---------KGFTGTYRWMAPEMIKEKR------HTKKVDVY 123 (244)
Q Consensus 90 ~~~~~~~---------~~~~~~~~y~aPE~~~~~~------~~~~~Di~ 123 (244)
....... ....+++.|++||.+.... .+..+|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4432211 2345677899999886543 23446666
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.2e-16 Score=119.20 Aligned_cols=74 Identities=19% Similarity=0.239 Sum_probs=63.7
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 14 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~l-H~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
+|||||++|+++.....+.. .++...+..++.|++.+|.++ |+.|++||||||+||+++ ++.++|+|||++...
T Consensus 93 ~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 93 VLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 79999998877765543333 578899999999999999999 799999999999999998 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.7e-17 Score=144.26 Aligned_cols=190 Identities=25% Similarity=0.398 Sum_probs=152.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHH-hhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcCCC-
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYL-HQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDM- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i-~~~~~~~~~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~nil~~~~~- 77 (244)
+++++........+++.+|..|+++.+-+ .... ...+...+..++.|+..++.|+| ..++.|+|+||+|.+++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~ 162 (601)
T KOG0590|consen 84 VHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS 162 (601)
T ss_pred cccCCccCCCcccccccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC
Confidence 35667778889999999999999999998 4332 24666788889999999999999 99999999999999999999
Q ss_pred cEEEecCCCcccccc-c---CCCCCCCc-ccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026042 78 CVKVADFGISCLESQ-C---GSAKGFTG-TYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~-~---~~~~~~~~-~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 151 (244)
.+++.|||+|..... . ......+| ++.|++||...+ .......|+||.|+++.-+++|..||............
T Consensus 163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~ 242 (601)
T KOG0590|consen 163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS 242 (601)
T ss_pred cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee
Confidence 999999999875544 2 22345567 999999999987 46688999999999999999999999876554433222
Q ss_pred HhhCC---CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQKNA---RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+.... ........+....+++.+++..+|..|.+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 22221 23444667788899999999999999999988876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-15 Score=114.93 Aligned_cols=74 Identities=18% Similarity=0.196 Sum_probs=63.3
Q ss_pred EEEEEeccCCCCHHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 13 FCIITEYLAGGSLRKY-LHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~-i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
.++||||++|+++... +.. . .++...+..++.|++.++.++|+ +|++||||||+||+++ ++.++|+|||++...
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~-~--~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKD-V--PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEEecCCCchhhhhhh-c--cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 3799999988765443 433 2 46788999999999999999999 9999999999999998 789999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.8e-14 Score=107.59 Aligned_cols=80 Identities=15% Similarity=0.228 Sum_probs=63.6
Q ss_pred CcEEEEeecCC---c-EEEEEec--cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCccCCCCCCcEEE
Q 026042 1 MQFVAACKKPP---V-FCIITEY--LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGM-QYLHSQGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L-~~lH~~~i~H~dikp~nil~ 73 (244)
+++++++.++. . +.+|+|| +.+++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+||++
T Consensus 64 vr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl 138 (210)
T PRK10345 64 PRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILC 138 (210)
T ss_pred ceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE
Confidence 57899998874 4 3478999 5579999999763 25555 35678888777 99999999999999999999
Q ss_pred cCC----CcEEEecCC
Q 026042 74 GED----MCVKVADFG 85 (244)
Q Consensus 74 ~~~----~~~kl~dfg 85 (244)
+.. +.++|+||+
T Consensus 139 ~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 139 QRISESEVIPVVCDNI 154 (210)
T ss_pred eccCCCCCcEEEEECC
Confidence 743 379999944
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.1e-14 Score=110.47 Aligned_cols=75 Identities=24% Similarity=0.267 Sum_probs=63.8
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~-i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
.++||||++|.+|..+..... ......+..++.|++.+|.+||+.| ++|+||||+||+++ ++.++|+|||.+...
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 479999999988877653333 3556677899999999999999999 99999999999999 789999999987543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.2e-13 Score=110.03 Aligned_cols=175 Identities=21% Similarity=0.300 Sum_probs=122.6
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCcEEEecCC
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
.....++.||++.|+|..++++.. .+.+....-.+|+.||++||.|||+.. ++|+++..+.|++..+|-+|+.--.
T Consensus 144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~a 223 (458)
T KOG1266|consen 144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVA 223 (458)
T ss_pred ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccC
Confidence 345788999999999999998632 335677778899999999999999984 9999999999999999988875422
Q ss_pred Cccccc-----ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhCC
Q 026042 86 ISCLES-----QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNA 156 (244)
Q Consensus 86 ~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~ 156 (244)
-..... .........+.++|.+||.-.....+-++|||++|...++|..+..--.+.. .+..........
T Consensus 224 p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l- 302 (458)
T KOG1266|consen 224 PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL- 302 (458)
T ss_pred ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-
Confidence 111110 0111223346788999987766677889999999999999987755422211 111111110000
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
. ...=+.++.+|++..|+.||++++++-.
T Consensus 303 ----e---n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 303 ----E---NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred ----c---CccccCcCcccccCCCCCCcchhhhhcC
Confidence 0 1122467899999999999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.6e-13 Score=103.68 Aligned_cols=77 Identities=31% Similarity=0.558 Sum_probs=67.4
Q ss_pred EeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCC
Q 026042 6 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 6 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
++......+++|||++|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||
T Consensus 67 ~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 67 YFVDPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred EEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 4455677889999999999999987543 1 7888999999999999999999999999999999 7889999999
Q ss_pred Cccc
Q 026042 86 ISCL 89 (244)
Q Consensus 86 ~~~~ 89 (244)
.+..
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8754
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.2e-13 Score=104.60 Aligned_cols=69 Identities=26% Similarity=0.354 Sum_probs=59.2
Q ss_pred EEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 14 CIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 14 ~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
++|+|+++| .+|.+++... .+++. .+.+++.+|.+||++||+|+||||.||+++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 599999997 6999998653 34443 356899999999999999999999999999988999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.8e-13 Score=102.26 Aligned_cols=73 Identities=29% Similarity=0.491 Sum_probs=63.2
Q ss_pred eecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 7 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
+...+..++||||++|++|.+++..... .++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.
T Consensus 66 ~~~~~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 66 DVDPDNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred EEECCCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence 3455667899999999999998765321 7889999999999999999999999999999 78999999998
Q ss_pred ccc
Q 026042 87 SCL 89 (244)
Q Consensus 87 ~~~ 89 (244)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=7.8e-13 Score=101.97 Aligned_cols=72 Identities=19% Similarity=0.250 Sum_probs=61.4
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
...++||||++|++|...... .....++.+++.++.++|+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 345899999999998765431 335678899999999999999999999999999999999999999988543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.3e-12 Score=115.37 Aligned_cols=75 Identities=28% Similarity=0.428 Sum_probs=65.0
Q ss_pred EEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEec
Q 026042 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 83 (244)
Q Consensus 4 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~d 83 (244)
+.++......++||||++|++|.+++. ....++.+++.+|.+||+.|++|||+||+||++ .++.++|+|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEe
Confidence 345555667789999999999999886 346788999999999999999999999999999 577899999
Q ss_pred CCCccc
Q 026042 84 FGISCL 89 (244)
Q Consensus 84 fg~~~~ 89 (244)
||++..
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999755
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-12 Score=109.62 Aligned_cols=185 Identities=23% Similarity=0.235 Sum_probs=139.1
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCccCCCCCCcEEEcCC-C
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSENLLLGED-M 77 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~----~L~~lH~~~i~H~dikp~nil~~~~-~ 77 (244)
.+..+...+..|+-+|.+ |.+|.++...... .++...++..+.+... ||.++|..+++|.|++|.||+...+ .
T Consensus 183 ~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 183 DSPAWEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cCcccccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc
Confidence 345677888999999999 6899999876543 4778888899999888 9999999999999999999999998 7
Q ss_pred cEEEecCCCcccccccCCC------CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026042 78 CVKVADFGISCLESQCGSA------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 151 (244)
..+++|||+.......... ....+...|++||..+ .-++.++|+|++|.++++..+|..+......... .+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCc-ccc
Confidence 8999999998765554422 1225788999999885 4568889999999999998887655443211110 000
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+....+.++...+..|++.+|..|++.+.+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111222333445667778999999999999998888776
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.3e-12 Score=115.11 Aligned_cols=178 Identities=27% Similarity=0.408 Sum_probs=143.7
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
......+++++|+.|++|...+++.+ ..+..-++.....+..++++||...+.|+|++|.|.+...+|..++.||+..
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~ 951 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTL 951 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccc
Confidence 45667889999999999999999877 4566677788889999999999999999999999999999999999999832
Q ss_pred ccccc--------------------------------cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC
Q 026042 88 CLESQ--------------------------------CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 135 (244)
Q Consensus 88 ~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 135 (244)
..... ........+++.|.+||...+......+|+|++|+.+++.++|
T Consensus 952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen 952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence 11000 0012245589999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhCCC-CCCCCCchHHHHHHHHHhcccCCCCCCCHH
Q 026042 136 LTPFDNMTPEQAAFAVCQKNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFD 187 (244)
Q Consensus 136 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 187 (244)
..||......+....+...... +..+...+....+++...+..+|.+|..+.
T Consensus 1032 ~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999998888776554432222 233445678899999999999999997766
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.5e-11 Score=93.79 Aligned_cols=74 Identities=22% Similarity=0.253 Sum_probs=58.4
Q ss_pred cEEEEEeccCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 12 VFCIITEYLAGGSLRK-YLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~-~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
..++||||++|+++.. .+.... .. ..+..++.+++.++.++|. .|++|+||||+||+++ ++.++|+|||.+..
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 3589999998854321 111111 11 5678899999999999999 9999999999999999 88999999998854
Q ss_pred c
Q 026042 90 E 90 (244)
Q Consensus 90 ~ 90 (244)
.
T Consensus 164 ~ 164 (187)
T cd05119 164 I 164 (187)
T ss_pred c
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.6e-10 Score=94.41 Aligned_cols=190 Identities=17% Similarity=0.313 Sum_probs=133.5
Q ss_pred EEEEEeccCCC-CHHHHHhh-cCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 13 FCIITEYLAGG-SLRKYLHQ-QEP---YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 13 ~~lv~e~~~~~-~L~~~i~~-~~~---~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
.-++|..++|. .+.++... ..+ ....|..+.++++.++.+.+.||..|..-||++++|+|+++++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 66777777764 23333321 111 13678899999999999999999999999999999999999999999985432
Q ss_pred ccccccCCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhC-CCCCCCCC-------HHHHHH-----
Q 026042 88 CLESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTA-LTPFDNMT-------PEQAAF----- 149 (244)
Q Consensus 88 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~-------~~~~~~----- 149 (244)
............+|...|.+||... +...+...|.|.||+++++++.| +.||.+.- +.+...
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2222223344567899999999765 33457789999999999999885 99997542 111100
Q ss_pred HH--HhhCCCCCCC-----CCchHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhhhhccC
Q 026042 150 AV--CQKNARPPVP-----PTCPKAFSYLISRCWSS--SPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 150 ~~--~~~~~~~~~~-----~~~~~~l~~li~~~l~~--~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
.. .......+.| ..+++.+..+..+|+.. ++.-|||++.++..|..+...+..
T Consensus 245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 00 0111111222 34578899999999974 356899999999999988776553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.4e-11 Score=88.02 Aligned_cols=79 Identities=18% Similarity=0.270 Sum_probs=67.3
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCcEEEcCCCc
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---GILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~---~i~H~dikp~nil~~~~~~ 78 (244)
+++.+...++..++++||++|+++..+ +......++.+++.+++.+|.. +++|+|++|.||+++..+.
T Consensus 57 ~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~ 127 (155)
T cd05120 57 KVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127 (155)
T ss_pred eEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE
Confidence 466777777889999999988777654 4466677889999999999985 6999999999999999899
Q ss_pred EEEecCCCccc
Q 026042 79 VKVADFGISCL 89 (244)
Q Consensus 79 ~kl~dfg~~~~ 89 (244)
++++|||.+..
T Consensus 128 ~~l~Df~~~~~ 138 (155)
T cd05120 128 LGIIDWEYAGY 138 (155)
T ss_pred EEEEecccccC
Confidence 99999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.3e-12 Score=110.14 Aligned_cols=150 Identities=15% Similarity=0.235 Sum_probs=110.4
Q ss_pred HHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEecCCCcccccccCC----------CCCCCcccceeccce
Q 026042 42 VLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS----------AKGFTGTYRWMAPEM 110 (244)
Q Consensus 42 ~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~ 110 (244)
...=+.+++.|+.++|+. +++|++|.|++|.++.+|.+||+.|+.+........ .........|.+||.
T Consensus 101 ~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 334455667999999976 899999999999999999999999988654332111 111224668999999
Q ss_pred eccCCCCCccchhhhHHHHHHHH-hCCCCCCCCCHHHHH--HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHH
Q 026042 111 IKEKRHTKKVDVYSFGIVLWELL-TALTPFDNMTPEQAA--FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 187 (244)
Q Consensus 111 ~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 187 (244)
+.+...+.++|+||+|+++|.+. .|+.-+......... ...............+|+++++=+.+++..++.-||++.
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 99988899999999999999998 465555543222211 111112222344578899999999999999999999887
Q ss_pred HHHH
Q 026042 188 QIVS 191 (244)
Q Consensus 188 el~~ 191 (244)
++..
T Consensus 261 ~l~~ 264 (700)
T KOG2137|consen 261 LLLS 264 (700)
T ss_pred hhhc
Confidence 7765
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1e-10 Score=86.79 Aligned_cols=74 Identities=28% Similarity=0.456 Sum_probs=61.1
Q ss_pred EeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCC
Q 026042 6 ACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 6 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
+.-+.+...|+|||++|..|.+++.... ..++..+=.-+.-||..||+|||++++||++...+ +.++|||
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhcc---------hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECC
Confidence 3455667779999999999999998762 34556666777889999999999999999997765 9999999
Q ss_pred Cccc
Q 026042 86 ISCL 89 (244)
Q Consensus 86 ~~~~ 89 (244)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.9e-10 Score=96.79 Aligned_cols=127 Identities=16% Similarity=0.258 Sum_probs=98.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~nil~~~~~~~ 79 (244)
++|++.+...+..|||+|-+ ..|..++++.+ ...+..-+.||+.||.||| +.+++|++|.-++|+|+..|..
T Consensus 72 l~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeW 144 (690)
T KOG1243|consen 72 LSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEW 144 (690)
T ss_pred hhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcE
Confidence 46788889999999999999 58999998755 4566777899999999998 5689999999999999999999
Q ss_pred EEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCC
Q 026042 80 KVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTAL 136 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 136 (244)
||++|.......... ..........|..|+.+.... -..|.|.|||++++++.|.
T Consensus 145 kLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 145 KLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred EEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 999998765433322 122222334556665543222 4569999999999999983
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-10 Score=88.85 Aligned_cols=77 Identities=16% Similarity=0.174 Sum_probs=59.1
Q ss_pred CcEEEEEeccCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 11 PVFCIITEYLAGGSLRK-YLHQQEPYSVPLNLVLKLALDIARGMQYL-HSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~-~i~~~~~~~~~~~~~~~~~~~l~~~L~~l-H~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
...+|||||+.+..+.. .++.. .++......+..+++.+|..+ |+.|++|||+++.||+++ ++.+.|+|||.+.
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav 172 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSV 172 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCce
Confidence 45679999996644422 22221 345566777889999999999 899999999999999997 4679999999886
Q ss_pred ccc
Q 026042 89 LES 91 (244)
Q Consensus 89 ~~~ 91 (244)
...
T Consensus 173 ~~~ 175 (197)
T cd05146 173 EPT 175 (197)
T ss_pred eCC
Confidence 544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.1e-10 Score=90.38 Aligned_cols=78 Identities=29% Similarity=0.256 Sum_probs=65.1
Q ss_pred CcEEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-------CCcEEEe
Q 026042 11 PVFCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-------DMCVKVA 82 (244)
Q Consensus 11 ~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-------~~~~kl~ 82 (244)
...++|+|++++. +|.+++........+......++.+++..+..||+.|++|+|+++.||+++. ++.+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999875 8999987533224566777899999999999999999999999999999975 4579999
Q ss_pred cCCCcc
Q 026042 83 DFGISC 88 (244)
Q Consensus 83 dfg~~~ 88 (244)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.4e-10 Score=83.31 Aligned_cols=85 Identities=24% Similarity=0.310 Sum_probs=67.0
Q ss_pred EeecCCcEEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEE
Q 026042 6 ACKKPPVFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKV 81 (244)
Q Consensus 6 ~~~~~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~---~~kl 81 (244)
++.+...-.|+|||++| .++.+++...............++..+-+.+.-||.++++||||+.+||++..+| .+.+
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEE
Confidence 34455666799999966 5899999876543444444478899999999999999999999999999997765 3589
Q ss_pred ecCCCcccc
Q 026042 82 ADFGISCLE 90 (244)
Q Consensus 82 ~dfg~~~~~ 90 (244)
+|||++...
T Consensus 158 Idfgls~~s 166 (229)
T KOG3087|consen 158 IDFGLSSVS 166 (229)
T ss_pred Eeecchhcc
Confidence 999997543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=82.70 Aligned_cols=76 Identities=32% Similarity=0.370 Sum_probs=65.8
Q ss_pred cEEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---cEEEecCCCc
Q 026042 12 VFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM---CVKVADFGIS 87 (244)
Q Consensus 12 ~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~---~~kl~dfg~~ 87 (244)
..++|+|+++| .+|.+++..... .+......++.+++..++-||++|++|+|+++.|||++.++ .+.++||+-+
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 45899999987 489999987542 56677889999999999999999999999999999999887 8999999865
Q ss_pred cc
Q 026042 88 CL 89 (244)
Q Consensus 88 ~~ 89 (244)
..
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 43
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.4e-10 Score=95.15 Aligned_cols=76 Identities=25% Similarity=0.308 Sum_probs=59.1
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR-GMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~-~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
..+|||||++|++|.++...... ..+ ...++.+++. .+..+|..|++|+|++|.||+++.+|.++++|||++...
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 45799999999999988754321 122 2345555555 478899999999999999999999999999999997554
Q ss_pred c
Q 026042 91 S 91 (244)
Q Consensus 91 ~ 91 (244)
.
T Consensus 308 ~ 308 (437)
T TIGR01982 308 S 308 (437)
T ss_pred C
Confidence 3
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.4e-10 Score=97.85 Aligned_cols=181 Identities=20% Similarity=0.252 Sum_probs=128.9
Q ss_pred EEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcEEEe
Q 026042 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCVKVA 82 (244)
Q Consensus 4 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-~~~kl~ 82 (244)
+..+......|+=.|||.++++...+.-.. .+++...+++..|++.++-++|+..++|+|++|+||++..+ +.-++.
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~--~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ--MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHHHH--hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcc
Confidence 345556667779999999999988773322 57778899999999999999999999999999999999886 677899
Q ss_pred cCCCcccccccCCCCCCCc-ccce-eccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 83 DFGISCLESQCGSAKGFTG-TYRW-MAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 83 dfg~~~~~~~~~~~~~~~~-~~~y-~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|||......- ....... +..| .++.......+..++|+++||..+.+.++|...-........ ......+.
T Consensus 410 ~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~-----i~~~~~p~ 482 (524)
T KOG0601|consen 410 DFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT-----IRSGDTPN 482 (524)
T ss_pred ccccccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee-----eecccccC
Confidence 9998754111 1112222 3333 355566666788999999999999999887543222111110 11222233
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
.+.....+..+...++..++..||.+.++..+.
T Consensus 483 ~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 483 LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 344447788888999999999999988877644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-09 Score=81.34 Aligned_cols=66 Identities=27% Similarity=0.297 Sum_probs=53.0
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI-----LHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i-----~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
..++||||++|.++.+. . ......+.+++.+|+.||+.++ +|+|++|.||+++ ++.++++||+.
T Consensus 65 ~~~lv~e~i~G~~l~~~----~------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 65 TGVLITEFIEGSELLTE----D------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CCeEEEEecCCCccccc----c------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 34799999999887643 0 1112456789999999999985 9999999999999 66899999997
Q ss_pred cc
Q 026042 87 SC 88 (244)
Q Consensus 87 ~~ 88 (244)
+.
T Consensus 134 a~ 135 (170)
T cd05151 134 AG 135 (170)
T ss_pred cc
Confidence 64
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=7e-09 Score=78.78 Aligned_cols=73 Identities=27% Similarity=0.380 Sum_probs=49.1
Q ss_pred EEEEEeccC--CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 13 FCIITEYLA--GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQY-LHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 13 ~~lv~e~~~--~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~-lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
..|||||++ |..+..+..... +......++.+++..+.. +|..|++|||+++.||+++++ .+.++|||.+..
T Consensus 81 ~~ivME~I~~~G~~~~~l~~~~~----~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 81 NVIVMEYIGEDGVPLPRLKDVDL----SPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp TEEEEE--EETTEEGGCHHHCGG----GGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred CEEEEEecCCCccchhhHHhccc----cchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 359999998 655555444321 123455667777775555 579999999999999999887 899999998755
Q ss_pred c
Q 026042 90 E 90 (244)
Q Consensus 90 ~ 90 (244)
.
T Consensus 156 ~ 156 (188)
T PF01163_consen 156 S 156 (188)
T ss_dssp T
T ss_pred c
Confidence 4
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=4.4e-07 Score=77.30 Aligned_cols=161 Identities=12% Similarity=0.222 Sum_probs=115.2
Q ss_pred cCCcEEEEEeccCC-CCHHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 9 KPPVFCIITEYLAG-GSLRKYLHQQE-------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 9 ~~~~~~lv~e~~~~-~~L~~~i~~~~-------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
.+..+++|++|+++ ++|.++-.... +...++..+|.++.|+..||.++|+.|+..+-|.|.+|+++
T Consensus 348 ~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~ 427 (655)
T KOG3741|consen 348 GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT 427 (655)
T ss_pred CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee
Confidence 34567899999986 78888653321 23467889999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~ 153 (244)
.+.+++|...|......... . +.+. --.+.|.-.||.+++.|.+|..- +......+..
T Consensus 428 G~~RIriS~C~i~Dvl~~d~-----------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~----- 486 (655)
T KOG3741|consen 428 GKMRIRISGCGIMDVLQEDP-----------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH----- 486 (655)
T ss_pred CcceEEEecccceeeecCCC-----------C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHH-----
Confidence 99889988766543322211 0 1111 12356888999999999998554 2222222111
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
...+...++.++++++......++++ -++.+++.++.
T Consensus 487 ---~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~ 523 (655)
T KOG3741|consen 487 ---LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIG 523 (655)
T ss_pred ---HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHH
Confidence 12234467889999999999999886 46999888654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.3e-08 Score=75.50 Aligned_cols=67 Identities=22% Similarity=0.407 Sum_probs=52.6
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
...++++||++|..|.+... +++ .+...+.+++..+|+.|++|||.+|.|+++++++ ++++||+...
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 44568999999988876532 222 2445677889999999999999999999998665 9999997643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.8e-08 Score=86.85 Aligned_cols=73 Identities=16% Similarity=0.164 Sum_probs=51.2
Q ss_pred CcEEEEEeccCCCCHHHHH--hhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----cEEEe
Q 026042 11 PVFCIITEYLAGGSLRKYL--HQQEP--YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----CVKVA 82 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i--~~~~~--~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~----~~kl~ 82 (244)
...+|||||+.|++|.++- ...+. ..+....+..++. .+...|++|+|+||.||+++.+| .++++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~ll 306 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-------QVFRDGFFHADMHPGNIFVSYDPPENPRYIAL 306 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-------HHHhCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence 3456999999999998753 32220 0122222333333 34568999999999999999888 99999
Q ss_pred cCCCcccc
Q 026042 83 DFGISCLE 90 (244)
Q Consensus 83 dfg~~~~~ 90 (244)
|||+....
T Consensus 307 DFGivg~l 314 (537)
T PRK04750 307 DFGIVGSL 314 (537)
T ss_pred ecceEEEC
Confidence 99987544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.7e-07 Score=71.91 Aligned_cols=77 Identities=16% Similarity=0.105 Sum_probs=64.7
Q ss_pred cEEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--EEEecCCCcc
Q 026042 12 VFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC--VKVADFGISC 88 (244)
Q Consensus 12 ~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~--~kl~dfg~~~ 88 (244)
..+||+|-++| .+|.+++.+..-...+......++.+++..++-||+.|+.|+|+.+.||+++.+|. +.++||.-++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 36899998853 79999987654334567777899999999999999999999999999999987666 9999998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.9e-07 Score=70.48 Aligned_cols=84 Identities=27% Similarity=0.397 Sum_probs=61.3
Q ss_pred EEEEeecC---CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------
Q 026042 3 FVAACKKP---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS--------------------- 58 (244)
Q Consensus 3 ~~~~~~~~---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~--------------------- 58 (244)
++.+.... +..++||||++|.++.+.+.. . .++......++.+++.+|..||+
T Consensus 62 ~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 138 (223)
T cd05154 62 VLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-P--ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQ 138 (223)
T ss_pred EEEECCCCCccCCceEEEEEeCCEecCCCCCC-C--CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHH
Confidence 45555553 266899999999888775532 1 35566666677777777777763
Q ss_pred -----------------------------------CCCccCCCCCCcEEEcC--CCcEEEecCCCccc
Q 026042 59 -----------------------------------QGILHRDLKSENLLLGE--DMCVKVADFGISCL 89 (244)
Q Consensus 59 -----------------------------------~~i~H~dikp~nil~~~--~~~~kl~dfg~~~~ 89 (244)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 139 VARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 56689999987644
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=9.6e-07 Score=69.77 Aligned_cols=73 Identities=22% Similarity=0.256 Sum_probs=54.7
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
+...+|||+++|..|...-- +......++..|+.-+..+-..|++|||+++-||+++++|.+.++||-.+...
T Consensus 180 nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCcccccC
Confidence 44569999998866654421 23344455556666666666899999999999999999999999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.5e-05 Score=56.92 Aligned_cols=82 Identities=22% Similarity=0.326 Sum_probs=64.2
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCcEEEcC
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKY---LHQQEPYSVPLNLVLKLALDIARGMQYLHS---QGILHRDLKSENLLLGE 75 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~---i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~---~~i~H~dikp~nil~~~ 75 (244)
+++|+|-. +++.||...+++... +.... ..+|..+.+++.++++.+.+++. ..+.-.|++++|+.+++
T Consensus 24 k~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~--~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~ 97 (188)
T PF12260_consen 24 KLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFL--QSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVND 97 (188)
T ss_pred CeeeECCC----EEEEEeecCcccccccccccccc--ccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeC
Confidence 57788733 479999976666432 11111 35789999999999999999998 45788899999999999
Q ss_pred CCcEEEecCCCccc
Q 026042 76 DMCVKVADFGISCL 89 (244)
Q Consensus 76 ~~~~kl~dfg~~~~ 89 (244)
+|.+|++|......
T Consensus 98 ~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 98 DGRLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEEechhcch
Confidence 99999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.6e-05 Score=62.34 Aligned_cols=76 Identities=18% Similarity=0.202 Sum_probs=55.4
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEecCCCccccc
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLES 91 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~ 91 (244)
..|||||+.. . ..--..-....+....+..+..++++.+.-|-. .|++|+||+.-|||+. ++.+.++|||.+....
T Consensus 141 nVLvMEfIg~-~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 141 NVLVMEFIGD-D-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEeccC-C-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 4599999954 3 111111111123334677888899999998888 8999999999999999 7789999999886654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.88 E-value=5.7e-05 Score=70.44 Aligned_cols=166 Identities=17% Similarity=0.212 Sum_probs=114.1
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC---cEEEcCCCcEEEe--cCCCccc
Q 026042 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE---NLLLGEDMCVKVA--DFGISCL 89 (244)
Q Consensus 15 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~---nil~~~~~~~kl~--dfg~~~~ 89 (244)
+..+++.+.++...+.... ..+...++.+..++..||+++|+....|.-+... +-..+..+.+... ||+.+..
T Consensus 263 v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~ 340 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKP 340 (1351)
T ss_pred HHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhccccc
Confidence 4457888888988888876 5778999999999999999999996666554444 3333444555555 7777665
Q ss_pred ccccCCCCCCCcccceeccceeccCCC--CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHH
Q 026042 90 ESQCGSAKGFTGTYRWMAPEMIKEKRH--TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKA 167 (244)
Q Consensus 90 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (244)
...............+.++|....... ....|+|++|.+...+..|..+-...... ..-.+......
T Consensus 341 l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~-----------~~~l~~~~~~~ 409 (1351)
T KOG1035|consen 341 LPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP-----------VSLLDVLSTSE 409 (1351)
T ss_pred CCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch-----------hhhhccccchh
Confidence 554444444445666777777765544 45579999999999998875543211100 01111122236
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 026042 168 FSYLISRCWSSSPDRRPHFDQIVSIL 193 (244)
Q Consensus 168 l~~li~~~l~~~p~~Rps~~el~~~l 193 (244)
..+...+|+..++++|+++.+++...
T Consensus 410 ~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 410 LLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhhhhcchhhhhccchhhhhhch
Confidence 78888999999999999999999854
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00017 Score=56.67 Aligned_cols=29 Identities=24% Similarity=0.203 Sum_probs=25.4
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.++|+|+.|.||++++++ +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999888 99999987643
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00019 Score=57.06 Aligned_cols=29 Identities=17% Similarity=0.166 Sum_probs=25.6
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 48999999999999997778899998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00013 Score=63.92 Aligned_cols=77 Identities=18% Similarity=0.243 Sum_probs=54.8
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
+.-.|+|||++|..+.+...... ...+.+.+...+.++ -+..+=..|++|.|.+|.||+++.+|.+.+.|||+....
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 44569999999999998853222 135544443333222 233444589999999999999999999999999986543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=8.2e-05 Score=65.44 Aligned_cols=133 Identities=22% Similarity=0.203 Sum_probs=95.9
Q ss_pred cEEEEeecCCcEEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
++++.++-+....+.++++.++ +....+.... -.+..-+.....+.-..+++++|+.--+|+| ||+.++ +..+
T Consensus 298 ~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~ 371 (829)
T KOG0576|consen 298 RYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVK 371 (829)
T ss_pred cccccCCcccccchhhhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccc
Confidence 4566677778888999999776 2222211111 0122234455566677889999988667887 777655 5789
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 140 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 140 (244)
..||+...............+++.+++||+.....+..+.|.|++|.-..++..|..|-.
T Consensus 372 ~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 372 LLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999998877666556777889999999999999999999999999987777777766644
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0013 Score=57.78 Aligned_cols=76 Identities=17% Similarity=0.309 Sum_probs=52.9
Q ss_pred CcEEEEEeccCCCCHHHH--HhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC----CCcEEEecC
Q 026042 11 PVFCIITEYLAGGSLRKY--LHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----DMCVKVADF 84 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~--i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~----~~~~kl~df 84 (244)
..-.|+|||++|..+.|. |++++ ++...+..-+.+... ..+=..|++|+|=+|.||++.. ++.+.+.||
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 345699999999887664 44443 555554444433322 2333468999999999999984 568999999
Q ss_pred CCccccc
Q 026042 85 GISCLES 91 (244)
Q Consensus 85 g~~~~~~ 91 (244)
|+.....
T Consensus 350 Gl~~~is 356 (538)
T KOG1235|consen 350 GLYAVIS 356 (538)
T ss_pred ccccccc
Confidence 9875543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0063 Score=46.75 Aligned_cols=75 Identities=17% Similarity=0.267 Sum_probs=56.2
Q ss_pred cEEEEeecCCcEEEEEeccCC------CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 2 QFVAACKKPPVFCIITEYLAG------GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~------~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
+++|+.+++-...+|+|.+.+ .+|.+++++.. ++. ... ..+-+-..+|-+.+|+.+|++|.||++..
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 579999999999999998754 56888886543 444 333 34444556778899999999999999965
Q ss_pred CC----cEEEec
Q 026042 76 DM----CVKVAD 83 (244)
Q Consensus 76 ~~----~~kl~d 83 (244)
.+ .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0013 Score=54.60 Aligned_cols=75 Identities=17% Similarity=0.193 Sum_probs=59.3
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
.++-+.|++|++- |++|.-.- .....++..++.+.+..+.-+..+ ..-|||+.-+||+|+ +|.+.|+||.+
T Consensus 296 de~~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 296 DETLYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CCceEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence 3455678888877 66664321 134578889999998888888876 789999999999999 99999999999
Q ss_pred cccc
Q 026042 87 SCLE 90 (244)
Q Consensus 87 ~~~~ 90 (244)
++..
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 8754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.00092 Score=54.76 Aligned_cols=70 Identities=24% Similarity=0.355 Sum_probs=53.2
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
+..++|||++.|..|...-+- .+ +..+...+..-+--|..+|++|+|.+--||++++++.++++||-...
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeechHhh
Confidence 455799999988777654322 12 22344556666778889999999999999999999999999997543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.007 Score=56.72 Aligned_cols=30 Identities=30% Similarity=0.609 Sum_probs=24.2
Q ss_pred CCccCCCCCCcEEEcC-CCc-EEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGE-DMC-VKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~-~~~-~kl~dfg~~~~ 89 (244)
.++|+|++++||+++. ++. .-++||+++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 4999999999999985 333 57999988654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.81 E-value=7.6e-05 Score=71.63 Aligned_cols=180 Identities=12% Similarity=-0.040 Sum_probs=113.2
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCC--CCHHHHHHHHHHHHHHHHHHHhC-C----CccCCCCCCcEEEcCCCcEEEec
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYS--VPLNLVLKLALDIARGMQYLHSQ-G----ILHRDLKSENLLLGEDMCVKVAD 83 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~--~~~~~~~~~~~~l~~~L~~lH~~-~----i~H~dikp~nil~~~~~~~kl~d 83 (244)
..-+..++|+.+|.+.+.|-+..... +...-+...-.+.+....-+|+. | .+|.++|+.|.+|..+-.+++.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 34567888999999999887643222 22223333333435555666654 1 68999999999999999999999
Q ss_pred CCCcc-cccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCC
Q 026042 84 FGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP 162 (244)
Q Consensus 84 fg~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 162 (244)
+|+.+ ............+++.|+.++..+.-.++.++|+|..|+.+|....|..+|....... ...+.........+.
T Consensus 1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~-Lkgiidn~tf~sIe~ 1462 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPA-LKGIIDNHTFFSIEK 1462 (2724)
T ss_pred cccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHH-HcCcccccccccccc
Confidence 99987 3322233445667888999999888888999999999999999887866654321111 111111111222233
Q ss_pred CchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 163 ~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..|.+.-.....+|-.....||.-...+.
T Consensus 1463 l~pgdaNve~~~~Ll~K~~~rp~q~isls 1491 (2724)
T KOG1826|consen 1463 LKPGDANVEALHRLLWKYMERPGQYISLS 1491 (2724)
T ss_pred cCCCcccHHHHHHHHHHhhhcchhhhhcc
Confidence 33333344444445455567766555544
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0036 Score=51.53 Aligned_cols=31 Identities=23% Similarity=0.438 Sum_probs=27.7
Q ss_pred CccCCCCCCcEEEcCCCcEEEecCCCccccc
Q 026042 61 ILHRDLKSENLLLGEDMCVKVADFGISCLES 91 (244)
Q Consensus 61 i~H~dikp~nil~~~~~~~kl~dfg~~~~~~ 91 (244)
++|||+++.|++++..+.+-++||+++....
T Consensus 200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 8999999999999998889999999876543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.0095 Score=48.10 Aligned_cols=49 Identities=24% Similarity=0.306 Sum_probs=38.2
Q ss_pred HHHHHHHHHHHHHHHHHhC--CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 41 LVLKLALDIARGMQYLHSQ--GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 41 ~~~~~~~~l~~~L~~lH~~--~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
...+.+..+-.++.-.+.. -++|+|+.|+|++.++.|.++|+||.-|..
T Consensus 133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3444555666666666655 589999999999999989999999987644
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.012 Score=48.45 Aligned_cols=30 Identities=37% Similarity=0.702 Sum_probs=26.6
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.+++|+|+++.||++++++...++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.0082 Score=47.24 Aligned_cols=30 Identities=30% Similarity=0.397 Sum_probs=26.2
Q ss_pred CCccCCCCCCcEEEcC-CCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGE-DMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~-~~~~kl~dfg~~~~ 89 (244)
+++|+|+.+.||++++ ++.+.++||..+..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5999999999999998 57899999987643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.036 Score=45.50 Aligned_cols=26 Identities=12% Similarity=0.197 Sum_probs=21.1
Q ss_pred CCccCCCCCCcEEEcCC-Cc-EEEecCC
Q 026042 60 GILHRDLKSENLLLGED-MC-VKVADFG 85 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~-~~-~kl~dfg 85 (244)
.++|||+.+.||+++.+ +. +.++|..
T Consensus 194 sLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 194 VLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred eeEeCCCCcccEEECCCCCceEEEECch
Confidence 48999999999999865 43 6788865
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.017 Score=45.05 Aligned_cols=37 Identities=22% Similarity=0.277 Sum_probs=32.4
Q ss_pred HHHHHHHHhC--CCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 50 ARGMQYLHSQ--GILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 50 ~~~L~~lH~~--~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
+.+|.-.|+. +.+|||..|+||+-|..|.+||.|-+.
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 5678888854 799999999999999999999999764
|
The function of this family is unknown. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.0081 Score=47.43 Aligned_cols=31 Identities=32% Similarity=0.409 Sum_probs=25.5
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.+++|+|+.+.||++++++..-++||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998766567999997643
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.015 Score=47.52 Aligned_cols=30 Identities=37% Similarity=0.680 Sum_probs=26.4
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.022 Score=47.12 Aligned_cols=31 Identities=32% Similarity=0.584 Sum_probs=26.1
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.|++|+|++|+||+++++...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999998765568999997643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.023 Score=46.70 Aligned_cols=28 Identities=36% Similarity=0.525 Sum_probs=24.7
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
.+++|||+++.||+++. +.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999988 66899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.011 Score=44.87 Aligned_cols=28 Identities=21% Similarity=0.306 Sum_probs=24.9
Q ss_pred CccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 61 ILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 61 i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.+|+|+.|.|++++++| ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998877 89999998644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.012 Score=45.92 Aligned_cols=30 Identities=27% Similarity=0.426 Sum_probs=20.9
Q ss_pred CCCccCCCCCCcEEEc-CCCcEEEecCCCcc
Q 026042 59 QGILHRDLKSENLLLG-EDMCVKVADFGISC 88 (244)
Q Consensus 59 ~~i~H~dikp~nil~~-~~~~~kl~dfg~~~ 88 (244)
..++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3599999999999999 66777899998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.025 Score=46.36 Aligned_cols=29 Identities=28% Similarity=0.355 Sum_probs=25.8
Q ss_pred CCccCCCCCCcEEEcCC----CcEEEecCCCcc
Q 026042 60 GILHRDLKSENLLLGED----MCVKVADFGISC 88 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~----~~~kl~dfg~~~ 88 (244)
+++|+|+.+.||+++++ +.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999884 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.031 Score=48.79 Aligned_cols=73 Identities=19% Similarity=0.229 Sum_probs=47.0
Q ss_pred CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC----------CCCCchHHHHHHHHHhcccCCCCCCCHH
Q 026042 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----------VPPTCPKAFSYLISRCWSSSPDRRPHFD 187 (244)
Q Consensus 118 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 187 (244)
+++|||++|.++.++.-|...+......+....+..-..... ..-.+++.+.++..+|+-..|..||...
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~ 189 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPM 189 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchh
Confidence 499999999999999998877765554444433332221111 0112345667788889888888887555
Q ss_pred HHH
Q 026042 188 QIV 190 (244)
Q Consensus 188 el~ 190 (244)
++.
T Consensus 190 ~~~ 192 (725)
T KOG1093|consen 190 ELS 192 (725)
T ss_pred HHh
Confidence 443
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.018 Score=46.12 Aligned_cols=29 Identities=24% Similarity=0.334 Sum_probs=25.3
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.++|+|+.|.||++++++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999877 78999987644
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.042 Score=45.73 Aligned_cols=29 Identities=31% Similarity=0.504 Sum_probs=25.7
Q ss_pred CccCCCCCCcEEEcCCCc-EEEecCCCccc
Q 026042 61 ILHRDLKSENLLLGEDMC-VKVADFGISCL 89 (244)
Q Consensus 61 i~H~dikp~nil~~~~~~-~kl~dfg~~~~ 89 (244)
++|+|+.|+||+++.+.. ..++||+.++.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999999874 88999997643
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.092 Score=40.25 Aligned_cols=31 Identities=29% Similarity=0.366 Sum_probs=25.3
Q ss_pred CCCccCCCCCCcEEEcCCC-----cEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDM-----CVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~-----~~kl~dfg~~~~ 89 (244)
..++|||+.+.||++..++ .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4689999999999997543 589999987643
|
subfamily of choline kinases |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.021 Score=44.23 Aligned_cols=30 Identities=33% Similarity=0.464 Sum_probs=21.0
Q ss_pred CCccCCCCCCcEEE-cCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLL-GEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~-~~~~~~kl~dfg~~~~ 89 (244)
.++|+|+.+.||++ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 7788999999987643
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.084 Score=43.54 Aligned_cols=30 Identities=17% Similarity=0.220 Sum_probs=27.0
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
+++|+|+.++|+++++++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998899999987644
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.062 Score=45.07 Aligned_cols=29 Identities=24% Similarity=0.571 Sum_probs=25.3
Q ss_pred CCccCCCCCCcEEEcC-CCcEEEecCCCcc
Q 026042 60 GILHRDLKSENLLLGE-DMCVKVADFGISC 88 (244)
Q Consensus 60 ~i~H~dikp~nil~~~-~~~~kl~dfg~~~ 88 (244)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4689999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.67 E-value=0.11 Score=49.96 Aligned_cols=31 Identities=26% Similarity=0.463 Sum_probs=26.0
Q ss_pred CCCccCCCCCCcEEEcCCC--cEE-EecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDM--CVK-VADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~--~~k-l~dfg~~~~ 89 (244)
.+++|+|++++||+++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998644
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.055 Score=43.91 Aligned_cols=30 Identities=23% Similarity=0.401 Sum_probs=24.9
Q ss_pred CCccCCCCCCcEEEcCCCc-EEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMC-VKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~-~kl~dfg~~~~ 89 (244)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 46999997644
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.19 Score=38.70 Aligned_cols=57 Identities=28% Similarity=0.511 Sum_probs=41.5
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
....||.||++... .....-+.+|.+-+..+|..||+-+|+++.|.. + -+|+|||.+
T Consensus 150 ~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 150 PIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKILHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred ccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHHHHCCeeeccCcccccc---C--CEEEecccC
Confidence 34567777775532 122334567888889999999999999999987 3 488999864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.16 Score=42.28 Aligned_cols=29 Identities=24% Similarity=0.224 Sum_probs=23.9
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.+++|+|+.+.||+++ + .+.++||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 3 578999997643
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.2 Score=41.68 Aligned_cols=36 Identities=31% Similarity=0.334 Sum_probs=24.8
Q ss_pred HHHHHHHHHHHHHHHHHH----hCCCccCCCCCCcEEEcC
Q 026042 40 NLVLKLALDIARGMQYLH----SQGILHRDLKSENLLLGE 75 (244)
Q Consensus 40 ~~~~~~~~~l~~~L~~lH----~~~i~H~dikp~nil~~~ 75 (244)
+-++-++.|++--.--+- -.+.+|-||||+|||+-+
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 445667777765542232 236999999999999944
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.76 E-value=0.31 Score=41.19 Aligned_cols=77 Identities=21% Similarity=0.182 Sum_probs=54.6
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEecCCCccccc
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLES 91 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~ 91 (244)
..|||+|+.+ +=+..= +.....++...+..+-.|++.-+.-|-+ .+++|.||.--|+|+ .+|.+.++|.+.+.-..
T Consensus 239 hVLVM~FlGr-dgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 239 HVLVMEFLGR-DGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred ceEeeeeccC-CCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccCC
Confidence 3599999943 211110 1112246677788888888888877765 489999999999999 55789999998876544
Q ss_pred c
Q 026042 92 Q 92 (244)
Q Consensus 92 ~ 92 (244)
.
T Consensus 316 H 316 (520)
T KOG2270|consen 316 H 316 (520)
T ss_pred C
Confidence 3
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.18 Score=48.38 Aligned_cols=30 Identities=27% Similarity=0.330 Sum_probs=24.8
Q ss_pred CCCccCCCCCCcEEEcCCC--c---EEEecCCCcc
Q 026042 59 QGILHRDLKSENLLLGEDM--C---VKVADFGISC 88 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~--~---~kl~dfg~~~ 88 (244)
.+++|+|++++||+++.++ . .-|+|||.+.
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 5899999999999998652 3 3799999764
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.20 E-value=0.32 Score=40.58 Aligned_cols=29 Identities=34% Similarity=0.447 Sum_probs=25.0
Q ss_pred CccCCCCCCcEEEcC-CCcEEEecCCCccc
Q 026042 61 ILHRDLKSENLLLGE-DMCVKVADFGISCL 89 (244)
Q Consensus 61 i~H~dikp~nil~~~-~~~~kl~dfg~~~~ 89 (244)
++|+|+.+.||++++ ++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975 56899999987643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=91.77 E-value=0.29 Score=38.51 Aligned_cols=25 Identities=24% Similarity=0.373 Sum_probs=21.8
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHH
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLR 26 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~ 26 (244)
+++.+....++.|+|+||++-+.+.
T Consensus 75 ~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 75 KVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ceEEecCCCCeeEEEEeeccCCCCC
Confidence 5788899999999999999986665
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.59 E-value=0.97 Score=34.16 Aligned_cols=66 Identities=26% Similarity=0.258 Sum_probs=44.2
Q ss_pred EEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC-CCcEEEcCCCcEEEecCCCccc
Q 026042 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK-SENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 15 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dik-p~nil~~~~~~~kl~dfg~~~~ 89 (244)
+.|||+.|.+|.++-... +.+. ...+++.---|-..||-|+.|+ |...++..++.+.|+||..|..
T Consensus 89 i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 559999988887765532 1222 2345555555667799999985 4545554555899999998763
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.46 E-value=0.88 Score=39.07 Aligned_cols=60 Identities=22% Similarity=0.314 Sum_probs=44.7
Q ss_pred EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcC
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGE 75 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~nil~~~ 75 (244)
..|+-+|..|.++..+++... .++....+++.-.+.|+-.+- -.+++|.|++|.||++--
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 357778999999999998654 455566666666666655444 458999999999999943
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=90.26 E-value=0.51 Score=38.44 Aligned_cols=28 Identities=29% Similarity=0.404 Sum_probs=23.5
Q ss_pred CccCCCCCCcEEEcCC--C---cEEEecCCCcc
Q 026042 61 ILHRDLKSENLLLGED--M---CVKVADFGISC 88 (244)
Q Consensus 61 i~H~dikp~nil~~~~--~---~~kl~dfg~~~ 88 (244)
++|||++.+||++..+ | .++++||-.++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999664 3 58999998653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 244 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-36 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-33 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-31 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-31 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-31 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-31 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-31 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-31 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-31 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-31 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-31 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-31 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-31 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-30 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-30 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-30 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-30 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-30 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-30 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-30 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-30 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-30 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-30 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-30 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-30 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-30 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-30 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-30 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-30 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-30 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-29 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-29 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-29 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-29 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-29 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-29 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-29 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-29 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-29 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-29 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-29 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-29 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-29 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-29 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-29 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-29 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-29 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-28 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-28 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-28 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-28 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-28 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-28 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-28 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-28 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-28 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-28 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-28 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-28 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-28 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-28 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-28 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-28 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-28 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-28 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-28 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-28 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-28 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-28 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-28 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-28 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-28 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-28 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-28 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-28 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-28 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-28 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-28 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-28 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-28 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-28 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-28 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-28 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-28 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-28 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-28 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-28 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-28 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-28 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-28 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-27 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-27 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-27 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-27 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-27 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-27 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-27 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-27 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-27 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-27 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-27 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-27 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-27 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-27 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-26 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-26 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-26 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-26 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-26 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-26 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-26 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-26 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-26 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-26 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-26 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-26 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-26 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-26 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-26 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-26 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-26 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-26 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-26 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-26 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-26 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-26 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-26 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-26 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-26 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-26 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-26 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-26 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-26 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-26 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-26 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-26 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-25 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-25 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-25 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-25 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-25 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-25 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-25 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-25 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-25 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-24 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-24 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-24 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-24 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-24 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-24 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-24 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-24 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-24 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-24 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-24 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-24 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-24 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-24 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-24 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-24 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-23 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-23 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-23 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-23 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-23 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-22 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-22 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-22 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-22 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-22 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-22 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-22 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-22 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-22 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-22 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-22 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-22 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-22 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-22 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-22 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-22 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-22 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-22 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-22 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-22 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-22 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-22 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-22 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-22 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-22 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-22 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-22 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-22 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-22 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-22 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-21 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-21 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-21 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-21 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-21 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-21 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-21 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-21 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-21 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-21 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-21 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-21 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-20 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-20 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-20 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-20 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-20 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-20 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-20 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-20 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-20 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-20 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-20 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-20 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-20 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-20 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-20 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-20 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-20 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-20 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-20 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-20 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-20 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-20 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-19 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-19 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-19 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-19 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-19 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-19 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-19 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-19 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-19 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-19 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-19 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-19 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-18 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-18 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-18 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-18 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-18 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-18 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-18 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-18 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-18 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-18 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-18 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-18 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-18 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-17 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-17 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-17 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-17 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-17 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-17 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-17 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-16 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-16 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-14 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 7e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-08 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-112
Identities = 81/208 (38%), Positives = 120/208 (57%), Gaps = 4/208 (1%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQG 60
F+ A +PP I+TEYL+ GSL + LH+ + L +A D+A+GM YLH++
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 61 --ILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHT 117
I+HR+LKS NLL+ + VKV DFG+S L++ S+K GT WMAPE+++++
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+K DVYSFG++LWEL T P+ N+ P Q AV K R +P + +I CW+
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 178 SSPDRRPHFDQIVSILEGYSESLEQDPE 205
+ P +RP F I+ +L +S P
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKSAVPPPN 305
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-105
Identities = 70/204 (34%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG- 60
C K P C++ E+ GG L + L + +P ++++ A+ IARGM YLH +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 61 --ILHRDLKSENLLLGE--------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEM 110
I+HRDLKS N+L+ + + +K+ DFG++ + G Y WMAPE+
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEV 185
Query: 111 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY 170
I+ +K DV+S+G++LWELLT PF + A+ V P+P TCP+ F+
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAK 245
Query: 171 LISRCWSSSPDRRPHFDQIVSILE 194
L+ CW+ P RP F I+ L
Sbjct: 246 LMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = e-104
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 2 QFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
+ AC+ PP +IT ++ GSL LH+ + V + +K ALD+ARGM +LH+
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 60 G--ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-- 115
I L S ++++ EDM +++ + G W+APE +++K
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPED 186
Query: 116 -HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 174
+ + D++SF ++LWEL+T PF +++ + V + RP +PP S L+
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKI 246
Query: 175 CWSSSPDRRPHFDQIVSILEGYSE 198
C + P +RP FD IV ILE +
Sbjct: 247 CMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = e-101
Identities = 74/240 (30%), Positives = 106/240 (44%), Gaps = 28/240 (11%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+F+ K ITEY+ GG+LR + + P + + A DIA GM YLHS I
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQC---------------GSAKGFTGTYRWM 106
+HRDL S N L+ E+ V VADFG++ L G WM
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-CQKNARPPVPPTCP 165
APEMI + + +KVDV+SFGIVL E++ + + P F + + PP CP
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCP 249
Query: 166 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE-----------QDPEFFSSFIPSP 214
+F + RC P++RP F ++ LE L D F+ ++
Sbjct: 250 PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGE 309
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = e-100
Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 12/203 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
F+ P I+T++ G SL +LH E + ++ +A ARGM YLH++ I
Sbjct: 84 LFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSA---KGFTGTYRWMAPEMIKEKRH-- 116
+HRDLKS N+ L ED VK+ DFG++ +S+ + + +G+ WMAPE+I+ +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 117 -TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----VPPTCPKAFSYL 171
+ + DVY+FGIVL+EL+T P+ N+ + + + P V CPK L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 172 ISRCWSSSPDRRPHFDQIVSILE 194
++ C D RP F +I++ +E
Sbjct: 262 MAECLKKKRDERPSFPRILAEIE 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = e-100
Identities = 71/204 (34%), Positives = 109/204 (53%), Gaps = 16/204 (7%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG- 60
+ PP ++ E++ G L L + + + ++ L+L LDIA G++Y+ +Q
Sbjct: 87 KLYGLMHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 61 -ILHRDLKSENLLLGE-----DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI--K 112
I+HRDL+S N+ L +C KVADFG+S S G G ++WMAPE I +
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAE 201
Query: 113 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF--AVCQKNARPPVPPTCPKAFSY 170
E+ +T+K D YSF ++L+ +LT PFD + + F + ++ RP +P CP
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRN 261
Query: 171 LISRCWSSSPDRRPHFDQIVSILE 194
+I CWS P +RPHF IV L
Sbjct: 262 VIELCWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 3e-98
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
F+ AC PP IIT G +L + + + +N ++A +I +GM YLH++GI
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQC------GSAKGFTGTYRWMAPEMIK--- 112
LH+DLKS+N+ ++ V + DFG+ + + G +APE+I+
Sbjct: 152 LHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 113 ------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCP 165
+ +K DV++ G + +EL PF E + + +P +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-GTGMKPNLSQIGMG 269
Query: 166 KAFSYLISRCWSSSPDRRPHFDQIVSILE 194
K S ++ CW+ + RP F +++ +LE
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 4e-98
Identities = 74/229 (32%), Positives = 108/229 (47%), Gaps = 15/229 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHS- 58
++ AC P C++ EY GGSL LH EP + L ++G+ YLHS
Sbjct: 64 VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 59 --QGILHRDLKSENLLLGEDM-CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 115
+ ++HRDLK NLLL +K+ DFG +C G+ WMAPE+ +
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSN 179
Query: 116 HTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKAFSYLISR 174
+++K DV+S+GI+LWE++T PFD + P RPP+ PK L++R
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239
Query: 175 CWSSSPDRRPHFDQIVSILEGYSESLEQDPE-----FFSSFIPSPDHTI 218
CWS P +RP ++IV I+ E S P D +
Sbjct: 240 CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 5e-85
Identities = 64/236 (27%), Positives = 103/236 (43%), Gaps = 46/236 (19%)
Query: 2 QFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 57
F+A+ +IT Y GSL YL ++ L++ L IA G+ +LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLH 122
Query: 58 SQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-----AKGFTGTYR 104
+ I HRDLKS+N+L+ ++ +AD G++ + SQ + GT R
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 105 WMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALT----------PFDNMTPEQAA 148
+MAPE++ E K+VD+++FG+VLWE+ + PF ++ P +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 149 F-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
F VC RP +P + + L+ CW +P R +I L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-83
Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 46/243 (18%)
Query: 2 QFVAACKKPPV----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 57
F+AA K +IT+Y GSL YL ++ +LKLA G+ +LH
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH 151
Query: 58 SQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTYR 104
++ I HRDLKS+N+L+ ++ +AD G++ GT R
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 105 WMAPEMIKEKRH------TKKVDVYSFGIVLWELLTALT----------PFDNMTPEQAA 148
+M PE++ E + D+YSFG++LWE+ P+ ++ P +
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 149 F-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198
+ VC K RP P C + L++ CW+ +P R ++ L SE
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 199 SLE 201
S +
Sbjct: 332 SQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 4e-79
Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 46/241 (19%)
Query: 2 QFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 57
F+AA K ++++Y GSL YL++ Y+V + ++KLAL A G+ +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLH 156
Query: 58 SQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-----AKGFTGTYR 104
+ I HRDLKS+N+L+ ++ +AD G++ GT R
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 105 WMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALT----------PFDNMTPEQAA 148
+MAPE++ + K+ D+Y+ G+V WE+ + P+ ++ P +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 149 F-----AVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198
VC++ RP +P + + ++ CW ++ R +I L S+
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
Query: 199 S 199
Sbjct: 337 Q 337
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-72
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 57/262 (21%)
Query: 2 QFVAACKKPPV-----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 56
+F+ ++ + ++ EY GSL KYL + +LA + RG+ YL
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYL 127
Query: 57 HSQ---------GILHRDLKSENLLLGEDMCVKVADFGISCLES---------QCGSAKG 98
H++ I HRDL S N+L+ D ++DFG+S + + +A
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 99 FTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTALT---PFDNMTPEQAA 148
GT R+MAPE+++ + K+VD+Y+ G++ WE+ T P +++ Q A
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 149 FA---------------VCQKNARPPVPPTC------PKAFSYLISRCWSSSPDRRPHFD 187
F V ++ RP P ++ I CW + R
Sbjct: 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ 307
Query: 188 QIVSILEGYSESLEQDPEFFSS 209
+ E++ +
Sbjct: 308 XAEERMAELMMIWERNKSVSPT 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 4e-71
Identities = 62/236 (26%), Positives = 94/236 (39%), Gaps = 46/236 (19%)
Query: 2 QFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH 57
QF+ A K+ +IT + GSL +L V N + +A +ARG+ YLH
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH 138
Query: 58 SQ----------GILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYR 104
I HRD+KS+N+LL ++ +ADFG++ G G GT R
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 105 WMAPEMI-----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAF--------- 149
+MAPE++ ++ ++D+Y+ G+VLWEL + T D E F
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 150 ------AVCQKNARPPVPPTCPK-----AFSYLISRCWSSSPDRRPHFDQIVSILE 194
V K RP + K I CW + R + +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-59
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 5/205 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ A + P++ IITEY+ GSL +L + +N +L +A IA GM ++ +
Sbjct: 72 RLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL++ N+L+ + + K+ADFG++ +++ + +G +W APE I T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFGI+L E++T P+ MT + + ++ R P CP+ L+ CW
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 179 SPDRRPHFDQIVSILEGYSESLEQD 203
P+ RP FD + S+LE + + E
Sbjct: 250 RPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-58
Identities = 66/205 (32%), Positives = 113/205 (55%), Gaps = 5/205 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ A K P++ IITE++A GSL +L E PL ++ + IA GM ++ +
Sbjct: 247 KLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL++ N+L+ + K+ADFG++ +++ + +G +W APE I T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFGI+L E++T P+ M+ + A+ ++ R P P CP+ ++ RCW +
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKN 424
Query: 179 SPDRRPHFDQIVSILEGYSESLEQD 203
P+ RP F+ I S+L+ + + E
Sbjct: 425 RPEERPTFEYIQSVLDDFYTATESQ 449
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 72/212 (33%), Positives = 115/212 (54%), Gaps = 8/212 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q A + P++ I+TEY++ GSL +L + + L ++ +A IA GM Y+
Sbjct: 243 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL++ N+L+GE++ KVADFG++ +++ + +G +W APE R T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFGI+L EL T P+ M + V ++ R P PP CP++ L+ +CW
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRK 420
Query: 179 SPDRRPHFDQIVSILEGY---SESLEQDPEFF 207
P+ RP F+ + + LE Y +E Q E
Sbjct: 421 EPEERPTFEYLQAFLEDYFTSTEPQYQPGENL 452
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-58
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2 QFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
Q + ++ I+TEY+A GSL YL + + + +LK +LD+ M+YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
+HRDL + N+L+ ED KV+DFG++ S +W APE ++EK+ + K
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKS 367
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFGI+LWE+ + P+ + + V +K + P CP A ++ CW
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYDVMKNCWHLD 426
Query: 180 PDRRPHFDQIVSILEGYSES 199
RP F Q+ LE
Sbjct: 427 AATRPTFLQLREQLEHIRTH 446
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 3e-58
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 8/212 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q + C + P F IITE++ G+L YL + V ++L +A I+ M+YL +
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HR+L + N L+GE+ VKVADFG+S + G +W APE + + + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV++FG++LWE+ T ++P+ + Q + +K+ R P CP+ L+ CW
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACWQW 458
Query: 179 SPDRRPHFDQIVSILEGY----SESLEQDPEF 206
+P RP F +I E S S E + E
Sbjct: 459 NPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 1e-57
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 63
V K+P I+ E + GG +L + E + + +L++ D A GM+YL S+ +H
Sbjct: 180 VCTQKQP--IYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 64 RDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT--YRWMAPEMIKEKRHTKKV 120
RDL + N L+ E +K++DFG+S +A G +W APE + R++ +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFGI+LWE + +P+ N++ +Q V +K R P P CP A L+ +CW+
Sbjct: 297 DVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGGRLPCPELCPDAVFRLMEQCWAYE 355
Query: 180 PDRRPHFDQIVSILE 194
P +RP F I L+
Sbjct: 356 PGQRPSFSTIYQELQ 370
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-57
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q + C + P F IITE++ G+L YL + V ++L +A I+ M+YL +
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + N L+GE+ VKVADFG+S + +A G +W APE + + +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH--AGAKFPIKWTAPESLAYNKFS 190
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K DV++FG++LWE+ T ++P+ + Q + +K+ R P CP+ L+ CW
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRACW 249
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQDPE 205
+P RP F +I E + E
Sbjct: 250 QWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-57
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 2 QFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
Q + ++ I+TEY+A GSL YL + + + +LK +LD+ M+YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
+HRDL + N+L+ ED KV+DFG++ S +W APE ++EK+ + K
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKS 195
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFGI+LWE+ + P+ + + V +K + P CP A ++ CW
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWHLD 254
Query: 180 PDRRPHFDQIVSILEGYSES 199
RP F Q+ LE
Sbjct: 255 AAMRPSFLQLREQLEHIKTH 274
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-57
Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C V +IT+ + G L Y+ + + ++ +L + IA+GM YL + +
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTK 118
+HRDL + N+L+ VK+ DFG++ L ++ G +WMA E I + +T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+ DV+S+G+ +WEL+T P+D + + + + +K R P PP C ++ +CW
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMRKCWM 257
Query: 178 SSPDRRPHFDQIVSILEGYSESLEQDPE 205
D RP F +++ + +DP+
Sbjct: 258 IDADSRPKFRELIIEF----SKMARDPQ 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 6e-57
Identities = 71/205 (34%), Positives = 113/205 (55%), Gaps = 5/205 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q A + P++ I+TEY++ GSL +L + + L ++ +A IA GM Y+
Sbjct: 326 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL++ N+L+GE++ KVADFG++ +++ + +G +W APE R T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFGI+L EL T P+ M + V ++ R P PP CP++ L+ +CW
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRK 503
Query: 179 SPDRRPHFDQIVSILEGYSESLEQD 203
P+ RP F+ + + LE Y S E
Sbjct: 504 EPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-56
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 7/198 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ PP+ ++TE GSL L + + L + + A+ +A GM YL S+
Sbjct: 85 RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + NLLL VK+ DFG+ L + W APE +K + +
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 202
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
D + FG+ LWE+ T P+ + Q + ++ R P P CP+ ++ +CW
Sbjct: 203 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCW 262
Query: 177 SSSPDRRPHFDQIVSILE 194
+ P+ RP F + L
Sbjct: 263 AHKPEDRPTFVALRDFLL 280
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-56
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
+ + + ++ Y+ G L +++ + + + ++ L +ARGM+YL Q
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGT---YRWMAPEMIKEK 114
+HRDL + N +L E VKVADFG++ L+ + S + +W A E ++
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 115 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 173
R T K DV+SFG++LWELLT P+ ++ P + + R P P CP + ++
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-AQGRRLPQPEYCPDSLYQVMQ 262
Query: 174 RCWSSSPDRRPHFDQIVSILEGYSESLEQD 203
+CW + P RP F +V +E +L D
Sbjct: 263 QCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-56
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 10/206 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + + PV+ II E G LR +L ++ S+ L ++ A ++ + YL S+
Sbjct: 80 KLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRF 137
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRD+ + N+L+ + CVK+ DFG+S +E +WMAPE I +R T
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFT 195
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+ FG+ +WE+L + PF + + + R P+PP CP L+++CW
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCW 254
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQ 202
+ P RRP F ++ + L E +
Sbjct: 255 AYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-56
Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 11/210 (5%)
Query: 2 QFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
+ C + ++ Y+ G LR ++ + + + ++ L +A+GM+YL S+
Sbjct: 90 SLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASK 147
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGT---YRWMAPEMIKEK 114
+HRDL + N +L E VKVADFG++ + + S TG +WMA E ++ +
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 115 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 173
+ T K DV+SFG++LWEL+T P+ ++ + + R P CP ++
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLYEVML 266
Query: 174 RCWSSSPDRRPHFDQIVSILEGYSESLEQD 203
+CW + RP F ++VS + + +
Sbjct: 267 KCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-56
Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 7/205 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + + I+TEY+ GSL +L + + ++ + + GM+YL G
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + N+L+ ++ KV+DFG+S LE +A TG RW APE I + +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+SFG+V+WE+L P+ NMT +V ++ R P P CP A L+ CW
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-EEGYRLPAPMGCPHALHQLMLDCW 291
Query: 177 SSSPDRRPHFDQIVSILEGYSESLE 201
+RP F QIVS+L+ S E
Sbjct: 292 HKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 9e-56
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 9/210 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C+ ++ E G L KYL Q+ V +++L ++ GM+YL
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + N+LL K++DFG+S L + K T +W APE I + +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K DV+SFG+++WE + P+ M + + +K R P CP+ L++ CW
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCW 257
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQDPEF 206
+ + RP F + L Y + +
Sbjct: 258 TYDVENRPGFAAVELRLRNYYYDVVNEGHH 287
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-55
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 5/201 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q C + C++TE++ G L YL Q +L + LD+ GM YL +
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL + N L+GE+ +KV+DFG++ L+ Q S+ G +W +PE+ R++ K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 120 VDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
DV+SFG+++WE+ + P++N + + + R P +++ CW
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQIMNHCWRE 244
Query: 179 SPDRRPHFDQIVSILEGYSES 199
P+ RP F +++ L +ES
Sbjct: 245 RPEDRPAFSRLLRQLAEIAES 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-55
Identities = 72/228 (31%), Positives = 113/228 (49%), Gaps = 11/228 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ K IITEY+ G+L K+L +++ + ++ + IA GM+YL +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + N+L+ ++ KV+DFG+S LE + +G RW APE I ++ T
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+SFGIV+WE++T P+ ++ + A+ R P P CP A L+ +CW
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMDCPSAIYQLMMQCW 287
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCLPT 224
RRP F IVSIL + L + P+ + +R T
Sbjct: 288 QQERARRPKFADIVSIL----DKLIRAPDSLKTLADFDPRVSIRLPST 331
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-55
Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 7/201 (3%)
Query: 2 QFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+F C K+ P++ I+TEY++ G L YL + + + +L++ D+ GM +L S
Sbjct: 67 KFYGVCSKEYPIY-IVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDL + N L+ D+CVKV+DFG++ + Q S+ G +W APE+ +++
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K DV++FGI++WE+ + P+D T + V + R P ++ CW
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-SQGHRLYRPHLASDTIYQIMYSCWH 243
Query: 178 SSPDRRPHFDQIVSILEGYSE 198
P++RP F Q++S +E E
Sbjct: 244 ELPEKRPTFQQLLSSIEPLRE 264
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-55
Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 6/176 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I E+ G+L +++ ++ + L L+L I +G+ Y+HS+ +++RDLK N+ L
Sbjct: 96 FIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ VK+ DFG+ G GT R+M+PE I + + K+VD+Y+ G++L ELL
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ + K L+ + S P+ RP+ +I
Sbjct: 216 HVCDTAFETS------KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-55
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + ++ P + II E G L YL + + S+ + ++ +L I + M YL S
Sbjct: 77 KLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINC 134
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRD+ N+L+ CVK+ DFG+S +E + T +WM+PE I +R T
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS--VTRLPIKWMSPESINFRRFT 192
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+ F + +WE+L+ PF + + + +K R P P CP L++RCW
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL-EKGDRLPKPDLCPPVLYTLMTRCW 251
Query: 177 SSSPDRRPHFDQIVSILEGYSES 199
P RP F ++V L +
Sbjct: 252 DYDPSDRPRFTELVCSLSDVYQM 274
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-55
Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 11/227 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C + ++T+YL GSL ++ Q ++ L+L + IA+GM YL G+
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWMAPEMIKEKRHTK 118
+HR+L + N+LL V+VADFG++ L ++ +WMA E I ++T
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+ DV+S+G+ +WEL+T P+ + + + +K R P C ++ +CW
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGERLAQPQICTIDVYMVMVKCWM 255
Query: 178 SSPDRRPHFDQIVSILEGY----SESLEQDPEFFSSFIPSPDHTILR 220
+ RP F ++ + L E P P+ L
Sbjct: 256 IDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLT 302
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-55
Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ K I+TEY+ GSL +L + + + LV + IA GM+YL G
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV-GMLRGIASGMKYLSDMGY 168
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + N+L+ ++ KV+DFG+ LE +A G RW +PE I ++ T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+S+GIVLWE+++ P+ M+ + AV + R P P CP A L+ CW
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCW 287
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSP 214
+ RP F+QIVSIL + L ++P +
Sbjct: 288 QKDRNNRPKFEQIVSIL----DKLIRNPGSLKIITSAA 321
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-55
Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 1 MQFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 58
+ + C + ++ Y+ G LR ++ + + + ++ L +A+GM++L S
Sbjct: 153 LSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLAS 210
Query: 59 QGILHRDLKSENLLLGEDMCVKVADFGIS--CLESQCGSAKGFTGT---YRWMAPEMIKE 113
+ +HRDL + N +L E VKVADFG++ + + S TG +WMA E ++
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 114 KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 172
++ T K DV+SFG++LWEL+T P+ ++ + + R P CP ++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPDPLYEVM 329
Query: 173 SRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203
+CW + RP F ++VS + + +
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 6e-55
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 10/227 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C V +IT+ + G L Y+ + + ++ +L + IA+GM YL + +
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTK 118
+HRDL + N+L+ VK+ DFG++ L ++ G +WMA E I + +T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 119 KVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
+ DV+S+G+ +WEL+T P+D + + + + +K R P PP C ++ +CW
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIMVKCWM 257
Query: 178 SSPDRRPHFDQIVSILEGY---SESLEQDPEFFSSFIPSPDHTILRC 221
D RP F +++ + +PSP +
Sbjct: 258 IDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYR 304
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 9e-55
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 8/209 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C+ + ++ E GG L K+L + N+ +L ++ GM+YL +
Sbjct: 74 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEKNF 131
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRDL + N+LL K++DFG+S L + + +W APE I ++ +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
+ DV+S+G+ +WE L+ P+ M + + ++ R PP CP L+S CW
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCW 250
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQDPE 205
+ RP F + + SL E
Sbjct: 251 IYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-54
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 9/203 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q C K IITEY+A G L YL + +L++ D+ M+YL S+
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
LHRDL + N L+ + VKV+DFG+S + ++ G+ RW PE++ + +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV--GSKFPVRWSPPEVLMYSKFS 199
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K D+++FG+++WE+ + P++ T + A + + R P + ++ CW
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYTIMYSCW 258
Query: 177 SSSPDRRPHFDQIVSILEGYSES 199
D RP F ++S + +
Sbjct: 259 HEKADERPTFKILLSNILDVMDE 281
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-54
Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 15/223 (6%)
Query: 8 KKPPVFCIITEYLAGGSLRKYL----HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 63
+ P+ +I ++ G L +L + P+++PL +++ +DIA GM+YL S+ +H
Sbjct: 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIH 160
Query: 64 RDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKV 120
RDL + N +L EDM V VADFG+S + S +G +W+A E + + +T
Sbjct: 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHS 220
Query: 121 DVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV++FG+ +WE++T TP+ + + + R PP C + L+ +CWS+
Sbjct: 221 DVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-IGGNRLKQPPECMEEVYDLMYQCWSAD 279
Query: 180 PDRRPHFDQIVSILEGYSESLE-----QDPEFFSSFIPSPDHT 217
P +RP F + LE L QDP + + + H
Sbjct: 280 PKQRPSFTCLRMELENILGHLSVLSTSQDPLYI-NIERAHHHH 321
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-53
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 10 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLK----LALDIARGMQYLHSQGILHRD 65
P +I ++ G L YL + P ++ L+ +DIA GM+YL ++ LHRD
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD 172
Query: 66 LKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--RWMAPEMIKEKRHTKKVDV 122
L + N +L +DM V VADFG+S + S +G +W+A E + ++ +T K DV
Sbjct: 173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 232
Query: 123 YSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
++FG+ +WE+ T +TP+ + + + R P C ++ CW + P
Sbjct: 233 WAFGVTMWEIATRGMTPYPGVQNHEMYDYL-LHGHRLKQPEDCLDELYEIMYSCWRTDPL 291
Query: 182 RRPHFDQIVSILEGYSESLE 201
RP F + LE ESL
Sbjct: 292 DRPTFSVLRLQLEKLLESLP 311
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-53
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 29/229 (12%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYL------HQQEPYSVPLNLV--LKLALDIARG 52
++ + + +I E + G L+ YL P P +L +++A +IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 53 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY-------- 103
M YL++ +HRDL + N ++ ED VK+ DFG++ + T Y
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--------TDYYRKGGKGLL 202
Query: 104 --RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPV 160
RWM+PE +K+ T DV+SFG+VLWE+ T A P+ ++ EQ V +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-MEGGLLDK 261
Query: 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 209
P CP L+ CW +P RP F +I+S ++ E ++ F+ S
Sbjct: 262 PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-53
Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + + PV+ II E G LR +L ++ S+ L ++ A ++ + YL S+
Sbjct: 455 KLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRF 512
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HRD+ + N+L+ + CVK+ DFG+S +E +WMAPE I +R T
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFT 570
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
DV+ FG+ +WE+L + PF + + + R P+PP CP L+++CW
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNCPPTLYSLMTKCW 629
Query: 177 SSSPDRRPHFDQIVSILEGY 196
+ P RRP F ++ + L
Sbjct: 630 AYDPSRRPRFTELKAQLSTI 649
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-53
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 2 QFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
++ C +I EYL GSLR YL + + + +L+ I +GM+YL ++
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 133
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKR 115
+HRDL + N+L+ + VK+ DFG++ L K W APE + E +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 116 HTKKVDVYSFGIVLWELLT----------------ALTPFDNMTPEQAAFAVCQKNARPP 159
+ DV+SFG+VL+EL T M + + N R P
Sbjct: 194 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLP 252
Query: 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201
P CP +++ CW+++ ++RP F + ++ +++
Sbjct: 253 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-52
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 2 QFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
++ C + +I E+L GSL++YL + + + L LK A+ I +GM YL S+
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR 145
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKR 115
+HRDL + N+L+ + VK+ DFG++ +E+ W APE + + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 116 HTKKVDVYSFGIVLWELLT---------------ALTPFDNMTPEQAAFAVCQKNARPPV 160
DV+SFG+ L ELLT MT + + ++ R P
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL-KEGKRLPC 264
Query: 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
PP CP L+ +CW P R F ++ E
Sbjct: 265 PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-52
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 2 QFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------LKLA 46
+ K P+ +I Y + G L ++L + P+S + + L
Sbjct: 76 CLLGVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY-- 103
IA GM+YL S ++H+DL + N+L+ + + VK++D G+ + + Y
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA--------ADYYKL 186
Query: 104 --------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 154
RWMAPE I + + D++S+G+VLWE+ + L P+ + + + +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-RN 245
Query: 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196
P P CP L+ CW+ P RRP F I S L +
Sbjct: 246 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-52
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 33/234 (14%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYL-----HQQEPYSVPLNLVLKLALDIARGMQYL 56
+ + + I+ E +AGG L+ +L +P S+ + +L +A DIA G QYL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 57 HSQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQCGSAKGFTGTY--------- 103
+HRD+ + N LL G K+ DFG++ + Y
Sbjct: 157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR--------ASYYRKGGCAMLP 208
Query: 104 -RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 161
+WM PE E T K D +SFG++LWE+ + P+ + + ++ V R P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPP 267
Query: 162 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPD 215
CP ++++CW P+ RP+F I+ + E QDP+ ++ +P
Sbjct: 268 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQDPDVINTALPIEY 317
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-52
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILH 63
+ + ++ EYL G LR +L + + + +L + I +GM+YL S+ +H
Sbjct: 93 SYGPGRQSL-RLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVH 150
Query: 64 RDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKK 119
RDL + N+L+ + VK+ADFG++ L W APE + + +++
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 210
Query: 120 VDVYSFGIVLWELLT---------------ALTPFDNMTPEQAAFAVCQKNARPPVPPTC 164
DV+SFG+VL+EL T D + + ++ R P PP C
Sbjct: 211 SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL-EEGQRLPAPPAC 269
Query: 165 PKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE-QDPEFFSSFIPSPDHTI 218
P L+ CW+ SP RP F + L+ + F++ H++
Sbjct: 270 PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSL 324
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 4e-52
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 2 QFVAACKKPPV--FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
++ C +I EYL GSLR YL + + + +L+ I +GM+YL ++
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK 164
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKR 115
+HRDL + N+L+ + VK+ DFG++ L K W APE + E +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 116 HTKKVDVYSFGIVLWELLT----------------ALTPFDNMTPEQAAFAVCQKNARPP 159
+ DV+SFG+VL+EL T M + + N R P
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLP 283
Query: 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201
P CP +++ CW+++ ++RP F + ++ + +
Sbjct: 284 RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-52
Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 33/234 (14%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYL-----HQQEPYSVPLNLVLKLALDIARGMQYL 56
+ + + I+ E +AGG L+ +L +P S+ + +L +A DIA G QYL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 57 HSQGILHRDLKSENLLL---GEDMCVKVADFGIS-CLESQCGSAKGFTGTY--------- 103
+HRD+ + N LL G K+ DFG++ + G Y
Sbjct: 198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR--------AGYYRKGGCAMLP 249
Query: 104 -RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 161
+WM PE E T K D +SFG++LWE+ + P+ + + ++ V R P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-TSGGRMDPP 308
Query: 162 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPD 215
CP ++++CW P+ RP+F I+ + E QDP+ ++ +P
Sbjct: 309 KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQDPDVINTALPIEY 358
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-51
Identities = 65/221 (29%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 2 QFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
++ C+ ++ EY+ GSLR YL + S+ L +L A I GM YLH+Q
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKR 115
+HRDL + N+LL D VK+ DFG++ + + W APE +KE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 116 HTKKVDVYSFGIVLWELLT---------------ALTPFDNMTPEQAAFAVCQKNARPPV 160
DV+SFG+ L+ELLT MT + + ++ R P
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL-ERGERLPR 272
Query: 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201
P CP +L+ CW + RP F+ ++ IL+ E +
Sbjct: 273 PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 5e-51
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 8/209 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C+ + ++ E GG L K+L + +P++ V +L ++ GM+YL +
Sbjct: 400 RLIGVCQAEAL-MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 62 LHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGT---YRWMAPEMIKEKRHT 117
+HR+L + N+LL K++DFG+S L + + +W APE I ++ +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 118 KKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
+ DV+S+G+ +WE L+ P+ M + + ++ R PP CP L+S CW
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDCW 576
Query: 177 SSSPDRRPHFDQIVSILEGYSESLEQDPE 205
+ RP F + + SL E
Sbjct: 577 IYKWEDRPDFLTVEQRMRACYYSLASKVE 605
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-51
Identities = 64/245 (26%), Positives = 97/245 (39%), Gaps = 42/245 (17%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------LKLAL 47
+ AC+ + EY G+L +L + L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 48 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---- 103
D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S Y
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------RGQEVYVKKT 199
Query: 104 ------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156
RWMA E + +T DV+S+G++LWE+++ TP+ MT + + +
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGY 258
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES------LEQDPEFFSSF 210
R P C L+ +CW P RP F QI+ L E +F +
Sbjct: 259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAG 318
Query: 211 IPSPD 215
I
Sbjct: 319 IDCSA 323
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-51
Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 19/222 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYL--------------HQQEPYSVPLNLVLKLA 46
+ + AC + +I EY + G+LR+YL ++ + ++
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---Y 103
+ARGM+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K T
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFG+++WE+ T +P+ + E+ + ++ R P
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPA 282
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 204
C ++ CW + P +RP F Q+V L+ +
Sbjct: 283 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-50
Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------LKLAL 47
+F C ++ EY+ G L K+L P ++ L L +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 48 DIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY--- 103
IA GM YL SQ +HRDL + N L+G ++ VK+ DFG+S + S T Y
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS--------TDYYRVG 192
Query: 104 -------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155
RWM PE I ++ T + DV+SFG++LWE+ T P+ ++ + + +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI-TQG 251
Query: 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199
P CPK ++ CW P +R + +I IL ++
Sbjct: 252 RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-50
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 34/225 (15%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV-----------PLNLV--LKLALD 48
+F C + ++ EY+ G L ++L P + PL L L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY---- 103
+A GM YL +HRDL + N L+G+ + VK+ DFG+S + S T Y
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--------TDYYRVGG 218
Query: 104 ------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156
RWM PE I ++ T + DV+SFG+VLWE+ T P+ ++ +A + +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-TQGR 277
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201
P CP ++ CW P +R + + L+ +++
Sbjct: 278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-50
Identities = 64/229 (27%), Positives = 114/229 (49%), Gaps = 20/229 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------LKLA 46
+ + AC + +I EY + G+LR+YL + P + + + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---Y 103
+ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG++ K T
Sbjct: 198 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 257
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFG++LWE+ T +P+ + E+ + ++ R P
Sbjct: 258 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHRMDKPS 316
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY-SESLEQDPEFFSSF 210
C ++ CW + P +RP F Q+V L+ + + Q+ ++
Sbjct: 317 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH 365
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-50
Identities = 60/221 (27%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYL--------------HQQEPYSVPLNLVLKLA 46
+ + AC + +I EY + G+LR+YL ++ + ++
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---Y 103
+ARGM+YL SQ +HRDL + N+L+ E+ +K+ADFG++ + K T
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPP 162
+WMAPE + ++ +T + DV+SFG+++WE+ T +P+ + E+ + ++ R P
Sbjct: 270 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRMDKPA 328
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203
C ++ CW + P +RP F Q+V L+ +
Sbjct: 329 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 369
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-50
Identities = 51/178 (28%), Positives = 92/178 (51%), Gaps = 2/178 (1%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ +Y GG L K ++ Q+ + +L + I ++++H + ILHRD+KS+N+
Sbjct: 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157
Query: 73 LGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
L +D V++ DFGI+ L S A+ GT +++PE+ + K + K D+++ G VL+E
Sbjct: 158 LTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYE 217
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
L T F+ + + + + PPV L+S+ + +P RP + I
Sbjct: 218 LCTLKHAFEAGSMKNLVLKII-SGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-50
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 21/221 (9%)
Query: 2 QFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV--------------LKL 45
+ AC P +I E+ G+L YL + VP + +
Sbjct: 95 NLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 46 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--- 102
+ +A+GM++L S+ +HRDL + N+LL E VK+ DFG++ +
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 103 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 161
+WMAPE I ++ +T + DV+SFG++LWE+ + +P+ + ++ ++ R P
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 273
Query: 162 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202
+ CW P +RP F ++V L ++ Q
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-49
Identities = 71/234 (30%), Positives = 104/234 (44%), Gaps = 43/234 (18%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV------------------- 42
+ + C C++ EY+A G L ++L P++V
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 43 ---LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG 98
L +A +A GM YL + +HRDL + N L+GE+M VK+ADFG+S + S
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS------- 226
Query: 99 FTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 147
Y RWM PE I R+T + DV+++G+VLWE+ + L P+ M E+
Sbjct: 227 -ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 148 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201
+ V + P CP L+ CWS P RP F I IL+ E E
Sbjct: 286 IYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-49
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYL----------------HQQEPYSVPLNLVLKL 45
+ AC +ITEY G L +L + + ++ L +L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 46 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--- 102
+ +A+GM +L S+ +HRDL + N+LL K+ DFG++ +
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 103 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVP 161
+WMAPE I +T + DV+S+GI LWEL + +P+ M + + + ++ R P
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270
Query: 162 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196
P ++ CW + P +RP F QIV ++E
Sbjct: 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-48
Identities = 55/220 (25%), Positives = 97/220 (44%), Gaps = 16/220 (7%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV------------LKLALDI 49
+ AC +ITEY G L +L ++ L + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 50 ARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT---YRWM 106
A+GM +L S+ +HRD+ + N+LL K+ DFG++ + +WM
Sbjct: 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM 233
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
APE I + +T + DV+S+GI+LWE+ + L P+ + + + + + P P
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 293
Query: 166 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 205
K ++ CW+ P RP F QI S L+ ++ ++ +
Sbjct: 294 KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRERD 333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-48
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 43/227 (18%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYL--------------------HQQEPYSVPLNL 41
+ AC + +I EY GSLR +L P L +
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 42 V--LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKG 98
+ A I++GMQYL ++HRDL + N+L+ E +K++DFG+S +
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE------- 202
Query: 99 FTGTY----------RWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 147
+Y +WMA E + + +T + DV+SFG++LWE++T P+ + PE+
Sbjct: 203 -EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 148 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
+ + R P C + L+ +CW PD+RP F I LE
Sbjct: 262 FNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-47
Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 17/190 (8%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYS-VPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I + +L+ +++ + ++ L + L IA +++LHS+G++HRDLK N+
Sbjct: 91 YIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIF 150
Query: 73 LGEDMCVKVADFGISCL-------------ESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
D VKV DFG+ G GT +M+PE I ++ K
Sbjct: 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK 210
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
VD++S G++L+EL L PF + PP+ ++ S S
Sbjct: 211 VDIFSLGLILFEL---LYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 180 PDRRPHFDQI 189
P RP I
Sbjct: 268 PMERPEAINI 277
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-47
Identities = 49/231 (21%), Positives = 87/231 (37%), Gaps = 38/231 (16%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
C ++ E++ GSL YL + + + + L++A +A M +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTL 134
Query: 62 LHRDLKSENLLL--------GEDMCVKVADFGIS-CLESQCGSAKGFTGTY----RWMAP 108
+H ++ ++N+LL G +K++D GIS + W+ P
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--------KDILQERIPWVPP 186
Query: 109 EMIKEKRH-TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 166
E I+ ++ D +SFG LWE+ + P + ++ + + P P
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDRHQLPAPKAAE- 244
Query: 167 AFSY-LISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDH 216
LI+ C PD RP F I+ L F +P H
Sbjct: 245 --LANLINNCMDYEPDHRPSFRAIIRDLNSL---------FTPDLVPRGSH 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-47
Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 6/177 (3%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+ TE G SL+++ + S+P V D + +LHSQG++H D+K N+
Sbjct: 132 LYLQTEL-CGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
LG K+ DFG+ G+ + G R+MAPE+++ + DV+S G+ + E+
Sbjct: 190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEV 248
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ Q + Q P ++ P R + +
Sbjct: 249 ACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV------------------- 42
+ AC +I EY G L YL + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 43 --LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT 100
L A +A+GM++L + +HRDL + N+L+ VK+ DFG++ +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 101 GT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156
+WMAPE + E +T K DV+S+GI+LWE+ + + P+ + + + + Q
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 292
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196
+ P + ++ CW+ +RP F + S L
Sbjct: 293 KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-46
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 8/186 (4%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-- 60
+ + K ++TE + G+L+ YL + + + ++ I +G+Q+LH++
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 61 ILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
I+HRDLK +N+ + G VK+ D G++ L+ AK GT +MAPEM +EK + +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-YDES 209
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPP-TCPKAFSYLISRCWSS 178
VDVY+FG+ + E+ T+ P+ + +P +I C
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269
Query: 179 SPDRRP 184
+ D R
Sbjct: 270 NKDERY 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-46
Identities = 46/186 (24%), Positives = 89/186 (47%), Gaps = 7/186 (3%)
Query: 13 FCIITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
I+ E G L + + +++ +P V K + + ++++HS+ ++HRD+K N
Sbjct: 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166
Query: 71 LLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+ + VK+ D G+ S+ +A GT +M+PE I E + K D++S G +L
Sbjct: 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226
Query: 130 WELLTALTPF--DNMTPEQAAFAVCQKNARPPVPPTC-PKAFSYLISRCWSSSPDRRPHF 186
+E+ +PF D M + Q + PP+P + L++ C + P++RP
Sbjct: 227 YEMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285
Query: 187 DQIVSI 192
+ +
Sbjct: 286 TYVYDV 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-44
Identities = 48/191 (25%), Positives = 77/191 (40%), Gaps = 10/191 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
A ++ P I E L GGSL + + Q P + L G++YLH++ I
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCL--PEDRALYYLGQALEGLEYLHTRRI 171
Query: 62 LHRDLKSENLLLGED-MCVKVADFGIS------CLESQCGSAKGFTGTYRWMAPEMIKEK 114
LH D+K++N+LL D + DFG + L + GT MAPE++ K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 115 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLIS 173
KVD++S ++ +L P+ + + +PP+C + I
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQ 291
Query: 174 RCWSSSPDRRP 184
P R
Sbjct: 292 EGLRKEPVHRA 302
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-44
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 16/198 (8%)
Query: 13 FCIITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++ + G+L + + + + + +L L L I RG++ +H++G HRDLK N
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN 164
Query: 71 LLLGEDMCVKVADFGISCLES----------QCGSAKGFTGTYRWMAPEMIKEKRH---T 117
+LLG++ + D G T + APE+ + H
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAFSYLISRCW 176
++ DV+S G VL+ ++ P+D + + + A Q P P A L++
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMM 284
Query: 177 SSSPDRRPHFDQIVSILE 194
+ P +RPH ++S LE
Sbjct: 285 TVDPHQRPHIPLLLSQLE 302
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-43
Identities = 40/198 (20%), Positives = 76/198 (38%), Gaps = 29/198 (14%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
I EY GGSL + + + L L + RG++Y+HS ++H D+K N+
Sbjct: 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNI 146
Query: 72 LLGED-------------------MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK 112
+ + K+ D G ++ S + G R++A E+++
Sbjct: 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVEEGDSRFLANEVLQ 203
Query: 113 E-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 171
E H K D+++ + + A N + ++ P +P + F+ L
Sbjct: 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WHEIRQGRLPRIPQVLSQEFTEL 259
Query: 172 ISRCWSSSPDRRPHFDQI 189
+ P+RRP +
Sbjct: 260 LKVMIHPDPERRPSAMAL 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-43
Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 9/185 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQG-----ILHRD 65
I+ EY GG L + + L VL++ + ++ H + +LHRD
Sbjct: 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 66 LKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYS 124
LK N+ L VK+ DFG++ L AK F GT +M+PE + + +K D++S
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
G +L+EL + PF + ++ A + + +P + +I+R + RP
Sbjct: 202 LGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 185 HFDQI 189
++I
Sbjct: 261 SVEEI 265
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 3e-43
Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 17/203 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP-LNLVLKLALDIARGMQYLHSQ 59
+ + I + +L+ +++++ + L + + IA +++LHS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFT------------GTYRWM 106
G++HRDLK N+ D VKV DFG+ ++ T GT +M
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 166
+PE I ++ KVD++S G++L+ELL + + + P +
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVRNLKFPLLFTQKYP 300
Query: 167 AFSYLISRCWSSSPDRRPHFDQI 189
++ S SP RP I
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDI 323
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-43
Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 25/202 (12%)
Query: 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
KK I EY G+L +H + + +L I + Y+HSQGI+HRDLK
Sbjct: 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEYWRLFRQILEALSYIHSQGIIHRDLK 143
Query: 68 SENLLLGEDMCVKVADFGIS---------------CLESQCGSAKGFTGTYRWMAPEMIK 112
N+ + E VK+ DFG++ L + GT ++A E++
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 113 EKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY- 170
H +K+D+YS GI+ +E++ M + ++ PP
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL--RSVSIEFPPDFDDNKMKV 259
Query: 171 ---LISRCWSSSPDRRPHFDQI 189
+I P++RP +
Sbjct: 260 EKKIIRLLIDHDPNKRPGARTL 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 6/189 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQG 60
Q++ + + I E + GGSL L + P + I G++YLH
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 61 ILHRDLKSENLLLGEDM-CVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKR--H 116
I+HRD+K +N+L+ +K++DFG S L + FTGT ++MAPE+I + +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSYLISRC 175
K D++S G + E+ T PF + QAA F V P +P + I +C
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262
Query: 176 WSSSPDRRP 184
+ PD+R
Sbjct: 263 FEPDPDKRA 271
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-41
Identities = 43/199 (21%), Positives = 77/199 (38%), Gaps = 33/199 (16%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E L +L +++ ++ + +H GI+H DLK N L
Sbjct: 84 IYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 140
Query: 73 LGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK-------- 114
+ + M +K+ DFGI+ +SQ GT +M PE IK+
Sbjct: 141 IVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMPPEAIKDMSSSRENGK 192
Query: 115 ---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNARPPVPPTCPKAFSY 170
+ + K DV+S G +L+ + TPF + + + A+ N P K
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 252
Query: 171 LISRCWSSSPDRRPHFDQI 189
++ C P +R ++
Sbjct: 253 VLKCCLKRDPKQRISIPEL 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-41
Identities = 43/199 (21%), Positives = 75/199 (37%), Gaps = 33/199 (16%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E L +L +++ ++ + +H GI+H DLK N L
Sbjct: 103 IYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 159
Query: 73 LGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK-------- 114
+ + M +K+ DFGI+ +SQ GT +M PE IK+
Sbjct: 160 IVDGM-LKLIDFGIANQMQPDTTSVVKDSQV-------GTVNYMPPEAIKDMSSSRENGK 211
Query: 115 ---RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSY 170
+ + K DV+S G +L+ + TPF + A+ N P K
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 171 LISRCWSSSPDRRPHFDQI 189
++ C P +R ++
Sbjct: 272 VLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 42/199 (21%), Positives = 73/199 (36%), Gaps = 33/199 (16%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E L +L +++ ++ + +H GI+H DLK N L
Sbjct: 131 IYMVMEC-GNIDLNSWLKKKKSI--DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFL 187
Query: 73 LGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAPEMIKEK-------- 114
+ D +K+ DFGI+ +SQ G +M PE IK+
Sbjct: 188 I-VDGMLKLIDFGIANQMQPDTTSVVKDSQV-------GAVNYMPPEAIKDMSSSRENGK 239
Query: 115 ---RHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQKNARPPVPPTCPKAFSY 170
+ + K DV+S G +L+ + TPF + A+ N P K
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 171 LISRCWSSSPDRRPHFDQI 189
++ C P +R ++
Sbjct: 300 VLKCCLKRDPKQRISIPEL 318
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-39
Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 19/182 (10%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ EY+ G +L +Y+ P + ++ + I G+++ H I+HRD+K +N+L+
Sbjct: 88 LVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT------GTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
+ +K+ DFGI ++ S T GT ++ +PE K + + D+YS GIV
Sbjct: 146 SNKTLKIFDFGI----AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRR 183
L+E+L PF+ T A P T P++ S +I R R
Sbjct: 202 LYEMLVGEPPFNGETAVSIAIK--HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
Query: 184 PH 185
Sbjct: 260 YK 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 18 EYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
+Y+ G+L+++L+ + ++ + L++ + ARG+ YLH++ I+HRD+KS N+LL E
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE 174
Query: 76 DMCVKVADFGISCLESQCGSAKGFT---GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ K+ DFGIS ++ T GT ++ PE + R T+K DVYSFG+VL+E+
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 133 LTALTPFDNMTPEQAAFAV-----CQKNARPP----------VPPTCPKAFSYLISRCWS 177
L A + P + N + + P + F +C +
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 178 SSPDRRPHFDQIVSILEG 195
S + RP ++ LE
Sbjct: 295 LSSEDRPSMGDVLWKLEY 312
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-38
Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY+ G +LR +H + P + +++ D + + + H GI+HRD+K N+++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT----GTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
VKV DFGI+ + G++ T GT ++++PE + + DVYS G VL+
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWSSSPDRRP 184
E+LT PF +P A+ +++ PP ++ + + +P+ R
Sbjct: 211 EVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-38
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 4/173 (2%)
Query: 26 RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 85
+ + L ++ + +A+GM++L S+ +HRDL + N+LL E VK+ DFG
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 238
Query: 86 ISCLESQCGSAKGFTGT---YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 141
++ + +WMAPE I ++ +T + DV+SFG++LWE+ + +P+
Sbjct: 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 142 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
+ ++ ++ R P + CW P +RP F ++V L
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-37
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I EY G++ + L + + ++A + Y HS+ ++HRD+K ENLLLG
Sbjct: 86 LILEYAPLGTVYRELQKLSKFDEQR--TATYITELANALSYCHSKRVIHRDIKPENLLLG 143
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
+K+ADFG S + GT ++ PEMI+ + H +KVD++S G++ +E L
Sbjct: 144 SAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQIV 190
PF+ T ++ ++ +R V T P + LISR +P +RP +++
Sbjct: 203 GKPPFEANTYQE----TYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256
Query: 191 S---ILEGYSESLEQDPE 205
I S+ +
Sbjct: 257 EHPWITANSSKPSNCQNK 274
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-37
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 11/176 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+ + G L L +Q P + + + I + H+ G HRD+K EN+L+
Sbjct: 111 VDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 75 EDMCVKVADFGI--SCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
D + DFGI + + + GT +MAPE E T + D+Y+ VL+E
Sbjct: 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRP 184
LT P+ +Q + N P P P P AF +I+R + +P+ R
Sbjct: 229 LTGSPPYQG---DQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRY 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-36
Identities = 61/178 (34%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 15 IITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
II EYL GGS L E + +L+ L +G+ YLHS+ +HRD+K+ N+
Sbjct: 97 IIMEYLGGGSALDLLEPGPLDETQ---IATILREIL---KGLDYLHSEKKIHRDIKAANV 150
Query: 72 LLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
LL E VK+ADFG++ L F GT WMAPE+IK+ + K D++S GI
Sbjct: 151 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAI 210
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL----ISRCWSSSPDRRP 184
EL P + P + F + + N PPT +S + C + P RP
Sbjct: 211 ELARGEPPHSELHPMKVLFLIPKNN-----PPTLEGNYSKPLKEFVEACLNKEPSFRP 263
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 22/212 (10%)
Query: 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSE 69
F ++TE G + + + + VLK+ R +Q++H Q I+HRDLK E
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167
Query: 70 NLLLGEDMCVKVADFGISCLES----QCGSAKGFT---------GTYRWMAPEMI---KE 113
NLLL +K+ DFG + S SA+ T + PE+I
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 173
+K D+++ G +L+ L PF+ + A + P T F LI
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFE----DGAKLRIVNGKYSIPPHDTQYTVFHSLIR 283
Query: 174 RCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 205
+P+ R ++V L+ + + +P+
Sbjct: 284 AMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 13/176 (7%)
Query: 15 IITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
++ EYLAGGSL + + E + V + L + +++LHS ++HRD+KS+N+
Sbjct: 94 VVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECL---QALEFLHSNQVIHRDIKSDNI 147
Query: 72 LLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
LLG D VK+ DFG + + GT WMAPE++ K + KVD++S GI+
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 207
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP 184
E++ P+ N P +A + + N P + P F ++RC ++R
Sbjct: 208 EMIEGEPPYLNENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRG 262
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 13/176 (7%)
Query: 15 IITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
++ E+L GG+L + Q E + V + L + + YLH+QG++HRD+KS+++
Sbjct: 119 VLMEFLQGGALTDIVSQVRLNEEQ---IATVCEAVL---QALAYLHAQGVIHRDIKSDSI 172
Query: 72 LLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
LL D VK++DFG + K GT WMAPE+I + +VD++S GI++
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP 184
E++ P+ + +P QA + + + P + + R P R
Sbjct: 233 EMVDGEPPYFSDSPVQAMKRL-RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-34
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 17/179 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN-----LVLKLALDIARGMQYLHSQGILHRDLKSE 69
I+ EY GS+ + + L +L+ L +G++YLH +HRD+K+
Sbjct: 101 IVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTL---KGLEYLHFMRKIHRDIKAG 154
Query: 70 NLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
N+LL + K+ADFG++ L GT WMAPE+I+E + D++S GI
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSSPDRRP 184
E+ P+ ++ P +A F + PP P F+ + +C SP++R
Sbjct: 215 AIEMAEGKPPYADIHPMRAIFMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRA 271
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-34
Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 48/214 (22%)
Query: 18 EYLAGGSLRKYLHQQEPYSVPL--NLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75
Y+ GSL L + PL ++ K+A A G+ +LH +HRD+KS N+LL E
Sbjct: 110 VYMPNGSLLDRLSCLDGTP-PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE 168
Query: 76 DMCVKVADFGISCLESQCGSAKGFT-------GTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
K++DFG++ T GT +MAPE ++ + T K D+YSFG+V
Sbjct: 169 AFTAKISDFGLARA----SEKFAQTVMTSRIVGTTAYMAPEALRGEI-TPKSDIYSFGVV 223
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKN----ARPPVPPTCPKAFSYLI------------ 172
L E++T L D Q K I
Sbjct: 224 LLEIITGLPAVDEHREPQ--------LLLDIKEEIE--DEEKTIEDYIDKKMNDADSTSV 273
Query: 173 -------SRCWSSSPDRRPHFDQIVSILEGYSES 199
S+C ++RP ++ +L+ + S
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-34
Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E+ G L K L + + ++A + Y H + ++HRD+K ENLL+G
Sbjct: 91 LMLEFAPRGELYKELQKHGRFDEQR--SATFMEELADALHYCHERKVIHRDIKPENLLMG 148
Query: 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
+K+ADFG S + + + GT ++ PEMI+ K H +KVD++ G++ +E L
Sbjct: 149 YKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRPHFDQI 189
+ PFD+ + ++ V P S LIS+ P +R +
Sbjct: 208 GMPPFDSPSHT----ETHRRIVN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-34
Identities = 44/211 (20%), Positives = 75/211 (35%), Gaps = 20/211 (9%)
Query: 13 FCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
+I E+ GSL L + Y +P + L + D+ GM +L GI+HR++K N+
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 72 LLG----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------EKRHTKK 119
+ K+ DFG + GT ++ P+M + +K++
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
VD++S G+ + T PF + V K P+ +
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPSGAISGVQKAENGPIDW 261
Query: 180 PDRRPHFDQIVSILEGYSES-----LEQDPE 205
P + L+ LE D E
Sbjct: 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 27/181 (14%), Positives = 60/181 (33%), Gaps = 22/181 (12%)
Query: 22 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81
G L + + + L+L L + R + LH G++H L+ +++L + V +
Sbjct: 190 GEVLLSHSSTHKSL--VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247
Query: 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIK-----------EKRHTKKVDVYSFGIVLW 130
F + G+ + + + PE+ T D ++ G+V++
Sbjct: 248 TGFEHLVRD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
+ A P + + + P+ L+ + R Q +
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358
Query: 191 S 191
Sbjct: 359 E 359
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 60/193 (31%), Positives = 95/193 (49%), Gaps = 25/193 (12%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLK------LALDIARGMQYLHSQGILHRDLKS 68
++ + L+GGS+ + + VL + ++ G++YLH G +HRD+K+
Sbjct: 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKA 149
Query: 69 ENLLLGEDMCVKVADFGIS-CLESQCGSAKG-----FTGTYRWMAPEMIKEKR-HTKKVD 121
N+LLGED V++ADFG+S L + + F GT WMAPE++++ R + K D
Sbjct: 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209
Query: 122 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCP----------KAFSYL 171
++SFGI EL T P+ P + Q + PP T K+F +
Sbjct: 210 IWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--PPSLETGVQDKEMLKKYGKSFRKM 267
Query: 172 ISRCWSSSPDRRP 184
IS C P++RP
Sbjct: 268 ISLCLQKDPEKRP 280
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-33
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENLL 72
I E++ GGSL + L + +P ++ K+++ + +G+ YL + I+HRD+K N+L
Sbjct: 107 SICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164
Query: 73 LGEDMCVKVADFGISC--LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
+ +K+ DFG+S ++S A F GT +M+PE ++ ++ + D++S G+ L
Sbjct: 165 VNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 221
Query: 131 ELLTALTPF-DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
E+ P E CQ P P+ +++ S F+ +
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281
Query: 190 VSILEGYSESLEQD--PEFFSSFI 211
I+ L F F+
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFV 305
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-33
Identities = 52/194 (26%), Positives = 79/194 (40%), Gaps = 9/194 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E G + +YL + N I GM YLHS GILHRDL NLLL
Sbjct: 88 LVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+M +K+ADFG++ +T GT +++PE+ H + DV+S G + + L
Sbjct: 147 RNMNIKIADFGLATQLKMPHEKH-YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS- 191
L PFD T A +P LI + +P R ++
Sbjct: 206 LIGRPPFD--TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263
Query: 192 --ILEGYSESLEQD 203
+ S + +
Sbjct: 264 PFMSRNSSTKSKDE 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-33
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E SL + +++ + P I G QYLH ++HRDLK NL L
Sbjct: 92 VVLELCRRRSLLELHKRRKALTEPE--ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 149
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
ED+ VK+ DFG++ G K GT ++APE++ +K H+ +VDV+S G +++ L
Sbjct: 150 EDLEVKIGDFGLATKVEYDGERK-KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS- 191
L PF+ T + K +P + LI + + P RP +++++
Sbjct: 209 LVGKPPFE--TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266
Query: 192 --ILEGY------SESLEQDPEFFSSFIPS 213
GY L P F S PS
Sbjct: 267 EFFTSGYIPARLPITCLTIPPRF--SIAPS 294
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-33
Identities = 41/176 (23%), Positives = 71/176 (40%), Gaps = 29/176 (16%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I+ EY+ G SL++ Q+ +P+ + L+I + YLHS G+++ DLK EN++L
Sbjct: 161 IVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT 216
Query: 75 EDMCVKVADFGISCLESQCGSAKGFT------GTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
E+ +K+ D G GT + APE+++ T D+Y+ G
Sbjct: 217 EEQ-LKLIDLGA---------VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRT 265
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
L L L + + ++ L+ R P +R
Sbjct: 266 LAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-33
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E SL + +++ + P I G QYLH ++HRDLK NL L
Sbjct: 118 VVLELCRRRSLLELHKRRKALTEPE--ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 75 EDMCVKVADFGISCLESQCGSAKG-FTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
ED+ VK+ DFG++ G K GT ++APE++ +K H+ +VDV+S G +++ LL
Sbjct: 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
PF+ T + K +P + LI + + P RP ++++
Sbjct: 236 VGKPPFE--TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL--- 290
Query: 194 EGYSESLEQDPEFFSSFIPS 213
D F S +IP+
Sbjct: 291 --------NDEFFTSGYIPA 302
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-33
Identities = 29/192 (15%), Positives = 58/192 (30%), Gaps = 15/192 (7%)
Query: 13 FCIITEYLAG--GSLRKYLHQQEPYSVPLNL--VLKLALDIARGMQYLHSQGILHRDLKS 68
+ ++ + L L + + + L + R L S+G++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222
Query: 69 ENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI--KEKRHTKKVDVYSFG 126
+NL + D + + D G A TY E + T ++ + G
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTY--APREFLNASTATFTHALNAWQLG 280
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY-------LISRCWSSS 179
+ ++ + PF +TP P + + LI R +
Sbjct: 281 LSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340
Query: 180 PDRRPHFDQIVS 191
RR + +
Sbjct: 341 RRRRLLPLEAME 352
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-33
Identities = 57/176 (32%), Positives = 80/176 (45%), Gaps = 14/176 (7%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVP-LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ EY G + ++P + V AL +G+ YLHS ++HRD+K+ N+LL
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHNMIHRDVKAGNILL 187
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLW 130
E VK+ DFG + S A F GT WMAPE+I E ++ KVDV+S GI
Sbjct: 188 SEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP 184
EL P NM A + + Q P + F + C P RP
Sbjct: 245 ELAERKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRP 298
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 10/136 (7%)
Query: 15 IITEYLAGGSLRKYL------HQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLK 67
II EY+ S+ K+ + +P+ ++ + + Y+H++ I HRD+K
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVK 179
Query: 68 SENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSF 125
N+L+ ++ VK++DFG S KG GTY +M PE + + KVD++S
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVD-KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSL 238
Query: 126 GIVLWELLTALTPFDN 141
GI L+ + + PF
Sbjct: 239 GICLYVMFYNVVPFSL 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-32
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 7/180 (3%)
Query: 15 IITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ EY GG LRKYL+Q E + + L DI+ ++YLH I+HRDLK EN++L
Sbjct: 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154
Query: 74 ---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
+ + K+ D G + Q F GT +++APE++++K++T VD +SFG + +
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 131 ELLTALTPF-DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
E +T PF N P Q + + + +P+
Sbjct: 215 ECITGFRPFLPNWQPVQ--WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG 272
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 10/178 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++ E+ GS+ + + ++ + + +I RG+ +LH ++HRD+K +N+LL
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 75 EDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTK-----KVDVYSFGIV 128
E+ VK+ DFG+S L+ G F GT WMAPE+I + K D++S GI
Sbjct: 164 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT 223
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPV--PPTCPKAFSYLISRCWSSSPDRRP 184
E+ P +M P +A F + + P K F I C + +RP
Sbjct: 224 AIEMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRP 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 44/211 (20%), Positives = 75/211 (35%), Gaps = 20/211 (9%)
Query: 13 FCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
+I E+ GSL L + Y +P + L + D+ GM +L GI+HR++K N+
Sbjct: 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143
Query: 72 LLG----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------EKRHTKK 119
+ K+ DFG + GT ++ P+M + +K++
Sbjct: 144 MRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
VD++S G+ + T PF + V K P+ +
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG--KPSGAISGVQKAENGPIDW 261
Query: 180 PDRRPHFDQIVSILEGYSES-----LEQDPE 205
P + L+ LE D E
Sbjct: 262 SGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 40/218 (18%), Positives = 79/218 (36%), Gaps = 12/218 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
++T ++A GS + + + + + + + + Y+H G +HR +K+ ++L+
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 162
Query: 75 EDMCVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRH--TKKVDVYS 124
D V ++ + G K W++PE++++ K D+YS
Sbjct: 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
GI EL PF +M Q P + ++ S S
Sbjct: 223 VGITACELANGHVPFKDMPATQMLLEKLNGT--VPCLLDTSTIPAEELTMSPSRSVANSG 280
Query: 185 HFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 222
D + + S + +F P H + +CL
Sbjct: 281 LSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 22/184 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN-----LVLKLALDIARGMQYLHSQGILHRDLKSE 69
I+ E+ GG++ + + + L +V + L + +LHS+ I+HRDLK+
Sbjct: 93 IMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQML---EALNFLHSKRIIHRDLKAG 146
Query: 70 NLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVY 123
N+L+ + +++ADFG+S F GT WMAPE++ K+ + K D++
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206
Query: 124 SFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV---PPTCPKAFSYLISRCWSSSP 180
S GI L E+ P + P + + + + PP P F + +P
Sbjct: 207 SLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNP 264
Query: 181 DRRP 184
+ RP
Sbjct: 265 ETRP 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-32
Identities = 27/176 (15%), Positives = 59/176 (33%), Gaps = 15/176 (8%)
Query: 22 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81
G L + + + + L+L L + R + LH G++H L+ +++L + V +
Sbjct: 195 GEVLLSHSSTHKS--LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
Query: 82 ADFGISCLESQCGSAKG--FTGTYRWMAPEMIKEKRH-----TKKVDVYSFGIVLWELLT 134
F + + A M+ +H T D ++ G+ ++ +
Sbjct: 253 TGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190
A P + + + + P P L+ + R Q +
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIPQP------VRALLEGFLRYPKEDRLLPLQAM 362
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 16/189 (8%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
I E L +L++Y+ Q++ ++ + L G+ +LHS I+HRDLK N+L+
Sbjct: 95 IAIE-LCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILIS 152
Query: 75 E-----DMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDV 122
+ ++DFG+ G GT W+APEM+ E + T VD+
Sbjct: 153 MPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212
Query: 123 YSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVP-PTCPKAFSYLISRCWSSSP 180
+S G V + +++ PF QA + + P LI + + P
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDP 272
Query: 181 DRRPHFDQI 189
+RP +
Sbjct: 273 QKRPSAKHV 281
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 42/211 (19%)
Query: 18 EYLAGGSLRKYLHQQEPYSVPLNLV--LKLALDIARGMQYLHSQG---ILHRDLKSENLL 72
Y+A GS+ L ++ PL+ ++AL ARG+ YLH I+HRD+K+ N+L
Sbjct: 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166
Query: 73 LGEDMCVKVADFGISCLESQCGSAK----GFT-------GTYRWMAPEMIKEKRHTKKVD 121
L E+ V DFG+ AK T GT +APE + + ++K D
Sbjct: 167 LDEEFEAVVGDFGL---------AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTD 217
Query: 122 VYSFGIVLWELLTALTPFDNMTP---------EQAAFAVCQKNARPPVPPTCPKAFSY-- 170
V+ +G++L EL+T FD + + +K V +
Sbjct: 218 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE 277
Query: 171 ---LI---SRCWSSSPDRRPHFDQIVSILEG 195
LI C SSP RP ++V +LEG
Sbjct: 278 VEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-30
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 10/178 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLL 73
I E + + + Q P +P ++ K+ + I + + YL + G++HRD+K N+LL
Sbjct: 101 IAMELMGTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL 158
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK-----KVDVYSFGIV 128
E +K+ DFGIS + G +MAPE I TK + DV+S GI
Sbjct: 159 DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 129 LWELLTALTPFDNMTPE-QAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSSSPDRRP 184
L EL T P+ N + + V Q+ P F + C + +RP
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 31/204 (15%), Positives = 69/204 (33%), Gaps = 22/204 (10%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYS---VPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69
++ E + G+L ++ + +P LV+ A+ + ++ +H I+H D+K +
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201
Query: 70 NLLLGEDMC-----------VKVADFGISC---LESQCGSAKGFTGTYRWMAPEMIKEKR 115
N +LG + + D G S L + T + EM+ K
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 116 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 175
++D + ++ +L + + R P + F +++
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR--RLPHLDMWNEFFHVMLN-- 317
Query: 176 WSSSPDRRPHFDQIVSILEGYSES 199
P D + L+ +
Sbjct: 318 -IPDCHHLPSLDLLRQKLKKVFQQ 340
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 10/176 (5%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
++ + L GG LR +L Q + +KL ++ + YL +Q I+HRD+K +N+L
Sbjct: 91 FMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVL 129
L E V + DF I+ + + GT +MAPEM ++ ++ VD +S G+
Sbjct: 148 LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTA 207
Query: 130 WELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 183
+ELL P+ + + + P + L+ + +PD+R
Sbjct: 208 YELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRD 65
+I EY +GG + YL ++ AR +QY H + I+HRD
Sbjct: 90 YLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT-KKVDVYS 124
LK+ENLLL DM +K+ADFG S + G F G + APE+ + K++ +VDV+S
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWS 199
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
G++L+ L++ PFD + +P L+ R +P +R
Sbjct: 200 LGVILYTLVSGSLPFDGQN--LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRG 257
Query: 185 HFDQI 189
+QI
Sbjct: 258 TLEQI 262
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 12/177 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
++ E GG L + + ++ + + G+ YLH I+HRDLK ENLLL
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNE--VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170
Query: 74 --GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D +K+ DFG+S + K GT ++APE+++ K++ +K DV+S G++L+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFI 229
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY----LISRCWSSSPDRRP 184
LL PF T ++ V + + K S LI + RR
Sbjct: 230 LLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 38/128 (29%), Positives = 74/128 (57%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C++ + GG L+ +++ P + A +I G++ LH + I++RDLK EN+LL
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
+ ++++D G++ + + KG GT +MAPE++K +R+T D ++ G +L+E++
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 134 TALTPFDN 141
+PF
Sbjct: 380 AGQSPFQQ 387
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-29
Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLV-----LKLALDIARGMQYLHSQGILHRDLKSE 69
I E +L+ + + L L + L IA G+ +LHS I+HRDLK +
Sbjct: 86 IALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 70 NLLL-------------GEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRWMAPEMI 111
N+L+ E++ + ++DFG+ S + +GT W APE++
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204
Query: 112 KE-------KRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPT 163
+E +R T+ +D++S G V + +L+ PF + ++ + +
Sbjct: 205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL-DEMKCL 263
Query: 164 CPKAFSY----LISRCWSSSPDRRPHFDQI 189
++ LIS+ P +RP ++
Sbjct: 264 HDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 10/176 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
++ E GG L + ++ +S ++ + G+ Y+H I+HRDLK ENLLL
Sbjct: 103 LVGEVYTGGELFDEIISRKRFSE--VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLE 160
Query: 74 --GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D +++ DFG+S K GT ++APE++ + +K DV+S G++L+
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYI 219
Query: 132 LLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
LL+ PF+ V + P A LI + + P R
Sbjct: 220 LLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD-LIRKMLTYVPSMRI 274
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 48/189 (25%), Positives = 81/189 (42%), Gaps = 19/189 (10%)
Query: 15 IITEYLAGGSLR--KYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSENL 71
I E ++ + KY++ +P ++ K+ L + + +L I+HRD+K N+
Sbjct: 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNI 157
Query: 72 LLGEDMCVKVADFGIS-CLESQCGSAKGFT-GTYRWMAPEMIKEKRHTK----KVDVYSF 125
LL +K+ DFGIS L AK G +MAPE I + + DV+S
Sbjct: 158 LLDRSGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSL 215
Query: 126 GIVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCP-----KAFSYLISRCWSSS 179
GI L+EL T P+ + V + + PP +F ++ C +
Sbjct: 216 GITLYELATGRFPYPKWNSVFDQLTQVVKGD--PPQLSNSEEREFSPSFINFVNLCLTKD 273
Query: 180 PDRRPHFDQ 188
+RP + +
Sbjct: 274 ESKRPKYKE 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 10/176 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
++TE+ GG L + + + + + I G+ YLH I+HRD+K EN+LL
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDE--CDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180
Query: 74 --GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ DFG+S S+ + GT ++APE++K K++ +K DV+S G++++
Sbjct: 181 NKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYI 239
Query: 132 LLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
LL PF + V + +A LI + ++R
Sbjct: 240 LLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKE-LIKLMLTYDYNKRC 294
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 7/137 (5%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
Y G L KY+ + + + +I ++YLH +GI+HRDLK EN+L
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 162
Query: 73 LGEDMCVKVADFG---ISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
L EDM +++ DFG + ES+ A F GT ++++PE++ EK K D+++ G ++
Sbjct: 163 LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCII 222
Query: 130 WELLTALTPFDNMTPEQ 146
++L+ L PF
Sbjct: 223 YQLVAGLPPFRAGNEYL 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E + G + + + PL+ D+ +G++YLH Q I+HRD+K NLL
Sbjct: 115 MVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169
Query: 73 LGEDMCVKVADFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHT---KKVDVYSFGIV 128
+GED +K+ADFG+S + GT +MAPE + E R K +DV++ G+
Sbjct: 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQ 188
L+ + PF + + + P P + LI+R +P+ R +
Sbjct: 230 LYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE 289
Query: 189 I 189
I
Sbjct: 290 I 290
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 10/176 (5%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
I+ E GG L + +++ +S + ++ + G+ Y+H I+HRDLK EN+LL
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 74 --GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D +K+ DFG+S Q K GT ++APE+++ + +K DV+S G++L+
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYI 214
Query: 132 LLTALTPFDNMTPEQAAFAVCQKN---ARPPVPPTCPKAFSYLISRCWSSSPDRRP 184
LL+ PF V P A LI + + P R
Sbjct: 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD-LIRKMLTFHPSLRI 269
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-28
Identities = 51/183 (27%), Positives = 89/183 (48%), Gaps = 9/183 (4%)
Query: 14 CIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQG-ILHRDLKSEN 70
I E + SL K+ Q + ++P +++ K+A+ I + +++LHS+ ++HRD+K N
Sbjct: 82 WICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSN 140
Query: 71 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK----EKRHTKKVDVYSFG 126
+L+ VK+ DFGIS + G +MAPE I +K ++ K D++S G
Sbjct: 141 VLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
Query: 127 IVLWELLTALTPFDNM-TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 185
I + EL P+D+ TP Q V ++ + F S+C + RP
Sbjct: 201 ITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPT 260
Query: 186 FDQ 188
+ +
Sbjct: 261 YPE 263
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 37/131 (28%), Positives = 73/131 (55%), Gaps = 3/131 (2%)
Query: 14 CIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
C++ + GG +R +++ ++ + I G+++LH + I++RDLK EN+
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENV 320
Query: 72 LLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
LL +D V+++D G++ + KG+ GT +MAPE++ + + VD ++ G+ L+
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLY 380
Query: 131 ELLTALTPFDN 141
E++ A PF
Sbjct: 381 EMIAARGPFRA 391
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 40/135 (29%), Positives = 72/135 (53%), Gaps = 5/135 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ E++ GG L ++ + + A +I + +LH +GI++RDLK +N+LL
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRRFDEAR--ARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ K+ADFG+ C E C T GT ++APE+++E + VD ++ G++L+E
Sbjct: 158 DHEGHCKLADFGM-CKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216
Query: 132 LLTALTPFDNMTPEQ 146
+L PF+ +
Sbjct: 217 MLCGHAPFEAENEDD 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 56/175 (32%), Positives = 94/175 (53%), Gaps = 13/175 (7%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
+ EYL GG L ++ + + A +I G+Q+LHS+GI++RDLK +N+L
Sbjct: 94 FFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 150
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
L +D +K+ADFG+ C E+ G AK T GT ++APE++ +++ VD +SFG++L+
Sbjct: 151 LDKDGHIKIADFGM-CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 209
Query: 131 ELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 183
E+L +PF E+ + P P K L+ + + P++R
Sbjct: 210 EMLIGQSPFHGQDEEE----LFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 38/127 (29%), Positives = 70/127 (55%), Gaps = 4/127 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
I + + GG L +L Q +S + A +I G++++H++ +++RDLK N+LL
Sbjct: 268 SFILDLMNGGDLHYHLSQHGVFSEAD--MRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWEL 132
E V+++D G++C + GT+ +MAPE++ K + D +S G +L++L
Sbjct: 326 DEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 133 LTALTPF 139
L +PF
Sbjct: 385 LRGHSPF 391
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-27
Identities = 48/174 (27%), Positives = 88/174 (50%), Gaps = 11/174 (6%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C + EY GG L +L ++ ++ +I ++YLHS+ +++RD+K ENL+L
Sbjct: 81 CFVMEYANGGELFFHLSRERVFTEER--ARFYGAEIVSALEYLHSRDVVYRDIKLENLML 138
Query: 74 GEDMCVKVADFGISCLE--SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D +K+ DFG+ C E S + K F GT ++APE++++ + + VD + G+V++E
Sbjct: 139 DKDGHIKITDFGL-CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 132 LLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 183
++ PF N E+ + + P T L++ P +R
Sbjct: 198 MMCGRLPFYNQDHER----LFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 45/130 (34%), Positives = 77/130 (59%), Gaps = 5/130 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ EY+ GG L ++ Q + P + A +IA G+ +L S+GI++RDLK +N++L
Sbjct: 97 YFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ADFG+ C E+ T GT ++APE+I + + K VD ++FG++L+E
Sbjct: 155 DSEGHIKIADFGM-CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
Query: 132 LLTALTPFDN 141
+L PF+
Sbjct: 214 MLAGQAPFEG 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 37/135 (27%), Positives = 73/135 (54%), Gaps = 5/135 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ EY+ GG L ++ +Q + +I+ + YLH +GI++RDLK +N+LL
Sbjct: 86 FFVIEYVNGGDLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ D+G+ C E T GT ++APE+++ + + VD ++ G++++E
Sbjct: 144 DSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 132 LLTALTPFDNMTPEQ 146
++ +PFD +
Sbjct: 203 MMAGRSPFDIVGSSD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 37/139 (26%), Positives = 73/139 (52%), Gaps = 5/139 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ EY+ GG L ++ +Q + +I+ + YLH +GI++RDLK +N+LL
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEEH--ARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ D+G+ C E T GT ++APE+++ + + VD ++ G++++E
Sbjct: 187 DSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
Query: 132 LLTALTPFDNMTPEQAAFA 150
++ +PFD +
Sbjct: 246 MMAGRSPFDIVGSSDNPDQ 264
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 18/181 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++ E + GG L + ++ YS I + YLH GI+HRDLK EN
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAA------DAVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 71 LLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
LL D +K+ADFG+S + K GT + APE+++ + +VD++S GI
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
Query: 128 VLWELLTALTPFDNMTPEQAAFAVCQKNA----RPPVPPTCPKAFSYLISRCWSSSPDRR 183
+ + LL PF + +Q F P A L+ + P +R
Sbjct: 239 ITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD-LVRKLIVLDPKKR 297
Query: 184 P 184
Sbjct: 298 L 298
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 21/138 (15%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRD 65
+I EYL+GG L L ++ D A + +LH +GI++RD
Sbjct: 97 YLILEYLSGGELFMQLEREG----------IFMEDTACFYLAEISMALGHLHQKGIIYRD 146
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVY 123
LK EN++L VK+ DFG+ C ES T GT +MAPE++ H + VD +
Sbjct: 147 LKPENIMLNHQGHVKLTDFGL-CKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWW 205
Query: 124 SFGIVLWELLTALTPFDN 141
S G +++++LT PF
Sbjct: 206 SLGALMYDMLTGAPPFTG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 44/138 (31%), Positives = 73/138 (52%), Gaps = 21/138 (15%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRD 65
+I ++L GG L L ++ + + + +LHS GI++RD
Sbjct: 102 YLILDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVY 123
LK EN+LL E+ +K+ DFG+ ES K ++ GT +MAPE++ + HT+ D +
Sbjct: 152 LKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 124 SFGIVLWELLTALTPFDN 141
SFG++++E+LT PF
Sbjct: 211 SFGVLMFEMLTGTLPFQG 228
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 45/130 (34%), Positives = 77/130 (59%), Gaps = 5/130 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ EY+ GG L ++ Q + P + A +IA G+ +L S+GI++RDLK +N++L
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKEPH--AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+ +K+ADFG+ C E+ T GT ++APE+I + + K VD ++FG++L+E
Sbjct: 476 DSEGHIKIADFGM-CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 132 LLTALTPFDN 141
+L PF+
Sbjct: 535 MLAGQAPFEG 544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-25
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 13/170 (7%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMA 107
+ +++ H+ G+LHRD+K EN+L+ +K+ DFG L F GT +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 216
Query: 108 PEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 166
PE I+ R H + V+S GI+L++++ PF++ E+ +
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH--DEEI------IRGQVFFRQRVSS 268
Query: 167 AFSYLISRCWSSSPDRRPHFDQIVSI--LEGYSESLEQDPEFFSSFIPSP 214
+LI C + P RP F++I + ++ E S P P
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGP 318
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-25
Identities = 43/133 (32%), Positives = 74/133 (55%), Gaps = 13/133 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSEN 70
++ + + GG L + + +E YS A + + Y HS GI+HR+LK EN
Sbjct: 82 LVFDLVTGGELFEDIVAREFYSE------ADASHCIQQILESIAYCHSNGIVHRNLKPEN 135
Query: 71 LLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
LLL + VK+ADFG++ + + GF GT +++PE++K+ ++K VD+++ G+
Sbjct: 136 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
Query: 128 VLWELLTALTPFD 140
+L+ LL PF
Sbjct: 196 ILYILLVGYPPFW 208
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 43/136 (31%), Positives = 75/136 (55%), Gaps = 7/136 (5%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
+ +Y+ GG L +L ++ + P + A +IA + YLHS I++RDLK EN+L
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASALGYLHSLNIVYRDLKPENIL 171
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
L + + DFG+ C E+ ++ T GT ++APE++ ++ + + VD + G VL+
Sbjct: 172 LDSQGHIVLTDFGL-CKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 230
Query: 131 ELLTALTPFDNMTPEQ 146
E+L L PF + +
Sbjct: 231 EMLYGLPPFYSRNTAE 246
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 42/130 (32%), Positives = 74/130 (56%), Gaps = 4/130 (3%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLL 72
C + EY GG L +L ++ +S +I + YLHS+ +++RDLK ENL+
Sbjct: 224 CFVMEYANGGELFFHLSRERVFSEDR--ARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
Query: 73 LGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
L +D +K+ DFG+ + G+ K F GT ++APE++++ + + VD + G+V++E
Sbjct: 282 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341
Query: 132 LLTALTPFDN 141
++ PF N
Sbjct: 342 MMCGRLPFYN 351
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 30/219 (13%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
+ EY +GG L + + A+ G+ YLH GI HRD+
Sbjct: 82 LFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGF--T--GTYRWMAPEMIKEKR-HTKKVD 121
K ENLLL E +K++DFG++ + + + + GT ++APE++K + H + VD
Sbjct: 132 KPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 122 VYSFGIVLWELLTALTPFDNMTPEQAAFA--VCQKNARPPVPPTCPKAFSYLISRCWSSS 179
V+S GIVL +L P+D + ++ +K P + L+ + +
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-LLHKILVEN 249
Query: 180 PDRRPHFDQIVS---ILEGYSESLEQDPEFFSSFIPSPD 215
P R I + + ++ SP
Sbjct: 250 PSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPS 288
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-25
Identities = 39/173 (22%), Positives = 76/173 (43%), Gaps = 16/173 (9%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP 108
+ + YL + I+HRD+K EN+++ ED +K+ DFG + + F GT + AP
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
Query: 109 EMIKEKRHT-KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCP 165
E++ + +++++S G+ L+ L+ PF + ++ A P
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL----------EETVEAAIHPPYLVS 248
Query: 166 KAFSYLISRCWSSSPDRRPHFDQIVS---ILEGYSESLEQDPEFFSSFIPSPD 215
K L+S P+RR +++V+ + + + + E F P
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESG 301
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-25
Identities = 26/176 (14%), Positives = 46/176 (26%), Gaps = 37/176 (21%)
Query: 15 IITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ E++ GGSL++ P ++ +A H G+ + +
Sbjct: 108 VVAEWIRGGSLQEVADTSPSPVGA-----IRAMQSLAAAADAAHRAGVALSIDHPSRVRV 162
Query: 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELL 133
D V +A M + D+ G L+ LL
Sbjct: 163 SIDGDVVLAYPAT-------------------MPDA-------NPQDDIRGIGASLYALL 196
Query: 134 TALTPFDNMTPEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRP 184
P + A P+ P P S + +R R
Sbjct: 197 VNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-25
Identities = 42/135 (31%), Positives = 68/135 (50%), Gaps = 19/135 (14%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
++ EY++GG L Y+ + ++ AR + Y H ++HRDL
Sbjct: 88 MVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSF 125
K EN+LL M K+ADFG+S + S + G+ + APE+I + +VD++S
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSC 197
Query: 126 GIVLWELLTALTPFD 140
G++L+ LL PFD
Sbjct: 198 GVILYALLCGTLPFD 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-25
Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 16/142 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSEN 70
++ + + G L YL ++ S K I R + LH I+HRDLK EN
Sbjct: 101 LVFDLMKKGELFDYLTEKVTLSE------KETRKIMRALLEVICALHKLNIVHRDLKPEN 154
Query: 71 LLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK------EKRHTKKVDVYS 124
+LL +DM +K+ DFG SC + GT ++APE+I+ + K+VD++S
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 125 FGIVLWELLTALTPFDNMTPEQ 146
G++++ LL PF +
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQML 236
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-25
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 27/190 (14%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
+ EY +GG L + + A+ G+ YLH GI HRD+
Sbjct: 82 LFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIGITHRDI 131
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGF--T--GTYRWMAPEMIKEKR-HTKKVD 121
K ENLLL E +K++DFG++ + + + + GT ++APE++K + H + VD
Sbjct: 132 KPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190
Query: 122 VYSFGIVLWELLTALTPFDNMTPEQAAFA--VCQKNARPPVPPTCPKAFSYLISRCWSSS 179
V+S GIVL +L P+D + ++ +K P + L+ + +
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA-LLHKILVEN 249
Query: 180 PDRRPHFDQI 189
P R I
Sbjct: 250 PSARITIPDI 259
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-25
Identities = 52/177 (29%), Positives = 93/177 (52%), Gaps = 10/177 (5%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
+I +Y+ GG L +L Q+E ++ +++ +I +++LH GI++RD+K EN+L
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 73 LGEDMCVKVADFGIS--CLESQCGSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIV 128
L + V + DFG+S + + A F GT +MAP++++ H K VD +S G++
Sbjct: 192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISRCWSSSPDRR 183
++ELLT +PF + + + ++ + PP P LI R P +R
Sbjct: 252 MYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-25
Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
++ EY AGG L Y+ +++ ++ D R ++Y H I+HRDL
Sbjct: 86 MVIEY-AGGELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSF 125
K ENLLL +++ VK+ADFG+S + + K G+ + APE+I K +VDV+S
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSC 194
Query: 126 GIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 185
GIVL+ +L PFD+ V + +P LI R + P +R
Sbjct: 195 GIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIVADPMQRIT 252
Query: 186 FDQIVS---ILEGYSESLEQDPEFFSSFIPSPDHTILRCL 222
+I + L E S+ D I+ L
Sbjct: 253 IQEIRRDPWFNVNLPDYLRPMEEVQGSYA---DSRIVSKL 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-25
Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 29/147 (19%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++TE + GG L + +Q+ +S + I + ++YLH+QG++HRDLK N
Sbjct: 93 VVTELMKGGELLDKILRQKFFSEREAS------AVLFTITKTVEYLHAQGVVHRDLKPSN 146
Query: 71 LLL----GEDMCVKVADFGIS--------CLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+L G +++ DFG + L + C +A + +APE+++ + +
Sbjct: 147 ILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA-----NF--VAPEVLERQGYDA 199
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPE 145
D++S G++L+ +LT TPF N +
Sbjct: 200 ACDIWSLGVLLYTMLTGYTPFANGPDD 226
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-25
Identities = 48/197 (24%), Positives = 74/197 (37%), Gaps = 48/197 (24%)
Query: 13 FCIITEY-LAGGSL---------------RKYLHQQEPYSVPLNLVLKLALDIARGMQYL 56
F ++ E L L R + Q + +Q+
Sbjct: 113 FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ-----------------VVAAIQHC 155
Query: 57 HSQGILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR 115
HS+G++HRD+K EN+L+ C K+ DFG L F GT + PE I +
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ 214
Query: 116 -HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLI 172
H V+S GI+L++++ PF+ Q+ A P LI
Sbjct: 215 YHALPATVWSLGILLYDMVCGDIPFERD----------QEILEAELHFPAHVSPDCCALI 264
Query: 173 SRCWSSSPDRRPHFDQI 189
RC + P RP ++I
Sbjct: 265 RRCLAPKPSSRPSLEEI 281
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-25
Identities = 40/133 (30%), Positives = 70/133 (52%), Gaps = 14/133 (10%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++ + ++GG L + ++ Y+ + + ++YLH GI+HRDLK EN
Sbjct: 83 LVMQLVSGGELFDRILERGVYTEKDAS------LVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 71 LLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
LL E+ + + DFG+S +E G GT ++APE++ +K ++K VD +S G+
Sbjct: 137 LLYLTPEENSKIMITDFGLSKMEQN-GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195
Query: 128 VLWELLTALTPFD 140
+ + LL PF
Sbjct: 196 ITYILLCGYPPFY 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 43/133 (32%), Positives = 74/133 (55%), Gaps = 13/133 (9%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSEN 70
++ + + GG L + + +E YS A + + Y HS GI+HR+LK EN
Sbjct: 105 LVFDLVTGGELFEDIVAREFYSE------ADASHCIQQILESIAYCHSNGIVHRNLKPEN 158
Query: 71 LLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
LLL + VK+ADFG++ + + GF GT +++PE++K+ ++K VD+++ G+
Sbjct: 159 LLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
Query: 128 VLWELLTALTPFD 140
+L+ LL PF
Sbjct: 219 ILYILLVGYPPFW 231
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-24
Identities = 30/129 (23%), Positives = 61/129 (47%), Gaps = 6/129 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
++ E GG L + + + + + ++ D+ + Y H + HRDLK EN L
Sbjct: 83 LVMELCTGGELFERVVHKRVFRE--SDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140
Query: 74 --GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
D +K+ DFG++ + GT +++P++++ + + D +S G++++
Sbjct: 141 TDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYV 199
Query: 132 LLTALTPFD 140
LL PF
Sbjct: 200 LLCGYPPFS 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 20/138 (14%)
Query: 15 IITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68
I+ E + GG L K L + + +QYLH GI+HRDLK
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEAT--------CKLYFYQMLLAVQYLHENGIIHRDLKP 267
Query: 69 ENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDV 122
EN+LL ED +K+ DFG S + + + GT ++APE++ + + VD
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 327
Query: 123 YSFGIVLWELLTALTPFD 140
+S G++L+ L+ PF
Sbjct: 328 WSLGVILFICLSGYPPFS 345
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-24
Identities = 43/134 (32%), Positives = 70/134 (52%), Gaps = 6/134 (4%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
++ EY+AGG + +L + +S P + A I +YLHS +++RDLK ENLL
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEP---HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ + ++V DFG + G GT +APE+I K + K VD ++ G++++E+
Sbjct: 174 IDQQGYIQVTDFGF-AKRVK-GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 133 LTALTPFDNMTPEQ 146
PF P Q
Sbjct: 232 AAGYPPFFADQPIQ 245
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-24
Identities = 44/134 (32%), Positives = 76/134 (56%), Gaps = 6/134 (4%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKL-ALDIARGMQYLHSQGILHRDLKSENLL 72
+I +Y+ GG L L + + + P V K A ++ ++YLHS+ I++RDLK EN+L
Sbjct: 82 FMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
L ++ +K+ DFG + GT ++APE++ K + K +D +SFGI+++E+
Sbjct: 139 LDKNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 196
Query: 133 LTALTPFDNMTPEQ 146
L TPF + +
Sbjct: 197 LAGYTPFYDSNTMK 210
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-24
Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 6/131 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+I E ++GG L +L ++E + + I G+ YLHS+ I H DLK EN++
Sbjct: 83 VVLILELVSGGELFDFLAEKESLTEDE--ATQFLKQILDGVHYLHSKRIAHFDLKPENIM 140
Query: 73 L----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
L + +K+ DFGI+ K GT ++APE++ + + D++S G++
Sbjct: 141 LLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
Query: 129 LWELLTALTPF 139
+ LL+ +PF
Sbjct: 201 TYILLSGASPF 211
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-24
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 32/150 (21%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS-----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69
++ + + G L YL ++ S + + + +LH+ I+HRDLK E
Sbjct: 177 LVFDLMRKGELFDYLTEKVALSEKETR-------SIMRSLLEAVSFLHANNIVHRDLKPE 229
Query: 70 NLLLGEDMCVKVADFGISC-------LESQCGSAKGFTGTYRWMAPEMIK------EKRH 116
N+LL ++M ++++DFG SC L CG+ Y +APE++K +
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTP-----GY--LAPEILKCSMDETHPGY 282
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
K+VD+++ G++L+ LL PF +
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-24
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 28/155 (18%)
Query: 15 IITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68
II E + GG L R E + ++ DI +Q+LHS I HRD+K
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAA------EIMRDIGTAIQFLHSHNIAHRDVKP 156
Query: 69 ENLLL---GEDMCVKVADFGIS------CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
ENLL +D +K+ DFG + L++ C + Y +APE++ +++ K
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTP-----YY--VAPEVLGPEKYDKS 209
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154
D++S G++++ LL PF + T + + + ++
Sbjct: 210 CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 41/134 (30%), Positives = 74/134 (55%), Gaps = 14/134 (10%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR----GMQYLHSQGILHRDLKSEN 70
+I + + GG L + + +E YS A + + + H G++HR+LK EN
Sbjct: 87 LIFDLVTGGELFEDIVAREYYSE------ADASHCIQQILEAVLHCHQMGVVHRNLKPEN 140
Query: 71 LLL---GEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 126
LLL + VK+ADFG++ +E + + GF GT +++PE++++ + K VD+++ G
Sbjct: 141 LLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG 200
Query: 127 IVLWELLTALTPFD 140
++L+ LL PF
Sbjct: 201 VILYILLVGYPPFW 214
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-23
Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 6/131 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+I E +AGG L +L ++E + + I G+ YLHS I H DLK EN++
Sbjct: 89 VILILELVAGGELFDFLAEKESLTEEE--ATEFLKQILNGVYYLHSLQIAHFDLKPENIM 146
Query: 73 L----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
L +K+ DFG++ K GT ++APE++ + + D++S G++
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 129 LWELLTALTPF 139
+ LL+ +PF
Sbjct: 207 TYILLSGASPF 217
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 44/205 (21%), Positives = 72/205 (35%), Gaps = 58/205 (28%)
Query: 15 IITEYLAGGSL----------------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS 58
++ EY G Y Q + G++YLHS
Sbjct: 85 MVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ-----------------LIDGLEYLHS 127
Query: 59 QGILHRDLKSENLLLGEDMCVKVADFGIS----------CLESQCGSAKGFTGTYRWMAP 108
QGI+H+D+K NLLL +K++ G++ + GS + P
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP-----AF--QPP 180
Query: 109 EMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTC 164
E+ KVD++S G+ L+ + T L PF+ + + + +P C
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE----GDNIYKLFENIGKGSYAIPGDC 236
Query: 165 PKAFSYLISRCWSSSPDRRPHFDQI 189
S L+ P +R QI
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQI 261
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 6/131 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+I E ++GG L +L Q+E S I G+ YLH++ I H DLK EN++
Sbjct: 90 VVLILELVSGGELFDFLAQKESLSEEE--ATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 73 L----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
L +K+ DFG++ K GT ++APE++ + + D++S G++
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
Query: 129 LWELLTALTPF 139
+ LL+ +PF
Sbjct: 208 TYILLSGASPF 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-23
Identities = 33/135 (24%), Positives = 67/135 (49%), Gaps = 16/135 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS-----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69
++ E L GG L + + +++ +S + + + ++H G++HRDLK E
Sbjct: 83 LVMELLNGGELFERIKKKKHFSETEAS-------YIMRKLVSAVSHMHDVGVVHRDLKPE 135
Query: 70 NLLL---GEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 125
NLL +++ +K+ DFG + K T + APE++ + + + D++S
Sbjct: 136 NLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSL 195
Query: 126 GIVLWELLTALTPFD 140
G++L+ +L+ PF
Sbjct: 196 GVILYTMLSGQVPFQ 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-23
Identities = 42/129 (32%), Positives = 72/129 (55%), Gaps = 6/129 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL- 73
I+ E GG L + +++ +S + ++ + G+ Y+H I+HRDLK EN+LL
Sbjct: 98 IVGELYTGGELFDEIIKRKRFSE--HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 74 --GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWE 131
+D +K+ DFG+S Q K GT ++APE+++ + +K DV+S G++L+
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYI 214
Query: 132 LLTALTPFD 140
LL+ PF
Sbjct: 215 LLSGTPPFY 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-23
Identities = 43/135 (31%), Positives = 69/135 (51%), Gaps = 19/135 (14%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRDL 66
++ EY++GG L Y+ + +L +R G+ Y H ++HRDL
Sbjct: 93 MVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILSGVDYCHRHMVVHRDL 142
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSF 125
K EN+LL M K+ADFG+S + S + G+ + APE+I + +VD++S
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSS 202
Query: 126 GIVLWELLTALTPFD 140
G++L+ LL PFD
Sbjct: 203 GVILYALLCGTLPFD 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 39/131 (29%), Positives = 66/131 (50%), Gaps = 6/131 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+I E ++GG L +L Q+E S I G+ YLH++ I H DLK EN++
Sbjct: 90 VVLILELVSGGELFDFLAQKESLSE--EEATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
Query: 73 L----GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
L +K+ DFG++ K GT ++APE++ + + D++S G++
Sbjct: 148 LLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
Query: 129 LWELLTALTPF 139
+ LL+ +PF
Sbjct: 208 TYILLSGASPF 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 6/132 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E++ G L + ++ + + I ++Y H I+HRD+K +L
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
Query: 73 L---GEDMCVKVADFGISCLESQCGSA-KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
L VK+ FG++ + G G GT +MAPE++K + + K VDV+ G++
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 129 LWELLTALTPFD 140
L+ LL+ PF
Sbjct: 223 LFILLSGCLPFY 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-23
Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 6/131 (4%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E GG L + + + L+ V +L + + Y HSQ ++H+DLK EN+L
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156
Query: 73 L---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+K+ DFG++ L + GT +MAPE+ K + T K D++S G+V+
Sbjct: 157 FQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
Query: 130 WELLTALTPFD 140
+ LLT PF
Sbjct: 216 YFLLTGCLPFT 226
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-23
Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 20/138 (14%)
Query: 15 IITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68
I+ E + GG L K L + + +QYLH GI+HRDLK
Sbjct: 91 IVLELMEGGELFDKVVGNKRLKEATCK--------LYFYQMLLAVQYLHENGIIHRDLKP 142
Query: 69 ENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDV 122
EN+LL ED +K+ DFG S + + + GT ++APE++ + + VD
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC 202
Query: 123 YSFGIVLWELLTALTPFD 140
+S G++L+ L+ PF
Sbjct: 203 WSLGVILFICLSGYPPFS 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 34/151 (22%), Positives = 68/151 (45%), Gaps = 28/151 (18%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRD 65
++ EY GG L L + ++ ++AR + +H G +HRD
Sbjct: 137 YLVMEYYVGGDLLTLLSKFGE---------RIPAEMARFYLAEIVMAIDSVHRLGYVHRD 187
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEK-------R 115
+K +N+LL +++ADFG SCL+ + + GT +++PE+++
Sbjct: 188 IKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 116 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146
+ + D ++ G+ +E+ TPF + +
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAE 277
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-23
Identities = 40/136 (29%), Positives = 62/136 (45%), Gaps = 15/136 (11%)
Query: 13 FCIITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
+I EY AGG + E + +L I G+ YLH I+H DL
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIKQILEGVYYLHQNNIVHLDL 157
Query: 67 KSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVY 123
K +N+LL +K+ DFG+S + GT ++APE++ T D++
Sbjct: 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 124 SFGIVLWELLTALTPF 139
+ GI+ + LLT +PF
Sbjct: 218 NIGIIAYMLLTHTSPF 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 7e-23
Identities = 44/138 (31%), Positives = 62/138 (44%), Gaps = 21/138 (15%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRD 65
II EY +GG L + + + + D AR G+ Y HS I HRD
Sbjct: 92 AIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 66 LKSENLLLGED--MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKR-HTKKVDV 122
LK EN LL +K+ DFG S K GT ++APE++ + K DV
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADV 201
Query: 123 YSFGIVLWELLTALTPFD 140
+S G+ L+ +L PF+
Sbjct: 202 WSCGVTLYVMLVGAYPFE 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-22
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 13/154 (8%)
Query: 48 DIARGMQYLHSQGILHRDLKSENLLLG--EDMCVKVADFGISCL-----ESQCGSAKGFT 100
I + YLH+QGI HRD+K EN L + +K+ DFG+S +
Sbjct: 176 QIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235
Query: 101 GTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN--- 155
GT ++APE++ + + K D +S G++L LL PF + V K
Sbjct: 236 GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF 295
Query: 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
P P A L+S + + D R +
Sbjct: 296 ENPNYNVLSPLARD-LLSNLLNRNVDERFDAMRA 328
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 36/168 (21%), Positives = 73/168 (43%), Gaps = 24/168 (14%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIAR--------GMQYLHSQGILHRD 65
++ +Y GG L L + E +L ++AR + +H +HRD
Sbjct: 150 YLVMDYYVGGDLLTLLSKFED---------RLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200
Query: 66 LKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT--GTYRWMAPEMIKEK-----RHTK 118
+K +N+L+ + +++ADFG + G+ + GT +++PE+++ R+
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 166
+ D +S G+ ++E+L TPF + + + R P
Sbjct: 261 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 11/140 (7%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ EY+ GG L ++ Y VP ++ + +HS G +HRD+K +N+LL
Sbjct: 145 YMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201
Query: 74 GEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEK----RHTKKVDVYSFG 126
+ +K+ADFG +C++ GT +++PE++K + + ++ D +S G
Sbjct: 202 DKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260
Query: 127 IVLWELLTALTPFDNMTPEQ 146
+ L+E+L TPF +
Sbjct: 261 VFLYEMLVGDTPFYADSLVG 280
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-22
Identities = 27/146 (18%), Positives = 59/146 (40%), Gaps = 13/146 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSL-----RKYLHQQEPYSVPLNLVLKLALDIARGMQY 55
+ + + +I E+++G + E V + +Q+
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV------SYVHQVCEALQF 117
Query: 56 LHSQGILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 113
LHS I H D++ EN++ +K+ +FG + + + + APE+ +
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPF 139
+ D++S G +++ LL+ + PF
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPF 203
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-22
Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 15/134 (11%)
Query: 15 IITEYLAGGSL------RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68
I+ E L GG L R E + ++ I +QYLHS I HRD+K
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREAS------EIMKSIGEAIQYLHSINIAHRDVKP 189
Query: 69 ENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 125
ENLL + +K+ DFG + + S T ++APE++ +++ K D++S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 126 GIVLWELLTALTPF 139
G++++ LL PF
Sbjct: 250 GVIMYILLCGYPPF 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-21
Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 13/134 (9%)
Query: 13 FCIITEYLAGGSL-----RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67
+I E+L+GG L + E + G++++H I+H D+K
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVI------NYMRQACEGLKHMHEHSIVHLDIK 176
Query: 68 SENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSF 125
EN++ + VK+ DFG++ + K T T + APE++ + D+++
Sbjct: 177 PENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236
Query: 126 GIVLWELLTALTPF 139
G++ + LL+ L+PF
Sbjct: 237 GVLGYVLLSGLSPF 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 37/142 (26%), Positives = 69/142 (48%), Gaps = 5/142 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSL-RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ 59
+ A + +I E+++GG L K + S + ++ + +G+ ++H
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE--DEAVEYMRQVCKGLCHMHEN 274
Query: 60 GILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
+H DLK EN++ +K+ DFG++ S K TGT + APE+ + K
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 118 KKVDVYSFGIVLWELLTALTPF 139
D++S G++ + LL+ L+PF
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPF 356
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-21
Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 40/153 (26%)
Query: 15 IITEYLAGGSLRKYLHQQEPYS----VPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70
++ E + GGS+ ++H++ ++ + D+A + +LH++GI HRDLK EN
Sbjct: 88 LVFEKMRGGSILSHIHKRRHFNELEAS------VVVQDVASALDFLHNKGIAHRDLKPEN 141
Query: 71 LLL---GEDMCVKVADFGIS---------------CLESQCGSAKGFTGTYRWMAPEMIK 112
+L + VK+ DF + L + CGSA Y MAPE+++
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA-----EY--MAPEVVE 194
Query: 113 -----EKRHTKKVDVYSFGIVLWELLTALTPFD 140
+ K+ D++S G++L+ LL+ PF
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 35/130 (26%), Positives = 65/130 (50%), Gaps = 5/130 (3%)
Query: 13 FCIITEYLAGGSL-RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
++ EY+ GG L + + + + + I G++++H ILH DLK EN+
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTE--LDTILFMKQICEGIRHMHQMYILHLDLKPENI 218
Query: 72 LLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
L + +K+ DFG++ K GT ++APE++ + D++S G++
Sbjct: 219 LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
Query: 130 WELLTALTPF 139
+ LL+ L+PF
Sbjct: 279 YMLLSGLSPF 288
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 38/91 (41%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY---RW 105
I RG++Y+HS +LHRDLK NLLL +K+ DFG++ + GF Y RW
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 106 M-APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
APE M+ K +TK +D++S G +L E+L+
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 45/129 (34%), Positives = 64/129 (49%), Gaps = 5/129 (3%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
C+ E L +L + + + + L LV K A I + + LH I+H DLK EN+L
Sbjct: 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 73 LGE--DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLW 130
L + +KV DFG SC E Q + YR APE+I R+ +D++S G +L
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYGMPIDMWSLGCILA 290
Query: 131 ELLTALTPF 139
ELLT
Sbjct: 291 ELLTGYPLL 299
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 35/135 (25%), Positives = 68/135 (50%), Gaps = 10/135 (7%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLL 72
++ E L G +L + + E +PL V +++ + G+ Y+H + GI+H D+K EN+L
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 73 LGE------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 126
+ + +K+AD G +C + + T YR +PE++ D++S
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPEVLLGAPWGCGADIWSTA 222
Query: 127 IVLWELLTALTPFDN 141
+++EL+T F+
Sbjct: 223 CLIFELITGDFLFEP 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-18
Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
LR YL + P +P + L RG+ +LH+ I+HRDLK EN+L+ VK+ADF
Sbjct: 105 LRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164
Query: 85 GISCLESQCGSAKGFTGT-----YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
G L T YR APE++ + + VD++S G + E+
Sbjct: 165 G---LARIYSYQMALTPVVVTLWYR--APEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-18
Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L YL + VP + + + RG+ +LHS ++HRDLK +N+L+ +K+ADF
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164
Query: 85 GISCLESQCGSAKGFTGT-----YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134
G L T YR APE++ + + VD++S G + E+
Sbjct: 165 G---LARIYSFQMALTSVVVTLWYR--APEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 36/171 (21%), Positives = 65/171 (38%), Gaps = 36/171 (21%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTY---R 104
+ RG++Y+HS +LHRDLK NL + + +K+ DFG++ + S KG +
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 105 WM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF---DNM-----------TPEQAA 148
W +P ++ +TK +D+++ G + E+LT T F + +
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 149 FAVCQKNAR------PPVPP---------TCPKAFSYLISRCWSSSPDRRP 184
P +A + + + SP R
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD-FLEQILTFSPMDRL 298
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 28/89 (31%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--YRWM 106
I G+ LH G++HRDL N+LL ++ + + DF ++ ++ + + YR
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR-- 200
Query: 107 APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
APE +++ K TK VD++S G V+ E+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 44/176 (25%), Positives = 63/176 (35%), Gaps = 51/176 (28%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTGT----- 102
+ R + ++HS GI HRD+K +NLL+ K+ DF GSAK +
Sbjct: 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF---------GSAKKLIPSEPSVA 200
Query: 103 ------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT--AL----------------- 136
YR APE M+ +T +D++S G V EL+ L
Sbjct: 201 YICSRFYR--APELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIM 258
Query: 137 -TP----FDNMTPEQAAFAVCQKNARP---PVPPTCPKAFSYLISRCWSSSPDRRP 184
TP M P A+ +P P L+ + PD R
Sbjct: 259 GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 38/130 (29%), Positives = 56/130 (43%), Gaps = 28/130 (21%)
Query: 15 IITEYLAGGSL--RKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
I+ E L GG L R + ++ ++ I +QYLHS I HRD+K ENLL
Sbjct: 92 IVMECLDGGELFSRIQDRGDQAFTE--REASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
Query: 73 L---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+ +K+ DFG A E EK + K D++S G+++
Sbjct: 150 YTSKRPNAILKLTDFGF--------------------AKETTGEK-YDKSCDMWSLGVIM 188
Query: 130 WELLTALTPF 139
+ LL PF
Sbjct: 189 YILLCGYPPF 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 55/177 (31%), Positives = 69/177 (38%), Gaps = 53/177 (29%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTGT----- 102
+ R + Y+HS GI HRD+K +NLLL D V K+ DF GSAK
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDF---------GSAKQLVRGEPNVS 215
Query: 103 ------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT--AL----------------- 136
YR APE + +T +DV+S G VL ELL +
Sbjct: 216 YICSRYYR--APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273
Query: 137 -TP----FDNMTPEQAAFAVCQKNARPP----VPPTCPKAFSYLISRCWSSSPDRRP 184
TP M P F Q A P P T P+A + L SR +P R
Sbjct: 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIA-LCSRLLEYTPTARL 329
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 4/88 (4%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGT--YRWM 106
+ G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T YR
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR-- 230
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLT 134
APE+I + + VD++S G ++ E++
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 2/87 (2%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM-A 107
+ G+++LHS GI+HRDLK N+++ D +K+ DFG++ + T R+ A
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT-RYYRA 194
Query: 108 PEMIKEKRHTKKVDVYSFGIVLWELLT 134
PE+I + + VD++S G ++ E++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 3e-17
Identities = 35/119 (29%), Positives = 63/119 (52%), Gaps = 7/119 (5%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L+KY + +V + +G+ + HS+ +LHRDLK +NLL+ + +K+A+F
Sbjct: 87 LKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANF 145
Query: 85 GIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 139
G++ + +C SA+ T YR P+ + K ++ +D++S G + EL A P
Sbjct: 146 GLARAFGIPVRCYSAEVVTLWYR--PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWM- 106
R ++ LH ++HRDLK NLL+ + +KV DFG++ ++ TG M
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 107 ---------APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
APE M+ ++++ +DV+S G +L EL
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-16
Identities = 32/88 (36%), Positives = 54/88 (61%), Gaps = 5/88 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MA 107
+ +G++Y+HS G++HRDLK NL + ED +K+ DFG++ G+ T RW A
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--RHADAEMTGYVVT-RWYRA 191
Query: 108 PE-MIKEKRHTKKVDVYSFGIVLWELLT 134
PE ++ + + VD++S G ++ E+LT
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 33/88 (37%), Positives = 56/88 (63%), Gaps = 5/88 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM-A 107
+ +G++Y+H+ GI+HRDLK NL + ED +K+ DFG++ G+ T RW A
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--RQADSEMTGYVVT-RWYRA 193
Query: 108 PE-MIKEKRHTKKVDVYSFGIVLWELLT 134
PE ++ R+T+ VD++S G ++ E++T
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 37/182 (20%), Positives = 61/182 (33%), Gaps = 58/182 (31%)
Query: 49 IARGMQYLH--SQGILHRDLKSENLLLGEDMCV-KVADFGISCLESQCGSAKGFTGT--- 102
+ R + LH S + HRD+K N+L+ E K+ DF GSAK + +
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF---------GSAKKLSPSEPN 188
Query: 103 --------YRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT--AL--------------- 136
YR APE + + +T VD++S G + E++ +
Sbjct: 189 VAYICSRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246
Query: 137 ---TP----FDNMTPEQAAFAVCQKNARP-------PVPPTCPKAFSYLISRCWSSSPDR 182
P + P + P +A+ L+S P+
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYD-LLSALLQYLPEE 305
Query: 183 RP 184
R
Sbjct: 306 RM 307
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-16
Identities = 34/114 (29%), Positives = 63/114 (55%), Gaps = 7/114 (6%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L+K L + + + + + RG+ + H ILHRDLK +NLL+ D +K+ADF
Sbjct: 105 LKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADF 163
Query: 85 GIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 134
G++ + + + + T YR AP+ ++ K+++ VD++S G + E++T
Sbjct: 164 GLARAFGIPVRSYTHEVVTLWYR--APDVLMGSKKYSTSVDIWSIGCIFAEMIT 215
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 3e-16
Identities = 31/114 (27%), Positives = 60/114 (52%), Gaps = 7/114 (6%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L+K L + L + G+ Y H + +LHRDLK +NLL+ + +K+ADF
Sbjct: 86 LKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144
Query: 85 GIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 134
G++ + + + + T YR AP+ ++ K+++ +D++S G + E++
Sbjct: 145 GLARAFGIPVRKYTHEIVTLWYR--APDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-16
Identities = 39/131 (29%), Positives = 61/131 (46%), Gaps = 7/131 (5%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--GILHRDLKSEN 70
C++ E L +L L V LNL K A + + +L + I+H DLK EN
Sbjct: 131 LCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189
Query: 71 LLL--GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV 128
+LL + +K+ DFG SC Q + YR +PE++ + +D++S G +
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPEVLLGMPYDLAIDMWSLGCI 247
Query: 129 LWELLTALTPF 139
L E+ T F
Sbjct: 248 LVEMHTGEPLF 258
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-16
Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 27/135 (20%)
Query: 15 IITEYLAGGSLRKYL--HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ EY+ ++ + + + ++P+ L+ + R + Y+HS GI HRD+K +NLL
Sbjct: 115 LVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 73 L-GEDMCVKVADFGISCLESQCGSAKGFTGT-----------YRWMAPE-MIKEKRHTKK 119
L +K+ DF GSAK YR APE + +T
Sbjct: 174 LDPPSGVLKLIDF---------GSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTN 222
Query: 120 VDVYSFGIVLWELLT 134
+D++S G V+ EL+
Sbjct: 223 IDIWSTGCVMAELMQ 237
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 5e-16
Identities = 36/88 (40%), Positives = 53/88 (60%), Gaps = 5/88 (5%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MA 107
I RG++Y+HS I+HRDLK NL + ED +K+ DFG++ G+ T RW A
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--RHTADEMTGYVAT-RWYRA 197
Query: 108 PE-MIKEKRHTKKVDVYSFGIVLWELLT 134
PE M+ + + VD++S G ++ ELLT
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 42/175 (24%), Positives = 65/175 (37%), Gaps = 39/175 (22%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG----ISCLESQCGSAKGFTGTY- 103
+ G++Y+HS GILHRDLK N L+ +D VKV DFG + E+
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 104 ----------------------RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 139
RW APE ++ ++ +T+ +DV+S G + ELL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 140 DNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
++ P P + S R + DQ+ I
Sbjct: 285 VAYHADR----------GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 34/169 (20%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTY---- 103
+ G ++H GI+HRDLK N LL +D VKV DFG++ + S+ +
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 104 -----------------RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP 144
RW APE ++ ++ +TK +D++S G + ELL L N
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 145 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSIL 193
+ P P + S + R + I +I+
Sbjct: 258 NR----------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-15
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 23/109 (21%)
Query: 49 IARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTY----- 103
+ + ++YLHS G+LHRD+K N+LL + VKVADFG+S
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 104 ----------------RWM-APE-MIKEKRHTKKVDVYSFGIVLWELLT 134
RW APE ++ ++TK +D++S G +L E+L
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-15
Identities = 34/118 (28%), Positives = 64/118 (54%), Gaps = 10/118 (8%)
Query: 25 LRKYLHQQEPYSVPLNL----VLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80
L+KY+ + + P L V + +G+ + H ILHRDLK +NLL+ + +K
Sbjct: 89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLK 148
Query: 81 VADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 134
+ DFG++ + S++ T YR AP+ ++ + ++ +D++S G +L E++T
Sbjct: 149 LGDFGLARAFGIPVNTFSSEVVTLWYR--APDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-15
Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 22/146 (15%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
CI E L G + ++L + PL V +A + +++LH + H DLK EN+L
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 73 LGEDMC-------------------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 113
++VADFG + + + + T YR PE+I E
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR--PPEVILE 213
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPF 139
+ DV+S G +L+E T F
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLF 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 21/121 (17%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
+ L + VP +LV + + + + H +HRD+K EN+L+ + +K+ DF
Sbjct: 88 VLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDF 146
Query: 85 GISCLESQCGSAKGFTG---TY------RWM-APEMI-KEKRHTKKVDVYSFGIVLWELL 133
G A+ TG Y RW +PE++ + ++ VDV++ G V ELL
Sbjct: 147 GF---------ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197
Query: 134 T 134
+
Sbjct: 198 S 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 32/114 (28%), Positives = 62/114 (54%), Gaps = 7/114 (6%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
L++YL + ++ V + RG+ Y H Q +LHRDLK +NLL+ E +K+ADF
Sbjct: 86 LKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADF 144
Query: 85 GIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 134
G++ + ++ + T YR P+ ++ ++ ++D++ G + +E+ T
Sbjct: 145 GLARAKSIPTKTYDNEVVTLWYR--PPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 3e-14
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 21/121 (17%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84
+ L + P + +V K I G+ + HS I+HRD+K EN+L+ + VK+ DF
Sbjct: 110 ILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDF 168
Query: 85 GISCLESQCGSAKGFTG---TY------RWM-APEMI-KEKRHTKKVDVYSFGIVLWELL 133
G A+ Y RW APE++ + ++ K VDV++ G ++ E+
Sbjct: 169 GF---------ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219
Query: 134 T 134
Sbjct: 220 M 220
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 4e-14
Identities = 39/183 (21%), Positives = 71/183 (38%), Gaps = 53/183 (28%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLL 72
C++ E + G L K++ + +PL V K+ + +G+ YLH++ I+H D+K EN+L
Sbjct: 121 CMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 73 LG-------------------------------------------------EDMCVKVAD 83
L E + VK+AD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 84 FGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 143
G +C + + T YR + E++ + D++S + +EL T F+ +
Sbjct: 240 LGNACWVHKHFTEDIQTRQYR--SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297
Query: 144 PEQ 146
E+
Sbjct: 298 GEE 300
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 22/146 (15%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
CI+ E L G S ++ + L+ + K+A I + + +LHS + H DLK EN+L
Sbjct: 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENIL 150
Query: 73 LGEDMC-------------------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE 113
+ +KV DFG + + + S T YR APE+I
Sbjct: 151 FVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APEVILA 208
Query: 114 KRHTKKVDVYSFGIVLWELLTALTPF 139
++ DV+S G +L E T F
Sbjct: 209 LGWSQPCDVWSIGCILIEYYLGFTVF 234
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 29/119 (24%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 25 LRKYL-HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 83
L L + +++ + ++ + G+ Y+H ILHRD+K+ N+L+ D +K+AD
Sbjct: 110 LAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167
Query: 84 FGI--SCLESQCGSAKGFTGT-----YRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT 134
FG+ + ++ +T YR PE++ E+ + +D++ G ++ E+ T
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVVTLWYR--PPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-14
Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 26/131 (19%)
Query: 25 LRKYLH-------QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM 77
L + ++P +P +V L I G+ YLH+ +LHRDLK N+L+ +
Sbjct: 106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG 165
Query: 78 ----CVKVADFGISCLESQCGS-AKGFTGT--------YRWMAPE-MIKEKRHTKKVDVY 123
VK+AD G S K YR APE ++ + +TK +D++
Sbjct: 166 PERGRVKIADMG---FARLFNSPLKPLADLDPVVVTFWYR--APELLLGARHYTKAIDIW 220
Query: 124 SFGIVLWELLT 134
+ G + ELLT
Sbjct: 221 AIGCIFAELLT 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-14
Identities = 39/118 (33%), Positives = 58/118 (49%), Gaps = 15/118 (12%)
Query: 25 LRKYL-HQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 83
L + + + L +G++YLH ILHRDLK NLLL E+ +K+AD
Sbjct: 98 LEVIIKDNSLVLTPSH--IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD 155
Query: 84 FGISCLESQCGS-AKGFTGT-----YRWMAPEMI-KEKRHTKKVDVYSFGIVLWELLT 134
FG L GS + +T YR APE++ + + VD+++ G +L ELL
Sbjct: 156 FG---LAKSFGSPNRAYTHQVVTRWYR--APELLFGARMYGVGVDMWAVGCILAELLL 208
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-14
Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 28/146 (19%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
C+I E L G SL + + + + + ++I + + YL + H DLK EN+LL
Sbjct: 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170
Query: 74 GEDMC-------------------------VKVADFGISCLESQCGSAKGFTGTYRWMAP 108
+ +K+ DFG + +S + T YR AP
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--AP 228
Query: 109 EMIKEKRHTKKVDVYSFGIVLWELLT 134
E+I D++SFG VL EL T
Sbjct: 229 EVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 32/119 (26%), Positives = 60/119 (50%), Gaps = 13/119 (10%)
Query: 25 LRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL-----GEDMCV 79
L+KY+ + S + ++ + G+ + HS+ LHRDLK +NLLL E +
Sbjct: 119 LKKYMDKNPDVS--MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 80 KVADFGIS---CLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLWELLT 134
K+ DFG++ + + + + T YR PE ++ + ++ VD++S + E+L
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYR--PPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 22/95 (23%), Positives = 47/95 (49%), Gaps = 10/95 (10%)
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMC-VKVADFGISCLESQCGSAKGFTGTY---RWM 106
+ + Y HS GI+HRD+K N+++ + +++ D+G L + + R+
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEYNV-RVASRYF 196
Query: 107 -APE-MIKEKRHTKKVDVYSFGIVLWELLTALTPF 139
PE ++ + + +D++S G +L ++ PF
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-12
Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 19/198 (9%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ E L G SL + L L VL LA + ++Y+HS+ +HRD+K +N L+
Sbjct: 81 VMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138
Query: 74 GEDMC---VKVADFGISC--LESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKVDV 122
G V + DFG++ +++ K TGT R+ + +++ D+
Sbjct: 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDL 198
Query: 123 YSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNARPPVPPTC---PKAFSYLISRCW 176
S G VL P+ + T Q + +K P+ C P F+ ++ C
Sbjct: 199 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCR 258
Query: 177 SSSPDRRPHFDQIVSILE 194
S D +P + + +
Sbjct: 259 SLRFDDKPDYSYLRQLFR 276
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 29/103 (28%), Positives = 48/103 (46%), Gaps = 13/103 (12%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ E L G L+K Q + + VL+L + + ++Y+H +H D+K+ NLLL
Sbjct: 128 FMVMERL-GIDLQKISGQNGTFK--KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
Query: 74 GEDMCVKV--ADFGISC--------LESQCGSAKGFTGTYRWM 106
G +V AD+G+S + Q KG GT +
Sbjct: 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT 227
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-12
Identities = 18/95 (18%), Positives = 40/95 (42%), Gaps = 10/95 (10%)
Query: 22 GGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81
G SL+ L + + VL++A + +++LH +H ++ +EN+ + + +V
Sbjct: 141 GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200
Query: 82 --ADFGISC--------LESQCGSAKGFTGTYRWM 106
A +G + + GS G ++
Sbjct: 201 TLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 9e-12
Identities = 39/200 (19%), Positives = 79/200 (39%), Gaps = 21/200 (10%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ + L G SL + L + V A + +Q +H + +++RD+K +N L+
Sbjct: 82 VLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
Query: 74 GEDMC-----VKVADFGIS--CLESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKV 120
G + V DFG+ + K +GT R+M+ + +++
Sbjct: 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 199
Query: 121 DVYSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNARPPVPPTC---PKAFSYLISR 174
D+ + G V L P+ + T +Q + +K P+ C P+ F +
Sbjct: 200 DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHY 259
Query: 175 CWSSSPDRRPHFDQIVSILE 194
+ + D P +D + +
Sbjct: 260 ARNLAFDATPDYDYLQGLFS 279
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 46/198 (23%), Positives = 82/198 (41%), Gaps = 19/198 (9%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ + L G SL + L + L VL LA + ++++HS+ LHRD+K +N L+
Sbjct: 79 VLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 74 GEDMC---VKVADFGISCL--ESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKVDV 122
G V + DFG++ ++ K TGT R+ + +++ D+
Sbjct: 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDL 196
Query: 123 YSFGIVLWELLTALTPFDNM---TPEQAAFAVCQKNARPPVPPTC---PKAFSYLISRCW 176
S G VL L P+ + T +Q + +K + C P F+ C
Sbjct: 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCR 256
Query: 177 SSSPDRRPHFDQIVSILE 194
S D +P + + +
Sbjct: 257 SLRFDDKPDYSYLKRLFR 274
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 6e-11
Identities = 23/102 (22%), Positives = 40/102 (39%), Gaps = 12/102 (11%)
Query: 15 IITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74
+I + G L+K VL+L+L I ++Y+H +H D+K+ NLLL
Sbjct: 129 MIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186
Query: 75 EDMCVKV--ADFGISC--------LESQCGSAKGFTGTYRWM 106
+V D+G++ + GT +
Sbjct: 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 15/106 (14%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
++ E L G SL + L + L VL +A+ + M+Y+HS+ +++RD+K EN L+
Sbjct: 81 AMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138
Query: 74 GEDM-----CVKVADFGIS--CLESQCGS------AKGFTGTYRWM 106
G + + DF ++ ++ + K TGT R+M
Sbjct: 139 GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 244 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.45 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.7 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.17 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.88 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.24 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.84 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.09 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 93.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 93.44 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.92 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 91.77 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 91.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 91.29 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.06 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 86.68 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 86.32 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.86 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=329.43 Aligned_cols=199 Identities=24% Similarity=0.386 Sum_probs=172.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-cE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM-CV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~-~~ 79 (244)
|++++++.+++.+|||||||+||+|.+++++.+ .+++..++.++.|++.||+|||++||+||||||+|||++.+| .+
T Consensus 113 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~v 190 (336)
T 4g3f_A 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA 190 (336)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCE
T ss_pred CcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEE
Confidence 689999999999999999999999999998876 689999999999999999999999999999999999999987 69
Q ss_pred EEecCCCcccccccC------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 80 KVADFGISCLESQCG------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
||+|||+|+...... .....+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 191 Kl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270 (336)
T ss_dssp EECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH
T ss_pred EEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc
Confidence 999999997644322 12346799999999999999999999999999999999999999988766655555544
Q ss_pred hCCC-CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 154 KNAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 154 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.... ...++.+++.+.++|.+||+.||.+|||+.|+++.|........
T Consensus 271 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 3322 24677899999999999999999999999999999887766544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=330.82 Aligned_cols=190 Identities=26% Similarity=0.463 Sum_probs=171.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|||||||+||+|.++|....+..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 86 V~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vK 165 (350)
T 4b9d_A 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQ 165 (350)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEE
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEE
Confidence 68999999999999999999999999999877666789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.... .+.
T Consensus 166 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~ 244 (350)
T 4b9d_A 166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPP 244 (350)
T ss_dssp ECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCC
T ss_pred EcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCC
Confidence 99999997654322 2335679999999999999999999999999999999999999999988888777665443 456
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++++.+||.+||+.||.+|||++|+++
T Consensus 245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67789999999999999999999999999987
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=321.37 Aligned_cols=198 Identities=31% Similarity=0.593 Sum_probs=176.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-----------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSE 69 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-----------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ 69 (244)
|+++++|.+++..|||||||+||+|.+++++++ ...+++.+++.++.|++.||.|||+++|+||||||+
T Consensus 78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~ 157 (299)
T 4asz_A 78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 157 (299)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHh
Confidence 789999999999999999999999999997643 346999999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 026042 70 NLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 145 (244)
Q Consensus 70 nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 145 (244)
|||++.++.+||+|||+|+...... ......||+.|||||.+.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus 158 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred hEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999997543322 2234568999999999999999999999999999999998 99999999888
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+....+.. ......|..+|+++.+|+.+||+.||++|||++++.++|+.+...
T Consensus 238 ~~~~~i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 238 EVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 77766654 445677889999999999999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=318.28 Aligned_cols=198 Identities=35% Similarity=0.619 Sum_probs=164.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+ +.+|||||||+||+|.+++....+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 95 V~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~-~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~K 172 (307)
T 3omv_A 95 LLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVK 172 (307)
T ss_dssp CCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEE
T ss_pred eeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEE
Confidence 689999865 567899999999999999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceecc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||+|+..... .......||+.|||||++.+ .+++.++|||||||++|||++|+.||.+.+...........
T Consensus 173 i~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~ 252 (307)
T 3omv_A 173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR 252 (307)
T ss_dssp ECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred EeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 9999999764332 22345689999999999864 35899999999999999999999999987765555444433
Q ss_pred CCCC----CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 155 NARP----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 155 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
.... ..+..+++++.+|+.+||+.||.+|||+.|+++.|+.+...+
T Consensus 253 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 253 GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 3222 345678999999999999999999999999999998765443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=322.88 Aligned_cols=187 Identities=25% Similarity=0.431 Sum_probs=169.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|||||||+||+|.+++++.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 95 v~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 95 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred CeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEE
Confidence 689999999999999999999999999998876 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+|...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-- 250 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-- 250 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--
Confidence 9999999765322 23456789999999999999999999999999999999999999999988887777665543
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+++++++||.+||+.||.+|||++|++.
T Consensus 251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 4567889999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=324.27 Aligned_cols=188 Identities=25% Similarity=0.441 Sum_probs=167.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|||||||+||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 134 V~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vK 210 (346)
T 4fih_A 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 210 (346)
T ss_dssp CCEEEEEEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEE
Confidence 68999999999999999999999999999864 489999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-CC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~ 158 (244)
|+|||++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 211 l~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~ 290 (346)
T 4fih_A 211 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL 290 (346)
T ss_dssp ECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC
T ss_pred EecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 9999999765433 345677899999999999999999999999999999999999999999888777666544322 22
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..+++++.+||.+||+.||.+|||++|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 344578999999999999999999999999987
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=314.04 Aligned_cols=186 Identities=28% Similarity=0.426 Sum_probs=157.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|+||||+ +|+|.+++.+++ .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 76 v~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 76 IKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp CCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEE
T ss_pred CeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEE
Confidence 68999999999999999999 789999998876 699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||+|............+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+.......+... ...
T Consensus 153 l~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~ 230 (275)
T 3hyh_A 153 IADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYT 230 (275)
T ss_dssp ECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCC
T ss_pred EeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 999999987666556667889999999999988775 68999999999999999999999988877766655443 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++++.+||.+||+.||.+|||++|+++
T Consensus 231 ~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 67789999999999999999999999999997
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=320.20 Aligned_cols=197 Identities=28% Similarity=0.581 Sum_probs=169.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dik 67 (244)
|+++++|.+++..|||||||++|+|.++++++.. ..+++.+++.++.|++.||+|||+++|+|||||
T Consensus 106 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK 185 (329)
T 4aoj_A 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185 (329)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 7899999999999999999999999999986432 358999999999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCC
Q 026042 68 SENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMT 143 (244)
Q Consensus 68 p~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 143 (244)
|+|||++.++.+||+|||+++...... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+
T Consensus 186 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 186 TRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp GGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred HhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999999997543322 2335678999999999999999999999999999999999 999999988
Q ss_pred HHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 144 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+....+. .......|..+++++.+|+.+||+.||++|||++|+++.|+.+..
T Consensus 266 ~~~~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 266 NTEAIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 887766654 445677888999999999999999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=318.44 Aligned_cols=187 Identities=28% Similarity=0.445 Sum_probs=167.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|||||||+||+|.+++.+.+ .+++..++.++.|++.||+|||++||+||||||+|||++.+|.+|
T Consensus 89 v~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vK 166 (304)
T 3ubd_A 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166 (304)
T ss_dssp ECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEE
T ss_pred CeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEE
Confidence 579999999999999999999999999999876 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||+|+.... .......+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+... ...
T Consensus 167 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~ 244 (304)
T 3ubd_A 167 LTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLG 244 (304)
T ss_dssp EESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred ecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCC
Confidence 999999975433 33455678999999999999999999999999999999999999999998888877766543 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF-----DQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~el~~ 191 (244)
.+..+++++.+||.+||+.||.+|||+ +|+++
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 678899999999999999999999984 56664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=317.37 Aligned_cols=195 Identities=28% Similarity=0.533 Sum_probs=173.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|+++++|.+++..+||||||++|+|.+++..+. ...+++..+..++.|++.||+|||+++|+||||
T Consensus 92 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDL 171 (308)
T 4gt4_A 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDL 171 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 689999999999999999999999999997542 125889999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+|||+++++.+||+|||+++..... .......||+.|+|||.+.++.++.++|||||||++|||+| |..||.+.
T Consensus 172 K~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 172 ATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp SGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred cccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999754332 22345678999999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
+..+....+. .....+.+..+|+.+.+++.+||+.||.+|||+.||++.|+++
T Consensus 252 ~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 252 SNQDVVEMIR-NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CHHHHHHHHH-cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 8887766654 4455677889999999999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=325.84 Aligned_cols=188 Identities=25% Similarity=0.441 Sum_probs=168.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+++.+|||||||+||+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 211 V~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vK 287 (423)
T 4fie_A 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVK 287 (423)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEE
T ss_pred CceEEEEEECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence 68999999999999999999999999999764 489999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-CC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~ 158 (244)
|+|||++...... ......+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+..+....+..... ..
T Consensus 288 l~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~ 367 (423)
T 4fie_A 288 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL 367 (423)
T ss_dssp ECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred EecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 9999999765433 345577899999999999999999999999999999999999999999888777766654322 23
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..+++++.+||.+||+.||.+|||++|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 445678999999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=310.80 Aligned_cols=187 Identities=25% Similarity=0.500 Sum_probs=158.9
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~ 74 (244)
|+++++|.. ++.+|||||||+||+|.+++++.. .+++..++.++.|++.||+|||++| |+||||||+|||++
T Consensus 88 V~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~ 165 (290)
T 3fpq_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES
T ss_pred CcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE
Confidence 688998865 466899999999999999998876 6899999999999999999999998 99999999999998
Q ss_pred C-CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 E-DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
. +|.+||+|||+|+.... ......+||+.|||||++.+ +++.++|||||||++|+|++|..||.+.+..........
T Consensus 166 ~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~ 243 (290)
T 3fpq_A 166 GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHH
Confidence 5 78999999999975433 34456789999999998865 689999999999999999999999987655444433333
Q ss_pred h-CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 K-NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ......+..+++++.+||.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3 3333455677899999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=320.92 Aligned_cols=198 Identities=27% Similarity=0.535 Sum_probs=173.3
Q ss_pred CcEEEEeec-CCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 026042 1 MQFVAACKK-PPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 65 (244)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~d 65 (244)
|+++++|.+ ++.+|||||||++|+|.+++++.. ...+++..+..++.|++.||+|||+++|+|||
T Consensus 131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 689999965 467899999999999999997642 23478999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 026042 66 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 141 (244)
Q Consensus 66 ikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~ 141 (244)
|||+|||++.++.+||+|||+|+...... ......||+.|||||++.+..++.++|||||||++|||+| |..||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997643322 2334568999999999999999999999999999999998 9999998
Q ss_pred CCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 142 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.+..+..........+...|..+++++.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 776555555566677788889999999999999999999999999999999987754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=295.30 Aligned_cols=195 Identities=29% Similarity=0.547 Sum_probs=155.0
Q ss_pred CcEEEEeecCC----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCC
Q 026042 1 MQFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~--------~i~H~dikp 68 (244)
|+++++|.+++ .+||||||++||+|.+++++. .+++..+.+++.|++.||+|||++ +|+||||||
T Consensus 60 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp 136 (303)
T 3hmm_A 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCG
T ss_pred CcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCc
Confidence 68999997664 579999999999999999875 488999999999999999999987 999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccC-----CCCCCCcccceeccceeccC------CCCCccchhhhHHHHHHHHhCCC
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTALT 137 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~ 137 (244)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|..
T Consensus 137 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~ 216 (303)
T 3hmm_A 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred ccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCC
Confidence 99999999999999999987644322 22345799999999998654 35779999999999999999976
Q ss_pred CCC----------CC-----CHHHHHHHHHhhCCCCCCCCC-----chHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 138 PFD----------NM-----TPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 138 p~~----------~~-----~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
|+. .. ........+.....++..+.. .++.+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 217 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 553 21 122333333333444444433 3457899999999999999999999999999876
Q ss_pred h
Q 026042 198 E 198 (244)
Q Consensus 198 ~ 198 (244)
.
T Consensus 297 ~ 297 (303)
T 3hmm_A 297 Q 297 (303)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=294.75 Aligned_cols=188 Identities=27% Similarity=0.445 Sum_probs=142.6
Q ss_pred CcEEEEeecCC------------cEEEEEeccCCCCHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCC
Q 026042 1 MQFVAACKKPP------------VFCIITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLK 67 (244)
Q Consensus 1 v~~~~~~~~~~------------~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dik 67 (244)
|++++++.+.+ ++|||||||+||+|.++++..... ..++..++.++.|++.||+|||++||+|||||
T Consensus 66 V~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlK 145 (299)
T 4g31_A 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145 (299)
T ss_dssp CCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCc
Confidence 67888886544 479999999999999999876532 24567789999999999999999999999999
Q ss_pred CCcEEEcCCCcEEEecCCCcccccccCC-------------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh
Q 026042 68 SENLLLGEDMCVKVADFGISCLESQCGS-------------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT 134 (244)
Q Consensus 68 p~nil~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 134 (244)
|+||+++.+|.+||+|||+|+....... ....+||+.|||||++.+..++.++|||||||++|||++
T Consensus 146 p~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 146 PSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp GGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS
T ss_pred HHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc
Confidence 9999999999999999999976433211 234579999999999999999999999999999999996
Q ss_pred CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
||..................++.....++...+||.+||+.||.+|||+.|+++
T Consensus 226 ---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 ---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 775432221111111122222222334566788999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=314.75 Aligned_cols=186 Identities=23% Similarity=0.366 Sum_probs=162.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+.+.+||||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 255 V~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vK 332 (689)
T 3v5w_A 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 332 (689)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEE
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEE
Confidence 689999999999999999999999999998876 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~ 156 (244)
|+|||+|..... ......+||+.|||||++.. ..++.++|||||||++|+|++|..||.+.+ .......+ ...
T Consensus 333 L~DFGlA~~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--~~~ 409 (689)
T 3v5w_A 333 ISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTM 409 (689)
T ss_dssp ECCCTTCEECSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH--HHC
T ss_pred ecccceeeecCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh--cCC
Confidence 999999976544 33456789999999999964 579999999999999999999999997542 22222222 334
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
....+..+++++.+||.+||+.||.+|++ ++|+++
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 45677889999999999999999999998 678776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=292.54 Aligned_cols=186 Identities=22% Similarity=0.308 Sum_probs=149.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC-CcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-MCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-~~~ 79 (244)
|++++++.+++++|+||||++|++|.++++ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+
T Consensus 83 v~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~ 157 (361)
T 4f9c_A 83 MGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKY 157 (361)
T ss_dssp CCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEE
T ss_pred ceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeE
Confidence 578899999999999999999999999984 48899999999999999999999999999999999999876 799
Q ss_pred EEecCCCcccccccC-----------------------------CCCCCCcccceeccceeccC-CCCCccchhhhHHHH
Q 026042 80 KVADFGISCLESQCG-----------------------------SAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVL 129 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l 129 (244)
||+|||+|+...... .....+||+.|+|||++.+. .++.++||||+||++
T Consensus 158 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il 237 (361)
T 4f9c_A 158 ALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237 (361)
T ss_dssp EECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred EECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHH
Confidence 999999986432211 12345799999999998775 589999999999999
Q ss_pred HHHHhCCCCCCCCC-HHHHHHHHHhh----------------------------------------------------CC
Q 026042 130 WELLTALTPFDNMT-PEQAAFAVCQK----------------------------------------------------NA 156 (244)
Q Consensus 130 ~~l~~g~~p~~~~~-~~~~~~~~~~~----------------------------------------------------~~ 156 (244)
|+|++|+.||...+ ..+....+... ..
T Consensus 238 ~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 317 (361)
T 4f9c_A 238 LSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHAT 317 (361)
T ss_dssp HHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------------
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccc
Confidence 99999999995443 22222211110 00
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......+++++.+||.+||+.||.+|+|++|+++
T Consensus 318 ~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 318 NLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp ----CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 01122456889999999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=294.92 Aligned_cols=188 Identities=21% Similarity=0.344 Sum_probs=157.8
Q ss_pred CcEEEEeec------CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKK------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++.. .+.+|||||||+ |+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 116 v~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 116 IAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN 192 (398)
T ss_dssp CCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred ceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC
Confidence 578887653 468899999995 68999998765 699999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCccccccc-----CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 026042 75 EDMCVKVADFGISCLESQC-----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 148 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 148 (244)
.+|.+||+|||+++..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+..
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l 272 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9999999999999754322 234467899999999998775 5699999999999999999999999998877766
Q ss_pred HHHHhhCCCCC-----------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 149 FAVCQKNARPP-----------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 149 ~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+......+. ..+.+++++.+||.+||..||.+|||++|+++
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 65543322211 01346789999999999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=309.73 Aligned_cols=190 Identities=21% Similarity=0.327 Sum_probs=170.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC--Cc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~--~~ 78 (244)
|++++++.+++.+|||||||+||+|.+++.+..+ .+++..++.++.||+.||.|||++||+||||||+||+++.+ |.
T Consensus 217 v~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~ 295 (573)
T 3uto_A 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 295 (573)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC
T ss_pred CeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCC
Confidence 6899999999999999999999999999975433 68999999999999999999999999999999999999864 89
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||+++...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 296 vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~ 375 (573)
T 3uto_A 296 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 375 (573)
T ss_dssp EEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCC
Confidence 99999999987766555566789999999999999999999999999999999999999999998888877766544332
Q ss_pred --CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 --PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+++++.+||.+||+.||.+|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233678999999999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=278.97 Aligned_cols=201 Identities=40% Similarity=0.705 Sum_probs=169.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~~ 77 (244)
|++++++...+..++||||+++++|.+++.+... ..+++..++.++.|++.||+|||++| ++||||||+||+++.++
T Consensus 97 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp CCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC
T ss_pred eeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC
Confidence 5789999999999999999999999999987542 23889999999999999999999999 99999999999999999
Q ss_pred cEEEecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 CVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.+||+|||++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 177 ~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~ 256 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK 256 (309)
T ss_dssp CEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC
T ss_pred cEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999999998754332 223456789999999999999999999999999999999999999999988887777766777
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
....+..+++.+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 778888999999999999999999999999999999998876533
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=278.54 Aligned_cols=187 Identities=29% Similarity=0.478 Sum_probs=168.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+||||++|++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 77 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred eeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEE
Confidence 578999999999999999999999999998776 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.............|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||.+.+.......+... ...
T Consensus 155 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~ 232 (328)
T 3fe3_A 155 IADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYR 232 (328)
T ss_dssp ECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 999999976655555567789999999999988776 48999999999999999999999998887776666543 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++++.+++.+||+.||.+|||++|+++
T Consensus 233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 66778999999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=273.55 Aligned_cols=187 Identities=25% Similarity=0.422 Sum_probs=167.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||++|++||||||+||+++.+|.+|
T Consensus 68 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vk 145 (337)
T 1o6l_A 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... .........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+... ...
T Consensus 146 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~ 223 (337)
T 1o6l_A 146 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIR 223 (337)
T ss_dssp ECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 99999987532 233445678999999999999999999999999999999999999999988877766655443 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..+++++.++|.+||+.||.+|| +++++++
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 6778999999999999999999999 8999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=270.51 Aligned_cols=188 Identities=27% Similarity=0.511 Sum_probs=166.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||++|++|.+++.+. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k 156 (297)
T 3fxz_A 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK 156 (297)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred CeEeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEE
Confidence 57899999999999999999999999999875 388999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~ 158 (244)
|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ....
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (297)
T 3fxz_A 157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236 (297)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC
T ss_pred EeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99999987544332 344567999999999999999999999999999999999999999988877665554433 3334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..+++.+.+++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 456778999999999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=278.09 Aligned_cols=198 Identities=30% Similarity=0.613 Sum_probs=172.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|+++++|..++..|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||++|++||||
T Consensus 150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 229 (370)
T 2psq_A 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229 (370)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 6799999999999999999999999999987542 24788999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.+|.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999987543322 2234456789999999999999999999999999999999 99999988
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+..+....+ ........+..++.++.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 310 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 310 PVEELFKLL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp CGGGHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 776655444 34445667788999999999999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=278.93 Aligned_cols=187 Identities=24% Similarity=0.385 Sum_probs=162.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+||||++|++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 87 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ik 164 (353)
T 3txo_A 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998876 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... ........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+... ...
T Consensus 165 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~ 242 (353)
T 3txo_A 165 LADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVV 242 (353)
T ss_dssp ECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 99999987533 223445678999999999999888999999999999999999999999998888777666543 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF------DQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~------~el~~ 191 (244)
.+..+++.+.+++.+||+.||.+||++ +++++
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 667789999999999999999999998 77776
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=276.57 Aligned_cols=202 Identities=30% Similarity=0.597 Sum_probs=176.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 217 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 6799999999999999999999999999987542 35899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++++|++ |..||.+.
T Consensus 218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987654322 2334457889999999999999999999999999999999 99999988
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
+..+....+. .......+..+++++.+++.+||+.||.+||++.++++.|+.+.......
T Consensus 298 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 298 PVEELFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp CHHHHHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 8776655443 44456677889999999999999999999999999999999987765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=276.49 Aligned_cols=189 Identities=22% Similarity=0.345 Sum_probs=167.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 78 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 155 (361)
T 2yab_A 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred CcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCc
Confidence 578999999999999999999999999998765 689999999999999999999999999999999999998876
Q ss_pred -cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 -CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.+||+|||++.............|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 235 (361)
T 2yab_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235 (361)
T ss_dssp CCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred cCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 7999999999876655555667899999999999988999999999999999999999999999887777666544332
Q ss_pred CCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ....+++.+.+||.+||..||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 221 22567899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=274.40 Aligned_cols=197 Identities=32% Similarity=0.619 Sum_probs=170.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||++|++|.++++...+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 191 (325)
T 3kul_A 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCK 191 (325)
T ss_dssp CCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred CcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEE
Confidence 5789999999999999999999999999976543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ..
T Consensus 192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~ 270 (325)
T 3kul_A 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EG 270 (325)
T ss_dssp ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TT
T ss_pred ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cC
Confidence 999999876443221 223345778999999988899999999999999999999 999999988877666554 34
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.....+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 55667788999999999999999999999999999999988664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=273.77 Aligned_cols=187 Identities=26% Similarity=0.422 Sum_probs=166.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 84 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk 161 (353)
T 2i0e_A 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred eeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEE
Confidence 578999999999999999999999999998766 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... ........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+... ...
T Consensus 162 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~ 239 (353)
T 2i0e_A 162 IADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVA 239 (353)
T ss_dssp ECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 99999987532 233455678999999999999999999999999999999999999999998887776666543 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
.+..+++++.++|.+||+.||.+||+ ++++++
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 67789999999999999999999995 567765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=267.39 Aligned_cols=197 Identities=24% Similarity=0.441 Sum_probs=165.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.+.+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 74 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred ceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998876 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+...............
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231 (294)
T ss_dssp ECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC
T ss_pred EEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC
Confidence 99999987654322 2334568999999999999999999999999999999999999999888776655444332221
Q ss_pred ---CCCCCchHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 026042 159 ---PVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYSES 199 (244)
Q Consensus 159 ---~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~el~~~l~~~~~~ 199 (244)
..+..+++.+.+++.+||+.||.+|| +++++.+.|..+...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 23467899999999999999999998 999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=263.86 Aligned_cols=196 Identities=28% Similarity=0.608 Sum_probs=172.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.+++..++||||+++++|.+++....+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 146 (269)
T 4hcu_A 68 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 146 (269)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEE
T ss_pred eeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEE
Confidence 5789999999999999999999999999977543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+. ....
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~ 225 (269)
T 4hcu_A 147 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFR 225 (269)
T ss_dssp ECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCC
T ss_pred eccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCcc
Confidence 9999998754322 22344556788999999998899999999999999999999 999999988777665554 3445
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++.+.+++.+||+.||.+||++.++++.|+.+.+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 56677789999999999999999999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=275.30 Aligned_cols=187 Identities=28% Similarity=0.476 Sum_probs=166.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+.+..|+||||++||+|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.+|.+|
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+... ...
T Consensus 159 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~ 236 (345)
T 1xjd_A 159 IADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF 236 (345)
T ss_dssp ECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 999999875432 23445678999999999999999999999999999999999999999988887766665443 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD-QIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-el~~ 191 (244)
.+..+++++.++|.+||+.||.+||++. ++++
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 6678899999999999999999999997 6654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=269.53 Aligned_cols=199 Identities=29% Similarity=0.550 Sum_probs=174.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------YSVPLNLVLKLALDIARGMQYLHSQGILHR 64 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~ 64 (244)
|++++++..++..++|+||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 5789999999999999999999999999987543 248999999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 026042 65 DLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 140 (244)
Q Consensus 65 dikp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~ 140 (244)
||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++++|++ |..||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876543322 234456788999999988899999999999999999998 999998
Q ss_pred CCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 141 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
....................+..++..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 87766655555556666667788999999999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=276.79 Aligned_cols=188 Identities=23% Similarity=0.437 Sum_probs=161.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 116 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998866 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccc-ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Q 026042 81 VADFGISCL-ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--------EQAAFAV 151 (244)
Q Consensus 81 l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~ 151 (244)
|+|||++.. ..........+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .......
T Consensus 194 L~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 273 (396)
T 4dc2_A 194 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273 (396)
T ss_dssp ECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH
T ss_pred EeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH
Confidence 999999875 3333445677899999999999999999999999999999999999999964321 1112222
Q ss_pred HhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 026042 152 CQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF------DQIVS 191 (244)
Q Consensus 152 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~el~~ 191 (244)
. .......+..+++++.++|.+||+.||.+||++ +++++
T Consensus 274 i-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 274 I-LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp H-HHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred H-hccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 2 234456777899999999999999999999985 56655
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=277.12 Aligned_cols=199 Identities=28% Similarity=0.547 Sum_probs=171.7
Q ss_pred CcEEEEeecCCc-EEEEEeccCCCCHHHHHhhcCC---------------------------------------------
Q 026042 1 MQFVAACKKPPV-FCIITEYLAGGSLRKYLHQQEP--------------------------------------------- 34 (244)
Q Consensus 1 v~~~~~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~--------------------------------------------- 34 (244)
|++++++...+. .++||||+++|+|.+++.....
T Consensus 89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 578999877554 8999999999999999987542
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccccccC-
Q 026042 35 -------------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG- 94 (244)
Q Consensus 35 -------------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~- 94 (244)
..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 128889999999999999999999999999999999999999999999999987543222
Q ss_pred --CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHH
Q 026042 95 --SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYL 171 (244)
Q Consensus 95 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 171 (244)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...................+..+++++.++
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 328 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQT 328 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 2334567889999999998899999999999999999998 9999998776666666666666777888899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 172 ISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 172 i~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+.+||+.||.+|||+.++++.|+.+...
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=264.37 Aligned_cols=191 Identities=37% Similarity=0.789 Sum_probs=163.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CccCCCCCCcEEEcC--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG---ILHRDLKSENLLLGE-- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~---i~H~dikp~nil~~~-- 75 (244)
+++++++..++..++||||+++++|.+++... .+++..++.++.|++.||.|||++| ++||||||+||+++.
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~ 145 (271)
T 3dtc_A 69 IALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145 (271)
T ss_dssp CCEEEEECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCC
T ss_pred eeEEEEEecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccc
Confidence 57899999999999999999999999999643 5899999999999999999999999 899999999999986
Q ss_pred ------CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Q 026042 76 ------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF 149 (244)
Q Consensus 76 ------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 149 (244)
++.++|+|||.+...... ......+++.|+|||.+.+..++.++||||||+++++|++|..||.+.+......
T Consensus 146 ~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (271)
T 3dtc_A 146 ENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224 (271)
T ss_dssp SSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred ccccccCcceEEccCCcccccccc-cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 678999999998754432 2335578999999999998889999999999999999999999999988887777
Q ss_pred HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 150 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
...........+..+++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 7776777777888999999999999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=262.35 Aligned_cols=193 Identities=32% Similarity=0.610 Sum_probs=172.0
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~ 76 (244)
|++++++... +..++|+||+++++|.+++.+..+..+++..++.++.|++.||.|||++| ++||||||+||+++.+
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 149 (271)
T 3kmu_A 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED 149 (271)
T ss_dssp ECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT
T ss_pred hheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC
Confidence 4788999887 88899999999999999999877656899999999999999999999999 9999999999999999
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCC---ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK---KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
+.++++||+++... ......+++.|+|||.+.+...+. ++||||||+++|+|++|..||...+..........
T Consensus 150 ~~~~l~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 225 (271)
T 3kmu_A 150 MTARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225 (271)
T ss_dssp SCEEEEGGGSCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH
T ss_pred cceeEEeccceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh
Confidence 99999988876442 233456899999999998765544 79999999999999999999999988888777777
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.......+..+++.+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 77778888899999999999999999999999999999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=274.84 Aligned_cols=186 Identities=24% Similarity=0.369 Sum_probs=165.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+.+..|+||||++||+|.+++.+.. .+++..++.++.||+.||+|||++|++||||||+||+++.+|.+|
T Consensus 102 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ik 179 (373)
T 2r5t_A 102 VGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179 (373)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998865 588999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.... ........+||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+... ...
T Consensus 180 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~ 257 (373)
T 2r5t_A 180 LTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQ 257 (373)
T ss_dssp ECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCC
T ss_pred EeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccC
Confidence 99999987533 333455678999999999999999999999999999999999999999988877776666543 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~ 190 (244)
.+..++..+.++|.+||+.||.+||++.+..
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 5678899999999999999999999985433
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=266.74 Aligned_cols=200 Identities=19% Similarity=0.285 Sum_probs=167.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
+++++++..+...++|+||+ +++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~ 146 (298)
T 1csn_A 69 PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN 146 (298)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT
T ss_pred CeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCC
Confidence 46889999999999999999 9999999987643 5899999999999999999999999999999999999987765
Q ss_pred ---EEEecCCCcccccccC--------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC---H
Q 026042 79 ---VKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT---P 144 (244)
Q Consensus 79 ---~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~ 144 (244)
+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+ .
T Consensus 147 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 226 (298)
T 1csn_A 147 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 226 (298)
T ss_dssp TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred CCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc
Confidence 9999999987544322 2345668999999999999899999999999999999999999998743 3
Q ss_pred HHHHHHHHhh---CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 026042 145 EQAAFAVCQK---NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 145 ~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
......+... .........+++++.+++.+||+.||.+||+++++++.|+.+......
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 227 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 3322222221 222223457889999999999999999999999999999998876553
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.29 Aligned_cols=189 Identities=23% Similarity=0.343 Sum_probs=167.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---CCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~---~~~ 77 (244)
|++++++.+++..|+||||++||+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++ .++
T Consensus 73 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 73 VRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp CCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTC
T ss_pred CeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCC
Confidence 689999999999999999999999999998866 589999999999999999999999999999999999998 457
Q ss_pred cEEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 CVKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.+||+|||++....... ......|++.|+|||++.+..++.++||||+|+++|+|++|..||.+.+.......+.....
T Consensus 151 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 230 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230 (444)
T ss_dssp CEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred cEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC
Confidence 89999999997654332 23456799999999999988999999999999999999999999999888777777665544
Q ss_pred CCCC--CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+. ...+++++.++|.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 4333 2578999999999999999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=272.21 Aligned_cols=200 Identities=34% Similarity=0.626 Sum_probs=171.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------------YSVPLNLVLKLALDIARGMQYLHS 58 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------------------~~~~~~~~~~~~~~l~~~L~~lH~ 58 (244)
|++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~ 192 (343)
T 1luf_A 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192 (343)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 5789999999999999999999999999987431 468999999999999999999999
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT- 134 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 134 (244)
+|++||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 193 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 193 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999999999999999999998654322 22334567889999999988899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
|..||.+.+..+....+. .......+..+++.+.+++.+||+.||.+||++.++++.|+++.....
T Consensus 273 g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 273 GLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 999999888777665554 344456678899999999999999999999999999999998766543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=270.06 Aligned_cols=189 Identities=25% Similarity=0.360 Sum_probs=166.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++..++..++||||++|++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 77 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSS
T ss_pred CcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCC
Confidence 578999999999999999999999999998755 689999999999999999999999999999999999999877
Q ss_pred -cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 -CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.+||+|||++.............|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 234 (326)
T ss_dssp CCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC
T ss_pred CCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC
Confidence 7999999999776554455567799999999999988999999999999999999999999998887776655544332
Q ss_pred CCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ....++..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222 22567899999999999999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=267.80 Aligned_cols=185 Identities=26% Similarity=0.468 Sum_probs=166.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+.+..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 146 (318)
T 1fot_A 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK 146 (318)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEE
T ss_pred ceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEE
Confidence 578999999999999999999999999998865 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......||+.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+... ....
T Consensus 147 L~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~ 222 (318)
T 1fot_A 147 ITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRF 222 (318)
T ss_dssp ECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCC
T ss_pred EeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCC
Confidence 999999876433 334567999999999999999999999999999999999999999988877766665543 3456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
+..+++++.+++.+||..||.+|| +++++++
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 678899999999999999999999 8898886
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=272.62 Aligned_cols=190 Identities=15% Similarity=0.248 Sum_probs=166.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~--~~~ 78 (244)
|++++++...+..++||||++|++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++. ++.
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~ 142 (321)
T 1tki_A 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST 142 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC
T ss_pred CeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCC
Confidence 5789999999999999999999999999976542 6899999999999999999999999999999999999987 789
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 143 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 222 (321)
T 1tki_A 143 IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222 (321)
T ss_dssp EEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred EEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC
Confidence 99999999976655444445678999999999998888999999999999999999999999988877766665544332
Q ss_pred C--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....++.++.+++.+||..||.+|||+.|+++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2 12467899999999999999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=273.19 Aligned_cols=189 Identities=26% Similarity=0.434 Sum_probs=166.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++..++..|+||||++|++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 91 VRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTC
T ss_pred CeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence 678999999999999999999999999998765 589999999999999999999999999999999999998654
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 169 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~ 248 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248 (362)
T ss_dssp CEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 59999999997766555555678999999999999889999999999999999999999999988877766666554433
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+.+ ..+++++.++|.+||+.||.+||++.++++
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3322 467899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=273.58 Aligned_cols=199 Identities=26% Similarity=0.504 Sum_probs=171.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------------------YSVPLNLVLKLALDIARGMQYLHSQ 59 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---------------------~~~~~~~~~~~~~~l~~~L~~lH~~ 59 (244)
|++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++
T Consensus 112 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5789999999999999999999999999987543 2378899999999999999999999
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-C
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 135 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 135 (244)
|++||||||+||+++.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999876543222 223456788999999988899999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 136 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 136 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
..||.+...................+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 9999887766555555556666677788999999999999999999999999999999987554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=262.48 Aligned_cols=196 Identities=31% Similarity=0.631 Sum_probs=171.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~ 144 (268)
T 3sxs_A 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVK 144 (268)
T ss_dssp CCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEE
T ss_pred eeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEE
Confidence 5789999999999999999999999999987542 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... ......++..|+|||.+.+..++.++||||||+++++|++ |..||...+......... ....
T Consensus 145 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~ 223 (268)
T 3sxs_A 145 VSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHR 223 (268)
T ss_dssp ECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCC
T ss_pred EccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCC
Confidence 99999986543322 2234456778999999988889999999999999999999 999999888777665554 3444
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 55667789999999999999999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=271.08 Aligned_cols=185 Identities=24% Similarity=0.361 Sum_probs=166.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEE
Confidence 578999999999999999999999999998866 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+... ....
T Consensus 182 L~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~ 257 (350)
T 1rdq_E 182 VTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRF 257 (350)
T ss_dssp ECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC
T ss_pred EcccccceeccC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCC
Confidence 999999876543 234567999999999999999999999999999999999999999988877766666544 3456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
+..+++.+.++|.+||+.||.+||+ ++++++
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 7789999999999999999999998 888876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=268.72 Aligned_cols=198 Identities=19% Similarity=0.292 Sum_probs=164.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
+++++++..++..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~ 145 (330)
T 2izr_A 68 PQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKT 145 (330)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTC
T ss_pred CEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCC
Confidence 57899999999999999999 999999998753 36899999999999999999999999999999999999998887
Q ss_pred ---EEEecCCCcccccccCC--------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--
Q 026042 79 ---VKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-- 145 (244)
Q Consensus 79 ---~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-- 145 (244)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..
T Consensus 146 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 146 QQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp TTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred CceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 99999999975433222 24567999999999999999999999999999999999999999875332
Q ss_pred -HHHHHHHhhCC---CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 146 -QAAFAVCQKNA---RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 146 -~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
+....+..... .......+| ++.+++.+||+.+|.+||+++++++.|+.+.....
T Consensus 226 ~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 226 KERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 22222211111 111223456 99999999999999999999999999998876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=264.42 Aligned_cols=190 Identities=24% Similarity=0.386 Sum_probs=164.6
Q ss_pred CcEEEEeecCC-----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPP-----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++.... ..++|+||+. ++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155 (308)
T ss_dssp CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT
T ss_pred EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 57889987766 5899999995 69999999877656999999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++.+||+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp TSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999999987665555566788999999999999999999999999999999999999999988777666554322
Q ss_pred CCCC-------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPP-------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... ..+.+++.+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111 11357789999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=262.26 Aligned_cols=196 Identities=29% Similarity=0.564 Sum_probs=171.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp CCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEE
T ss_pred eeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEE
Confidence 5789999999999999999999999999987433 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+. ....
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~ 239 (283)
T 3gen_A 161 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLR 239 (283)
T ss_dssp ECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCC
T ss_pred EccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccC
Confidence 9999998654322 12334456788999999998899999999999999999998 999999988777666554 3445
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++.+.+++.+||+.+|.+|||+.++++.|.++..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 56667789999999999999999999999999999988765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.39 Aligned_cols=187 Identities=24% Similarity=0.419 Sum_probs=162.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+|+||+.||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus 78 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred CcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc---CCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhh
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMT---PEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~ 154 (244)
|+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+ .
T Consensus 156 L~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~--~ 233 (384)
T 4fr4_A 156 ITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--E 233 (384)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH--H
T ss_pred EeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH--h
Confidence 999999987665556667889999999999864 458899999999999999999999997543 22222222 3
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPH-FDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~el~~ 191 (244)
......+..+++.+.++|.+||+.||.+||+ ++++++
T Consensus 234 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 3445677889999999999999999999998 677665
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=272.82 Aligned_cols=200 Identities=36% Similarity=0.599 Sum_probs=164.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+++++|.++++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 70 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~k 148 (310)
T 3s95_A 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVV 148 (310)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEE
T ss_pred ccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEE
Confidence 5789999999999999999999999999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCC---------------CCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Q 026042 81 VADFGISCLESQCGSA---------------KGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 145 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 145 (244)
|+|||++......... ....|++.|+|||.+.+..++.++||||||+++|+|++|..|+......
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 9999998654332211 1457899999999999999999999999999999999999998653221
Q ss_pred HHHH-HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 146 QAAF-AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 146 ~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.... ...........+..+++.+.+++.+||+.||.+|||+.++++.|+.+...+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp CTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1000 0000000112356778899999999999999999999999999998877654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=277.88 Aligned_cols=191 Identities=23% Similarity=0.354 Sum_probs=152.0
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE- 75 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~- 75 (244)
|++++++.. +...|+||||++||+|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 118 v~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 197 (400)
T 1nxk_A 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 197 (400)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred ceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC
Confidence 467787765 678999999999999999998876557999999999999999999999999999999999999998
Q ss_pred --CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----HHH
Q 026042 76 --DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ----AAF 149 (244)
Q Consensus 76 --~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~ 149 (244)
++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||....... ...
T Consensus 198 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 198 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp STTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred CCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence 78899999999976655444556778999999999998999999999999999999999999997654321 122
Q ss_pred HHHhhCCCC--CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 150 AVCQKNARP--PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 150 ~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+....... .....+++++.+||.+||+.||.+|||+.++++
T Consensus 278 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222222222 222568999999999999999999999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=276.64 Aligned_cols=197 Identities=31% Similarity=0.618 Sum_probs=170.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+++++|.++++..+. .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 175 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~k 253 (377)
T 3cbl_A 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLK 253 (377)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEE
Confidence 6789999999999999999999999999987543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+ ....
T Consensus 254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~ 332 (377)
T 3cbl_A 254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV-EKGG 332 (377)
T ss_dssp ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH-HTTC
T ss_pred ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCC
Confidence 99999986533221 1122335678999999988889999999999999999998 99999998877665544 3455
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
..+.+..+++.+.+++.+||+.||.+|||++++++.|+.+...
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 5677788999999999999999999999999999999987653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=269.27 Aligned_cols=198 Identities=31% Similarity=0.551 Sum_probs=171.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
+++++++..++..++||||+++++|.+++.+.. ...+++..++.++.|++.||.|||++|++||||
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 168 (327)
T 1fvr_A 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 168 (327)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 578999999999999999999999999998653 236899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHH
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPE 145 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~ 145 (244)
||+||+++.++.+||+|||++.............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 169 kp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 169 AARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp SGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 99999999999999999999875544444445567889999999988889999999999999999998 99999988877
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+....+. .......+..+++.+.+++.+||+.||.+||+++++++.|..+...
T Consensus 249 ~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 249 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 6555443 3445566778899999999999999999999999999999987664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=276.75 Aligned_cols=201 Identities=17% Similarity=0.257 Sum_probs=162.5
Q ss_pred CcEEEEeecC----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--
Q 026042 1 MQFVAACKKP----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-- 74 (244)
Q Consensus 1 v~~~~~~~~~----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~-- 74 (244)
|++++++... ...|+||||+ |++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK-RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence 5688888765 5689999999 9999999987533 689999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCC--------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 75 EDMCVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 889999999999965433221 234459999999999999999999999999999999999999998532221
Q ss_pred HHHHHHhhCCC---------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 147 AAFAVCQKNAR---------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 147 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
........... ......+++++.+++..||+.+|.+||+++++++.|+.+.......
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11111000000 0112567899999999999999999999999999999888765543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=268.91 Aligned_cols=187 Identities=22% Similarity=0.424 Sum_probs=160.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 73 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC---------CHHHHHHH
Q 026042 81 VADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---------TPEQAAFA 150 (244)
Q Consensus 81 l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------~~~~~~~~ 150 (244)
|+|||++.... .........||+.|+|||++.+..++.++|+|||||++|+|++|..||... ........
T Consensus 151 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 151 LTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp ECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred EEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 99999987532 233455678999999999999999999999999999999999999999752 12222222
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF------DQIVS 191 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~el~~ 191 (244)
+. ......+..++..+.++|.+||+.||.+||++ +++++
T Consensus 231 i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 231 IL--EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HH--HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HH--cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 22 23455677899999999999999999999995 56654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=270.01 Aligned_cols=191 Identities=26% Similarity=0.403 Sum_probs=163.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~---~~ 77 (244)
+++++++..++..++||||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++. ++
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC
T ss_pred EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC
Confidence 578999999999999999999999999997765557999999999999999999999999999999999999988 78
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......
T Consensus 172 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp CEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 99999999998765555555678999999999999999999999999999999999999999998877766655544333
Q ss_pred C--CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 P--PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .....+++.+.+++.+||+.||.+|||++++++
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 2 334578999999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=266.44 Aligned_cols=197 Identities=30% Similarity=0.566 Sum_probs=171.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------------YSVPLNLVLKLALDIARGMQYLHS 58 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------------------~~~~~~~~~~~~~~l~~~L~~lH~ 58 (244)
|++++++..++..++|+||+++++|.+++..... ..+++..++.++.|++.||.|||+
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 168 (314)
T 2ivs_A 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168 (314)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence 5789999999999999999999999999987542 237889999999999999999999
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT- 134 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~- 134 (244)
+|++||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 169 ~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 169 MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999987543322 2234456788999999988889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 135 ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 135 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
|..||.+.........+ ........+..+++.+.+++.+||+.||.+||++.++++.|+++..
T Consensus 249 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLL-KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp SCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHh-hcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999988776655444 3444566778899999999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=272.23 Aligned_cols=197 Identities=33% Similarity=0.636 Sum_probs=161.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+++++|.+++++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 187 (373)
T 2qol_A 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187 (373)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred CeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEE
Confidence 5799999999999999999999999999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ..
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~ 266 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EG 266 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TT
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 999999876543221 112234678999999998999999999999999999998 999999888777665543 33
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+.+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 34556678899999999999999999999999999999988654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=262.90 Aligned_cols=196 Identities=30% Similarity=0.613 Sum_probs=158.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++. ++..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 79 v~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 156 (281)
T 1mp8_A 79 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 156 (281)
T ss_dssp CCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEE
Confidence 57888885 5678899999999999999987542 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. ....
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~ 235 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGER 235 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCC
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCC
Confidence 999999876543222 223446788999999988899999999999999999996 999999877766555443 3344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 567788999999999999999999999999999999987653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=276.52 Aligned_cols=187 Identities=26% Similarity=0.424 Sum_probs=165.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++...+..|+||||++|++|.+++.+.. .+++..+..++.|++.||+|||+ +||+||||||+||+++.+|.+
T Consensus 211 v~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 211 TALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp CCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCE
T ss_pred eeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCE
Confidence 578999999999999999999999999998766 68999999999999999999998 999999999999999999999
Q ss_pred EEecCCCccccc-ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLES-QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||+|||++.... .........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+... ..
T Consensus 289 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~ 366 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EI 366 (446)
T ss_dssp EECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC
T ss_pred EEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CC
Confidence 999999987532 223345678999999999999999999999999999999999999999988877766665443 34
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
..+..+++++.++|.+||+.||.+|| +++|+++
T Consensus 367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 56678899999999999999999999 9999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=271.05 Aligned_cols=199 Identities=28% Similarity=0.546 Sum_probs=172.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp 68 (244)
|++++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||
T Consensus 113 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 578999999999999999999999999997642 23578999999999999999999999999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCH
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTP 144 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 144 (244)
+||+++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999875433221 233456788999999988899999999999999999998 9999988776
Q ss_pred HHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 145 EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
................+..+++.+.+++.+||+.||.+|||+.++++.|+.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 6655555566666677788899999999999999999999999999999877543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=278.19 Aligned_cols=196 Identities=32% Similarity=0.576 Sum_probs=169.3
Q ss_pred CcEEEEeecCC-cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++...+ ..|+||||+++|+|.+++++.+...+++..++.++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 249 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~ 328 (450)
T 1k9a_A 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 328 (450)
T ss_dssp CCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCE
T ss_pred EEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCE
Confidence 57899886655 79999999999999999998765557999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .....
T Consensus 329 kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~ 405 (450)
T 1k9a_A 329 KVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKM 405 (450)
T ss_dssp EECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCC
T ss_pred EEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99999998754322 223356789999999999999999999999999999998 999999887666555443 44566
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
..+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 77888999999999999999999999999999999987653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=263.62 Aligned_cols=198 Identities=33% Similarity=0.628 Sum_probs=173.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||++|++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~ 151 (288)
T 3kfa_A 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 151 (288)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEE
T ss_pred eeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEE
Confidence 57899999999999999999999999999987666799999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+ .....
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-~~~~~ 230 (288)
T 3kfa_A 152 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYR 230 (288)
T ss_dssp ECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCC
T ss_pred EccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hccCC
Confidence 999999876543221 223446778999999998899999999999999999999 99999987766655444 34455
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+..+++.+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 667788999999999999999999999999999999987664
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=272.28 Aligned_cols=198 Identities=28% Similarity=0.542 Sum_probs=170.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++..+...++||||++|++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 5789999999999999999999999999987542 35889999999999999999999999999999999999996
Q ss_pred CC---cEEEecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 76 DM---CVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 76 ~~---~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
+| .+||+|||++...... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+..
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 55 5999999998643222 22334567889999999988899999999999999999998 99999998877766
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
..+. .......+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 297 ~~i~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 297 EFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHH-cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 5554 4445566778899999999999999999999999999999877654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.00 Aligned_cols=199 Identities=32% Similarity=0.627 Sum_probs=172.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++. .+..++||||+++|+|.++++...+..+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 246 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 324 (454)
T 1qcf_A 246 VKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCK 324 (454)
T ss_dssp CCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEE
T ss_pred eeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEE
Confidence 57888887 66789999999999999999865444688999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......++..|+|||.+....++.++||||||+++|+|++ |..||.+.+..+....+. ....
T Consensus 325 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 403 (454)
T 1qcf_A 325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYR 403 (454)
T ss_dssp ECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCC
T ss_pred EeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 9999999764322 12234456788999999998899999999999999999999 999999988877766554 4455
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.+.+..+++.+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus 404 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~ 447 (454)
T 1qcf_A 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447 (454)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence 66778899999999999999999999999999999998765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=268.58 Aligned_cols=195 Identities=28% Similarity=0.542 Sum_probs=165.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++. ++..++|+||+.+++|.+++....+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 78 v~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~k 155 (325)
T 3kex_A 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQ 155 (325)
T ss_dssp CCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGG-GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEE
T ss_pred CeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccc-cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEE
Confidence 57889886 5668899999999999999987532 588899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+ ....
T Consensus 156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~ 234 (325)
T 3kex_A 156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-EKGE 234 (325)
T ss_dssp ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH-HTTC
T ss_pred ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH-HcCC
Confidence 99999997654322 2234457789999999998899999999999999999999 99999987766554444 3444
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
....+..++.++.+++.+||+.||.+||++.++++.|+.+..
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 566677788999999999999999999999999999988754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=264.62 Aligned_cols=187 Identities=25% Similarity=0.419 Sum_probs=162.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp CCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEE
T ss_pred cceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEE
Confidence 578999999999999999999999999998765 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+... ...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~ 239 (327)
T 3a62_A 162 LTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLN 239 (327)
T ss_dssp ECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCC
T ss_pred EEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCC
Confidence 999999865332 22344567999999999999888999999999999999999999999988877766655443 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
.+..+++.+.+++.+||..||.+|| ++.++++
T Consensus 240 ~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 6678899999999999999999999 7778876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=258.65 Aligned_cols=189 Identities=26% Similarity=0.406 Sum_probs=167.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
+++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 68 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~ 145 (284)
T 3kk8_A 68 VRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 145 (284)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTC
T ss_pred CeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCC
Confidence 578999999999999999999999999998765 5899999999999999999999999999999999999987655
Q ss_pred -EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 79 -VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 79 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
+||+|||.+.............+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+......
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 225 (284)
T 3kk8_A 146 AVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 225 (284)
T ss_dssp CEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc
Confidence 9999999997766555556678999999999999999999999999999999999999999988887776666555443
Q ss_pred CCC--CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+. ...+++++.+++.+||+.||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 333 2578999999999999999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=272.61 Aligned_cols=186 Identities=30% Similarity=0.444 Sum_probs=161.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+ +|+|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 72 v~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 72 IKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp CCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEE
T ss_pred CeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEE
Confidence 57899999999999999999 789999998766 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.............|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...........+ ......
T Consensus 149 l~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~ 226 (336)
T 3h4j_B 149 IADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYV 226 (336)
T ss_dssp ECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCC
T ss_pred EEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCC
Confidence 999999987666555667789999999999988765 78999999999999999999999865433221111 122334
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++.+.+++.+||+.||.+|||++|+++
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 56778999999999999999999999999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=268.89 Aligned_cols=189 Identities=27% Similarity=0.394 Sum_probs=150.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++..++..++||||++|++|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 79 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~ 156 (361)
T 3uc3_A 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPR 156 (361)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCC
T ss_pred CcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCce
Confidence 578999999999999999999999999998766 5899999999999999999999999999999999999987765
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHh
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK-VDVYSFGIVLWELLTALTPFDNMTP----EQAAFAVCQ 153 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~ 153 (244)
+||+|||++.............|++.|+|||.+.+..++.+ +||||||+++|+|++|..||.+... ......+..
T Consensus 157 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 236 (361)
T 3uc3_A 157 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236 (361)
T ss_dssp EEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT
T ss_pred EEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc
Confidence 99999999875544444556679999999999988777555 8999999999999999999986443 333333333
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 33334444568999999999999999999999999997
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=257.76 Aligned_cols=196 Identities=29% Similarity=0.616 Sum_probs=171.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 66 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~k 144 (267)
T 3t9t_A 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 144 (267)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEE
T ss_pred eeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEE
Confidence 5789999999999999999999999999987643 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+. ....
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~ 223 (267)
T 3t9t_A 145 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFR 223 (267)
T ss_dssp ECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCC
T ss_pred EcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCc
Confidence 9999998754321 12334557789999999988889999999999999999999 999999888776665554 3344
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 55667789999999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=264.18 Aligned_cols=197 Identities=34% Similarity=0.623 Sum_probs=166.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k 187 (333)
T 1mqb_A 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK 187 (333)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred CcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEE
Confidence 5789999999999999999999999999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~ 266 (333)
T 1mqb_A 188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DG 266 (333)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TT
T ss_pred ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CC
Confidence 999999876443221 122345778999999998899999999999999999998 999999888776655543 34
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+.+..+++.+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 45566778999999999999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=271.13 Aligned_cols=195 Identities=21% Similarity=0.269 Sum_probs=169.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE--cCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL--GEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~--~~~~~ 78 (244)
|++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||++ +.++.
T Consensus 149 v~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 227 (373)
T 2x4f_A 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ 227 (373)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTE
T ss_pred CeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCc
Confidence 6789999999999999999999999999876432 58999999999999999999999999999999999999 56778
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||++.............|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 228 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 307 (373)
T 2x4f_A 228 IKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307 (373)
T ss_dssp EEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS
T ss_pred EEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC
Confidence 99999999987655555556679999999999988889999999999999999999999999988777766665543332
Q ss_pred C--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 159 P--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 159 ~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
. ....+++++.+||.+||+.||.+||++.|+++ ++...
T Consensus 308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 2 22568899999999999999999999999998 55543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=267.41 Aligned_cols=189 Identities=25% Similarity=0.351 Sum_probs=152.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~---~~ 77 (244)
|++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++. ++
T Consensus 111 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~ 188 (349)
T 2w4o_A 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188 (349)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC
T ss_pred cceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC
Confidence 578999999999999999999999999998765 5899999999999999999999999999999999999975 78
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVCQKNA 156 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~ 156 (244)
.+||+|||++.............|++.|+|||.+.+..++.++||||||+++|+|++|..||......... ..+.....
T Consensus 189 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~ 268 (349)
T 2w4o_A 189 PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268 (349)
T ss_dssp CEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC
T ss_pred CEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC
Confidence 99999999987665544455667999999999999889999999999999999999999999876655433 33332222
Q ss_pred CC--CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RP--PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. +....++.++.+++.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21 233578899999999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=263.83 Aligned_cols=199 Identities=28% Similarity=0.567 Sum_probs=162.3
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++.. ....++||||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 74 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~ 152 (295)
T 3ugc_A 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152 (295)
T ss_dssp CCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE
T ss_pred eeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe
Confidence 567888844 4568999999999999999987643 5899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------
Q 026042 79 VKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------- 146 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------- 146 (244)
+||+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++|..|+.......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence 9999999987653322 2233456778999999999999999999999999999999999886532211
Q ss_pred -------HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 147 -------AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 147 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
............+.+..+++++.+++.+||+.||.+|||+.++++.|+.+...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 112223345556677889999999999999999999999999999999887654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=272.07 Aligned_cols=190 Identities=21% Similarity=0.334 Sum_probs=165.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~--~~~ 78 (244)
|++++++..++..++||||++|++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++. ++.
T Consensus 111 v~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~ 189 (387)
T 1kob_A 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 189 (387)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCC
T ss_pred CeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCc
Confidence 578999999999999999999999999998654 25899999999999999999999999999999999999974 467
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 190 vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~ 269 (387)
T 1kob_A 190 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269 (387)
T ss_dssp EEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC
T ss_pred eEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999999997665444444567999999999999989999999999999999999999999988877666655544322
Q ss_pred -CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+++++.++|.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 2334578999999999999999999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=277.89 Aligned_cols=199 Identities=36% Similarity=0.638 Sum_probs=167.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.. +..++||||+++|+|.++++...+..+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 242 v~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 320 (452)
T 1fmk_A 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 320 (452)
T ss_dssp CCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred eeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEE
Confidence 578899876 6789999999999999999865444689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. ....
T Consensus 321 l~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 399 (452)
T 1fmk_A 321 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 399 (452)
T ss_dssp ECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred ECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99999997654322 1223446788999999998899999999999999999999 999999988877665553 4455
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.+.+..+++.+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 66778899999999999999999999999999999998765543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=275.55 Aligned_cols=188 Identities=24% Similarity=0.395 Sum_probs=164.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++++. .+++..++.++.|++.||+|||++||+||||||+||+++.+|.+|
T Consensus 132 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik 208 (410)
T 3v8s_A 132 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208 (410)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred CeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEE
Confidence 67899999999999999999999999999764 489999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCC----CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKR----HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++....... .....+||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 99999987544322 234678999999999997665 788999999999999999999999998887777666543
Q ss_pred C--CCCCCCCCchHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 026042 155 N--ARPPVPPTCPKAFSYLISRCWSSSPDR--RPHFDQIVS 191 (244)
Q Consensus 155 ~--~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~el~~ 191 (244)
. ...+....+++++.+||.+||+.+|.+ ||+++|+++
T Consensus 289 ~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 289 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 3 233344578999999999999999988 999999997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=262.92 Aligned_cols=188 Identities=25% Similarity=0.436 Sum_probs=163.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||++|++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 181 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK 181 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEE
Confidence 57899999999999999999999999998754 489999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-C
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR-P 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~ 158 (244)
|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...... .
T Consensus 182 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 261 (321)
T 2c30_A 182 LSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL 261 (321)
T ss_dssp ECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC
T ss_pred EeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc
Confidence 99999987544322 334567999999999999889999999999999999999999999988777665554433221 2
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+++.+.+++.+||+.||.+|||+.++++
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 233467899999999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.25 Aligned_cols=190 Identities=21% Similarity=0.343 Sum_probs=163.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+++..|+||||++||+|.+++.+..+ .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+|
T Consensus 137 v~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 137 TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED-RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred EEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEE
Confidence 5789999999999999999999999999987432 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 216 L~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp ECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred EcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 999999865433222 33467999999999986 45689999999999999999999999999888777766654
Q ss_pred hC---CCCCCCCCchHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 026042 154 KN---ARPPVPPTCPKAFSYLISRCWSSSPDR--RPHFDQIVS 191 (244)
Q Consensus 154 ~~---~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~el~~ 191 (244)
.. ..+.....+++++.+||++||..+|++ |++++|+++
T Consensus 296 ~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 296 HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 32 223333568999999999999888888 999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=265.69 Aligned_cols=196 Identities=28% Similarity=0.595 Sum_probs=167.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..+. .++|+||+.+++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 80 v~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp CCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred eEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEE
Confidence 57899998765 7799999999999999987553 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+ ....
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~ 236 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGE 236 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTC
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-HcCC
Confidence 999999875433222 223446789999999999999999999999999999999 99999987766654443 3445
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
....+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 5667788999999999999999999999999999999887653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=263.72 Aligned_cols=189 Identities=22% Similarity=0.345 Sum_probs=166.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
+++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~ 155 (321)
T 2a2a_A 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155 (321)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSS
T ss_pred ceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCc
Confidence 578999999999999999999999999998755 589999999999999999999999999999999999999887
Q ss_pred -cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 -CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.++|+|||++.............|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 235 (321)
T 2a2a_A 156 PHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY 235 (321)
T ss_dssp CCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 7999999999766555455566799999999999988999999999999999999999999998887776655543322
Q ss_pred CCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ....++..+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 211 12567899999999999999999999999997
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=277.37 Aligned_cols=187 Identities=27% Similarity=0.443 Sum_probs=167.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..|+|+||++|++|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 79 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 79 IKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEE
T ss_pred CcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.............|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+... ...
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~ 234 (476)
T 2y94_A 157 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFY 234 (476)
T ss_dssp ECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCC
T ss_pred EEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcC
Confidence 999999987655555566789999999999988765 78999999999999999999999988776665555433 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++++.+++.+||+.||.+|||++++++
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 56778999999999999999999999999997
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=287.28 Aligned_cols=187 Identities=26% Similarity=0.423 Sum_probs=167.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.+.+.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 405 ~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp CCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEE
T ss_pred EEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEE
Confidence 468899999999999999999999999999876 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccc-cccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLE-SQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++... ..........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.. ....
T Consensus 483 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~ 560 (674)
T 3pfq_A 483 IADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVA 560 (674)
T ss_dssp ECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCC
T ss_pred EeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCC
Confidence 9999998753 233345667899999999999999999999999999999999999999999888777766644 3456
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHF-----DQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~-----~el~~ 191 (244)
.+..+++++.+||.+||+.||.+||++ +++++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 777899999999999999999999997 66665
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=259.73 Aligned_cols=200 Identities=27% Similarity=0.564 Sum_probs=171.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++ ..+..++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 73 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~k 150 (287)
T 1u59_A 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 150 (287)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEE
T ss_pred eEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCc-cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEE
Confidence 5788998 55678999999999999999976543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ..
T Consensus 151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~ 229 (287)
T 1u59_A 151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QG 229 (287)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TT
T ss_pred ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cC
Confidence 99999987543322 1233456889999999988889999999999999999998 999999887766655443 44
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
.....+..+++.+.+++.+||+.+|.+||++.++++.|+.+.......
T Consensus 230 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 230 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 456677889999999999999999999999999999999987765543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=260.08 Aligned_cols=201 Identities=30% Similarity=0.591 Sum_probs=168.8
Q ss_pred CcEEEEeecCCcE-EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVF-CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~-~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++...+.. ++|+||+.+++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 85 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~ 163 (298)
T 3pls_A 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTV 163 (298)
T ss_dssp CCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred eeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 5678888766655 999999999999999987443 68899999999999999999999999999999999999999999
Q ss_pred EEecCCCccccccc-----CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 026042 80 KVADFGISCLESQC-----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 153 (244)
||+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.......+ .
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~ 242 (298)
T 3pls_A 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-A 242 (298)
T ss_dssp EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-H
T ss_pred EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-h
Confidence 99999998643321 22344567889999999999899999999999999999999 55556655555444433 3
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
.......+..+++.+.+++.+||+.||.+|||+.++++.|+.+...+...
T Consensus 243 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 44556677788999999999999999999999999999999988876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=258.09 Aligned_cols=188 Identities=21% Similarity=0.326 Sum_probs=164.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---~~~~ 77 (244)
+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++ +.++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 146 (277)
T 3f3z_A 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS 146 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC
T ss_pred eeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC
Confidence 578999999999999999999999999998766 58999999999999999999999999999999999999 7788
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.++|+|||++.............+++.|+|||.+.+. ++.++||||||+++++|++|..||...+..+....+......
T Consensus 147 ~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (277)
T 3f3z_A 147 PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225 (277)
T ss_dssp CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999999999776655555667899999999998654 899999999999999999999999998877766665544332
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+.. ..+++.+.+++.+||+.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2211 367899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=260.13 Aligned_cols=197 Identities=27% Similarity=0.544 Sum_probs=169.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++ ..+..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 81 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~k 157 (291)
T 1xbb_A 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK 157 (291)
T ss_dssp CCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred EEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEE
Confidence 5788988 5677889999999999999998865 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ..
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~ 236 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KG 236 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cC
Confidence 999999865433221 223345688999999988888999999999999999999 999999888776655443 44
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.....+..+++.+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 237 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 4566778899999999999999999999999999999998876543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=280.87 Aligned_cols=197 Identities=33% Similarity=0.632 Sum_probs=172.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..++..|+||||+++++|.+++++.....+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 279 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~k 358 (495)
T 1opk_A 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVK 358 (495)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred eeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEE
Confidence 68999999999999999999999999999886666789999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+ .....
T Consensus 359 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~ 437 (495)
T 1opk_A 359 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYR 437 (495)
T ss_dssp ECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCC
T ss_pred EeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC
Confidence 99999987643321 2233446788999999998889999999999999999999 99999988776655443 34556
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++.+.++|.+||+.||.+||++.++++.|+.+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 67778899999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=264.50 Aligned_cols=200 Identities=30% Similarity=0.598 Sum_probs=173.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--------------YSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|++++++..++..++|+||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 5789999999999999999999999999987542 24789999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 9999999999999999999987544322 2234456788999999988889999999999999999999 99999988
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
+..+....+. .......+..++..+.+++.+||+.+|.+||++.++++.|+++.....
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 264 PVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp CHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 8776655443 444556677899999999999999999999999999999998876544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=264.84 Aligned_cols=197 Identities=31% Similarity=0.553 Sum_probs=169.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIl 170 (322)
T 1p4o_A 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170 (322)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEE
Confidence 578999999999999999999999999997632 125688999999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 73 LGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 9999999999999987543322 1223456889999999998889999999999999999999 89999988877766
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+.. ......+..++..+.+++.+||+.||.+||++.++++.|+....
T Consensus 251 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 251 RFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 55543 34455677899999999999999999999999999999987644
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=267.90 Aligned_cols=201 Identities=16% Similarity=0.256 Sum_probs=164.2
Q ss_pred cEEEEeec-CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC--c
Q 026042 2 QFVAACKK-PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--C 78 (244)
Q Consensus 2 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--~ 78 (244)
++++++.. ++..++||||+ +++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++ .
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~ 199 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ 199 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCce
Confidence 35677765 78899999999 99999999986444799999999999999999999999999999999999999988 8
Q ss_pred EEEecCCCcccccccC--------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHH
Q 026042 79 VKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAA 148 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~ 148 (244)
+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .....
T Consensus 200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 279 (352)
T 2jii_A 200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIM 279 (352)
T ss_dssp EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHH
Confidence 9999999986543322 1234578999999999999899999999999999999999999998753 22222
Q ss_pred HHHHh-hCCCCCCC------CCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 149 FAVCQ-KNARPPVP------PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 149 ~~~~~-~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
..... ........ ..+++.+.+++.+||+.||.+||+++++++.|+.+.......
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 280 KQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 22111 11111111 256899999999999999999999999999999988765543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=257.99 Aligned_cols=186 Identities=27% Similarity=0.479 Sum_probs=162.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++||||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 149 (279)
T 3fdn_A 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK 149 (279)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEE
T ss_pred cchhheEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++...... ......+++.|+|||.+.+..++.++||||||+++++|++|..||...+.......+.. .....
T Consensus 150 l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~ 226 (279)
T 3fdn_A 150 IADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTF 226 (279)
T ss_dssp ECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCC
T ss_pred EEeccccccCCcc-cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCC
Confidence 9999988554332 23455789999999999998999999999999999999999999998887766655533 33456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+..+++.+.+++.+||+.||.+||++.|+++
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 6778999999999999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=259.08 Aligned_cols=199 Identities=21% Similarity=0.309 Sum_probs=162.8
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCcE
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMCV 79 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---~~~~~~ 79 (244)
+..++..++..++||||+ +++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||++ +.++.+
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~ 147 (296)
T 4hgt_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCE
T ss_pred eeeecCCCCceEEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeE
Confidence 445558888999999999 9999999986443 58999999999999999999999999999999999999 788999
Q ss_pred EEecCCCcccccccC--------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH
Q 026042 80 KVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAA 148 (244)
Q Consensus 80 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~ 148 (244)
||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.. ...
T Consensus 148 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 4hgt_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhh
Confidence 999999987544322 223567899999999999999999999999999999999999999764321 111
Q ss_pred HHHHh---hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 149 FAVCQ---KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 149 ~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
..... ..........+++.+.+++.+||+.||.+|||++++++.|+.+.......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 228 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred hhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 11111 11111233567899999999999999999999999999999988765543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=272.47 Aligned_cols=192 Identities=23% Similarity=0.326 Sum_probs=159.0
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
+++++++.. +...|+||||+ |++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 568888877 88999999999 999999998766 68999999999999999999999999999999999999987
Q ss_pred C--cEEEecCCCcccccccCC--------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC--CH
Q 026042 77 M--CVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM--TP 144 (244)
Q Consensus 77 ~--~~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~ 144 (244)
+ .+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||... +.
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999965432211 13457899999999999888999999999999999999999999652 22
Q ss_pred HHHHHHHHhhCCCCCC---------CCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 145 EQAAFAVCQKNARPPV---------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 145 ~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
....... ....... ...+++++.+++.+||+.||.+||+++++++.|+...
T Consensus 268 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAVQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2221111 1111111 1278899999999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.86 Aligned_cols=190 Identities=36% Similarity=0.697 Sum_probs=162.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~~~~~ 78 (244)
|++++++.... ++||||+++++|.+++.+... .+++..++.++.|++.||+|||++| ++|+||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 86 VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp CCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred hhhheeecCCC--eEEEEecCCCCHHHHHhcccC-CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence 57888887666 699999999999999876543 6899999999999999999999999 999999999999988776
Q ss_pred -----EEEecCCCcccccccCCCCCCCcccceeccceec--cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH
Q 026042 79 -----VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA--AF 149 (244)
Q Consensus 79 -----~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~ 149 (244)
+||+|||++..... ......+++.|+|||.+. ...++.++||||||+++|+|++|..||...+.... ..
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 240 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN 240 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred CCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence 99999999875433 234567899999999984 44578999999999999999999999987654433 34
Q ss_pred HHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 150 AVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
...........+..+++.+.+++.+||+.||.+|||++++++.|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 4444566667788899999999999999999999999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=260.88 Aligned_cols=188 Identities=26% Similarity=0.399 Sum_probs=160.8
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++.. ++..++||||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~ 175 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH 175 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC
Confidence 578899876 67899999999999998865432 5899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCC---CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
+||+|||++....... ......|++.|+|||.+.+.. .+.++||||||+++|+|++|..||...+.......+...
T Consensus 176 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 255 (298)
T 2zv2_A 176 IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ 255 (298)
T ss_dssp EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcc
Confidence 9999999987644322 234567899999999997765 378899999999999999999999988777666655555
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+....+++.+.+++.+||+.||++||++.|+++
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 256 ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4444555678999999999999999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=264.86 Aligned_cols=199 Identities=28% Similarity=0.551 Sum_probs=169.7
Q ss_pred CcEEEEeecCC-cEEEEEeccCCCCHHHHHhhcCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 026042 1 MQFVAACKKPP-VFCIITEYLAGGSLRKYLHQQEPY--------------SVPLNLVLKLALDIARGMQYLHSQGILHRD 65 (244)
Q Consensus 1 v~~~~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~--------------~~~~~~~~~~~~~l~~~L~~lH~~~i~H~d 65 (244)
|++++++...+ ..++|+||+++++|.+++...... .+++..++.++.|++.||.|||++|++|||
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 57888887654 589999999999999999876531 278899999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCC
Q 026042 66 LKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDN 141 (244)
Q Consensus 66 ikp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~ 141 (244)
|||+||+++.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999875433221 234456789999999998899999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 142 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...................+..+++.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 7655555555555556677788999999999999999999999999999999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=266.92 Aligned_cols=200 Identities=29% Similarity=0.541 Sum_probs=165.2
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++. .....++||||+++++|.+++..... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~ 165 (327)
T 3lxl_A 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH 165 (327)
T ss_dssp CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC
Confidence 46778775 66779999999999999999987543 5899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------
Q 026042 79 VKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------- 145 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------- 145 (244)
+||+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++|..||......
T Consensus 166 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 9999999987543322 233455788899999998888999999999999999999999998643322
Q ss_pred -----HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 146 -----QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 146 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
...............+..+++.+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 22233334555666778899999999999999999999999999999998866544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=259.91 Aligned_cols=195 Identities=34% Similarity=0.664 Sum_probs=153.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++ .....++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 83 v~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp CCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEeec-cCCccEEEEEecCCCcHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEE
Confidence 4677765 55668899999999999999976543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc---cCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQ---CGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++..... ........|++.|+|||.+. +..++.++||||||+++++|++|..||...............
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 999999865432 12233456899999999986 556788999999999999999999999887655544444333
Q ss_pred CCCC----CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 155 NARP----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 155 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.... .....+++.+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 3222 234578899999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=263.22 Aligned_cols=185 Identities=22% Similarity=0.318 Sum_probs=153.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..++..++||||+ +++|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 120 v~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEE
T ss_pred EEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEE
Confidence 57899999999999999999 7799999987653 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++.............|++.|+|||.+.+ .++.++||||||+++++|++|..|+..... ...+.........
T Consensus 198 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~ 273 (311)
T 3p1a_A 198 LGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEF 273 (311)
T ss_dssp ECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHH
T ss_pred EccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCccc
Confidence 999999877655555566679999999998875 789999999999999999999766544221 2222222222234
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+..+++++.+++.+||+.||.+|||++|+++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 4678899999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=272.98 Aligned_cols=189 Identities=22% Similarity=0.358 Sum_probs=160.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+.+..|+||||++||+|.+++.+.+. .+++..++.++.|++.||+|||++||+||||||+||+++.+|.+|
T Consensus 124 v~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 124 TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred eeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEE
Confidence 5789999999999999999999999999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceec-------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIK-------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV 151 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 151 (244)
|+|||++........ ....+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 203 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 282 (412)
T 2vd5_A 203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282 (412)
T ss_dssp ECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999876543322 33568999999999987 356899999999999999999999999998887766665
Q ss_pred Hhh---CCCCCCCCCchHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 026042 152 CQK---NARPPVPPTCPKAFSYLISRCWSSSPDRR---PHFDQIVS 191 (244)
Q Consensus 152 ~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~el~~ 191 (244)
... ...+..+..+++++.++|.+||. +|.+| |+++|+++
T Consensus 283 ~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 283 VHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 532 22233346789999999999999 99998 58999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=259.35 Aligned_cols=199 Identities=33% Similarity=0.612 Sum_probs=170.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++.. +..++|+||+++++|.+++....+..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 71 ~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~k 149 (279)
T 1qpc_A 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149 (279)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred ceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEE
Confidence 578888864 5588999999999999999865444689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||.+....... ......++..|+|||.+.+..++.++||||||+++++|++ |..||.+.+..+....+. ....
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 228 (279)
T 1qpc_A 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYR 228 (279)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred ECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccC
Confidence 99999987654322 2234456788999999988889999999999999999999 999999888776655543 3445
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
...+..+++.+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 56677889999999999999999999999999999998876644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=260.76 Aligned_cols=199 Identities=28% Similarity=0.584 Sum_probs=166.5
Q ss_pred CcEEEEe-ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++ ..++..++|+||+++++|.+++++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 89 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~ 167 (298)
T 3f66_A 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 167 (298)
T ss_dssp CCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred eeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCE
Confidence 4677874 566788999999999999999986443 58899999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 026042 80 KVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 153 (244)
||+|||++....... ......+++.|+|||.+.+..++.++||||||+++++|++ |..||...+..+......
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~- 246 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 246 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-
Confidence 999999987543321 2234457789999999998899999999999999999999 677777766555444443
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.......+..+++.+.+++.+||+.||.+||++.++++.|+++...+.
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 444556677889999999999999999999999999999999877654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=267.55 Aligned_cols=189 Identities=26% Similarity=0.405 Sum_probs=160.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 68 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~k 145 (323)
T 3tki_A 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK 145 (323)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred CeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhC
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-CQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~ 155 (244)
|+|||++...... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+........ ....
T Consensus 146 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 225 (323)
T 3tki_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (323)
T ss_dssp ECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC
T ss_pred EEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc
Confidence 9999998654322 22345679999999999987765 78999999999999999999999876544322222 2222
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+++.+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 223333568899999999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=264.23 Aligned_cols=190 Identities=22% Similarity=0.368 Sum_probs=159.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++..++..|+||||++|++|.+++.+. .+..+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~ 168 (351)
T 3c0i_A 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKEN 168 (351)
T ss_dssp CCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSST
T ss_pred CcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCC
Confidence 67899999999999999999999999888653 3345899999999999999999999999999999999999987654
Q ss_pred ---EEEecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 79 ---VKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 79 ---~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.. ......+...
T Consensus 169 ~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~ 247 (351)
T 3c0i_A 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKG 247 (351)
T ss_dssp TCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHT
T ss_pred CCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcC
Confidence 99999999876544322 345679999999999998899999999999999999999999998753 3333333332
Q ss_pred CCCCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..... ....+++.+.++|.+||+.||.+||++.++++
T Consensus 248 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22211 12567899999999999999999999999996
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=265.34 Aligned_cols=189 Identities=23% Similarity=0.418 Sum_probs=164.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++||||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++
T Consensus 163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp CCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++.............|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+...
T Consensus 241 l~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~ 320 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320 (365)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 999999877655555566789999999998863 35788999999999999999999999988776666555444
Q ss_pred CCCCCC--CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...... ...++..+.+++.+||+.||.+||++.++++
T Consensus 321 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333222 2467889999999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=256.79 Aligned_cols=195 Identities=30% Similarity=0.562 Sum_probs=164.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+ ..++|+||+++++|.+++.+... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+|
T Consensus 76 ~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 153 (281)
T 3cc6_A 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVK 153 (281)
T ss_dssp CCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEE
T ss_pred ceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEE
Confidence 5788888765 56899999999999999987543 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. ....
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~ 232 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDR 232 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCC
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCC
Confidence 99999987654322 2234456789999999988899999999999999999998 999998776665544443 4445
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++.+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 56677889999999999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=260.07 Aligned_cols=196 Identities=29% Similarity=0.546 Sum_probs=164.7
Q ss_pred CcEEEEeecC--CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKP--PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++... ...++||||+++++|.+++.+... .+++..++.++.|++.||+|||++|++|+||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~ 164 (302)
T 4e5w_A 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ 164 (302)
T ss_dssp CCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred eeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC
Confidence 5788898777 778999999999999999976543 5899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC------------
Q 026042 79 VKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM------------ 142 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------------ 142 (244)
++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus 165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (302)
T 4e5w_A 165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244 (302)
T ss_dssp EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc
Confidence 9999999987654322 233456788899999998888999999999999999999998875321
Q ss_pred --CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 143 --TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 143 --~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
..................+..+++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222233334455566777889999999999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=259.85 Aligned_cols=196 Identities=29% Similarity=0.556 Sum_probs=168.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+. .++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+|
T Consensus 84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~k 161 (291)
T 1u46_A 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 161 (291)
T ss_dssp CCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred ccEEEEEccCC-ceeeEecccCCCHHHHHHhccC-CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEE
Confidence 57889988765 7899999999999999987532 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 99999986543322 1233456778999999988888999999999999999999 999999988888777776666
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.....+..+++.+.+++.+||+.||.+||++.++++.|+....
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 6667778899999999999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=263.21 Aligned_cols=199 Identities=30% Similarity=0.568 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcE------EEEEeccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCc
Q 026042 1 MQFVAACKKPPVF------CIITEYLAGGSLRKYLHQQE----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSEN 70 (244)
Q Consensus 1 v~~~~~~~~~~~~------~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~n 70 (244)
|++++++...... ++|+||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~N 167 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcce
Confidence 4678888777766 99999999999999996532 2258999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHH
Q 026042 71 LLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQ 146 (244)
Q Consensus 71 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 146 (244)
|+++.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999876433222 223446778999999999999999999999999999999 999999887766
Q ss_pred HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 147 AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
....+. .......+..+++.+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 248 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 IYNYLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 655543 34455667789999999999999999999999999999999887643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=262.15 Aligned_cols=198 Identities=27% Similarity=0.488 Sum_probs=163.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..++|+||++|++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++ ++.++
T Consensus 92 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred eEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence 578899999999999999999999999998754 3588899999999999999999999999999999999998 67999
Q ss_pred EecCCCcccccc------cCCCCCCCcccceeccceecc---------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Q 026042 81 VADFGISCLESQ------CGSAKGFTGTYRWMAPEMIKE---------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPE 145 (244)
Q Consensus 81 l~dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 145 (244)
|+|||++..... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 249 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999998764321 122234458999999999864 34688999999999999999999999998887
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
.....+............++.++.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 250 AIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 7766665544444444578899999999999999999999999999999876643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=281.09 Aligned_cols=189 Identities=24% Similarity=0.402 Sum_probs=165.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus 247 v~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 247 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred eeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeE
Confidence 57899999999999999999999999999887655699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~ 156 (244)
|+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+. ..
T Consensus 327 L~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~ 404 (576)
T 2acx_A 327 ISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EV 404 (576)
T ss_dssp ECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HC
T ss_pred EEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cc
Confidence 999999976655444456689999999999998889999999999999999999999998753 233332222 23
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
....+..+++++.++|.+||+.||.+|| +++|+++
T Consensus 405 ~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 4456678999999999999999999999 7888886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=255.90 Aligned_cols=198 Identities=21% Similarity=0.325 Sum_probs=161.8
Q ss_pred EEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---CCCcE
Q 026042 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDMCV 79 (244)
Q Consensus 3 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~---~~~~~ 79 (244)
+..++..++..++|+||+ +++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++ .++.+
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~ 147 (296)
T 3uzp_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLV 147 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCE
T ss_pred cccccCCCCceEEEEEec-CCCHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeE
Confidence 444557888899999999 8999999985443 689999999999999999999999999999999999994 78899
Q ss_pred EEecCCCcccccccCC--------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH
Q 026042 80 KVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAA 148 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~ 148 (244)
||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.. ...
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 227 (296)
T 3uzp_A 148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 227 (296)
T ss_dssp EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHH
T ss_pred EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhh
Confidence 9999999876443322 24567899999999999989999999999999999999999999864321 111
Q ss_pred HHHHh---hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 026042 149 FAVCQ---KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 149 ~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
..+.. ..........+++.+.+++.+||+.||.+||+++++++.|+.+......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 228 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 11111 1111223367889999999999999999999999999999998776544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=269.90 Aligned_cols=191 Identities=20% Similarity=0.360 Sum_probs=156.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+++++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 68999999999999999999999999999887555799999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--------CCCCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 81 VADFGISCLESQC--------GSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 81 l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
|+|||.+...... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 248 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248 (389)
T ss_dssp ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999987543211 12234578999999999987 5789999999999999999999999987654433322
Q ss_pred HHhhCC--------------------------------------------CCCCCCCchHHHHHHHHHhcccCCCCCCCH
Q 026042 151 VCQKNA--------------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186 (244)
Q Consensus 151 ~~~~~~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 186 (244)
...... ....+..+++.+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta 328 (389)
T 3gni_B 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328 (389)
T ss_dssp C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence 211100 112345578899999999999999999999
Q ss_pred HHHHH
Q 026042 187 DQIVS 191 (244)
Q Consensus 187 ~el~~ 191 (244)
+|+++
T Consensus 329 ~ell~ 333 (389)
T 3gni_B 329 STLLN 333 (389)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99996
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=255.82 Aligned_cols=186 Identities=25% Similarity=0.448 Sum_probs=165.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 77 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 77 LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEE
T ss_pred eeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. .....
T Consensus 155 l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~ 231 (284)
T 2vgo_A 155 IADFGWSVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKF 231 (284)
T ss_dssp ECCCTTCEECSS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCC
T ss_pred EecccccccCcc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCC
Confidence 999999865433 233456789999999999998899999999999999999999999998877666555433 33456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+..++..+.+++.+||+.||.+||+++++++
T Consensus 232 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 6788999999999999999999999999997
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=280.66 Aligned_cols=201 Identities=27% Similarity=0.555 Sum_probs=170.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.. +..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 399 v~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 399 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp CCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred eeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEE
Confidence 678999976 568999999999999999976543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. ..
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~ 555 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QG 555 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TT
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cC
Confidence 999999976533221 122335678999999998999999999999999999998 999999988777655543 44
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCCc
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDP 204 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~~ 204 (244)
.....+..+++++.+++.+||+.+|.+||++.++++.|+.+...+....
T Consensus 556 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 5667788899999999999999999999999999999999877665443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=268.48 Aligned_cols=201 Identities=27% Similarity=0.576 Sum_probs=161.2
Q ss_pred CcEEEEe-ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAAC-KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~-~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++ ..++..++||||+++++|.+++++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 153 v~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 231 (373)
T 3c1x_A 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231 (373)
T ss_dssp CCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred ceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCE
Confidence 5678876 455688999999999999999986543 57899999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 026042 80 KVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 153 (244)
||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+.
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~- 310 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL- 310 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-
Confidence 999999987543221 1223456788999999999999999999999999999999 788888766555444433
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
.......+..++..+.+++.+||+.||.+||++.++++.|+.+...+...
T Consensus 311 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 34455667789999999999999999999999999999999988765533
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=255.44 Aligned_cols=190 Identities=26% Similarity=0.398 Sum_probs=156.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---~~ 75 (244)
|++++++...+..++|+||+++++|.+++... .+..+++..++.++.|++.||.|||++|++||||||+||++ +.
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~ 162 (285)
T 3is5_A 83 IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSP 162 (285)
T ss_dssp CCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSST
T ss_pred HhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCC
Confidence 57899999999999999999999999998653 23468999999999999999999999999999999999999 44
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++.+||+|||++.............+++.|+|||.+. ..++.++||||||+++++|++|..||.+.+............
T Consensus 163 ~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 241 (285)
T 3is5_A 163 HSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE 241 (285)
T ss_dssp TCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC
Confidence 6789999999997665555556677999999999885 567899999999999999999999999988777665554433
Q ss_pred CCCC-CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPP-VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... ....+++.+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 3322 22457899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=265.10 Aligned_cols=196 Identities=30% Similarity=0.503 Sum_probs=157.8
Q ss_pred CcEEEEeecCC----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCccCCC
Q 026042 1 MQFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ----------GILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~----------~i~H~di 66 (244)
|++++++.... .+++||||+++++|.++++... +++..++.++.|++.||.|||+. |++||||
T Consensus 81 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dl 157 (322)
T 3soc_A 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157 (322)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCC
T ss_pred hhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCC
Confidence 57889988754 3799999999999999998753 89999999999999999999999 9999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccC-----CCCCccchhhhHHHHHHHHhCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEK-----RHTKKVDVYSFGIVLWELLTALTP 138 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~p 138 (244)
||+||+++.++.+||+|||++....... ......|++.|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus 158 kp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p 237 (322)
T 3soc_A 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237 (322)
T ss_dssp SGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred ChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence 9999999999999999999996544322 23345789999999998763 456788999999999999999999
Q ss_pred CCCCC----------------HHHHHHHHHhhCCCCCCCC-----CchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 139 FDNMT----------------PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 139 ~~~~~----------------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
|.+.. ..............+..+. ..++++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 238 ADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 96532 2222222222222232222 23456999999999999999999999999999876
Q ss_pred hh
Q 026042 198 ES 199 (244)
Q Consensus 198 ~~ 199 (244)
+.
T Consensus 318 ~~ 319 (322)
T 3soc_A 318 RL 319 (322)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=254.53 Aligned_cols=187 Identities=27% Similarity=0.433 Sum_probs=156.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++.............+++.|+|||.+.+... +.++|+||||+++++|++|..||...........+... ...
T Consensus 152 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~ 229 (276)
T 2h6d_A 152 IADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFY 229 (276)
T ss_dssp ECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccc
Confidence 999999876655444455678999999999987765 68999999999999999999999988776665554332 344
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++..+.+++.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 56778999999999999999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=262.44 Aligned_cols=196 Identities=28% Similarity=0.596 Sum_probs=163.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..+. .++|+||+.+++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 80 v~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k 157 (327)
T 3lzb_A 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp CCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred eEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEE
Confidence 56788888765 7799999999999999987653 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.......+ ....
T Consensus 158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-~~~~ 236 (327)
T 3lzb_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGE 236 (327)
T ss_dssp ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTC
T ss_pred EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCC
Confidence 999999876433222 223446778999999999999999999999999999999 99999988776655444 3455
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
....+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 5667788999999999999999999999999999999987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=258.94 Aligned_cols=197 Identities=23% Similarity=0.337 Sum_probs=157.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 97 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~k 174 (309)
T 2h34_A 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAY 174 (309)
T ss_dssp CCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred eEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-C
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-R 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 157 (244)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..... .
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (309)
T 2h34_A 175 LVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRP 254 (309)
T ss_dssp ECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCG
T ss_pred EecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCc
Confidence 99999986544322 22345689999999999988899999999999999999999999988765533332222111 1
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYSES 199 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~el~~~l~~~~~~ 199 (244)
...+..+++.+.+++.+||+.||.+|| +++++++.|+.....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 234567899999999999999999999 999999999876544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=263.88 Aligned_cols=189 Identities=23% Similarity=0.386 Sum_probs=159.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---- 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---- 76 (244)
|++++++.+++..|+||||++||+|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~ 156 (342)
T 2qr7_A 79 ITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNP 156 (342)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSG
T ss_pred CeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCc
Confidence 578999999999999999999999999998765 58999999999999999999999999999999999998543
Q ss_pred CcEEEecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Q 026042 77 MCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNM---TPEQAAFAVC 152 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~ 152 (244)
+.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||... +..+....+.
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~ 236 (342)
T 2qr7_A 157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236 (342)
T ss_dssp GGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH
T ss_pred CeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc
Confidence 35999999998754432 2344567899999999998888899999999999999999999999753 3444444444
Q ss_pred hhCCCC--CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARP--PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...... .....+++++.++|.+||..||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 237 SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 333222 233678999999999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=261.38 Aligned_cols=187 Identities=26% Similarity=0.441 Sum_probs=165.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred CeEEEEEecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........++..|+|||.+.+..++.++||||||+++|+|++|..||......+....+... ...
T Consensus 182 l~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~ 259 (335)
T 2owb_A 182 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYS 259 (335)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCC
T ss_pred EeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCC
Confidence 999999875432 22344567899999999999888999999999999999999999999988776665554433 345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++.+.+++.+||+.||.+||+++++++
T Consensus 260 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 260 IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 66788999999999999999999999999997
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=257.27 Aligned_cols=186 Identities=27% Similarity=0.425 Sum_probs=157.2
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
....++||||+++++|.+++.+..+..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 171 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhhee
Confidence 56689999999999999999876555789999999999999999999999999999999999999999999999999876
Q ss_pred ccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHH
Q 026042 90 ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFS 169 (244)
Q Consensus 90 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 169 (244)
...........+++.|+|||.+.+..++.++||||||+++|+|++|..|+... ...... ......+..++..+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~ 245 (284)
T 2a19_B 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTD----LRDGIISDIFDKKEK 245 (284)
T ss_dssp SSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHH----HHTTCCCTTSCHHHH
T ss_pred ccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHH----hhcccccccCCHHHH
Confidence 65544555667999999999999888999999999999999999998887431 111111 112345567889999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 170 YLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 170 ~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
+++.+||+.||.+||++.++++.|..+.....
T Consensus 246 ~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 246 TLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 99999999999999999999999988765433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=259.38 Aligned_cols=189 Identities=22% Similarity=0.345 Sum_probs=156.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||++ ++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~k 159 (311)
T 3niz_A 82 VSLIDVIHSERCLTLVFEFME-KDLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK 159 (311)
T ss_dssp CCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred eeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEE
Confidence 578999999999999999996 599998877543 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 160 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 239 (311)
T 3niz_A 160 LADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239 (311)
T ss_dssp ECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCC
T ss_pred EccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCC
Confidence 9999998765432 23344578999999999876 568999999999999999999999998776655544443211111
Q ss_pred C----------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P----------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ..+.+++++.+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 240 NPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 12346788999999999999999999999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=264.48 Aligned_cols=188 Identities=23% Similarity=0.340 Sum_probs=159.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~----- 75 (244)
|++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 57899999999999999999 899999999876657999999999999999999999999999999999999975
Q ss_pred --------------------CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC
Q 026042 76 --------------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 135 (244)
Q Consensus 76 --------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 135 (244)
++.+||+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 78899999999875433 33456789999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhCCCCC------------------------CC--------------------CCchHHHHHH
Q 026042 136 LTPFDNMTPEQAAFAVCQKNARPP------------------------VP--------------------PTCPKAFSYL 171 (244)
Q Consensus 136 ~~p~~~~~~~~~~~~~~~~~~~~~------------------------~~--------------------~~~~~~l~~l 171 (244)
..||...+..+....+.......+ .+ ...++.+.+|
T Consensus 256 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 335 (360)
T 3llt_A 256 SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDF 335 (360)
T ss_dssp SCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHH
T ss_pred CCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHH
Confidence 999998877665554433221111 00 1123678899
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 026042 172 ISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 172 i~~~l~~~p~~Rps~~el~~ 191 (244)
+.+||+.||.+|||++|+++
T Consensus 336 i~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 336 LYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCChhhCCCHHHHhc
Confidence 99999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=262.46 Aligned_cols=186 Identities=29% Similarity=0.490 Sum_probs=163.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+. |+|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 117 v~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 194 (348)
T 1u5q_A 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 194 (348)
T ss_dssp CCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred eeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence 578999999999999999996 689998865443 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++..... .....|++.|+|||.+. ...++.++||||||+++++|++|..||...+.......+......
T Consensus 195 L~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 271 (348)
T 1u5q_A 195 LGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 271 (348)
T ss_dssp ECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred EeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence 999999876543 34567999999999984 467899999999999999999999999988877766666555554
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+++.+.+++.+||+.||.+|||++++++
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 5556788999999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=262.49 Aligned_cols=200 Identities=31% Similarity=0.584 Sum_probs=167.6
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++.. ....++||||+++++|.+++.+.. +++..++.++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~ 172 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL 172 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC
Confidence 578899877 467899999999999999998754 899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------
Q 026042 79 VKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-------- 146 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------- 146 (244)
+||+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++|..||.......
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 252 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccc
Confidence 9999999987654322 2334557888999999998889999999999999999999999987533221
Q ss_pred ------HHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccCC
Q 026042 147 ------AAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQD 203 (244)
Q Consensus 147 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~~ 203 (244)
..............+..++..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 253 GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred cchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 122233345556677889999999999999999999999999999999988776543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=255.85 Aligned_cols=189 Identities=20% Similarity=0.313 Sum_probs=155.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+++ +|.+++....+ .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 140 (288)
T 1ob3_A 63 VKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140 (288)
T ss_dssp CCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred eeeeeEEccCCeEEEEEEecCC-CHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence 5789999999999999999965 99999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++...... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 141 l~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 220 (288)
T 1ob3_A 141 IADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220 (288)
T ss_dssp ECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC
Confidence 9999998654322 223345689999999998764 58999999999999999999999999887766655443321110
Q ss_pred ---------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+++++.+++.+||+.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112457899999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=258.79 Aligned_cols=199 Identities=31% Similarity=0.563 Sum_probs=162.2
Q ss_pred CcEEEEeecCC-----cEEEEEeccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAACKKPP-----VFCIITEYLAGGSLRKYLHQQ----EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~i~~~----~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
|++++++...+ ..++|+||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NI 178 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGE
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 46778887655 359999999999999999532 234689999999999999999999999999999999999
Q ss_pred EEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 147 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 147 (244)
+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 99999999999999987543322 2233456789999999999899999999999999999999 9999988777665
Q ss_pred HHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 148 AFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
..... .......+..+++.+.+++.+||+.||.+||++.++++.|+.+...+
T Consensus 259 ~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 YDYLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 55443 34455667889999999999999999999999999999999887654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=279.47 Aligned_cols=199 Identities=36% Similarity=0.637 Sum_probs=172.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.. +..||||||+++++|.++++...+..+++..++.++.||+.||.|||++|++||||||+||+++.++.+|
T Consensus 325 v~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~k 403 (535)
T 2h8h_A 325 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 403 (535)
T ss_dssp CCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred eeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEE
Confidence 578999876 6789999999999999999865444689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+. ....
T Consensus 404 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~ 482 (535)
T 2h8h_A 404 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYR 482 (535)
T ss_dssp ECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCC
T ss_pred EcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCC
Confidence 9999998754321 12233456789999999988899999999999999999999 999999988877665553 4445
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
...+..++..+.+||.+||+.||++|||+++|++.|+.+.....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 66778899999999999999999999999999999998765544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=272.86 Aligned_cols=193 Identities=26% Similarity=0.397 Sum_probs=168.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---C
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---M 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---~ 77 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.. +
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred CeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCC
Confidence 689999999999999999999999999998765 58999999999999999999999999999999999999764 4
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............|++.|+|||++. ..++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus 177 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255 (494)
T ss_dssp CEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred cEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 59999999998766555556678999999999886 56899999999999999999999999998888777766655444
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
...+ ..+++.+.++|.+||+.||.+|||+.++++ +++..
T Consensus 256 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 3322 568999999999999999999999999996 45543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=259.56 Aligned_cols=191 Identities=28% Similarity=0.493 Sum_probs=158.0
Q ss_pred CcEEEEeec------CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKK------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
+++++++.. .+..++||||+++++|.+++....+..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 163 (326)
T 2x7f_A 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163 (326)
T ss_dssp CCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred eeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc
Confidence 467888876 57899999999999999999876545789999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCccccccc-CCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Q 026042 75 EDMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA 148 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 148 (244)
.++.+||+|||++...... .......+++.|+|||.+. +..++.++||||||+++|+|++|..||.........
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 164 ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp TTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 9999999999998764432 2234557899999999986 456889999999999999999999999988877666
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+............++..+.++|.+||..||.+||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 6555444444456778999999999999999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=254.26 Aligned_cols=189 Identities=19% Similarity=0.310 Sum_probs=155.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+++ +|.+++....+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 64 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp CCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred eeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 5789999999999999999965 77777765433 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCC-CCCccchhhhHHHHHHHHhCCCC-CCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..| |.+.+..+....+......
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 142 LANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp ECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence 9999998765432 2344567899999999987765 79999999999999999988777 5555555554444331111
Q ss_pred ---------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ---------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+++.+.+++.+||+.||.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1122357889999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=271.44 Aligned_cols=188 Identities=27% Similarity=0.406 Sum_probs=163.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~---~~ 77 (244)
|++++++...+.+|+|+||+.|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++. ++
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTC
T ss_pred CeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCC
Confidence 679999999999999999999999999998765 5899999999999999999999999999999999999954 56
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............|++.|+|||++.+ .++.++||||+|+++|+|++|..||.+.+..+....+......
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 240 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240 (486)
T ss_dssp CEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred CEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 799999999977655555566789999999999875 5899999999999999999999999998887777666655443
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+ ..+++++.++|.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3332 467899999999999999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=262.09 Aligned_cols=181 Identities=23% Similarity=0.427 Sum_probs=160.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++...+..++|+||+.+| +|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 92 v~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp CCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE
T ss_pred eeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcE
Confidence 57899999999999999999766 9999998766 58999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||+|||++.............|++.|+|||.+.+..+ +.++||||||+++|+|++|..||..... ......
T Consensus 170 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~ 241 (335)
T 3dls_A 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAI 241 (335)
T ss_dssp EECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCC
T ss_pred EEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhcc
Confidence 9999999977655555556779999999999988776 8899999999999999999999976322 122334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..+++++.+++.+||+.||.+|||++++++
T Consensus 242 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 242 HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 456678999999999999999999999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=254.72 Aligned_cols=195 Identities=25% Similarity=0.373 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
+++++++..+...++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.++
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSS
T ss_pred eehhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCC
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999998877
Q ss_pred -cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 -CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.++|+|||.+.............+++.|+|||.+.+..++.++||||||+++++|++|..||...+..+....+.....
T Consensus 149 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY 228 (283)
T ss_dssp CCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred CceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc
Confidence 7999999998766554445566789999999999988999999999999999999999999998887766555443322
Q ss_pred CCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 026042 157 RPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYS 197 (244)
Q Consensus 157 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~ 197 (244)
... ....+++.+.+++.+||+.||.+||++.++++ +++...
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 211 22567899999999999999999999999998 555543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=256.24 Aligned_cols=202 Identities=21% Similarity=0.382 Sum_probs=158.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++..++..++|+||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.+|.
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~ 174 (310)
T 2wqm_A 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV 174 (310)
T ss_dssp CCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred eeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC
Confidence 57899999999999999999999999999752 2346899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhhC
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT--PEQAAFAVCQKN 155 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~ 155 (244)
++|+|||++....... ......++..|+|||.+.+..++.++||||||+++++|++|..||.+.. .......+....
T Consensus 175 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 254 (310)
T 2wqm_A 175 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254 (310)
T ss_dssp EEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC
T ss_pred EEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc
Confidence 9999999986544322 2334568999999999998899999999999999999999999997543 223333333333
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
........+++++.+++.+||+.||.+||++.++++.|+.+......
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 33333467899999999999999999999999999999988776543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=258.03 Aligned_cols=195 Identities=32% Similarity=0.576 Sum_probs=160.7
Q ss_pred CcEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++. .++..++|+||+++++|.+++.+.....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 77 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (278)
T 1byg_A 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 156 (278)
T ss_dssp CCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred eeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcE
Confidence 57888864 44578999999999999999987653347889999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+|+|||++...... .....++..|+|||.+.+..++.++||||||+++++|++ |..||...+..+....+. .....
T Consensus 157 ~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 233 (278)
T 1byg_A 157 KVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKM 233 (278)
T ss_dssp EECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCC
T ss_pred EEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCC
Confidence 99999998654432 223456889999999988899999999999999999998 999998877665554443 34455
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+..+++.+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 6678899999999999999999999999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=259.94 Aligned_cols=196 Identities=20% Similarity=0.347 Sum_probs=160.2
Q ss_pred CcEEEEeecCC--cEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----
Q 026042 1 MQFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---- 73 (244)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---- 73 (244)
|++++++.... ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 149 (319)
T 4euu_A 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149 (319)
T ss_dssp CCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT
T ss_pred ceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC
Confidence 57888887665 78999999999999999987542 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEecCCCcccccccCCCCCCCcccceeccceec--------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-
Q 026042 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK--------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTP- 144 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~- 144 (244)
+.++.+||+|||++.............|++.|+|||.+. +..++.++||||||+++|+|++|..||.....
T Consensus 150 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 229 (319)
T 4euu_A 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (319)
T ss_dssp TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 778889999999998766555555677999999999886 46789999999999999999999999974432
Q ss_pred ---HHHHHHHHhhCCCC-----------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 145 ---EQAAFAVCQKNARP-----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 145 ---~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
......+....... .....++..+.+++.+||+.||.+|||++|+++...+.
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 23333333222110 12234567899999999999999999999999988754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=281.40 Aligned_cols=196 Identities=28% Similarity=0.549 Sum_probs=167.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.. +..++||||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus 433 v~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~k 509 (635)
T 4fl3_A 433 VRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK 509 (635)
T ss_dssp CCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred eeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEE
Confidence 678999975 45789999999999999998765 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. ..
T Consensus 510 L~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~ 588 (635)
T 4fl3_A 510 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KG 588 (635)
T ss_dssp ECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT
T ss_pred EEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999987543322 1223346788999999999899999999999999999998 999999988877655554 45
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
.....+..+++++.++|.+||+.||++||+++++++.|+.+...+
T Consensus 589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 566778889999999999999999999999999999999876554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=255.90 Aligned_cols=187 Identities=26% Similarity=0.438 Sum_probs=165.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 78 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 78 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred eeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||.+..... ........+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+. .....
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~ 233 (294)
T 2rku_A 156 IGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYS 233 (294)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCC
T ss_pred EEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCC
Confidence 999999876442 223445678999999999998889999999999999999999999999887766555443 33345
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..+++.+.+++.+||+.||.+||+++++++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 234 IPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 66788999999999999999999999999997
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=263.09 Aligned_cols=187 Identities=20% Similarity=0.356 Sum_probs=138.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++..+...|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~ 146 (325)
T 3kn6_A 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146 (325)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----C
T ss_pred eEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcc
Confidence 579999999999999999999999999998865 689999999999999999999999999999999999998765
Q ss_pred cEEEecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHH
Q 026042 78 CVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP-------EQAAF 149 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~ 149 (244)
.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+. .+...
T Consensus 147 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 226 (325)
T 3kn6_A 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226 (325)
T ss_dssp EEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred cEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence 8999999998754332 233456689999999999999999999999999999999999999986543 22222
Q ss_pred HHHhhCCCCCCC----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 150 AVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 150 ~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+.... ...+ ..+++++.+++.+||+.||.+|||++++++
T Consensus 227 ~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 227 KIKKGD--FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTTTC--CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHcCC--CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 222211 1222 357899999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=255.51 Aligned_cols=189 Identities=26% Similarity=0.429 Sum_probs=165.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEE
Confidence 578999999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceec------cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIK------EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||.+.............+++.|+|||.+. ...++.++||||||+++++|++|..||...+.......+...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 99999987765555555677899999999885 446789999999999999999999999988877666655554
Q ss_pred CCCCCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+ ..++..+.+++.+||+.||.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 4333322 467899999999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=265.03 Aligned_cols=198 Identities=29% Similarity=0.519 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 98 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 98 VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV 177 (321)
T ss_dssp CCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC
T ss_pred eeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC
Confidence 578999999999999999999999999997643 235899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HH
Q 026042 79 VKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA------AF 149 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~ 149 (244)
+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ..
T Consensus 178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 257 (321)
T 2qkw_B 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257 (321)
T ss_dssp EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence 9999999986543221 22344589999999999888999999999999999999999999975432211 00
Q ss_pred HHHhhC---------CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 150 AVCQKN---------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 150 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...... .....+..++..+.+++.+||+.||.+|||+.++++.|+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 111010 0112223456789999999999999999999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=255.93 Aligned_cols=188 Identities=27% Similarity=0.426 Sum_probs=139.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~k 152 (278)
T 3cok_A 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIK 152 (278)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEE
T ss_pred EeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEE
Confidence 5789999999999999999999999999987543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++...... .......+++.|+|||.+.+..++.++||||||+++++|++|..||...+........ ......
T Consensus 153 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~ 230 (278)
T 3cok_A 153 IADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYE 230 (278)
T ss_dssp ECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C--CSSCCC
T ss_pred EEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH--hhcccC
Confidence 9999998754422 2233456899999999999888999999999999999999999999876544332222 122234
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+..++.++.+++.+||+.||.+||+++++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 56678999999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=267.44 Aligned_cols=188 Identities=26% Similarity=0.361 Sum_probs=160.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||+++.++.
T Consensus 162 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCC
T ss_pred EEEEeecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcc
Confidence 57899999999999999999 569999998876667999999999999999999999999999999999999999887
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 241 vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p 318 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMP 318 (429)
T ss_dssp EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eEEeecccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999865433 3345678999999999999999999999999999999999999999888776655443221110
Q ss_pred C---------------------------------------------------------CCCCchHHHHHHHHHhcccCCC
Q 026042 159 P---------------------------------------------------------VPPTCPKAFSYLISRCWSSSPD 181 (244)
Q Consensus 159 ~---------------------------------------------------------~~~~~~~~l~~li~~~l~~~p~ 181 (244)
. .+...++.+.+||.+||+.||.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~ 398 (429)
T 3kvw_A 319 SQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPA 398 (429)
T ss_dssp CHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTT
T ss_pred CHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChh
Confidence 0 1123367899999999999999
Q ss_pred CCCCHHHHHH
Q 026042 182 RRPHFDQIVS 191 (244)
Q Consensus 182 ~Rps~~el~~ 191 (244)
+|||++|+++
T Consensus 399 ~Rpta~e~L~ 408 (429)
T 3kvw_A 399 VRMTPGQALR 408 (429)
T ss_dssp TSCCHHHHHT
T ss_pred hCCCHHHHhC
Confidence 9999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=258.89 Aligned_cols=192 Identities=24% Similarity=0.430 Sum_probs=161.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++..++..++||||++|++|.+++.+... .+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 75 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp CCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGG
T ss_pred eEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccc
Confidence 5789999999999999999999999999987643 4899999999999999999999999999999999999998886
Q ss_pred ------EEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 026042 79 ------VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFA 150 (244)
Q Consensus 79 ------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 150 (244)
+||+|||.+..... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.......
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred ccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999999865432 123457888999999987 678999999999999999999 5566666555544333
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
. ......+...++++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 231 ~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 Y---EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp H---HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred h---hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 2 223455566788999999999999999999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=261.72 Aligned_cols=197 Identities=24% Similarity=0.354 Sum_probs=161.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------------------------------CCCCCHHHH
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------------------------------PYSVPLNLV 42 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------------------------------~~~~~~~~~ 42 (244)
|++++++.+++..++||||++|++|.+++.... ...+++..+
T Consensus 91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (345)
T 3hko_A 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170 (345)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred ceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence 579999999999999999999999999996311 112356778
Q ss_pred HHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC--cEEEecCCCcccccccC-----CCCCCCcccceeccceecc--
Q 026042 43 LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--CVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKE-- 113 (244)
Q Consensus 43 ~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~-- 113 (244)
+.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....... ......|++.|+|||.+.+
T Consensus 171 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 99999999999999999999999999999998766 89999999987543321 1345678999999999865
Q ss_pred CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 114 KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 114 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..++.++||||||+++|+|++|..||.+.+..+....+.........+ ..+++.+.++|.+||+.||.+||++.++++
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 578899999999999999999999999988887777666554433333 347899999999999999999999999998
Q ss_pred --HHHhhh
Q 026042 192 --ILEGYS 197 (244)
Q Consensus 192 --~l~~~~ 197 (244)
+++.+.
T Consensus 331 hp~~~~~~ 338 (345)
T 3hko_A 331 HPWISQFS 338 (345)
T ss_dssp SHHHHTTS
T ss_pred ChhhccCh
Confidence 455443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=260.70 Aligned_cols=187 Identities=22% Similarity=0.365 Sum_probs=155.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|||+. +++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++ ++.+|
T Consensus 72 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~k 147 (343)
T 3dbq_A 72 IRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 147 (343)
T ss_dssp CCEEEEEECSSEEEEEECCC-SEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEE
T ss_pred EEEeeeEeeCCEEEEEEeCC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEE
Confidence 57899999999999999955 889999999865 689999999999999999999999999999999999997 57899
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceecc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPE- 145 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 145 (244)
|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 99999997654322 2335679999999999865 56788999999999999999999999875433
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...............+...+..+.+++.+||+.||.+|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 3334444445555677778899999999999999999999999997
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=258.06 Aligned_cols=187 Identities=25% Similarity=0.388 Sum_probs=151.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++..++..|+||||++|++|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.
T Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 151 (316)
T 2ac3_A 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151 (316)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSC
T ss_pred eeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcC
Confidence 578999999999999999999999999998865 5899999999999999999999999999999999999988765
Q ss_pred -EEEecCCCcccccccC--------CCCCCCcccceeccceecc-----CCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Q 026042 79 -VKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKE-----KRHTKKVDVYSFGIVLWELLTALTPFDNMTP 144 (244)
Q Consensus 79 -~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 144 (244)
+||+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....
T Consensus 152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp SEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 9999999986543211 1224458999999999875 4578999999999999999999999976542
Q ss_pred ---------------HHHHHHHHhhCCCCCCC----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 145 ---------------EQAAFAVCQKNARPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 145 ---------------~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+.... ...+ ..+++.+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 232 SDCGWDRGEACPACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp SCSCC----CCHHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccchhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11222222222 2222 467899999999999999999999999988
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=254.81 Aligned_cols=198 Identities=34% Similarity=0.682 Sum_probs=159.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHS---QGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~l~~~L~~lH~---~~i~H~dikp~nil~~~~ 76 (244)
|++++++. +..++||||++|++|.+++...... .++...++.++.|++.||.|||+ +|++||||||+||+++.+
T Consensus 64 v~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~ 141 (307)
T 2eva_A 64 VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG 141 (307)
T ss_dssp CCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETT
T ss_pred CeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCC
Confidence 56778776 3478999999999999999875432 47889999999999999999999 899999999999999988
Q ss_pred Cc-EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhh
Q 026042 77 MC-VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ-AAFAVCQK 154 (244)
Q Consensus 77 ~~-~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~ 154 (244)
+. +||+|||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ........
T Consensus 142 ~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 219 (307)
T 2eva_A 142 GTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219 (307)
T ss_dssp TTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT
T ss_pred CCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc
Confidence 86 799999998654332 234468999999999998899999999999999999999999998653222 22222334
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhccC
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~~ 202 (244)
......+..+++.+.+++.+||+.||.+|||++++++.|+.+...+..
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 455566778999999999999999999999999999999988776543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=255.98 Aligned_cols=194 Identities=27% Similarity=0.414 Sum_probs=152.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~ 77 (244)
+++++++..++..++||||++ ++|.+++.. ..+..+++..++.++.|++.||.|||++ |++||||||+||+++.++
T Consensus 69 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~ 147 (290)
T 3fme_A 69 VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 147 (290)
T ss_dssp CCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC
T ss_pred EEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC
Confidence 578999999999999999996 599888765 2334689999999999999999999998 999999999999999999
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceecccee----ccCCCCCccchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHH
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI----KEKRHTKKVDVYSFGIVLWELLTALTPFDNM-TPEQAAFAVC 152 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~ 152 (244)
.+||+|||++.............+++.|+|||.+ .+..++.++||||||+++++|++|..||... ..........
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 148 QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence 9999999999776555555556799999999996 4567889999999999999999999999874 3444444444
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
...........+++.+.+++.+||+.||.+|||+.++++ +++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 444444445678999999999999999999999999998 4543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=258.35 Aligned_cols=197 Identities=32% Similarity=0.574 Sum_probs=159.2
Q ss_pred CcEEEEeecC----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccCCCCC
Q 026042 1 MQFVAACKKP----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ--------GILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~--------~i~H~dikp 68 (244)
|++++++... ...++||||+++++|.++++.. .+++..++.++.|++.||.|||++ |++||||||
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence 5788888877 7899999999999999999765 489999999999999999999999 999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccCC-----CCCCCcccceeccceeccCCCCCc------cchhhhHHHHHHHHhC--
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEKRHTKK------VDVYSFGIVLWELLTA-- 135 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~l~~g-- 135 (244)
+||+++.++.+||+|||++........ .....|++.|+|||.+.+...... +||||||+++|+|++|
T Consensus 171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 999999999999999999865433221 235579999999999987766555 9999999999999999
Q ss_pred --------CCCCCCCC-----HHHHHHHHHhhCCCCCCCC-----CchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 136 --------LTPFDNMT-----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 136 --------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
..||.... .................+. .+++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 77775432 1222222222333333332 56778999999999999999999999999999887
Q ss_pred hhc
Q 026042 198 ESL 200 (244)
Q Consensus 198 ~~~ 200 (244)
+..
T Consensus 331 ~~~ 333 (337)
T 3mdy_A 331 ESQ 333 (337)
T ss_dssp HTT
T ss_pred hhc
Confidence 653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=273.00 Aligned_cols=192 Identities=24% Similarity=0.382 Sum_probs=168.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++..+...|+||||++|++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 109 IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCS
T ss_pred CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCc
Confidence 679999999999999999999999999998765 589999999999999999999999999999999999998876
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............|++.|+|||.+. ..++.++||||+|+++|+|++|..||.+.+..+....+......
T Consensus 187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 69999999998766555556778999999999986 46899999999999999999999999998888777766554433
Q ss_pred CCC--CCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 158 PPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 158 ~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
... ...+++++.++|.+||+.||.+|||++|+++ +++.
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 307 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence 222 2578899999999999999999999999997 4544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=261.67 Aligned_cols=194 Identities=24% Similarity=0.452 Sum_probs=155.4
Q ss_pred CcEEEEeecCCc----EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPPV----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
|++++++..... .|+||||++|++|.++++..+ .+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 75 v~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 152 (311)
T 3ork_A 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 152 (311)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT
T ss_pred ceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC
Confidence 567888766554 399999999999999998766 58999999999999999999999999999999999999999
Q ss_pred CcEEEecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 77 MCVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
+.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+.........
T Consensus 153 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 232 (311)
T 3ork_A 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 232 (311)
T ss_dssp SCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 999999999987543322 2234568999999999999899999999999999999999999999988777665554
Q ss_pred hhCCCCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhh
Q 026042 153 QKNARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIV-SILEGY 196 (244)
Q Consensus 153 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~-~~l~~~ 196 (244)
....... ....++.++.+++.+||+.||.+||+..+++ ..+...
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 233 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 4433222 2356889999999999999999999766655 445443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=257.62 Aligned_cols=190 Identities=22% Similarity=0.366 Sum_probs=159.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
|++++++..++..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 66 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~ 144 (317)
T 2pmi_A 66 VRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR 144 (317)
T ss_dssp CCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred ceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC
Confidence 678999999999999999996 59999987542 2358899999999999999999999999999999999999999
Q ss_pred CcEEEecCCCccccccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 77 MCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|.+||+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 224 (317)
T 2pmi_A 145 GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224 (317)
T ss_dssp CCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999998765432 23345578999999999876 46899999999999999999999999988877665554332
Q ss_pred CCCC--------------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP--------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~--------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... .....++.++.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 1100 112356789999999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=258.03 Aligned_cols=189 Identities=22% Similarity=0.353 Sum_probs=155.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||++ ++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 63 v~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~k 140 (324)
T 3mtl_A 63 VTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELK 140 (324)
T ss_dssp CCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEE
T ss_pred CeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEE
Confidence 578999999999999999996 599999987653 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+......+
T Consensus 141 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 220 (324)
T 3mtl_A 141 LADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTP 220 (324)
T ss_dssp ECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999998654432 22344568999999999876 567999999999999999999999999988777665554322111
Q ss_pred C----------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P----------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+++++.+|+.+||+.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 221 TEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1 11346788999999999999999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=254.93 Aligned_cols=188 Identities=23% Similarity=0.385 Sum_probs=163.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---~~~~ 77 (244)
+++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++ +.++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~ 146 (304)
T 2jam_A 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS 146 (304)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC
T ss_pred eehhhhcccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC
Confidence 578999999999999999999999999998765 58999999999999999999999999999999999999 7788
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.++|+|||++...... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+......
T Consensus 147 ~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (304)
T 2jam_A 147 KIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225 (304)
T ss_dssp CEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC
T ss_pred CEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999999998654322 223345899999999999889999999999999999999999999988877766655544332
Q ss_pred --CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 --PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+++.+.+++.+||+.||.+||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2334678999999999999999999999999997
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=263.62 Aligned_cols=187 Identities=22% Similarity=0.363 Sum_probs=156.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+|||+ .+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||+++ ++.+|
T Consensus 119 v~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp CCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEE
T ss_pred EEEEEEEecCCEEEEEEec-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEE
Confidence 5789999999999999995 5889999998865 688899999999999999999999999999999999995 57899
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceecc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCH-H
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTP-E 145 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~ 145 (244)
|+|||++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||..... .
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 99999997654322 2345679999999999865 3678899999999999999999999987543 3
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+.........+...+..+.++|.+||+.||.+||++.|+++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 3344444444455666777899999999999999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=274.49 Aligned_cols=192 Identities=24% Similarity=0.393 Sum_probs=167.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---~~~~ 77 (244)
|++++++...+..|+|+||+.|++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||++ +.++
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC
T ss_pred CcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC
Confidence 679999999999999999999999999998765 58999999999999999999999999999999999999 4578
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......
T Consensus 167 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245 (484)
T ss_dssp CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 899999999876655444455679999999999865 6899999999999999999999999998888777776655444
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
...+ ..+++.+.++|.+||+.||.+|||+.++++ +++.
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~ 287 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence 3333 467899999999999999999999999997 4443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=258.78 Aligned_cols=193 Identities=33% Similarity=0.572 Sum_probs=153.7
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCC
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--------SQGILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH--------~~~i~H~dikp 68 (244)
|++++++.. ....++|+||+++++|.++++.. .+++..++.++.|++.||.||| ++|++||||||
T Consensus 65 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 141 (301)
T 3q4u_A 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKS 141 (301)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCG
T ss_pred eeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCCh
Confidence 466776533 45689999999999999999654 4899999999999999999999 99999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccCC-----CCCCCcccceeccceeccC------CCCCccchhhhHHHHHHHHhC--
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKEK------RHTKKVDVYSFGIVLWELLTA-- 135 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g-- 135 (244)
+||+++.++.+||+|||++........ .....|++.|+|||.+.+. .++.++||||||+++|+|++|
T Consensus 142 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~ 221 (301)
T 3q4u_A 142 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221 (301)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhc
Confidence 999999999999999999865433221 2345799999999999776 345789999999999999999
Q ss_pred --------CCCCCCCC-----HHHHHHHHHhhCCCCCCCC-----CchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 136 --------LTPFDNMT-----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 136 --------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..||.... .................+. .+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 222 SNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88885432 2222222222233333332 2567899999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=257.72 Aligned_cols=188 Identities=23% Similarity=0.351 Sum_probs=159.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~----- 75 (244)
+++++++...+..++||||+ +++|.+++.......+++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEE
T ss_pred EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccc
Confidence 47899999999999999999 889999998877667899999999999999999999999999999999999987
Q ss_pred --------------CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 026042 76 --------------DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 141 (244)
Q Consensus 76 --------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 141 (244)
++.+||+|||++..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 66799999999876433 23456789999999999998999999999999999999999999998
Q ss_pred CCHHHHHHHHHhhCCC------------------------------------------CCCCCCchHHHHHHHHHhcccC
Q 026042 142 MTPEQAAFAVCQKNAR------------------------------------------PPVPPTCPKAFSYLISRCWSSS 179 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~~ 179 (244)
.+..+....+...... .......++.+.+++.+||+.|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 8776554433221110 0112234678999999999999
Q ss_pred CCCCCCHHHHHH
Q 026042 180 PDRRPHFDQIVS 191 (244)
Q Consensus 180 p~~Rps~~el~~ 191 (244)
|.+|||+.|+++
T Consensus 317 P~~Rpt~~ell~ 328 (339)
T 1z57_A 317 PAKRITLREALK 328 (339)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccccCHHHHhc
Confidence 999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=273.99 Aligned_cols=189 Identities=24% Similarity=0.420 Sum_probs=161.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++...+..|+||||++||+|.+++.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.
T Consensus 248 v~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~ 327 (543)
T 3c4z_A 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN 327 (543)
T ss_dssp CCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred eeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC
Confidence 578999999999999999999999999998654 346899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHh
Q 026042 79 VKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVCQ 153 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~ 153 (244)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+ .......+.
T Consensus 328 vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~- 406 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL- 406 (543)
T ss_dssp EEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-
T ss_pred EEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-
Confidence 99999999976544332 344589999999999999999999999999999999999999998653 333333332
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF-----DQIVS 191 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~el~~ 191 (244)
......+..+++.+.++|.+||+.||.+||++ +++++
T Consensus 407 -~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 407 -EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -hcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 23345677899999999999999999999975 66664
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=255.45 Aligned_cols=190 Identities=21% Similarity=0.352 Sum_probs=163.4
Q ss_pred CcEEEEee-----cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACK-----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
+++++++. .....++|+||+. ++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~ 155 (326)
T 1blx_A 77 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 155 (326)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred EeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC
Confidence 56788887 6788999999996 69999998876556999999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++.+||+|||++.............++..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......+....
T Consensus 156 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (326)
T 1blx_A 156 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 235 (326)
T ss_dssp TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHc
Confidence 99999999999876655444556678999999999998899999999999999999999999999887766655544321
Q ss_pred CC-------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 AR-------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ......++..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10 0123567899999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=257.03 Aligned_cols=189 Identities=21% Similarity=0.356 Sum_probs=154.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 65 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k 142 (311)
T 4agu_A 65 VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIK 142 (311)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred cchhheeecCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEE
Confidence 578999999999999999999999999887665 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||++..... ........++..|+|||.+.+ ..++.++||||||+++++|++|..||.+.+..+....+......
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 143 LCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp ECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred EeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence 999999876543 223345578999999999876 56799999999999999999999999988776655443321110
Q ss_pred ------------------CCC----------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 ------------------PPV----------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ------------------~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.+. .+.+++.+.+++.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 1457888999999999999999999999997
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=257.79 Aligned_cols=197 Identities=28% Similarity=0.551 Sum_probs=168.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP-----YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++..+...|+||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~ 175 (327)
T 2yfx_A 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 175 (327)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEec
Confidence 5789999999999999999999999999987542 34889999999999999999999999999999999999984
Q ss_pred C---CcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHH
Q 026042 76 D---MCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAA 148 (244)
Q Consensus 76 ~---~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 148 (244)
+ +.++|+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.....
T Consensus 176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 4 469999999986433221 2234457889999999988899999999999999999998 99999988776655
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+. .......+..++..+.+++.+||+.||.+||++.++++.|..+..
T Consensus 256 ~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EFVT-SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh-cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 5443 344556677899999999999999999999999999999987655
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=253.83 Aligned_cols=188 Identities=31% Similarity=0.535 Sum_probs=166.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..+...++|+||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 159 (303)
T 3a7i_A 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVK 159 (303)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred eEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEE
Confidence 57899999999999999999999999999753 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++....... ......+++.|+|||.+.+..++.++||||||+++++|++|..||...........+. ......
T Consensus 160 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 238 (303)
T 3a7i_A 160 LADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPT 238 (303)
T ss_dssp ECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCC
T ss_pred EeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCC
Confidence 99999986644322 3345678999999999998899999999999999999999999999887766555443 344556
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~ 192 (244)
.+..++..+.+++.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 677889999999999999999999999999973
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=263.67 Aligned_cols=187 Identities=22% Similarity=0.353 Sum_probs=153.7
Q ss_pred CcEEEEeecCC--cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++...+ ..|+||||++ ++|.++++.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.
T Consensus 72 v~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~ 147 (388)
T 3oz6_A 72 VNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH 147 (388)
T ss_dssp CCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC
T ss_pred CeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC
Confidence 57889987544 7899999996 6999999874 4889999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccc----------------------cCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhC
Q 026042 79 VKVADFGISCLESQ----------------------CGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTA 135 (244)
Q Consensus 79 ~kl~dfg~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g 135 (244)
+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++++|++|
T Consensus 148 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 227 (388)
T 3oz6_A 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227 (388)
T ss_dssp EEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhC
Confidence 99999999865422 111234579999999999876 5789999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhhCCCCC---------------------------------------------CCCCchHHHHH
Q 026042 136 LTPFDNMTPEQAAFAVCQKNARPP---------------------------------------------VPPTCPKAFSY 170 (244)
Q Consensus 136 ~~p~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~l~~ 170 (244)
..||.+.+.......+......+. ....+++++.+
T Consensus 228 ~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 307 (388)
T 3oz6_A 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307 (388)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHH
Confidence 999998877665554432211110 12266789999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 026042 171 LISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 171 li~~~l~~~p~~Rps~~el~~ 191 (244)
|+.+||+.||.+|||++|+++
T Consensus 308 ll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 308 LLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp HHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhhccCcccCCCHHHHhC
Confidence 999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=264.45 Aligned_cols=196 Identities=28% Similarity=0.471 Sum_probs=158.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP--YSVPLNLVLKLALDIARGMQYLHSQ---GILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~l~~~L~~lH~~---~i~H~dikp~nil~~~ 75 (244)
|++++++..++..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 90 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp CCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred cceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 5789999999999999999999999999987542 2489999999999999999999999 9999999999999999
Q ss_pred CCcEEEecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHHH
Q 026042 76 DMCVKVADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP----EQAAF 149 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~ 149 (244)
++.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... .....
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 9999999999987543322 23345589999999999888899999999999999999999999952110 00000
Q ss_pred HHHhh-------------CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 150 AVCQK-------------NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 150 ~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
..... ......+...+..+.+++.+||+.||.+|||+.++++.|++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00000 000112223457899999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.25 Aligned_cols=188 Identities=23% Similarity=0.445 Sum_probs=158.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++..++..++||||++|++|.+++.+.. .+++..+..++.|++.||.|||++ |++||||||+||+++.++.+
T Consensus 94 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~ 171 (360)
T 3eqc_A 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171 (360)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCE
T ss_pred EEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCE
Confidence 578999999999999999999999999998876 588999999999999999999996 99999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---------
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA--------- 150 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--------- 150 (244)
+|+|||++...... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......
T Consensus 172 kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 172 KLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp EECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred EEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 99999998654332 23455789999999999998999999999999999999999999987665543221
Q ss_pred ---------------------------------HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 ---------------------------------VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ---------------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.............++.++.+|+.+||+.||.+|||++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11112222223457899999999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=251.69 Aligned_cols=187 Identities=25% Similarity=0.503 Sum_probs=156.2
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~ 74 (244)
|++++++.. +...++|+||+++++|.+++.+.. .+++..++.++.|++.||.|||++| ++|+||||+||+++
T Consensus 88 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~ 165 (290)
T 1t4h_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165 (290)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES
T ss_pred eeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE
Confidence 467777754 567899999999999999998865 5889999999999999999999999 99999999999998
Q ss_pred -CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-HH
Q 026042 75 -EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VC 152 (244)
Q Consensus 75 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~ 152 (244)
.++.++|+|||++..... .......+++.|+|||.+. +.++.++||||||+++|+|++|..||........... ..
T Consensus 166 ~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 243 (290)
T 1t4h_A 166 GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243 (290)
T ss_dssp STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCCCCEEEeeCCCcccccc-cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh
Confidence 788999999999865433 2334456899999999886 4589999999999999999999999987554444333 33
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+...++++.+++.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 333333445667789999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.40 Aligned_cols=196 Identities=21% Similarity=0.332 Sum_probs=162.6
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE---cCCCc
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---GEDMC 78 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---~~~~~ 78 (244)
.+..++..++..+|||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+||++ +.++.
T Consensus 67 ~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 67 NVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC
T ss_pred eEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe
Confidence 3566778899999999999 9999999986443 68999999999999999999999999999999999999 57889
Q ss_pred EEEecCCCcccccccCC--------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHH
Q 026042 79 VKVADFGISCLESQCGS--------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP---EQA 147 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 147 (244)
+||+|||++........ .....|+..|+|||.+.+..++.++|||||||++|+|++|..||.+... .+.
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence 99999999876543222 2256799999999999999999999999999999999999999987543 222
Q ss_pred HHHHHhh---CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 148 AFAVCQK---NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 148 ~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+... .........+++++.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 225 YEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 2222111 111223357789999999999999999999999999999988654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=258.06 Aligned_cols=199 Identities=28% Similarity=0.569 Sum_probs=163.7
Q ss_pred CcEEEEeecCC--cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
|++++++...+ ..++|+||+++++|.+++.+... .+++..++.++.|++.||.+||++|++|+||||+||+++.++.
T Consensus 105 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 183 (326)
T 2w1i_A 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 183 (326)
T ss_dssp CCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE
T ss_pred eeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc
Confidence 56788876544 78999999999999999987643 5899999999999999999999999999999999999999999
Q ss_pred EEEecCCCcccccccCC----CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---------
Q 026042 79 VKVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE--------- 145 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------- 145 (244)
++|+|||++........ .....++..|+|||.+.+..++.++||||||+++++|++|..|+......
T Consensus 184 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~ 263 (326)
T 2w1i_A 184 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263 (326)
T ss_dssp EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTC
T ss_pred EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcccc
Confidence 99999999876543221 23345677899999998888899999999999999999999988643111
Q ss_pred ------HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 146 ------QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 146 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
.............+.+..+++++.+++.+||+.||.+||++.++++.|+.+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111222334455667889999999999999999999999999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=251.69 Aligned_cols=189 Identities=26% Similarity=0.403 Sum_probs=158.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 68 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 145 (276)
T 2yex_A 68 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK 145 (276)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred eeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEE
Confidence 578999999999999999999999999997654 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhC
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-AVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~ 155 (244)
|+|||.+...... .......+++.|+|||.+.+..+ +.++||||||+++++|++|..||.......... ......
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 225 (276)
T 2yex_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225 (276)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC
T ss_pred EeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc
Confidence 9999998654322 22345678999999999987665 789999999999999999999998765432222 222222
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+++.+.+++.+||+.||.+|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 222333567899999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=255.45 Aligned_cols=196 Identities=27% Similarity=0.482 Sum_probs=159.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++..++..++|+||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 172 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA 172 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcE
Confidence 578999999999999999999999999997532 3368999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHH
Q 026042 80 KVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA----AFAVC 152 (244)
Q Consensus 80 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~ 152 (244)
+|+|||++....... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||........ .....
T Consensus 173 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (307)
T 2nru_A 173 KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251 (307)
T ss_dssp EECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH
T ss_pred EEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh
Confidence 999999986543322 1334568999999998865 578999999999999999999999986543221 11111
Q ss_pred h---------hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 153 Q---------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 153 ~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
. .......+..++..+.+++.+||+.+|.+||++.++++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 0 01112233445678999999999999999999999999998764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=256.04 Aligned_cols=188 Identities=21% Similarity=0.315 Sum_probs=152.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-----C
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-----E 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~-----~ 75 (244)
|++++++..++..++||||++ ++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++ .
T Consensus 96 v~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~ 172 (329)
T 3gbz_A 96 IELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE 172 (329)
T ss_dssp CCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----
T ss_pred ceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCc
Confidence 578999999999999999996 59999998876 589999999999999999999999999999999999994 4
Q ss_pred CCcEEEecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 76 DMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
++.+||+|||++...... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 556999999998754322 233445679999999999774 479999999999999999999999998887776665543
Q ss_pred hCCCCCC----------------------------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARPPV----------------------------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+.. +..+++++.+||.+||+.||.+|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 253 VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 3211110 0115789999999999999999999999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=252.28 Aligned_cols=190 Identities=25% Similarity=0.465 Sum_probs=163.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++...+..++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~k 165 (314)
T 3com_A 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAK 165 (314)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred ccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEE
Confidence 5789999999999999999999999999975432 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-CC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~ 158 (244)
|+|||.+...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||................. ..
T Consensus 166 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T 3com_A 166 LADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF 245 (314)
T ss_dssp ECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred EeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc
Confidence 9999998654432 223456789999999999988899999999999999999999999998877665544433221 22
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..++..+.+++.+||+.||.+||++.++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 334567899999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.81 Aligned_cols=188 Identities=30% Similarity=0.450 Sum_probs=158.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 122 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 199 (355)
T 1vzo_A 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199 (355)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred eEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEE
Confidence 578899999999999999999999999998765 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc--CCCCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHH
Q 026042 81 VADFGISCLESQC--GSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMT----PEQAAFAVC 152 (244)
Q Consensus 81 l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~ 152 (244)
|+|||++...... .......|++.|+|||.+.+. .++.++||||||+++|+|++|..||.... ........
T Consensus 200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~- 278 (355)
T 1vzo_A 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI- 278 (355)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH-
T ss_pred EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH-
Confidence 9999998654322 223345789999999999753 47899999999999999999999997432 22222222
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVSI 192 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~~ 192 (244)
.......+..++..+.++|.+||+.||.+|| +++++++.
T Consensus 279 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 -LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -hccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 2334566778899999999999999999999 99999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=261.43 Aligned_cols=193 Identities=16% Similarity=0.177 Sum_probs=159.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-- 75 (244)
|++++++..++..|+||||++||+|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.
T Consensus 130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGG
T ss_pred hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccc
Confidence 57899999999999999999999999999752 2346999999999999999999999999999999999999998
Q ss_pred ---------CCcEEEecCCCccccc---ccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 026042 76 ---------DMCVKVADFGISCLES---QCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMT 143 (244)
Q Consensus 76 ---------~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 143 (244)
++.+||+|||++.... .........||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 8999999999996433 2223345679999999999999999999999999999999999999986432
Q ss_pred HHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhh
Q 026042 144 PEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRR-PHFDQIVSILEGYSES 199 (244)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~el~~~l~~~~~~ 199 (244)
.... ...........++.+.+++..||+.+|.+| |+++++.+.|+.+...
T Consensus 290 ~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 290 GGEC------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TTEE------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCce------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 2110 000111112347889999999999999998 6888888888877654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=248.98 Aligned_cols=188 Identities=23% Similarity=0.389 Sum_probs=158.2
Q ss_pred CcEEEEe--ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc
Q 026042 1 MQFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC 78 (244)
Q Consensus 1 v~~~~~~--~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~ 78 (244)
+++++++ ..+...++||||+++ +|.+++.......+++..++.++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 69 IQLVDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp CCEEEEEECC---CEEEEEECCSE-EHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred eEEEEEEEcCCCCeEEEEehhccC-CHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc
Confidence 5788888 566789999999976 4888888766667999999999999999999999999999999999999999999
Q ss_pred EEEecCCCccccccc---CCCCCCCcccceeccceeccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 79 VKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
++|+|||.+...... .......++..|+|||.+.+.. .+.++||||||+++|+|++|..||...+.......+..
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 227 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK 227 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc
Confidence 999999998754322 2223556899999999987644 37899999999999999999999998877766555543
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+..+++.+.+++.+||+.||.+||+++++++
T Consensus 228 ~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 228 G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3 34566788999999999999999999999999997
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=259.98 Aligned_cols=192 Identities=28% Similarity=0.491 Sum_probs=150.0
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCccCCCCCCcEEEcCCCcEE
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---------GILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~---------~i~H~dikp~nil~~~~~~~k 80 (244)
...+++||||+++++|.+++.... .++..++.++.|++.||.|||++ |++||||||+||+++.++.+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 446789999999999999998765 48899999999999999999999 999999999999999999999
Q ss_pred EecCCCccccccc---------CCCCCCCcccceeccceecc-------CCCCCccchhhhHHHHHHHHhCCCCCCCCC-
Q 026042 81 VADFGISCLESQC---------GSAKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLWELLTALTPFDNMT- 143 (244)
Q Consensus 81 l~dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~- 143 (244)
|+|||++...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 9999998654321 12234568999999999876 345678999999999999999976653211
Q ss_pred -----------------HHHHHHHHHhhCCCCCCCCC------chHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 144 -----------------PEQAAFAVCQKNARPPVPPT------CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 144 -----------------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
.................+.. +++.+.++|.+||+.||.+|||+.|+++.|+.+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 11111222222333333333 4568999999999999999999999999999988766
Q ss_pred cCCc
Q 026042 201 EQDP 204 (244)
Q Consensus 201 ~~~~ 204 (244)
..+.
T Consensus 321 ~~~~ 324 (336)
T 3g2f_A 321 ERNK 324 (336)
T ss_dssp CC--
T ss_pred Hhcc
Confidence 5443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=250.78 Aligned_cols=191 Identities=28% Similarity=0.495 Sum_probs=160.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE-PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~ 78 (244)
|++++++...+..++|+||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++. ++.
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~ 161 (295)
T 2clq_A 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV 161 (295)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC
T ss_pred eeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC
Confidence 578999999999999999999999999998753 335678899999999999999999999999999999999988 889
Q ss_pred EEEecCCCcccccccC-CCCCCCcccceeccceeccCC--CCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHhh
Q 026042 79 VKVADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR--HTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQK 154 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~ 154 (244)
++|+|||.+....... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...... .........
T Consensus 162 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 241 (295)
T 2clq_A 162 LKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241 (295)
T ss_dssp EEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH
T ss_pred EEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc
Confidence 9999999987544322 234567899999999987653 789999999999999999999999765433 223333334
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+..+++++.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 5556677889999999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=248.59 Aligned_cols=192 Identities=26% Similarity=0.393 Sum_probs=164.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC---C
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED---M 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~---~ 77 (244)
+++++++...+..++|+||+++++|.+++.+.. .+++..++.++.|++.||.+||++|++|+||||+||+++.+ +
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~ 161 (287)
T 2wei_A 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDC 161 (287)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred cEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcc
Confidence 578999999999999999999999999998765 58999999999999999999999999999999999999764 3
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............+++.|+|||.+.+ .++.++||||||+++++|++|..||...+..+....+......
T Consensus 162 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (287)
T 2wei_A 162 DIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240 (287)
T ss_dssp CEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 699999999876655444455568999999998865 4889999999999999999999999988877766655544433
Q ss_pred CCCC--CCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 158 PPVP--PTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 158 ~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
...+ ..+++++.+++.+||+.||.+|||+.++++ ++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 3322 568899999999999999999999999998 4443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=258.71 Aligned_cols=189 Identities=23% Similarity=0.353 Sum_probs=147.8
Q ss_pred CcEEEEe-----ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAAC-----KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++ ......|+||||+. ++|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-VISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC
Confidence 4567777 34457899999996 699998876543 6899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
++.+||+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 249 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249 (362)
T ss_dssp TCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999976555555556678999999999877 67899999999999999999999999988766655544322
Q ss_pred CCCC------------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+ .....+++.+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 250 VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111 112356788999999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=256.29 Aligned_cols=189 Identities=22% Similarity=0.284 Sum_probs=159.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++...+..++|+||+++ +|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 75 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~k 152 (346)
T 1ua2_A 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL-VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK 152 (346)
T ss_dssp CCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS-SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred CeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc-CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEE
Confidence 5789999999999999999965 99999977543 588899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++...... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 153 LADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp ECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999998765432 233456789999999998654 57899999999999999999999999888776665554321111
Q ss_pred C--------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P--------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+++++.++|.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 01456789999999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=249.69 Aligned_cols=184 Identities=23% Similarity=0.372 Sum_probs=154.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED-- 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~-- 76 (244)
|++++++..++..++|+||++|++|.+++.+.. ...+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 74 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~ 153 (289)
T 1x8b_A 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSI 153 (289)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----
T ss_pred eeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCC
Confidence 578999999999999999999999999997642 1368999999999999999999999999999999999999844
Q ss_pred -----------------CcEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCC
Q 026042 77 -----------------MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTP 138 (244)
Q Consensus 77 -----------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p 138 (244)
..++|+|||.+..... .....+++.|+|||.+.+. .++.++||||||+++++|++|..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred CcccccccccccccCCceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 4799999999876543 2334689999999999766 566899999999999999999877
Q ss_pred CCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 139 FDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+...... ...........+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 231 PRNGDQW----HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CSSSHHH----HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcchhHH----HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 6543221 222344556677889999999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=256.43 Aligned_cols=196 Identities=30% Similarity=0.562 Sum_probs=160.2
Q ss_pred CcEEEEeecCC----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccCCCCC
Q 026042 1 MQFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--------SQGILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH--------~~~i~H~dikp 68 (244)
+++++++.... ..++|+||+++++|.+++.+. .+++..++.++.|++.||.||| +.|++||||||
T Consensus 99 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp 175 (342)
T 1b6c_B 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175 (342)
T ss_dssp CCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSG
T ss_pred EEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCH
Confidence 57889988876 899999999999999999864 4899999999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccC-----CCCCCCcccceeccceeccCC------CCCccchhhhHHHHHHHHhC--
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTA-- 135 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g-- 135 (244)
+||+++.++.+||+|||++....... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~ 255 (342)
T 1b6c_B 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255 (342)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence 99999999999999999987654332 234557899999999987653 33689999999999999999
Q ss_pred --------CCCCCCCC-----HHHHHHHHHhhCCCCCCCC-----CchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 136 --------LTPFDNMT-----PEQAAFAVCQKNARPPVPP-----TCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 136 --------~~p~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
..||.... .................+. .+++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 256 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 78886542 2233333323333333332 34568999999999999999999999999999886
Q ss_pred hh
Q 026042 198 ES 199 (244)
Q Consensus 198 ~~ 199 (244)
..
T Consensus 336 ~~ 337 (342)
T 1b6c_B 336 QQ 337 (342)
T ss_dssp HT
T ss_pred HH
Confidence 64
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=258.07 Aligned_cols=189 Identities=25% Similarity=0.392 Sum_probs=155.1
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcEEEecC
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADF 84 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~-~~~~~kl~df 84 (244)
....+.++||||++ ++|.+.+.. ..+..+++..++.++.||+.||.|||++|++||||||+||+++ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Df 186 (383)
T 3eb0_A 108 SQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186 (383)
T ss_dssp --CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEEC
Confidence 34455899999996 588888764 2334689999999999999999999999999999999999998 5889999999
Q ss_pred CCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC-----
Q 026042 85 GISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP----- 158 (244)
Q Consensus 85 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 158 (244)
|++.............+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+....+......+
T Consensus 187 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp TTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 999876655566677889999999998765 48999999999999999999999999888776655554321111
Q ss_pred ----------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 026042 159 ----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYS 197 (244)
Q Consensus 159 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~ 197 (244)
..+..+++++.+|+.+||+.||.+|||+.|+++ +++.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 267 IRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred HHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 134557889999999999999999999999996 454443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=258.04 Aligned_cols=190 Identities=24% Similarity=0.367 Sum_probs=135.0
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
+++++++.. +...++||||++|++|.+++.+..+..+++..++.++.|++.||.|||++|++||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~ 164 (336)
T 3fhr_A 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK 164 (336)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS
T ss_pred HHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec
Confidence 467788766 5668999999999999999998776679999999999999999999999999999999999999864
Q ss_pred ---CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Q 026042 77 ---MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC- 152 (244)
Q Consensus 77 ---~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 152 (244)
+.+||+|||++..... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 165 ~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 243 (336)
T 3fhr_A 165 EKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR 243 (336)
T ss_dssp STTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred CCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence 4599999999875443 23345678999999999988888999999999999999999999997665443321111
Q ss_pred ---hh--CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 ---QK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ---~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. .........+++.+.+++.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 244 RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 1112223578999999999999999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.03 Aligned_cols=185 Identities=23% Similarity=0.421 Sum_probs=155.7
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++.... .+|+||||+ +++|.++++.. .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 87 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 87 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162 (367)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred CCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc
Confidence 46778877653 469999999 88999999873 489999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.++.+||+|||++..... ......+++.|+|||.+.+ ..++.++||||+||++++|++|+.||.+.+..+....+..
T Consensus 163 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 163 EDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp TTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999876543 2345678999999999877 6789999999999999999999999998876655544432
Q ss_pred hCCCC-----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARP-----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+ ......++.+.+|+.+||+.||.+|||++++++
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 21111 123456899999999999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=273.41 Aligned_cols=195 Identities=30% Similarity=0.633 Sum_probs=166.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.. +..++||||+++++|.++++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 454 v~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vk 531 (656)
T 2j0j_A 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 531 (656)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred CeEEEEEec-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEE
Confidence 578899854 56889999999999999998654 3589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+....+. ....
T Consensus 532 L~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~ 610 (656)
T 2j0j_A 532 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGER 610 (656)
T ss_dssp ECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCC
T ss_pred EEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 999999876543222 223446789999999988899999999999999999997 999999988777665554 3445
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++.+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 66778899999999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=264.58 Aligned_cols=188 Identities=22% Similarity=0.354 Sum_probs=146.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++.. +..|+||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++
T Consensus 203 v~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 203 IKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp CCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSC
T ss_pred eeEEEEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcc
Confidence 567888765 45789999999999999988765 689999999999999999999999999999999999997654
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceecc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.+||+|||++.............|++.|+|||.+.+ ..++.++||||||+++|+|++|..||...............
T Consensus 280 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 280 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp CEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred eEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 599999999987665555566789999999999853 56788999999999999999999999865433222222222
Q ss_pred CCCCC---CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..... ....+++.+.+++.+||+.||.+||+++++++
T Consensus 360 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22221 12467899999999999999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=253.64 Aligned_cols=188 Identities=22% Similarity=0.340 Sum_probs=156.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE-------
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL------- 73 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~------- 73 (244)
+.+++++...+..++||||+ +++|.+++.......+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 46788999999999999999 7788888877665579999999999999999999999999999999999999
Q ss_pred ------------cCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCC
Q 026042 74 ------------GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDN 141 (244)
Q Consensus 74 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 141 (244)
+.++.+||+|||++..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 5678899999999875433 23456789999999999988999999999999999999999999998
Q ss_pred CCHHHHHHHHHhhCCCC------------------------------------------CCCCCchHHHHHHHHHhcccC
Q 026042 142 MTPEQAAFAVCQKNARP------------------------------------------PVPPTCPKAFSYLISRCWSSS 179 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~l~~li~~~l~~~ 179 (244)
.+..+....+....... ......+..+.+|+.+||+.|
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence 77665444332211110 011223568999999999999
Q ss_pred CCCCCCHHHHHH
Q 026042 180 PDRRPHFDQIVS 191 (244)
Q Consensus 180 p~~Rps~~el~~ 191 (244)
|.+|||+.|+++
T Consensus 322 P~~Rpt~~e~l~ 333 (355)
T 2eu9_A 322 PAQRITLAEALL 333 (355)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCcCHHHHhc
Confidence 999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=255.81 Aligned_cols=189 Identities=23% Similarity=0.401 Sum_probs=154.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 87 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~k 164 (331)
T 4aaa_A 87 VNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVK 164 (331)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred eeEEEEeecCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEE
Confidence 578999999999999999999988888876655 589999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC-
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR- 157 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 157 (244)
|+|||++...... .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+..+....+......
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (331)
T 4aaa_A 165 LCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244 (331)
T ss_dssp ECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred EEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 9999998654332 233456789999999998775 6899999999999999999999999988776655444321110
Q ss_pred -------------------CC---------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -------------------PP---------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -------------------~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ..+.+++.+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 11356899999999999999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=250.73 Aligned_cols=191 Identities=28% Similarity=0.541 Sum_probs=156.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQ------EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~------~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
+++++++..++..++|+||++|++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 155 (303)
T 2vwi_A 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG 155 (303)
T ss_dssp CCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred eeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc
Confidence 57899999999999999999999999999741 223589999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCccccccc------CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH
Q 026042 75 EDMCVKVADFGISCLESQC------GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 147 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 147 (244)
.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........
T Consensus 156 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 235 (303)
T 2vwi_A 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235 (303)
T ss_dssp TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence 9999999999987644321 12234568999999999866 5689999999999999999999999988776555
Q ss_pred HHHHHhhCCC--------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 148 AFAVCQKNAR--------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 148 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......... ......++..+.+++.+||+.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 4433322211 1223567899999999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=252.20 Aligned_cols=193 Identities=24% Similarity=0.434 Sum_probs=161.4
Q ss_pred CcEEEEe--ecCCcEEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCcE
Q 026042 1 MQFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQE--PYSVPLNLVLKLALDIARGMQYLHSQG-----ILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~--~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~l~~~L~~lH~~~-----i~H~dikp~ni 71 (244)
|++++++ ..+...++|+||+++++|.+++.... ...+++..++.++.|++.||+|||++| ++|+||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NI 147 (279)
T 2w5a_A 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 147 (279)
T ss_dssp CCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGE
T ss_pred CeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhE
Confidence 5788877 45788999999999999999997632 335899999999999999999999999 99999999999
Q ss_pred EEcCCCcEEEecCCCcccccccCC-CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
+++.++.+||+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+..+....
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 227 (279)
T 2w5a_A 148 FLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 227 (279)
T ss_dssp EECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH
Confidence 999999999999999865433211 1234578999999999988899999999999999999999999998887665555
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
+. .......+..++.++.+++.+||+.||.+||+++++++.+.
T Consensus 228 i~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IR-EGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred Hh-hcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 44 34445677789999999999999999999999999998543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=264.92 Aligned_cols=186 Identities=20% Similarity=0.306 Sum_probs=148.3
Q ss_pred CcEEEEeecC------CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKP------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++... ...|+||||+++ +|.+.+.. .+++..++.++.|++.||+|||++||+||||||+||+++
T Consensus 124 v~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 198 (464)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe
Confidence 5677888655 457999999954 67777754 378999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.++.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 199 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999998766555556678999999999999999999999999999999999999999988766655544332
Q ss_pred CCCC--------------------CCC---------CC-----------chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP--------------------PVP---------PT-----------CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~--------------------~~~---------~~-----------~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+ ... .. .++++.+|+.+||..||.+|||++|+++
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111 000 00 1567899999999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=250.63 Aligned_cols=190 Identities=24% Similarity=0.468 Sum_probs=158.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++..++..++|+||+++++|.+++..... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 157 (302)
T 2j7t_A 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIR 157 (302)
T ss_dssp CCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEE
T ss_pred eeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEE
Confidence 5789999999999999999999999999876443 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceecccee-----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMI-----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++..... ........++..|+|||.+ .+..++.++||||||+++|+|++|..||...+...........
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (302)
T 2j7t_A 158 LADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237 (302)
T ss_dssp ECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence 999998753221 1223445789999999988 4567889999999999999999999999988877665555433
Q ss_pred CCC-CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NAR-PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ...+..++..+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 322 2345678899999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=260.45 Aligned_cols=188 Identities=24% Similarity=0.352 Sum_probs=144.2
Q ss_pred CcEEEEe-----ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAAC-----KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++ ......|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 115 v~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~ 191 (458)
T 3rp9_A 115 VKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191 (458)
T ss_dssp CCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC
Confidence 5788888 4446799999998 679999998765 6899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccC----------------------------CCCCCCcccceecccee-ccCCCCCccchhhhH
Q 026042 76 DMCVKVADFGISCLESQCG----------------------------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFG 126 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG 126 (244)
++.+||+|||+++...... .....+||+.|+|||++ .+..++.++||||||
T Consensus 192 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG 271 (458)
T 3rp9_A 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271 (458)
T ss_dssp TCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred CCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHH
Confidence 9999999999997643211 12345679999999976 556789999999999
Q ss_pred HHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHhhCCC------------------
Q 026042 127 IVLWELLT-----------ALTPFDNMTP--------------------EQAAFAVCQKNAR------------------ 157 (244)
Q Consensus 127 ~~l~~l~~-----------g~~p~~~~~~--------------------~~~~~~~~~~~~~------------------ 157 (244)
|++|+|++ |..+|.+.+. .+....+......
T Consensus 272 ~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 351 (458)
T 3rp9_A 272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351 (458)
T ss_dssp HHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHH
T ss_pred HHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHH
Confidence 99999998 6666655331 0111111000000
Q ss_pred -----------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -----------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+..++++.+||.+||..||.+|||++|+++
T Consensus 352 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp TTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0112456889999999999999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=253.25 Aligned_cols=196 Identities=27% Similarity=0.382 Sum_probs=143.2
Q ss_pred CcEEEEe--------ecCCcEEEEEeccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCC
Q 026042 1 MQFVAAC--------KKPPVFCIITEYLAGGSLRKYLHQQ-EPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSE 69 (244)
Q Consensus 1 v~~~~~~--------~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~ 69 (244)
|++++++ .....+++|+||+ +|+|.+++... ....+++..++.++.|++.||.|||++| ++||||||+
T Consensus 89 v~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~ 167 (337)
T 3ll6_A 89 VQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167 (337)
T ss_dssp CCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGG
T ss_pred hhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcc
Confidence 4677887 4555689999999 57999998752 2336899999999999999999999999 999999999
Q ss_pred cEEEcCCCcEEEecCCCcccccccCC-------------CCCCCcccceecccee---ccCCCCCccchhhhHHHHHHHH
Q 026042 70 NLLLGEDMCVKVADFGISCLESQCGS-------------AKGFTGTYRWMAPEMI---KEKRHTKKVDVYSFGIVLWELL 133 (244)
Q Consensus 70 nil~~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~ 133 (244)
||+++.++.+||+|||++........ .....+++.|+|||.+ .+..++.++||||||+++|+|+
T Consensus 168 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp GCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred cEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 99999999999999999876443221 1144589999999998 5567889999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 134 TALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 134 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
+|..||........ ............++..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 248 ~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 248 FRQHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp HSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hCCCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 99999976544322 22333344556677889999999999999999999999999998876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.22 Aligned_cols=190 Identities=23% Similarity=0.342 Sum_probs=155.0
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
|++++++...+ ..++||||+++ ++.+.+.. .....+++..++.++.|++.||+|||++|++||||||+||+
T Consensus 95 v~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil 173 (394)
T 4e7w_A 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173 (394)
T ss_dssp CCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEE
Confidence 56788884443 38899999966 55554432 22336899999999999999999999999999999999999
Q ss_pred Ec-CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 73 LG-EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 73 ~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++ .++.+||+|||++.............+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+....
T Consensus 174 l~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~ 253 (394)
T 4e7w_A 174 LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253 (394)
T ss_dssp EETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99 7899999999999876555556677889999999998664 589999999999999999999999998887665554
Q ss_pred HHhhCCCC---------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNARP---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+......+ ..+..+++++.+|+.+||+.||.+|||+.|+++
T Consensus 254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 44321110 123457889999999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=256.73 Aligned_cols=188 Identities=24% Similarity=0.396 Sum_probs=159.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKY------LHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~------i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~ 73 (244)
+++++++...+..++||||+++++|.++ +.+.....+++..++.++.|++.||.|||+ +|++|+||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 5788999999999999999999999999 666444579999999999999999999999 999999999999999
Q ss_pred cCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCC-ccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHH
Q 026042 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTK-KVDVYSFGIVLWELLTALTPFDNMTP-EQAAFA 150 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~ 150 (244)
+.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++||||||+++++|++|..||..... .+....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99999999999998764332 34456789999999999877 5555 99999999999999999999988765 444443
Q ss_pred HHhhCCCCCCC-------------------CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNARPPVP-------------------PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+.... ...+ ..++..+.+++.+||+.||.+||++.++++
T Consensus 265 i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 265 IRTKN--IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HTSCC--CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccC--cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 33222 2222 568899999999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=256.65 Aligned_cols=188 Identities=25% Similarity=0.357 Sum_probs=156.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCCcEEEc--CC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH--SQGILHRDLKSENLLLG--ED 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH--~~~i~H~dikp~nil~~--~~ 76 (244)
|++++++...+..++||||++ ++|.+++.......+++..++.++.|++.||.||| +.||+||||||+||+++ .+
T Consensus 119 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 119 VHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp CCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred EEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 568899999999999999995 59999998876556899999999999999999999 57999999999999995 47
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
+.+||+|||++..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 198 ~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp CCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 7899999999876543 23456789999999999999999999999999999999999999998887766555443211
Q ss_pred CCC----------------------------------CCC----------------------------CchHHHHHHHHH
Q 026042 157 RPP----------------------------------VPP----------------------------TCPKAFSYLISR 174 (244)
Q Consensus 157 ~~~----------------------------------~~~----------------------------~~~~~l~~li~~ 174 (244)
.++ .++ ...+++.+||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 100 000 011478999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 026042 175 CWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 175 ~l~~~p~~Rps~~el~~ 191 (244)
||+.||.+|||++|+++
T Consensus 356 mL~~dP~~Rpta~e~L~ 372 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQ 372 (382)
T ss_dssp HTCSCTTTSCCHHHHTT
T ss_pred hcCCChhhCCCHHHHhc
Confidence 99999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=257.34 Aligned_cols=188 Identities=24% Similarity=0.364 Sum_probs=145.0
Q ss_pred CcEEEEeecC-----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKP-----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++... ...|+||||+ +++|.++++... .+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus 88 v~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~ 164 (432)
T 3n9x_A 88 IRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ 164 (432)
T ss_dssp CCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred ceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC
Confidence 5788888766 6799999999 469999998765 6899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccC-----------------------CCCCCCcccceecccee-ccCCCCCccchhhhHHHHHH
Q 026042 76 DMCVKVADFGISCLESQCG-----------------------SAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWE 131 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~ 131 (244)
++.+||+|||+++...... ......||+.|+|||++ ....++.++|||||||++|+
T Consensus 165 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e 244 (432)
T 3n9x_A 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244 (432)
T ss_dssp TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence 9999999999997644321 12456789999999986 55678999999999999999
Q ss_pred HHhCCCC-----------CCCCCH-----------------HHHHHHH------------------------HhhCCCCC
Q 026042 132 LLTALTP-----------FDNMTP-----------------EQAAFAV------------------------CQKNARPP 159 (244)
Q Consensus 132 l~~g~~p-----------~~~~~~-----------------~~~~~~~------------------------~~~~~~~~ 159 (244)
|++|..| |.+.+. .+....+ ........
T Consensus 245 ll~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (432)
T 3n9x_A 245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324 (432)
T ss_dssp HHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred HHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC
Confidence 9985443 333220 0111111 00011111
Q ss_pred C-----CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 160 V-----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 160 ~-----~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .+.+++++.+||.+||+.||.+|||++|+++
T Consensus 325 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1457899999999999999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=254.78 Aligned_cols=197 Identities=24% Similarity=0.400 Sum_probs=156.2
Q ss_pred CcEEEEee----cCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACK----KPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~----~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++. .....++|+||+++++|.+++... .+..+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 89 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~ 168 (317)
T 2buj_A 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG 168 (317)
T ss_dssp CCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred eeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc
Confidence 46777775 456889999999999999999763 234689999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCC----------CCCCCcccceeccceeccCC---CCCccchhhhHHHHHHHHhCCCCCCC
Q 026042 75 EDMCVKVADFGISCLESQCGS----------AKGFTGTYRWMAPEMIKEKR---HTKKVDVYSFGIVLWELLTALTPFDN 141 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~ 141 (244)
.++.++|+|||.+........ .....|++.|+|||.+.+.. ++.++||||||+++|+|++|..||..
T Consensus 169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 999999999998764322111 01234689999999987554 68899999999999999999999953
Q ss_pred CCHH-HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 142 MTPE-QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 142 ~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
.... .............+....++..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 249 VFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 2111 0111122223334455678999999999999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=251.63 Aligned_cols=189 Identities=20% Similarity=0.304 Sum_probs=153.8
Q ss_pred CcEEEEeec--------CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKK--------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
|++++++.. ++..++||||++ ++|.+.+..... .+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 79 v~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl 156 (351)
T 3mi9_A 79 VNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 156 (351)
T ss_dssp CCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEE
Confidence 467788776 557899999996 588888876543 5899999999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCccccccc-----CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 73 LGEDMCVKVADFGISCLESQC-----GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
++.++.+||+|||++...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+...
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 236 (351)
T 3mi9_A 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236 (351)
T ss_dssp ECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999998654321 22344568999999998876 457999999999999999999999999988776
Q ss_pred HHHHHHhhCCCCC--CCCC----------------------------chHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 147 AAFAVCQKNARPP--VPPT----------------------------CPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 147 ~~~~~~~~~~~~~--~~~~----------------------------~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+........ ..+. .++.+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 6655543222111 1111 1567899999999999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=266.23 Aligned_cols=198 Identities=20% Similarity=0.340 Sum_probs=160.7
Q ss_pred CcEEEEeecCC--cEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE----
Q 026042 1 MQFVAACKKPP--VFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL---- 73 (244)
Q Consensus 1 v~~~~~~~~~~--~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~---- 73 (244)
|++++++...+ ..++||||++|++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 70 v~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 149 (396)
T 4eut_A 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149 (396)
T ss_dssp CCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT
T ss_pred CeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC
Confidence 57888887655 78999999999999999986542 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEecCCCcccccccCCCCCCCcccceeccceecc--------CCCCCccchhhhHHHHHHHHhCCCCCCCCC--
Q 026042 74 GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE--------KRHTKKVDVYSFGIVLWELLTALTPFDNMT-- 143 (244)
Q Consensus 74 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-- 143 (244)
+.++.+||+|||++.............|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 150 ~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~ 229 (396)
T 4eut_A 150 DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229 (396)
T ss_dssp TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 7778899999999977655555556779999999998865 456789999999999999999999996432
Q ss_pred --HHHHHHHHHhhCCCC-----------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 144 --PEQAAFAVCQKNARP-----------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 144 --~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+....+....... .....++..+.+++.+||+.||.+||+++++++.+..+..
T Consensus 230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 233333333222110 1113356788999999999999999999999998887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=253.05 Aligned_cols=177 Identities=26% Similarity=0.438 Sum_probs=140.9
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPY-SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
..++||||++|++|.+++.+.... ..++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 489999999999999999875432 3556678999999999999999999999999999999999999999999998765
Q ss_pred ccc-------------CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 91 SQC-------------GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 91 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|..|+.. .............
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~ 291 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKF 291 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCC
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCC
Confidence 432 123345799999999999998999999999999999999998666421 1111111112222
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+......++.+.+++.+||+.||.+||+++|+++
T Consensus 292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 2222345678899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=246.97 Aligned_cols=187 Identities=22% Similarity=0.362 Sum_probs=153.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++|||+. +++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||++++ +.+|
T Consensus 91 v~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 91 IRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp CCEEEEEECSSEEEEEECCC-SEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEE
T ss_pred EEEEEEeecCCEEEEEEecC-CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEE
Confidence 57899999999999999954 889999998865 6889999999999999999999999999999999999965 8999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceecc-----------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKE-----------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPE- 145 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~- 145 (244)
|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 99999987654322 1234568999999999865 46788999999999999999999999876433
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...............+...+..+.+++.+||+.||.+||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 3333344444455667778899999999999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=256.38 Aligned_cols=189 Identities=21% Similarity=0.312 Sum_probs=146.7
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++...+ ..|+||||++ ++|.+++.. .+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 87 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 87 IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 161 (371)
T ss_dssp CCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred cceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 57888887665 7899999995 589998863 478999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.++.+||+|||++.............|++.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 241 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 241 (371)
T ss_dssp TTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred CCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999997665544455667899999999999989999999999999999999999999988776655544322
Q ss_pred CCCC--------------------CC--------------CC------CchHHHHHHHHHhcccCCCCCCCHHHHHH--H
Q 026042 155 NARP--------------------PV--------------PP------TCPKAFSYLISRCWSSSPDRRPHFDQIVS--I 192 (244)
Q Consensus 155 ~~~~--------------------~~--------------~~------~~~~~l~~li~~~l~~~p~~Rps~~el~~--~ 192 (244)
...+ .. +. ..+..+.+|+.+||+.||.+|||++|+++ +
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 1111 00 00 12568999999999999999999999998 4
Q ss_pred HH
Q 026042 193 LE 194 (244)
Q Consensus 193 l~ 194 (244)
++
T Consensus 322 ~~ 323 (371)
T 2xrw_A 322 IN 323 (371)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.39 Aligned_cols=190 Identities=23% Similarity=0.309 Sum_probs=153.1
Q ss_pred CcEEEEeec------CCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKK------PPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
|++++++.. ..++++|+||+++ +|.+.+.. .....+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 110 v~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIL 188 (420)
T 1j1b_A 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188 (420)
T ss_dssp CCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEE
T ss_pred cceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEE
Confidence 467777732 2347799999965 78777653 23346899999999999999999999999999999999999
Q ss_pred EcCC-CcEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 73 LGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 73 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++.+ +.+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 189 l~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~ 268 (420)
T 1j1b_A 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268 (420)
T ss_dssp EETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9965 67899999999866554455567889999999998764 789999999999999999999999998876655544
Q ss_pred HHhhCCC---------------CC------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNAR---------------PP------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~---------------~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+...... .. .+...++++.+||.+||+.||.+||++.|+++
T Consensus 269 i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 4331110 00 23456889999999999999999999999996
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=248.67 Aligned_cols=186 Identities=13% Similarity=0.235 Sum_probs=152.9
Q ss_pred CcEEEEeec--CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM- 77 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~- 77 (244)
+++++++.. ....++||||+.+++|.++++. +++..++.++.|++.||+|||++|++||||||+||+++.++
T Consensus 94 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~ 168 (330)
T 3nsz_A 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 168 (330)
T ss_dssp CCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred EEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC
Confidence 578888887 7789999999999999999863 78899999999999999999999999999999999999776
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHh--
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT-PEQAAFAVCQ-- 153 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~-- 153 (244)
.+||+|||++.............++..|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..+....+..
T Consensus 169 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~ 248 (330)
T 3nsz_A 169 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 248 (330)
T ss_dssp EEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred EEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence 899999999976655555566789999999999877 668999999999999999999999995432 2222111110
Q ss_pred ----------hC-----------------------CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 ----------KN-----------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ----------~~-----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ........+++++.+||.+||+.||.+|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 001112236899999999999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=253.53 Aligned_cols=188 Identities=22% Similarity=0.355 Sum_probs=152.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCc--
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMC-- 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~-- 78 (244)
|++++++..++ .|+|+||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 78 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp CCEEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSC
T ss_pred ceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCC
Confidence 57888887765 899999999999999998755 6899999999999999999999999999999999999987664
Q ss_pred -EEEecCCCcccccccCCCCCCCcccceeccceec---cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 79 -VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK---EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 79 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
+||+|||++.............|++.|+|||.+. ...++.++||||||+++|+|++|..||...............
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp CEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred eEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 9999999987654332223456899999999874 456789999999999999999999999765433222222222
Q ss_pred CCCCC---CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPP---VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..... ....+++.+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 22111 22567899999999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=250.72 Aligned_cols=187 Identities=21% Similarity=0.333 Sum_probs=152.2
Q ss_pred CcEEEEeecC-----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKP-----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++... ...++|+||+. ++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 72 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~ 147 (353)
T 2b9h_A 72 ITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS 147 (353)
T ss_dssp CCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC
Confidence 4677777654 78999999995 6999999874 4899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCC-----------CCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Q 026042 76 DMCVKVADFGISCLESQCGS-----------AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMT 143 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~-----------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 143 (244)
++.+||+|||++........ .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp TCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999875432211 223468999999998754 678999999999999999999999999887
Q ss_pred HHHHHHHHHhhCCCC------------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 144 PEQAAFAVCQKNARP------------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 144 ~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......+......+ .....+++++.+++.+||+.||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 665444332211110 011467889999999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=257.21 Aligned_cols=188 Identities=22% Similarity=0.348 Sum_probs=151.8
Q ss_pred CcEEEEee----cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcC
Q 026042 1 MQFVAACK----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~ 75 (244)
|++++++. .+...++||||+ +++|.+++.+.....+++..++.++.||+.||.|||++ |++||||||+||+++.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 46788887 677899999999 67888888766545799999999999999999999998 9999999999999987
Q ss_pred CC-------------------------------------------------cEEEecCCCcccccccCCCCCCCccccee
Q 026042 76 DM-------------------------------------------------CVKVADFGISCLESQCGSAKGFTGTYRWM 106 (244)
Q Consensus 76 ~~-------------------------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~ 106 (244)
++ .+||+|||++...... .....||+.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~ 260 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYR 260 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGC
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCccc
Confidence 75 7999999998765432 34457899999
Q ss_pred ccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhhCCC-----------------------
Q 026042 107 APEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP------EQAAFAVCQKNAR----------------------- 157 (244)
Q Consensus 107 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~----------------------- 157 (244)
|||++.+..++.++|||||||++|+|++|..||...+. ......+......
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999998999999999999999999999999976542 1222111111000
Q ss_pred -----------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -----------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+...+..+.+||.+||+.||.+|||++|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0112334577899999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=247.27 Aligned_cols=193 Identities=25% Similarity=0.449 Sum_probs=148.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~ 79 (244)
+++++++..++..++||||+ ++.+..+..... ..+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 87 VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp CCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCE
T ss_pred eeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCE
Confidence 57899999999999999999 666766665433 2689999999999999999999995 99999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHHh
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAVCQ 153 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~ 153 (244)
||+|||++.............+++.|+|||.+. ...++.++||||||+++|+|++|..||...... .......
T Consensus 165 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~- 243 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL- 243 (318)
T ss_dssp EECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-
T ss_pred EEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-
Confidence 999999987655544455567899999999984 456788999999999999999999999875433 3333332
Q ss_pred hCCCCCC--CCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 154 KNARPPV--PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 154 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
....... ...+++++.+++.+||+.||.+||+++++++ +++..
T Consensus 244 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 3322222 3468999999999999999999999999997 44443
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.42 Aligned_cols=190 Identities=25% Similarity=0.409 Sum_probs=135.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQ---QEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~ 76 (244)
|++++++..++..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||++ |++||||||+||+++.+
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~ 162 (327)
T 3aln_A 84 VQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS 162 (327)
T ss_dssp CCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT
T ss_pred eeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC
Confidence 5789999999999999999964 88888763 2234689999999999999999999999 99999999999999999
Q ss_pred CcEEEecCCCcccccccCCCCCCCcccceecccee----ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 77 MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI----KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
+.+||+|||++.............|++.|+|||.+ .+..++.++||||||+++|+|++|..||.............
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 242 (327)
T 3aln_A 163 GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242 (327)
T ss_dssp TEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC
T ss_pred CCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH
Confidence 99999999999766554444455789999999998 45668999999999999999999999998754322111111
Q ss_pred hhCCCCCC----CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPPV----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........ ...+++.+.+++.+||+.||.+||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111 2457899999999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=249.39 Aligned_cols=190 Identities=21% Similarity=0.280 Sum_probs=155.5
Q ss_pred CcEEEEeecCCc-------EEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCccCCCCCC
Q 026042 1 MQFVAACKKPPV-------FCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLH--SQGILHRDLKSE 69 (244)
Q Consensus 1 v~~~~~~~~~~~-------~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH--~~~i~H~dikp~ 69 (244)
|++++++...+. .++||||+++ +|.+.+.. .....+++..++.++.|++.||.||| ++|++||||||+
T Consensus 82 v~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~ 160 (360)
T 3e3p_A 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPH 160 (360)
T ss_dssp CCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGG
T ss_pred ccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHH
Confidence 567888865443 8999999965 66665543 23336889999999999999999999 999999999999
Q ss_pred cEEEcC-CCcEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH
Q 026042 70 NLLLGE-DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA 147 (244)
Q Consensus 70 nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 147 (244)
||+++. ++.+||+|||++.............|++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.+....
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence 999997 899999999999876665556667889999999998665 489999999999999999999999998887766
Q ss_pred HHHHHhhCCC------------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 148 AFAVCQKNAR------------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 148 ~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+...... .......++++.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 6555432111 1122336789999999999999999999999997
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=264.13 Aligned_cols=176 Identities=15% Similarity=0.150 Sum_probs=141.2
Q ss_pred EEEEEeccCCCCHHHHHhhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 13 FCIITEYLAGGSLRKYLHQQEPY-----SVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 13 ~~lv~e~~~~~~L~~~i~~~~~~-----~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
.|+||||+ +|+|.+++.+.... .+++..++.++.|++.||+|||++|++||||||+||+++.+|.+||+|||++
T Consensus 175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a 253 (377)
T 3byv_A 175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253 (377)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhh
Confidence 89999999 67999999875421 1224778889999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCcccceeccceeccC-----------CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 88 CLESQCGSAKGFTGTYRWMAPEMIKEK-----------RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 88 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
..... ......| +.|+|||.+.+. .++.++||||||+++|+|++|..||...+.......
T Consensus 254 ~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~------ 324 (377)
T 3byv_A 254 VRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW------ 324 (377)
T ss_dssp EETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG------
T ss_pred eecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh------
Confidence 75333 2334567 999999999887 789999999999999999999999976543322111
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~~~ 198 (244)
.......+++++.+++.+||+.||.+||++.++++ +++.+..
T Consensus 325 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 325 IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 11233678899999999999999999999999997 5555443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=248.02 Aligned_cols=180 Identities=24% Similarity=0.447 Sum_probs=155.7
Q ss_pred CcEEEEeecCCcEEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~-~~~~ 78 (244)
+++++++..++..++|+|++.+ ++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++ .++.
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC
Confidence 5789999999999999999976 89999998765 589999999999999999999999999999999999999 6889
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
+||+|||++...... ......|++.|+|||.+.+... +.++||||||+++|+|++|..||..... . ....
T Consensus 189 ~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~--~~~~ 259 (320)
T 3a99_A 189 LKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I--IRGQ 259 (320)
T ss_dssp EEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H--HHCC
T ss_pred EEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------h--hccc
Confidence 999999998765432 3345578999999999877665 6889999999999999999999975321 1 1223
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+++++.+++.+||+.||.+||+++++++
T Consensus 260 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4456778999999999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=250.85 Aligned_cols=184 Identities=23% Similarity=0.398 Sum_probs=150.7
Q ss_pred CcEEEEeecCCcE------EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPPVF------CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~~~------~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++...+.. ++|+||+. ++|.+++.. .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 104 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 178 (371)
T 4exu_A 104 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 178 (371)
T ss_dssp CCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred hhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC
Confidence 4678888877765 99999995 699888743 489999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.++.+||+|||++..... ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+.+..+....+..
T Consensus 179 ~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 179 EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp TTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999999875443 2345578999999999877 6789999999999999999999999998876665554433
Q ss_pred hCCCC-----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARP-----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+ .....+++.+.+||.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 257 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11111 112456899999999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=252.94 Aligned_cols=185 Identities=25% Similarity=0.381 Sum_probs=140.4
Q ss_pred CcEEEEeecC------CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKP------PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++... ...|+|+|++ +++|.++++.. .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 91 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 166 (367)
T 2fst_X 91 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN 166 (367)
T ss_dssp CCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred CcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC
Confidence 4567777554 6689999999 78999999763 589999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.++.+||+|||++..... ......+++.|+|||.+.+ ..++.++|||||||++++|++|..||.+.+..+....+..
T Consensus 167 ~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 167 EDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp TTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999876443 2344578999999999877 6789999999999999999999999998877655544432
Q ss_pred hCCCC---------------------C--------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNARP---------------------P--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~~---------------------~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+ . .....++.+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11110 0 11345788999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=251.79 Aligned_cols=187 Identities=25% Similarity=0.396 Sum_probs=152.8
Q ss_pred CcEEEEeecC-----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKP-----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++... ...|+|+||+. ++|.++++.. .+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 88 v~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 163 (364)
T 3qyz_A 88 IGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163 (364)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred ccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC
Confidence 4667777655 47899999995 5999999764 4899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCC----CCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 76 DMCVKVADFGISCLESQCGS----AKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++.+||+|||++........ .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....
T Consensus 164 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 243 (364)
T 3qyz_A 164 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 243 (364)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred CCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence 99999999999875543221 244578999999998654 4589999999999999999999999988765554443
Q ss_pred HHhhCCCC-----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNARP-----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+......+ .....+++++.+|+.+||+.||.+|||+.|+++
T Consensus 244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 32211110 012456889999999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=253.28 Aligned_cols=190 Identities=23% Similarity=0.340 Sum_probs=142.1
Q ss_pred CcEEEEe--ecCCcEEEEEeccCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcE
Q 026042 1 MQFVAAC--KKPPVFCIITEYLAGGSLRKYLHQQE-------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~--~~~~~~~lv~e~~~~~~L~~~i~~~~-------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ni 71 (244)
|++++++ ..+...|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 81 v~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NI 159 (405)
T 3rgf_A 81 ISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANI 159 (405)
T ss_dssp CCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred eeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHe
Confidence 5678888 45889999999995 59998886321 22489999999999999999999999999999999999
Q ss_pred EE----cCCCcEEEecCCCccccccc----CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCC
Q 026042 72 LL----GEDMCVKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNM 142 (244)
Q Consensus 72 l~----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~ 142 (244)
++ +.++.+||+|||++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 160 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 160 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99 67789999999999765432 223456789999999998774 5899999999999999999999999765
Q ss_pred CHH---------HHHHHHHhhCCCCC------------------------------------CCCCchHHHHHHHHHhcc
Q 026042 143 TPE---------QAAFAVCQKNARPP------------------------------------VPPTCPKAFSYLISRCWS 177 (244)
Q Consensus 143 ~~~---------~~~~~~~~~~~~~~------------------------------------~~~~~~~~l~~li~~~l~ 177 (244)
... +....+......+. .....++.+.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~ 319 (405)
T 3rgf_A 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319 (405)
T ss_dssp C------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSC
T ss_pred cccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHcc
Confidence 432 12222211111100 011125678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 026042 178 SSPDRRPHFDQIVS 191 (244)
Q Consensus 178 ~~p~~Rps~~el~~ 191 (244)
.||.+|||++|+++
T Consensus 320 ~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 320 MDPIKRITSEQAMQ 333 (405)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=260.24 Aligned_cols=182 Identities=14% Similarity=0.150 Sum_probs=142.4
Q ss_pred CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecC
Q 026042 11 PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLV------LKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADF 84 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~------~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~df 84 (244)
...|+||||++ ++|.+++..... .++...+ ..++.|++.||+|||++|++||||||+||+++.+|.+||+||
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DF 238 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCG
T ss_pred eeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEec
Confidence 34899999997 799999987532 2344455 677799999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----HH--hhC
Q 026042 85 GISCLESQCGSAKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-----VC--QKN 155 (244)
Q Consensus 85 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~--~~~ 155 (244)
|++....... ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........... .. ...
T Consensus 239 G~a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 316 (371)
T 3q60_A 239 SALWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316 (371)
T ss_dssp GGEEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCS
T ss_pred ceeeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccc
Confidence 9987654322 14456699999999987 6789999999999999999999999987643211000 00 001
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~~ 196 (244)
...+....+++.+.+++.+||+.||.+|||+.++++ +++..
T Consensus 317 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 317 LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 111223578999999999999999999999999986 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=252.09 Aligned_cols=188 Identities=21% Similarity=0.356 Sum_probs=149.4
Q ss_pred CcEEEEeecCC----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEc-
Q 026042 1 MQFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLG- 74 (244)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~- 74 (244)
+++++++...+ ..++|+||+ +++|.+++.......+++..++.++.||+.||.|||++ |++||||||+||+++
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 45677776554 889999999 89999999886655799999999999999999999998 999999999999995
Q ss_pred -----CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----
Q 026042 75 -----EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP----- 144 (244)
Q Consensus 75 -----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----- 144 (244)
..+.+||+|||++..... ......+++.|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 344799999999876543 23345789999999999998999999999999999999999999986542
Q ss_pred -HHHHHHHHhhCC----------------------------------------CCCCCCCchHHHHHHHHHhcccCCCCC
Q 026042 145 -EQAAFAVCQKNA----------------------------------------RPPVPPTCPKAFSYLISRCWSSSPDRR 183 (244)
Q Consensus 145 -~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R 183 (244)
......+..... ....+..+++++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111111000 112334457889999999999999999
Q ss_pred CCHHHHHH
Q 026042 184 PHFDQIVS 191 (244)
Q Consensus 184 ps~~el~~ 191 (244)
||++|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=241.15 Aligned_cols=180 Identities=24% Similarity=0.387 Sum_probs=147.2
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCcEEEecCCC
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMCVKVADFGI 86 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~-~~~~~kl~dfg~ 86 (244)
......++|+||++ ++|.+++.+. .+++..++.++.|++.||+|||++|++||||||+||+++ .++.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 56688999999996 6999999753 488999999999999999999999999999999999997 467999999999
Q ss_pred ccccccc----CCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC----
Q 026042 87 SCLESQC----GSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR---- 157 (244)
Q Consensus 87 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 157 (244)
+...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.......+......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 8764322 12234456889999998765 67899999999999999999999999988776555444322111
Q ss_pred -------------------C-----CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 -------------------P-----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 -------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .....++.++.+++.+||+.||.+||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 112467899999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=239.43 Aligned_cols=179 Identities=26% Similarity=0.440 Sum_probs=138.8
Q ss_pred cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 9 KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 9 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
..+..|+|+||+++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred cCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 3577899999999999999998654 257889999999999999999999999999999999999999999999999986
Q ss_pred ccccc---------------CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q 026042 89 LESQC---------------GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPE-QAAFAV 151 (244)
Q Consensus 89 ~~~~~---------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~ 151 (244)
..... .......+++.|+|||.+.+. .++.++||||||+++|+|++ ||...... .....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~ 241 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence 54321 122345689999999998764 68999999999999999998 55432222 222222
Q ss_pred Hhh--CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 152 CQK--NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 152 ~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ......+...++.+.+++.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 211 1122344567788999999999999999999999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=242.47 Aligned_cols=180 Identities=25% Similarity=0.458 Sum_probs=151.2
Q ss_pred CcEEEEeecCCcEEEEEec-cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc-CCCc
Q 026042 1 MQFVAACKKPPVFCIITEY-LAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG-EDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~-~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~-~~~~ 78 (244)
+++++++...+..++|+|+ +.+++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++ .++.
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 5789999999999999999 78999999998865 589999999999999999999999999999999999999 7899
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
++|+|||++...... ......++..|+|||.+.+..+ +.++||||||+++|+|++|..||..... . ....
T Consensus 179 ~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~--~~~~ 249 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------I--LEAE 249 (312)
T ss_dssp EEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H--HHTC
T ss_pred EEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------H--hhhc
Confidence 999999998765432 3345668999999999877665 4589999999999999999999975321 1 1223
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..++..+.+++.+||+.||++||+++++++
T Consensus 250 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 250 LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4566788999999999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=245.48 Aligned_cols=184 Identities=23% Similarity=0.388 Sum_probs=149.5
Q ss_pred CcEEEEeecCCc------EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPPV------FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~~------~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|++++++..... +|+||||+. ++|.+++.. .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 86 v~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~ 160 (353)
T 3coi_A 86 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160 (353)
T ss_dssp CCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC
T ss_pred ccHhheEecccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC
Confidence 467788877654 499999995 688887743 489999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.++.+||+|||++..... ......+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+.+..+....+..
T Consensus 161 ~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~ 238 (353)
T 3coi_A 161 EDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238 (353)
T ss_dssp TTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred CCCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999876433 2334578999999999876 6789999999999999999999999998876655444322
Q ss_pred hC-----------------------------CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KN-----------------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ........+++.+.+++.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11 011233567899999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.71 Aligned_cols=189 Identities=25% Similarity=0.383 Sum_probs=145.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---C-
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---D- 76 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~---~- 76 (244)
|++++++..+...|+||||+. ++|.+++..... ..++..++.++.|++.||.|||++||+||||||+||+++. +
T Consensus 81 v~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~ 158 (432)
T 3p23_A 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHG 158 (432)
T ss_dssp CCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTT
T ss_pred CeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCC
Confidence 678999999999999999995 699999987653 3455567899999999999999999999999999999953 2
Q ss_pred -CcEEEecCCCccccccc----CCCCCCCcccceeccceecc---CCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHH
Q 026042 77 -MCVKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQA 147 (244)
Q Consensus 77 -~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~ 147 (244)
..+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||........
T Consensus 159 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~ 238 (432)
T 3p23_A 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238 (432)
T ss_dssp BCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH
T ss_pred ceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH
Confidence 35889999998765432 22345679999999999874 566889999999999999999 9999976554443
Q ss_pred HHHHHhhCCCC-CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 148 AFAVCQKNARP-PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 148 ~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........... ......+..+.++|.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 32221111111 112334667899999999999999999999995
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=251.31 Aligned_cols=188 Identities=23% Similarity=0.384 Sum_probs=142.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCC-----CHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV-----PLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~-----~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++..++..|+|+||+. ++|.+++........ ++..++.++.|++.||+|||++|++||||||+||+++.
T Consensus 72 v~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150 (434)
T ss_dssp CCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEC
T ss_pred CeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 678999999999999999995 699999987543211 22345789999999999999999999999999999975
Q ss_pred C-------------CcEEEecCCCcccccccCC-----CCCCCcccceeccceecc-------CCCCCccchhhhHHHHH
Q 026042 76 D-------------MCVKVADFGISCLESQCGS-----AKGFTGTYRWMAPEMIKE-------KRHTKKVDVYSFGIVLW 130 (244)
Q Consensus 76 ~-------------~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~ 130 (244)
+ +.+||+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ 230 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence 4 4799999999876543221 234579999999999865 56899999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHHhhCCCCC-C----CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 131 ELLT-ALTPFDNMTPEQAAFAVCQKNARPP-V----PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 131 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+|++ |..||........ .+........ . ...+++++.+++.+||+.||.+|||+.++++
T Consensus 231 ellt~g~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 231 YILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHTTSCCTTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 9999 9999976544332 2222221111 1 1235688999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=236.66 Aligned_cols=170 Identities=23% Similarity=0.389 Sum_probs=137.8
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE- 75 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~- 75 (244)
+++++++.. +...++||||++|++|.+++....+..+++..++.++.|++.||.|||++|++||||||+||+++.
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 153 (299)
T 3m2w_A 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 153 (299)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred hhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC
Confidence 567888876 788999999999999999999877667999999999999999999999999999999999999998
Q ss_pred --CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 76 --DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 76 --~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
++.++|+|||++.... +..++.++||||||+++|+|++|..||..............
T Consensus 154 ~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 212 (299)
T 3m2w_A 154 RPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212 (299)
T ss_dssp STTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC
T ss_pred CCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH
Confidence 7889999999875432 24567899999999999999999999977554332111111
Q ss_pred hCCC--CCCC----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNAR--PPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~--~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... ...+ ..+++++.+++.+||+.||.+|||+.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111 1112 467899999999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=248.72 Aligned_cols=171 Identities=16% Similarity=0.162 Sum_probs=139.2
Q ss_pred CcEEEEEeccCCCCHHHHHhh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCC
Q 026042 11 PVFCIITEYLAGGSLRKYLHQ-----QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 11 ~~~~lv~e~~~~~~L~~~i~~-----~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
..++++++++ +++|.++++. ..+..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 178 ~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG 256 (413)
T 3dzo_A 178 LSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256 (413)
T ss_dssp CSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGG
T ss_pred cceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEecc
Confidence 4567888877 7899999952 223346778889999999999999999999999999999999999999999999
Q ss_pred CcccccccCCCCCCCcccceecccee----------ccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 86 ISCLESQCGSAKGFTGTYRWMAPEMI----------KEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 86 ~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
++...... .....| +.|+|||++ ....++.++|||||||++|+|++|+.||...+.......+
T Consensus 257 ~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~---- 329 (413)
T 3dzo_A 257 HLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI---- 329 (413)
T ss_dssp GCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG----
T ss_pred ceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH----
Confidence 98765443 344567 999999998 5556788999999999999999999999876543221111
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
......+++.+.+++.+||+.||.+||++.++++
T Consensus 330 --~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 330 --FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp --GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1222467899999999999999999999877764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=252.97 Aligned_cols=190 Identities=26% Similarity=0.340 Sum_probs=150.1
Q ss_pred CcEEEEeec------CCcEEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEE
Q 026042 1 MQFVAACKK------PPVFCIITEYLAGGSLRKYLHQQEP-YSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73 (244)
Q Consensus 1 v~~~~~~~~------~~~~~lv~e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~ 73 (244)
|++++++.. ++..++||||++|++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 75 V~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl 154 (676)
T 3qa8_A 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVL 154 (676)
T ss_dssp CCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEE
T ss_pred CceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEe
Confidence 456676655 7888999999999999999987542 358889999999999999999999999999999999999
Q ss_pred cCCCc---EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-
Q 026042 74 GEDMC---VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF- 149 (244)
Q Consensus 74 ~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~- 149 (244)
+.++. ++|+|||.+.............|++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 155 ~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~ 234 (676)
T 3qa8_A 155 QPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG 234 (676)
T ss_dssp ECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST
T ss_pred ecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh
Confidence 97764 99999999987666555566789999999999999999999999999999999999999997643321100
Q ss_pred --------HHHhh---------CC----CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHH
Q 026042 150 --------AVCQK---------NA----RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190 (244)
Q Consensus 150 --------~~~~~---------~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~ 190 (244)
..... .. .......+++.+.+++.+||..||.+|||+.+++
T Consensus 235 ~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 235 KVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp TCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 00000 00 0012234678999999999999999999998744
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=226.30 Aligned_cols=168 Identities=14% Similarity=0.164 Sum_probs=136.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||++|++|.+++++. .....+..++.|++.||.|||++|++||||||+||+++.+|.+|
T Consensus 94 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 94 ARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp CCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEE
T ss_pred ceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEE
Confidence 57899999999999999999999999999643 35567889999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCCC-
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK-NARP- 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~- 158 (244)
|++++. ++ +++.++||||||+++|+|++|+.||.+.+........... ....
T Consensus 170 l~~~~~-------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T 3uqc_A 170 LAYPAT-------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI 223 (286)
T ss_dssp ECSCCC-------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC
T ss_pred EEeccc-------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC
Confidence 985432 22 3688999999999999999999999875432211000000 0000
Q ss_pred ---CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 159 ---PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 159 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.....+++.+.+++.+||+.||++| |+.|+++.|++....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 1235688999999999999999999 999999999987654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=246.23 Aligned_cols=181 Identities=24% Similarity=0.359 Sum_probs=143.3
Q ss_pred CcEEEEeecCCc-----EEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPPV-----FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~~-----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++...+. .||||||++|++|.+++.. .+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 142 v~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~ 217 (681)
T 2pzi_A 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217 (681)
T ss_dssp CCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS
T ss_pred CeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC
Confidence 578999987776 7999999999999988765 5899999999999999999999999999999999999988
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
+ .+||+|||++...... ....||+.|+|||++.+.. +.++||||||+++++|++|..||.+..... .
T Consensus 218 ~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~ 284 (681)
T 2pzi_A 218 E-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------L 284 (681)
T ss_dssp S-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------C
T ss_pred C-cEEEEecccchhcccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------c
Confidence 5 8999999998765432 4567999999999987654 889999999999999999988876421100 0
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGYSE 198 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~el~~~l~~~~~ 198 (244)
.........++.+.++|.+||+.||.+|| +++++...|.....
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00000011347899999999999999999 56667777766543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=225.28 Aligned_cols=168 Identities=14% Similarity=0.109 Sum_probs=132.0
Q ss_pred CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcCCC-----------
Q 026042 10 PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDM----------- 77 (244)
Q Consensus 10 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~nil~~~~~----------- 77 (244)
++..|+||||+++|++.+.+.+ ..+++..++.++.||+.||.||| ++||+||||||+||+++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred cCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 7899999999999977776644 25899999999999999999999 99999999999999999887
Q ss_pred ---------cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHH-HHHHHhCCCCCCCCCH-HH
Q 026042 78 ---------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIV-LWELLTALTPFDNMTP-EQ 146 (244)
Q Consensus 78 ---------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~-l~~l~~g~~p~~~~~~-~~ 146 (244)
.+||+|||+++.... ....||+.|+|||++.+.. +.++||||+|++ .+++++|..||..... ..
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~ 285 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY 285 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH
T ss_pred cccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH
Confidence 899999999976543 2347899999999998766 889999998777 7778889999854211 11
Q ss_pred HHHHHHhhCCCC-CC----CCCchHHHHHHHHHhcccCCCCCCCHHHHH
Q 026042 147 AAFAVCQKNARP-PV----PPTCPKAFSYLISRCWSSSPDRRPHFDQIV 190 (244)
Q Consensus 147 ~~~~~~~~~~~~-~~----~~~~~~~l~~li~~~l~~~p~~Rps~~el~ 190 (244)
............ .. ...+++++.+||.+||+.| |++|++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 286 LTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 111222111111 11 2346889999999999976 898888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=223.32 Aligned_cols=129 Identities=18% Similarity=0.208 Sum_probs=96.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
+++++++++++..||||||++|++|.++|.+.+ .+++. +++.||+.||+|+|++||+||||||+|||++.+|.+|
T Consensus 305 ~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 305 PAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp CCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEE
T ss_pred eEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEE
Confidence 579999999999999999999999999999876 46654 4789999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 135 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 135 (244)
|+|||+++..... ......+||+.|+|||++.+. ...++|+|++|++.+++.++
T Consensus 380 L~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 380 LIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp ECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred EeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 9999998754432 234456799999999999754 56789999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.2e-22 Score=176.03 Aligned_cols=125 Identities=16% Similarity=0.203 Sum_probs=104.8
Q ss_pred EEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEec
Q 026042 4 VAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVAD 83 (244)
Q Consensus 4 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~d 83 (244)
..++...+..|+||||++|++|.+++.+ +..++.|++.||.|||++||+||||||+||+++. .+||+|
T Consensus 405 ~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 405 YIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp CEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECC
T ss_pred EEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEE
Confidence 4455567777999999999999999986 4589999999999999999999999999999998 999999
Q ss_pred CCCcccccccCC--------CCCCCcccceeccceecc--CCCCCccchhhhHHHHHHHHhCCCCCC
Q 026042 84 FGISCLESQCGS--------AKGFTGTYRWMAPEMIKE--KRHTKKVDVYSFGIVLWELLTALTPFD 140 (244)
Q Consensus 84 fg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~ 140 (244)
||+++....... .....||+.|+|||++.. ..++...|+|+..+-.++-+.++-+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999976543221 135678999999999987 567888899999988888777766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.7e-18 Score=139.52 Aligned_cols=88 Identities=16% Similarity=0.121 Sum_probs=70.4
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEE
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKV 81 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl 81 (244)
++.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.+||++|++||||||+||+++ +|.+||
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEE
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEE
Confidence 34455544 45589999999999988 421 22447999999999999999999999999999999 999999
Q ss_pred ecCCCcccccccCCCCCCCcccceeccceec
Q 026042 82 ADFGISCLESQCGSAKGFTGTYRWMAPEMIK 112 (244)
Q Consensus 82 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 112 (244)
+|||+++. +..+.|||.+.
T Consensus 234 ~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CCCTTCEE------------TTSTTHHHHHH
T ss_pred EECCCCeE------------CCCCCHHHHHH
Confidence 99999853 23456777764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=6.1e-14 Score=111.43 Aligned_cols=72 Identities=17% Similarity=0.182 Sum_probs=59.9
Q ss_pred cEEEEEeccCC-C----CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCccCCCCCCcEEEcCCCcEEEecCC
Q 026042 12 VFCIITEYLAG-G----SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 12 ~~~lv~e~~~~-~----~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
..+|||||+.+ | +|.++.... ++..+..++.|++.+|.+|| +.|++||||||+||+++. .++|+|||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~~-----~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG 214 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGREL-----KELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMG 214 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGGG-----GGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCT
T ss_pred CCEEEEEecCCCCCccccHHHHhhcc-----ChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECc
Confidence 56799999932 3 787775432 24567789999999999999 999999999999999988 89999999
Q ss_pred Ccccc
Q 026042 86 ISCLE 90 (244)
Q Consensus 86 ~~~~~ 90 (244)
++...
T Consensus 215 ~a~~~ 219 (258)
T 1zth_A 215 QAVTL 219 (258)
T ss_dssp TCEET
T ss_pred ccccC
Confidence 98653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.25 E-value=2.2e-12 Score=107.40 Aligned_cols=69 Identities=19% Similarity=0.224 Sum_probs=57.0
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC----------cEEEec
Q 026042 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM----------CVKVAD 83 (244)
Q Consensus 14 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~----------~~kl~d 83 (244)
+|||||++|++|..+.. . .....++.|++.+|.+||++|++||||||.|||++++| .+.++|
T Consensus 187 ~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp EEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred eEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 69999999988865422 1 23456889999999999999999999999999998876 389999
Q ss_pred CCCcccc
Q 026042 84 FGISCLE 90 (244)
Q Consensus 84 fg~~~~~ 90 (244)
|+.+...
T Consensus 259 ~~Q~V~~ 265 (397)
T 4gyi_A 259 FPQMVSM 265 (397)
T ss_dssp CTTCEET
T ss_pred eCCcccC
Confidence 9987543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=2.6e-09 Score=84.54 Aligned_cols=80 Identities=15% Similarity=0.092 Sum_probs=64.8
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS----------------------- 58 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~----------------------- 58 (244)
++++++...+..|+||||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 74 ~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 74 KVLHFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp CEEEEEEETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred eEEEEEecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 578889999999999999999999876321 12234678899999999998
Q ss_pred ------------------------------------CCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 59 ------------------------------------QGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 59 ------------------------------------~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.+++|||++|.||++++++.+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876556799998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.2e-08 Score=80.25 Aligned_cols=78 Identities=14% Similarity=0.137 Sum_probs=59.3
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--------------------- 60 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--------------------- 60 (244)
++++++..++..++||||++|.+|. ... .+. ..++.+++..|..||+..
T Consensus 79 ~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~ 148 (264)
T 1nd4_A 79 AVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRM 148 (264)
T ss_dssp CEEEEEECSSCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHH
T ss_pred eEEEeccCCCCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHH
Confidence 4788888888899999999998884 111 111 245667777777777643
Q ss_pred -------------------------------------CccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 61 -------------------------------------ILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 61 -------------------------------------i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
++|+|++|.||++++++.+.|+||+.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 149 EAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776667999997643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.70 E-value=3.6e-08 Score=81.65 Aligned_cols=84 Identities=20% Similarity=0.290 Sum_probs=66.9
Q ss_pred cEEEEeecC---CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------
Q 026042 2 QFVAACKKP---PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-------------------- 58 (244)
Q Consensus 2 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-------------------- 58 (244)
+++.++... +..|+||||++|.++.+.. -..++......++.+++..|+.||+
T Consensus 102 ~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3dxp_A 102 KMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQR 177 (359)
T ss_dssp CEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHH
T ss_pred cEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHH
Confidence 567777766 4589999999997775411 1136778888999999999999997
Q ss_pred --------------------------------------CCCccCCCCCCcEEEcCCCc--EEEecCCCccc
Q 026042 59 --------------------------------------QGILHRDLKSENLLLGEDMC--VKVADFGISCL 89 (244)
Q Consensus 59 --------------------------------------~~i~H~dikp~nil~~~~~~--~kl~dfg~~~~ 89 (244)
.+++|||+++.||+++.++. +.|+||+.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 178 QIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997653 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=8.6e-09 Score=83.47 Aligned_cols=124 Identities=18% Similarity=0.234 Sum_probs=79.6
Q ss_pred cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 026042 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS--------------------------------- 58 (244)
Q Consensus 12 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~--------------------------------- 58 (244)
..|+||++++|.+|.+.... .++..+...++.+++..|+.||+
T Consensus 90 ~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp CSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred cceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 34899999999888764332 35667778888888888888886
Q ss_pred -------------------------CCCccCCCCCCcEEEcC--CCcEEEecCCCcccccccCCCCCCCcccceecccee
Q 026042 59 -------------------------QGILHRDLKSENLLLGE--DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI 111 (244)
Q Consensus 59 -------------------------~~i~H~dikp~nil~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 111 (244)
..++|+|++|.||+++. .+.+.++||+.+.................-..|+..
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFV 245 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHH
Confidence 13699999999999998 456789999987543221000000000000111111
Q ss_pred cc---C--C---------CCCccchhhhHHHHHHHHhCCCCC
Q 026042 112 KE---K--R---------HTKKVDVYSFGIVLWELLTALTPF 139 (244)
Q Consensus 112 ~~---~--~---------~~~~~Di~slG~~l~~l~~g~~p~ 139 (244)
.. . . .....+.|+++.+++.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 0 0 011258899999999999997765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.49 E-value=3.1e-06 Score=64.28 Aligned_cols=141 Identities=11% Similarity=0.079 Sum_probs=95.9
Q ss_pred CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCCCcEEEecCCCcccccccCCCCCCCc
Q 026042 23 GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTG 101 (244)
Q Consensus 23 ~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 101 (244)
.||.+.++..+. +++++++|.++.|.+.+|..+-. +.-...=+.|..|++..+|.+.+.+ ..+. ..
T Consensus 33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~ 99 (229)
T 2yle_A 33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AG 99 (229)
T ss_dssp EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cc
Confidence 479999987654 79999999999999999888732 2222333467999999999887764 1110 12
Q ss_pred ccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhccc---
Q 026042 102 TYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS--- 178 (244)
Q Consensus 102 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--- 178 (244)
...+.+||... ...+.+.=|||||+++|.-+--..| ...+..+++.|.+||..|...
T Consensus 100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt~~~~d 159 (229)
T 2yle_A 100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMANTVEA 159 (229)
T ss_dssp -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHTTCCC-
T ss_pred ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHHhcccc
Confidence 23456777653 4557888999999999988763332 233446788999999999755
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhh
Q 026042 179 ----------------------SPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 179 ----------------------~p~~Rps~~el~~~l~~~ 196 (244)
.+..|.+++++++.....
T Consensus 160 ~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h 199 (229)
T 2yle_A 160 DGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH 199 (229)
T ss_dssp -------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence 246788999998877643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.5e-06 Score=66.05 Aligned_cols=82 Identities=18% Similarity=0.217 Sum_probs=61.1
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---------------------- 59 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~---------------------- 59 (244)
+++.++..++..++|||+++|.++.+...... .....+..++...|..||+.
T Consensus 84 ~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~ 157 (272)
T 4gkh_A 84 TIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRM 157 (272)
T ss_dssp CEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHH
T ss_pred eEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHH
Confidence 47888999999999999999988887655422 12234555666666666641
Q ss_pred ------------------------------------CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 ------------------------------------GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ------------------------------------~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.++|||+++.||+++.++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 158 NNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999877677999997643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.2e-05 Score=63.39 Aligned_cols=83 Identities=22% Similarity=0.221 Sum_probs=55.0
Q ss_pred EEEEee-cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------
Q 026042 3 FVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ---------------------- 59 (244)
Q Consensus 3 ~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~---------------------- 59 (244)
++.++. ..+..++|||+++|.+|.+..-. .++......++.++...|+.||+.
T Consensus 77 ~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~ 152 (306)
T 3tdw_A 77 YVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLL 152 (306)
T ss_dssp EEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHH
T ss_pred eEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHH
Confidence 445553 45667899999999888763211 123444444455555555555432
Q ss_pred --------------------------------------CCccCCCCCCcEEEcC---CCc-EEEecCCCccc
Q 026042 60 --------------------------------------GILHRDLKSENLLLGE---DMC-VKVADFGISCL 89 (244)
Q Consensus 60 --------------------------------------~i~H~dikp~nil~~~---~~~-~kl~dfg~~~~ 89 (244)
.++|+|++|.||+++. ++. ..|+||+.+..
T Consensus 153 ~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 153 SEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 48999997644
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=4.5e-05 Score=62.79 Aligned_cols=31 Identities=26% Similarity=0.295 Sum_probs=25.6
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
..++|+|+++.||++++++.+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4689999999999999644578999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0031 Score=51.20 Aligned_cols=31 Identities=35% Similarity=0.425 Sum_probs=26.7
Q ss_pred CCCccCCCCCCcEEEcCC----CcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGED----MCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~----~~~kl~dfg~~~~ 89 (244)
..++|||+++.||+++.+ +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6799999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.002 Score=52.28 Aligned_cols=30 Identities=30% Similarity=0.438 Sum_probs=26.8
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
.+++|||+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999877889999999753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0033 Score=50.26 Aligned_cols=29 Identities=24% Similarity=0.264 Sum_probs=24.2
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5566789999987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0037 Score=52.56 Aligned_cols=33 Identities=24% Similarity=0.430 Sum_probs=28.2
Q ss_pred HhCCCccCCCCCCcEEEcCCCcEEEecCCCcccc
Q 026042 57 HSQGILHRDLKSENLLLGEDMCVKVADFGISCLE 90 (244)
Q Consensus 57 H~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~ 90 (244)
+...++|||++|.||+++.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456899999999999998876 999999987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.021 Score=46.05 Aligned_cols=25 Identities=32% Similarity=0.357 Sum_probs=22.6
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCC
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFG 85 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg 85 (244)
.++|+|+.+.|++++.++ +.++|+.
T Consensus 208 ~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 208 SILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp EEECSSCSGGGEEEETTE-EEECSCC
T ss_pred eeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 589999999999999887 8899974
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.09 E-value=0.0094 Score=47.95 Aligned_cols=31 Identities=29% Similarity=0.525 Sum_probs=25.9
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.+++|+|+++.||++++++.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998876568999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.79 E-value=0.028 Score=45.26 Aligned_cols=29 Identities=24% Similarity=0.143 Sum_probs=24.7
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
..++|||+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999998 4 799999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.17 E-value=0.031 Score=45.51 Aligned_cols=31 Identities=23% Similarity=0.460 Sum_probs=26.9
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999878899999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=93.89 E-value=0.054 Score=44.93 Aligned_cols=31 Identities=23% Similarity=0.393 Sum_probs=25.8
Q ss_pred hCCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 58 SQGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 58 ~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
...++|||+++.||+++.++ +.++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 35799999999999998764 89999987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=93.44 E-value=0.065 Score=44.00 Aligned_cols=29 Identities=24% Similarity=0.432 Sum_probs=24.1
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
+++|+|+++.||++++++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999998655 89999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.92 E-value=0.087 Score=44.81 Aligned_cols=15 Identities=33% Similarity=0.359 Sum_probs=14.1
Q ss_pred CCccCCCCCCcEEEc
Q 026042 60 GILHRDLKSENLLLG 74 (244)
Q Consensus 60 ~i~H~dikp~nil~~ 74 (244)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=91.57 E-value=0.062 Score=45.28 Aligned_cols=30 Identities=27% Similarity=0.402 Sum_probs=23.9
Q ss_pred CCccCCCCCCcEEEcCC----------------------------CcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGED----------------------------MCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~----------------------------~~~kl~dfg~~~~ 89 (244)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 48999999999999875 6788999887643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=91.29 E-value=0.093 Score=43.46 Aligned_cols=30 Identities=27% Similarity=0.400 Sum_probs=26.2
Q ss_pred CCccCCCCCCcEEEcCC----CcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGED----MCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~----~~~kl~dfg~~~~ 89 (244)
.++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 48999999999999876 6899999987643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.56 E-value=0.17 Score=42.20 Aligned_cols=29 Identities=31% Similarity=0.450 Sum_probs=24.5
Q ss_pred CccCCCCCCcEEE------cCCCcEEEecCCCccc
Q 026042 61 ILHRDLKSENLLL------GEDMCVKVADFGISCL 89 (244)
Q Consensus 61 i~H~dikp~nil~------~~~~~~kl~dfg~~~~ 89 (244)
++|+|+.+.||++ +.++.+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 3456799999998744
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=86.68 E-value=0.28 Score=41.27 Aligned_cols=29 Identities=28% Similarity=0.485 Sum_probs=25.4
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.++|+|+.+.||+ +.++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 4899999999999 7788899999998743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=86.32 E-value=0.4 Score=37.67 Aligned_cols=24 Identities=33% Similarity=0.353 Sum_probs=20.1
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecC
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADF 84 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~df 84 (244)
.++|||+.+.||+++.+|. .++|.
T Consensus 189 ~LvHGDlw~gNvl~~~~g~-~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDGA-VVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETTEE-EECSC
T ss_pred eeeecCCCCCcEEEcCCCe-EEEec
Confidence 5899999999999999874 56663
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.98 E-value=1.6 Score=33.03 Aligned_cols=72 Identities=10% Similarity=0.016 Sum_probs=49.8
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCccCCCCCCcEEEcCCCcEEEecCCC
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQ-YLHSQGILHRDLKSENLLLGEDMCVKVADFGI 86 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~-~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~ 86 (244)
.+.+.+.+.++.-+++.=...++ ..+....++++.+|+.... ++ ..-+|--++|+|++++.++.+++.-.|+
T Consensus 58 ~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 58 VSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGV 130 (219)
T ss_dssp ECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEE
T ss_pred EeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCC
Confidence 45566666666543322223333 3567888888888887665 43 3456778999999999999999997775
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.86 E-value=1.5 Score=32.98 Aligned_cols=105 Identities=13% Similarity=0.085 Sum_probs=64.8
Q ss_pred ecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCc
Q 026042 8 KKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGIS 87 (244)
Q Consensus 8 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~ 87 (244)
...+.+.+.++.- .+...|-.-. ..+....++++.+|+....+++ .-+|--++|+|++++.++.+++.-.|+.
T Consensus 54 e~eD~v~~~y~~~--~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 54 ELRDSFQIHYDIN--DNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp ECSSEEEEEECCC--TTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTSCEEESCCEET
T ss_pred EcccEEEEEEEcC--cccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCCCEEEEEccCc
Confidence 4455555555533 3333332211 3567888999999988874443 3467789999999999999999877653
Q ss_pred ccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCC
Q 026042 88 CLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFD 140 (244)
Q Consensus 88 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 140 (244)
.. ++|. ..+...-+-..=|++..+++++..|.
T Consensus 127 ~~----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 127 NV----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp TT----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cC----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 21 1221 11222223355678888888877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 244 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-52 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-28 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-62
Identities = 71/211 (33%), Positives = 114/211 (54%), Gaps = 12/211 (5%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
F+ P + I+T++ G SL +LH E + ++ +A A+GM YLH++ I
Sbjct: 68 LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIK---EKR 115
+HRDLKS N+ L ED+ VK+ DFG++ + S + +G+ WMAPE+I+ +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 116 HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP----VPPTCPKAFSYL 171
++ + DVY+FGIVL+EL+T P+ N+ + + P V CPKA L
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 245
Query: 172 ISRCWSSSPDRRPHFDQIVSILEGYSESLEQ 202
++ C D RP F QI++ +E + SL +
Sbjct: 246 MAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 7e-57
Identities = 61/188 (32%), Positives = 95/188 (50%), Gaps = 2/188 (1%)
Query: 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
++ I+TEY+A GSL YL + + + +LK +LD+ M+YL +HRDL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 129
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFG 126
+ N+L+ ED KV+DFG++ S + +W APE ++EK+ + K DV+SFG
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 187
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186
I+LWE+ + P + +K + P CP A ++ CW RP F
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 247
Query: 187 DQIVSILE 194
Q+ LE
Sbjct: 248 LQLREQLE 255
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-56
Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 3/202 (1%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ A + P++ IITEY+ GSL +L + +N +L +A IA GM ++ +
Sbjct: 72 RLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL++ N+L+ + + K+ADFG++ L +++ + +G +W APE I T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFGI+L E++T ++ R P CP+ L+ CW
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKER 250
Query: 180 PDRRPHFDQIVSILEGYSESLE 201
P+ RP FD + S+LE + + E
Sbjct: 251 PEDRPTFDYLRSVLEDFFTATE 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 4e-54
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 8/210 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + C+ ++ E GG L K+L + +P++ V +L ++ GM+YL +
Sbjct: 72 VRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRH 116
+HRDL + N+LL K++DFG+S +S + +W APE I ++
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 117 TKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 175
+ + DV+S+G+ +WE L+ P+ M + + ++ R PP CP L+S C
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMECPPECPPELYALMSDC 248
Query: 176 WSSSPDRRPHFDQIVSILEGYSESLEQDPE 205
W + RP F + + SL E
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 9e-54
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 5/190 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ +I EY G++ + L + + ++A + Y HS+ +
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR--TATYITELANALSYCHSKRV 127
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVD 121
+HRD+K ENLLLG +K+ADFG S + GT ++ PEMI+ + H +KVD
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVD 186
Query: 122 VYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPD 181
++S G++ +E L PF+ T ++ + P + LISR +P
Sbjct: 187 LWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHNPS 244
Query: 182 RRPHFDQIVS 191
+RP +++
Sbjct: 245 QRPMLREVLE 254
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-53
Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 3/206 (1%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q A + P+ I+TEY++ GSL +L + + L ++ +A IA GM Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+HRDL++ N+L+GE++ KVADFG++ L +++ + +G +W APE R T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+SFGI+L EL T + ++ R P PP CP++ L+ +CW
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 254
Query: 180 PDRRPHFDQIVSILEGYSESLEQDPE 205
P+ RP F+ + + LE Y S E +
Sbjct: 255 PEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 1e-52
Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 8/193 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
Q+ + ++ EY G + ++P + + +G+ YLHS +
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL--QEVEIAAVTHGALQGLAYLHSHNM 136
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI---KEKRHTK 118
+HRD+K+ N+LL E VK+ DFG + + + S F GT WMAPE+I E ++
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEGQYDG 193
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
KVDV+S GI EL P NM A + + Q + + F + C
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 179 SPDRRPHFDQIVS 191
P RP + ++
Sbjct: 254 IPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-52
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQ---------------------EPYSVPLN 40
+ AC +I EY G L YL + + +
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164
Query: 41 LVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--- 97
+L A +A+GM++L + +HRDL + N+L+ VK+ DFG++ +
Sbjct: 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224
Query: 98 GFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNA 156
+WMAPE + E +T K DV+S+GI+LWE+ + + P+ + + + + Q
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284
Query: 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
+ P + ++ CW+ +RP F + S L
Sbjct: 285 KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-52
Identities = 48/198 (24%), Positives = 87/198 (43%), Gaps = 9/198 (4%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLN--LVLKLALDIARGMQYLHS 58
+ I+ EY GG L + + L+ VL++ + ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 59 QG-----ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIK 112
+ +LHRDLK N+ L VK+ DFG++ L AK F GT +M+PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 113 EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLI 172
+ +K D++S G +L+EL + PF + ++ A + + +P + +I
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEII 246
Query: 173 SRCWSSSPDRRPHFDQIV 190
+R + RP ++I+
Sbjct: 247 TRMLNLKDYHRPSVEEIL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-52
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 9/198 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + C+ + ++ E G L KYL Q V +++L ++ GM+YL
Sbjct: 72 RMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESNF 128
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
+HRDL + N+LL K++DFG+S E+ + +W APE I + +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 118 KKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
K DV+SFG+++WE + P+ M + + +K R P CP+ L++ CW
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCW 247
Query: 177 SSSPDRRPHFDQIVSILE 194
+ + RP F + L
Sbjct: 248 TYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-51
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 8/196 (4%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + A I+ E+ AGG++ + + E + + + + + YLH
Sbjct: 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNK 130
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMI-----KEK 114
I+HRDLK+ N+L D +K+ADFG+S F GT WMAPE++ K++
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190
Query: 115 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLIS 173
+ K DV+S GI L E+ P + P + + + P F +
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250
Query: 174 RCWSSSPDRRPHFDQI 189
+C + D R Q+
Sbjct: 251 KCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-51
Identities = 50/193 (25%), Positives = 92/193 (47%), Gaps = 8/193 (4%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG-- 60
+ + K ++TE + G+L+ YL + + + ++ I +G+Q+LH++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM--KIKVLRSWCRQILKGLQFLHTRTPP 134
Query: 61 ILHRDLKSENLLL-GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
I+HRDLK +N+ + G VK+ D G++ L+ AK GT +MAPEM +EK + +
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-YDES 192
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-VPPTCPKAFSYLISRCWSS 178
VDVY+FG+ + E+ T+ P+ + +P +I C
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252
Query: 179 SPDRRPHFDQIVS 191
+ D R +++
Sbjct: 253 NKDERYSIKDLLN 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-51
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 3/201 (1%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q C + C++ E++ G L YL Q +L + LD+ GM YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
++HRDL + N L+GE+ +KV+DFG++ + Q S+ G +W +PE+ R++
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
K DV+SFG+++WE+ + R P +++ CW
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 179 SPDRRPHFDQIVSILEGYSES 199
P+ RP F +++ L +ES
Sbjct: 242 RPEDRPAFSRLLRQLAEIAES 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-50
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPY--------------SVPLNLVLKLA 46
+ + AC+ + EY G+L +L + ++ +L A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWM 106
D+ARGM YL + +HRDL + N+L+GE+ K+ADFG+S + RWM
Sbjct: 134 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 107 APEMIKEKRHTKKVDVYSFGIVLWELLTAL-TPFDNMTPEQAAFAVCQKNARPPVPPTCP 165
A E + +T DV+S+G++LWE+++ TP+ MT + + + R P C
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLNCD 252
Query: 166 KAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQ--DPEFFSSF 210
L+ +CW P RP F QI+ L E + + + F
Sbjct: 253 DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-50
Identities = 51/191 (26%), Positives = 92/191 (48%), Gaps = 5/191 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ ++ + ++ EYLAGGSL + + + + + + + +++LHS
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKK 119
++HRD+KS+N+LLG D VK+ DFG + S GT WMAPE++ K + K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA-RPPVPPTCPKAFSYLISRCWSS 178
VD++S GI+ E++ P+ N P +A + + P F ++RC
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 179 SPDRRPHFDQI 189
++R ++
Sbjct: 257 DVEKRGSAKEL 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (417), Expect = 1e-50
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 3/206 (1%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q + C + P F IITE++ G+L YL + V ++L +A I+ M+YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDL + N L+GE+ VKVADFG+S L + G +W APE + + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
K DV++FG++LWE+ T + + +K+ R P CP+ L+ CW
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 255
Query: 179 SPDRRPHFDQIVSILEG-YSESLEQD 203
+P RP F +I E + ES D
Sbjct: 256 NPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 163 bits (414), Expect = 4e-50
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ K IITE++ GSL +L Q + + ++ + IA GM+YL
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMKYLADMN 148
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS------AKGFTGTYRWMAPEMIKEK 114
+HRDL + N+L+ ++ KV+DFG+S S A G RW APE I+ +
Sbjct: 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 208
Query: 115 RHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLIS 173
+ T DV+S+GIV+WE+++ P+ +MT + A+ +++ R P P CP A L+
Sbjct: 209 KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPPPMDCPSALHQLML 267
Query: 174 RCWSSSPDRRPHFDQIVSILEGYSESLEQDPE 205
CW + RP F QIV+ L + + ++P
Sbjct: 268 DCWQKDRNHRPKFGQIVNTL----DKMIRNPN 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-50
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 5/197 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q C K IITEY+A G L YL + +L++ D+ M+YL S+
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL--ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
LHRDL + N L+ + VKV+DFG+S + + S+ G RW PE++ + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 119 KVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K D+++FG+++WE+ + P++ T + A + Q R P + ++ CW
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSCWH 239
Query: 178 SSPDRRPHFDQIVSILE 194
D RP F ++S +
Sbjct: 240 EKADERPTFKILLSNIL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-49
Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV----------------------P 38
++ + C C++ EY+A G L ++L P++V
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 39 LNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGS 95
L +A +A GM YL + +HRDL + N L+GE+M VK+ADFG+S +
Sbjct: 139 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 198
Query: 96 AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQK 154
RWM PE I R+T + DV+++G+VLWE+ + L P+ M E+ + V
Sbjct: 199 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 258
Query: 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198
N P CP L+ CWS P RP F I IL+ E
Sbjct: 259 N-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-49
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ PP ++TE GSL L + + L + + A+ +A GM YL S+
Sbjct: 74 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRH 116
+HRDL + NLLL VK+ DFG+ + + + W APE +K +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 117 TKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRC 175
+ D + FG+ LWE+ T P+ + Q + ++ R P P CP+ ++ +C
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251
Query: 176 WSSSPDRRPHFDQIVSILE 194
W+ P+ RP F + L
Sbjct: 252 WAHKPEDRPTFVALRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-49
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+IT+ + G L Y+ + + + +L + IA+GM YL + ++HRDL + N+L
Sbjct: 85 VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143
Query: 73 LGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVL 129
+ VK+ DFG++ L E + A+G +WMA E I + +T + DV+S+G+ +
Sbjct: 144 VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
WEL+T + + P ++ +K R P PP C ++ +CW D RP F ++
Sbjct: 204 WELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 263
Query: 190 VSILEGYSESLEQDPEFFSSFIPS 213
+ + +DP+ +
Sbjct: 264 IIEF----SKMARDPQRYLVIQGD 283
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-49
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 8/213 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ K IITEY+ G+L K+L +++ + ++ + IA GM+YL +
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANMN 130
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRH 116
+HRDL + N+L+ ++ KV+DFG+S + + G RW APE I ++
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCW 176
T DV+SFGIV+WE++T R P P CP A L+ +CW
Sbjct: 191 TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250
Query: 177 SSSPDRRPHFDQIVSILEGY---SESLEQDPEF 206
RRP F IVSIL+ +SL+ +F
Sbjct: 251 QQERARRPKFADIVSILDKLIRAPDSLKTLADF 283
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 8e-49
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQ----------------EPYSVPLNLVLKL 45
+ AC +ITEY G L +L ++ + ++ L +L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 46 ALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGT 102
+ +A+GM +L S+ +HRDL + N+LL K+ DFG++ +S
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 103 YRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTP-FDNMTPEQAAFAVCQKNARPPVP 161
+WMAPE I +T + DV+S+GI LWEL + + + M + + + ++ R P
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270
Query: 162 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY-SES 199
P ++ CW + P +RP F QIV ++E SES
Sbjct: 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (403), Expect = 1e-48
Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 10/197 (5%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+Q + F ++ + + G L YL ++ K+ + + LH
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL--SEKETRKIMRALLEVICALHKLN 130
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI------KEK 114
I+HRDLK EN+LL +DM +K+ DFG SC + GT ++APE+I
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190
Query: 115 RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLI 172
+ K+VD++S G++++ LL PF + + N + P L+
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250
Query: 173 SRCWSSSPDRRPHFDQI 189
SR P +R ++
Sbjct: 251 SRFLVVQPQKRYTAEEA 267
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-48
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 6/196 (3%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ Y+ G LR + + E ++ + ++ L +A+GM++L S+ +HRDL + N +
Sbjct: 104 PLVVLPYMKHGDLRNF-IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 162
Query: 73 LGEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGI 127
L E VKVADFG++ + G +WMA E ++ ++ T K DV+SFG+
Sbjct: 163 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGV 222
Query: 128 VLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFD 187
+LWEL+T P + R P CP ++ +CW + RP F
Sbjct: 223 LLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282
Query: 188 QIVSILEGYSESLEQD 203
++VS + + +
Sbjct: 283 ELVSRISAIFSTFIGE 298
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (399), Expect = 3e-47
Identities = 46/223 (20%), Positives = 89/223 (39%), Gaps = 10/223 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
A + +I E+L+GG L + + Y + V+ G++++H I
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 62 LHRDLKSENLLL--GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+H D+K EN++ + VK+ DFG++ + K T T + APE++ +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWS 177
D+++ G++ + LL+ L+PF + V + + + I
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQ 268
Query: 178 SSPDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPDHTILR 220
P +R + L+ D +S IPS + +R
Sbjct: 269 KEPRKRLTVHDALE-----HPWLKGDHSNLTSRIPSSRYNKIR 306
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-47
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 4/195 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + + PV+ II E G LR + Q YS+ L ++ A ++ + YL S+
Sbjct: 72 KLIGVITENPVW-IIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAK--GFTGTYRWMAPEMIKEKRHTKK 119
+HRD+ + N+L+ + CVK+ DFG+S K +WMAPE I +R T
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
DV+ FG+ +WE+L + R P+PP CP L+++CW+
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYD 249
Query: 180 PDRRPHFDQIVSILE 194
P RRP F ++ + L
Sbjct: 250 PSRRPRFTELKAQLS 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 157 bits (397), Expect = 5e-47
Identities = 40/192 (20%), Positives = 81/192 (42%), Gaps = 5/192 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
A + +I E+++GG L + + + + + ++ + +G+ ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 62 LHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
+H DLK EN++ +K+ DFG++ S K TGT + APE+ + K
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCWS 177
D++S G++ + LL+ L+PF ++ V + + I +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLL 265
Query: 178 SSPDRRPHFDQI 189
+ P+ R Q
Sbjct: 266 ADPNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-46
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNL--------------VLKLA 46
+ + AC + +I EY + G+LR+YL + P + + ++ A
Sbjct: 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141
Query: 47 LDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTY 103
+ARGM+YL S+ +HRDL + N+L+ ED +K+ADFG++
Sbjct: 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201
Query: 104 RWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPT 163
+WMAPE + ++ +T + DV+SFG++LWE+ T P + F + ++ R P
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN 261
Query: 164 CPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
C ++ CW + P +RP F Q+V L+
Sbjct: 262 CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-46
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 7/196 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++F ++ + + EY +GG L + P + + G+ YLH G
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM--PEPDAQRFFHQLMAGVVYLHGIG 123
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKR-H 116
I HRD+K ENLLL E +K++DFG++ + ++ GT ++APE++K + H
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA-VCQKNARPPVPPTCPKAFSYLISRC 175
+ VDV+S GIVL +L P+D + ++ +K A L+ +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 176 WSSSPDRRPHFDQIVS 191
+P R I
Sbjct: 244 LVENPSARITIPDIKK 259
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-46
Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 12/225 (5%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ- 59
+ F A I E++ GGSL + L + P ++ K+++ + +G+ YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI--PEQILGKVSIAVIKGLTYLREKH 124
Query: 60 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
I+HRD+K N+L+ +K+ DFG+S A F GT +M+PE ++ ++ +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
D++S G+ L E+ P ++ P S
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMF--GCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 180 PDRRPHFDQIVSILEGYSESLEQDPEFFSSFIPSPD--HTILRCL 222
D RP +I E + + P S + S + + +CL
Sbjct: 242 MDSRPPM----AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-45
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 13/213 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + Y G L KY+ + + +I ++YLH +G
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLHGKG 128
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCL---ESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
I+HRDLK EN+LL EDM +++ DFG + + ES+ A F GT ++++PE++ EK
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWS 177
K D+++ G ++++L+ L PF + P L+ +
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII--KLEYDFPEKFFPKARDLVEKLLV 246
Query: 178 SSPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 210
+R +++ L+ P FF S
Sbjct: 247 LDATKRLGCEEMEGYGP-----LKAHP-FFESV 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 29/193 (15%), Positives = 72/193 (37%), Gaps = 5/193 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ + + +I E+++G + + ++ + + ++ + +Q+LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 61 ILHRDLKSENLLLG--EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
I H D++ EN++ +K+ +FG + + + + APE+ + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCW 176
D++S G +++ LL+ + PF T +Q + + R
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 177 SSSPDRRPHFDQI 189
R +
Sbjct: 243 VKERKSRMTASEA 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-44
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 13/221 (5%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSV--------PLNLVLKLALDIARG 52
++ + + +I E + G L+ YL P L+ ++++A +IA G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 53 MQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFT---GTYRWMAPE 109
M YL++ +HRDL + N ++ ED VK+ DFG++ + + RWM+PE
Sbjct: 146 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205
Query: 110 MIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAF 168
+K+ T DV+SFG+VLWE+ T A P+ ++ EQ V + P CP
Sbjct: 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDNCPDML 264
Query: 169 SYLISRCWSSSPDRRPHFDQIVSILEGYSESLEQDPEFFSS 209
L+ CW +P RP F +I+S ++ E ++ F+ S
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 305
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-44
Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 9/196 (4%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 62
+ I+ E L GG L + + + ++ I +QYLHS I
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 133
Query: 63 HRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKK 119
HRD+K ENLL + +K+ DFG + + S T ++APE++ +++ K
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 193
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP------PVPPTCPKAFSYLIS 173
D++S G++++ LL PF + + + + P + LI
Sbjct: 194 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 253
Query: 174 RCWSSSPDRRPHFDQI 189
+ P +R +
Sbjct: 254 NLLKTEPTQRMTITEF 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-44
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 5 AACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVP--------------LNLVLKLALDIA 50
A K +I E+ G+L YL + VP L ++ + +A
Sbjct: 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 144
Query: 51 RGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMA 107
+GM++L S+ +HRDL + N+LL E VK+ DFG++ + +WMA
Sbjct: 145 KGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 204
Query: 108 PEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARPPVPPTCPK 166
PE I ++ +T + DV+SFG++LWE+ + +P+ + ++ ++ R P
Sbjct: 205 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 264
Query: 167 AFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199
+ CW P +RP F ++V L ++
Sbjct: 265 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 4e-44
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 7/193 (3%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ +I + ++GG L + ++ Y +L + ++YLH GI
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFY--TERDASRLIFQVLDAVKYLHDLGI 128
Query: 62 LHRDLKSENLLL---GEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
+HRDLK ENLL ED + ++DFG+S +E GT ++APE++ +K ++K
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVP--PTCPKAFSYLISRCW 176
VD +S G++ + LL PF + + + + P + I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248
Query: 177 SSSPDRRPHFDQI 189
P++R +Q
Sbjct: 249 EKDPEKRFTCEQA 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-44
Identities = 58/242 (23%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 1 MQFVAACKKP----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYL 56
+ F+AA K ++++Y GSL YL++ Y+V + ++KLAL A G+ +L
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHL 116
Query: 57 HSQ--------GILHRDLKSENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTY 103
H + I HRDLKS+N+L+ ++ +AD G++ + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 104 RWMAPEMIKEKRH------TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-------- 149
R+MAPE++ + + K+ D+Y+ G+V WE+ + Q +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 150 -------AVCQKNARPPVP-----PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197
VC++ RP +P + + ++ CW ++ R +I L S
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 198 ES 199
+
Sbjct: 297 QQ 298
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 6e-44
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 5/184 (2%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ + EYL GG L ++ + L+ A +I G+Q+LHS+GI
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF--DLSRATFYAAEIILGLQFLHSKGI 124
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISC-LESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
++RDLK +N+LL +D +K+ADFG+ F GT ++APE++ +++ V
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 184
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
D +SFG++L+E+L +PF E+ + P P K L+ + + P
Sbjct: 185 DWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFYPRWLEKEAKDLLVKLFVREP 242
Query: 181 DRRP 184
++R
Sbjct: 243 EKRL 246
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (362), Expect = 1e-42
Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 8/188 (4%)
Query: 3 FVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGIL 62
A P+ I+ EY+ G +LR +H + P + +++ D + + + H GI+
Sbjct: 76 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR--AIEVIADACQALNFSHQNGII 133
Query: 63 HRDLKSENLLLGEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMIKEKRHTK 118
HRD+K N+++ VKV DFGI+ + GT ++++PE +
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRCW 176
+ DVYS G VL+E+LT PF +P A+ +++ PP ++ +
Sbjct: 194 RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKAL 253
Query: 177 SSSPDRRP 184
+ +P+ R
Sbjct: 254 AKNPENRY 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (365), Expect = 3e-42
Identities = 50/212 (23%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ A P I + + GG L +L Q +S + A +I G++++H++
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRFYAAEIILGLEHMHNRF 127
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKK 119
+++RDLK N+LL E V+++D G++C S+ GT+ +MAPE++ K +
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 120 VDVYSFGIVLWELLTALTPFDNMTP-EQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
D +S G +L++LL +PF ++ +P + L+
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246
Query: 179 SPDRRPHFDQIVSILEGYSESLEQDPEFFSSF 210
+RR L ++ +++ P FF S
Sbjct: 247 DVNRRL------GCLGRGAQEVKESP-FFRSL 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (344), Expect = 1e-39
Identities = 37/219 (16%), Positives = 78/219 (35%), Gaps = 21/219 (9%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ ++ + L G + L + V A + +Q +H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 61 ILHRDLKSENLLLGEDMC-----VKVADFGISCLESQCGS--------AKGFTGTYRWMA 107
+++RD+K +N L+G + V DFG+ + K +GT R+M+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 108 PEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPE---QAAFAVCQKNARPPV---P 161
+ +++ D+ + G V L P+ + Q + +K P+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 162 PTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200
P+ F + + + D P +D + + E L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 135 bits (342), Expect = 4e-39
Identities = 51/188 (27%), Positives = 92/188 (48%), Gaps = 6/188 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + +I +Y+ GG L L + + + P + A ++ ++YLHS+
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLHSKD 124
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
I++RDLK EN+LL ++ +K+ DFG + GT ++APE++ K + K +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
D +SFGI+++E+L TPF + + + NA PP + L+SR +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLSRLITRDL 240
Query: 181 DRRPHFDQ 188
+R Q
Sbjct: 241 SQRLGNLQ 248
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 8e-39
Identities = 37/210 (17%), Positives = 74/210 (35%), Gaps = 19/210 (9%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ ++ E L + + L VL LA + ++Y+HS+
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKNF 124
Query: 62 LHRDLKSENLL---LGEDMCVKVADFGISCLESQCGS--------AKGFTGTYRWMAPEM 110
+HRD+K +N L + V + DFG++ + K TGT R+ +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 111 IKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR------PPVPPTC 164
+++ D+ S G VL P+ + + + + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 165 PKAFSYLISRCWSSSPDRRPHFDQIVSILE 194
P F+ ++ C S D +P + + +
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-38
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 8/194 (4%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ +I E +AGG L +L ++E + I G+ YLHS I
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESL--TEEEATEFLKQILNGVYYLHSLQI 134
Query: 62 LHRDLKSENLLLGEDMC----VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHT 117
H DLK EN++L + +K+ DFG++ K GT ++APE++ +
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194
Query: 118 KKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP--VPPTCPKAFSYLISRC 175
+ D++S G++ + LL+ +PF T ++ V N I R
Sbjct: 195 LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRL 254
Query: 176 WSSSPDRRPHFDQI 189
P +R
Sbjct: 255 LVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-37
Identities = 42/191 (21%), Positives = 80/191 (41%), Gaps = 12/191 (6%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + ++P F +I E + ++ L + +++ H+ G
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 130
Query: 61 ILHRDLKSENLLLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-EKRHTK 118
+LHRD+K EN+L+ + +K+ DFG L F GT + PE I+ + H +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGR 189
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSS 178
V+S GI+L++++ PF++ + +LI C +
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHDEE--------IIRGQVFFRQRVSSECQHLIRWCLAL 241
Query: 179 SPDRRPHFDQI 189
P RP F++I
Sbjct: 242 RPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-36
Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 5/185 (2%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
A + C + EY GG L +L ++ + +I ++YLHS+
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVF--TEERARFYGAEIVSALEYLHSRD 125
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS-AKGFTGTYRWMAPEMIKEKRHTKK 119
+++RD+K ENL+L +D +K+ DFG+ G+ K F GT ++APE++++ + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSS 179
VD + G+V++E++ PF N E+ + P T L++
Sbjct: 186 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRTLSPEAKSLLAGLLKKD 243
Query: 180 PDRRP 184
P +R
Sbjct: 244 PKQRL 248
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-34
Identities = 38/202 (18%), Positives = 76/202 (37%), Gaps = 26/202 (12%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E++ YL + VP + + + RG+ +LHS ++HRDLK +N+L
Sbjct: 90 LTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNIL 148
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ +K+ADFG++ + S + T + APE++ + + VD++S G + E+
Sbjct: 149 VTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 208
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPP-------------------------VPPTCPKA 167
F + + P +
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL 268
Query: 168 FSYLISRCWSSSPDRRPHFDQI 189
L+ +C + +P +R
Sbjct: 269 GKDLLLKCLTFNPAKRISAYSA 290
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 3e-34
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 8/190 (4%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ A + +I +Y+ GG L +L Q+E + + V +I +++LH G
Sbjct: 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--TEHEVQIYVGEIVLALEHLHKLG 149
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS--AKGFTGTYRWMAPEMI--KEKRH 116
I++RD+K EN+LL + V + DFG+S + A F GT +MAP+++ + H
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209
Query: 117 TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK--NARPPVPPTCPKAFSYLISR 174
K VD +S G++++ELLT +PF + + + ++ + PP P LI R
Sbjct: 210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 269
Query: 175 CWSSSPDRRP 184
P +R
Sbjct: 270 LLMKDPKKRL 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (306), Expect = 1e-33
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 6/184 (3%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + K ++ EY+AGG + +L + +S P A I +YLHS
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH--ARFYAAQIVLTFEYLHSLD 161
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKV 120
+++RDLK ENLL+ + ++V DFG + G GT +APE+I K + K V
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 121 DVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSP 180
D ++ G++++E+ PF P Q + + + P L+
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIV--SGKVRFPSHFSSDLKDLLRNLLQVDL 277
Query: 181 DRRP 184
+R
Sbjct: 278 TKRF 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-29
Identities = 42/217 (19%), Positives = 75/217 (34%), Gaps = 30/217 (13%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ + A ++ +++ + + L +G++YLH
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL--TPSHIKAYMLMTLQGLEYLHQHW 120
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGIS-CLESQCGSAKGFTGTYRWMAPEMIKEKR-HTK 118
ILHRDLK NLLL E+ +K+ADFG++ S + T + APE++ R +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------- 159
VD+++ G +L ELL + + + + P
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 160 -------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ LI + +P R Q
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-29
Identities = 45/207 (21%), Positives = 74/207 (35%), Gaps = 30/207 (14%)
Query: 13 FCIITEYLAGGSLRKYLH-QQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENL 71
++ +Y+ R H + ++P+ V + R + Y+HS GI HRD+K +NL
Sbjct: 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153
Query: 72 LLGED-MCVKVADFGISCLESQCGSAKGFTGTYRWMAP-EMIKEKRHTKKVDVYSFGIVL 129
LL D +K+ DFG + + + + + AP + +T +DV+S G VL
Sbjct: 154 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 130 WELLTALTPFDNMTPEQAAFAVCQKNARPP---------------------------VPP 162
ELL F + + + P P
Sbjct: 214 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 273
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQI 189
P L SR +P R +
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-28
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 37/210 (17%)
Query: 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLL 73
+ +L G L K L Q + + + I RG++Y+HS +LHRDLK NLLL
Sbjct: 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142
Query: 74 GEDMCVKVADFGISCL----ESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIV 128
+K+ DFG++ + G + T + APE++ K +TK +D++S G +
Sbjct: 143 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 202
Query: 129 LWELLTALTPFDNMTPEQAAFAVCQKNARPP----------------------------- 159
L E+L+ F + P
Sbjct: 203 LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR 262
Query: 160 VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
+ P L+ + + +P +R +Q
Sbjct: 263 LFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-28
Identities = 44/218 (20%), Positives = 84/218 (38%), Gaps = 30/218 (13%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
++ + ++ E+L L+K++ +PL L+ + +G+ + HS
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRW-MAPEMI-KEKRHTK 118
+LHRDLK +NLL+ + +K+ADFG++ W APE++ K ++
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 119 KVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------- 159
VD++S G + E++T F + F + + P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242
Query: 160 --------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
V P + L+S+ P++R
Sbjct: 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-28
Identities = 37/214 (17%), Positives = 75/214 (35%), Gaps = 40/214 (18%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ ++ + +++ + ++ + G+ Y+H ILHRD+K+ N+L
Sbjct: 92 IYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLLNGLYYIHRNKILHRDMKAANVL 149
Query: 73 LGEDMCVKVADFGISCL-----ESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFG 126
+ D +K+ADFG++ SQ T + PE++ E+ + +D++ G
Sbjct: 150 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 209
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSY---------------- 170
++ E+ T T + + Q P P +Y
Sbjct: 210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT-PEVWPNVDNYELYEKLELVKGQKRKV 268
Query: 171 ---------------LISRCWSSSPDRRPHFDQI 189
LI + P +R D
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 103 bits (257), Expect = 4e-27
Identities = 33/217 (15%), Positives = 70/217 (32%), Gaps = 31/217 (14%)
Query: 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGI 61
+ ++ E+L + + L + G+ Y H + +
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGL--ESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 62 LHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI--KEKRHTKK 119
LHRDLK +NLL+ + +K+ADFG++ W + K+++
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 120 VDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP-------------------- 159
+D++S G + E++ F ++ + + P
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241
Query: 160 -------VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
++ L+S+ P++R Q
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 99 bits (248), Expect = 2e-25
Identities = 25/175 (14%), Positives = 66/175 (37%), Gaps = 7/175 (4%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E++ ++ ++ + +I + + Y HS GI+HRD+K N++
Sbjct: 107 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161
Query: 73 LG-EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPE-MIKEKRHTKKVDVYSFGIVLW 130
+ E +++ D+G++ + + PE ++ + + +D++S G +L
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 131 ELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPH 185
++ PF + K ++ + ++ R
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSR 276
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 3e-25
Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 36/207 (17%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
F ++ ++ G+ L + E + + L + +G++Y+H+ GI+HRDLK NL
Sbjct: 98 FYLVMPFM--GTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA 153
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMI-KEKRHTKKVDVYSFGIVLWE 131
+ ED +K+ DFG++ G+ T + APE+I R+T+ VD++S G ++ E
Sbjct: 154 VNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211
Query: 132 LLTALTPFDNMTPEQAAFAVCQKNARPP-----------------------------VPP 162
++T T F + + PP +
Sbjct: 212 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 271
Query: 163 TCPKAFSYLISRCWSSSPDRRPHFDQI 189
L+ + ++R +
Sbjct: 272 NASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 3e-24
Identities = 34/213 (15%), Positives = 67/213 (31%), Gaps = 32/213 (15%)
Query: 7 CKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66
++ E+ + + +V + +G+ + HS+ +LHRDL
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAP--EMIKEKRHTKKVDVYS 124
K +NLL+ + +K+A+FG++ W P + K ++ +D++S
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187
Query: 125 FGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP------------------------- 159
G + EL A P + P
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS 247
Query: 160 ---VPPTCPKAFSYLISRCWSSSPDRRPHFDQI 189
V P L+ +P +R ++
Sbjct: 248 LVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 1e-23
Identities = 38/210 (18%), Positives = 76/210 (36%), Gaps = 11/210 (5%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
++ E + + + + L + G+++LHS GI+HRDLK N++
Sbjct: 97 VYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ D +K+ DFG++ + T + APE+I + + VD++S G ++ E+
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSI 192
+ F V ++ P F + + + RP + +
Sbjct: 212 VRHKILFPGRDYIDQWNKVIEQLGTP------CPEFMKKLQPTVRNYVENRPKYAGLTFP 265
Query: 193 LEGYSESLEQDPEFFSSFIPSPDHTILRCL 222
D E + + L
Sbjct: 266 KLFPDSLFPADSEHNKLKASQARDLLSKML 295
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 1e-21
Identities = 49/238 (20%), Positives = 82/238 (34%), Gaps = 36/238 (15%)
Query: 13 FCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72
+ +L G L + Q+ + V L I RG++Y+HS I+HRDLK NL
Sbjct: 97 DVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153
Query: 73 LGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWEL 132
+ ED +K+ DFG++ + T Y M+ + + VD++S G ++ EL
Sbjct: 154 VNEDCELKILDFGLARHTDDEMTGYVATRWY-RAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 133 LTALTPFDNMTPEQAAFAVCQKNARPP-----------------------------VPPT 163
LT T F + + P V
Sbjct: 213 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG 272
Query: 164 CPKAFSYLISRCWSSSPDRRPHFDQIVS---ILEGYSESLEQDPEFFSSFIPSPDHTI 218
L+ + D+R Q ++ + + E + + S D I
Sbjct: 273 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLI 330
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.9 bits (193), Expect = 1e-17
Identities = 36/216 (16%), Positives = 75/216 (34%), Gaps = 5/216 (2%)
Query: 12 VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLH-SQGILHRDLKSEN 70
V ++ + G +L + + E +PL V +++ + G+ Y+H GI+H D+K EN
Sbjct: 97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156
Query: 71 LLL-GEDMCVKVADFGISCLESQCGSAKG---FTGTYRWMAPEMIKEKRHTKKVDVYSFG 126
+L+ D + I+ L + C + T + +PE++ D++S
Sbjct: 157 VLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 216
Query: 127 IVLWELLTALTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHF 186
+++EL+T F+ + P + R
Sbjct: 217 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 276
Query: 187 DQIVSILEGYSESLEQDPEFFSSFIPSPDHTILRCL 222
+ + L + +F + L
Sbjct: 277 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.2 bits (132), Expect = 4e-10
Identities = 19/134 (14%), Positives = 46/134 (34%), Gaps = 24/134 (17%)
Query: 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG 60
+ + + V + + L + + +E Y V + ++ I + + +G
Sbjct: 65 FRALQKLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG 123
Query: 61 ILHRDLKSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIK-------- 112
I+H DL N+L+ + + + DF S E+++
Sbjct: 124 IVHGDLSQYNVLVS-EEGIWIIDFPQS------------VEVGEEGWREILERDVRNIIT 170
Query: 113 --EKRHTKKVDVYS 124
+ + + D+ S
Sbjct: 171 YFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 244 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.64 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.91 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.13 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.47 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=308.73 Aligned_cols=186 Identities=27% Similarity=0.475 Sum_probs=168.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 69 v~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEe
Confidence 689999999999999999999999999998876 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. ......
T Consensus 147 l~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~ 223 (263)
T d2j4za1 147 IADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTF 223 (263)
T ss_dssp ECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCC
T ss_pred ecccceeeecCCC-cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCC
Confidence 9999999765432 3445679999999999999999999999999999999999999999888777666554 334567
Q ss_pred CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+..+++++.+|+.+||+.||.+|||++|+++
T Consensus 224 p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 7889999999999999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=306.10 Aligned_cols=188 Identities=27% Similarity=0.514 Sum_probs=167.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|+||||++||+|.+++.+. .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 80 v~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vk 156 (293)
T d1yhwa1 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVK 156 (293)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred eeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEe
Confidence 68999999999999999999999999998764 489999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-CCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN-ARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~ 158 (244)
|+|||++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+.... ...
T Consensus 157 l~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~ 236 (293)
T d1yhwa1 157 LTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236 (293)
T ss_dssp ECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC
T ss_pred eccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 9999999765432 34456679999999999999999999999999999999999999999888777666555443 334
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..+..+++++++||.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 556778999999999999999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=304.07 Aligned_cols=198 Identities=35% Similarity=0.651 Sum_probs=164.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.. +..++||||++||+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 67 v~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~K 144 (276)
T d1uwha_ 67 LLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVK 144 (276)
T ss_dssp CCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEE
T ss_pred eeeeEEEec-cEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEE
Confidence 678998765 567899999999999999986543 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC---CCCCCCcccceeccceeccC---CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEK---RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+...........
T Consensus 145 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 224 (276)
T d1uwha_ 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224 (276)
T ss_dssp ECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH
T ss_pred EccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 99999997654322 23456799999999998643 4788999999999999999999999987766555444443
Q ss_pred CCCC----CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhc
Q 026042 155 NARP----PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESL 200 (244)
Q Consensus 155 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~ 200 (244)
.... ..+..+++++.+++.+||+.||++|||++++++.|+.+..++
T Consensus 225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 3322 345678999999999999999999999999999999877654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=312.33 Aligned_cols=194 Identities=27% Similarity=0.526 Sum_probs=172.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP---------------------YSVPLNLVLKLALDIARGMQYLHSQ 59 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---------------------~~~~~~~~~~~~~~l~~~L~~lH~~ 59 (244)
|++++++.+.+..|+||||++||+|.++++++.. ..+++..++.++.|++.||+|||++
T Consensus 104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~ 183 (325)
T d1rjba_ 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 183 (325)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 6899999999999999999999999999976532 2478899999999999999999999
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-C
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-A 135 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 135 (244)
||+||||||+||+++.++.+||+|||+|+....... .....||+.|+|||.+.++.++.++|||||||++|||++ |
T Consensus 184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 999999999999999999999999999976544332 234557999999999999999999999999999999997 8
Q ss_pred CCCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 026042 136 LTPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILE 194 (244)
Q Consensus 136 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~ 194 (244)
..||.+.+.......+.........+..+++++.+||.+||+.||++|||++||++.|.
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99999877766666666677777888899999999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=305.14 Aligned_cols=196 Identities=34% Similarity=0.622 Sum_probs=164.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..++..++||||+++|+|.+++....+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 90 v~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred ccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEE
Confidence 6899999999999999999999999999887543 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC------CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q 026042 81 VADFGISCLESQCGS------AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 81 l~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 153 (244)
|+|||+++....... .....+++.|+|||.+.++.++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~- 247 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE- 247 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999976443222 112357889999999999999999999999999999998 899999988877666554
Q ss_pred hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 154 KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 154 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.....+.+..+++.+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 445566778899999999999999999999999999999987654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=305.81 Aligned_cols=189 Identities=24% Similarity=0.378 Sum_probs=156.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc---CCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG---EDM 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~---~~~ 77 (244)
|++++++.+++.+||||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++|++||||||+||++. .+|
T Consensus 70 v~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~ 147 (307)
T d1a06a_ 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 147 (307)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC
T ss_pred CcEEEEEEECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCc
Confidence 689999999999999999999999999998765 699999999999999999999999999999999999995 478
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 148 ~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 148 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp CEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC
T ss_pred eEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC
Confidence 89999999998766655566778999999999999999999999999999999999999999998887777666554443
Q ss_pred C--CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 P--PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. +....+++++.+|+.+||+.||.+|||++|+++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 3 334678999999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-46 Score=303.62 Aligned_cols=196 Identities=33% Similarity=0.602 Sum_probs=170.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+++..++||||+++|+|.+++.+.....+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 76 v~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred ecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEE
Confidence 68999999999999999999999999999887666899999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPF-DNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++....... .....|++.|+|||.+.+..++.++||||||+++|||++|..|+ .+.+... ..........
T Consensus 156 l~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~ 234 (287)
T d1opja_ 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYR 234 (287)
T ss_dssp ECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCC
T ss_pred EccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCC
Confidence 999999976543222 22345788999999999999999999999999999999966654 4555544 4444456667
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
...+..+++++.+|+.+||+.||.+|||++++++.|+.+.
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 7888899999999999999999999999999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=304.50 Aligned_cols=189 Identities=26% Similarity=0.403 Sum_probs=161.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..||||||++||+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus 66 v~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~K 143 (271)
T d1nvra_ 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLK 143 (271)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred eeEeeeeccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEE
Confidence 689999999999999999999999999998655 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HHHhhC
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAF-AVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~ 155 (244)
|+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+...... ......
T Consensus 144 L~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~ 223 (271)
T d1nvra_ 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223 (271)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred EccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence 9999999764332 23456679999999999988775 678999999999999999999997655433322 222233
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+++++.+|+.+||+.||.+|||++|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333344678899999999999999999999999876
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=298.21 Aligned_cols=196 Identities=28% Similarity=0.609 Sum_probs=163.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus 63 v~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~K 141 (263)
T d1sm2a_ 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIK 141 (263)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEE
T ss_pred ccccceeccCCceEEEEEecCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeE
Confidence 6899999999999999999999999999877543 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++...... ......|+..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ....
T Consensus 142 l~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~ 220 (263)
T d1sm2a_ 142 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFR 220 (263)
T ss_dssp ECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCC
T ss_pred ecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCC
Confidence 99999997654332 2334568999999999999999999999999999999999 567777767666555543 4556
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+..+++++.+++.+||+.||.+|||++++++.|+++.+
T Consensus 221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 67778899999999999999999999999999999998754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=304.67 Aligned_cols=187 Identities=25% Similarity=0.426 Sum_probs=165.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+++.+|.+|
T Consensus 71 v~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vk 148 (288)
T d1uu3a_ 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ 148 (288)
T ss_dssp CCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred eEEEEEEEECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEE
Confidence 689999999999999999999999999998876 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~ 226 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--E 226 (288)
T ss_dssp ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--C
T ss_pred ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--C
Confidence 9999999765332 2334567999999999999999999999999999999999999999998877776665433 3
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+++++.+||.+||+.||.+|||++|+++
T Consensus 227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 4567889999999999999999999999999765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=299.55 Aligned_cols=198 Identities=27% Similarity=0.575 Sum_probs=171.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..+ ..|+||||+++|+|.+++..... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 72 v~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~K 149 (285)
T d1u59a_ 72 VRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 149 (285)
T ss_dssp CCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTT-TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEE
T ss_pred eeEeeeeccC-eEEEEEEeCCCCcHHHHhhcccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCcee
Confidence 6899999764 57899999999999999866443 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||+++...... ......|++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+ ...
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-~~~ 228 (285)
T d1u59a_ 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQG 228 (285)
T ss_dssp ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTT
T ss_pred eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcC
Confidence 99999997544322 2334568899999999998999999999999999999998 99999988877665544 355
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
.+...+..+|+++.+|+.+||+.||++|||+.++++.|+.....+.
T Consensus 229 ~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 5677888999999999999999999999999999999987665443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=298.47 Aligned_cols=194 Identities=28% Similarity=0.551 Sum_probs=168.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|..+ ..+|||||+++|+|.+++++.. .+++..++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 71 v~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~k 147 (277)
T d1xbba_ 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAK 147 (277)
T ss_dssp CCEEEEEESS-SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEeccC-CEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCccc
Confidence 6899999754 5789999999999999998766 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+. ..
T Consensus 148 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~ 226 (277)
T d1xbba_ 148 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KG 226 (277)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TT
T ss_pred ccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cC
Confidence 99999987543322 2234568999999999999999999999999999999998 899999988776655543 45
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.....+..+|+++.+|+.+||+.||.+|||++++++.|+.+..
T Consensus 227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 5677888999999999999999999999999999999887654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=303.07 Aligned_cols=190 Identities=26% Similarity=0.470 Sum_probs=165.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|.+++.+..+ .+++..+..++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus 72 v~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~K 150 (288)
T d2jfla1 72 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIK 150 (288)
T ss_dssp CCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred CeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEE
Confidence 6899999999999999999999999999876543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceec-----cCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIK-----EKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++...... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 151 l~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 151 LADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp ECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred EEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 9999998654332 2234568999999999884 456789999999999999999999999988877776665544
Q ss_pred CC-CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NA-RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ....+..+++++.+||.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 32 23445678999999999999999999999999976
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=300.51 Aligned_cols=190 Identities=25% Similarity=0.450 Sum_probs=154.3
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CccCCCCCCcE
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQ--EPYSVPLNLVLKLALDIARGMQYLHSQG-----ILHRDLKSENL 71 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~l~~~L~~lH~~~-----i~H~dikp~ni 71 (244)
|++++++. .++.+|+||||++||+|.+++.+. .+..+++..++.++.|++.||.|||++| |+||||||+||
T Consensus 66 v~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NI 145 (269)
T d2java1 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145 (269)
T ss_dssp CCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGE
T ss_pred eeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhc
Confidence 67899885 456789999999999999999653 2346999999999999999999999976 99999999999
Q ss_pred EEcCCCcEEEecCCCccccccc-CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 72 LLGEDMCVKVADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 72 l~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
+++.+|.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 146 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~ 225 (269)
T d2java1 146 FLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 225 (269)
T ss_dssp EECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999999999765432 234567899999999999999999999999999999999999999999888776666
Q ss_pred HHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+.. ......+..+++++.+|+.+||+.||.+|||++|+++
T Consensus 226 i~~-~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IRE-GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 544 3445677889999999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=299.55 Aligned_cols=197 Identities=32% Similarity=0.620 Sum_probs=169.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+ +..++||||+++|+|.+++....+..+++..++.++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 71 v~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~K 149 (272)
T d1qpca_ 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCK 149 (272)
T ss_dssp CCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEE
T ss_pred eEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccccee
Confidence 689998865 4568999999999999988765555689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++| ..|+...+..+....+ .....
T Consensus 150 l~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i-~~~~~ 228 (272)
T d1qpca_ 150 IADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYR 228 (272)
T ss_dssp ECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCC
T ss_pred eccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCC
Confidence 99999997654322 33456688999999999988999999999999999999995 5556666665555444 45566
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
...+..+++++.+|+.+||+.||++|||++++++.|+.+..+
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 777889999999999999999999999999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-46 Score=301.23 Aligned_cols=186 Identities=27% Similarity=0.465 Sum_probs=166.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+|||||.+|+|..++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+|
T Consensus 78 v~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp CCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEE
T ss_pred eeEEEEEEECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEE
Confidence 689999999999999999999999987776655 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc---CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE---KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 156 l~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~ 232 (309)
T d1u5ra_ 156 LGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232 (309)
T ss_dssp ECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred EeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 999999976543 345679999999999854 45789999999999999999999999998888777776666655
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+++++.+||.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 5566789999999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=300.93 Aligned_cols=187 Identities=25% Similarity=0.418 Sum_probs=169.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 68 v~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEeeeccccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEE
Confidence 689999999999999999999999999999877 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ...
T Consensus 146 l~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~ 223 (337)
T d1o6la_ 146 ITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIR 223 (337)
T ss_dssp ECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred EeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCC
Confidence 999999976543 33455678999999999999999999999999999999999999999998887776655443 356
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
.+..+++++.+||.+||++||.+|++ ++|+++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 77889999999999999999999995 788876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=294.81 Aligned_cols=187 Identities=26% Similarity=0.492 Sum_probs=158.1
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CccCCCCCCcEEEc
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQG--ILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~nil~~ 74 (244)
|++++++.. +..+|+||||++||+|.+++.+.. .+++..++.++.|++.||.|||++| |+||||||+||+++
T Consensus 71 v~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~ 148 (270)
T d1t4ha_ 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 148 (270)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES
T ss_pred eeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee
Confidence 678898854 566899999999999999998876 5899999999999999999999998 99999999999997
Q ss_pred C-CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Q 026042 75 E-DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAA-FAVC 152 (244)
Q Consensus 75 ~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~ 152 (244)
+ ++.+||+|||++..... .......||+.|+|||++.+ +++.++|||||||++|+|++|+.||.+....... ..+.
T Consensus 149 ~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~ 226 (270)
T d1t4ha_ 149 GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226 (270)
T ss_dssp STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred CCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence 4 78999999999975433 23446689999999999865 5899999999999999999999999876544443 3333
Q ss_pred hhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 153 QKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 153 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........+..+++++.++|.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 333333455678899999999999999999999999986
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.6e-46 Score=305.65 Aligned_cols=190 Identities=21% Similarity=0.325 Sum_probs=169.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC--CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE--DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~--~~~ 78 (244)
|++++++.+++.+||||||++||+|.+++.+..+ .+++..++.++.||+.||.|||++|++||||||+||+++. +|.
T Consensus 86 v~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~ 164 (350)
T d1koaa2 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE 164 (350)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCC
T ss_pred CcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCe
Confidence 6899999999999999999999999999965443 5899999999999999999999999999999999999964 678
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 165 vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 244 (350)
T d1koaa2 165 LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 244 (350)
T ss_dssp EEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS
T ss_pred EEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99999999987666555666789999999999999999999999999999999999999999988888777766554433
Q ss_pred C--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+++++.+||.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 23568899999999999999999999999988
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-45 Score=304.76 Aligned_cols=190 Identities=20% Similarity=0.312 Sum_probs=170.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc--CCCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG--EDMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~--~~~~ 78 (244)
|++++++.+++.+|||||||+||+|.+++.+... .+++..++.++.||+.||.|||++||+||||||+|||++ .+|.
T Consensus 89 v~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~ 167 (352)
T d1koba_ 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS 167 (352)
T ss_dssp CCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC-CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCC
T ss_pred CcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCe
Confidence 6899999999999999999999999998876543 689999999999999999999999999999999999998 5689
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||++.............|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 168 vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 247 (352)
T d1koba_ 168 VKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 247 (352)
T ss_dssp EEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99999999987766555566789999999999999999999999999999999999999999988888777766554432
Q ss_pred --CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 --PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+++++.+||.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 344678999999999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=302.47 Aligned_cols=192 Identities=23% Similarity=0.458 Sum_probs=159.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQ-GILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~nil~~~~~~~ 79 (244)
|+++++|.+++.+|+||||++||+|.+++.+.+ .+++..++.++.|++.||.|||++ ||+||||||+||+++.+|.+
T Consensus 67 v~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~v 144 (322)
T d1s9ja_ 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144 (322)
T ss_dssp CCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCE
T ss_pred CcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCE
Confidence 689999999999999999999999999998876 589999999999999999999974 99999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-------- 151 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------- 151 (244)
||+|||+|...... .....+||+.|+|||++.+.+++.++||||+||++|+|++|+.||.+.+........
T Consensus 145 kl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~ 223 (322)
T d1s9ja_ 145 KLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223 (322)
T ss_dssp EECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------
T ss_pred EEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCc
Confidence 99999999765432 344678999999999999999999999999999999999999999765432211100
Q ss_pred ---------------------------------HhhCCCCCC-CCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 152 ---------------------------------CQKNARPPV-PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 152 ---------------------------------~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
......+.. ...++.++.+|+.+||+.||.+|||++|+++ ++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000111111 1346789999999999999999999999998 5554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-45 Score=292.67 Aligned_cols=189 Identities=25% Similarity=0.399 Sum_probs=168.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..||||||++||+|.++++.++ .+++..++.++.||+.||+|||++|++||||||+||+++.++.+|
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~k 150 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 150 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEE
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeE
Confidence 689999999999999999999999999998876 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE------KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
|+|||++.............||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+...
T Consensus 151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 999999987766556667789999999998753 34688999999999999999999999998887777666655
Q ss_pred CCCCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
..... ...++|+++++|+.+||+.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 44333 33578999999999999999999999999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=295.95 Aligned_cols=189 Identities=25% Similarity=0.360 Sum_probs=169.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC---
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM--- 77 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~--- 77 (244)
|++++++.+++.+||||||++||+|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.+|
T Consensus 76 v~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSS
T ss_pred CcEEEEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcc
Confidence 689999999999999999999999999998876 689999999999999999999999999999999999998776
Q ss_pred -cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Q 026042 78 -CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 78 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
.+|++|||++.............+++.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+.....
T Consensus 154 ~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~ 233 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233 (293)
T ss_dssp CCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC
T ss_pred cceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence 4999999999877665666677899999999999999999999999999999999999999999888877766654433
Q ss_pred CCC--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 RPP--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... .+..+++.+.+||.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 322 23678999999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=292.12 Aligned_cols=196 Identities=34% Similarity=0.619 Sum_probs=163.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+.+..++|+||+.+++|.+++....+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 72 v~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~K 150 (283)
T d1mqba_ 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCK 150 (283)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred eeeeEEEecCCceEEEEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEE
Confidence 6899999999999999999999999998876543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++| ..|+...+..+.... ....
T Consensus 151 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~ 229 (283)
T d1mqba_ 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDG 229 (283)
T ss_dssp ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTT
T ss_pred EcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-Hhcc
Confidence 99999997643322 22344678999999999999999999999999999999995 445555565555444 4455
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
...+.+..++..+.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 6677888899999999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=288.22 Aligned_cols=193 Identities=29% Similarity=0.566 Sum_probs=171.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+++..++||||+++|+|.+++..... .+++..+++++.|+++||+|||++|++||||||+||+++.++.+|
T Consensus 62 v~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~k 140 (258)
T d1k2pa_ 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK 140 (258)
T ss_dssp CCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEE
T ss_pred eeEEEEEeeCCceEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEE
Confidence 6899999999999999999999999999876543 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC--CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCGS--AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+. ....
T Consensus 141 l~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~ 219 (258)
T d1k2pa_ 141 VSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLR 219 (258)
T ss_dssp ECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCC
T ss_pred ECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCC
Confidence 999999975443322 234568999999999999999999999999999999998 899999999887766554 4556
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEG 195 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~ 195 (244)
...+..+++++.+|+.+||+.||++|||++++++.|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 77888999999999999999999999999999998854
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=296.45 Aligned_cols=198 Identities=27% Similarity=0.532 Sum_probs=163.8
Q ss_pred CcEEEEeec-CCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCC
Q 026042 1 MQFVAACKK-PPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRD 65 (244)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~d 65 (244)
|++++++.. +...++||||+++|+|.++++... ...+++..++.++.|++.||.|||++||+|||
T Consensus 80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrD 159 (299)
T d1ywna1 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 159 (299)
T ss_dssp CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCc
Confidence 456777644 557899999999999999997543 22478999999999999999999999999999
Q ss_pred CCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC-CCCCCC
Q 026042 66 LKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDN 141 (244)
Q Consensus 66 ikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~ 141 (244)
|||+||+++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||+||++|||++| ..||.+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997543322 23456799999999999999999999999999999999986 568887
Q ss_pred CCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 142 MTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.+.................+..+++++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 766555555556677778888999999999999999999999999999999987653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-45 Score=292.27 Aligned_cols=197 Identities=36% Similarity=0.643 Sum_probs=163.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+ +..++||||+++|+|..++.......+++.+++.++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 75 v~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~k 153 (285)
T d1fmka3 75 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCK 153 (285)
T ss_dssp CCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred eEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEE
Confidence 689999965 4578999999999999998765444699999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCC-CCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALT-PFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++...... ......+++.|+|||.+..+.++.++||||||+++|||++|.. |+......+....+ .....
T Consensus 154 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-~~~~~ 232 (285)
T d1fmka3 154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYR 232 (285)
T ss_dssp ECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCC
T ss_pred EcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-HhcCC
Confidence 99999997653322 2334568999999999999999999999999999999999544 55555555554444 44556
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
.+.+..+++++.+++.+||+.||++||++++++++|+.+...
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 678889999999999999999999999999999999886654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=300.67 Aligned_cols=191 Identities=23% Similarity=0.372 Sum_probs=160.0
Q ss_pred CcEEEEeec----CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-
Q 026042 1 MQFVAACKK----PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE- 75 (244)
Q Consensus 1 v~~~~~~~~----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~- 75 (244)
|+++++|.+ +..+|+|||||+||+|.+++.+.+...+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 68 v~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~ 147 (335)
T d2ozaa1 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 147 (335)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred CeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc
Confidence 678888865 577899999999999999998876667999999999999999999999999999999999999986
Q ss_pred --CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 76 --DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 76 --~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.+.+||+|||++.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 148 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~ 227 (335)
T d2ozaa1 148 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227 (335)
T ss_dssp STTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred cccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence 457999999999877666666778899999999999999999999999999999999999999976654333322222
Q ss_pred hCC--CCCCC----CCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNA--RPPVP----PTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~--~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
... ....+ ..+++++.+||.+||+.||.+|||+.|+++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 11222 247889999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=290.49 Aligned_cols=197 Identities=30% Similarity=0.605 Sum_probs=175.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|+++++|.+++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++|++||||
T Consensus 82 v~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp CCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 689999999999999999999999999997653 235899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCC
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNM 142 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 142 (244)
||+||+++.++.+||+|||++........ .....+++.|+|||.+.++.++.++||||||+++|+|++ |..||.+.
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 99999999999999999999976544332 334668999999999999999999999999999999998 79999988
Q ss_pred CHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 143 TPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
+..+....+ ........+..+++++.+||.+||+.||++|||+.|+++.|+++..
T Consensus 242 ~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PVEELFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHHHHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 877665544 4566677888999999999999999999999999999999988754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.1e-44 Score=292.63 Aligned_cols=185 Identities=26% Similarity=0.468 Sum_probs=167.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||++||+|..++.... .+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 67 v~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEE
T ss_pred hheeeeEeeCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEE
Confidence 689999999999999999999999999998876 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+... ....
T Consensus 145 L~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~ 220 (316)
T d1fota_ 145 ITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRF 220 (316)
T ss_dssp ECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCC
T ss_pred EecCccceEecc--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCC
Confidence 999999976543 334578999999999999999999999999999999999999999998888777666544 3456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
+..+++++.+++.+||+.||.+|+ |++++++
T Consensus 221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 778999999999999999999996 8999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=295.42 Aligned_cols=187 Identities=28% Similarity=0.476 Sum_probs=168.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..||||||++||+|.++++... .+++..++.++.||+.||+|||++|++||||||+|||++.+|.+|
T Consensus 66 v~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~k 143 (320)
T d1xjda_ 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIK 143 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred EEEEEEEccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCcee
Confidence 689999999999999999999999999998876 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPP 159 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 159 (244)
|+|||++..... ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+... ...
T Consensus 144 l~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~ 221 (320)
T d1xjda_ 144 IADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPF 221 (320)
T ss_dssp ECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCC
T ss_pred ccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCC
Confidence 999999975443 23344567999999999999999999999999999999999999999998888777666543 456
Q ss_pred CCCCchHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 026042 160 VPPTCPKAFSYLISRCWSSSPDRRPHFD-QIVS 191 (244)
Q Consensus 160 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-el~~ 191 (244)
.+..+++++.+||.+||+.||.+||++. ++++
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 7788999999999999999999999995 7765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-44 Score=294.08 Aligned_cols=185 Identities=24% Similarity=0.361 Sum_probs=167.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++......++|+||+.||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+|
T Consensus 104 v~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEE
T ss_pred eecccccccccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEE
Confidence 689999999999999999999999999998876 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARPPV 160 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 160 (244)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+... ....
T Consensus 182 L~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~ 257 (350)
T d1rdqe_ 182 VTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRF 257 (350)
T ss_dssp ECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCC
T ss_pred eeeceeeeeccc--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCC
Confidence 999999976543 234567999999999999999999999999999999999999999998887776666544 3456
Q ss_pred CCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 161 PPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 161 ~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
+..+++++.++|++||+.||.+|+ +++++++
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 778999999999999999999994 8999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-44 Score=298.67 Aligned_cols=188 Identities=23% Similarity=0.353 Sum_probs=162.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++.+|+||||++||+|.+++.+.. .+++..++.++.||+.||.|||++|++||||||+|||++.+|.+|
T Consensus 70 v~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEE
T ss_pred EEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEE
Confidence 678999999999999999999999999998876 588999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-HhhCCCC
Q 026042 81 VADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAV-CQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~ 158 (244)
|+|||+++..... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+........ .......
T Consensus 148 l~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~ 226 (364)
T d1omwa3 148 ISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226 (364)
T ss_dssp ECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC
T ss_pred EeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 9999999765443 3455679999999999864 56899999999999999999999999875543322222 2234445
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPH-----FDQIVS 191 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~el~~ 191 (244)
..+..+++++.+||.+||+.||.+||| ++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 667789999999999999999999999 688886
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=288.94 Aligned_cols=195 Identities=30% Similarity=0.622 Sum_probs=161.3
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+ +..|+||||+++|+|.+++..... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 71 v~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~K 148 (273)
T d1mp8a_ 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVK 148 (273)
T ss_dssp CCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTT-TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEE
T ss_pred eeEEEEEec-CeEEEEEEeccCCcHHhhhhccCC-CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEE
Confidence 689999964 678999999999999999876543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC--CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCC
Q 026042 81 VADFGISCLESQCG--SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 81 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ....
T Consensus 149 l~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~ 227 (273)
T d1mp8a_ 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGER 227 (273)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCC
T ss_pred EccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 99999997654322 2334567899999999999999999999999999999998 899999888877666554 4455
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
.+.+..+|+.+.+||.+||+.||++|||++|+++.|+.+.+
T Consensus 228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 67788999999999999999999999999999999987654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=288.15 Aligned_cols=194 Identities=28% Similarity=0.547 Sum_probs=170.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.++ ..++|+||+++++|.+++..+.+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+|
T Consensus 74 v~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vk 151 (273)
T d1u46a_ 74 IRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151 (273)
T ss_dssp CCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEE
T ss_pred EEEEEEEeec-chheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccccee
Confidence 6899999764 67899999999999998876543 589999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhC
Q 026042 81 VADFGISCLESQCG----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 81 l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 155 (244)
|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+....
T Consensus 152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~ 231 (273)
T d1u46a_ 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231 (273)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCC
Confidence 99999987643322 2234457889999999999999999999999999999998 899999999998888777777
Q ss_pred CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 026042 156 ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGY 196 (244)
Q Consensus 156 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~ 196 (244)
...+.+..+|+++.+++.+||+.||++|||+.++++.|+..
T Consensus 232 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 77788889999999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-44 Score=290.30 Aligned_cols=198 Identities=31% Similarity=0.548 Sum_probs=174.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDL 66 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~di 66 (244)
|+++++|.+++..++||||++||+|.+++++.. ...+++..+..++.|++.||.|||++|++||||
T Consensus 74 v~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDl 153 (309)
T d1fvra_ 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 153 (309)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccccc
Confidence 689999999999999999999999999997542 346899999999999999999999999999999
Q ss_pred CCCcEEEcCCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCHH
Q 026042 67 KSENLLLGEDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPE 145 (244)
Q Consensus 67 kp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~ 145 (244)
||+||+++.++.+||+|||++.............++..|+|||.+.+..++.++||||||+++|||++| ..||.+.+..
T Consensus 154 kp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~ 233 (309)
T d1fvra_ 154 AARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233 (309)
T ss_dssp SGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999999876665556667799999999999999999999999999999999996 4678888877
Q ss_pred HHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 146 QAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
+....+. .......+..+++++.+||.+||+.||++|||++|+++.|+++.+.
T Consensus 234 ~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 234 ELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 7665544 4556777889999999999999999999999999999999987653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=286.11 Aligned_cols=195 Identities=32% Similarity=0.580 Sum_probs=164.2
Q ss_pred CcEEEEee-cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACK-KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|+++++|. ..+.+|+||||+++|+|.+++.+.....+++..+++++.|++.||.|||+++++||||||+||+++.+|.+
T Consensus 63 v~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~ 142 (262)
T d1byga_ 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 142 (262)
T ss_dssp CCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred eeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCE
Confidence 68999885 45678999999999999999977654458999999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 80 KVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 80 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
||+|||++..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+. ....+
T Consensus 143 kl~dfg~s~~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~ 219 (262)
T d1byga_ 143 KVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKM 219 (262)
T ss_dssp EECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCC
T ss_pred eecccccceecCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 9999999876443 2334567889999999998999999999999999999998 799998887777666553 45667
Q ss_pred CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 159 PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 159 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
+.+..+++++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 7888899999999999999999999999999999988754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=292.36 Aligned_cols=194 Identities=15% Similarity=0.246 Sum_probs=170.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC--Cc
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED--MC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~--~~ 78 (244)
|++++++.+++.+|||||||+||+|.+++.+.+. .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.
T Consensus 64 v~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~-~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ 142 (321)
T d1tkia_ 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSST 142 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCC
T ss_pred CeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceE
Confidence 6899999999999999999999999999987543 58999999999999999999999999999999999999854 47
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
+||+|||++.............+++.|+|||...+..++.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus 143 ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (321)
T d1tkia_ 143 IKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222 (321)
T ss_dssp EEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred EEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 99999999977655444556678999999999999999999999999999999999999999988888777766544332
Q ss_pred C--CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 026042 159 P--VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS--ILEG 195 (244)
Q Consensus 159 ~--~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~--~l~~ 195 (244)
+ ....+++++.+||.+||+.||.+|||++|+++ +++.
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 2 22468899999999999999999999999998 4543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-43 Score=284.92 Aligned_cols=194 Identities=23% Similarity=0.435 Sum_probs=161.2
Q ss_pred CcEEEEeecCC----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~ 76 (244)
|++++++...+ ..|+||||++|++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.+
T Consensus 70 v~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~ 147 (277)
T d1o6ya_ 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT 147 (277)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT
T ss_pred CcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc
Confidence 57888887654 3899999999999999998876 58999999999999999999999999999999999999999
Q ss_pred CcEEEecCCCccccccc----CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 026042 77 MCVKVADFGISCLESQC----GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC 152 (244)
Q Consensus 77 ~~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 152 (244)
+..+++|||.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+......
T Consensus 148 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~ 227 (277)
T d1o6ya_ 148 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227 (277)
T ss_dssp SCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 99999999987543222 23345679999999999999999999999999999999999999999988887776665
Q ss_pred hhCCCC--CCCCCchHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhh
Q 026042 153 QKNARP--PVPPTCPKAFSYLISRCWSSSPDRRP-HFDQIVSILEGY 196 (244)
Q Consensus 153 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~el~~~l~~~ 196 (244)
...... .....+|+++.++|.+||+.||.+|| |++++++.|.++
T Consensus 228 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred hcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 544433 23467899999999999999999999 899999988765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-43 Score=286.39 Aligned_cols=198 Identities=29% Similarity=0.549 Sum_probs=174.5
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccC
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEP----------------YSVPLNLVLKLALDIARGMQYLHSQGILHR 64 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~----------------~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~ 64 (244)
|+++++|..++..++||||+++|+|.+++++... ..+++..+..++.||+.||+|||++|++||
T Consensus 90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHr 169 (311)
T d1t46a_ 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (311)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 6899999999999999999999999999976432 258889999999999999999999999999
Q ss_pred CCCCCcEEEcCCCcEEEecCCCcccccccC---CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCC
Q 026042 65 DLKSENLLLGEDMCVKVADFGISCLESQCG---SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFD 140 (244)
Q Consensus 65 dikp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~ 140 (244)
||||+||+++.++.++++|||.++...... ......|++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987654322 2334568999999999999999999999999999999998 677777
Q ss_pred CCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 141 NMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+.......+.........+..+++.+.+||.+||+.||.+|||+++++++|++...
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 7776666666666777788888999999999999999999999999999999987654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-43 Score=283.94 Aligned_cols=196 Identities=33% Similarity=0.610 Sum_probs=169.4
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE----------------------PYSVPLNLVLKLALDIARGMQYLHS 58 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----------------------~~~~~~~~~~~~~~~l~~~L~~lH~ 58 (244)
|+++++|..++..++|+||+++|+|.+++.... ...+++..++.++.|++.||+|||+
T Consensus 79 v~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~ 158 (301)
T d1lufa_ 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158 (301)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence 578999999999999999999999999997533 2247888999999999999999999
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccccccc---CCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCLESQC---GSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA 135 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 135 (244)
+|++||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|||++|
T Consensus 159 ~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 159 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 99999999999999999999999999998644322 223355688999999999999999999999999999999998
Q ss_pred C-CCCCCCCHHHHHHHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 136 L-TPFDNMTPEQAAFAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 136 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
. .||.+.+..+....+. ....+..+..+++++.+|+.+||+.+|.+|||+.|++++|+++.
T Consensus 239 ~~~p~~~~~~~e~~~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5 6888888887776654 44456778889999999999999999999999999999998763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=285.59 Aligned_cols=195 Identities=28% Similarity=0.597 Sum_probs=166.6
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|+++++|.+++ .++++||+.+++|.+++..... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 74 v~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~k 151 (317)
T d1xkka_ 74 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVK 151 (317)
T ss_dssp CCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEE
T ss_pred eeEEEEEecCC-eeEEEEeccCCccccccccccc-CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeE
Confidence 68999998764 5678888989999999887543 689999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHHHHhhCC
Q 026042 81 VADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLT-ALTPFDNMTPEQAAFAVCQKNA 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 156 (244)
|+|||++........ .....||+.|+|||.+.++.++.++||||||+++|||++ |..||.+.+..+....+ ....
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i-~~~~ 230 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGE 230 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-HHTC
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCC
Confidence 999999876433222 233468999999999999999999999999999999998 89999988776654444 4556
Q ss_pred CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 026042 157 RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSE 198 (244)
Q Consensus 157 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~ 198 (244)
..+.+..+++.+.+++.+||+.||.+|||+.|+++.|..+..
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 677788999999999999999999999999999999887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=282.11 Aligned_cols=189 Identities=21% Similarity=0.252 Sum_probs=158.7
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..|+||||+.++++..+..... .+++..+..++.||+.||+|||++|++||||||+||+++.++.+|
T Consensus 63 v~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~K 140 (299)
T d1ua2a_ 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK 140 (299)
T ss_dssp CCEEEEECCTTCCEEEEECCSEEHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eEEEeeeccCCceeehhhhhcchHHhhhhhccc--CCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccc
Confidence 689999999999999999998877666665444 588899999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||++...... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+......+
T Consensus 141 L~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 141 LADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220 (299)
T ss_dssp ECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999999765433 334456799999999988654 57999999999999999999999999888777665554321110
Q ss_pred C--------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P--------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. .....++++.+|+.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 01345789999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=280.62 Aligned_cols=200 Identities=27% Similarity=0.524 Sum_probs=165.6
Q ss_pred CcEEEEeec-CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcE
Q 026042 1 MQFVAACKK-PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCV 79 (244)
Q Consensus 1 v~~~~~~~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~ 79 (244)
|++++++.. ++..++||||+++++|.+++..... ..++..++.++.|++.||.|||+.|++||||||+||++++++.+
T Consensus 91 v~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~ 169 (311)
T d1r0pa_ 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 169 (311)
T ss_dssp CCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE
T ss_pred eEEeEEEEecCCceEEEEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCE
Confidence 678898764 5689999999999999999886543 57788999999999999999999999999999999999999999
Q ss_pred EEecCCCcccccccC-----CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 80 KVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 80 kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
||+|||++....... ......|++.|+|||.+....++.++||||||+++|||++|..||...............
T Consensus 170 kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~ 249 (311)
T d1r0pa_ 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249 (311)
T ss_dssp EECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT
T ss_pred EEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 999999987543322 122346889999999999999999999999999999999977776554333222333334
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
......+..+++.+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus 250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 56677788899999999999999999999999999999998876533
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=277.57 Aligned_cols=180 Identities=24% Similarity=0.443 Sum_probs=155.7
Q ss_pred CcEEEEeecCCcEEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-CCc
Q 026042 1 MQFVAACKKPPVFCIITEYLAG-GSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE-DMC 78 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~-~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~-~~~ 78 (244)
|++++++.+++..|+||||+.+ +++.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++. ++.
T Consensus 72 v~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE
T ss_pred cEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCe
Confidence 6899999999999999999975 68889988766 6899999999999999999999999999999999999985 579
Q ss_pred EEEecCCCcccccccCCCCCCCcccceeccceeccCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCC
Q 026042 79 VKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRH-TKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNAR 157 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 157 (244)
+||+|||++..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+ . + ....
T Consensus 150 vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i--~~~~ 220 (273)
T d1xwsa_ 150 LKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----I--IRGQ 220 (273)
T ss_dssp EEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----H--HHCC
T ss_pred EEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----H--hhcc
Confidence 99999999975443 23456789999999999877654 678999999999999999999997632 1 1 1223
Q ss_pred CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 158 PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 158 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
...+..+|+++.+||.+||+.||.+|||++|+++
T Consensus 221 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 4567789999999999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=275.62 Aligned_cols=190 Identities=19% Similarity=0.305 Sum_probs=159.8
Q ss_pred CcEEEEee-----cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACK-----KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|+++++|. .....++++||+.++++..... .....+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~ 151 (305)
T d1blxa_ 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151 (305)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred ceeeeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC
Confidence 57888874 4467899999997755544443 34447899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKN 155 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 155 (244)
+|.+||+|||++.............||+.|+|||++.+.+++.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 152 SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp TCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999999877666566677889999999999999999999999999999999999999999988777665553321
Q ss_pred CC-------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 156 AR-------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 156 ~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.. ......+++.+.+|+.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11 0123457889999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=275.77 Aligned_cols=196 Identities=30% Similarity=0.539 Sum_probs=171.1
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQE--------PYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--------~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
|+++++|..++..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence 689999999999999999999999999986432 124688999999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCcccccccCC---CCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHH
Q 026042 73 LGEDMCVKVADFGISCLESQCGS---AKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTA-LTPFDNMTPEQAA 148 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~ 148 (244)
++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+..
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999975443222 3344689999999999999999999999999999999997 5889888888877
Q ss_pred HHHHhhCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 149 FAVCQKNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
..+. .......+..+++.+.+++.+||+.+|++|||++++++.|+...
T Consensus 246 ~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 246 RFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 6654 44556777889999999999999999999999999999998653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=272.55 Aligned_cols=190 Identities=23% Similarity=0.403 Sum_probs=158.9
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+++..|+||||+. +++.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.+|
T Consensus 64 v~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 64 VKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp CCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred EEeccccccccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcce
Confidence 689999999999999999995 5777776655555799999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc-cCCCCCCCcccceeccceeccCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQ-CGSAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||.+..... ........|++.|+|||...... .+.++||||+||++|+|++|+.||.+.+..+....+......+
T Consensus 143 l~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 143 LADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222 (298)
T ss_dssp ECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999999876543 23445567999999999876655 5889999999999999999999999888776655543321110
Q ss_pred C---------------------------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 P---------------------------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. ....+++++.+|+++||+.||.+|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 01245688999999999999999999999987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-40 Score=267.00 Aligned_cols=199 Identities=19% Similarity=0.282 Sum_probs=164.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC-----
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE----- 75 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~----- 75 (244)
+.+++++..+...++||||+ +++|.+++..... .++...+..++.|++.||+|||++|++||||||+||+++.
T Consensus 64 ~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~ 141 (293)
T d1csna_ 64 PNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKN 141 (293)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTT
T ss_pred CEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccccc
Confidence 46889999999999999999 7899999977553 6899999999999999999999999999999999999974
Q ss_pred CCcEEEecCCCcccccccC--------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---
Q 026042 76 DMCVKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTP--- 144 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--- 144 (244)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+...
T Consensus 142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~ 221 (293)
T d1csna_ 142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221 (293)
T ss_dssp TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred CCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence 5689999999997643321 23356799999999999999999999999999999999999999975432
Q ss_pred HHHHHHHHh---hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhcc
Q 026042 145 EQAAFAVCQ---KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSESLE 201 (244)
Q Consensus 145 ~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~~~ 201 (244)
......+.. ..........+|+++.+++..|+..+|++||+++.+.+.|+.+.....
T Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 222222211 111222346788999999999999999999999999999988766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=269.73 Aligned_cols=196 Identities=29% Similarity=0.521 Sum_probs=154.6
Q ss_pred CcEEEEeecCC----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccCCCCC
Q 026042 1 MQFVAACKKPP----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS--------QGILHRDLKS 68 (244)
Q Consensus 1 v~~~~~~~~~~----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~--------~~i~H~dikp 68 (244)
|+++++|.+.+ .+|+||||+++|+|.+++++. .+++..++.++.|++.||.|+|+ +||+||||||
T Consensus 60 v~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp 136 (303)
T d1vjya_ 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 136 (303)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCG
T ss_pred cceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCc
Confidence 67899997654 689999999999999999875 48899999999999999999996 5999999999
Q ss_pred CcEEEcCCCcEEEecCCCcccccccC-----CCCCCCcccceeccceeccCC------CCCccchhhhHHHHHHHHhCCC
Q 026042 69 ENLLLGEDMCVKVADFGISCLESQCG-----SAKGFTGTYRWMAPEMIKEKR------HTKKVDVYSFGIVLWELLTALT 137 (244)
Q Consensus 69 ~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~ 137 (244)
+||+++.+|.+||+|||++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|..
T Consensus 137 ~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~ 216 (303)
T d1vjya_ 137 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216 (303)
T ss_dssp GGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBC
T ss_pred cceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCC
Confidence 99999999999999999987543322 234567999999999986643 4678999999999999999987
Q ss_pred CCCCC---------------CHHHHHHHHHhhCCCCCCCCC-----chHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 026042 138 PFDNM---------------TPEQAAFAVCQKNARPPVPPT-----CPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYS 197 (244)
Q Consensus 138 p~~~~---------------~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~ 197 (244)
|+... ..............++..+.. .+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 66321 222222233223333333332 2356899999999999999999999999999876
Q ss_pred hh
Q 026042 198 ES 199 (244)
Q Consensus 198 ~~ 199 (244)
..
T Consensus 297 ~~ 298 (303)
T d1vjya_ 297 QQ 298 (303)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-40 Score=266.62 Aligned_cols=196 Identities=21% Similarity=0.316 Sum_probs=157.6
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC---CCc
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE---DMC 78 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~---~~~ 78 (244)
.+..++..++..++||||+ +++|.+.+..... .+++..+..++.|++.||+|||++||+||||||+||+++. +..
T Consensus 67 ~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~ 144 (299)
T d1ckia_ 67 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144 (299)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC
T ss_pred EEEEEEecCCEEEEEEEEc-CCchhhhhhhccC-CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCce
Confidence 3566778999999999999 6688877765443 6899999999999999999999999999999999999864 457
Q ss_pred EEEecCCCcccccccC--------CCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 79 VKVADFGISCLESQCG--------SAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 79 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++|+|||++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...........
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp EEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred eeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 9999999997654322 23456799999999999999999999999999999999999999987655433222
Q ss_pred HHh------hCCCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 026042 151 VCQ------KNARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVSILEGYSES 199 (244)
Q Consensus 151 ~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~~l~~~~~~ 199 (244)
... ..........+|+++.+++.+||+.+|.+||+++++.+.|+.+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 225 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 111 1122234467899999999999999999999999999999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=269.51 Aligned_cols=185 Identities=22% Similarity=0.408 Sum_probs=154.7
Q ss_pred CcEEEEeecCC------cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACKKPP------VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~~~~------~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|+++++|...+ .+|+||||+ +.+|..+++.. .+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 80 v~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~ 155 (346)
T d1cm8a_ 80 IGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 155 (346)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred eEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc
Confidence 57788887665 579999999 77888887654 489999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQ 153 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 153 (244)
.++.+|++|||++..... ......+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..........
T Consensus 156 ~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 156 EDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp TTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 999999999999976543 3345679999999999866 4578999999999999999999999998876655443322
Q ss_pred hCCC-----------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 KNAR-----------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... .......++.+.+||.+||..||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111 1123456889999999999999999999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.9e-40 Score=265.19 Aligned_cols=189 Identities=18% Similarity=0.271 Sum_probs=154.2
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++..++..++++||+.++.+..+..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 63 v~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~k 140 (286)
T d1ob3a_ 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140 (286)
T ss_dssp CCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred EeeeeecccCCceeEEEEeehhhhHHHHHhhcC--CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEE
Confidence 689999999999999999997766666655444 699999999999999999999999999999999999999999999
Q ss_pred EecCCCccccccc-CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCCC
Q 026042 81 VADFGISCLESQC-GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQKNARP 158 (244)
Q Consensus 81 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 158 (244)
|+|||.+...... .......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+......+
T Consensus 141 l~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~ 220 (286)
T d1ob3a_ 141 IADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220 (286)
T ss_dssp ECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9999998764432 234455689999999998654 56899999999999999999999999888776655543211110
Q ss_pred ---------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 159 ---------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 159 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.....+++.+.+|+++||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123456789999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-39 Score=268.35 Aligned_cols=190 Identities=23% Similarity=0.314 Sum_probs=153.6
Q ss_pred CcEEEEee------cCCcEEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACK------KPPVFCIITEYLAGGSLRKYLHQ--QEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~------~~~~~~lv~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
|+++++|. ...++||||||+++ ++.+.+.. .....+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 76 v~~~~~~~~~~~~~~~~~~~lv~Ey~~~-~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NIL 154 (350)
T d1q5ka_ 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154 (350)
T ss_dssp CCEEEEEEEC--CCSCCEEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CcEEEEEEecCccCCceEEEEEEeccCC-ccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEE
Confidence 56788874 33457999999965 44444432 23346999999999999999999999999999999999999
Q ss_pred EcCCC-cEEEecCCCcccccccCCCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 73 LGEDM-CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 73 ~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
++.++ .+||+|||++.............|+..|+|||.+.+ ..++.++||||+||++|+|++|..||...+..+....
T Consensus 155 l~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~ 234 (350)
T d1q5ka_ 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234 (350)
T ss_dssp ECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred EecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH
Confidence 99875 899999999987666566667789999999998765 4689999999999999999999999998877665544
Q ss_pred HHhhCCC---------------------------CCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNAR---------------------------PPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
+...... .......++++.+|+.+||..||.+|||+.|+++
T Consensus 235 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4321000 0112456889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-40 Score=266.96 Aligned_cols=189 Identities=30% Similarity=0.456 Sum_probs=159.0
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++.+....++++||+.+++|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.+|.+|
T Consensus 92 v~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 92 VTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEeeeeeccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEE
Confidence 578999999999999999999999999998877 578899999999999999999999999999999999999999999
Q ss_pred EecCCCcccccc--cCCCCCCCcccceeccceeccC--CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hh
Q 026042 81 VADFGISCLESQ--CGSAKGFTGTYRWMAPEMIKEK--RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVC--QK 154 (244)
Q Consensus 81 l~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~ 154 (244)
|+|||++..... ........|++.|++||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+. ..
T Consensus 170 L~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~ 249 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249 (322)
T ss_dssp ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred EeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc
Confidence 999999865432 2234456789999999998764 46889999999999999999999997654333322222 22
Q ss_pred CCCCCCCCCchHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 026042 155 NARPPVPPTCPKAFSYLISRCWSSSPDRRP-----HFDQIVS 191 (244)
Q Consensus 155 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~el~~ 191 (244)
......+..+++++.+|+.+||+.||.+|| |++|+++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 334566778999999999999999999999 4788875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=265.52 Aligned_cols=187 Identities=26% Similarity=0.405 Sum_probs=149.9
Q ss_pred CcEEEEeecCC-----cEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKPP-----VFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++.... .+|++++ +.|++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.
T Consensus 69 v~~~~~~~~~~~~~~~~~~l~~~-~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 69 IGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144 (345)
T ss_dssp CCCCEEECCSSTTTCCCEEEEEE-CCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CcEEEEEeeccccccceEEEEEe-ecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC
Confidence 46777776543 3555554 5599999999764 4899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccC----CCCCCCcccceeccceecc-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Q 026042 76 DMCVKVADFGISCLESQCG----SAKGFTGTYRWMAPEMIKE-KRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFA 150 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 150 (244)
+|.+||+|||++....... ......|++.|+|||.+.. ..++.++||||+||++|+|++|..||.+.+..+....
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~ 224 (345)
T d1pmea_ 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224 (345)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999986543322 2345678999999999844 4678999999999999999999999988776554443
Q ss_pred HHhhCCCC-----------------------------CCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 151 VCQKNARP-----------------------------PVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 151 ~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
........ ...+.+++++.+|+.+||+.||.+|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 32211110 112456788999999999999999999999987
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-38 Score=255.35 Aligned_cols=189 Identities=19% Similarity=0.277 Sum_probs=147.3
Q ss_pred CcEEEEeec--------CCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEE
Q 026042 1 MQFVAACKK--------PPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLL 72 (244)
Q Consensus 1 v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil 72 (244)
+++++++.. ++..|+||||+.++++..+..... .+++..++.++.|++.||.|||++||+||||||+||+
T Consensus 72 i~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~--~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NIL 149 (318)
T d3blha1 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL 149 (318)
T ss_dssp CCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cceEeeeecccccccccCceEEEEEeccCCCccchhhhccc--ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchhee
Confidence 355666544 567899999997655554433333 6889999999999999999999999999999999999
Q ss_pred EcCCCcEEEecCCCccccccc-----CCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHH
Q 026042 73 LGEDMCVKVADFGISCLESQC-----GSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ 146 (244)
Q Consensus 73 ~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 146 (244)
++.++.+||+|||++...... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+...
T Consensus 150 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~ 229 (318)
T d3blha1 150 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229 (318)
T ss_dssp ECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence 999999999999998654321 223445799999999998765 68999999999999999999999999887766
Q ss_pred HHHHHHhhCCCCC--CCC----------------------------CchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 147 AAFAVCQKNARPP--VPP----------------------------TCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 147 ~~~~~~~~~~~~~--~~~----------------------------~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
....+........ ... ..++.+.+||.+||+.||++|||++|+++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 6554433221111 000 02457788999999999999999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=251.04 Aligned_cols=189 Identities=17% Similarity=0.247 Sum_probs=155.8
Q ss_pred CcEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEE
Q 026042 1 MQFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVK 80 (244)
Q Consensus 1 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~k 80 (244)
|++++++......++++|++.+++|..++...+ .+++..++.++.|++.||+|||++||+||||||+||+++.++.+|
T Consensus 64 v~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp CCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred EeeccccccccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCcee
Confidence 678999999999999999999999888887665 688999999999999999999999999999999999999999999
Q ss_pred EecCCCcccccccC-CCCCCCcccceeccceeccCC-CCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhCC-
Q 026042 81 VADFGISCLESQCG-SAKGFTGTYRWMAPEMIKEKR-HTKKVDVYSFGIVLWELLTALTPFD-NMTPEQAAFAVCQKNA- 156 (244)
Q Consensus 81 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~- 156 (244)
|+|||.+....... ......++..|+|||.+.+.. ++.++||||+||++|+|++|..||. +.+..+....+.....
T Consensus 142 l~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 142 LANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221 (292)
T ss_dssp ECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCC
Confidence 99999997654433 344556788899999887654 6899999999999999999999864 4444444433322111
Q ss_pred --------------------------CCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 157 --------------------------RPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 157 --------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.......+++.+.+|+.+||+.||.+|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122456789999999999999999999999987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-38 Score=257.98 Aligned_cols=186 Identities=14% Similarity=0.239 Sum_probs=150.5
Q ss_pred CcEEEEee--cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCC-
Q 026042 1 MQFVAACK--KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDM- 77 (244)
Q Consensus 1 v~~~~~~~--~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~- 77 (244)
|++++++. .....++||||+.+++|..+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 93 v~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~ 167 (328)
T d3bqca1 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR 167 (328)
T ss_dssp CCEEEEEECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred cEEEEEEEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC
Confidence 57888887 4467999999999999976632 589999999999999999999999999999999999998755
Q ss_pred cEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHh--
Q 026042 78 CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQA-AFAVCQ-- 153 (244)
Q Consensus 78 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~-- 153 (244)
.+||+|||++.............+|+.|+|||.+.+. .++.++||||+||++++|++|..||........ ...+..
T Consensus 168 ~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 168 KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred eeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 6999999999877665666777899999999998765 479999999999999999999999976543221 111100
Q ss_pred ----------h-C----------------------CCCCCCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 154 ----------K-N----------------------ARPPVPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 154 ----------~-~----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
. . ........+++++.+||++||..||.+|||++|+++
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 000111336789999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=257.32 Aligned_cols=186 Identities=25% Similarity=0.348 Sum_probs=147.8
Q ss_pred CcEEEEeecC-----CcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcC
Q 026042 1 MQFVAACKKP-----PVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGE 75 (244)
Q Consensus 1 v~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~ 75 (244)
|++++++... ...+++++|+.||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 80 v~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156 (348)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred eeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc
Confidence 4667777533 2335556667799999999654 4899999999999999999999999999999999999999
Q ss_pred CCcEEEecCCCcccccccCCCCCCCcccceeccceeccC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 76 DMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEK-RHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 76 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
+|.+|++|||.+..... ......|++.|+|||...+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 157 ~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~ 234 (348)
T d2gfsa1 157 DCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234 (348)
T ss_dssp TCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cccccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999865443 34456789999999987665 5689999999999999999999999988776655544332
Q ss_pred CCCC---------------------C--------CCCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP---------------------P--------VPPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~---------------------~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... . .....++++.+||.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 2111 0 11356789999999999999999999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-37 Score=256.91 Aligned_cols=186 Identities=20% Similarity=0.293 Sum_probs=142.4
Q ss_pred CcEEEEee------cCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEc
Q 026042 1 MQFVAACK------KPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLG 74 (244)
Q Consensus 1 v~~~~~~~------~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~ 74 (244)
|+++++|. ...+.|+||||+.+ ++.+.+.. .+++..++.++.|++.||.|||++||+||||||+||+++
T Consensus 79 v~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~ 153 (355)
T d2b1pa1 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153 (355)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecccccccCceeEEEEeccch-HHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc
Confidence 56778885 44788999999965 55555532 578999999999999999999999999999999999999
Q ss_pred CCCcEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhh
Q 026042 75 EDMCVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQAAFAVCQK 154 (244)
Q Consensus 75 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 154 (244)
.++.++++|||++.............+|+.|+|||++.+..++.++||||+||++++|++|+.||.+.+.......+...
T Consensus 154 ~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~ 233 (355)
T d2b1pa1 154 SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233 (355)
T ss_dssp TTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999988776666666778999999999999999999999999999999999999999887766554433221
Q ss_pred CCCC---------------------C-------------C------CCCchHHHHHHHHHhcccCCCCCCCHHHHHH
Q 026042 155 NARP---------------------P-------------V------PPTCPKAFSYLISRCWSSSPDRRPHFDQIVS 191 (244)
Q Consensus 155 ~~~~---------------------~-------------~------~~~~~~~l~~li~~~l~~~p~~Rps~~el~~ 191 (244)
.... . . ....++++.+|+++||..||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1110 0 0 0113567899999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.1e-32 Score=228.40 Aligned_cols=189 Identities=20% Similarity=0.331 Sum_probs=139.0
Q ss_pred CcEEEEeec--CCcEEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCccCCCCCCcEEEcCC
Q 026042 1 MQFVAACKK--PPVFCIITEYLAGG-SLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS-QGILHRDLKSENLLLGED 76 (244)
Q Consensus 1 v~~~~~~~~--~~~~~lv~e~~~~~-~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~nil~~~~ 76 (244)
|++++++.. ....+++++++..+ +............+++..++.++.|++.||.|||+ .||+||||||+||+++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 456666643 34555666655443 44444455555578999999999999999999998 899999999999999875
Q ss_pred C------cEEEecCCCcccccccCCCCCCCcccceeccceeccCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH----
Q 026042 77 M------CVKVADFGISCLESQCGSAKGFTGTYRWMAPEMIKEKRHTKKVDVYSFGIVLWELLTALTPFDNMTPEQ---- 146 (244)
Q Consensus 77 ~------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 146 (244)
+ .++++|||.+..... ......|++.|+|||++.+..++.++|+||+||++++|++|+.||.......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 5 399999999875443 3456679999999999999999999999999999999999999997543211
Q ss_pred --HHHHHHhh-C------------------------C---------------CCCCCCCchHHHHHHHHHhcccCCCCCC
Q 026042 147 --AAFAVCQK-N------------------------A---------------RPPVPPTCPKAFSYLISRCWSSSPDRRP 184 (244)
Q Consensus 147 --~~~~~~~~-~------------------------~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp 184 (244)
........ . . ........++++.+|+.+||..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 11111000 0 0 0011223467899999999999999999
Q ss_pred CHHHHHH
Q 026042 185 HFDQIVS 191 (244)
Q Consensus 185 s~~el~~ 191 (244)
|++|+++
T Consensus 321 ta~e~L~ 327 (362)
T d1q8ya_ 321 DAGGLVN 327 (362)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.64 E-value=6.2e-18 Score=126.76 Aligned_cols=99 Identities=18% Similarity=0.184 Sum_probs=71.0
Q ss_pred EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCCccCCCCCCcEEEcCCCcEEEecCCCccccccc
Q 026042 14 CIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHSQGILHRDLKSENLLLGEDMCVKVADFGISCLESQC 93 (244)
Q Consensus 14 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~nil~~~~~~~kl~dfg~~~~~~~~ 93 (244)
+++|||+++..+.+ ++...+..++.|++.+|.+||++|++||||||+||++++++ ++|+|||.+......
T Consensus 86 ~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~~~~~~ 155 (191)
T d1zara2 86 AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEE 155 (191)
T ss_dssp EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCEETTST
T ss_pred EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcccCCCC
Confidence 69999998755432 34455678899999999999999999999999999998654 899999998654322
Q ss_pred CCCCCCCcccceeccc-----eeccCCCCCccchhhhHHHH
Q 026042 94 GSAKGFTGTYRWMAPE-----MIKEKRHTKKVDVYSFGIVL 129 (244)
Q Consensus 94 ~~~~~~~~~~~y~aPE-----~~~~~~~~~~~Di~slG~~l 129 (244)
.. ..|.... .+-.+.++.++|+||+.--+
T Consensus 156 ~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 156 GW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred Cc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 11 1111110 01134578889999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.82 E-value=2.2e-05 Score=59.75 Aligned_cols=81 Identities=15% Similarity=0.128 Sum_probs=54.5
Q ss_pred cEEEEeecCCcEEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------
Q 026042 2 QFVAACKKPPVFCIITEYLAGGSLRKYLHQQEPYSVPLNLVLKLALDIARGMQYLHS----------------------- 58 (244)
Q Consensus 2 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~L~~lH~----------------------- 58 (244)
+++.++..++..++||++++|.++.+...... . ...++.++...+..||+
T Consensus 74 ~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T d1j7la_ 74 KVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp CEEEEEEETTEEEEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred cEEEEEecCCceEEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence 46788888999999999999988765432211 1 11223333333333432
Q ss_pred ------------------------------C------CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 ------------------------------Q------GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ------------------------------~------~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
. .++|+|+.|.||++++++...|+||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 278999999999998776667999987643
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.39 E-value=9.9e-05 Score=55.69 Aligned_cols=28 Identities=18% Similarity=0.181 Sum_probs=24.5
Q ss_pred CccCCCCCCcEEEcCCCcEEEecCCCcc
Q 026042 61 ILHRDLKSENLLLGEDMCVKVADFGISC 88 (244)
Q Consensus 61 i~H~dikp~nil~~~~~~~kl~dfg~~~ 88 (244)
++|+|+.|.||++++++.+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 7999999999999987667899998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.73 E-value=0.00094 Score=53.80 Aligned_cols=29 Identities=24% Similarity=0.387 Sum_probs=25.1
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.++|||++|.||++++++ ++++||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998765 89999987644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.91 E-value=0.001 Score=51.64 Aligned_cols=31 Identities=29% Similarity=0.525 Sum_probs=27.1
Q ss_pred CCCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 59 QGILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 59 ~~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
.|++|+|+.++||+++.+...-++||+.++.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999887778999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.13 E-value=0.0079 Score=48.14 Aligned_cols=15 Identities=40% Similarity=0.658 Sum_probs=13.3
Q ss_pred CccCCCCCCcEEEcC
Q 026042 61 ILHRDLKSENLLLGE 75 (244)
Q Consensus 61 i~H~dikp~nil~~~ 75 (244)
++|+|+.+.||++.+
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999854
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.47 E-value=0.038 Score=42.74 Aligned_cols=28 Identities=21% Similarity=0.125 Sum_probs=23.1
Q ss_pred CCccCCCCCCcEEEcCCCcEEEecCCCccc
Q 026042 60 GILHRDLKSENLLLGEDMCVKVADFGISCL 89 (244)
Q Consensus 60 ~i~H~dikp~nil~~~~~~~kl~dfg~~~~ 89 (244)
+++|+|+.+.||++++ + ..++||+.++.
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 6899999999999974 3 45899997754
|